data_2la4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2la4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.787 0.327 . . . . 74.5 110.918 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.95 -25.09 27.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 71.129999999999995 111.125 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' VAL . . . . . 0.465 ' CG2' ' HB ' ' A' ' 394' ' ' VAL . 7.9 t -79.96 -29.78 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 72.319999999999993 111.096 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -54.54 -36.88 64.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 73.319999999999993 110.865 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -64.2 -32.24 73.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 74.329999999999998 110.854 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 22.6 mm -60.31 -52.81 56.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 75.200000000000003 111.151 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 4.8 mt -55.48 -41.63 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 75.430000000000007 111.137 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.96 -16.69 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 74.530000000000001 110.856 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.56 23.49 8.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 75.519999999999996 110.878 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -174.96 159.09 2.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.574 0.702 . . . . 71.140000000000001 111.087 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 150.2 68.06 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.67 2.247 . . . . 73.219999999999999 112.365 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -14.23 35.74 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.701 2.267 . . . . 73.420000000000002 112.332 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.43 -63.13 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 73.150000000000006 110.882 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.64 143.83 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 75.230000000000004 111.091 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 386' ' ' HIS . 22.3 p -146.98 68.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 74.430000000000007 111.128 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.461 HG22 ' N ' ' A' ' 343' ' ' ALA . 87.7 m -133.78 139.46 46.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 65.230000000000004 111.116 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.461 ' N ' HG22 ' A' ' 342' ' ' THR . . . -105.78 121.78 44.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 75.200000000000003 111.083 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.602 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -102.93 122.09 43.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 72.310000000000002 110.877 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.58 112.85 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 72.099999999999994 111.149 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -102.23 171.82 21.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.76 -0.734 . . . . 62.229999999999997 112.479 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.416 ' O ' ' CD2' ' A' ' 406' ' ' LEU . 1.4 t30 71.45 46.59 0.41 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.337 . . . . 74.450000000000003 110.917 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.419 HG21 ' N ' ' A' ' 349' ' ' PRO . 86.9 mt -102.77 137.17 19.24 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.622 0.725 . . . . 72.019999999999996 111.147 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . 0.532 ' HB2' ' CD1' ' A' ' 351' ' ' PHE . 53.6 Cg_endo -69.76 163.53 37.94 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.679 2.253 . . . . 73.530000000000001 112.341 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -70.5 -24.05 62.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 70.319999999999993 110.884 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.532 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 29.4 p90 -90.74 29.46 1.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 74.25 110.883 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . 0.588 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -112.63 99.11 7.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 43.240000000000002 111.13 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 13.3 p -99.2 169.49 9.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 72.340000000000003 111.13 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . 0.495 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.29 -29.76 69.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 73.510000000000005 110.839 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -59.0 -26.04 64.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 74.319999999999993 111.13 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.78 -13.09 13.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 71.349999999999994 110.841 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.439 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.5 mp -99.93 -53.24 3.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 73.040000000000006 110.936 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.636 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -41.49 -51.14 8.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.574 0.702 . . . . 70.439999999999998 111.118 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.4 Cg_endo -69.78 -30.47 22.15 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.668 2.246 . . . . 75.439999999999998 112.339 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.584 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -64.96 -20.12 66.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 74.140000000000001 110.955 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.55 ' CD1' HD13 ' A' ' 381' ' ' ILE . 88.1 m-85 -104.8 -37.01 7.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 73.329999999999998 110.89 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -48.56 -45.51 37.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 75.129999999999995 110.931 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . 0.419 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.8 OUTLIER -44.49 -23.77 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 72.310000000000002 110.858 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 392' ' ' CYS . 32.2 m-85 -69.85 -51.29 34.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 74.549999999999997 110.846 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -163.26 -88.0 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 54.329999999999998 112.473 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -151.74 144.49 24.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 74.519999999999996 110.913 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.426 HG22 ' CG2' ' A' ' 381' ' ' ILE . 25.9 mt -121.07 109.74 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 75.019999999999996 111.147 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.43 -19.42 29.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 74.239999999999995 110.889 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -170.96 120.74 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 72.340000000000003 110.889 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 33.5 t80 -113.61 131.33 56.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 72.409999999999997 110.902 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.31 100.73 7.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 75.450000000000003 110.928 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . 0.588 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 13.6 t-80 -97.81 127.44 43.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 72.340000000000003 110.905 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -122.85 86.58 50.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.712 0.768 . . . . 75.439999999999998 110.944 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' PRO . . . . . 0.498 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 54.0 Cg_endo -69.76 -21.38 33.56 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.732 2.288 . . . . 61.409999999999997 112.357 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.47 -23.76 63.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 72.120000000000005 110.871 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -115.39 -25.79 7.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 74.329999999999998 110.893 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.09 44.83 4.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.718 -0.753 . . . . 64.420000000000002 112.458 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 93.9 m -156.93 147.94 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 74.420000000000002 110.886 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.484 ' HB2' ' CE1' ' A' ' 370' ' ' PHE . 21.5 p -138.01 153.18 49.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 75.010000000000005 110.882 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 380' ' ' PHE . 2.3 m-85 -128.48 118.92 23.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 73.430000000000007 110.877 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.55 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -107.7 128.73 62.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 73.099999999999994 111.108 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.94 132.25 43.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 75.209999999999994 110.909 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -114.67 -178.9 3.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 73.439999999999998 110.96 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -76.78 -40.58 47.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.469 . . . . 71.209999999999994 110.898 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' THR . . . . . 0.415 ' C ' HG22 ' A' ' 341' ' ' THR . 53.5 p -125.17 167.11 15.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 74.420000000000002 111.143 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' HIS . . . . . 0.472 ' N ' HG22 ' A' ' 341' ' ' THR . 9.8 p-80 -72.99 -40.58 65.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 71.239999999999995 110.869 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . 0.428 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 0.4 OUTLIER -57.87 -26.97 62.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 72.340000000000003 110.878 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -65.71 -33.48 75.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 75.420000000000002 110.848 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -78.93 -34.65 44.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 70.25 111.057 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -61.15 -34.46 75.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.239 -0.437 . . . . 63.399999999999999 111.097 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.8 -57.24 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 71.129999999999995 111.132 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 364' ' ' PHE . 30.1 p -66.28 -27.06 67.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 73.340000000000003 110.906 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.48 ' O ' ' CG2' ' A' ' 408' ' ' THR . 1.3 mt -58.21 -54.56 30.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 61.420000000000002 111.112 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.465 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 0.5 OUTLIER -71.5 -34.21 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 60.32 111.105 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.8 -37.05 85.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 75.209999999999994 111.143 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . 0.564 HD12 ' CE1' ' A' ' 399' ' ' PHE . 2.8 mm? -86.14 -12.91 48.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 73.5 110.916 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' ALA . . . . . 0.481 ' N ' HG22 ' A' ' 408' ' ' THR . . . -53.45 111.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 74.200000000000003 111.089 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.9 m120 47.73 48.91 17.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 73.129999999999995 110.927 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.589 ' O ' ' CD1' ' A' ' 399' ' ' PHE . 0.0 OUTLIER -104.59 144.26 28.35 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.608 0.718 . . . . 73.530000000000001 110.874 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 139.09 39.35 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.653 2.236 . . . . 73.329999999999998 112.364 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' PHE . . . . . 0.615 ' CZ ' ' NE2' ' A' ' 402' ' ' GLN . 41.0 t80 -145.85 111.8 5.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 74.010000000000005 110.9 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . 0.615 ' NE2' ' CZ ' ' A' ' 401' ' ' PHE . 20.9 mt-30 51.07 32.64 7.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 63.520000000000003 110.976 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.92 -26.23 25.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.696 -0.764 . . . . 71.310000000000002 112.448 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' A' ' 401' ' ' PHE . 3.3 ttt180 -109.43 141.3 42.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.761 0.315 . . . . 70.010000000000005 110.876 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -82.52 155.19 24.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 75.230000000000004 110.873 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . 0.416 ' CD2' ' O ' ' A' ' 347' ' ' ASN . 27.3 mt -117.19 178.31 4.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.519999999999996 110.91 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.59 176.02 5.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 74.549999999999997 110.864 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' THR . . . . . 0.504 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 1.8 p -146.77 156.67 43.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 75.450000000000003 111.142 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.725 -0.75 . . . . 64.040000000000006 112.478 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.797 0.332 . . . . 74.5 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -52.58 -24.84 9.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 71.129999999999995 111.082 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' VAL . . . . . 0.464 ' CG2' HG12 ' A' ' 394' ' ' VAL . 5.0 t -81.58 -30.06 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 72.319999999999993 111.098 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -55.06 -38.06 67.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 73.319999999999993 110.817 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -59.9 -37.69 80.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 74.329999999999998 110.902 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 16.6 mm -54.96 -54.46 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 75.200000000000003 111.138 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 7.2 mt -51.61 -41.35 27.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 75.430000000000007 111.148 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -16.84 2.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 74.530000000000001 110.853 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.38 29.01 5.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.205 -0.452 . . . . 75.519999999999996 110.872 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -159.59 154.27 20.9 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.57 0.7 . . . . 71.140000000000001 111.13 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 156.52 63.01 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.677 2.251 . . . . 73.219999999999999 112.36 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -6.68 19.19 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.661 2.24 . . . . 73.420000000000002 112.395 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -119.93 76.45 1.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 73.150000000000006 110.944 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 7.5 p -179.62 141.84 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 75.230000000000004 111.156 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' THR . . . . . 0.415 HG21 ' C ' ' A' ' 385' ' ' THR . 21.0 p -149.46 69.79 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.430000000000007 111.13 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 96.4 m -133.5 116.08 15.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 65.230000000000004 111.109 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -89.14 121.86 31.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 75.200000000000003 111.077 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.56 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -102.99 125.56 49.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 72.310000000000002 110.907 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . . . . . . . . . 1.9 mp -122.52 118.86 56.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 72.099999999999994 111.17 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -105.91 -179.01 23.6 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.725 -0.75 . . . . 62.229999999999997 112.482 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.483 ' O ' ' CD2' ' A' ' 406' ' ' LEU . 0.7 OUTLIER 62.82 49.73 3.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.753 0.311 . . . . 74.450000000000003 110.811 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 86.8 mt -103.25 134.17 19.92 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.57 0.7 . . . . 72.019999999999996 111.177 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . 0.402 ' CG ' ' CE1' ' A' ' 351' ' ' PHE . 53.7 Cg_endo -69.77 165.38 31.18 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.704 2.27 . . . . 73.530000000000001 112.367 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.78 -25.8 63.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 70.319999999999993 110.916 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.402 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 2.9 p90 -89.88 31.87 0.94 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.851 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . 0.575 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -120.62 99.18 6.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 43.240000000000002 111.107 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 79.5 p -104.79 173.66 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.269 -0.423 . . . . 72.340000000000003 111.208 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . 0.513 ' O ' ' CG1' ' A' ' 358' ' ' ILE . 0.6 OUTLIER -66.71 -29.85 69.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 73.510000000000005 110.915 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.41 -26.28 63.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 74.319999999999993 111.038 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.42 -17.51 12.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.258 -0.428 . . . . 71.349999999999994 110.804 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.463 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 4.0 mp -92.33 -51.1 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 73.040000000000006 110.851 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.667 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.3 mm -42.34 -49.98 11.95 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.581 0.705 . . . . 70.439999999999998 111.082 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.6 Cg_endo -69.76 -28.0 25.78 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.685 2.257 . . . . 75.439999999999998 112.365 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.576 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.2 OUTLIER -68.11 -25.99 65.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 74.140000000000001 110.891 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.559 ' CD2' HD12 ' A' ' 360' ' ' LEU . 85.3 m-85 -102.42 -34.69 9.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 73.329999999999998 110.886 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' GLN . . . . . 0.431 ' N ' HD12 ' A' ' 367' ' ' ILE . 2.0 mt-30 -54.63 -32.36 58.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 75.129999999999995 110.882 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.05 -13.67 12.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 72.310000000000002 110.872 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . 0.458 ' CD2' ' HB3' ' A' ' 392' ' ' CYS . 39.3 m-85 -78.78 -55.9 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 74.549999999999997 110.926 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -155.19 -86.77 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.647 -0.787 . . . . 54.329999999999998 112.443 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.438 ' CE2' ' HG ' ' A' ' 368' ' ' LEU . 61.2 t80 -153.62 140.78 19.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.337 . . . . 74.519999999999996 110.906 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 362' ' ' GLN . 42.0 mt -120.33 109.29 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 75.019999999999996 111.161 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.438 ' HG ' ' CE2' ' A' ' 366' ' ' PHE . 0.9 OUTLIER -86.18 -20.24 28.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 74.239999999999995 110.93 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.89 121.36 0.67 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 72.340000000000003 110.923 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 35.0 t80 -113.61 145.7 40.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 72.409999999999997 110.895 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -131.44 101.97 5.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 75.450000000000003 110.952 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 6.2 t-80 -100.83 127.24 47.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.295 -0.412 . . . . 72.340000000000003 110.856 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -118.2 90.55 38.24 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.703 0.763 . . . . 75.439999999999998 110.958 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' PRO . . . . . 0.44 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.4 Cg_endo -69.75 -19.69 35.84 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.718 2.278 . . . . 61.409999999999997 112.335 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -84.38 -21.96 30.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 72.120000000000005 110.823 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -106.53 -26.43 11.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 74.329999999999998 110.866 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . 0.4 ' C ' ' SG ' ' A' ' 378' ' ' CYS . . . 84.74 35.38 13.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 64.420000000000002 112.489 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . 0.4 ' SG ' ' C ' ' A' ' 377' ' ' GLY . 1.8 m -153.64 140.98 19.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.774 0.321 . . . . 74.420000000000002 110.901 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 17.7 p -133.14 146.08 51.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 75.010000000000005 110.889 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.463 ' CE2' ' HB2' ' A' ' 344' ' ' TYR . 7.4 m-85 -124.15 127.69 48.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 73.430000000000007 110.911 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.556 HD11 ' CD1' ' A' ' 361' ' ' PHE . 1.0 OUTLIER -113.36 130.74 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 73.099999999999994 111.145 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -94.67 131.35 40.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 75.209999999999994 110.922 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -114.85 -174.58 2.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 73.439999999999998 110.902 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -93.47 -30.49 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 71.209999999999994 110.9 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' THR . . . . . 0.415 ' C ' HG21 ' A' ' 341' ' ' THR . 24.8 p -125.7 165.8 17.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 74.420000000000002 111.088 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' HIS . . . . . 0.426 ' CG ' ' N ' ' A' ' 387' ' ' GLU . 17.9 p-80 -78.42 -41.46 32.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 71.239999999999995 110.855 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 6.6 tm-20 -57.37 -31.27 65.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 72.340000000000003 110.861 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -36.29 82.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 75.420000000000002 110.933 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -76.02 -27.14 57.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 70.25 111.063 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -72.72 -35.51 67.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 63.399999999999999 111.063 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 82.7 t -66.02 -53.57 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 71.129999999999995 111.124 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . 0.458 ' HB3' ' CD2' ' A' ' 364' ' ' PHE . 31.5 p -65.35 -31.76 73.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.484 . . . . 73.340000000000003 110.861 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 408' ' ' THR . 0.7 OUTLIER -55.67 -55.65 16.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 61.420000000000002 111.133 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.464 HG12 ' CG2' ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.67 -36.79 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 60.32 111.164 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.2 -30.57 71.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 75.209999999999994 111.119 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . 0.569 HD12 ' CE1' ' A' ' 399' ' ' PHE . 2.1 mm? -95.93 -16.07 21.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 73.5 110.889 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -48.58 110.39 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.200000000000003 111.131 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 42.5 t30 49.45 50.57 17.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 73.129999999999995 110.923 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.569 ' CE1' HD12 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -107.47 145.62 31.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.655 0.74 . . . . 73.530000000000001 110.899 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 143.32 50.81 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.74 2.293 . . . . 73.329999999999998 112.333 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' PHE . . . . . 0.516 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 31.6 t80 -150.37 110.97 4.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 74.010000000000005 110.892 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 49.82 33.02 5.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 63.520000000000003 110.949 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 99.54 -27.76 18.63 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.683 -0.77 . . . . 71.310000000000002 112.503 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.3 OUTLIER -107.0 142.03 37.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.903 0.382 . . . . 70.010000000000005 110.901 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -83.05 154.79 24.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 75.230000000000004 110.834 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . 0.483 ' CD2' ' O ' ' A' ' 347' ' ' ASN . 19.6 mt -117.78 167.77 11.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 74.519999999999996 110.889 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.58 179.12 4.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 74.549999999999997 110.92 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' THR . . . . . 0.423 ' CG2' ' O ' ' A' ' 393' ' ' ILE . 5.9 p -152.86 153.56 33.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 75.450000000000003 111.191 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.749 . . . . 64.040000000000006 112.454 -179.978 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.779 0.323 . . . . 74.5 110.874 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -58.48 -25.01 61.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 71.129999999999995 111.002 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' VAL . . . . . 0.469 ' CG2' HG11 ' A' ' 394' ' ' VAL . 14.6 t -74.82 -30.03 23.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 72.319999999999993 111.117 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -55.03 -36.92 66.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.319999999999993 110.878 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -62.42 -36.34 82.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 74.329999999999998 110.909 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 20.4 mm -55.42 -53.25 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 75.200000000000003 111.071 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 5.5 mt -53.02 -40.51 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 75.430000000000007 111.163 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -16.27 2.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 74.530000000000001 110.844 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' A' ' 336' ' ' ALA . 0.2 OUTLIER -105.02 44.75 1.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 75.519999999999996 110.823 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 335' ' ' SER . . . 167.32 147.31 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.659 0.742 . . . . 71.140000000000001 111.095 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.404 ' O ' ' CG1' ' A' ' 340' ' ' VAL . 53.4 Cg_endo -69.81 151.27 68.76 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.667 2.245 . . . . 73.219999999999999 112.342 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -8.88 24.74 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.766 2.311 . . . . 73.420000000000002 112.332 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.42 16.58 3.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 73.150000000000006 110.863 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.404 ' CG1' ' O ' ' A' ' 337' ' ' PRO . 13.9 p -131.29 140.15 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 75.230000000000004 111.164 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' THR . . . . . 0.416 HG23 ' CA ' ' A' ' 386' ' ' HIS . 21.0 p -148.78 68.11 1.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 74.430000000000007 111.138 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 28.1 m -133.78 127.62 33.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.474 . . . . 65.230000000000004 111.098 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.96 120.69 35.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 75.200000000000003 111.169 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.47 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -105.86 131.72 52.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 72.310000000000002 110.92 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.437 ' CG2' ' HB3' ' A' ' 406' ' ' LEU . 1.7 mp -126.22 117.68 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 72.099999999999994 111.121 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -105.11 162.59 14.48 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.741 . . . . 62.229999999999997 112.524 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.5 t30 76.14 44.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 74.450000000000003 110.888 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 67.3 mt -94.59 135.2 24.23 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.613 0.721 . . . . 72.019999999999996 111.115 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . 0.4 ' CB ' ' CE1' ' A' ' 351' ' ' PHE . 52.9 Cg_endo -69.77 159.75 52.25 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.732 2.288 . . . . 73.530000000000001 112.337 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -67.86 -21.47 65.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 70.319999999999993 110.817 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.4 ' CE1' ' CB ' ' A' ' 349' ' ' PRO . 5.4 p90 -93.86 28.49 2.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 74.25 110.903 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . 0.587 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -110.83 102.07 10.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 43.240000000000002 111.117 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 14.3 p -102.8 169.26 8.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 72.340000000000003 111.109 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . 0.496 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.49 -31.32 71.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 73.510000000000005 110.865 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.96 -26.38 59.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 74.319999999999993 111.1 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -111.98 -13.11 13.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 71.349999999999994 110.902 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.438 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.4 mp -99.47 -54.18 3.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 73.040000000000006 110.91 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.619 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -40.29 -51.79 6.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.664 0.745 . . . . 70.439999999999998 111.088 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.3 Cg_endo -69.76 -38.12 8.24 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.72 2.28 . . . . 75.439999999999998 112.339 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.579 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -55.32 -26.67 42.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.442 . . . . 74.140000000000001 110.925 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.56 ' CD1' HD11 ' A' ' 381' ' ' ILE . 85.2 m-85 -97.42 -39.22 9.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 73.329999999999998 110.861 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' GLN . . . . . 0.47 ' N ' HD11 ' A' ' 367' ' ' ILE . 6.8 mt-30 -47.52 -44.26 25.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 75.129999999999995 111.006 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 360' ' ' LEU . 0.9 OUTLIER -45.05 -29.01 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 72.310000000000002 110.879 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . 0.566 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 34.0 m-85 -63.33 -57.39 10.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 74.549999999999997 110.913 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -156.8 -83.7 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.729 . . . . 54.329999999999998 112.507 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -153.5 144.76 23.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.798 0.332 . . . . 74.519999999999996 110.885 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.47 HD11 ' N ' ' A' ' 362' ' ' GLN . 69.1 mt -121.13 109.08 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 75.019999999999996 111.12 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.3 mt -88.1 -19.8 26.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 74.239999999999995 110.877 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.15 120.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 72.340000000000003 110.848 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' A' ' 372' ' ' HIS . 34.9 t80 -113.1 142.2 46.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 72.409999999999997 110.899 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.5 100.48 5.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 75.450000000000003 110.88 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . 0.587 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.0 t-80 -99.59 119.02 37.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 72.340000000000003 110.877 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.86 88.21 11.37 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.709 0.766 . . . . 75.439999999999998 110.944 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' PRO . . . . . 0.423 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 54.1 Cg_endo -69.78 -26.9 27.01 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.705 2.27 . . . . 61.409999999999997 112.355 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.55 -19.75 62.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 72.120000000000005 110.871 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -111.14 -27.07 8.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 74.329999999999998 110.895 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 89.11 39.83 6.33 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.781 -0.723 . . . . 64.420000000000002 112.479 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.8 p -159.58 153.59 23.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.752 0.31 . . . . 74.420000000000002 110.87 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.516 ' C ' ' CD1' ' A' ' 380' ' ' PHE . 15.2 p -138.72 166.71 23.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 75.010000000000005 110.866 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 379' ' ' CYS . 7.0 m-85 -142.12 125.57 16.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 73.430000000000007 110.806 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.56 HD11 ' CD1' ' A' ' 361' ' ' PHE . 0.7 OUTLIER -115.48 126.43 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 73.099999999999994 111.15 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.71 128.38 42.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 75.209999999999994 110.911 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -109.83 179.32 4.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 73.439999999999998 110.95 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -81.05 -34.95 32.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.469 . . . . 71.209999999999994 110.878 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' THR . . . . . 0.408 ' C ' HG21 ' A' ' 341' ' ' THR . 82.8 p -125.65 166.75 16.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 74.420000000000002 111.174 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' HIS . . . . . 0.416 ' CA ' HG23 ' A' ' 341' ' ' THR . 4.1 p-80 -82.58 -38.69 23.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 71.239999999999995 110.861 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . 0.403 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 4.5 tt0 -57.4 -27.71 62.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 72.340000000000003 110.84 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -35.59 66.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 75.420000000000002 110.91 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -68.47 -37.94 80.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 70.25 111.077 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -58.59 -33.61 70.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 63.399999999999999 111.068 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.3 t -63.58 -57.52 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 71.129999999999995 111.128 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . 0.566 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 10.5 t -59.33 -30.18 68.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.496 . . . . 73.340000000000003 110.919 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -55.21 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 61.420000000000002 111.102 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.469 HG11 ' CG2' ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.79 -34.82 52.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 60.32 111.129 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.19 -45.38 88.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 75.209999999999994 111.149 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . 0.562 ' CB ' ' CG2' ' A' ' 408' ' ' THR . 2.7 mm? -81.59 -12.58 58.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 73.5 110.986 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' ALA . . . . . 0.464 ' N ' HG21 ' A' ' 408' ' ' THR . . . -49.37 111.08 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 74.200000000000003 111.098 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 6.6 m120 44.26 48.74 7.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 73.129999999999995 110.825 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.559 ' O ' ' CD1' ' A' ' 399' ' ' PHE . 0.0 OUTLIER -103.6 145.77 31.24 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.66 0.743 . . . . 73.530000000000001 110.916 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 141.8 46.19 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.692 2.261 . . . . 73.329999999999998 112.34 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' PHE . . . . . 0.544 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 30.4 t80 -146.94 110.85 5.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 74.010000000000005 110.913 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 47.92 32.96 3.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 63.520000000000003 110.936 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.04 -29.85 11.63 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.815 -0.707 . . . . 71.310000000000002 112.517 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.76 137.02 43.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 70.010000000000005 110.887 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -81.65 150.38 28.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 75.230000000000004 110.89 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . 0.437 ' HB3' ' CG2' ' A' ' 345' ' ' ILE . 28.4 mt -112.39 171.43 7.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 74.519999999999996 110.902 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 346' ' ' GLY . 13.4 ttt180 -112.73 174.66 5.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 74.549999999999997 110.842 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' THR . . . . . 0.562 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 70.7 p -154.28 146.97 24.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 75.450000000000003 111.17 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 C-N-CA 120.764 -0.731 . . . . 64.040000000000006 112.506 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.825 0.345 . . . . 74.5 110.922 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -53.78 -24.87 16.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 71.129999999999995 111.163 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' VAL . . . . . 0.469 ' CG2' HG13 ' A' ' 394' ' ' VAL . 6.9 t -84.36 -30.06 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 72.319999999999993 111.165 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -54.67 -41.17 69.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 73.319999999999993 110.953 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -56.6 -39.23 73.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 74.329999999999998 110.887 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . 0.404 HG13 ' CG2' ' A' ' 393' ' ' ILE . 21.5 mm -54.4 -54.34 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 75.200000000000003 111.097 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.475 ' CG2' ' NE2' ' A' ' 386' ' ' HIS . 4.3 mt -53.69 -36.34 28.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 75.430000000000007 111.124 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -7.98 5.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 74.530000000000001 110.873 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.8 7.68 37.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 75.519999999999996 110.887 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -153.0 147.1 18.6 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.598 0.714 . . . . 71.140000000000001 111.062 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 153.27 69.07 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.694 2.263 . . . . 73.219999999999999 112.356 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -7.75 21.85 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.67 2.246 . . . . 73.420000000000002 112.351 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 31.9 mtt180 -92.25 37.11 0.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 73.150000000000006 110.844 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 7.7 p -157.74 142.59 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 75.230000000000004 111.138 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' THR . . . . . 0.463 HG21 ' N ' ' A' ' 386' ' ' HIS . 18.2 p -144.39 67.93 1.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 74.430000000000007 111.18 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 72.7 m -134.06 137.59 44.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 65.230000000000004 111.175 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -108.74 122.22 46.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 75.200000000000003 111.138 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -102.06 124.87 48.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.267 -0.424 . . . . 72.310000000000002 110.937 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.73 104.41 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 72.099999999999994 111.083 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -93.3 165.62 27.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.825 -0.703 . . . . 62.229999999999997 112.536 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.5 t30 74.99 55.47 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.358 . . . . 74.450000000000003 110.89 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.401 HG21 ' N ' ' A' ' 349' ' ' PRO . 76.7 mt -110.19 136.36 20.5 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.634 0.73 . . . . 72.019999999999996 111.153 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . 0.485 ' CG ' ' CE1' ' A' ' 351' ' ' PHE . 54.5 Cg_endo -69.68 162.93 40.12 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.664 2.243 . . . . 73.530000000000001 112.359 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.41 -21.27 61.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 70.319999999999993 110.862 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.485 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 7.4 p90 -88.02 19.92 3.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 74.25 110.864 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . 0.598 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -104.65 121.34 43.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 43.240000000000002 111.08 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 11.5 p -123.08 167.99 12.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 72.340000000000003 111.215 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . 0.487 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.3 OUTLIER -63.64 -35.12 79.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 73.510000000000005 110.839 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -55.03 -26.89 40.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 74.319999999999993 111.114 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.99 -13.5 13.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 71.349999999999994 110.914 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.439 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.2 mp -99.06 -55.0 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 73.040000000000006 110.94 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.612 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -38.82 -52.42 3.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.704 0.764 . . . . 70.439999999999998 111.146 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.3 Cg_endo -69.75 -40.36 5.42 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.703 2.269 . . . . 75.439999999999998 112.381 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.58 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -53.89 -25.28 19.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 74.140000000000001 110.929 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.565 ' CD2' HD13 ' A' ' 360' ' ' LEU . 83.4 m-85 -100.46 -39.43 7.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 73.329999999999998 110.863 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -51.64 -39.22 57.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 75.129999999999995 110.878 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -51.42 -16.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 72.310000000000002 110.922 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' A' ' 392' ' ' CYS . 31.6 m-85 -75.55 -60.04 2.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 74.549999999999997 110.927 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -150.02 -85.36 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.646 -0.788 . . . . 54.329999999999998 112.42 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -153.62 141.73 20.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.819 0.342 . . . . 74.519999999999996 110.876 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.46 HG22 ' CG2' ' A' ' 381' ' ' ILE . 40.8 mt -121.04 109.04 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 75.019999999999996 111.1 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 2.8 pp -89.3 -16.2 31.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 74.239999999999995 110.938 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.02 120.83 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.476 . . . . 72.340000000000003 110.903 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.483 ' CD2' HG12 ' A' ' 358' ' ' ILE . 35.9 t80 -114.4 141.64 47.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 72.409999999999997 110.894 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 5.2 mtmm -129.4 101.12 5.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 75.450000000000003 110.907 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . 0.598 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 14.2 t-80 -95.93 121.66 37.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 72.340000000000003 110.829 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -116.83 84.0 15.12 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.657 0.741 . . . . 75.439999999999998 110.926 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' PRO . . . . . 0.477 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 54.4 Cg_endo -69.71 -27.08 27.16 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.67 2.247 . . . . 61.409999999999997 112.37 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -65.65 -23.58 66.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 72.120000000000005 110.914 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -112.83 -25.59 8.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 74.329999999999998 110.889 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.61 46.32 4.04 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.728 -0.749 . . . . 64.420000000000002 112.476 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 27.4 p -159.78 151.82 20.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.877 0.37 . . . . 74.420000000000002 110.906 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 15.1 p -140.52 137.38 33.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 75.010000000000005 110.922 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -115.99 119.94 37.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 73.430000000000007 110.921 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.471 HG12 ' CD1' ' A' ' 370' ' ' PHE . 1.2 mt -107.64 142.51 20.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 73.099999999999994 111.18 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.27 131.6 50.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 75.209999999999994 110.909 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.456 ' CD2' ' HB3' ' A' ' 388' ' ' GLN . 53.1 m-85 -120.33 137.02 54.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 73.439999999999998 110.919 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -45.36 -28.77 0.91 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 71.209999999999994 110.864 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 69.4 p -130.07 162.69 28.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 74.420000000000002 111.139 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' HIS . . . . . 0.475 ' NE2' ' CG2' ' A' ' 333' ' ' ILE . 10.0 t60 -80.43 -34.42 36.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 71.239999999999995 110.863 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -57.31 -32.19 66.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 72.340000000000003 110.954 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.456 ' HB3' ' CD2' ' A' ' 383' ' ' TYR . 0.0 OUTLIER -66.8 -34.49 77.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.113 -0.494 . . . . 75.420000000000002 110.906 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -71.35 -23.85 61.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 70.25 111.095 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . 0.444 ' HB3' ' CG1' ' A' ' 329' ' ' VAL . . . -78.79 -38.42 38.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 63.399999999999999 111.063 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.24 -48.6 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 71.129999999999995 111.103 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . 0.486 ' HB2' ' CE2' ' A' ' 364' ' ' PHE . 19.1 p -71.36 -32.44 68.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 73.340000000000003 110.856 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.404 ' CG2' HG13 ' A' ' 332' ' ' ILE . 0.9 OUTLIER -53.68 -55.35 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 61.420000000000002 111.171 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.469 HG13 ' CG2' ' A' ' 329' ' ' VAL . 0.3 OUTLIER -72.08 -34.32 49.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 60.32 111.144 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -67.08 -29.09 68.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 111.147 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . 0.555 HD11 ' CE1' ' A' ' 399' ' ' PHE . 1.9 mm? -97.97 -2.82 39.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 73.5 110.858 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -63.53 111.73 2.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 74.200000000000003 111.012 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 50.67 48.1 23.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 73.129999999999995 110.893 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.555 ' CE1' HD11 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -106.48 142.97 26.05 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.642 0.734 . . . . 73.530000000000001 110.867 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.421 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.8 Cg_endo -69.77 141.61 45.64 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.747 2.298 . . . . 73.329999999999998 112.34 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' PHE . . . . . 0.55 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 50.1 t80 -147.94 114.25 5.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 74.010000000000005 110.838 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER 48.91 32.74 3.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 63.520000000000003 110.937 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.36 -27.58 18.78 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.76 -0.733 . . . . 71.310000000000002 112.504 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.4 138.76 41.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 70.010000000000005 110.864 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.66 149.75 29.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 75.230000000000004 110.827 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 9.3 mt -112.24 174.93 5.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 74.519999999999996 110.948 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 346' ' ' GLY . 0.0 OUTLIER -120.78 173.02 7.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 74.549999999999997 110.891 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' THR . . . . . 0.533 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 2.2 p -146.41 153.6 40.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 75.450000000000003 111.072 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 64.040000000000006 112.443 179.899 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.835 0.35 . . . . 74.5 110.947 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.1 -24.78 18.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.457 . . . . 71.129999999999995 111.104 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' VAL . . . . . 0.456 ' CG2' ' HB ' ' A' ' 394' ' ' VAL . 5.7 t -84.78 -30.04 6.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 72.319999999999993 111.176 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -54.74 -45.86 74.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 73.319999999999993 110.905 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -53.01 -34.81 58.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.329999999999998 110.808 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . 0.477 ' CG2' HG23 ' A' ' 393' ' ' ILE . 26.1 mm -61.29 -48.87 86.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 75.200000000000003 111.167 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 8.0 mt -54.39 -33.05 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 75.430000000000007 111.093 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.61 -7.96 12.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 74.530000000000001 110.951 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.29 17.58 12.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 75.519999999999996 110.894 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . 177.8 164.49 0.57 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.533 0.682 . . . . 71.140000000000001 111.154 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.471 ' O ' ' CG2' ' A' ' 340' ' ' VAL . 54.7 Cg_endo -69.66 156.86 62.47 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.77 2.313 . . . . 73.219999999999999 112.37 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -7.32 20.73 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.678 2.252 . . . . 73.420000000000002 112.36 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 35.3 mtt85 -97.57 53.68 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 73.150000000000006 110.898 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.471 ' CG2' ' O ' ' A' ' 337' ' ' PRO . 7.0 m -150.53 135.56 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 75.230000000000004 111.088 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' THR . . . . . 0.422 HG23 ' C ' ' A' ' 385' ' ' THR . 28.0 p -138.08 66.4 1.44 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 74.430000000000007 111.117 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 19.4 m -134.3 142.15 47.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 65.230000000000004 111.118 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -118.83 98.93 6.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 75.200000000000003 111.121 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.53 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -85.77 121.19 28.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.332 -0.394 . . . . 72.310000000000002 110.91 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.428 HG23 ' CD1' ' A' ' 406' ' ' LEU . 2.0 mp -118.29 118.79 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.086 -0.506 . . . . 72.099999999999994 111.131 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -104.64 164.88 14.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.76 -0.733 . . . . 62.229999999999997 112.504 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 0.2 OUTLIER 76.62 45.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 74.450000000000003 110.884 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 59.4 mt -99.58 133.32 21.94 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.653 0.74 . . . . 72.019999999999996 111.142 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . 0.426 ' HB2' ' CD1' ' A' ' 351' ' ' PHE . 53.7 Cg_endo -69.74 164.87 32.9 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.657 2.238 . . . . 73.530000000000001 112.329 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.32 -20.88 59.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 70.319999999999993 110.809 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.504 ' O ' ' CD2' ' A' ' 351' ' ' PHE . 25.0 p90 -97.25 29.48 3.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 74.25 110.885 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . 0.602 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -114.36 90.84 3.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 43.240000000000002 111.17 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 19.7 p -87.83 170.77 10.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 72.340000000000003 111.101 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . 0.489 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -65.6 -31.94 73.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 73.510000000000005 110.888 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -53.49 -26.13 19.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 74.319999999999993 111.128 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.63 -13.18 13.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.273 -0.421 . . . . 71.349999999999994 110.866 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.437 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.3 mp -98.85 -55.86 2.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 73.040000000000006 110.952 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.621 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -39.74 -52.16 5.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.625 0.726 . . . . 70.439999999999998 111.106 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.5 Cg_endo -69.66 -35.58 12.66 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.711 2.274 . . . . 75.439999999999998 112.37 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.589 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -58.61 -23.55 59.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 74.140000000000001 110.927 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.59 ' CG ' ' CD1' ' A' ' 381' ' ' ILE . 84.9 m-85 -103.02 -35.25 8.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 73.329999999999998 110.873 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -54.14 -34.76 61.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 75.129999999999995 110.852 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -55.48 -13.47 1.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 72.310000000000002 110.954 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . 0.576 ' CE2' ' HB2' ' A' ' 392' ' ' CYS . 38.2 m-85 -81.3 -53.99 5.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 74.549999999999997 110.901 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -156.24 -95.35 0.11 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.807 -0.711 . . . . 54.329999999999998 112.557 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.424 ' CE2' ' HG ' ' A' ' 368' ' ' LEU . 58.8 t80 -143.81 143.97 31.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.818 0.342 . . . . 74.519999999999996 110.909 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.469 HG22 ' CG2' ' A' ' 381' ' ' ILE . 71.6 mt -120.73 109.05 24.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 75.019999999999996 111.145 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.424 ' HG ' ' CE2' ' A' ' 366' ' ' PHE . 1.1 mp -87.64 -19.8 27.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 74.239999999999995 110.862 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.92 120.62 0.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 72.340000000000003 110.872 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.554 ' CE2' ' HB2' ' A' ' 372' ' ' HIS . 35.1 t80 -112.47 143.0 44.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 72.409999999999997 110.888 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.27 101.28 5.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 75.450000000000003 110.895 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . 0.602 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 10.0 t-80 -99.66 136.01 40.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 72.340000000000003 110.884 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -128.19 90.03 48.35 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.73 0.776 . . . . 75.439999999999998 110.965 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' PRO . . . . . 0.421 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.9 Cg_endo -69.77 -21.85 32.85 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.791 2.327 . . . . 61.409999999999997 112.343 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.0 -33.33 65.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 72.120000000000005 110.887 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.08 -18.99 14.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 110.933 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 81.01 40.16 12.03 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.741 -0.742 . . . . 64.420000000000002 112.465 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.2 p -148.49 155.62 41.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.716 0.293 . . . . 74.420000000000002 110.976 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 18.6 p -149.78 158.08 43.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.429 . . . . 75.010000000000005 110.897 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.491 ' N ' ' CD1' ' A' ' 380' ' ' PHE . 1.8 m-85 -136.24 132.5 35.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 73.430000000000007 110.922 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.59 ' CD1' ' CG ' ' A' ' 361' ' ' PHE . 0.9 OUTLIER -119.67 123.02 70.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 73.099999999999994 111.136 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.19 131.84 34.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 75.209999999999994 110.943 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.51 -179.63 3.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 73.439999999999998 110.93 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -80.65 -43.76 19.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.082 -0.508 . . . . 71.209999999999994 110.884 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' THR . . . . . 0.422 ' C ' HG23 ' A' ' 341' ' ' THR . 82.3 p -115.71 159.86 20.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 74.420000000000002 111.122 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' HIS . . . . . 0.435 ' CG ' ' N ' ' A' ' 387' ' ' GLU . 19.5 p-80 -69.44 -42.09 75.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 71.239999999999995 110.842 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . 0.435 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 2.2 tt0 -59.04 -29.83 67.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 72.340000000000003 110.876 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.53 -35.07 71.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 75.420000000000002 110.865 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -75.46 -24.83 57.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 70.25 111.136 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . 0.437 ' CB ' ' CG1' ' A' ' 329' ' ' VAL . . . -72.39 -37.11 68.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 63.399999999999999 111.143 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.83 -56.62 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 71.129999999999995 111.085 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . 0.576 ' HB2' ' CE2' ' A' ' 364' ' ' PHE . 14.5 p -63.99 -32.77 74.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 110.845 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.477 HG23 ' CG2' ' A' ' 332' ' ' ILE . 1.7 mt -53.32 -54.12 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 61.420000000000002 111.122 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.456 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 0.5 OUTLIER -71.18 -34.14 53.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 60.32 111.136 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -69.41 -28.49 66.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.209999999999994 111.109 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . 0.569 HD13 ' CE1' ' A' ' 399' ' ' PHE . 2.4 mm? -97.75 -17.86 19.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.276 -0.42 . . . . 73.5 110.945 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -47.97 114.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 74.200000000000003 111.073 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 38.0 t30 44.77 44.75 7.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.129999999999995 110.831 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.569 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -100.66 143.99 27.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.644 0.735 . . . . 73.530000000000001 110.861 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.405 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.4 Cg_endo -69.75 145.11 56.2 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.674 2.249 . . . . 73.329999999999998 112.284 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' PHE . . . . . 0.565 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 56.1 t80 -150.12 110.8 4.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 74.010000000000005 110.886 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 49.08 33.45 4.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 63.520000000000003 110.923 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 99.95 -28.21 16.68 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.726 -0.749 . . . . 71.310000000000002 112.458 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -105.01 141.06 37.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 70.010000000000005 110.852 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -83.88 154.13 23.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 75.230000000000004 110.888 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . 0.428 ' CD1' HG23 ' A' ' 345' ' ' ILE . 8.7 mt -116.4 174.08 6.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 74.519999999999996 110.973 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.82 176.85 5.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 74.549999999999997 110.886 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' THR . . . . . 0.42 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 23.5 p -151.67 151.28 31.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 75.450000000000003 111.109 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.409 0 C-N-CA 120.74 -0.743 . . . . 64.040000000000006 112.501 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.756 0.313 . . . . 74.5 110.89 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.24 -28.25 40.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 71.129999999999995 111.066 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' VAL . . . . . 0.532 ' CG1' ' CB ' ' A' ' 390' ' ' ALA . 16.0 t -71.1 -29.84 38.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 72.319999999999993 111.163 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -54.18 -35.44 62.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 110.892 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -69.34 -31.78 70.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 74.329999999999998 110.825 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 46.9 mm -54.79 -54.21 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 75.200000000000003 111.099 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.402 HG12 ' CD2' ' A' ' 386' ' ' HIS . 8.2 mt -52.36 -40.55 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 75.430000000000007 111.149 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -15.41 1.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 74.530000000000001 110.857 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.45 41.69 1.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 75.519999999999996 110.897 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . 170.59 157.05 0.21 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.626 0.727 . . . . 71.140000000000001 111.048 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 153.78 68.4 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.649 2.233 . . . . 73.219999999999999 112.369 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -11.55 31.04 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.742 2.295 . . . . 73.420000000000002 112.304 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -100.82 66.0 1.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 73.150000000000006 110.812 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 14.4 p -171.39 131.72 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 75.230000000000004 111.054 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' THR . . . . . 0.402 HG23 ' C ' ' A' ' 385' ' ' THR . 22.0 p -137.0 68.53 1.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 111.11 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 87.5 m -133.59 111.7 10.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.445 . . . . 65.230000000000004 111.099 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -85.72 137.39 32.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 75.200000000000003 111.139 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -116.99 134.55 54.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.47 . . . . 72.310000000000002 110.882 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.43 HG22 ' CD1' ' A' ' 406' ' ' LEU . 1.8 mp -131.68 110.99 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 72.099999999999994 111.142 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -101.09 161.62 18.36 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.774 -0.727 . . . . 62.229999999999997 112.52 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 2.4 t30 78.95 49.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.794 0.33 . . . . 74.450000000000003 110.85 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 349' ' ' PRO . 85.1 mt -103.69 135.83 19.3 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.662 0.744 . . . . 72.019999999999996 111.115 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . 0.407 ' N ' HG22 ' A' ' 348' ' ' ILE . 53.8 Cg_endo -69.73 164.4 34.66 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.687 2.258 . . . . 73.530000000000001 112.41 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.62 -28.09 63.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 70.319999999999993 110.882 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -83.17 20.09 1.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 74.25 110.892 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . 0.545 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -107.64 112.83 25.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 43.240000000000002 111.089 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 19.0 p -116.32 170.94 8.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 72.340000000000003 111.107 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . 0.498 ' O ' ' CG1' ' A' ' 358' ' ' ILE . 0.2 OUTLIER -66.23 -29.89 70.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 73.510000000000005 110.886 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.56 -26.64 63.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 74.319999999999993 111.168 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.48 -16.01 12.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 71.349999999999994 110.88 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.452 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.5 mp -93.5 -50.92 5.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 73.040000000000006 110.928 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.674 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.3 mm -44.0 -49.48 21.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.687 0.756 . . . . 70.439999999999998 111.171 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.0 Cg_endo -69.75 -27.84 26.02 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.255 . . . . 75.439999999999998 112.361 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.582 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -69.96 -26.95 64.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 74.140000000000001 110.907 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.477 ' CD2' HD13 ' A' ' 360' ' ' LEU . 85.6 m-85 -94.75 -36.39 11.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 73.329999999999998 110.844 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' GLN . . . . . 0.405 ' O ' ' N ' ' A' ' 364' ' ' PHE . 11.4 mm-40 -49.45 -46.81 48.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 75.129999999999995 110.886 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -42.5 -24.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 72.310000000000002 110.884 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . 0.405 ' N ' ' O ' ' A' ' 362' ' ' GLN . 28.6 m-85 -70.52 -59.77 2.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 74.549999999999997 110.904 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -155.1 -86.32 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.762 -0.732 . . . . 54.329999999999998 112.51 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -153.52 144.48 22.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 74.519999999999996 110.933 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.464 HG22 ' CG2' ' A' ' 381' ' ' ILE . 17.3 mt -120.92 109.32 24.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 75.019999999999996 111.139 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.03 -20.02 27.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.476 . . . . 74.239999999999995 110.92 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.3 121.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 72.340000000000003 110.837 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.562 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 28.9 t80 -113.42 143.52 44.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 72.409999999999997 110.855 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.07 101.42 5.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 75.450000000000003 110.865 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 9.3 t-80 -97.27 115.13 27.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 72.340000000000003 110.811 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -108.04 86.09 2.98 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.685 0.755 . . . . 75.439999999999998 110.953 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' PRO . . . . . 0.485 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 53.7 Cg_endo -69.8 -17.27 37.48 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.671 2.247 . . . . 61.409999999999997 112.318 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -79.32 -23.76 43.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 72.120000000000005 110.903 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -108.41 -26.65 10.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 74.329999999999998 110.952 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.91 41.05 5.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.721 -0.752 . . . . 64.420000000000002 112.5 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 27.0 p -159.86 153.27 22.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.89 0.376 . . . . 74.420000000000002 110.819 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 29.0 p -138.53 145.32 40.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 75.010000000000005 110.886 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -119.85 129.42 54.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 73.430000000000007 110.895 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.511 ' CG1' ' CD1' ' A' ' 370' ' ' PHE . 1.0 OUTLIER -120.82 132.94 69.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 73.099999999999994 111.147 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -98.77 134.79 41.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 75.209999999999994 110.822 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -117.45 -179.46 3.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 73.439999999999998 110.893 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.23 -39.56 22.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 71.209999999999994 110.849 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' THR . . . . . 0.402 ' C ' HG23 ' A' ' 341' ' ' THR . 67.3 p -120.42 171.39 8.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 111.18 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' HIS . . . . . 0.402 ' CD2' HG12 ' A' ' 333' ' ' ILE . 4.4 t60 -83.65 -42.28 16.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 71.239999999999995 110.868 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.3 -28.72 63.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 72.340000000000003 110.841 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -36.51 82.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 75.420000000000002 110.947 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.9 -34.23 64.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 70.25 111.165 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . 0.532 ' CB ' ' CG1' ' A' ' 329' ' ' VAL . . . -56.05 -34.41 65.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 63.399999999999999 111.071 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 95.9 t -71.4 -42.99 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 71.129999999999995 111.188 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 35.3 t -65.83 -34.17 77.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 73.340000000000003 110.905 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.407 ' O ' ' CG2' ' A' ' 408' ' ' THR . 1.1 mt -55.9 -56.01 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 61.420000000000002 111.159 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.483 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 1.8 t -72.04 -36.87 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 60.32 111.132 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.6 94.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 75.209999999999994 111.089 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . 0.588 ' CD1' ' CE1' ' A' ' 399' ' ' PHE . 1.9 mm? -89.09 -18.56 27.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 73.5 110.917 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 398' ' ' ASN . . . -44.7 117.89 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 74.200000000000003 111.031 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 397' ' ' ALA . 4.6 p-10 34.5 42.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 73.129999999999995 110.936 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.588 ' CE1' ' CD1' ' A' ' 396' ' ' LEU . 0.0 OUTLIER -97.38 148.0 33.79 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.664 0.745 . . . . 73.530000000000001 110.897 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 144.26 53.72 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.635 2.223 . . . . 73.329999999999998 112.399 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' PHE . . . . . 0.437 ' N ' ' O ' ' A' ' 404' ' ' ARG . 58.3 t80 -153.36 112.96 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 74.010000000000005 110.892 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 49.64 33.29 5.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 63.520000000000003 110.946 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 97.85 -27.66 17.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.735 -0.745 . . . . 71.310000000000002 112.453 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -106.06 142.22 36.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.819 0.342 . . . . 70.010000000000005 110.864 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -86.42 150.62 24.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 75.230000000000004 110.883 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . 0.43 ' CD1' HG22 ' A' ' 345' ' ' ILE . 17.8 mt -112.06 -177.98 3.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 74.519999999999996 110.94 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 346' ' ' GLY . 8.3 ttt180 -125.87 177.29 6.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 74.549999999999997 110.943 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' THR . . . . . 0.439 ' CG2' ' HB2' ' A' ' 396' ' ' LEU . 16.7 p -153.59 157.91 40.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 75.450000000000003 111.102 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . 0.437 ' O ' ' CD1' ' A' ' 344' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.262 0 C-N-CA 120.674 -0.774 . . . . 64.040000000000006 112.448 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.783 0.325 . . . . 74.5 110.891 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.64 -24.6 34.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 71.129999999999995 111.058 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' VAL . . . . . 0.456 ' CG2' ' HB ' ' A' ' 394' ' ' VAL . 25.5 t -83.45 -29.73 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 72.319999999999993 111.175 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -54.57 -45.46 73.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.168 -0.469 . . . . 73.319999999999993 110.837 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -54.2 -31.9 54.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 74.329999999999998 110.916 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . 0.406 HG13 ' CG2' ' A' ' 393' ' ' ILE . 26.6 mm -69.88 -49.52 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 75.200000000000003 111.172 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 54.2 mt -54.18 -39.52 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 75.430000000000007 111.184 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -75.99 6.7 4.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 74.530000000000001 110.856 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 6.5 t -105.82 -13.2 15.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 75.519999999999996 110.914 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -150.19 150.51 29.66 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.641 0.734 . . . . 71.140000000000001 111.038 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 158.89 55.36 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.652 2.234 . . . . 73.219999999999999 112.322 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -28.84 24.78 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.692 2.261 . . . . 73.420000000000002 112.339 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.1 mtm105 -50.15 -40.66 47.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 73.150000000000006 110.879 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.7 p -95.17 134.32 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 75.230000000000004 111.107 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 386' ' ' HIS . 25.3 p -140.46 71.15 1.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 74.430000000000007 111.099 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 3.4 m -132.54 128.81 38.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 65.230000000000004 111.172 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -95.23 119.42 33.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 75.200000000000003 111.094 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.508 ' HB2' ' CD2' ' A' ' 380' ' ' PHE . 0.0 OUTLIER -100.28 129.13 46.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 72.310000000000002 110.936 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.46 HG21 ' CD1' ' A' ' 348' ' ' ILE . 1.8 mp -122.59 126.19 73.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.071 -0.513 . . . . 72.099999999999994 111.143 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -112.88 168.89 12.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 62.229999999999997 112.463 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.475 ' O ' ' CD2' ' A' ' 406' ' ' LEU . 1.9 t30 70.68 53.23 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.706 0.288 . . . . 74.450000000000003 110.877 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.46 ' CD1' HG21 ' A' ' 345' ' ' ILE . 2.0 mp -102.4 132.39 21.46 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.643 0.735 . . . . 72.019999999999996 111.116 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . 0.409 ' CG ' ' CE1' ' A' ' 351' ' ' PHE . 53.7 Cg_endo -69.72 153.55 68.97 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.683 2.255 . . . . 73.530000000000001 112.379 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.03 -18.96 64.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 70.319999999999993 110.836 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.409 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 5.2 p90 -94.38 19.78 9.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.862 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . 0.478 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -111.78 104.19 12.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 43.240000000000002 111.038 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 27.2 p -107.24 168.33 9.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 72.340000000000003 111.131 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . 0.495 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -59.59 -37.25 78.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 73.510000000000005 110.884 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -52.41 -26.11 11.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.319999999999993 111.067 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -112.14 -13.1 13.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 71.349999999999994 110.793 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.453 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 2.9 mp -99.25 -55.73 2.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 73.040000000000006 110.906 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.608 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -37.69 -52.44 2.67 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.619 0.723 . . . . 70.439999999999998 111.103 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.3 Cg_endo -69.76 -26.71 27.28 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.691 2.261 . . . . 75.439999999999998 112.352 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.488 ' CD1' ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -70.07 -21.94 63.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 74.140000000000001 110.965 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.474 ' CD1' HD12 ' A' ' 381' ' ' ILE . 86.8 m-85 -101.11 -30.77 11.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 73.329999999999998 110.9 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' GLN . . . . . 0.421 ' N ' HD11 ' A' ' 367' ' ' ILE . 0.0 OUTLIER -59.24 -32.84 70.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 75.129999999999995 110.9 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -57.79 -16.42 11.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 72.310000000000002 110.882 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . 0.545 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 36.3 m-85 -75.74 -57.79 3.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 74.549999999999997 110.917 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -154.87 -82.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.743 . . . . 54.329999999999998 112.468 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.633 ' CD2' ' CD2' ' A' ' 368' ' ' LEU . 7.5 t80 -153.77 139.55 18.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.377 . . . . 74.519999999999996 110.904 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.429 HG21 ' CG2' ' A' ' 381' ' ' ILE . 13.1 mt -114.78 109.37 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.019999999999996 111.161 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.633 ' CD2' ' CD2' ' A' ' 366' ' ' PHE . 0.9 OUTLIER -89.74 -21.36 22.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 74.239999999999995 110.944 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -170.94 121.19 0.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 72.340000000000003 110.814 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.553 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 30.6 t80 -111.13 138.78 47.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 72.409999999999997 110.955 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.11 100.47 6.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 75.450000000000003 110.935 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . 0.478 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 10.4 t-80 -97.82 132.82 43.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 72.340000000000003 110.864 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -123.92 88.82 52.12 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.677 0.751 . . . . 75.439999999999998 110.881 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 -17.03 37.86 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.622 2.215 . . . . 61.409999999999997 112.449 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -83.73 -26.43 29.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 72.120000000000005 110.846 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -104.63 -26.65 12.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 74.329999999999998 110.881 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 87.22 38.97 7.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.822 -0.704 . . . . 64.420000000000002 112.501 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.4 p -153.0 151.41 30.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 74.420000000000002 110.9 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.553 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 28.8 p -142.19 141.44 32.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 75.010000000000005 110.861 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.508 ' CD2' ' HB2' ' A' ' 344' ' ' TYR . 15.4 m-85 -119.69 138.53 53.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 73.430000000000007 110.886 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.474 HD12 ' CD1' ' A' ' 361' ' ' PHE . 0.6 OUTLIER -127.18 128.06 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 73.099999999999994 111.093 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.49 137.18 32.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 75.209999999999994 110.886 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -120.24 156.05 31.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 73.439999999999998 110.889 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -53.15 -50.33 64.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.102 -0.499 . . . . 71.209999999999994 110.863 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' THR . . . . . 0.409 ' C ' HG22 ' A' ' 341' ' ' THR . 38.7 p -113.41 176.06 5.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 111.203 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' HIS . . . . . 0.426 ' N ' HG22 ' A' ' 341' ' ' THR . 39.9 p-80 -83.88 -39.7 19.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 71.239999999999995 110.852 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.91 -28.82 67.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 72.340000000000003 110.836 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -34.98 79.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 110.924 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -74.94 -37.51 61.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 70.25 111.098 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -60.99 -32.07 71.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 63.399999999999999 111.052 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 81.2 t -66.29 -39.16 83.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 71.129999999999995 111.111 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . 0.545 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 1.7 t -79.4 -25.42 42.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 73.340000000000003 110.851 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 408' ' ' THR . 0.3 OUTLIER -60.79 -55.5 24.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 61.420000000000002 111.149 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 395' ' ' ALA . 0.3 OUTLIER -69.74 -42.27 80.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 60.32 111.071 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . 0.483 ' N ' ' CG1' ' A' ' 394' ' ' VAL . . . -55.95 -45.75 78.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 75.209999999999994 111.14 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . 0.569 HD12 ' CE1' ' A' ' 399' ' ' PHE . 0.5 OUTLIER -79.76 -19.27 49.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 73.5 110.939 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -48.38 113.96 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 111.1 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 45.52 50.26 10.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 73.129999999999995 110.877 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -110.17 143.7 28.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.712 0.768 . . . . 73.530000000000001 110.935 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 133.76 26.39 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.683 2.255 . . . . 73.329999999999998 112.382 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' PHE . . . . . 0.573 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 36.0 t80 -137.34 111.3 8.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 74.010000000000005 110.864 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 48.7 32.81 3.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 63.520000000000003 110.873 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.34 -30.72 9.78 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 71.310000000000002 112.488 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 134.81 48.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.912 0.387 . . . . 70.010000000000005 110.875 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -74.83 154.39 38.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 75.230000000000004 110.799 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . 0.475 ' CD2' ' O ' ' A' ' 347' ' ' ASN . 15.9 mt -117.66 171.05 8.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 74.519999999999996 110.898 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.02 177.0 4.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 74.549999999999997 110.843 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' THR . . . . . 0.445 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 6.9 p -152.7 152.17 31.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 75.450000000000003 111.181 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.695 -0.764 . . . . 64.040000000000006 112.427 179.954 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.79 0.329 . . . . 74.5 110.926 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -52.65 -28.75 22.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 71.129999999999995 111.141 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' VAL . . . . . 0.513 ' CG1' ' CB ' ' A' ' 390' ' ' ALA . 8.0 t -70.55 -29.87 40.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 72.319999999999993 111.087 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -54.21 -36.04 63.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.319999999999993 110.82 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -65.42 -31.87 73.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 74.329999999999998 110.884 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 38.7 mm -60.56 -49.01 86.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 75.200000000000003 111.185 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.464 HG21 ' CD2' ' A' ' 386' ' ' HIS . 19.6 mt -57.44 -32.63 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 75.430000000000007 111.055 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -5.74 13.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 74.530000000000001 110.814 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.95 7.91 44.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 75.519999999999996 110.882 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -161.33 159.56 23.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 71.140000000000001 111.059 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.71 154.07 68.38 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.672 2.248 . . . . 73.219999999999999 112.369 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -8.98 24.97 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.62 2.213 . . . . 73.420000000000002 112.388 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -47.07 15.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 73.150000000000006 110.882 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 8.3 p -73.18 132.86 32.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 75.230000000000004 111.134 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 386' ' ' HIS . 40.6 p -144.43 68.92 1.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 74.430000000000007 111.14 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 53.2 m -133.16 117.73 17.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 65.230000000000004 111.162 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -81.72 126.89 32.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 75.200000000000003 111.078 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -106.02 134.72 48.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 72.310000000000002 110.971 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . . . . . . . . . 1.8 mp -130.4 121.2 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 72.099999999999994 111.12 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -108.53 167.45 13.17 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.796 -0.716 . . . . 62.229999999999997 112.49 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.488 ' O ' ' CD2' ' A' ' 406' ' ' LEU . 1.4 t30 69.55 57.34 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.776 0.322 . . . . 74.450000000000003 110.876 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.435 ' CG2' ' HB1' ' A' ' 352' ' ' ALA . 47.7 mt -107.94 131.16 21.93 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.631 0.729 . . . . 72.019999999999996 111.091 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . 0.432 ' CG ' ' CE1' ' A' ' 351' ' ' PHE . 53.9 Cg_endo -69.68 161.46 45.82 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.687 2.258 . . . . 73.530000000000001 112.384 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -64.2 -29.08 70.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 70.319999999999993 110.867 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.432 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 6.4 p90 -85.14 33.16 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 74.25 110.887 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . 0.602 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -117.36 100.74 7.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 43.240000000000002 111.109 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 17.1 p -105.69 170.0 8.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 72.340000000000003 111.083 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . 0.493 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.28 -29.88 69.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 73.510000000000005 110.92 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.36 -26.31 63.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 111.102 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.15 -14.95 13.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 71.349999999999994 110.837 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.445 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.5 mp -97.24 -52.87 3.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.193 -0.458 . . . . 73.040000000000006 110.895 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.638 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -41.87 -50.89 10.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.622 0.725 . . . . 70.439999999999998 111.115 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.5 Cg_endo -69.83 -35.13 13.0 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.671 2.247 . . . . 75.439999999999998 112.339 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.579 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -59.73 -26.26 65.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 74.140000000000001 110.919 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.514 ' CD2' HD13 ' A' ' 360' ' ' LEU . 85.8 m-85 -96.73 -25.24 15.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.223 -0.444 . . . . 73.329999999999998 110.882 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' GLN . . . . . 0.479 ' N ' HD12 ' A' ' 367' ' ' ILE . 5.4 mt-30 -60.45 -47.76 84.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 75.129999999999995 110.903 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -42.44 -23.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 72.310000000000002 110.918 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 362' ' ' GLN . 23.3 m-85 -71.46 -60.07 2.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 74.549999999999997 110.913 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -150.7 -88.51 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.735 -0.745 . . . . 54.329999999999998 112.543 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.484 ' CE2' HD13 ' A' ' 368' ' ' LEU . 28.8 t80 -153.92 138.77 17.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.852 0.358 . . . . 74.519999999999996 110.893 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 362' ' ' GLN . 32.5 mt -120.43 116.87 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.477 . . . . 75.019999999999996 111.124 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.484 HD13 ' CE2' ' A' ' 366' ' ' PHE . 0.0 OUTLIER -104.42 -16.2 15.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 74.239999999999995 110.877 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.477 ' N ' HD22 ' A' ' 368' ' ' LEU . 3.7 m-20 -159.86 121.05 3.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 72.340000000000003 110.9 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 31.0 t80 -123.21 142.66 50.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 72.409999999999997 110.895 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -129.56 101.1 5.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 75.450000000000003 110.907 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . 0.602 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 11.2 t-80 -97.43 136.61 37.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 72.340000000000003 110.879 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -130.76 89.32 43.61 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.695 0.759 . . . . 75.439999999999998 110.893 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' PRO . . . . . 0.562 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 54.0 Cg_endo -69.77 -29.78 23.3 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.627 2.218 . . . . 61.409999999999997 112.364 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.1 -14.04 62.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 72.120000000000005 110.873 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -119.81 -24.38 6.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 110.869 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 80.34 44.35 8.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 64.420000000000002 112.434 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.2 p -156.83 137.81 13.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.825 0.345 . . . . 74.420000000000002 110.887 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 14.6 p -129.79 156.97 43.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 75.010000000000005 110.909 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -136.98 128.49 28.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.26 -0.427 . . . . 73.430000000000007 110.921 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.494 HD12 ' CD1' ' A' ' 361' ' ' PHE . 0.7 OUTLIER -117.83 131.34 70.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 73.099999999999994 111.155 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.72 137.23 37.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 75.209999999999994 110.907 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -120.88 173.52 7.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 73.439999999999998 110.913 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.56 -26.02 35.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 71.209999999999994 110.894 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' THR . . . . . 0.421 ' C ' HG22 ' A' ' 341' ' ' THR . 41.7 p -129.31 162.48 27.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 74.420000000000002 111.083 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' HIS . . . . . 0.464 ' CD2' HG21 ' A' ' 333' ' ' ILE . 26.3 p-80 -86.78 -33.7 19.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 71.239999999999995 110.865 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -60.8 -44.57 96.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 72.340000000000003 110.912 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -60.36 -35.29 75.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 75.420000000000002 110.964 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -68.57 -44.06 75.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 70.25 111.067 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . 0.513 ' CB ' ' CG1' ' A' ' 329' ' ' VAL . . . -50.1 -25.59 3.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 63.399999999999999 111.14 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 65.0 t -69.54 -49.76 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 71.129999999999995 111.164 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . 0.402 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 30.7 t -57.51 -31.57 66.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 73.340000000000003 110.893 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.65 -56.33 14.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.447 . . . . 61.420000000000002 111.097 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.499 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.2 t -72.07 -35.21 52.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 60.32 111.056 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.71 95.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 75.209999999999994 111.061 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . 0.559 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.5 mm? -93.63 -10.6 34.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.306 -0.407 . . . . 73.5 110.976 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' ALA . . . . . 0.451 ' N ' HG22 ' A' ' 408' ' ' THR . . . -51.8 110.12 0.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 74.200000000000003 111.102 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 57.6 t30 43.02 48.07 5.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 73.129999999999995 110.874 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.559 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -104.53 147.32 34.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.721 0.772 . . . . 73.530000000000001 110.848 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.429 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 54.6 Cg_endo -69.68 141.55 45.84 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.669 2.246 . . . . 73.329999999999998 112.339 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' PHE . . . . . 0.499 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 36.4 t80 -147.58 111.22 4.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 74.010000000000005 110.815 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 49.01 38.65 13.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 63.520000000000003 110.913 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 93.96 -29.07 9.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 71.310000000000002 112.409 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.4 OUTLIER -105.93 140.07 39.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.783 0.325 . . . . 70.010000000000005 110.97 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.438 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 9.0 m120 -81.62 154.63 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 75.230000000000004 110.875 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . 0.488 ' CD2' ' O ' ' A' ' 347' ' ' ASN . 13.3 mt -115.86 172.95 6.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 74.519999999999996 110.974 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -113.5 173.24 6.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 74.549999999999997 110.897 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' THR . . . . . 0.533 ' CG2' ' C ' ' A' ' 396' ' ' LEU . 71.0 p -154.18 151.55 29.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 75.450000000000003 111.118 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.236 0 C-N-CA 120.748 -0.739 . . . . 64.040000000000006 112.489 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.719 0.295 . . . . 74.5 110.905 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -57.14 -24.64 55.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 71.129999999999995 111.112 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' VAL . . . . . 0.476 ' CG1' ' CB ' ' A' ' 390' ' ' ALA . 11.4 t -77.16 -30.1 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 72.319999999999993 111.154 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -55.0 -41.67 71.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 73.319999999999993 110.842 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -55.86 -35.48 66.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 74.329999999999998 110.857 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 39.1 mm -63.67 -49.67 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 75.200000000000003 111.108 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 13.3 mt -51.49 -50.06 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 75.430000000000007 111.126 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.28 -8.75 6.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 74.530000000000001 110.92 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 2.2 t -96.98 25.57 5.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 75.519999999999996 110.839 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -173.95 154.75 2.29 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.725 . . . . 71.140000000000001 111.082 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 150.76 68.31 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 73.219999999999999 112.369 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . 0.402 ' HA ' ' ND1' ' A' ' 386' ' ' HIS . 54.4 Cg_endo -69.67 -12.11 32.37 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.669 2.246 . . . . 73.420000000000002 112.42 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -78.4 -53.39 7.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 73.150000000000006 110.832 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 4.1 p -69.34 135.19 28.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 75.230000000000004 111.13 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' THR . . . . . 0.472 HG23 ' N ' ' A' ' 386' ' ' HIS . 44.6 p -142.69 68.19 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 111.113 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 3.4 m -133.75 128.93 35.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 65.230000000000004 111.183 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -92.91 134.31 35.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 75.200000000000003 111.133 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.518 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -112.69 128.57 56.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 72.310000000000002 110.918 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.471 HG21 ' CD1' ' A' ' 348' ' ' ILE . 1.6 mp -124.94 110.05 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 72.099999999999994 111.139 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -101.86 161.4 17.63 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 62.229999999999997 112.535 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 405' ' ' ASN . 0.7 OUTLIER 81.14 50.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 74.450000000000003 110.864 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.471 ' CD1' HG21 ' A' ' 345' ' ' ILE . 74.2 mt -107.06 138.68 19.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.607 0.718 . . . . 72.019999999999996 111.118 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . 0.533 ' HB2' ' CD1' ' A' ' 351' ' ' PHE . 54.2 Cg_endo -69.72 166.23 28.24 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.695 2.263 . . . . 73.530000000000001 112.364 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -76.34 -15.67 59.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 70.319999999999993 110.839 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.533 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 47.8 p90 -100.44 29.31 4.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 74.25 110.85 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . 0.591 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -114.54 99.86 7.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 43.240000000000002 111.081 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 10.1 p -96.54 171.08 8.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 72.340000000000003 111.056 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . 0.495 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.32 -30.4 70.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 73.510000000000005 110.843 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -55.1 -26.41 37.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 74.319999999999993 111.12 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.3 -12.96 13.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 71.349999999999994 110.822 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.439 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.4 mp -98.58 -54.46 3.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 73.040000000000006 110.953 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.627 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 0.9 OUTLIER -40.71 -51.5 6.87 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.631 0.729 . . . . 70.439999999999998 111.139 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.5 Cg_endo -69.8 -34.36 14.6 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.7 2.267 . . . . 75.439999999999998 112.308 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.575 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -59.65 -25.07 64.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 74.140000000000001 110.904 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.512 ' CD1' ' CD1' ' A' ' 381' ' ' ILE . 87.6 m-85 -98.01 -37.33 9.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 73.329999999999998 110.885 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' GLN . . . . . 0.475 ' HG2' ' CD1' ' A' ' 367' ' ' ILE . 6.3 mm-40 -50.66 -45.02 57.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 75.129999999999995 110.863 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -44.95 -21.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 72.310000000000002 110.879 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . 0.447 ' CE2' ' HA ' ' A' ' 361' ' ' PHE . 30.9 m-85 -75.3 -56.86 4.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 74.549999999999997 110.925 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -152.89 -90.26 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 54.329999999999998 112.477 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -153.8 142.87 21.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.757 0.313 . . . . 74.519999999999996 110.84 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.475 ' CD1' ' HG2' ' A' ' 362' ' ' GLN . 59.1 mt -120.95 109.13 24.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.168 -0.469 . . . . 75.019999999999996 111.129 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.64 -16.81 35.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 74.239999999999995 110.876 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.93 120.74 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 72.340000000000003 110.881 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.558 ' CD1' HG12 ' A' ' 381' ' ' ILE . 35.9 t80 -114.13 144.81 42.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 72.409999999999997 110.898 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.52 100.09 5.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 75.450000000000003 110.875 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . 0.591 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 4.0 t-80 -103.13 131.91 49.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 72.340000000000003 110.835 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.448 ' CB ' ' HB2' ' A' ' 376' ' ' LYS . 96.6 m-85 -128.73 102.19 20.01 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.639 0.733 . . . . 75.439999999999998 110.904 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 373' ' ' TYR . 53.5 Cg_endo -69.76 -25.13 28.93 Favored 'Trans proline' 0 N--CA 1.466 -0.114 0 C-N-CA 122.711 2.274 . . . . 61.409999999999997 112.344 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -87.57 -8.77 55.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 72.120000000000005 110.897 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' LYS . . . . . 0.448 ' HB2' ' CB ' ' A' ' 373' ' ' TYR . 0.0 OUTLIER -106.5 -28.13 10.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 74.329999999999998 110.862 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 80.61 24.32 58.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 64.420000000000002 112.461 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 92.1 m -155.22 149.8 26.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.776 0.322 . . . . 74.420000000000002 110.867 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 14.9 p -133.8 151.27 51.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 75.010000000000005 110.874 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' A' ' 380' ' ' PHE . 3.5 m-85 -124.35 127.72 48.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 73.430000000000007 110.864 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.558 HG12 ' CD1' ' A' ' 370' ' ' PHE . 1.3 mt -119.24 121.35 66.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.516 . . . . 73.099999999999994 111.041 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.37 130.01 34.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 75.209999999999994 110.891 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -115.11 -174.89 2.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 73.439999999999998 110.906 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -73.61 -54.93 7.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.061 -0.518 . . . . 71.209999999999994 110.943 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 71.1 p -120.2 178.78 4.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 74.420000000000002 111.181 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' HIS . . . . . 0.472 ' N ' HG23 ' A' ' 341' ' ' THR . 21.2 p-80 -83.65 -39.43 20.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 71.239999999999995 110.857 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -57.35 -28.82 63.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.425 . . . . 72.340000000000003 110.877 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -46.09 78.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 75.420000000000002 110.943 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -62.79 -25.71 68.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.235 -0.439 . . . . 70.25 111.121 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . 0.476 ' CB ' ' CG1' ' A' ' 329' ' ' VAL . . . -58.27 -40.12 81.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 63.399999999999999 111.134 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 14.1 t -61.92 -57.9 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 71.129999999999995 111.081 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 18.4 p -58.91 -31.34 68.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 73.340000000000003 110.895 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.97 -55.38 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 61.420000000000002 111.087 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.468 HG13 ' CG2' ' A' ' 329' ' ' VAL . 0.3 OUTLIER -72.25 -35.74 53.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 60.32 111.187 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.57 -47.81 82.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 75.209999999999994 111.095 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . 0.593 ' CB ' ' CG2' ' A' ' 408' ' ' THR . 1.2 mm? -79.83 -13.42 59.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.258 -0.428 . . . . 73.5 110.913 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' ALA . . . . . 0.454 ' N ' HG22 ' A' ' 408' ' ' THR . . . -50.33 112.91 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 74.200000000000003 111.096 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.2 m120 44.13 51.49 7.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 73.129999999999995 110.835 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.575 ' CE1' HD11 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -108.0 147.94 36.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.689 0.757 . . . . 73.530000000000001 110.865 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.424 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.3 Cg_endo -69.71 145.16 56.58 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.706 2.271 . . . . 73.329999999999998 112.324 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' PHE . . . . . 0.571 ' CZ ' ' NE2' ' A' ' 402' ' ' GLN . 40.0 t80 -151.85 111.49 3.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 74.010000000000005 110.856 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . 0.571 ' NE2' ' CZ ' ' A' ' 401' ' ' PHE . 4.9 mt-30 46.7 38.63 6.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 63.520000000000003 110.893 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 94.57 -29.99 8.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.735 . . . . 71.310000000000002 112.539 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -104.91 137.62 42.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 70.010000000000005 110.83 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.477 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 4.6 m120 -80.04 152.75 29.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 75.230000000000004 110.895 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . 0.405 ' CD2' ' O ' ' A' ' 347' ' ' ASN . 13.9 mt -114.58 173.57 6.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 74.519999999999996 110.944 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 346' ' ' GLY . 5.5 ttm-85 -117.63 175.36 5.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 74.549999999999997 110.88 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' THR . . . . . 0.593 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 43.0 p -151.63 153.45 34.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 75.450000000000003 111.122 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.665 -0.779 . . . . 64.040000000000006 112.412 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.734 0.302 . . . . 74.5 110.898 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -51.05 -33.73 26.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.424 . . . . 71.129999999999995 111.11 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' VAL . . . . . 0.531 ' CG1' ' CB ' ' A' ' 390' ' ' ALA . 7.9 t -70.27 -28.66 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 72.319999999999993 111.113 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -53.11 -37.45 61.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 73.319999999999993 110.867 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -71.65 -31.81 67.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 74.329999999999998 110.805 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . 0.483 HG23 ' CD1' ' A' ' 393' ' ' ILE . 33.5 mm -54.59 -56.07 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 75.200000000000003 111.141 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 4.3 mt -49.72 -39.24 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 75.430000000000007 111.163 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -27.35 31.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 74.530000000000001 110.828 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 4.8 t -68.47 -32.1 71.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 75.519999999999996 110.858 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -113.93 155.43 45.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.606 0.717 . . . . 71.140000000000001 111.061 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 161.79 44.57 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.654 2.236 . . . . 73.219999999999999 112.425 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.8 -11.47 30.86 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.667 2.245 . . . . 73.420000000000002 112.304 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -106.61 67.33 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 73.150000000000006 110.883 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 5.3 p 177.14 134.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 75.230000000000004 111.147 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 19.9 p -141.55 69.99 1.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 74.430000000000007 111.193 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 23.7 m -133.61 121.71 22.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 65.230000000000004 111.2 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -88.33 134.33 33.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 75.200000000000003 111.15 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.605 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -111.2 121.65 45.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.289 -0.414 . . . . 72.310000000000002 110.942 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . . . . . . . . . 2.3 mp -124.31 102.19 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 72.099999999999994 111.14 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -92.28 -173.19 41.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.69 -0.767 . . . . 62.229999999999997 112.519 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.9 t30 58.76 46.66 13.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 74.450000000000003 110.901 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.449 ' CG2' ' HB2' ' A' ' 352' ' ' ALA . 81.6 mt -100.08 131.38 24.37 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.529 0.68 . . . . 72.019999999999996 111.164 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . 0.523 ' CB ' ' CE1' ' A' ' 351' ' ' PHE . 53.9 Cg_endo -69.71 156.22 64.03 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.736 2.29 . . . . 73.530000000000001 112.372 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.7 -20.83 65.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 70.319999999999993 110.827 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.523 ' CE1' ' CB ' ' A' ' 349' ' ' PRO . 4.8 p90 -94.01 29.35 2.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 74.25 110.929 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . 0.565 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -116.0 96.14 5.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 43.240000000000002 111.109 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 15.2 p -98.39 170.69 8.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 72.340000000000003 111.161 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . 0.5 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.6 OUTLIER -67.31 -29.72 69.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 73.510000000000005 110.843 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.67 -26.21 63.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 74.319999999999993 111.084 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.3 -14.1 13.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 71.349999999999994 110.844 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.455 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 2.8 mp -97.78 -52.14 3.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 73.040000000000006 110.901 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.655 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -42.52 -50.32 12.34 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.627 0.727 . . . . 70.439999999999998 111.137 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 52.9 Cg_endo -69.78 -29.09 24.33 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.684 2.256 . . . . 75.439999999999998 112.313 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.58 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.2 OUTLIER -66.97 -21.83 65.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 74.140000000000001 110.924 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.459 ' CD2' HD13 ' A' ' 360' ' ' LEU . 87.8 m-85 -103.32 -36.04 8.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 73.329999999999998 110.891 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -49.14 -40.27 31.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 75.129999999999995 110.853 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -48.86 -27.84 3.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 72.310000000000002 110.928 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . 0.552 ' CE1' ' HA ' ' A' ' 392' ' ' CYS . 39.7 m-85 -64.19 -56.88 11.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 74.549999999999997 110.902 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -158.98 -84.69 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.786 -0.721 . . . . 54.329999999999998 112.537 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -153.24 145.45 23.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.799 0.333 . . . . 74.519999999999996 110.893 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.473 HG22 ' CG2' ' A' ' 381' ' ' ILE . 27.6 mt -121.1 111.31 31.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 75.019999999999996 111.165 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.86 -23.18 25.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 74.239999999999995 110.934 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.16 120.67 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 72.340000000000003 110.944 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.536 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 32.8 t80 -112.34 140.96 46.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 72.409999999999997 110.845 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.11 101.21 6.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 75.450000000000003 110.909 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.3 t-80 -97.43 124.07 41.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 72.340000000000003 110.795 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -118.02 89.01 33.37 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.698 0.761 . . . . 75.439999999999998 110.911 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' PRO . . . . . 0.438 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.4 Cg_endo -69.78 -26.16 27.76 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.648 2.232 . . . . 61.409999999999997 112.325 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -72.75 -12.7 61.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 72.120000000000005 110.829 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -119.75 -26.43 5.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 74.329999999999998 110.916 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 86.55 41.52 6.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.738 -0.744 . . . . 64.420000000000002 112.491 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.5 t -159.99 147.74 16.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.745 0.307 . . . . 74.420000000000002 110.863 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.536 ' HB2' ' CE1' ' A' ' 370' ' ' PHE . 21.5 p -134.18 155.13 50.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 75.010000000000005 110.824 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -128.95 122.79 30.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 73.430000000000007 110.887 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.481 ' CG1' ' CD1' ' A' ' 370' ' ' PHE . 1.1 mt -114.17 134.05 58.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 73.099999999999994 111.113 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.37 131.76 48.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 75.209999999999994 110.863 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -112.75 -173.83 2.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 73.439999999999998 110.931 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.62 -39.03 16.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 71.209999999999994 110.873 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 54.7 p -120.82 174.35 6.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 74.420000000000002 111.139 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -87.17 -32.13 20.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 71.239999999999995 110.88 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -61.16 -41.92 97.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 72.340000000000003 110.849 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.93 -35.79 67.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 75.420000000000002 110.892 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.39 -26.12 60.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.227 -0.442 . . . . 70.25 111.13 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . 0.531 ' CB ' ' CG1' ' A' ' 329' ' ' VAL . . . -68.56 -40.42 80.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 63.399999999999999 111.072 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.73 -55.2 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 71.129999999999995 111.141 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . 0.552 ' HA ' ' CE1' ' A' ' 364' ' ' PHE . 16.7 p -57.15 -29.69 63.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.485 . . . . 73.340000000000003 110.858 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.483 ' CD1' HG23 ' A' ' 332' ' ' ILE . 8.6 mt -60.03 -55.42 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 61.420000000000002 111.134 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.493 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 1.7 t -72.04 -34.43 50.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 60.32 111.132 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -63.77 -47.86 79.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 75.209999999999994 111.08 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . 0.534 ' C ' ' CG2' ' A' ' 408' ' ' THR . 0.3 OUTLIER -82.14 -6.38 59.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 73.5 110.899 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' ALA . . . . . 0.443 ' N ' HG22 ' A' ' 408' ' ' THR . . . -54.89 112.79 1.12 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.204 -0.453 . . . . 74.200000000000003 111.118 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 44.79 46.29 8.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 73.129999999999995 110.946 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.47 ' CD1' HD12 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -99.29 145.55 30.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.634 0.73 . . . . 73.530000000000001 110.85 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 141.91 46.22 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.714 2.276 . . . . 73.329999999999998 112.358 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' PHE . . . . . 0.453 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 48.2 t80 -151.01 112.86 4.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 74.010000000000005 110.871 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 52.97 32.74 13.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 63.520000000000003 110.917 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 96.63 -26.61 21.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.69 -0.767 . . . . 71.310000000000002 112.448 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 401' ' ' PHE . 9.9 ttt85 -108.57 143.61 37.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.827 0.346 . . . . 70.010000000000005 110.917 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -80.81 155.17 26.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 75.230000000000004 110.933 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 10.4 mt -114.77 175.13 5.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 74.519999999999996 110.899 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.02 176.21 5.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 74.549999999999997 110.902 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' THR . . . . . 0.534 ' CG2' ' C ' ' A' ' 396' ' ' LEU . 45.0 p -154.06 149.82 27.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 75.450000000000003 111.147 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.72 . . . . 64.040000000000006 112.506 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.732 0.301 . . . . 74.5 110.899 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -58.63 -25.49 62.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 71.129999999999995 111.065 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' VAL . . . . . 0.474 ' CG2' HG12 ' A' ' 394' ' ' VAL . 24.6 t -78.21 -29.98 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.434 . . . . 72.319999999999993 111.187 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -54.71 -35.64 63.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 73.319999999999993 110.877 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' HIS . . . . . 0.489 ' CD2' HD12 ' A' ' 332' ' ' ILE . 2.2 t60 -61.69 -38.27 87.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 74.329999999999998 110.884 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . 0.489 HD12 ' CD2' ' A' ' 331' ' ' HIS . 1.1 mp -54.21 -51.42 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 75.200000000000003 111.096 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 9.0 mt -53.67 -38.38 34.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 75.430000000000007 111.121 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -2.45 6.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.530000000000001 110.872 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 43.2 t -108.92 21.76 16.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 75.519999999999996 110.829 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -175.9 150.88 1.14 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.586 0.707 . . . . 71.140000000000001 111.083 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 154.28 67.65 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.629 2.219 . . . . 73.219999999999999 112.323 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -8.05 22.6 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.678 2.252 . . . . 73.420000000000002 112.351 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.08 -49.72 13.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 73.150000000000006 110.876 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.75 133.05 32.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 75.230000000000004 111.146 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' THR . . . . . 0.448 HG22 ' CB ' ' A' ' 386' ' ' HIS . 30.2 p -135.7 68.02 1.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.117 -0.492 . . . . 74.430000000000007 111.184 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 51.2 m -133.72 136.99 45.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 65.230000000000004 111.154 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . 0.446 ' CB ' ' SG ' ' A' ' 392' ' ' CYS . . . -109.18 129.54 55.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 75.200000000000003 111.088 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.486 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -105.95 134.44 49.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 72.310000000000002 110.899 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . . . . . . . . . 1.9 mp -129.61 100.7 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 72.099999999999994 111.171 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -90.07 178.61 43.56 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.713 -0.756 . . . . 62.229999999999997 112.488 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 405' ' ' ASN . 2.3 t30 67.64 49.23 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 74.450000000000003 110.899 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.47 ' CG2' ' HD2' ' A' ' 349' ' ' PRO . 77.4 mt -105.11 138.51 19.54 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.618 0.723 . . . . 72.019999999999996 111.156 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . 0.539 ' HB2' ' CD1' ' A' ' 351' ' ' PHE . 53.7 Cg_endo -69.75 164.04 36.03 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.708 2.272 . . . . 73.530000000000001 112.361 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -75.57 -18.64 59.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 70.319999999999993 110.817 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.539 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 55.4 p90 -92.88 17.65 10.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 74.25 110.9 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . 0.588 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -105.8 116.04 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 43.240000000000002 111.159 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 25.6 p -114.96 170.42 8.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 72.340000000000003 111.192 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . 0.488 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -64.82 -29.77 70.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 73.510000000000005 110.935 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.48 -26.59 63.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 74.319999999999993 111.108 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.27 -13.6 13.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 71.349999999999994 110.954 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.439 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.5 mp -98.47 -52.27 3.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 73.040000000000006 110.899 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.637 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -41.83 -51.07 9.95 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.639 0.733 . . . . 70.439999999999998 111.066 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.1 Cg_endo -69.79 -35.37 12.69 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.699 2.266 . . . . 75.439999999999998 112.388 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.588 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -59.45 -23.47 62.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 74.140000000000001 110.922 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.531 ' CD1' HD12 ' A' ' 381' ' ' ILE . 82.8 m-85 -100.97 -35.6 9.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 73.329999999999998 110.877 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -53.34 -35.41 60.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 75.129999999999995 110.934 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -54.11 -14.88 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 72.310000000000002 110.875 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -78.62 -56.78 4.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 74.549999999999997 110.862 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -157.09 -85.99 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 54.329999999999998 112.453 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.572 ' CD2' HD22 ' A' ' 368' ' ' LEU . 8.4 t80 -153.64 142.82 21.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 74.519999999999996 110.881 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.401 HG23 ' CG2' ' A' ' 381' ' ' ILE . 50.3 mt -120.87 112.3 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 75.019999999999996 111.156 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.572 HD22 ' CD2' ' A' ' 366' ' ' PHE . 0.3 OUTLIER -86.01 -21.82 27.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 74.239999999999995 110.889 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.94 121.2 0.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 72.340000000000003 110.88 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 33.5 t80 -111.11 139.77 46.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 72.409999999999997 110.891 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -126.82 100.93 6.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 75.450000000000003 110.95 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . 0.588 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 11.0 t-80 -96.37 115.71 27.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 72.340000000000003 110.793 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -107.25 84.58 1.77 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.744 . . . . 75.439999999999998 110.874 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' PRO . . . . . 0.509 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 53.9 Cg_endo -69.73 -17.38 37.72 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.701 2.267 . . . . 61.409999999999997 112.411 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -78.24 -24.67 46.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 72.120000000000005 110.908 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -108.7 -27.41 9.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 110.948 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 93.4 42.29 4.29 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.676 -0.774 . . . . 64.420000000000002 112.452 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 26.3 p -159.92 158.18 30.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.837 0.351 . . . . 74.420000000000002 110.942 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.57 ' HB2' ' CE1' ' A' ' 370' ' ' PHE . 28.1 p -143.35 152.32 41.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 75.010000000000005 110.872 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 344' ' ' TYR . 38.0 m-85 -125.8 125.03 42.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 73.430000000000007 110.827 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.531 HD12 ' CD1' ' A' ' 361' ' ' PHE . 0.7 OUTLIER -115.28 121.25 66.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 73.099999999999994 111.139 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -87.94 131.95 34.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 75.209999999999994 110.919 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -116.43 162.7 17.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 73.439999999999998 110.889 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -60.99 -45.55 94.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 71.209999999999994 110.873 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 30.2 p -112.92 169.02 9.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 74.420000000000002 111.143 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' HIS . . . . . 0.448 ' CB ' HG22 ' A' ' 341' ' ' THR . 18.0 p-80 -82.62 -36.14 26.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 71.239999999999995 110.891 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -62.73 -26.81 68.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.181 -0.463 . . . . 72.340000000000003 110.896 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -34.96 79.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 75.420000000000002 110.868 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.66 -41.26 62.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 70.25 111.05 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -58.87 -26.36 64.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 63.399999999999999 111.121 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 79.7 t -71.36 -55.76 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 71.129999999999995 111.145 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 343' ' ' ALA . 30.3 p -60.64 -32.05 71.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 73.340000000000003 110.913 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.465 ' CG2' HG12 ' A' ' 332' ' ' ILE . 0.2 OUTLIER -53.54 -54.98 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 61.420000000000002 111.092 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.474 HG12 ' CG2' ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.7 -38.91 68.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 60.32 111.139 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . 0.415 ' N ' ' CG1' ' A' ' 394' ' ' VAL . . . -62.03 -33.91 75.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 75.209999999999994 111.116 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . 0.57 HD11 ' CE1' ' A' ' 399' ' ' PHE . 2.6 mm? -93.61 -15.08 25.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 73.5 110.925 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' ALA . . . . . 0.409 ' N ' HG23 ' A' ' 408' ' ' THR . . . -47.39 111.47 0.42 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 74.200000000000003 111.065 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 43.14 47.43 5.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 73.129999999999995 110.944 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.57 ' CE1' HD11 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -100.88 146.28 31.85 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.661 0.744 . . . . 73.530000000000001 110.841 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.441 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 54.2 Cg_endo -69.76 137.05 34.57 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.717 2.278 . . . . 73.329999999999998 112.339 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' PHE . . . . . 0.563 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 29.9 t80 -142.64 111.13 6.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 74.010000000000005 110.967 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 48.98 34.5 5.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 63.520000000000003 110.935 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 99.28 -31.99 7.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.741 -0.743 . . . . 71.310000000000002 112.454 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.8 134.71 47.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 70.010000000000005 110.859 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.474 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 3.1 m120 -78.2 152.25 32.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 75.230000000000004 110.892 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 10.8 mt -111.62 177.5 4.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 74.519999999999996 110.872 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.77 172.26 7.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 74.549999999999997 110.85 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' THR . . . . . 0.488 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 45.8 p -154.77 146.09 22.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 75.450000000000003 111.18 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 344' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 64.040000000000006 112.512 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.839 0.352 . . . . 74.5 110.913 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.06 -33.78 63.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 71.129999999999995 111.145 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' VAL . . . . . 0.573 ' CG1' ' CB ' ' A' ' 390' ' ' ALA . 10.7 t -66.78 -29.88 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.178 -0.464 . . . . 72.319999999999993 111.156 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -54.11 -34.74 61.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 73.319999999999993 110.912 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -70.69 -31.99 69.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.446 . . . . 74.329999999999998 110.86 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . 0.447 ' CG2' HG23 ' A' ' 393' ' ' ILE . 29.4 mm -57.98 -44.9 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 75.200000000000003 111.093 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 6.0 mt -53.66 -44.39 57.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 75.430000000000007 111.181 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 -56.08 -13.85 2.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 74.530000000000001 110.93 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 11.7 t -76.32 -30.56 57.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 75.519999999999996 110.9 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -133.78 165.34 37.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.554 0.693 . . . . 71.140000000000001 111.114 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 148.75 65.85 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.675 2.25 . . . . 73.219999999999999 112.342 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -7.64 21.58 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.716 2.278 . . . . 73.420000000000002 112.313 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -43.8 40.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.224 -0.444 . . . . 73.150000000000006 110.806 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.1 p -81.6 139.73 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 75.230000000000004 111.077 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 34.7 p -138.46 69.09 1.38 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 74.430000000000007 111.171 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.466 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 98.6 m -133.59 124.96 27.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 65.230000000000004 111.088 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -85.6 126.47 33.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 75.200000000000003 111.064 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.419 ' C ' HD11 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -106.4 134.29 49.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 72.310000000000002 110.907 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.477 HG23 ' CD1' ' A' ' 406' ' ' LEU . 1.8 mp -135.41 110.97 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 72.099999999999994 111.126 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -100.03 161.08 19.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.696 -0.764 . . . . 62.229999999999997 112.419 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 1.0 OUTLIER 81.09 50.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.775 0.321 . . . . 74.450000000000003 110.882 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.474 ' CG2' ' HD2' ' A' ' 349' ' ' PRO . 46.5 mt -104.1 138.2 19.46 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.619 0.723 . . . . 72.019999999999996 111.149 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . 0.474 ' HD2' ' CG2' ' A' ' 348' ' ' ILE . 53.3 Cg_endo -69.78 166.48 27.47 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.732 2.288 . . . . 73.530000000000001 112.308 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -74.24 -29.66 61.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 70.319999999999993 110.884 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -83.5 12.87 5.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 74.25 110.908 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . 0.594 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -99.15 102.59 14.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 43.240000000000002 111.122 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 22.3 p -105.02 172.0 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 72.340000000000003 111.112 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . 0.487 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.3 OUTLIER -65.6 -30.25 70.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 73.510000000000005 110.845 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -57.25 -26.29 60.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 74.319999999999993 111.095 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.89 -18.68 12.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 71.349999999999994 110.868 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.442 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 4.6 mp -92.68 -52.51 4.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 73.040000000000006 110.957 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.641 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -41.76 -51.1 9.74 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.609 0.718 . . . . 70.439999999999998 111.122 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.8 Cg_endo -69.7 -30.15 23.01 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.669 2.246 . . . . 75.439999999999998 112.353 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.583 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -66.46 -23.96 66.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 74.140000000000001 110.912 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.537 ' CD2' HD12 ' A' ' 360' ' ' LEU . 81.3 m-85 -101.45 -27.43 13.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 73.329999999999998 110.919 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' GLN . . . . . 0.481 ' N ' HD13 ' A' ' 367' ' ' ILE . 0.0 OUTLIER -56.57 -22.93 36.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 75.129999999999995 110.852 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -71.29 -10.38 59.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 72.310000000000002 110.89 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . 0.415 ' CE2' ' SG ' ' A' ' 392' ' ' CYS . 23.6 m-85 -93.17 18.59 9.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 74.549999999999997 110.911 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 130.07 -96.02 0.36 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 54.329999999999998 112.506 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -152.55 150.8 29.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.767 0.318 . . . . 74.519999999999996 110.943 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.481 HD13 ' N ' ' A' ' 362' ' ' GLN . 45.8 mt -121.42 109.86 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 75.019999999999996 111.149 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.75 -18.71 28.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 74.239999999999995 110.922 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.27 120.8 0.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 72.340000000000003 110.906 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 29.4 t80 -112.36 145.4 40.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 72.409999999999997 110.902 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.82 101.16 4.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.469 . . . . 75.450000000000003 110.848 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . 0.594 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 12.9 t-80 -94.99 117.35 29.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 72.340000000000003 110.846 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -109.7 83.64 2.84 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.657 0.741 . . . . 75.439999999999998 110.846 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' PRO . . . . . 0.502 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 52.7 Cg_endo -69.86 -17.97 36.81 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.691 2.261 . . . . 61.409999999999997 112.304 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.28 -27.19 61.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 72.120000000000005 110.862 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -110.52 -27.29 9.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 74.329999999999998 110.856 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 94.25 43.51 3.74 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 64.420000000000002 112.476 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 79.7 m -154.8 152.93 30.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.827 0.346 . . . . 74.420000000000002 110.918 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 16.0 p -136.21 152.49 50.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 75.010000000000005 110.879 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.466 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 48.6 m-85 -129.02 124.79 35.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.430000000000007 110.869 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.446 HD12 ' CD1' ' A' ' 361' ' ' PHE . 0.7 OUTLIER -117.35 123.28 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 73.099999999999994 111.172 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -89.55 136.19 33.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 75.209999999999994 110.886 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -119.63 -178.63 3.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 73.439999999999998 110.925 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.75 -42.57 40.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.496 . . . . 71.209999999999994 110.874 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 55.4 p -127.97 170.3 13.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 74.420000000000002 111.104 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -80.41 -35.31 35.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 71.239999999999995 110.823 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -59.42 -27.18 65.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 72.340000000000003 110.938 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.84 -34.28 62.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 75.420000000000002 110.879 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -69.04 -44.09 73.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 70.25 111.081 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . 0.573 ' CB ' ' CG1' ' A' ' 329' ' ' VAL . . . -50.22 -28.85 8.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 63.399999999999999 111.082 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.57 -40.07 79.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 71.129999999999995 111.156 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . 0.415 ' SG ' ' CE2' ' A' ' 364' ' ' PHE . 45.4 t -69.93 -33.61 72.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 73.340000000000003 110.892 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.447 HG23 ' CG2' ' A' ' 332' ' ' ILE . 0.9 OUTLIER -53.2 -55.61 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 61.420000000000002 111.19 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.492 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.0 t -71.47 -40.82 72.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 60.32 111.141 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.09 -16.75 54.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 75.209999999999994 111.102 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . 0.553 HD12 ' CE1' ' A' ' 399' ' ' PHE . 0.6 OUTLIER -115.91 -8.7 11.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 73.5 110.934 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -59.23 108.43 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 74.200000000000003 111.136 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 11.1 m120 47.98 49.37 17.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 73.129999999999995 110.911 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.553 ' CE1' HD12 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -108.62 142.75 26.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.694 0.759 . . . . 73.530000000000001 110.884 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.499 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 54.1 Cg_endo -69.71 145.52 57.72 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.702 2.268 . . . . 73.329999999999998 112.306 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' PHE . . . . . 0.485 ' N ' ' O ' ' A' ' 404' ' ' ARG . 50.4 t80 -152.77 110.61 3.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 74.010000000000005 110.797 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 49.54 39.9 18.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.508 . . . . 63.520000000000003 110.948 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 81.72 10.48 84.18 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.775 -0.726 . . . . 71.310000000000002 112.478 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -135.02 132.73 38.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.855 0.36 . . . . 70.010000000000005 110.909 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -82.54 146.02 29.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 75.230000000000004 110.88 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . 0.477 ' CD1' HG23 ' A' ' 345' ' ' ILE . 6.3 mt -112.02 172.6 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 74.519999999999996 110.941 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 345' ' ' ILE . 0.0 OUTLIER -123.16 177.2 5.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 74.549999999999997 110.837 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 19.9 p -157.47 163.4 38.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 75.450000000000003 111.146 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.751 . . . . 64.040000000000006 112.512 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.836 0.35 . . . . 74.5 110.842 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -47.96 -25.27 1.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 71.129999999999995 111.117 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' VAL . . . . . 0.509 ' CG2' ' HB ' ' A' ' 394' ' ' VAL . 14.2 t -83.43 -29.72 7.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 72.319999999999993 111.079 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -53.94 -35.26 61.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 73.319999999999993 110.872 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -68.89 -31.78 70.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 74.329999999999998 110.82 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 31.4 mm -58.38 -51.69 68.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 75.200000000000003 111.151 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 4.8 mt -51.67 -42.54 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 75.430000000000007 111.192 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -53.66 -16.39 1.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 74.530000000000001 110.889 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 6.1 t -88.47 -25.67 22.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 75.519999999999996 110.816 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -116.56 151.22 46.8 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.556 0.694 . . . . 71.140000000000001 111.16 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.74 161.71 44.89 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.753 2.302 . . . . 73.219999999999999 112.374 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -8.43 23.57 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.704 2.269 . . . . 73.420000000000002 112.366 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -109.25 63.47 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 73.150000000000006 110.882 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.401 ' C ' HG22 ' A' ' 341' ' ' THR . 9.2 p -175.15 126.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.451 . . . . 75.230000000000004 111.131 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' THR . . . . . 0.464 HG23 ' N ' ' A' ' 386' ' ' HIS . 21.5 p -137.88 73.46 1.44 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 74.430000000000007 111.146 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 71.1 m -132.86 124.24 27.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 65.230000000000004 111.148 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -93.77 116.33 28.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 75.200000000000003 111.157 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.461 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -101.55 134.29 44.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.424 . . . . 72.310000000000002 110.864 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . . . . . . . . . 1.8 mp -133.43 112.22 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 72.099999999999994 111.155 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -97.31 176.63 31.67 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.75 -0.738 . . . . 62.229999999999997 112.482 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.3 t30 65.68 49.85 1.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.777 0.322 . . . . 74.450000000000003 110.847 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 74.3 mt -104.98 135.4 19.3 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.614 0.721 . . . . 72.019999999999996 111.124 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.74 164.86 32.94 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.692 2.261 . . . . 73.530000000000001 112.42 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -72.5 -23.34 61.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 70.319999999999993 110.893 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -92.9 28.73 2.0 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.47 . . . . 74.25 110.854 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . 0.545 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -113.63 87.6 2.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 43.240000000000002 111.188 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 38.1 p -87.92 171.29 10.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.201 -0.454 . . . . 72.340000000000003 111.144 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . 0.485 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -66.94 -29.81 69.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 73.510000000000005 110.925 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.21 -26.3 50.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 74.319999999999993 111.047 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.15 -13.28 13.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 71.349999999999994 110.903 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.44 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.3 mp -98.52 -53.88 3.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 73.040000000000006 110.967 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.637 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -41.17 -51.37 7.89 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.671 0.748 . . . . 70.439999999999998 111.15 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.9 Cg_endo -69.76 -31.56 20.3 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.704 2.269 . . . . 75.439999999999998 112.348 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.583 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -63.98 -23.52 67.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 74.140000000000001 110.898 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.527 ' CD2' HD11 ' A' ' 360' ' ' LEU . 86.9 m-85 -102.07 -33.64 9.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 73.329999999999998 110.938 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' GLN . . . . . 0.438 ' N ' HD12 ' A' ' 367' ' ' ILE . 1.4 tt0 -54.06 -31.8 52.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 75.129999999999995 110.927 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -57.2 -21.02 30.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 72.310000000000002 110.86 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . 0.538 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 41.6 m-85 -72.02 -57.4 4.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 74.549999999999997 110.883 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -155.87 -86.28 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.721 . . . . 54.329999999999998 112.483 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -152.41 143.55 23.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 74.519999999999996 110.952 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.438 HD12 ' N ' ' A' ' 362' ' ' GLN . 41.4 mt -120.81 109.17 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 75.019999999999996 111.109 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.27 -21.18 27.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 74.239999999999995 110.91 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.56 121.5 0.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 72.340000000000003 110.881 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.519 ' CD2' HG12 ' A' ' 358' ' ' ILE . 39.1 t80 -115.23 138.95 50.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 72.409999999999997 110.836 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -127.68 100.7 6.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 75.450000000000003 110.852 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 10.8 t-80 -94.98 119.46 33.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 72.340000000000003 110.826 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -113.37 85.58 8.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.67 0.747 . . . . 75.439999999999998 110.873 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' PRO . . . . . 0.512 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 53.7 Cg_endo -69.83 -29.8 22.95 Favored 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.706 2.27 . . . . 61.409999999999997 112.407 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.02 -17.02 64.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 72.120000000000005 110.869 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -116.36 -27.74 6.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.329999999999998 110.901 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.81 39.96 5.71 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.696 -0.764 . . . . 64.420000000000002 112.526 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 99.6 m -156.84 145.94 20.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.787 0.327 . . . . 74.420000000000002 110.877 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 20.7 p -134.76 153.76 51.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 75.010000000000005 110.892 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.454 ' N ' ' CD1' ' A' ' 380' ' ' PHE . 2.5 m-85 -129.28 131.67 47.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 73.430000000000007 110.89 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.488 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -122.8 119.65 58.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 73.099999999999994 111.063 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.98 134.02 33.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 75.209999999999994 110.909 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -115.36 -178.6 3.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 73.439999999999998 110.893 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -86.51 -29.14 22.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 71.209999999999994 110.873 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 66.0 p -129.54 166.25 20.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 74.420000000000002 111.156 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' HIS . . . . . 0.464 ' N ' HG23 ' A' ' 341' ' ' THR . 41.2 p-80 -80.65 -38.41 29.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 71.239999999999995 110.849 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -60.88 -29.88 69.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 72.340000000000003 110.861 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -35.56 80.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 75.420000000000002 110.875 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -75.63 -38.11 59.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 70.25 111.046 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . 0.498 ' CB ' ' CG1' ' A' ' 329' ' ' VAL . . . -60.29 -36.57 78.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 63.399999999999999 111.102 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 20.0 t -66.37 -33.38 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 71.129999999999995 111.129 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . 0.538 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 2.0 t -83.93 -23.85 30.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 73.340000000000003 110.847 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.508 ' O ' ' CG2' ' A' ' 408' ' ' THR . 13.4 mt -59.9 -57.93 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.262 -0.426 . . . . 61.420000000000002 111.107 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.509 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.7 t -72.1 -36.22 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 60.32 111.07 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -61.79 -22.71 65.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 75.209999999999994 111.086 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . 0.53 HD12 ' CD1' ' A' ' 399' ' ' PHE . 2.2 mm? -104.12 -10.6 17.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 73.5 110.873 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -57.5 119.95 7.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 74.200000000000003 111.076 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.8 m120 44.25 36.53 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 73.129999999999995 110.845 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.53 ' CD1' HD12 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -95.53 141.74 23.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.66 0.743 . . . . 73.530000000000001 110.844 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.462 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.5 Cg_endo -69.76 147.41 62.78 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.622 2.215 . . . . 73.329999999999998 112.372 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' PHE . . . . . 0.527 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 61.2 t80 -154.52 110.79 3.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 74.010000000000005 110.836 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 51.42 33.5 10.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 63.520000000000003 110.886 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 87.57 13.25 65.58 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.724 -0.751 . . . . 71.310000000000002 112.465 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 401' ' ' PHE . 19.3 mtt180 -140.57 135.75 32.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 70.010000000000005 110.882 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -78.93 150.78 32.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 75.230000000000004 110.878 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 11.2 mt -120.3 162.8 18.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.246 -0.434 . . . . 74.519999999999996 110.924 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.39 175.24 5.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 74.549999999999997 110.883 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' THR . . . . . 0.508 ' CG2' ' O ' ' A' ' 393' ' ' ILE . 2.1 p -154.38 155.59 35.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 75.450000000000003 111.179 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 C-N-CA 120.776 -0.726 . . . . 64.040000000000006 112.544 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.778 0.323 . . . . 74.5 110.863 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.33 -24.81 30.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 71.129999999999995 111.05 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' VAL . . . . . 0.473 ' CG2' ' HB ' ' A' ' 394' ' ' VAL . 19.4 t -76.88 -29.97 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 72.319999999999993 111.1 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -54.61 -40.84 69.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 73.319999999999993 110.878 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -62.7 -32.73 73.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 74.329999999999998 110.912 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . 0.478 ' CG2' HG22 ' A' ' 393' ' ' ILE . 30.9 mm -57.57 -43.49 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 75.200000000000003 111.124 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 18.2 mt -58.23 -32.6 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 75.430000000000007 111.112 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -4.32 11.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 74.530000000000001 110.834 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.69 38.91 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 75.519999999999996 110.901 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . 179.56 164.44 0.78 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.525 0.678 . . . . 71.140000000000001 111.18 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.68 159.66 52.62 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.744 2.296 . . . . 73.219999999999999 112.373 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -24.67 29.41 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.723 2.282 . . . . 73.420000000000002 112.339 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -104.24 73.51 1.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 73.150000000000006 110.854 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.5 p -167.91 128.94 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 75.230000000000004 111.09 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' THR . . . . . 0.457 HG23 ' CA ' ' A' ' 386' ' ' HIS . 19.8 p -137.41 68.07 1.42 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 74.430000000000007 111.093 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 66.4 m -133.87 116.36 15.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.204 -0.453 . . . . 65.230000000000004 111.117 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -86.61 127.01 34.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 75.200000000000003 111.107 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -105.75 135.04 47.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 72.310000000000002 110.886 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 407' ' ' ARG . 1.7 mp -132.94 116.96 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 72.099999999999994 111.179 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -107.01 173.87 19.43 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.681 -0.771 . . . . 62.229999999999997 112.464 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.3 t30 65.68 53.09 1.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.752 0.31 . . . . 74.450000000000003 110.826 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.469 ' CG2' ' HD2' ' A' ' 349' ' ' PRO . 80.0 mt -102.86 138.75 19.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.564 0.697 . . . . 72.019999999999996 111.165 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . 0.469 ' HD2' ' CG2' ' A' ' 348' ' ' ILE . 53.2 Cg_endo -69.78 166.24 28.28 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.7 2.266 . . . . 73.530000000000001 112.325 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -74.18 -22.62 59.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 70.319999999999993 110.888 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.437 ' CE1' ' CB ' ' A' ' 349' ' ' PRO . 2.7 p90 -91.27 27.15 1.99 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 74.25 110.857 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . 0.571 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -111.67 111.91 23.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 43.240000000000002 111.105 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 18.3 p -117.64 168.48 10.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 72.340000000000003 111.15 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . 0.502 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.2 OUTLIER -62.82 -30.43 71.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 73.510000000000005 110.909 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.93 67.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 74.319999999999993 111.096 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.14 -12.93 13.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 71.349999999999994 110.909 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.461 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 2.9 mp -100.51 -51.07 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 73.040000000000006 110.886 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.642 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -40.86 -51.03 7.37 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.641 0.734 . . . . 70.439999999999998 111.106 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.8 Cg_endo -69.67 -31.1 21.61 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.69 2.26 . . . . 75.439999999999998 112.385 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.527 HD22 ' CE1' ' A' ' 401' ' ' PHE . 0.1 OUTLIER -64.47 -27.31 68.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 74.140000000000001 110.889 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 381' ' ' ILE . 86.5 m-85 -95.28 -32.01 13.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 73.329999999999998 110.902 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' GLN . . . . . 0.475 ' N ' HD13 ' A' ' 367' ' ' ILE . 3.7 mt-30 -57.78 -35.55 70.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 75.129999999999995 110.95 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -54.71 -24.17 20.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 72.310000000000002 110.866 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -69.26 -57.75 4.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 74.549999999999997 110.876 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -154.66 -83.45 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.711 -0.757 . . . . 54.329999999999998 112.45 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -153.31 143.48 22.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.343 . . . . 74.519999999999996 110.892 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.475 HD13 ' N ' ' A' ' 362' ' ' GLN . 18.9 mt -121.01 109.16 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 75.019999999999996 111.096 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.29 -16.92 25.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 74.239999999999995 110.92 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -170.35 121.22 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 72.340000000000003 110.884 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 29.9 t80 -114.51 145.41 41.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 72.409999999999997 110.897 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.99 100.65 4.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 75.450000000000003 110.875 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . 0.571 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.4 t-80 -96.5 118.34 32.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 72.340000000000003 110.868 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -109.18 85.21 3.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.699 0.761 . . . . 75.439999999999998 110.949 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' PRO . . . . . 0.528 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 54.4 Cg_endo -69.7 -17.88 37.59 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.244 . . . . 61.409999999999997 112.369 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.16 -18.29 57.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 72.120000000000005 110.934 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.13 -25.56 7.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 74.329999999999998 110.946 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 91.99 31.11 9.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.782 -0.723 . . . . 64.420000000000002 112.509 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 57.8 m -143.23 154.45 43.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.76 0.314 . . . . 74.420000000000002 110.875 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 19.7 p -143.61 143.79 31.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 75.010000000000005 110.975 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -121.99 139.21 53.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.262 -0.426 . . . . 73.430000000000007 110.906 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -128.58 128.71 68.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 73.099999999999994 111.146 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -93.08 129.53 39.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 75.209999999999994 110.843 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -111.52 -178.61 3.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 73.439999999999998 110.96 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -82.54 -43.91 16.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 71.209999999999994 110.823 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 36.2 p -115.84 166.57 11.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 74.420000000000002 111.115 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' HIS . . . . . 0.457 ' CA ' HG23 ' A' ' 341' ' ' THR . 22.9 p-80 -85.28 -39.57 17.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 71.239999999999995 110.937 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.05 -27.11 63.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 72.340000000000003 110.888 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -52.19 36.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.420000000000002 110.912 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -51.77 -41.19 61.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 70.25 111.082 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -52.42 -34.12 46.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 63.399999999999999 111.094 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 15.0 t -67.42 -43.24 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 71.129999999999995 111.119 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 9.9 t -69.35 -33.65 73.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 73.340000000000003 110.85 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.478 HG22 ' CG2' ' A' ' 332' ' ' ILE . 0.7 OUTLIER -54.0 -54.98 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 61.420000000000002 111.133 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.473 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 0.5 OUTLIER -71.5 -37.52 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 60.32 111.117 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.62 -21.13 66.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 75.209999999999994 111.078 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . 0.538 HD11 ' CE1' ' A' ' 399' ' ' PHE . 1.7 mm? -106.53 -10.93 16.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.259 -0.428 . . . . 73.5 110.861 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -58.9 114.71 2.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.200000000000003 111.091 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . 0.453 ' C ' ' OD1' ' A' ' 405' ' ' ASN . 2.9 t-20 42.7 43.06 3.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 73.129999999999995 110.888 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.568 ' CE1' ' HB2' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -101.18 144.38 28.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.598 0.714 . . . . 73.530000000000001 110.902 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.455 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.8 Cg_endo -69.75 142.04 46.89 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.76 2.307 . . . . 73.329999999999998 112.323 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' PHE . . . . . 0.568 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 75.5 t80 -152.81 110.95 3.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 74.010000000000005 110.907 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . 0.464 ' OE1' ' CZ ' ' A' ' 401' ' ' PHE . 0.4 OUTLIER 53.86 32.6 15.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 63.520000000000003 110.917 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 94.86 -19.84 51.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.776 -0.725 . . . . 71.310000000000002 112.473 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 401' ' ' PHE . 8.6 mmt180 -110.99 141.01 45.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.782 0.325 . . . . 70.010000000000005 110.897 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.453 ' OD1' ' C ' ' A' ' 398' ' ' ASN . 0.5 OUTLIER -86.79 149.91 24.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 75.230000000000004 110.918 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . 0.411 HD21 ' C ' ' A' ' 405' ' ' ASN . 10.1 mt -113.78 171.84 7.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 74.519999999999996 110.941 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 345' ' ' ILE . 1.1 tpt85 -123.41 179.19 4.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 74.549999999999997 110.838 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 33.9 p -155.88 170.07 22.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 75.450000000000003 111.189 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.776 -0.726 . . . . 64.040000000000006 112.48 179.925 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.762 0.315 . . . . 74.5 110.897 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -57.63 -26.28 61.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 71.129999999999995 111.094 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' VAL . . . . . 0.509 ' CG2' ' HB ' ' A' ' 394' ' ' VAL . 16.1 t -78.74 -29.93 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 72.319999999999993 111.146 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -54.13 -38.85 65.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 73.319999999999993 110.876 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -65.6 -31.82 73.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 74.329999999999998 110.808 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 46.1 mm -55.55 -48.95 76.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 75.200000000000003 111.092 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 8.8 mt -55.06 -32.1 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 75.430000000000007 111.201 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.75 -7.19 7.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 74.530000000000001 110.942 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 23.0 t -102.63 11.62 37.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 75.519999999999996 110.884 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -158.78 150.02 16.51 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.596 0.713 . . . . 71.140000000000001 111.104 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 164.46 34.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.736 2.291 . . . . 73.219999999999999 112.341 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -11.68 31.33 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.625 2.217 . . . . 73.420000000000002 112.398 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -101.21 55.05 0.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 73.150000000000006 110.905 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.8 p -168.79 126.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 75.230000000000004 111.144 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 21.7 p -142.61 70.95 1.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 74.430000000000007 111.188 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 54.5 m -133.72 123.87 25.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 65.230000000000004 111.124 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -89.97 134.4 34.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 75.200000000000003 111.133 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -114.14 134.38 54.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 72.310000000000002 110.932 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.472 HG22 ' CD1' ' A' ' 348' ' ' ILE . 1.7 mp -132.07 113.22 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.504 . . . . 72.099999999999994 111.148 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -103.89 168.73 17.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.761 . . . . 62.229999999999997 112.501 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 405' ' ' ASN . 2.3 t30 72.22 54.19 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 74.450000000000003 110.958 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.493 ' CD1' ' SG ' ' A' ' 379' ' ' CYS . 87.7 mt -108.45 138.87 20.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.564 0.697 . . . . 72.019999999999996 111.178 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . 0.552 ' HB2' ' CD2' ' A' ' 351' ' ' PHE . 53.3 Cg_endo -69.85 164.89 32.96 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.714 2.276 . . . . 73.530000000000001 112.313 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -77.49 -10.96 59.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 70.319999999999993 110.829 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.552 ' CD2' ' HB2' ' A' ' 349' ' ' PRO . 31.8 p90 -97.38 1.21 49.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 74.25 110.927 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . 0.409 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -89.29 111.85 22.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 43.240000000000002 111.049 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 74.2 p -112.06 173.51 6.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.18 -0.464 . . . . 72.340000000000003 111.106 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . 0.482 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -67.01 -29.53 69.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 73.510000000000005 110.866 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -59.02 -26.38 64.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 74.319999999999993 111.159 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.27 -15.62 13.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 71.349999999999994 110.861 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.442 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.8 mp -94.77 -51.03 4.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 73.040000000000006 110.883 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.669 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.2 mm -43.89 -49.87 20.24 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.677 0.751 . . . . 70.439999999999998 111.184 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.7 Cg_endo -69.83 -20.41 34.56 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.672 2.248 . . . . 75.439999999999998 112.352 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.583 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -77.99 -25.39 48.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 74.140000000000001 110.968 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.517 ' CD2' HD13 ' A' ' 360' ' ' LEU . 85.7 m-85 -98.76 -30.08 12.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.329999999999998 110.941 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -57.64 -42.98 84.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 75.129999999999995 110.912 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -47.02 -21.67 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 72.310000000000002 110.901 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -71.98 -54.49 9.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 74.549999999999997 110.922 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -161.39 -85.62 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.74 -0.743 . . . . 54.329999999999998 112.456 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -153.56 142.29 20.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.775 0.321 . . . . 74.519999999999996 110.86 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.405 HD13 ' CG2' ' A' ' 381' ' ' ILE . 40.3 mt -120.78 109.46 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 75.019999999999996 111.208 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.75 -17.52 38.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.466 . . . . 74.239999999999995 110.964 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.72 121.33 0.58 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 72.340000000000003 110.9 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.565 ' CE1' ' HB3' ' A' ' 379' ' ' CYS . 25.2 t80 -114.97 123.54 49.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 72.409999999999997 110.858 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.19 99.2 7.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 75.450000000000003 110.877 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 3.4 t-80 -95.29 120.6 35.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.436 . . . . 72.340000000000003 110.878 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -113.96 92.28 25.29 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.7 0.762 . . . . 75.439999999999998 110.916 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -18.2 37.43 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.692 2.261 . . . . 61.409999999999997 112.375 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -78.18 -37.11 46.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 72.120000000000005 110.841 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -99.79 -18.01 17.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 74.329999999999998 110.897 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 75.07 43.67 25.83 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.764 -0.731 . . . . 64.420000000000002 112.468 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 1.6 p -151.93 143.45 23.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.758 0.313 . . . . 74.420000000000002 110.962 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.565 ' HB3' ' CE1' ' A' ' 370' ' ' PHE . 61.3 m -124.3 153.34 41.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 75.010000000000005 110.947 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -130.47 104.26 7.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 73.430000000000007 110.85 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.487 ' CG1' ' CD1' ' A' ' 370' ' ' PHE . 0.5 OUTLIER -105.0 129.24 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 73.099999999999994 111.155 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -102.01 136.83 41.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 75.209999999999994 110.923 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -118.18 172.34 7.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 73.439999999999998 110.931 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.62 -37.3 59.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 71.209999999999994 110.857 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 59.3 p -115.96 169.83 8.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 74.420000000000002 111.154 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -85.64 -38.93 17.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 71.239999999999995 110.939 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -60.54 -30.18 69.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 110.929 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -62.17 -38.57 89.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 75.420000000000002 110.852 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -75.94 -33.62 59.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 70.25 111.168 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . 0.466 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -55.91 -35.37 66.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 63.399999999999999 111.066 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 25.6 t -69.13 -46.62 77.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 71.129999999999995 111.057 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 48.8 t -56.18 -31.1 63.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 73.340000000000003 110.933 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . . . . . . . . . 1.1 mt -59.8 -56.36 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 61.420000000000002 111.154 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.509 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.1 t -71.68 -38.48 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 60.32 111.154 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -58.56 -48.07 82.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 75.209999999999994 111.099 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . 0.562 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.9 mm? -85.48 -10.35 56.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 73.5 110.865 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' ALA . . . . . 0.461 ' N ' HG21 ' A' ' 408' ' ' THR . . . -50.66 108.44 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 74.200000000000003 111.086 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 42.99 43.45 3.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 73.129999999999995 110.916 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.562 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -96.75 145.5 29.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.696 0.76 . . . . 73.530000000000001 110.884 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 144.13 52.93 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.647 2.231 . . . . 73.329999999999998 112.39 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' PHE . . . . . 0.517 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 41.9 t80 -151.03 113.23 4.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 74.010000000000005 110.887 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 49.47 32.93 5.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 63.520000000000003 110.871 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.6 -28.36 15.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 71.310000000000002 112.51 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.425 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.9 OUTLIER -105.52 141.05 37.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.361 . . . . 70.010000000000005 110.847 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.448 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 14.3 m120 -82.68 154.92 24.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 75.230000000000004 110.923 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . 0.424 ' CD1' HG21 ' A' ' 345' ' ' ILE . 10.9 mt -114.35 173.8 6.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 74.519999999999996 110.892 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 346' ' ' GLY . 0.0 OUTLIER -113.92 171.93 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 74.549999999999997 110.89 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' THR . . . . . 0.521 ' CG2' ' C ' ' A' ' 396' ' ' LEU . 64.3 p -154.18 154.19 33.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 75.450000000000003 111.098 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 64.040000000000006 112.508 179.956 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.879 0.371 . . . . 74.5 110.862 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -49.28 -24.3 1.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 71.129999999999995 111.064 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' VAL . . . . . 0.49 ' CG2' ' HB ' ' A' ' 394' ' ' VAL . 10.8 t -80.89 -29.18 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 72.319999999999993 111.146 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -53.42 -37.72 62.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.108 -0.496 . . . . 73.319999999999993 110.876 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -66.07 -31.63 72.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 74.329999999999998 110.796 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 27.4 mm -56.36 -47.74 80.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 75.200000000000003 111.098 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 9.5 mt -54.12 -26.16 14.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 75.430000000000007 111.051 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.66 2.11 5.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 74.530000000000001 110.926 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.69 31.79 6.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 75.519999999999996 110.868 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -174.32 151.15 1.6 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.535 0.684 . . . . 71.140000000000001 111.104 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.74 169.93 17.74 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.677 2.251 . . . . 73.219999999999999 112.353 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.84 -9.2 25.5 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.609 2.206 . . . . 73.420000000000002 112.356 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -115.41 64.1 0.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 73.150000000000006 110.899 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 7.9 p -160.38 129.19 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 75.230000000000004 111.073 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.96 69.2 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 111.102 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.473 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 45.0 m -131.42 108.88 9.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 65.230000000000004 111.224 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -80.28 111.3 16.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 75.200000000000003 111.061 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.571 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -93.78 118.8 31.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 72.310000000000002 110.953 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.47 117.52 54.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 72.099999999999994 111.15 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -107.98 -173.3 21.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.706 -0.759 . . . . 62.229999999999997 112.521 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.95 47.52 12.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.807 0.337 . . . . 74.450000000000003 110.895 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 34.2 mt -99.43 132.62 22.93 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.658 0.742 . . . . 72.019999999999996 111.163 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . 0.489 ' CG ' ' CE1' ' A' ' 351' ' ' PHE . 53.6 Cg_endo -69.82 161.89 44.22 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.621 2.214 . . . . 73.530000000000001 112.328 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -69.01 -21.01 64.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 70.319999999999993 110.813 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.489 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 7.1 p90 -90.85 30.74 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 74.25 110.878 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -116.23 124.82 51.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 43.240000000000002 111.098 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 14.3 p -126.54 167.71 15.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 72.340000000000003 111.128 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . 0.49 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -64.99 -34.06 77.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 73.510000000000005 110.876 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.23 -26.35 50.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 111.128 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.27 -13.12 13.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 71.349999999999994 110.865 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.436 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.5 mp -99.52 -54.21 3.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 73.040000000000006 110.895 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.611 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -39.81 -52.07 5.18 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.692 0.758 . . . . 70.439999999999998 111.199 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.2 Cg_endo -69.72 -39.51 6.49 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.612 2.208 . . . . 75.439999999999998 112.353 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.581 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -53.85 -25.36 19.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 74.140000000000001 110.87 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.471 ' HA ' ' CD2' ' A' ' 364' ' ' PHE . 85.5 m-85 -95.78 -37.22 10.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 73.329999999999998 110.894 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' GLN . . . . . 0.474 ' HG2' ' CD1' ' A' ' 367' ' ' ILE . 3.8 mt-30 -50.01 -46.46 52.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 75.129999999999995 110.879 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . 0.423 ' C ' ' OD1' ' A' ' 363' ' ' ASN . 0.6 OUTLIER -44.46 -25.08 0.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 72.310000000000002 110.79 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . 0.539 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 30.5 m-85 -70.1 -60.24 2.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 74.549999999999997 110.841 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -150.42 -86.64 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.79 -0.719 . . . . 54.329999999999998 112.511 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 368' ' ' LEU . 11.8 t80 -153.43 141.61 20.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.786 0.327 . . . . 74.519999999999996 110.898 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.474 ' CD1' ' HG2' ' A' ' 362' ' ' GLN . 23.9 mt -120.36 113.48 40.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 75.019999999999996 111.101 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 369' ' ' ASP . 2.7 pp -100.45 -14.84 18.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 74.239999999999995 110.862 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.49 ' N ' HD12 ' A' ' 368' ' ' LEU . 10.0 t0 -167.67 120.81 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 72.340000000000003 110.836 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 28.4 t80 -117.54 134.85 54.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 72.409999999999997 110.9 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -120.56 101.5 7.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 75.450000000000003 110.891 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -97.49 135.7 38.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 72.340000000000003 110.906 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -130.75 85.69 54.86 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 121.649 0.738 . . . . 75.439999999999998 110.967 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -22.58 31.73 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.638 2.226 . . . . 61.409999999999997 112.349 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -72.93 -19.39 61.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 72.120000000000005 110.911 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.49 -27.57 6.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 74.329999999999998 110.91 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 89.8 43.82 5.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.715 -0.755 . . . . 64.420000000000002 112.492 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 43.6 m -155.93 149.2 24.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.774 0.321 . . . . 74.420000000000002 110.886 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 15.5 p -140.79 144.14 35.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 75.010000000000005 110.909 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.473 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 18.9 m-85 -122.86 128.81 50.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 73.430000000000007 110.877 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.471 HD13 ' CE1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -117.92 119.37 61.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 73.099999999999994 111.124 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -88.39 127.07 35.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 75.209999999999994 110.94 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -106.08 171.59 7.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.428 . . . . 73.439999999999998 110.946 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -65.29 -37.5 87.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.093 -0.503 . . . . 71.209999999999994 110.897 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 58.6 p -130.12 178.02 6.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 74.420000000000002 111.179 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -83.21 -39.42 20.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 71.239999999999995 110.869 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -57.97 -27.1 63.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 72.340000000000003 110.877 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -37.18 77.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 75.420000000000002 110.858 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -75.77 -36.6 59.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 70.25 111.086 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . 0.479 ' CB ' ' CG1' ' A' ' 329' ' ' VAL . . . -55.34 -32.95 62.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 63.399999999999999 111.061 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 40.2 t -68.09 -55.57 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 71.129999999999995 111.105 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . 0.539 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 2.1 t -64.29 -26.1 68.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 73.340000000000003 110.881 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 408' ' ' THR . 5.6 mt -57.06 -57.2 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 61.420000000000002 111.135 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.49 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.5 t -73.06 -40.3 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 60.32 111.16 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -53.6 -51.47 62.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 75.209999999999994 111.102 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . 0.606 ' CB ' ' CG2' ' A' ' 408' ' ' THR . 1.9 mm? -75.46 -12.63 60.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 73.5 110.951 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' ALA . . . . . 0.462 ' N ' HG23 ' A' ' 408' ' ' THR . . . -50.49 112.9 0.76 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 74.200000000000003 111.076 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 54.8 t30 41.97 49.85 4.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.129999999999995 110.855 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.567 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -105.78 146.58 33.12 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.69 0.757 . . . . 73.530000000000001 110.825 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.8 137.47 35.42 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.679 2.253 . . . . 73.329999999999998 112.362 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' PHE . . . . . 0.526 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 33.8 t80 -141.83 110.78 6.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.010000000000005 110.912 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 49.11 32.71 4.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 63.520000000000003 110.886 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.45 -29.18 13.06 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.669 -0.776 . . . . 71.310000000000002 112.477 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 401' ' ' PHE . 24.7 ttt85 -107.11 139.1 42.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.321 . . . . 70.010000000000005 110.866 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -79.18 155.19 28.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 75.230000000000004 110.829 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 21.9 mt -118.97 170.32 9.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 74.519999999999996 110.884 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.42 175.59 5.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 74.549999999999997 110.824 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' THR . . . . . 0.606 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 75.5 p -154.05 155.51 35.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 75.450000000000003 111.144 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 C-N-CA 120.811 -0.709 . . . . 64.040000000000006 112.55 179.922 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.835 0.35 . . . . 74.5 110.89 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -57.19 -24.87 57.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 71.129999999999995 111.074 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' VAL . . . . . 0.481 ' CG2' ' HB ' ' A' ' 394' ' ' VAL . 23.4 t -76.66 -29.81 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 72.319999999999993 111.068 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -54.49 -37.75 65.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 73.319999999999993 110.84 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -62.82 -31.93 73.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 74.329999999999998 110.846 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 15.3 mm -65.25 -41.83 92.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 75.200000000000003 111.114 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 31.8 mt -52.29 -48.91 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 75.430000000000007 111.059 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.34 -7.03 5.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 74.530000000000001 110.879 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 3.1 t -82.43 -31.92 29.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 75.519999999999996 110.854 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -116.87 153.97 49.46 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.636 0.732 . . . . 71.140000000000001 111.066 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 158.88 55.41 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.708 2.272 . . . . 73.219999999999999 112.31 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -7.46 21.1 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.716 2.278 . . . . 73.420000000000002 112.338 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -101.86 51.0 0.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 73.150000000000006 110.848 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.7 p -175.9 128.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 75.230000000000004 111.157 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' THR . . . . . 0.413 HG22 ' C ' ' A' ' 385' ' ' THR . 20.4 p -137.1 67.92 1.43 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 74.430000000000007 111.207 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 23.3 m -133.76 137.0 44.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 65.230000000000004 111.152 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -100.18 129.47 46.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 75.200000000000003 111.101 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.404 ' O ' ' HA ' ' A' ' 408' ' ' THR . 0.0 OUTLIER -106.28 135.08 48.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 72.310000000000002 110.882 -179.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.439 HG21 ' CD1' ' A' ' 406' ' ' LEU . 1.7 mp -131.87 117.68 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 72.099999999999994 111.12 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -106.59 161.62 13.97 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.748 -0.739 . . . . 62.229999999999997 112.472 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 0.6 OUTLIER 79.24 49.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 74.450000000000003 110.937 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.454 ' CG2' ' HD2' ' A' ' 349' ' ' PRO . 64.8 mt -103.76 137.72 19.32 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.581 0.705 . . . . 72.019999999999996 111.13 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . 0.564 ' HB2' ' CD1' ' A' ' 351' ' ' PHE . 53.6 Cg_endo -69.75 165.09 32.11 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.714 2.276 . . . . 73.530000000000001 112.307 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -75.88 -17.1 59.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 70.319999999999993 110.846 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.564 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 27.1 p90 -99.05 24.11 8.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 74.25 110.886 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.87 93.16 4.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 43.240000000000002 111.17 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 46.2 p -90.54 173.51 8.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 72.340000000000003 111.173 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . 0.485 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -66.96 -29.77 69.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 73.510000000000005 110.824 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.01 -26.11 47.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 74.319999999999993 111.111 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.81 -13.74 13.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 71.349999999999994 110.89 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.431 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.4 mp -98.56 -54.38 3.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 73.040000000000006 110.895 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.636 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -40.88 -51.59 7.1 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.684 0.754 . . . . 70.439999999999998 111.134 179.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.1 Cg_endo -69.85 -34.08 15.0 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.656 2.237 . . . . 75.439999999999998 112.305 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.586 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -61.14 -23.49 65.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 74.140000000000001 110.944 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.569 ' CD2' HD13 ' A' ' 360' ' ' LEU . 81.4 m-85 -102.88 -33.67 9.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 73.329999999999998 110.912 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' GLN . . . . . 0.475 ' N ' HD13 ' A' ' 367' ' ' ILE . 0.1 OUTLIER -58.77 -32.72 69.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.5 . . . . 75.129999999999995 110.984 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -59.24 -11.25 3.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 72.310000000000002 110.924 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . 0.57 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 31.3 m-85 -81.01 -60.12 2.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 74.549999999999997 110.87 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -149.01 -84.03 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.782 -0.723 . . . . 54.329999999999998 112.492 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -152.64 143.61 23.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 74.519999999999996 110.852 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.475 HD13 ' N ' ' A' ' 362' ' ' GLN . 55.5 mt -121.0 109.28 24.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 75.019999999999996 111.126 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.02 -17.66 24.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.947 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -171.15 121.15 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 72.340000000000003 110.863 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.552 ' CD2' HG12 ' A' ' 358' ' ' ILE . 34.6 t80 -113.61 143.42 44.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 72.409999999999997 110.946 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.55 101.17 5.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 75.450000000000003 110.946 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . 0.535 ' CE1' ' HB3' ' A' ' 374' ' ' PRO . 11.2 t-80 -94.61 114.48 26.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 72.340000000000003 110.814 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -107.7 84.12 1.86 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.631 0.729 . . . . 75.439999999999998 110.874 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' PRO . . . . . 0.535 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 53.6 Cg_endo -69.79 -28.6 24.91 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.661 2.24 . . . . 61.409999999999997 112.355 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -63.44 -19.58 64.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 72.120000000000005 110.921 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.8 -21.7 7.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 74.329999999999998 110.945 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 87.33 38.33 7.79 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.776 -0.726 . . . . 64.420000000000002 112.475 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 19.1 p -147.15 153.63 40.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.764 0.316 . . . . 74.420000000000002 110.941 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 7.2 p -139.35 151.12 46.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 75.010000000000005 110.882 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -131.14 122.73 27.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 73.430000000000007 110.888 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.488 ' CD1' ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -114.28 126.3 71.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 73.099999999999994 111.08 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 10.2 mttp -90.6 133.86 34.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 75.209999999999994 110.877 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -116.21 -178.55 3.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 73.439999999999998 110.996 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.45 -46.3 16.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 71.209999999999994 110.857 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' THR . . . . . 0.413 ' C ' HG22 ' A' ' 341' ' ' THR . 68.0 p -114.83 170.66 8.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 74.420000000000002 111.232 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -85.64 -44.43 12.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 71.239999999999995 110.838 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -57.18 -32.9 66.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 72.340000000000003 110.868 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -67.88 -32.56 73.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 75.420000000000002 110.888 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -67.1 -39.32 86.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 70.25 111.114 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . 0.424 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -59.19 -27.88 66.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 63.399999999999999 111.097 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.58 -40.94 88.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 71.129999999999995 111.158 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . 0.57 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 1.5 t -77.78 -27.1 50.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 73.340000000000003 110.935 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.434 ' O ' ' CG2' ' A' ' 408' ' ' THR . 1.2 mp -54.99 -56.67 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 61.420000000000002 111.078 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.481 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 0.9 OUTLIER -73.06 -45.86 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 60.32 111.067 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -52.87 -21.67 4.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 75.209999999999994 111.076 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . 0.557 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.2 mm? -106.5 -19.27 13.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 73.5 110.945 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -48.76 114.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 74.200000000000003 111.142 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 44.26 46.89 7.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 73.129999999999995 110.855 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.557 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -107.03 144.79 29.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.632 0.73 . . . . 73.530000000000001 110.848 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.502 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.5 Cg_endo -69.85 145.23 56.04 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.672 2.248 . . . . 73.329999999999998 112.333 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' PHE . . . . . 0.554 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 64.6 t80 -152.34 111.81 3.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 74.010000000000005 110.908 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.63 33.36 8.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 63.520000000000003 110.932 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.4 -27.78 17.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 71.310000000000002 112.513 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.482 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -104.75 141.9 35.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.318 . . . . 70.010000000000005 110.895 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -86.99 145.15 26.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 75.230000000000004 110.936 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . 0.439 ' CD1' HG21 ' A' ' 345' ' ' ILE . 8.8 mt -107.03 179.88 4.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.239 -0.437 . . . . 74.519999999999996 110.905 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 345' ' ' ILE . 13.5 ttt85 -130.45 177.48 7.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 74.549999999999997 110.88 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' THR . . . . . 0.434 ' CG2' ' O ' ' A' ' 393' ' ' ILE . 17.2 p -156.13 163.48 39.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 75.450000000000003 111.124 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 64.040000000000006 112.474 179.985 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.757 0.313 . . . . 74.5 110.945 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.66 -32.85 59.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 71.129999999999995 111.065 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' VAL . . . . . 0.485 ' CG2' ' HB ' ' A' ' 394' ' ' VAL . 11.1 t -70.95 -29.53 37.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 72.319999999999993 111.128 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -53.99 -34.85 60.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 73.319999999999993 110.915 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -68.29 -31.95 71.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 74.329999999999998 110.854 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 37.5 mm -57.05 -51.5 68.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 75.200000000000003 111.102 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . 0.511 HG22 ' CD2' ' A' ' 386' ' ' HIS . 4.0 mt -55.19 -27.76 20.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 75.430000000000007 111.11 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.71 -12.7 55.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 74.530000000000001 110.893 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.43 27.1 9.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 75.519999999999996 110.887 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -169.41 148.93 3.6 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.472 0.653 . . . . 71.140000000000001 111.159 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 165.54 30.69 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.69 2.26 . . . . 73.219999999999999 112.314 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -15.67 37.02 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.645 2.23 . . . . 73.420000000000002 112.363 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -106.01 55.75 0.67 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 73.150000000000006 110.917 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.472 ' CG1' ' O ' ' A' ' 340' ' ' VAL . 14.4 p -156.1 95.24 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 75.230000000000004 111.117 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' THR . . . . . 0.422 HG22 ' C ' ' A' ' 385' ' ' THR . 18.7 p -113.34 67.73 0.67 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.479 . . . . 74.430000000000007 111.133 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.438 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 34.5 m -134.11 128.85 34.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 65.230000000000004 111.159 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -96.82 126.23 41.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 75.200000000000003 111.11 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.3 133.16 48.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 72.310000000000002 110.944 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.506 HD12 ' CE1' ' A' ' 361' ' ' PHE . 2.0 mp -126.72 125.93 67.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 72.099999999999994 111.171 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -111.65 166.69 12.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.684 -0.77 . . . . 62.229999999999997 112.473 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 6.2 t30 65.03 57.88 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.771 0.319 . . . . 74.450000000000003 110.904 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.473 ' CD1' HG21 ' A' ' 345' ' ' ILE . 97.0 mt -106.64 133.9 20.06 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.629 0.728 . . . . 72.019999999999996 111.096 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 166.51 27.29 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.635 2.224 . . . . 73.530000000000001 112.386 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -71.77 -26.52 62.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 70.319999999999993 110.824 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -85.51 18.12 2.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 74.25 110.889 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . 0.537 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -101.14 101.81 12.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 43.240000000000002 111.086 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 21.1 p -109.55 169.57 8.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 72.340000000000003 111.084 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . 0.5 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.7 OUTLIER -63.46 -29.75 70.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.161 -0.472 . . . . 73.510000000000005 110.907 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -61.94 -25.81 67.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 74.319999999999993 111.084 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.98 -16.2 13.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 71.349999999999994 110.84 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.439 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 4.4 mp -96.7 -49.42 5.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 73.040000000000006 110.939 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.658 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.2 mm -42.94 -50.46 13.52 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.619 0.723 . . . . 70.439999999999998 111.204 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.8 Cg_endo -69.75 -37.8 8.7 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.737 2.291 . . . . 75.439999999999998 112.35 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.571 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -58.06 -25.35 61.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.445 . . . . 74.140000000000001 110.919 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.543 ' CD1' ' CD1' ' A' ' 360' ' ' LEU . 74.1 m-85 -101.62 -38.3 7.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 73.329999999999998 110.945 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -51.36 -37.96 50.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 75.129999999999995 110.895 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -19.38 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 72.310000000000002 110.852 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . 0.569 ' CE2' ' SG ' ' A' ' 392' ' ' CYS . 30.3 m-85 -72.3 -54.54 9.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 74.549999999999997 110.89 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -158.5 -84.69 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.795 -0.717 . . . . 54.329999999999998 112.501 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -153.51 143.1 21.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.815 0.34 . . . . 74.519999999999996 110.893 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 54.1 mt -120.93 109.4 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 75.019999999999996 111.122 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.54 -19.13 29.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 74.239999999999995 110.946 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.48 121.31 0.6 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 72.340000000000003 110.891 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 31.7 t80 -112.73 143.02 44.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 72.409999999999997 110.919 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -128.64 101.64 6.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 75.450000000000003 110.858 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . 0.567 ' CE1' ' HD3' ' A' ' 374' ' ' PRO . 7.9 t-80 -99.05 135.42 40.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 72.340000000000003 110.816 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -129.17 89.91 46.73 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.712 0.768 . . . . 75.439999999999998 110.9 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' PRO . . . . . 0.567 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.6 Cg_endo -69.78 -20.99 34.02 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.706 2.271 . . . . 61.409999999999997 112.315 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -74.9 -25.81 59.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 72.120000000000005 110.844 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -113.55 -12.32 12.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 74.329999999999998 110.857 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 72.28 43.2 47.53 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.722 -0.752 . . . . 64.420000000000002 112.486 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 15.6 p -150.45 152.74 34.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.33 . . . . 74.420000000000002 110.898 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 14.6 p -146.66 152.75 39.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 75.010000000000005 110.851 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.438 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 54.3 m-85 -131.06 122.5 26.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 73.430000000000007 110.816 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.435 HD11 ' CG ' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -109.36 126.32 66.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 73.099999999999994 111.113 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -92.88 131.08 38.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 75.209999999999994 110.853 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -112.34 -174.42 2.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 73.439999999999998 110.849 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.75 -46.62 9.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 71.209999999999994 110.888 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' THR . . . . . 0.422 ' C ' HG22 ' A' ' 341' ' ' THR . 61.1 p -115.23 161.91 17.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 74.420000000000002 111.137 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' HIS . . . . . 0.511 ' CD2' HG22 ' A' ' 333' ' ' ILE . 75.0 t60 -79.58 -39.76 30.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 71.239999999999995 110.882 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.32 -32.74 68.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 72.340000000000003 110.798 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -66.37 -36.99 84.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 75.420000000000002 110.928 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -68.05 -45.78 72.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 70.25 111.074 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -50.06 -30.02 10.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 63.399999999999999 111.11 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 70.5 t -68.94 -50.72 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 71.129999999999995 111.125 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . 0.569 ' SG ' ' CE2' ' A' ' 364' ' ' PHE . 1.9 t -58.92 -26.38 64.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 73.340000000000003 110.882 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.64 -56.26 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 61.420000000000002 111.182 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.485 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.1 t -72.03 -46.91 57.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 60.32 111.094 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -60.89 -45.17 95.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 75.209999999999994 111.094 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . 0.567 ' HG ' ' CD1' ' A' ' 399' ' ' PHE . 0.3 OUTLIER -85.01 -4.89 59.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 73.5 110.9 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' ALA . . . . . 0.45 ' O ' ' CG ' ' A' ' 398' ' ' ASN . . . -58.4 115.24 2.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 74.200000000000003 111.085 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . 0.45 ' CG ' ' O ' ' A' ' 397' ' ' ALA . 3.3 p-10 48.25 41.09 15.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 73.129999999999995 110.907 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.567 ' CD1' ' HG ' ' A' ' 396' ' ' LEU . 0.2 OUTLIER -88.1 145.92 37.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.646 0.736 . . . . 73.530000000000001 110.913 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.431 ' HA ' ' ND2' ' A' ' 405' ' ' ASN . 53.4 Cg_endo -69.86 130.02 18.49 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 2.243 . . . . 73.329999999999998 112.325 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' PHE . . . . . 0.418 ' CE2' HD12 ' A' ' 357' ' ' LEU . 64.3 t80 -136.21 111.07 8.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 74.010000000000005 110.868 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 52.18 33.18 11.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 63.520000000000003 110.911 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 95.57 -22.86 36.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 71.310000000000002 112.448 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.28 132.41 53.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.846 0.355 . . . . 70.010000000000005 110.888 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 400' ' ' PRO . 0.6 OUTLIER -73.94 148.9 41.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 75.230000000000004 110.832 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . 0.457 ' CD1' HG23 ' A' ' 345' ' ' ILE . 4.2 mt -111.66 178.21 4.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 74.519999999999996 110.99 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -113.46 -179.38 3.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 74.549999999999997 110.935 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' THR . . . . . 0.466 ' CG2' ' HB3' ' A' ' 396' ' ' LEU . 33.8 p -153.72 153.93 33.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 75.450000000000003 111.107 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 C-N-CA 120.751 -0.737 . . . . 64.040000000000006 112.501 179.958 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.804 0.335 . . . . 74.5 110.924 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.8 -25.56 28.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 71.129999999999995 111.125 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' VAL . . . . . 0.463 ' CG2' ' HB ' ' A' ' 394' ' ' VAL . 8.6 t -81.61 -31.26 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 72.319999999999993 111.129 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -55.03 -38.66 68.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 73.319999999999993 110.906 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -59.0 -35.26 72.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 74.329999999999998 110.825 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . 0.472 ' CG2' HG23 ' A' ' 393' ' ' ILE . 32.4 mm -63.45 -45.9 96.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 75.200000000000003 111.166 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 8.6 mt -57.14 -25.34 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 75.430000000000007 111.206 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -76.2 -1.16 25.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 74.530000000000001 110.858 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.94 36.6 4.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 75.519999999999996 110.847 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -169.55 147.95 3.24 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.574 0.702 . . . . 71.140000000000001 111.091 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 165.5 30.76 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.677 2.251 . . . . 73.219999999999999 112.375 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -31.9 19.49 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.758 2.305 . . . . 73.420000000000002 112.316 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -93.25 72.39 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 73.150000000000006 110.857 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.403 ' O ' ' CG1' ' A' ' 340' ' ' VAL . 3.3 p -178.2 127.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 75.230000000000004 111.175 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' THR . . . . . 0.407 HG23 ' C ' ' A' ' 385' ' ' THR . 39.4 p -145.74 69.87 1.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 74.430000000000007 111.132 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' THR . . . . . 0.463 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 99.8 m -133.63 120.73 21.05 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.211 -0.449 . . . . 65.230000000000004 111.174 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -86.47 129.15 34.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 75.200000000000003 111.033 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.404 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -111.48 134.77 52.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 72.310000000000002 110.936 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.45 HG22 ' CD1' ' A' ' 406' ' ' LEU . 1.7 mp -126.28 124.47 65.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.051 -0.522 . . . . 72.099999999999994 111.166 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . 0.5 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -109.0 154.59 16.42 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 62.229999999999997 112.438 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 1.9 t30 82.82 45.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.859 0.362 . . . . 74.450000000000003 110.891 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.473 ' CG2' ' HB2' ' A' ' 352' ' ' ALA . 68.0 mt -99.26 129.85 28.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.642 0.734 . . . . 72.019999999999996 111.104 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . 0.563 ' HB2' ' CD1' ' A' ' 351' ' ' PHE . 54.1 Cg_endo -69.72 157.87 58.98 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.684 2.256 . . . . 73.530000000000001 112.375 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -60.81 -30.9 70.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 70.319999999999993 110.865 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . 0.563 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 28.1 p90 -86.1 33.3 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 74.25 110.876 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . 0.579 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -113.64 82.59 1.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 43.240000000000002 111.136 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 17.9 p -84.98 167.56 15.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.118 -0.492 . . . . 72.340000000000003 111.185 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . 0.507 ' O ' ' CG1' ' A' ' 358' ' ' ILE . 0.3 OUTLIER -67.21 -29.43 69.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 73.510000000000005 110.88 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -59.12 -25.65 64.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 111.108 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.0 -17.1 13.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 71.349999999999994 110.837 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.498 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 4.7 mp -95.56 -53.5 3.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.424 . . . . 73.040000000000006 110.896 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.656 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.3 mm -39.51 -50.7 5.03 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.537 0.684 . . . . 70.439999999999998 111.079 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.1 Cg_endo -69.74 -26.62 27.46 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.715 2.277 . . . . 75.439999999999998 112.311 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.538 HD23 ' CE1' ' A' ' 401' ' ' PHE . 0.1 OUTLIER -70.81 -24.25 62.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 74.140000000000001 110.91 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.569 ' CD1' HD13 ' A' ' 381' ' ' ILE . 91.4 m-85 -102.61 -41.05 6.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 73.329999999999998 110.952 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' GLN . . . . . 0.448 ' N ' HD13 ' A' ' 367' ' ' ILE . 8.4 mt-30 -47.73 -44.68 28.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 75.129999999999995 110.883 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . 0.416 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.3 OUTLIER -45.64 -28.47 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 72.310000000000002 110.922 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . 0.445 ' CD2' ' HA ' ' A' ' 361' ' ' PHE . 33.7 m-85 -63.35 -57.32 10.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 74.549999999999997 110.854 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -154.27 -86.59 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.742 . . . . 54.329999999999998 112.528 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -153.58 140.62 19.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.851 0.358 . . . . 74.519999999999996 110.833 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.448 HD13 ' N ' ' A' ' 362' ' ' GLN . 41.2 mt -120.97 109.09 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 75.019999999999996 111.195 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.8 mp -86.76 -18.04 32.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 74.239999999999995 110.948 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -170.76 120.9 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 72.340000000000003 110.88 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 33.0 t80 -113.48 141.88 46.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 72.409999999999997 110.903 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.64 101.21 6.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 75.450000000000003 110.905 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . 0.579 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.6 t-80 -98.46 130.25 45.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 72.340000000000003 110.901 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -125.89 90.59 50.05 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.718 0.77 . . . . 75.439999999999998 110.906 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' PRO . . . . . 0.571 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.5 Cg_endo -69.73 -38.25 8.11 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.739 2.293 . . . . 61.409999999999997 112.299 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.53 -21.3 62.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 72.120000000000005 110.861 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -111.55 -25.74 9.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 110.877 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 84.31 42.29 7.53 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.725 -0.75 . . . . 64.420000000000002 112.519 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 31.1 p -154.84 153.98 32.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.775 0.321 . . . . 74.420000000000002 110.866 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 13.7 p -144.89 146.23 31.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 75.010000000000005 110.867 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.463 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 43.1 m-85 -125.16 122.34 36.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 73.430000000000007 110.882 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.569 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -110.84 133.67 55.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 73.099999999999994 111.171 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 128.58 46.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 75.209999999999994 110.855 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -111.6 178.4 4.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 73.439999999999998 110.877 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -76.73 -45.54 28.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.078 -0.51 . . . . 71.209999999999994 110.894 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' THR . . . . . 0.407 ' C ' HG23 ' A' ' 341' ' ' THR . 40.5 p -117.08 172.47 7.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 74.420000000000002 111.154 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -85.29 -41.0 15.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 71.239999999999995 110.866 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -33.75 69.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 72.340000000000003 110.863 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -65.12 -34.93 79.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 75.420000000000002 110.889 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -67.11 -39.44 86.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 70.25 111.152 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . 0.411 ' HB3' ' CG1' ' A' ' 329' ' ' VAL . . . -56.07 -33.86 65.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 63.399999999999999 111.148 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.24 -40.21 85.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 71.129999999999995 111.166 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 13.3 t -75.04 -31.56 61.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 73.340000000000003 110.9 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . 0.472 HG23 ' CG2' ' A' ' 332' ' ' ILE . 0.2 OUTLIER -59.52 -54.97 27.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 61.420000000000002 111.145 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.463 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.81 -36.09 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 60.32 111.13 179.811 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.32 -48.25 80.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 111.163 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . 0.56 HD13 ' CD1' ' A' ' 399' ' ' PHE . 0.5 OUTLIER -79.3 -13.72 59.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 73.5 110.927 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -50.21 108.38 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 74.200000000000003 111.103 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 10.5 m120 49.62 50.8 17.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 73.129999999999995 110.91 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.56 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -109.2 146.97 35.0 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.629 0.728 . . . . 73.530000000000001 110.916 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . 0.519 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.7 Cg_endo -69.84 145.18 55.92 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.657 2.238 . . . . 73.329999999999998 112.383 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' PHE . . . . . 0.538 ' CE1' HD23 ' A' ' 360' ' ' LEU . 32.9 t80 -151.01 110.67 4.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 74.010000000000005 110.918 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 48.97 33.99 5.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 63.520000000000003 110.906 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.26 -32.7 7.17 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.727 -0.749 . . . . 71.310000000000002 112.549 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.3 OUTLIER -104.89 144.37 31.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 70.010000000000005 110.807 -179.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.03 154.44 24.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 75.230000000000004 110.849 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . 0.45 ' CD1' HG22 ' A' ' 345' ' ' ILE . 16.8 mt -113.7 169.92 8.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 74.519999999999996 110.959 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 346' ' ' GLY . 2.0 ttt180 -111.27 174.4 5.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 74.549999999999997 110.907 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' THR . . . . . 0.553 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 64.3 p -154.25 148.44 25.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.477 . . . . 75.450000000000003 111.118 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 64.040000000000006 112.488 179.964 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.842 0.353 . . . . 74.5 110.95 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.38 -31.46 61.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 71.129999999999995 111.103 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' VAL . . . . . 0.523 ' CG1' ' CB ' ' A' ' 390' ' ' ALA . 8.0 t -69.08 -29.58 43.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 72.319999999999993 111.118 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -53.94 -35.17 61.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 73.319999999999993 110.875 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -68.41 -31.85 71.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 74.329999999999998 110.879 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 40.8 mm -57.82 -51.29 72.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 75.200000000000003 111.125 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 5.4 mt -53.44 -37.23 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 75.430000000000007 111.16 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.82 -9.42 4.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 74.530000000000001 110.873 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.1 42.02 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 75.519999999999996 110.83 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . 178.35 162.83 0.64 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.566 0.698 . . . . 71.140000000000001 111.093 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 160.55 49.29 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.737 2.291 . . . . 73.219999999999999 112.371 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -16.0 37.71 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.69 2.26 . . . . 73.420000000000002 112.37 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -112.53 73.91 0.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 73.150000000000006 110.899 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 14.7 p -160.4 121.77 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 75.230000000000004 111.147 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' THR . . . . . 0.433 HG23 ' N ' ' A' ' 386' ' ' HIS . 18.8 p -136.02 67.9 1.46 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 74.430000000000007 111.084 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 33.8 m -133.84 108.23 8.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 65.230000000000004 111.165 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -80.27 129.77 34.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 75.200000000000003 111.178 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 0.502 ' CD1' ' C ' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -112.79 134.67 54.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 72.310000000000002 110.92 -179.801 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.464 HG23 ' CD1' ' A' ' 406' ' ' LEU . 1.5 mp -136.28 99.83 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.127 -0.488 . . . . 72.099999999999994 111.145 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -89.31 176.61 43.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 62.229999999999997 112.58 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.3 t30 68.38 47.27 0.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 74.450000000000003 110.892 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 55.0 mt -101.97 131.13 23.09 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.602 0.715 . . . . 72.019999999999996 111.144 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.85 165.98 29.24 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.249 . . . . 73.530000000000001 112.276 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -69.61 -26.33 64.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 70.319999999999993 110.858 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -85.47 32.23 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 74.25 110.877 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' ALA . . . . . 0.595 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -117.62 110.95 18.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 43.240000000000002 111.146 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 13.7 p -114.5 166.39 11.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 72.340000000000003 111.144 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' GLU . . . . . 0.491 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -63.45 -33.58 75.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 73.510000000000005 110.968 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.91 -26.77 59.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 74.319999999999993 111.092 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.22 -13.21 13.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 71.349999999999994 110.864 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.438 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.7 mp -99.37 -53.66 3.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 73.040000000000006 110.91 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.623 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -40.44 -51.73 6.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.628 0.728 . . . . 70.439999999999998 111.192 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.1 Cg_endo -69.73 -38.51 7.76 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.655 2.237 . . . . 75.439999999999998 112.331 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' LEU . . . . . 0.573 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -54.99 -27.7 46.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 74.140000000000001 110.889 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' PHE . . . . . 0.514 ' CD2' HD12 ' A' ' 360' ' ' LEU . 84.0 m-85 -95.16 -38.1 10.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 73.329999999999998 110.958 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' GLN . . . . . 0.447 ' N ' HD13 ' A' ' 367' ' ' ILE . 30.4 mt-30 -48.68 -43.25 36.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 75.129999999999995 110.911 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' ASN . . . . . 0.437 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.5 OUTLIER -42.87 -28.2 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 72.310000000000002 110.955 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' PHE . . . . . 0.551 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 18.7 m-85 -66.14 -58.55 5.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 74.549999999999997 110.92 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . 0.422 ' HA3' ' CD ' ' A' ' 388' ' ' GLN . . . -156.67 -84.34 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.76 -0.733 . . . . 54.329999999999998 112.519 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.412 ' O ' ' CD2' ' A' ' 383' ' ' TYR . 17.6 t80 -153.96 144.68 22.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 74.519999999999996 110.902 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' ILE . . . . . 0.447 HD13 ' N ' ' A' ' 362' ' ' GLN . 47.1 mt -120.86 108.78 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.019999999999996 111.138 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.32 -16.01 36.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.179 -0.464 . . . . 74.239999999999995 110.894 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -170.58 120.81 0.58 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.445 . . . . 72.340000000000003 110.862 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.574 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 34.7 t80 -115.44 136.11 53.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 72.409999999999997 110.894 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.62 100.3 6.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 75.450000000000003 110.866 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' HIS . . . . . 0.595 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 10.3 t-80 -100.2 110.79 23.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 72.340000000000003 110.862 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.577 ' CE2' ' HB2' ' A' ' 378' ' ' CYS . 1.0 OUTLIER -119.53 94.52 48.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.644 0.735 . . . . 75.439999999999998 110.89 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -17.4 37.3 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.724 2.282 . . . . 61.409999999999997 112.308 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.48 -28.62 69.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 72.120000000000005 110.917 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -111.69 -24.23 10.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 74.329999999999998 110.9 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 91.07 37.44 6.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.717 -0.754 . . . . 64.420000000000002 112.477 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' CYS . . . . . 0.577 ' HB2' ' CE2' ' A' ' 373' ' ' TYR . 0.0 OUTLIER -156.23 151.69 26.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 74.420000000000002 110.872 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' CYS . . . . . 0.574 ' HB2' ' CE1' ' A' ' 370' ' ' PHE . 25.6 p -126.05 171.35 10.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 75.010000000000005 110.834 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' PHE . . . . . 0.551 ' CE2' ' OH ' ' A' ' 373' ' ' TYR . 27.6 m-85 -137.63 107.32 6.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 73.430000000000007 110.829 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' ILE . . . . . 0.44 HD13 ' CE1' ' A' ' 361' ' ' PHE . 0.7 OUTLIER -106.21 113.31 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 73.099999999999994 111.119 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -87.33 130.85 34.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 75.209999999999994 110.9 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.583 ' CD2' ' OE1' ' A' ' 388' ' ' GLN . 46.6 m-85 -113.67 153.94 28.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 73.439999999999998 110.917 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -53.76 -47.3 70.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 71.209999999999994 110.885 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' THR . . . . . 0.427 ' C ' HG23 ' A' ' 341' ' ' THR . 1.7 p -108.82 157.73 18.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 74.420000000000002 111.119 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' HIS . . . . . 0.462 ' CG ' ' N ' ' A' ' 387' ' ' GLU . 20.8 p-80 -83.97 -44.49 14.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 71.239999999999995 110.777 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' GLU . . . . . 0.462 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 0.1 OUTLIER -57.24 -26.94 61.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 72.340000000000003 110.851 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' GLN . . . . . 0.583 ' OE1' ' CD2' ' A' ' 383' ' ' TYR . 0.8 OUTLIER -70.3 -32.52 70.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.182 -0.463 . . . . 75.420000000000002 110.965 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -68.4 -33.86 74.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 70.25 111.11 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' ALA . . . . . 0.523 ' CB ' ' CG1' ' A' ' 329' ' ' VAL . . . -54.55 -28.76 48.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 63.399999999999999 111.093 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 77.7 t -71.36 -51.02 36.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 71.129999999999995 111.196 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' CYS . . . . . 0.551 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 3.6 t -61.46 -31.08 71.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 73.340000000000003 110.847 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' ILE . . . . . . . . . . . . . 1.1 mt -57.15 -56.02 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 61.420000000000002 111.166 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' VAL . . . . . 0.475 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.2 t -72.39 -35.18 51.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 60.32 111.122 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.85 -49.75 76.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 75.209999999999994 111.116 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' LEU . . . . . 0.574 ' CB ' ' CG2' ' A' ' 408' ' ' THR . 2.7 mm? -77.16 -7.84 56.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.423 . . . . 73.5 110.981 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' ALA . . . . . 0.403 ' N ' HG22 ' A' ' 408' ' ' THR . . . -54.78 112.23 0.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.200000000000003 111.096 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 43.98 48.71 7.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.909 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' PHE . . . . . 0.565 ' CD1' HD11 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -102.79 141.58 22.79 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.726 0.774 . . . . 73.530000000000001 110.86 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 136.37 32.99 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.706 2.271 . . . . 73.329999999999998 112.388 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' PHE . . . . . 0.562 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 36.8 t80 -140.67 110.81 6.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 74.010000000000005 110.868 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 50.19 32.72 6.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 63.520000000000003 110.911 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 100.69 -30.09 11.01 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.699 -0.762 . . . . 71.310000000000002 112.451 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.07 138.89 40.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.838 0.351 . . . . 70.010000000000005 110.901 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -80.69 155.13 26.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 75.230000000000004 110.855 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . 0.464 ' CD1' HG23 ' A' ' 345' ' ' ILE . 16.5 mt -114.61 176.82 4.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.519999999999996 110.955 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.09 173.45 6.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 74.549999999999997 110.91 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' THR . . . . . 0.574 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 72.0 p -154.63 151.06 28.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 75.450000000000003 111.115 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 120.778 -0.725 . . . . 64.040000000000006 112.534 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.45 -0.26 . . . . 72.200000000000003 112.45 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 26.9 m -67.82 147.85 52.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 73.230000000000004 110.857 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -73.46 95.13 2.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 60.020000000000003 110.922 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.7 p -138.54 91.58 2.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 74.329999999999998 111.159 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.48 133.6 42.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 72.530000000000001 111.125 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -112.49 108.8 2.27 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 70.230000000000004 112.485 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.51 77.5 7.94 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.609 0.718 . . . . 73.409999999999997 110.934 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 157.39 60.5 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.675 2.25 . . . . 74.540000000000006 112.297 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -28.3 25.49 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.697 2.265 . . . . 74.510000000000005 112.341 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.56 140.66 49.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 75.209999999999994 110.88 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.46 HG11 ' CG1' ' A' ' 394' ' ' VAL . 10.7 t 67.56 142.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 74.200000000000003 111.132 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.29 130.5 23.58 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.634 0.73 . . . . 75.140000000000001 110.889 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -14.08 35.51 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.644 2.229 . . . . 75.519999999999996 112.342 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -71.99 -71.93 0.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 74.5 110.918 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.95 -25.09 27.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 71.129999999999995 111.125 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.465 ' CG2' ' HB ' ' A' ' 394' ' ' VAL . 7.9 t -79.96 -29.78 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 72.319999999999993 111.096 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -54.54 -36.88 64.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 73.319999999999993 110.865 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -64.2 -32.24 73.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 74.329999999999998 110.854 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 22.6 mm -60.31 -52.81 56.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 75.200000000000003 111.151 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 4.8 mt -55.48 -41.63 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 75.430000000000007 111.137 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.96 -16.69 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 74.530000000000001 110.856 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.56 23.49 8.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 75.519999999999996 110.878 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.566 ' HB1' ' CD1' ' A' ' 410' ' ' TRP . . . -174.96 159.09 2.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.574 0.702 . . . . 71.140000000000001 111.087 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 150.2 68.06 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.67 2.247 . . . . 73.219999999999999 112.365 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -14.23 35.74 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.701 2.267 . . . . 73.420000000000002 112.332 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.43 -63.13 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 73.150000000000006 110.882 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.64 143.83 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 75.230000000000004 111.091 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 386' ' ' HIS . 22.3 p -146.98 68.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 74.430000000000007 111.128 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.461 HG22 ' N ' ' A' ' 343' ' ' ALA . 87.7 m -133.78 139.46 46.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 65.230000000000004 111.116 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.461 ' N ' HG22 ' A' ' 342' ' ' THR . . . -105.78 121.78 44.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 75.200000000000003 111.083 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.602 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -102.93 122.09 43.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 72.310000000000002 110.877 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . . . . . . . . . 1.9 mp -118.58 112.85 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 72.099999999999994 111.149 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -102.23 171.82 21.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.76 -0.734 . . . . 62.229999999999997 112.479 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.416 ' O ' ' CD2' ' A' ' 406' ' ' LEU . 1.4 t30 71.45 46.59 0.41 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.337 . . . . 74.450000000000003 110.917 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.419 HG21 ' N ' ' A' ' 349' ' ' PRO . 86.9 mt -102.77 137.17 19.24 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.622 0.725 . . . . 72.019999999999996 111.147 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . 0.532 ' HB2' ' CD1' ' A' ' 351' ' ' PHE . 53.6 Cg_endo -69.76 163.53 37.94 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.679 2.253 . . . . 73.530000000000001 112.341 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -70.5 -24.05 62.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 70.319999999999993 110.884 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.532 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 29.4 p90 -90.74 29.46 1.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 74.25 110.883 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . 0.588 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -112.63 99.11 7.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 43.240000000000002 111.13 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 13.3 p -99.2 169.49 9.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 72.340000000000003 111.13 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.495 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.29 -29.76 69.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 73.510000000000005 110.839 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -59.0 -26.04 64.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 74.319999999999993 111.13 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.78 -13.09 13.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 71.349999999999994 110.841 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.439 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.5 mp -99.93 -53.24 3.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 73.040000000000006 110.936 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.636 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -41.49 -51.14 8.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.574 0.702 . . . . 70.439999999999998 111.118 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.4 Cg_endo -69.78 -30.47 22.15 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.668 2.246 . . . . 75.439999999999998 112.339 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.584 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -64.96 -20.12 66.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 74.140000000000001 110.955 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.55 ' CD1' HD13 ' A' ' 381' ' ' ILE . 88.1 m-85 -104.8 -37.01 7.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 73.329999999999998 110.89 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -48.56 -45.51 37.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 75.129999999999995 110.931 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . 0.419 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.8 OUTLIER -44.49 -23.77 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 72.310000000000002 110.858 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 392' ' ' CYS . 32.2 m-85 -69.85 -51.29 34.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 74.549999999999997 110.846 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -163.26 -88.0 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 54.329999999999998 112.473 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -151.74 144.49 24.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 74.519999999999996 110.913 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.426 HG22 ' CG2' ' A' ' 381' ' ' ILE . 25.9 mt -121.07 109.74 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 75.019999999999996 111.147 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.43 -19.42 29.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 74.239999999999995 110.889 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -170.96 120.74 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 72.340000000000003 110.889 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 33.5 t80 -113.61 131.33 56.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 72.409999999999997 110.902 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.31 100.73 7.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 75.450000000000003 110.928 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . 0.588 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 13.6 t-80 -97.81 127.44 43.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 72.340000000000003 110.905 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -122.85 86.58 50.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.712 0.768 . . . . 75.439999999999998 110.944 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . 0.498 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 54.0 Cg_endo -69.76 -21.38 33.56 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.732 2.288 . . . . 61.409999999999997 112.357 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.47 -23.76 63.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 72.120000000000005 110.871 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -115.39 -25.79 7.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 74.329999999999998 110.893 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.09 44.83 4.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.718 -0.753 . . . . 64.420000000000002 112.458 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 93.9 m -156.93 147.94 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 74.420000000000002 110.886 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.484 ' HB2' ' CE1' ' A' ' 370' ' ' PHE . 21.5 p -138.01 153.18 49.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 75.010000000000005 110.882 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 380' ' ' PHE . 2.3 m-85 -128.48 118.92 23.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 73.430000000000007 110.877 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.55 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -107.7 128.73 62.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 73.099999999999994 111.108 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.94 132.25 43.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 75.209999999999994 110.909 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -114.67 -178.9 3.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 73.439999999999998 110.96 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -76.78 -40.58 47.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.469 . . . . 71.209999999999994 110.898 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' THR . . . . . 0.415 ' C ' HG22 ' A' ' 341' ' ' THR . 53.5 p -125.17 167.11 15.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 74.420000000000002 111.143 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' HIS . . . . . 0.472 ' N ' HG22 ' A' ' 341' ' ' THR . 9.8 p-80 -72.99 -40.58 65.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 71.239999999999995 110.869 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . 0.428 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 0.4 OUTLIER -57.87 -26.97 62.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 72.340000000000003 110.878 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -65.71 -33.48 75.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 75.420000000000002 110.848 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.456 ' HB1' ' CZ3' ' A' ' 410' ' ' TRP . . . -78.93 -34.65 44.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 70.25 111.057 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -61.15 -34.46 75.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.239 -0.437 . . . . 63.399999999999999 111.097 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.8 -57.24 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 71.129999999999995 111.132 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 364' ' ' PHE . 30.1 p -66.28 -27.06 67.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 73.340000000000003 110.906 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.48 ' O ' ' CG2' ' A' ' 408' ' ' THR . 1.3 mt -58.21 -54.56 30.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 61.420000000000002 111.112 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.465 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 0.5 OUTLIER -71.5 -34.21 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 60.32 111.105 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.8 -37.05 85.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 75.209999999999994 111.143 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . 0.564 HD12 ' CE1' ' A' ' 399' ' ' PHE . 2.8 mm? -86.14 -12.91 48.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 73.5 110.916 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' ALA . . . . . 0.481 ' N ' HG22 ' A' ' 408' ' ' THR . . . -53.45 111.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 74.200000000000003 111.089 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.9 m120 47.73 48.91 17.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 73.129999999999995 110.927 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.589 ' O ' ' CD1' ' A' ' 399' ' ' PHE . 0.0 OUTLIER -104.59 144.26 28.35 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.608 0.718 . . . . 73.530000000000001 110.874 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 139.09 39.35 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.653 2.236 . . . . 73.329999999999998 112.364 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' PHE . . . . . 0.615 ' CZ ' ' NE2' ' A' ' 402' ' ' GLN . 41.0 t80 -145.85 111.8 5.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 74.010000000000005 110.9 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . 0.615 ' NE2' ' CZ ' ' A' ' 401' ' ' PHE . 20.9 mt-30 51.07 32.64 7.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 63.520000000000003 110.976 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.92 -26.23 25.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.696 -0.764 . . . . 71.310000000000002 112.448 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' A' ' 401' ' ' PHE . 3.3 ttt180 -109.43 141.3 42.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.761 0.315 . . . . 70.010000000000005 110.876 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -82.52 155.19 24.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 75.230000000000004 110.873 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.416 ' CD2' ' O ' ' A' ' 347' ' ' ASN . 27.3 mt -117.19 178.31 4.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.519999999999996 110.91 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.59 176.02 5.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 74.549999999999997 110.864 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' THR . . . . . 0.504 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 1.8 p -146.77 156.67 43.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 75.450000000000003 111.142 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 166.77 -176.14 41.91 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.725 -0.75 . . . . 64.040000000000006 112.478 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.566 ' CD1' ' HB1' ' A' ' 336' ' ' ALA . 73.3 m95 -95.11 119.04 32.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.757 0.313 . . . . 72.239999999999995 110.925 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 410' ' ' TRP . . . -34.36 111.04 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.796 -0.716 . . . . 72.430000000000007 112.442 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 413' ' ' GLU . 2.5 mtmp? -134.69 145.63 48.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.712 0.291 . . . . 74.239999999999995 110.9 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 412' ' ' LYS . 1.5 mt-10 -34.87 -45.32 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 72.319999999999993 110.919 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 71.129999999999995 110.877 -179.933 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.464 -0.255 . . . . 72.200000000000003 112.464 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 1.5 t -122.56 145.2 48.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.846 0.355 . . . . 73.230000000000004 110.875 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.93 -54.15 1.63 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 60.020000000000003 110.957 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 31.6 m 64.99 116.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 74.329999999999998 111.114 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 10.4 tp -95.98 148.65 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 72.530000000000001 111.11 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -98.0 -37.08 4.51 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.782 -0.723 . . . . 70.230000000000004 112.493 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 4.9 mt 65.28 67.54 0.78 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.589 0.709 . . . . 73.409999999999997 110.923 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 149.51 66.95 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.639 2.226 . . . . 74.540000000000006 112.399 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -7.09 20.16 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.738 2.292 . . . . 74.510000000000005 112.313 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.21 -168.83 2.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 75.209999999999994 110.921 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 21.6 m -38.22 158.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 74.200000000000003 111.167 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -113.08 143.77 29.82 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.619 0.723 . . . . 75.140000000000001 110.891 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.86 -14.17 35.41 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.664 2.243 . . . . 75.519999999999996 112.297 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -72.86 -72.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 74.5 110.869 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -52.58 -24.84 9.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 71.129999999999995 111.082 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.464 ' CG2' HG12 ' A' ' 394' ' ' VAL . 5.0 t -81.58 -30.06 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 72.319999999999993 111.098 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -55.06 -38.06 67.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 73.319999999999993 110.817 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -59.9 -37.69 80.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 74.329999999999998 110.902 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 16.6 mm -54.96 -54.46 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 75.200000000000003 111.138 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 7.2 mt -51.61 -41.35 27.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 75.430000000000007 111.148 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -16.84 2.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 74.530000000000001 110.853 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.38 29.01 5.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.205 -0.452 . . . . 75.519999999999996 110.872 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -159.59 154.27 20.9 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.57 0.7 . . . . 71.140000000000001 111.13 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 156.52 63.01 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.677 2.251 . . . . 73.219999999999999 112.36 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -6.68 19.19 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.661 2.24 . . . . 73.420000000000002 112.395 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -119.93 76.45 1.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 73.150000000000006 110.944 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 7.5 p -179.62 141.84 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 75.230000000000004 111.156 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' THR . . . . . 0.415 HG21 ' C ' ' A' ' 385' ' ' THR . 21.0 p -149.46 69.79 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 74.430000000000007 111.13 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 96.4 m -133.5 116.08 15.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 65.230000000000004 111.109 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -89.14 121.86 31.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 75.200000000000003 111.077 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.56 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -102.99 125.56 49.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 72.310000000000002 110.907 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . . . . . . . . . 1.9 mp -122.52 118.86 56.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 72.099999999999994 111.17 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -105.91 -179.01 23.6 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.725 -0.75 . . . . 62.229999999999997 112.482 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.483 ' O ' ' CD2' ' A' ' 406' ' ' LEU . 0.7 OUTLIER 62.82 49.73 3.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.753 0.311 . . . . 74.450000000000003 110.811 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 86.8 mt -103.25 134.17 19.92 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.57 0.7 . . . . 72.019999999999996 111.177 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . 0.402 ' CG ' ' CE1' ' A' ' 351' ' ' PHE . 53.7 Cg_endo -69.77 165.38 31.18 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.704 2.27 . . . . 73.530000000000001 112.367 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.78 -25.8 63.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 70.319999999999993 110.916 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.402 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 2.9 p90 -89.88 31.87 0.94 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.851 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . 0.575 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -120.62 99.18 6.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 43.240000000000002 111.107 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 79.5 p -104.79 173.66 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.269 -0.423 . . . . 72.340000000000003 111.208 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.513 ' O ' ' CG1' ' A' ' 358' ' ' ILE . 0.6 OUTLIER -66.71 -29.85 69.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 73.510000000000005 110.915 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.41 -26.28 63.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 74.319999999999993 111.038 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.42 -17.51 12.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.258 -0.428 . . . . 71.349999999999994 110.804 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.463 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 4.0 mp -92.33 -51.1 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 73.040000000000006 110.851 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.667 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.3 mm -42.34 -49.98 11.95 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.581 0.705 . . . . 70.439999999999998 111.082 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.6 Cg_endo -69.76 -28.0 25.78 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.685 2.257 . . . . 75.439999999999998 112.365 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.576 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.2 OUTLIER -68.11 -25.99 65.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 74.140000000000001 110.891 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.559 ' CD2' HD12 ' A' ' 360' ' ' LEU . 85.3 m-85 -102.42 -34.69 9.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 73.329999999999998 110.886 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' GLN . . . . . 0.431 ' N ' HD12 ' A' ' 367' ' ' ILE . 2.0 mt-30 -54.63 -32.36 58.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 75.129999999999995 110.882 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.05 -13.67 12.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 72.310000000000002 110.872 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . 0.458 ' CD2' ' HB3' ' A' ' 392' ' ' CYS . 39.3 m-85 -78.78 -55.9 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 74.549999999999997 110.926 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -155.19 -86.77 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.647 -0.787 . . . . 54.329999999999998 112.443 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.438 ' CE2' ' HG ' ' A' ' 368' ' ' LEU . 61.2 t80 -153.62 140.78 19.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.337 . . . . 74.519999999999996 110.906 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 362' ' ' GLN . 42.0 mt -120.33 109.29 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 75.019999999999996 111.161 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.438 ' HG ' ' CE2' ' A' ' 366' ' ' PHE . 0.9 OUTLIER -86.18 -20.24 28.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 74.239999999999995 110.93 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.89 121.36 0.67 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 72.340000000000003 110.923 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 35.0 t80 -113.61 145.7 40.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 72.409999999999997 110.895 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -131.44 101.97 5.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 75.450000000000003 110.952 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 6.2 t-80 -100.83 127.24 47.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.295 -0.412 . . . . 72.340000000000003 110.856 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -118.2 90.55 38.24 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.703 0.763 . . . . 75.439999999999998 110.958 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . 0.44 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.4 Cg_endo -69.75 -19.69 35.84 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.718 2.278 . . . . 61.409999999999997 112.335 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -84.38 -21.96 30.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 72.120000000000005 110.823 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -106.53 -26.43 11.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 74.329999999999998 110.866 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . 0.4 ' C ' ' SG ' ' A' ' 378' ' ' CYS . . . 84.74 35.38 13.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 64.420000000000002 112.489 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . 0.4 ' SG ' ' C ' ' A' ' 377' ' ' GLY . 1.8 m -153.64 140.98 19.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.774 0.321 . . . . 74.420000000000002 110.901 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 17.7 p -133.14 146.08 51.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 75.010000000000005 110.889 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.463 ' CE2' ' HB2' ' A' ' 344' ' ' TYR . 7.4 m-85 -124.15 127.69 48.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 73.430000000000007 110.911 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.556 HD11 ' CD1' ' A' ' 361' ' ' PHE . 1.0 OUTLIER -113.36 130.74 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 73.099999999999994 111.145 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -94.67 131.35 40.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 75.209999999999994 110.922 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -114.85 -174.58 2.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 73.439999999999998 110.902 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -93.47 -30.49 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 71.209999999999994 110.9 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' THR . . . . . 0.415 ' C ' HG21 ' A' ' 341' ' ' THR . 24.8 p -125.7 165.8 17.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 74.420000000000002 111.088 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' HIS . . . . . 0.426 ' CG ' ' N ' ' A' ' 387' ' ' GLU . 17.9 p-80 -78.42 -41.46 32.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 71.239999999999995 110.855 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 6.6 tm-20 -57.37 -31.27 65.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 72.340000000000003 110.861 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -36.29 82.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 75.420000000000002 110.933 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.423 ' HB1' ' CZ3' ' A' ' 410' ' ' TRP . . . -76.02 -27.14 57.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 70.25 111.063 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -72.72 -35.51 67.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 63.399999999999999 111.063 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 82.7 t -66.02 -53.57 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 71.129999999999995 111.124 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . 0.458 ' HB3' ' CD2' ' A' ' 364' ' ' PHE . 31.5 p -65.35 -31.76 73.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.484 . . . . 73.340000000000003 110.861 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 408' ' ' THR . 0.7 OUTLIER -55.67 -55.65 16.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 61.420000000000002 111.133 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.464 HG12 ' CG2' ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.67 -36.79 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 60.32 111.164 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.2 -30.57 71.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 75.209999999999994 111.119 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . 0.569 HD12 ' CE1' ' A' ' 399' ' ' PHE . 2.1 mm? -95.93 -16.07 21.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 73.5 110.889 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -48.58 110.39 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.200000000000003 111.131 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 42.5 t30 49.45 50.57 17.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 73.129999999999995 110.923 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.569 ' CE1' HD12 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -107.47 145.62 31.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.655 0.74 . . . . 73.530000000000001 110.899 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 143.32 50.81 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.74 2.293 . . . . 73.329999999999998 112.333 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' PHE . . . . . 0.516 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 31.6 t80 -150.37 110.97 4.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 74.010000000000005 110.892 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 49.82 33.02 5.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 63.520000000000003 110.949 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 99.54 -27.76 18.63 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.683 -0.77 . . . . 71.310000000000002 112.503 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.3 OUTLIER -107.0 142.03 37.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.903 0.382 . . . . 70.010000000000005 110.901 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -83.05 154.79 24.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 75.230000000000004 110.834 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.483 ' CD2' ' O ' ' A' ' 347' ' ' ASN . 19.6 mt -117.78 167.77 11.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 74.519999999999996 110.889 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.58 179.12 4.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 74.549999999999997 110.92 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' THR . . . . . 0.423 ' CG2' ' O ' ' A' ' 393' ' ' ILE . 5.9 p -152.86 153.56 33.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 75.450000000000003 111.191 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 169.72 -176.12 43.67 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.749 . . . . 64.040000000000006 112.454 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.423 ' CZ3' ' HB1' ' A' ' 389' ' ' ALA . 65.7 m95 -97.09 124.26 41.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.885 0.374 . . . . 72.239999999999995 110.898 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -47.04 124.21 8.43 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.7 -0.762 . . . . 72.430000000000007 112.507 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 413' ' ' GLU . 0.0 OUTLIER -136.4 88.78 2.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.697 0.284 . . . . 74.239999999999995 110.938 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 412' ' ' LYS . 0.9 OUTLIER -36.53 113.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 72.319999999999993 110.926 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 71.129999999999995 110.879 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.494 -0.242 . . . . 72.200000000000003 112.494 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 21.0 m -124.63 -68.16 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 73.230000000000004 110.896 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -179.94 -42.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 60.020000000000003 110.872 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 47.4 p -105.9 167.2 9.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 74.329999999999998 111.163 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 319' ' ' GLY . 5.5 tt -168.16 -45.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 72.530000000000001 111.121 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.466 ' N ' ' CG2' ' A' ' 318' ' ' ILE . . . 83.09 -36.49 2.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.761 -0.733 . . . . 70.230000000000004 112.472 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 3.5 mt 61.68 59.38 3.0 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.61 0.719 . . . . 73.409999999999997 110.933 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.71 164.91 32.71 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.642 2.228 . . . . 74.540000000000006 112.375 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -36.95 9.89 Favored 'Trans proline' 0 C--O 1.23 0.109 0 C-N-CA 122.688 2.259 . . . . 74.510000000000005 112.355 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.48 ' NE2' ' HA ' ' A' ' 323' ' ' GLN . 0.0 OUTLIER 169.83 94.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 75.209999999999994 110.907 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.469 HG22 ' CG1' ' A' ' 391' ' ' VAL . 5.8 t -157.16 148.52 10.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 74.200000000000003 111.195 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -112.95 118.27 44.83 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.629 0.728 . . . . 75.140000000000001 110.824 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -14.09 35.44 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.737 2.291 . . . . 75.519999999999996 112.29 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -70.99 -71.63 0.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 74.5 110.874 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -58.48 -25.01 61.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 71.129999999999995 111.002 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.469 ' CG2' HG11 ' A' ' 394' ' ' VAL . 14.6 t -74.82 -30.03 23.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 72.319999999999993 111.117 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -55.03 -36.92 66.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.319999999999993 110.878 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -62.42 -36.34 82.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 74.329999999999998 110.909 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.448 HG21 ' NE1' ' A' ' 410' ' ' TRP . 20.4 mm -55.42 -53.25 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 75.200000000000003 111.071 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 5.5 mt -53.02 -40.51 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 75.430000000000007 111.163 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -16.27 2.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 74.530000000000001 110.844 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' A' ' 336' ' ' ALA . 0.2 OUTLIER -105.02 44.75 1.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 75.519999999999996 110.823 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 335' ' ' SER . . . 167.32 147.31 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.659 0.742 . . . . 71.140000000000001 111.095 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.404 ' O ' ' CG1' ' A' ' 340' ' ' VAL . 53.4 Cg_endo -69.81 151.27 68.76 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.667 2.245 . . . . 73.219999999999999 112.342 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -8.88 24.74 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.766 2.311 . . . . 73.420000000000002 112.332 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.42 16.58 3.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 73.150000000000006 110.863 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.404 ' CG1' ' O ' ' A' ' 337' ' ' PRO . 13.9 p -131.29 140.15 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 75.230000000000004 111.164 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' THR . . . . . 0.416 HG23 ' CA ' ' A' ' 386' ' ' HIS . 21.0 p -148.78 68.11 1.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 74.430000000000007 111.138 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 28.1 m -133.78 127.62 33.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.474 . . . . 65.230000000000004 111.098 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.96 120.69 35.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 75.200000000000003 111.169 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.47 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -105.86 131.72 52.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 72.310000000000002 110.92 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.437 ' CG2' ' HB3' ' A' ' 406' ' ' LEU . 1.7 mp -126.22 117.68 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 72.099999999999994 111.121 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -105.11 162.59 14.48 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.741 . . . . 62.229999999999997 112.524 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.5 t30 76.14 44.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 74.450000000000003 110.888 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 67.3 mt -94.59 135.2 24.23 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.613 0.721 . . . . 72.019999999999996 111.115 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . 0.4 ' CB ' ' CE1' ' A' ' 351' ' ' PHE . 52.9 Cg_endo -69.77 159.75 52.25 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.732 2.288 . . . . 73.530000000000001 112.337 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -67.86 -21.47 65.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 70.319999999999993 110.817 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.4 ' CE1' ' CB ' ' A' ' 349' ' ' PRO . 5.4 p90 -93.86 28.49 2.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 74.25 110.903 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . 0.587 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -110.83 102.07 10.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 43.240000000000002 111.117 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 14.3 p -102.8 169.26 8.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 72.340000000000003 111.109 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.496 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.49 -31.32 71.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 73.510000000000005 110.865 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.96 -26.38 59.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 74.319999999999993 111.1 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -111.98 -13.11 13.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 71.349999999999994 110.902 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.438 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.4 mp -99.47 -54.18 3.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 73.040000000000006 110.91 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.619 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -40.29 -51.79 6.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.664 0.745 . . . . 70.439999999999998 111.088 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' PRO . . . . . 0.619 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.3 Cg_endo -69.76 -38.12 8.24 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.72 2.28 . . . . 75.439999999999998 112.339 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.579 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -55.32 -26.67 42.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.442 . . . . 74.140000000000001 110.925 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.56 ' CD1' HD11 ' A' ' 381' ' ' ILE . 85.2 m-85 -97.42 -39.22 9.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 73.329999999999998 110.861 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' GLN . . . . . 0.47 ' N ' HD11 ' A' ' 367' ' ' ILE . 6.8 mt-30 -47.52 -44.26 25.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 75.129999999999995 111.006 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 360' ' ' LEU . 0.9 OUTLIER -45.05 -29.01 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 72.310000000000002 110.879 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . 0.566 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 34.0 m-85 -63.33 -57.39 10.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 74.549999999999997 110.913 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -156.8 -83.7 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.729 . . . . 54.329999999999998 112.507 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -153.5 144.76 23.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.798 0.332 . . . . 74.519999999999996 110.885 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.47 HD11 ' N ' ' A' ' 362' ' ' GLN . 69.1 mt -121.13 109.08 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 75.019999999999996 111.12 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.3 mt -88.1 -19.8 26.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 74.239999999999995 110.877 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.15 120.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 72.340000000000003 110.848 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' A' ' 372' ' ' HIS . 34.9 t80 -113.1 142.2 46.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 72.409999999999997 110.899 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.5 100.48 5.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 75.450000000000003 110.88 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . 0.587 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.0 t-80 -99.59 119.02 37.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 72.340000000000003 110.877 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.86 88.21 11.37 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.709 0.766 . . . . 75.439999999999998 110.944 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . 0.423 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 54.1 Cg_endo -69.78 -26.9 27.01 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.705 2.27 . . . . 61.409999999999997 112.355 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.55 -19.75 62.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 72.120000000000005 110.871 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -111.14 -27.07 8.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 74.329999999999998 110.895 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 89.11 39.83 6.33 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.781 -0.723 . . . . 64.420000000000002 112.479 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.8 p -159.58 153.59 23.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.752 0.31 . . . . 74.420000000000002 110.87 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.516 ' C ' ' CD1' ' A' ' 380' ' ' PHE . 15.2 p -138.72 166.71 23.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 75.010000000000005 110.866 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 379' ' ' CYS . 7.0 m-85 -142.12 125.57 16.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 73.430000000000007 110.806 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.56 HD11 ' CD1' ' A' ' 361' ' ' PHE . 0.7 OUTLIER -115.48 126.43 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 73.099999999999994 111.15 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.71 128.38 42.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 75.209999999999994 110.911 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -109.83 179.32 4.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 73.439999999999998 110.95 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -81.05 -34.95 32.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.469 . . . . 71.209999999999994 110.878 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' THR . . . . . 0.408 ' C ' HG21 ' A' ' 341' ' ' THR . 82.8 p -125.65 166.75 16.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 74.420000000000002 111.174 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' HIS . . . . . 0.416 ' CA ' HG23 ' A' ' 341' ' ' THR . 4.1 p-80 -82.58 -38.69 23.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 71.239999999999995 110.861 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . 0.403 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 4.5 tt0 -57.4 -27.71 62.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 72.340000000000003 110.84 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -35.59 66.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 75.420000000000002 110.91 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -68.47 -37.94 80.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 70.25 111.077 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -58.59 -33.61 70.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 63.399999999999999 111.068 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.469 ' CG1' HG22 ' A' ' 324' ' ' VAL . 58.3 t -63.58 -57.52 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 71.129999999999995 111.128 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . 0.566 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 10.5 t -59.33 -30.18 68.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.496 . . . . 73.340000000000003 110.919 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -55.21 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 61.420000000000002 111.102 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.469 HG11 ' CG2' ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.79 -34.82 52.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 60.32 111.129 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.19 -45.38 88.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 75.209999999999994 111.149 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . 0.562 ' CB ' ' CG2' ' A' ' 408' ' ' THR . 2.7 mm? -81.59 -12.58 58.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 73.5 110.986 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' ALA . . . . . 0.464 ' N ' HG21 ' A' ' 408' ' ' THR . . . -49.37 111.08 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 74.200000000000003 111.098 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 6.6 m120 44.26 48.74 7.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 73.129999999999995 110.825 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.559 ' O ' ' CD1' ' A' ' 399' ' ' PHE . 0.0 OUTLIER -103.6 145.77 31.24 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.66 0.743 . . . . 73.530000000000001 110.916 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 141.8 46.19 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.692 2.261 . . . . 73.329999999999998 112.34 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' PHE . . . . . 0.544 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 30.4 t80 -146.94 110.85 5.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 74.010000000000005 110.913 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 47.92 32.96 3.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 63.520000000000003 110.936 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.04 -29.85 11.63 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.815 -0.707 . . . . 71.310000000000002 112.517 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.76 137.02 43.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 70.010000000000005 110.887 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -81.65 150.38 28.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 75.230000000000004 110.89 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.437 ' HB3' ' CG2' ' A' ' 345' ' ' ILE . 28.4 mt -112.39 171.43 7.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 74.519999999999996 110.902 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 346' ' ' GLY . 13.4 ttt180 -112.73 174.66 5.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 74.549999999999997 110.842 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' THR . . . . . 0.562 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 70.7 p -154.28 146.97 24.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 75.450000000000003 111.17 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . 0.456 ' O ' ' C ' ' A' ' 410' ' ' TRP . . . 159.78 131.91 1.3 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.764 -0.731 . . . . 64.040000000000006 112.506 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.456 ' C ' ' O ' ' A' ' 409' ' ' GLY . 66.1 m95 -33.59 144.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.853 0.359 . . . . 72.239999999999995 110.907 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -140.59 -172.2 12.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.709 -0.757 . . . . 72.430000000000007 112.504 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -144.55 121.26 11.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.748 0.309 . . . . 74.239999999999995 110.952 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -47.46 111.39 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 72.319999999999993 110.925 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 2.3 ttt-85 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 71.129999999999995 110.849 -179.87 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.518 -0.233 . . . . 72.200000000000003 112.518 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.21 158.42 24.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.744 0.307 . . . . 73.230000000000004 110.898 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -136.27 35.36 2.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 60.020000000000003 110.919 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 77.3 p -109.4 150.38 28.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 74.329999999999998 111.131 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.4 tt -108.65 -7.42 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.473 . . . . 72.530000000000001 111.114 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 70.66 -100.42 0.82 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.753 -0.737 . . . . 70.230000000000004 112.521 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 7.2 mt 51.67 73.02 1.04 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.531 0.682 . . . . 73.409999999999997 110.924 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.412 ' HB3' ' CG ' ' A' ' 325' ' ' ASN . 53.9 Cg_endo -69.74 150.9 68.92 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.643 2.229 . . . . 74.540000000000006 112.336 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 -21.83 32.94 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.725 2.283 . . . . 74.510000000000005 112.31 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -155.27 -66.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 75.209999999999994 110.869 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.463 HG11 ' CG1' ' A' ' 394' ' ' VAL . 1.7 t -147.45 134.84 14.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 74.200000000000003 111.1 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.412 ' CG ' ' HB3' ' A' ' 321' ' ' PRO . 2.6 m-20 -113.07 139.12 22.63 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.626 0.727 . . . . 75.140000000000001 110.875 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -14.66 36.44 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.723 2.282 . . . . 75.519999999999996 112.34 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -73.12 -72.39 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 74.5 110.922 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -53.78 -24.87 16.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 71.129999999999995 111.163 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.469 ' CG2' HG13 ' A' ' 394' ' ' VAL . 6.9 t -84.36 -30.06 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 72.319999999999993 111.165 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -54.67 -41.17 69.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 73.319999999999993 110.953 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -56.6 -39.23 73.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 74.329999999999998 110.887 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.404 HG13 ' CG2' ' A' ' 393' ' ' ILE . 21.5 mm -54.4 -54.34 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 75.200000000000003 111.097 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.475 ' CG2' ' NE2' ' A' ' 386' ' ' HIS . 4.3 mt -53.69 -36.34 28.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 75.430000000000007 111.124 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -7.98 5.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 74.530000000000001 110.873 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.8 7.68 37.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 75.519999999999996 110.887 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -153.0 147.1 18.6 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.598 0.714 . . . . 71.140000000000001 111.062 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 153.27 69.07 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.694 2.263 . . . . 73.219999999999999 112.356 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -7.75 21.85 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.67 2.246 . . . . 73.420000000000002 112.351 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 31.9 mtt180 -92.25 37.11 0.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 73.150000000000006 110.844 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 7.7 p -157.74 142.59 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 75.230000000000004 111.138 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' THR . . . . . 0.463 HG21 ' N ' ' A' ' 386' ' ' HIS . 18.2 p -144.39 67.93 1.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 74.430000000000007 111.18 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 72.7 m -134.06 137.59 44.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 65.230000000000004 111.175 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -108.74 122.22 46.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 75.200000000000003 111.138 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -102.06 124.87 48.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.267 -0.424 . . . . 72.310000000000002 110.937 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . . . . . . . . . 1.9 mp -120.73 104.41 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 72.099999999999994 111.083 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -93.3 165.62 27.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.825 -0.703 . . . . 62.229999999999997 112.536 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.5 t30 74.99 55.47 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.358 . . . . 74.450000000000003 110.89 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.401 HG21 ' N ' ' A' ' 349' ' ' PRO . 76.7 mt -110.19 136.36 20.5 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.634 0.73 . . . . 72.019999999999996 111.153 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . 0.485 ' CG ' ' CE1' ' A' ' 351' ' ' PHE . 54.5 Cg_endo -69.68 162.93 40.12 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.664 2.243 . . . . 73.530000000000001 112.359 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.41 -21.27 61.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 70.319999999999993 110.862 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.485 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 7.4 p90 -88.02 19.92 3.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 74.25 110.864 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . 0.598 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -104.65 121.34 43.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 43.240000000000002 111.08 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 11.5 p -123.08 167.99 12.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 72.340000000000003 111.215 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.487 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.3 OUTLIER -63.64 -35.12 79.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 73.510000000000005 110.839 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -55.03 -26.89 40.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 74.319999999999993 111.114 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.99 -13.5 13.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 71.349999999999994 110.914 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.439 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.2 mp -99.06 -55.0 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 73.040000000000006 110.94 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.612 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -38.82 -52.42 3.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.704 0.764 . . . . 70.439999999999998 111.146 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.3 Cg_endo -69.75 -40.36 5.42 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.703 2.269 . . . . 75.439999999999998 112.381 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.58 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -53.89 -25.28 19.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 74.140000000000001 110.929 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.565 ' CD2' HD13 ' A' ' 360' ' ' LEU . 83.4 m-85 -100.46 -39.43 7.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 73.329999999999998 110.863 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -51.64 -39.22 57.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 75.129999999999995 110.878 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -51.42 -16.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 72.310000000000002 110.922 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' A' ' 392' ' ' CYS . 31.6 m-85 -75.55 -60.04 2.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 74.549999999999997 110.927 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -150.02 -85.36 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.646 -0.788 . . . . 54.329999999999998 112.42 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -153.62 141.73 20.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.819 0.342 . . . . 74.519999999999996 110.876 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.46 HG22 ' CG2' ' A' ' 381' ' ' ILE . 40.8 mt -121.04 109.04 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 75.019999999999996 111.1 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 2.8 pp -89.3 -16.2 31.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 74.239999999999995 110.938 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -171.02 120.83 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.476 . . . . 72.340000000000003 110.903 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.483 ' CD2' HG12 ' A' ' 358' ' ' ILE . 35.9 t80 -114.4 141.64 47.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 72.409999999999997 110.894 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 5.2 mtmm -129.4 101.12 5.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 75.450000000000003 110.907 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . 0.598 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 14.2 t-80 -95.93 121.66 37.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 72.340000000000003 110.829 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -116.83 84.0 15.12 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.657 0.741 . . . . 75.439999999999998 110.926 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . 0.477 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 54.4 Cg_endo -69.71 -27.08 27.16 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.67 2.247 . . . . 61.409999999999997 112.37 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -65.65 -23.58 66.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 72.120000000000005 110.914 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -112.83 -25.59 8.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 74.329999999999998 110.889 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.61 46.32 4.04 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.728 -0.749 . . . . 64.420000000000002 112.476 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 27.4 p -159.78 151.82 20.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.877 0.37 . . . . 74.420000000000002 110.906 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 15.1 p -140.52 137.38 33.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 75.010000000000005 110.922 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -115.99 119.94 37.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 73.430000000000007 110.921 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.471 HG12 ' CD1' ' A' ' 370' ' ' PHE . 1.2 mt -107.64 142.51 20.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 73.099999999999994 111.18 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.27 131.6 50.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 75.209999999999994 110.909 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.456 ' CD2' ' HB3' ' A' ' 388' ' ' GLN . 53.1 m-85 -120.33 137.02 54.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 73.439999999999998 110.919 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -45.36 -28.77 0.91 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 71.209999999999994 110.864 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 69.4 p -130.07 162.69 28.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 74.420000000000002 111.139 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' HIS . . . . . 0.475 ' NE2' ' CG2' ' A' ' 333' ' ' ILE . 10.0 t60 -80.43 -34.42 36.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 71.239999999999995 110.863 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -57.31 -32.19 66.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 72.340000000000003 110.954 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.456 ' HB3' ' CD2' ' A' ' 383' ' ' TYR . 0.0 OUTLIER -66.8 -34.49 77.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.113 -0.494 . . . . 75.420000000000002 110.906 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -71.35 -23.85 61.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 70.25 111.095 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . 0.444 ' HB3' ' CG1' ' A' ' 329' ' ' VAL . . . -78.79 -38.42 38.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 63.399999999999999 111.063 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.24 -48.6 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 71.129999999999995 111.103 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . 0.486 ' HB2' ' CE2' ' A' ' 364' ' ' PHE . 19.1 p -71.36 -32.44 68.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 73.340000000000003 110.856 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.404 ' CG2' HG13 ' A' ' 332' ' ' ILE . 0.9 OUTLIER -53.68 -55.35 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 61.420000000000002 111.171 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.469 HG13 ' CG2' ' A' ' 329' ' ' VAL . 0.3 OUTLIER -72.08 -34.32 49.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 60.32 111.144 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -67.08 -29.09 68.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 111.147 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . 0.555 HD11 ' CE1' ' A' ' 399' ' ' PHE . 1.9 mm? -97.97 -2.82 39.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 73.5 110.858 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -63.53 111.73 2.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 74.200000000000003 111.012 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 50.67 48.1 23.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 73.129999999999995 110.893 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.555 ' CE1' HD11 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -106.48 142.97 26.05 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.642 0.734 . . . . 73.530000000000001 110.867 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.421 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.8 Cg_endo -69.77 141.61 45.64 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.747 2.298 . . . . 73.329999999999998 112.34 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' PHE . . . . . 0.55 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 50.1 t80 -147.94 114.25 5.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 74.010000000000005 110.838 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER 48.91 32.74 3.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 63.520000000000003 110.937 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.36 -27.58 18.78 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.76 -0.733 . . . . 71.310000000000002 112.504 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.4 138.76 41.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 70.010000000000005 110.864 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -80.66 149.75 29.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 75.230000000000004 110.827 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 9.3 mt -112.24 174.93 5.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 74.519999999999996 110.948 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 346' ' ' GLY . 0.0 OUTLIER -120.78 173.02 7.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 74.549999999999997 110.891 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' THR . . . . . 0.533 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 2.2 p -146.41 153.6 40.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 75.450000000000003 111.072 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 163.01 178.05 36.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 64.040000000000006 112.443 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.425 ' CZ2' ' CE1' ' A' ' 386' ' ' HIS . 77.4 m95 -91.58 132.18 36.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.717 0.294 . . . . 72.239999999999995 110.962 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -158.42 -177.98 32.02 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.671 -0.776 . . . . 72.430000000000007 112.382 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 414' ' ' ARG . 0.0 OUTLIER -166.73 151.84 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.729 0.3 . . . . 74.239999999999995 110.91 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.453 ' O ' ' C ' ' A' ' 414' ' ' ARG . 1.9 tt0 -55.47 82.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 72.319999999999993 110.816 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 412' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 71.129999999999995 110.898 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.525 -0.23 . . . . 72.200000000000003 112.525 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 56.6 m 51.67 19.52 0.91 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.833 0.349 . . . . 73.230000000000004 110.844 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 47.39 92.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 60.020000000000003 110.909 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 1.7 t -125.11 111.17 15.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 74.329999999999998 111.068 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 1.4 tt -172.8 -44.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 72.530000000000001 111.068 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 87.99 45.73 5.01 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.724 -0.75 . . . . 70.230000000000004 112.464 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.518 ' CB ' ' CD ' ' A' ' 321' ' ' PRO . 4.5 mt -43.92 -63.99 0.92 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.641 0.734 . . . . 73.409999999999997 110.897 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.518 ' CD ' ' CB ' ' A' ' 320' ' ' LEU . 53.2 Cg_endo -69.79 127.23 14.28 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.673 2.248 . . . . 74.540000000000006 112.334 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 -13.47 34.72 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.671 2.247 . . . . 74.510000000000005 112.331 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.411 ' C ' ' CG2' ' A' ' 324' ' ' VAL . 0.7 OUTLIER -166.22 -40.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 75.209999999999994 110.891 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.491 ' CG1' ' CG1' ' A' ' 394' ' ' VAL . 1.8 t -154.77 141.51 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 74.200000000000003 111.159 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -109.27 139.82 21.41 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.617 0.722 . . . . 75.140000000000001 110.912 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -14.44 36.32 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.68 2.254 . . . . 75.519999999999996 112.39 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -72.34 -71.61 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 74.5 110.947 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.1 -24.78 18.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.457 . . . . 71.129999999999995 111.104 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.456 ' CG2' ' HB ' ' A' ' 394' ' ' VAL . 5.7 t -84.78 -30.04 6.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 72.319999999999993 111.176 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -54.74 -45.86 74.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 73.319999999999993 110.905 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -53.01 -34.81 58.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.329999999999998 110.808 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.477 ' CG2' HG23 ' A' ' 393' ' ' ILE . 26.1 mm -61.29 -48.87 86.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 75.200000000000003 111.167 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 8.0 mt -54.39 -33.05 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 75.430000000000007 111.093 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.61 -7.96 12.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 74.530000000000001 110.951 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.29 17.58 12.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 75.519999999999996 110.894 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . 177.8 164.49 0.57 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.533 0.682 . . . . 71.140000000000001 111.154 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.471 ' O ' ' CG2' ' A' ' 340' ' ' VAL . 54.7 Cg_endo -69.66 156.86 62.47 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.77 2.313 . . . . 73.219999999999999 112.37 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -7.32 20.73 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.678 2.252 . . . . 73.420000000000002 112.36 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 35.3 mtt85 -97.57 53.68 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 73.150000000000006 110.898 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.599 HG22 ' CZ3' ' A' ' 410' ' ' TRP . 7.0 m -150.53 135.56 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 75.230000000000004 111.088 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' THR . . . . . 0.422 HG23 ' C ' ' A' ' 385' ' ' THR . 28.0 p -138.08 66.4 1.44 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 74.430000000000007 111.117 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 19.4 m -134.3 142.15 47.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 65.230000000000004 111.118 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -118.83 98.93 6.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 75.200000000000003 111.121 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.53 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -85.77 121.19 28.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.332 -0.394 . . . . 72.310000000000002 110.91 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.428 HG23 ' CD1' ' A' ' 406' ' ' LEU . 2.0 mp -118.29 118.79 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.086 -0.506 . . . . 72.099999999999994 111.131 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -104.64 164.88 14.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.76 -0.733 . . . . 62.229999999999997 112.504 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 0.2 OUTLIER 76.62 45.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 74.450000000000003 110.884 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 59.4 mt -99.58 133.32 21.94 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.653 0.74 . . . . 72.019999999999996 111.142 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . 0.426 ' HB2' ' CD1' ' A' ' 351' ' ' PHE . 53.7 Cg_endo -69.74 164.87 32.9 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.657 2.238 . . . . 73.530000000000001 112.329 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.32 -20.88 59.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 70.319999999999993 110.809 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.504 ' O ' ' CD2' ' A' ' 351' ' ' PHE . 25.0 p90 -97.25 29.48 3.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 74.25 110.885 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . 0.602 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -114.36 90.84 3.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 43.240000000000002 111.17 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 19.7 p -87.83 170.77 10.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 72.340000000000003 111.101 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.489 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -65.6 -31.94 73.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 73.510000000000005 110.888 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -53.49 -26.13 19.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 74.319999999999993 111.128 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.63 -13.18 13.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.273 -0.421 . . . . 71.349999999999994 110.866 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.437 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.3 mp -98.85 -55.86 2.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 73.040000000000006 110.952 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.621 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -39.74 -52.16 5.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.625 0.726 . . . . 70.439999999999998 111.106 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.5 Cg_endo -69.66 -35.58 12.66 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.711 2.274 . . . . 75.439999999999998 112.37 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.589 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -58.61 -23.55 59.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 74.140000000000001 110.927 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.59 ' CG ' ' CD1' ' A' ' 381' ' ' ILE . 84.9 m-85 -103.02 -35.25 8.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 73.329999999999998 110.873 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -54.14 -34.76 61.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 75.129999999999995 110.852 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -55.48 -13.47 1.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 72.310000000000002 110.954 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . 0.576 ' CE2' ' HB2' ' A' ' 392' ' ' CYS . 38.2 m-85 -81.3 -53.99 5.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 74.549999999999997 110.901 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -156.24 -95.35 0.11 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.807 -0.711 . . . . 54.329999999999998 112.557 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.424 ' CE2' ' HG ' ' A' ' 368' ' ' LEU . 58.8 t80 -143.81 143.97 31.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.818 0.342 . . . . 74.519999999999996 110.909 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.469 HG22 ' CG2' ' A' ' 381' ' ' ILE . 71.6 mt -120.73 109.05 24.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 75.019999999999996 111.145 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.424 ' HG ' ' CE2' ' A' ' 366' ' ' PHE . 1.1 mp -87.64 -19.8 27.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 74.239999999999995 110.862 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.92 120.62 0.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 72.340000000000003 110.872 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.554 ' CE2' ' HB2' ' A' ' 372' ' ' HIS . 35.1 t80 -112.47 143.0 44.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 72.409999999999997 110.888 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.27 101.28 5.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 75.450000000000003 110.895 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . 0.602 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 10.0 t-80 -99.66 136.01 40.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 72.340000000000003 110.884 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -128.19 90.03 48.35 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.73 0.776 . . . . 75.439999999999998 110.965 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . 0.421 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.9 Cg_endo -69.77 -21.85 32.85 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.791 2.327 . . . . 61.409999999999997 112.343 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.0 -33.33 65.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 72.120000000000005 110.887 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.08 -18.99 14.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 110.933 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 81.01 40.16 12.03 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.741 -0.742 . . . . 64.420000000000002 112.465 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.2 p -148.49 155.62 41.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.716 0.293 . . . . 74.420000000000002 110.976 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 18.6 p -149.78 158.08 43.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.429 . . . . 75.010000000000005 110.897 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.491 ' N ' ' CD1' ' A' ' 380' ' ' PHE . 1.8 m-85 -136.24 132.5 35.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 73.430000000000007 110.922 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.59 ' CD1' ' CG ' ' A' ' 361' ' ' PHE . 0.9 OUTLIER -119.67 123.02 70.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 73.099999999999994 111.136 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.19 131.84 34.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 75.209999999999994 110.943 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.51 -179.63 3.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 73.439999999999998 110.93 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -80.65 -43.76 19.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.082 -0.508 . . . . 71.209999999999994 110.884 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' THR . . . . . 0.422 ' C ' HG23 ' A' ' 341' ' ' THR . 82.3 p -115.71 159.86 20.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 74.420000000000002 111.122 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' HIS . . . . . 0.435 ' CG ' ' N ' ' A' ' 387' ' ' GLU . 19.5 p-80 -69.44 -42.09 75.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 71.239999999999995 110.842 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . 0.435 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 2.2 tt0 -59.04 -29.83 67.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 72.340000000000003 110.876 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.53 -35.07 71.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 75.420000000000002 110.865 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -75.46 -24.83 57.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 70.25 111.136 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . 0.437 ' CB ' ' CG1' ' A' ' 329' ' ' VAL . . . -72.39 -37.11 68.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 63.399999999999999 111.143 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.83 -56.62 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 71.129999999999995 111.085 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . 0.576 ' HB2' ' CE2' ' A' ' 364' ' ' PHE . 14.5 p -63.99 -32.77 74.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 110.845 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.477 HG23 ' CG2' ' A' ' 332' ' ' ILE . 1.7 mt -53.32 -54.12 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 61.420000000000002 111.122 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.491 ' CG1' ' CG1' ' A' ' 324' ' ' VAL . 0.5 OUTLIER -71.18 -34.14 53.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 60.32 111.136 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -69.41 -28.49 66.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.209999999999994 111.109 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . 0.569 HD13 ' CE1' ' A' ' 399' ' ' PHE . 2.4 mm? -97.75 -17.86 19.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.276 -0.42 . . . . 73.5 110.945 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -47.97 114.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 74.200000000000003 111.073 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 38.0 t30 44.77 44.75 7.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.129999999999995 110.831 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.569 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -100.66 143.99 27.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.644 0.735 . . . . 73.530000000000001 110.861 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.405 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.4 Cg_endo -69.75 145.11 56.2 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.674 2.249 . . . . 73.329999999999998 112.284 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' PHE . . . . . 0.565 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 56.1 t80 -150.12 110.8 4.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 74.010000000000005 110.886 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 49.08 33.45 4.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 63.520000000000003 110.923 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 99.95 -28.21 16.68 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.726 -0.749 . . . . 71.310000000000002 112.458 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -105.01 141.06 37.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 70.010000000000005 110.852 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -83.88 154.13 23.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 75.230000000000004 110.888 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.428 ' CD1' HG23 ' A' ' 345' ' ' ILE . 8.7 mt -116.4 174.08 6.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 74.519999999999996 110.973 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.82 176.85 5.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 74.549999999999997 110.886 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' THR . . . . . 0.42 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 23.5 p -151.67 151.28 31.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 75.450000000000003 111.109 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 164.83 173.13 33.13 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.74 -0.743 . . . . 64.040000000000006 112.501 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.599 ' CZ3' HG22 ' A' ' 340' ' ' VAL . 99.5 m95 -85.29 150.89 24.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 72.239999999999995 110.902 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -136.45 160.22 24.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.798 -0.715 . . . . 72.430000000000007 112.518 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -163.01 81.6 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.752 0.31 . . . . 74.239999999999995 110.944 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 414' ' ' ARG . 0.7 OUTLIER 43.2 44.72 4.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 72.319999999999993 110.953 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 413' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 71.129999999999995 110.905 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.465 -0.254 . . . . 72.200000000000003 112.465 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 84.9 p -125.38 102.93 7.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.848 0.356 . . . . 73.230000000000004 110.822 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -149.01 85.72 1.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 60.020000000000003 110.936 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 85.5 m -90.7 -75.71 0.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 74.329999999999998 111.154 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 4.1 tp -168.37 -50.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 72.530000000000001 111.117 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' A' ' 320' ' ' LEU . . . 90.57 -55.57 3.46 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.77 -0.729 . . . . 70.230000000000004 112.501 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.469 ' N ' ' CD ' ' A' ' 321' ' ' PRO . 0.5 OUTLIER 79.36 52.42 0.12 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.606 0.717 . . . . 73.409999999999997 110.893 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' A' ' 320' ' ' LEU . 54.0 Cg_endo -69.76 169.62 18.49 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.718 2.278 . . . . 74.540000000000006 112.399 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -50.24 0.48 Allowed 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.698 2.265 . . . . 74.510000000000005 112.33 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.433 ' C ' ' CD ' ' A' ' 323' ' ' GLN . 0.0 OUTLIER -175.98 86.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 75.209999999999994 110.886 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.461 HG12 ' CG1' ' A' ' 391' ' ' VAL . 58.9 t -140.35 145.82 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 74.200000000000003 111.067 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.457 ' N ' HG13 ' A' ' 324' ' ' VAL . 1.7 m120 -106.84 105.84 56.34 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.554 0.692 . . . . 75.140000000000001 110.947 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 -14.22 35.83 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.698 2.265 . . . . 75.519999999999996 112.367 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.95 -72.0 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 74.5 110.89 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.24 -28.25 40.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 71.129999999999995 111.066 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.532 ' CG1' ' CB ' ' A' ' 390' ' ' ALA . 16.0 t -71.1 -29.84 38.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 72.319999999999993 111.163 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -54.18 -35.44 62.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 110.892 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -69.34 -31.78 70.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 74.329999999999998 110.825 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 46.9 mm -54.79 -54.21 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 75.200000000000003 111.099 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.402 HG12 ' CD2' ' A' ' 386' ' ' HIS . 8.2 mt -52.36 -40.55 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 75.430000000000007 111.149 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -15.41 1.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 74.530000000000001 110.857 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.45 41.69 1.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 75.519999999999996 110.897 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . 170.59 157.05 0.21 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.626 0.727 . . . . 71.140000000000001 111.048 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 153.78 68.4 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.649 2.233 . . . . 73.219999999999999 112.369 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -11.55 31.04 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.742 2.295 . . . . 73.420000000000002 112.304 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -100.82 66.0 1.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 73.150000000000006 110.812 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 14.4 p -171.39 131.72 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 75.230000000000004 111.054 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' THR . . . . . 0.402 HG23 ' C ' ' A' ' 385' ' ' THR . 22.0 p -137.0 68.53 1.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 111.11 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 87.5 m -133.59 111.7 10.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.445 . . . . 65.230000000000004 111.099 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -85.72 137.39 32.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 75.200000000000003 111.139 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -116.99 134.55 54.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.47 . . . . 72.310000000000002 110.882 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.43 HG22 ' CD1' ' A' ' 406' ' ' LEU . 1.8 mp -131.68 110.99 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 72.099999999999994 111.142 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -101.09 161.62 18.36 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.774 -0.727 . . . . 62.229999999999997 112.52 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 2.4 t30 78.95 49.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.794 0.33 . . . . 74.450000000000003 110.85 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 349' ' ' PRO . 85.1 mt -103.69 135.83 19.3 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.662 0.744 . . . . 72.019999999999996 111.115 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . 0.407 ' N ' HG22 ' A' ' 348' ' ' ILE . 53.8 Cg_endo -69.73 164.4 34.66 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.687 2.258 . . . . 73.530000000000001 112.41 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.62 -28.09 63.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 70.319999999999993 110.882 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -83.17 20.09 1.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 74.25 110.892 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . 0.545 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -107.64 112.83 25.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 43.240000000000002 111.089 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 19.0 p -116.32 170.94 8.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 72.340000000000003 111.107 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.498 ' O ' ' CG1' ' A' ' 358' ' ' ILE . 0.2 OUTLIER -66.23 -29.89 70.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 73.510000000000005 110.886 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.56 -26.64 63.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 74.319999999999993 111.168 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.48 -16.01 12.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 71.349999999999994 110.88 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.452 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.5 mp -93.5 -50.92 5.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 73.040000000000006 110.928 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.674 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.3 mm -44.0 -49.48 21.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.687 0.756 . . . . 70.439999999999998 111.171 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.0 Cg_endo -69.75 -27.84 26.02 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.255 . . . . 75.439999999999998 112.361 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.582 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -69.96 -26.95 64.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 74.140000000000001 110.907 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.477 ' CD2' HD13 ' A' ' 360' ' ' LEU . 85.6 m-85 -94.75 -36.39 11.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 73.329999999999998 110.844 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' GLN . . . . . 0.405 ' O ' ' N ' ' A' ' 364' ' ' PHE . 11.4 mm-40 -49.45 -46.81 48.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 75.129999999999995 110.886 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -42.5 -24.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 72.310000000000002 110.884 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . 0.405 ' N ' ' O ' ' A' ' 362' ' ' GLN . 28.6 m-85 -70.52 -59.77 2.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 74.549999999999997 110.904 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -155.1 -86.32 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.762 -0.732 . . . . 54.329999999999998 112.51 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -153.52 144.48 22.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 74.519999999999996 110.933 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.464 HG22 ' CG2' ' A' ' 381' ' ' ILE . 17.3 mt -120.92 109.32 24.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 75.019999999999996 111.139 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.03 -20.02 27.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.476 . . . . 74.239999999999995 110.92 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.3 121.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 72.340000000000003 110.837 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.562 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 28.9 t80 -113.42 143.52 44.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 72.409999999999997 110.855 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.07 101.42 5.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 75.450000000000003 110.865 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 9.3 t-80 -97.27 115.13 27.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 72.340000000000003 110.811 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -108.04 86.09 2.98 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.685 0.755 . . . . 75.439999999999998 110.953 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . 0.485 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 53.7 Cg_endo -69.8 -17.27 37.48 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.671 2.247 . . . . 61.409999999999997 112.318 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -79.32 -23.76 43.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 72.120000000000005 110.903 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -108.41 -26.65 10.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 74.329999999999998 110.952 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.91 41.05 5.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.721 -0.752 . . . . 64.420000000000002 112.5 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 27.0 p -159.86 153.27 22.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.89 0.376 . . . . 74.420000000000002 110.819 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 29.0 p -138.53 145.32 40.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 75.010000000000005 110.886 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -119.85 129.42 54.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 73.430000000000007 110.895 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.511 ' CG1' ' CD1' ' A' ' 370' ' ' PHE . 1.0 OUTLIER -120.82 132.94 69.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 73.099999999999994 111.147 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -98.77 134.79 41.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 75.209999999999994 110.822 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -117.45 -179.46 3.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 73.439999999999998 110.893 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.23 -39.56 22.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 71.209999999999994 110.849 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' THR . . . . . 0.402 ' C ' HG23 ' A' ' 341' ' ' THR . 67.3 p -120.42 171.39 8.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 111.18 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' HIS . . . . . 0.638 ' NE2' ' CZ2' ' A' ' 410' ' ' TRP . 4.4 t60 -83.65 -42.28 16.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 71.239999999999995 110.868 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.3 -28.72 63.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 72.340000000000003 110.841 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -36.51 82.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 75.420000000000002 110.947 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.9 -34.23 64.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 70.25 111.165 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . 0.532 ' CB ' ' CG1' ' A' ' 329' ' ' VAL . . . -56.05 -34.41 65.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 63.399999999999999 111.071 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.461 ' CG1' HG12 ' A' ' 324' ' ' VAL . 95.9 t -71.4 -42.99 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 71.129999999999995 111.188 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 35.3 t -65.83 -34.17 77.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 73.340000000000003 110.905 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.407 ' O ' ' CG2' ' A' ' 408' ' ' THR . 1.1 mt -55.9 -56.01 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 61.420000000000002 111.159 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.483 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 1.8 t -72.04 -36.87 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 60.32 111.132 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.6 94.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 75.209999999999994 111.089 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . 0.588 ' CD1' ' CE1' ' A' ' 399' ' ' PHE . 1.9 mm? -89.09 -18.56 27.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 73.5 110.917 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 398' ' ' ASN . . . -44.7 117.89 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 74.200000000000003 111.031 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 397' ' ' ALA . 4.6 p-10 34.5 42.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 73.129999999999995 110.936 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.588 ' CE1' ' CD1' ' A' ' 396' ' ' LEU . 0.0 OUTLIER -97.38 148.0 33.79 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.664 0.745 . . . . 73.530000000000001 110.897 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 144.26 53.72 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.635 2.223 . . . . 73.329999999999998 112.399 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' PHE . . . . . 0.437 ' N ' ' O ' ' A' ' 404' ' ' ARG . 58.3 t80 -153.36 112.96 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 74.010000000000005 110.892 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 49.64 33.29 5.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 63.520000000000003 110.946 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 97.85 -27.66 17.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.735 -0.745 . . . . 71.310000000000002 112.453 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -106.06 142.22 36.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.819 0.342 . . . . 70.010000000000005 110.864 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -86.42 150.62 24.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 75.230000000000004 110.883 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.43 ' CD1' HG22 ' A' ' 345' ' ' ILE . 17.8 mt -112.06 -177.98 3.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 74.519999999999996 110.94 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 346' ' ' GLY . 8.3 ttt180 -125.87 177.29 6.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 74.549999999999997 110.943 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' THR . . . . . 0.439 ' CG2' ' HB2' ' A' ' 396' ' ' LEU . 16.7 p -153.59 157.91 40.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 75.450000000000003 111.102 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 410' ' ' TRP . . . 148.83 126.61 1.54 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.674 -0.774 . . . . 64.040000000000006 112.448 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.638 ' CZ2' ' NE2' ' A' ' 386' ' ' HIS . 76.1 m95 -35.11 137.72 0.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.901 0.381 . . . . 72.239999999999995 110.878 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -137.65 -172.61 12.6 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.758 -0.734 . . . . 72.430000000000007 112.526 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.41 162.46 19.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.736 0.303 . . . . 74.239999999999995 110.942 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 414' ' ' ARG . 22.7 tt0 -42.56 -42.54 3.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 72.319999999999993 110.834 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 413' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 71.129999999999995 110.858 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.477 -0.249 . . . . 72.200000000000003 112.477 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.15 -54.55 6.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.771 0.319 . . . . 73.230000000000004 110.834 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -89.15 -54.86 3.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 60.020000000000003 110.885 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 17.0 m -129.84 120.58 25.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.465 . . . . 74.329999999999998 111.168 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 1.1 tt -72.54 -44.2 61.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 72.530000000000001 111.171 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 71.43 116.21 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.784 -0.722 . . . . 70.230000000000004 112.498 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.83 81.4 52.69 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.577 0.704 . . . . 73.409999999999997 110.939 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 147.54 63.38 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.744 2.296 . . . . 74.540000000000006 112.356 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -25.47 28.95 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.748 2.298 . . . . 74.510000000000005 112.289 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -133.8 130.18 37.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 75.209999999999994 110.87 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.448 HG12 ' CG1' ' A' ' 391' ' ' VAL . 13.2 t 64.87 132.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.263 -0.426 . . . . 74.200000000000003 111.167 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -113.53 138.25 22.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.615 0.722 . . . . 75.140000000000001 110.859 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -14.14 35.65 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.635 2.223 . . . . 75.519999999999996 112.358 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -75.2 -72.67 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 74.5 110.891 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.64 -24.6 34.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 71.129999999999995 111.058 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.456 ' CG2' ' HB ' ' A' ' 394' ' ' VAL . 25.5 t -83.45 -29.73 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 72.319999999999993 111.175 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -54.57 -45.46 73.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.168 -0.469 . . . . 73.319999999999993 110.837 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -54.2 -31.9 54.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 74.329999999999998 110.916 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.454 HG21 ' NE1' ' A' ' 410' ' ' TRP . 26.6 mm -69.88 -49.52 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 75.200000000000003 111.172 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 54.2 mt -54.18 -39.52 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 75.430000000000007 111.184 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -75.99 6.7 4.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 74.530000000000001 110.856 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 6.5 t -105.82 -13.2 15.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 75.519999999999996 110.914 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.569 ' HB3' ' CD1' ' A' ' 410' ' ' TRP . . . -150.19 150.51 29.66 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.641 0.734 . . . . 71.140000000000001 111.038 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 158.89 55.36 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.652 2.234 . . . . 73.219999999999999 112.322 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -28.84 24.78 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.692 2.261 . . . . 73.420000000000002 112.339 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.1 mtm105 -50.15 -40.66 47.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 73.150000000000006 110.879 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.7 p -95.17 134.32 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 75.230000000000004 111.107 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 386' ' ' HIS . 25.3 p -140.46 71.15 1.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 74.430000000000007 111.099 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 3.4 m -132.54 128.81 38.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 65.230000000000004 111.172 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -95.23 119.42 33.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 75.200000000000003 111.094 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.508 ' HB2' ' CD2' ' A' ' 380' ' ' PHE . 0.0 OUTLIER -100.28 129.13 46.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 72.310000000000002 110.936 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.46 HG21 ' CD1' ' A' ' 348' ' ' ILE . 1.8 mp -122.59 126.19 73.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.071 -0.513 . . . . 72.099999999999994 111.143 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -112.88 168.89 12.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 62.229999999999997 112.463 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.475 ' O ' ' CD2' ' A' ' 406' ' ' LEU . 1.9 t30 70.68 53.23 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.706 0.288 . . . . 74.450000000000003 110.877 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.46 ' CD1' HG21 ' A' ' 345' ' ' ILE . 2.0 mp -102.4 132.39 21.46 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.643 0.735 . . . . 72.019999999999996 111.116 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . 0.409 ' CG ' ' CE1' ' A' ' 351' ' ' PHE . 53.7 Cg_endo -69.72 153.55 68.97 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.683 2.255 . . . . 73.530000000000001 112.379 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.03 -18.96 64.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 70.319999999999993 110.836 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.409 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 5.2 p90 -94.38 19.78 9.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.862 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . 0.478 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -111.78 104.19 12.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 43.240000000000002 111.038 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 27.2 p -107.24 168.33 9.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 72.340000000000003 111.131 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.495 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -59.59 -37.25 78.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 73.510000000000005 110.884 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -52.41 -26.11 11.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.319999999999993 111.067 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -112.14 -13.1 13.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 71.349999999999994 110.793 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.453 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 2.9 mp -99.25 -55.73 2.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 73.040000000000006 110.906 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.608 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -37.69 -52.44 2.67 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.619 0.723 . . . . 70.439999999999998 111.103 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.3 Cg_endo -69.76 -26.71 27.28 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.691 2.261 . . . . 75.439999999999998 112.352 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.488 ' CD1' ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -70.07 -21.94 63.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 74.140000000000001 110.965 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.474 ' CD1' HD12 ' A' ' 381' ' ' ILE . 86.8 m-85 -101.11 -30.77 11.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 73.329999999999998 110.9 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' GLN . . . . . 0.421 ' N ' HD11 ' A' ' 367' ' ' ILE . 0.0 OUTLIER -59.24 -32.84 70.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 75.129999999999995 110.9 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -57.79 -16.42 11.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 72.310000000000002 110.882 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . 0.545 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 36.3 m-85 -75.74 -57.79 3.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 74.549999999999997 110.917 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -154.87 -82.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.743 . . . . 54.329999999999998 112.468 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.633 ' CD2' ' CD2' ' A' ' 368' ' ' LEU . 7.5 t80 -153.77 139.55 18.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.377 . . . . 74.519999999999996 110.904 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.429 HG21 ' CG2' ' A' ' 381' ' ' ILE . 13.1 mt -114.78 109.37 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.019999999999996 111.161 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.633 ' CD2' ' CD2' ' A' ' 366' ' ' PHE . 0.9 OUTLIER -89.74 -21.36 22.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 74.239999999999995 110.944 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -170.94 121.19 0.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 72.340000000000003 110.814 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.553 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 30.6 t80 -111.13 138.78 47.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 72.409999999999997 110.955 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.11 100.47 6.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 75.450000000000003 110.935 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . 0.478 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 10.4 t-80 -97.82 132.82 43.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 72.340000000000003 110.864 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -123.92 88.82 52.12 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.677 0.751 . . . . 75.439999999999998 110.881 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 -17.03 37.86 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.622 2.215 . . . . 61.409999999999997 112.449 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -83.73 -26.43 29.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 72.120000000000005 110.846 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -104.63 -26.65 12.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 74.329999999999998 110.881 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 87.22 38.97 7.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.822 -0.704 . . . . 64.420000000000002 112.501 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.4 p -153.0 151.41 30.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 74.420000000000002 110.9 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.553 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 28.8 p -142.19 141.44 32.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 75.010000000000005 110.861 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.508 ' CD2' ' HB2' ' A' ' 344' ' ' TYR . 15.4 m-85 -119.69 138.53 53.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 73.430000000000007 110.886 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.474 HD12 ' CD1' ' A' ' 361' ' ' PHE . 0.6 OUTLIER -127.18 128.06 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 73.099999999999994 111.093 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.49 137.18 32.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 75.209999999999994 110.886 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -120.24 156.05 31.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 73.439999999999998 110.889 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -53.15 -50.33 64.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.102 -0.499 . . . . 71.209999999999994 110.863 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' THR . . . . . 0.409 ' C ' HG22 ' A' ' 341' ' ' THR . 38.7 p -113.41 176.06 5.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 111.203 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' HIS . . . . . 0.426 ' N ' HG22 ' A' ' 341' ' ' THR . 39.9 p-80 -83.88 -39.7 19.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 71.239999999999995 110.852 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.91 -28.82 67.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 72.340000000000003 110.836 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -34.98 79.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 110.924 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -74.94 -37.51 61.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 70.25 111.098 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -60.99 -32.07 71.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 63.399999999999999 111.052 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.448 ' CG1' HG12 ' A' ' 324' ' ' VAL . 81.2 t -66.29 -39.16 83.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 71.129999999999995 111.111 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . 0.545 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 1.7 t -79.4 -25.42 42.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 73.340000000000003 110.851 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 408' ' ' THR . 0.3 OUTLIER -60.79 -55.5 24.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 61.420000000000002 111.149 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 395' ' ' ALA . 0.3 OUTLIER -69.74 -42.27 80.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 60.32 111.071 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . 0.483 ' N ' ' CG1' ' A' ' 394' ' ' VAL . . . -55.95 -45.75 78.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 75.209999999999994 111.14 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . 0.569 HD12 ' CE1' ' A' ' 399' ' ' PHE . 0.5 OUTLIER -79.76 -19.27 49.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 73.5 110.939 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -48.38 113.96 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 111.1 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 45.52 50.26 10.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 73.129999999999995 110.877 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -110.17 143.7 28.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.712 0.768 . . . . 73.530000000000001 110.935 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 133.76 26.39 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.683 2.255 . . . . 73.329999999999998 112.382 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' PHE . . . . . 0.573 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 36.0 t80 -137.34 111.3 8.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 74.010000000000005 110.864 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 48.7 32.81 3.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 63.520000000000003 110.873 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.34 -30.72 9.78 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 71.310000000000002 112.488 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 134.81 48.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.912 0.387 . . . . 70.010000000000005 110.875 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -74.83 154.39 38.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 75.230000000000004 110.799 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.475 ' CD2' ' O ' ' A' ' 347' ' ' ASN . 15.9 mt -117.66 171.05 8.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 74.519999999999996 110.898 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.02 177.0 4.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 74.549999999999997 110.843 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' THR . . . . . 0.445 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 6.9 p -152.7 152.17 31.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 75.450000000000003 111.181 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 169.28 157.25 11.56 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.695 -0.764 . . . . 64.040000000000006 112.427 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.569 ' CD1' ' HB3' ' A' ' 336' ' ' ALA . 13.9 m95 -68.94 88.22 0.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.836 0.35 . . . . 72.239999999999995 110.941 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 410' ' ' TRP . . . 35.14 82.19 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.757 -0.735 . . . . 72.430000000000007 112.53 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -105.27 91.02 3.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.776 0.322 . . . . 74.239999999999995 110.906 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 414' ' ' ARG . 0.0 OUTLIER -68.0 116.97 9.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 72.319999999999993 110.851 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 413' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 71.129999999999995 110.862 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.595 -0.202 . . . . 72.200000000000003 112.595 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 1.4 m -126.86 -82.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.348 . . . . 73.230000000000004 110.794 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -117.49 87.32 2.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 60.020000000000003 110.886 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 47.5 p 48.5 -173.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 74.329999999999998 111.099 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.05 -46.97 25.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 72.530000000000001 111.074 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 101.43 -69.26 0.41 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.786 -0.721 . . . . 70.230000000000004 112.483 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 56.09 74.27 0.72 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.568 0.699 . . . . 73.409999999999997 110.969 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 167.47 24.26 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.696 2.264 . . . . 74.540000000000006 112.371 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -49.03 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.695 2.264 . . . . 74.510000000000005 112.393 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -154.82 -42.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 75.209999999999994 110.92 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.471 HG13 ' CB ' ' A' ' 395' ' ' ALA . 30.6 m -111.04 168.17 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 74.200000000000003 111.176 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.429 ' OD1' ' CB ' ' A' ' 327' ' ' GLN . 18.8 t-20 -112.57 121.95 37.53 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.615 0.721 . . . . 75.140000000000001 110.913 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -14.21 35.97 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.675 2.25 . . . . 75.519999999999996 112.331 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . 0.429 ' CB ' ' OD1' ' A' ' 325' ' ' ASN . 0.0 OUTLIER -69.89 -71.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 74.5 110.926 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -52.65 -28.75 22.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 71.129999999999995 111.141 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.513 ' CG1' ' CB ' ' A' ' 390' ' ' ALA . 8.0 t -70.55 -29.87 40.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 72.319999999999993 111.087 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -54.21 -36.04 63.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.319999999999993 110.82 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -65.42 -31.87 73.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 74.329999999999998 110.884 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.465 HG21 ' NE1' ' A' ' 410' ' ' TRP . 38.7 mm -60.56 -49.01 86.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 75.200000000000003 111.185 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.464 HG21 ' CD2' ' A' ' 386' ' ' HIS . 19.6 mt -57.44 -32.63 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 75.430000000000007 111.055 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -5.74 13.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 74.530000000000001 110.814 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.95 7.91 44.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 75.519999999999996 110.882 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.571 ' HB1' ' CD1' ' A' ' 410' ' ' TRP . . . -161.33 159.56 23.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 71.140000000000001 111.059 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.71 154.07 68.38 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.672 2.248 . . . . 73.219999999999999 112.369 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -8.98 24.97 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.62 2.213 . . . . 73.420000000000002 112.388 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -47.07 15.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 73.150000000000006 110.882 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 8.3 p -73.18 132.86 32.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 75.230000000000004 111.134 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 386' ' ' HIS . 40.6 p -144.43 68.92 1.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 74.430000000000007 111.14 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 53.2 m -133.16 117.73 17.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 65.230000000000004 111.162 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -81.72 126.89 32.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 75.200000000000003 111.078 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.524 ' CD2' ' HB2' ' A' ' 412' ' ' LYS . 0.0 OUTLIER -106.02 134.72 48.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 72.310000000000002 110.971 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . . . . . . . . . 1.8 mp -130.4 121.2 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 72.099999999999994 111.12 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -108.53 167.45 13.17 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.796 -0.716 . . . . 62.229999999999997 112.49 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.488 ' O ' ' CD2' ' A' ' 406' ' ' LEU . 1.4 t30 69.55 57.34 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.776 0.322 . . . . 74.450000000000003 110.876 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.435 ' CG2' ' HB1' ' A' ' 352' ' ' ALA . 47.7 mt -107.94 131.16 21.93 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.631 0.729 . . . . 72.019999999999996 111.091 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . 0.432 ' CG ' ' CE1' ' A' ' 351' ' ' PHE . 53.9 Cg_endo -69.68 161.46 45.82 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.687 2.258 . . . . 73.530000000000001 112.384 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -64.2 -29.08 70.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 70.319999999999993 110.867 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.432 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 6.4 p90 -85.14 33.16 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 74.25 110.887 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . 0.602 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -117.36 100.74 7.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 43.240000000000002 111.109 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 17.1 p -105.69 170.0 8.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 72.340000000000003 111.083 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.493 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.28 -29.88 69.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 73.510000000000005 110.92 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.36 -26.31 63.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 111.102 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.15 -14.95 13.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 71.349999999999994 110.837 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.445 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.5 mp -97.24 -52.87 3.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.193 -0.458 . . . . 73.040000000000006 110.895 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.638 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -41.87 -50.89 10.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.622 0.725 . . . . 70.439999999999998 111.115 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.5 Cg_endo -69.83 -35.13 13.0 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.671 2.247 . . . . 75.439999999999998 112.339 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.579 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -59.73 -26.26 65.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 74.140000000000001 110.919 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.514 ' CD2' HD13 ' A' ' 360' ' ' LEU . 85.8 m-85 -96.73 -25.24 15.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.223 -0.444 . . . . 73.329999999999998 110.882 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' GLN . . . . . 0.479 ' N ' HD12 ' A' ' 367' ' ' ILE . 5.4 mt-30 -60.45 -47.76 84.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 75.129999999999995 110.903 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -42.44 -23.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 72.310000000000002 110.918 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 362' ' ' GLN . 23.3 m-85 -71.46 -60.07 2.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 74.549999999999997 110.913 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -150.7 -88.51 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.735 -0.745 . . . . 54.329999999999998 112.543 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.484 ' CE2' HD13 ' A' ' 368' ' ' LEU . 28.8 t80 -153.92 138.77 17.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.852 0.358 . . . . 74.519999999999996 110.893 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 362' ' ' GLN . 32.5 mt -120.43 116.87 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.477 . . . . 75.019999999999996 111.124 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.484 HD13 ' CE2' ' A' ' 366' ' ' PHE . 0.0 OUTLIER -104.42 -16.2 15.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 74.239999999999995 110.877 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.477 ' N ' HD22 ' A' ' 368' ' ' LEU . 3.7 m-20 -159.86 121.05 3.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 72.340000000000003 110.9 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 31.0 t80 -123.21 142.66 50.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 72.409999999999997 110.895 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -129.56 101.1 5.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 75.450000000000003 110.907 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . 0.602 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 11.2 t-80 -97.43 136.61 37.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 72.340000000000003 110.879 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -130.76 89.32 43.61 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.695 0.759 . . . . 75.439999999999998 110.893 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . 0.562 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 54.0 Cg_endo -69.77 -29.78 23.3 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.627 2.218 . . . . 61.409999999999997 112.364 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.1 -14.04 62.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 72.120000000000005 110.873 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -119.81 -24.38 6.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 110.869 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 80.34 44.35 8.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 64.420000000000002 112.434 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.2 p -156.83 137.81 13.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.825 0.345 . . . . 74.420000000000002 110.887 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 14.6 p -129.79 156.97 43.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 75.010000000000005 110.909 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -136.98 128.49 28.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.26 -0.427 . . . . 73.430000000000007 110.921 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.494 HD12 ' CD1' ' A' ' 361' ' ' PHE . 0.7 OUTLIER -117.83 131.34 70.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 73.099999999999994 111.155 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.72 137.23 37.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 75.209999999999994 110.907 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -120.88 173.52 7.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 73.439999999999998 110.913 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.56 -26.02 35.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 71.209999999999994 110.894 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' THR . . . . . 0.421 ' C ' HG22 ' A' ' 341' ' ' THR . 41.7 p -129.31 162.48 27.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 74.420000000000002 111.083 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' HIS . . . . . 0.464 ' CD2' HG21 ' A' ' 333' ' ' ILE . 26.3 p-80 -86.78 -33.7 19.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 71.239999999999995 110.865 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -60.8 -44.57 96.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 72.340000000000003 110.912 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -60.36 -35.29 75.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 75.420000000000002 110.964 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -68.57 -44.06 75.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 70.25 111.067 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . 0.513 ' CB ' ' CG1' ' A' ' 329' ' ' VAL . . . -50.1 -25.59 3.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 63.399999999999999 111.14 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.441 HG12 ' CG2' ' A' ' 324' ' ' VAL . 65.0 t -69.54 -49.76 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 71.129999999999995 111.164 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . 0.402 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 30.7 t -57.51 -31.57 66.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 73.340000000000003 110.893 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.65 -56.33 14.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.447 . . . . 61.420000000000002 111.097 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.499 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.2 t -72.07 -35.21 52.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 60.32 111.056 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . 0.471 ' CB ' HG13 ' A' ' 324' ' ' VAL . . . -63.61 -39.71 95.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 75.209999999999994 111.061 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . 0.559 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.5 mm? -93.63 -10.6 34.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.306 -0.407 . . . . 73.5 110.976 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' ALA . . . . . 0.451 ' N ' HG22 ' A' ' 408' ' ' THR . . . -51.8 110.12 0.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 74.200000000000003 111.102 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 57.6 t30 43.02 48.07 5.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 73.129999999999995 110.874 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.559 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -104.53 147.32 34.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.721 0.772 . . . . 73.530000000000001 110.848 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.429 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 54.6 Cg_endo -69.68 141.55 45.84 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.669 2.246 . . . . 73.329999999999998 112.339 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' PHE . . . . . 0.499 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 36.4 t80 -147.58 111.22 4.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 74.010000000000005 110.815 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 49.01 38.65 13.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 63.520000000000003 110.913 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 93.96 -29.07 9.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 71.310000000000002 112.409 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.4 OUTLIER -105.93 140.07 39.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.783 0.325 . . . . 70.010000000000005 110.97 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.438 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 9.0 m120 -81.62 154.63 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 75.230000000000004 110.875 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.488 ' CD2' ' O ' ' A' ' 347' ' ' ASN . 13.3 mt -115.86 172.95 6.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 74.519999999999996 110.974 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -113.5 173.24 6.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 74.549999999999997 110.897 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' THR . . . . . 0.533 ' CG2' ' C ' ' A' ' 396' ' ' LEU . 71.0 p -154.18 151.55 29.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 75.450000000000003 111.118 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 410' ' ' TRP . . . 153.14 128.59 1.31 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.748 -0.739 . . . . 64.040000000000006 112.489 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.571 ' CD1' ' HB1' ' A' ' 336' ' ' ALA . 21.0 m95 -31.76 113.93 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.786 0.327 . . . . 72.239999999999995 110.893 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 410' ' ' TRP . . . 38.08 -158.1 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.736 -0.745 . . . . 72.430000000000007 112.437 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.524 ' HB2' ' CD2' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -167.6 -175.61 2.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.694 0.283 . . . . 74.239999999999995 110.933 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -104.61 45.54 0.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 72.319999999999993 110.835 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 71.129999999999995 110.839 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.484 -0.246 . . . . 72.200000000000003 112.484 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.23 97.78 5.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.807 0.337 . . . . 73.230000000000004 110.785 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -116.52 -55.83 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.083 -0.508 . . . . 60.020000000000003 110.915 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 71.5 p -42.22 162.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.491 . . . . 74.329999999999998 111.107 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 10.8 tp -116.51 151.5 18.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 72.530000000000001 111.171 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -81.29 40.19 2.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.743 . . . . 70.230000000000004 112.456 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -176.97 75.22 0.24 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.536 0.684 . . . . 73.409999999999997 110.934 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 143.63 51.6 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.721 2.281 . . . . 74.540000000000006 112.329 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -21.26 33.4 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.71 2.273 . . . . 74.510000000000005 112.315 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.497 ' O ' ' CG2' ' A' ' 324' ' ' VAL . 6.6 mt-30 -140.61 87.61 2.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 75.209999999999994 110.933 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 323' ' ' GLN . 33.2 m 45.05 -171.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 74.200000000000003 111.049 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.24 110.99 24.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.621 0.724 . . . . 75.140000000000001 110.928 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.68 -14.47 36.39 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.666 2.244 . . . . 75.519999999999996 112.351 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -68.86 -71.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 74.5 110.905 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -57.14 -24.64 55.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 71.129999999999995 111.112 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.476 ' CG1' ' CB ' ' A' ' 390' ' ' ALA . 11.4 t -77.16 -30.1 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 72.319999999999993 111.154 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -55.0 -41.67 71.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 73.319999999999993 110.842 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -55.86 -35.48 66.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 74.329999999999998 110.857 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 39.1 mm -63.67 -49.67 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 75.200000000000003 111.108 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 13.3 mt -51.49 -50.06 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 75.430000000000007 111.126 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.28 -8.75 6.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 74.530000000000001 110.92 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 2.2 t -96.98 25.57 5.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 75.519999999999996 110.839 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.444 ' HB3' ' NE1' ' A' ' 410' ' ' TRP . . . -173.95 154.75 2.29 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.725 . . . . 71.140000000000001 111.082 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 150.76 68.31 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 73.219999999999999 112.369 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . 0.402 ' HA ' ' ND1' ' A' ' 386' ' ' HIS . 54.4 Cg_endo -69.67 -12.11 32.37 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.669 2.246 . . . . 73.420000000000002 112.42 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -78.4 -53.39 7.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 73.150000000000006 110.832 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 4.1 p -69.34 135.19 28.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 75.230000000000004 111.13 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' THR . . . . . 0.472 HG23 ' N ' ' A' ' 386' ' ' HIS . 44.6 p -142.69 68.19 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 111.113 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 3.4 m -133.75 128.93 35.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 65.230000000000004 111.183 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -92.91 134.31 35.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 75.200000000000003 111.133 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.518 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -112.69 128.57 56.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 72.310000000000002 110.918 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.471 HG21 ' CD1' ' A' ' 348' ' ' ILE . 1.6 mp -124.94 110.05 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 72.099999999999994 111.139 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -101.86 161.4 17.63 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 62.229999999999997 112.535 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 405' ' ' ASN . 0.7 OUTLIER 81.14 50.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 74.450000000000003 110.864 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.471 ' CD1' HG21 ' A' ' 345' ' ' ILE . 74.2 mt -107.06 138.68 19.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.607 0.718 . . . . 72.019999999999996 111.118 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . 0.533 ' HB2' ' CD1' ' A' ' 351' ' ' PHE . 54.2 Cg_endo -69.72 166.23 28.24 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.695 2.263 . . . . 73.530000000000001 112.364 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -76.34 -15.67 59.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 70.319999999999993 110.839 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.533 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 47.8 p90 -100.44 29.31 4.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 74.25 110.85 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . 0.591 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -114.54 99.86 7.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 43.240000000000002 111.081 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 10.1 p -96.54 171.08 8.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 72.340000000000003 111.056 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.495 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.32 -30.4 70.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 73.510000000000005 110.843 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -55.1 -26.41 37.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 74.319999999999993 111.12 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.3 -12.96 13.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 71.349999999999994 110.822 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.439 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.4 mp -98.58 -54.46 3.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 73.040000000000006 110.953 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.627 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 0.9 OUTLIER -40.71 -51.5 6.87 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.631 0.729 . . . . 70.439999999999998 111.139 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.5 Cg_endo -69.8 -34.36 14.6 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.7 2.267 . . . . 75.439999999999998 112.308 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.575 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -59.65 -25.07 64.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 74.140000000000001 110.904 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.512 ' CD1' ' CD1' ' A' ' 381' ' ' ILE . 87.6 m-85 -98.01 -37.33 9.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 73.329999999999998 110.885 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' GLN . . . . . 0.475 ' HG2' ' CD1' ' A' ' 367' ' ' ILE . 6.3 mm-40 -50.66 -45.02 57.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 75.129999999999995 110.863 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -44.95 -21.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 72.310000000000002 110.879 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . 0.447 ' CE2' ' HA ' ' A' ' 361' ' ' PHE . 30.9 m-85 -75.3 -56.86 4.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 74.549999999999997 110.925 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -152.89 -90.26 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 54.329999999999998 112.477 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -153.8 142.87 21.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.757 0.313 . . . . 74.519999999999996 110.84 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.475 ' CD1' ' HG2' ' A' ' 362' ' ' GLN . 59.1 mt -120.95 109.13 24.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.168 -0.469 . . . . 75.019999999999996 111.129 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.64 -16.81 35.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 74.239999999999995 110.876 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.93 120.74 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 72.340000000000003 110.881 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.558 ' CD1' HG12 ' A' ' 381' ' ' ILE . 35.9 t80 -114.13 144.81 42.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 72.409999999999997 110.898 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.52 100.09 5.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 75.450000000000003 110.875 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . 0.591 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 4.0 t-80 -103.13 131.91 49.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 72.340000000000003 110.835 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.448 ' CB ' ' HB2' ' A' ' 376' ' ' LYS . 96.6 m-85 -128.73 102.19 20.01 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.639 0.733 . . . . 75.439999999999998 110.904 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 373' ' ' TYR . 53.5 Cg_endo -69.76 -25.13 28.93 Favored 'Trans proline' 0 N--CA 1.466 -0.114 0 C-N-CA 122.711 2.274 . . . . 61.409999999999997 112.344 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -87.57 -8.77 55.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 72.120000000000005 110.897 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . 0.448 ' HB2' ' CB ' ' A' ' 373' ' ' TYR . 0.0 OUTLIER -106.5 -28.13 10.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 74.329999999999998 110.862 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 80.61 24.32 58.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 64.420000000000002 112.461 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 92.1 m -155.22 149.8 26.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.776 0.322 . . . . 74.420000000000002 110.867 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 14.9 p -133.8 151.27 51.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 75.010000000000005 110.874 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.427 ' N ' ' CD1' ' A' ' 380' ' ' PHE . 3.5 m-85 -124.35 127.72 48.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 73.430000000000007 110.864 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.558 HG12 ' CD1' ' A' ' 370' ' ' PHE . 1.3 mt -119.24 121.35 66.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.516 . . . . 73.099999999999994 111.041 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.37 130.01 34.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 75.209999999999994 110.891 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -115.11 -174.89 2.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 73.439999999999998 110.906 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -73.61 -54.93 7.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.061 -0.518 . . . . 71.209999999999994 110.943 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 71.1 p -120.2 178.78 4.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 74.420000000000002 111.181 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' HIS . . . . . 0.472 ' N ' HG23 ' A' ' 341' ' ' THR . 21.2 p-80 -83.65 -39.43 20.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 71.239999999999995 110.857 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -57.35 -28.82 63.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.425 . . . . 72.340000000000003 110.877 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -46.09 78.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 75.420000000000002 110.943 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -62.79 -25.71 68.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.235 -0.439 . . . . 70.25 111.121 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . 0.476 ' CB ' ' CG1' ' A' ' 329' ' ' VAL . . . -58.27 -40.12 81.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 63.399999999999999 111.134 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 14.1 t -61.92 -57.9 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 71.129999999999995 111.081 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 18.4 p -58.91 -31.34 68.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 73.340000000000003 110.895 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.97 -55.38 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 61.420000000000002 111.087 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.468 HG13 ' CG2' ' A' ' 329' ' ' VAL . 0.3 OUTLIER -72.25 -35.74 53.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 60.32 111.187 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.57 -47.81 82.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 75.209999999999994 111.095 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . 0.593 ' CB ' ' CG2' ' A' ' 408' ' ' THR . 1.2 mm? -79.83 -13.42 59.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.258 -0.428 . . . . 73.5 110.913 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' ALA . . . . . 0.454 ' N ' HG22 ' A' ' 408' ' ' THR . . . -50.33 112.91 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 74.200000000000003 111.096 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.2 m120 44.13 51.49 7.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 73.129999999999995 110.835 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.575 ' CE1' HD11 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -108.0 147.94 36.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.689 0.757 . . . . 73.530000000000001 110.865 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.424 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.3 Cg_endo -69.71 145.16 56.58 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.706 2.271 . . . . 73.329999999999998 112.324 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' PHE . . . . . 0.571 ' CZ ' ' NE2' ' A' ' 402' ' ' GLN . 40.0 t80 -151.85 111.49 3.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 74.010000000000005 110.856 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . 0.571 ' NE2' ' CZ ' ' A' ' 401' ' ' PHE . 4.9 mt-30 46.7 38.63 6.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 63.520000000000003 110.893 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 94.57 -29.99 8.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.735 . . . . 71.310000000000002 112.539 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -104.91 137.62 42.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 70.010000000000005 110.83 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.477 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 4.6 m120 -80.04 152.75 29.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 75.230000000000004 110.895 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.405 ' CD2' ' O ' ' A' ' 347' ' ' ASN . 13.9 mt -114.58 173.57 6.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 74.519999999999996 110.944 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 346' ' ' GLY . 5.5 ttm-85 -117.63 175.36 5.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 74.549999999999997 110.88 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' THR . . . . . 0.593 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 43.0 p -151.63 153.45 34.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 75.450000000000003 111.122 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 165.11 174.54 34.9 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.665 -0.779 . . . . 64.040000000000006 112.412 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.444 ' NE1' ' HB3' ' A' ' 336' ' ' ALA . 41.1 m95 -81.45 122.64 27.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.787 0.327 . . . . 72.239999999999995 110.881 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -38.59 156.01 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.75 -0.738 . . . . 72.430000000000007 112.52 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 413' ' ' GLU . 0.0 OUTLIER -160.38 127.35 4.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.736 0.303 . . . . 74.239999999999995 110.906 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 412' ' ' LYS . 0.8 OUTLIER -36.63 126.91 0.85 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 72.319999999999993 110.925 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 71.129999999999995 110.843 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.483 -0.247 . . . . 72.200000000000003 112.483 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 34.5 p -69.83 148.92 48.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 73.230000000000004 110.924 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -166.6 -59.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 60.020000000000003 110.884 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 41.8 p 51.38 178.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 74.329999999999998 111.079 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 4.7 tt -166.42 173.9 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 72.530000000000001 111.155 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -112.29 67.11 0.24 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 70.230000000000004 112.456 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -177.77 140.47 0.43 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.722 . . . . 73.409999999999997 110.94 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 161.44 45.94 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.663 2.242 . . . . 74.540000000000006 112.3 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -11.9 31.68 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.646 2.231 . . . . 74.510000000000005 112.356 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.515 ' O ' ' C ' ' A' ' 324' ' ' VAL . 2.3 mp0 -104.91 143.43 33.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 75.209999999999994 110.946 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.515 ' C ' ' O ' ' A' ' 323' ' ' GLN . 11.7 p 28.27 75.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 74.200000000000003 111.15 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' A' ' 328' ' ' ALA . 0.2 OUTLIER -66.54 143.81 98.35 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.625 0.726 . . . . 75.140000000000001 110.887 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 -13.6 35.12 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.659 2.239 . . . . 75.519999999999996 112.443 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -73.55 -72.22 0.27 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 74.5 110.898 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.466 ' HB3' ' ND2' ' A' ' 325' ' ' ASN . . . -51.05 -33.73 26.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.424 . . . . 71.129999999999995 111.11 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.531 ' CG1' ' CB ' ' A' ' 390' ' ' ALA . 7.9 t -70.27 -28.66 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 72.319999999999993 111.113 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -53.11 -37.45 61.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 73.319999999999993 110.867 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -71.65 -31.81 67.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 74.329999999999998 110.805 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.483 HG23 ' CD1' ' A' ' 393' ' ' ILE . 33.5 mm -54.59 -56.07 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 75.200000000000003 111.141 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 4.3 mt -49.72 -39.24 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 75.430000000000007 111.163 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -27.35 31.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 74.530000000000001 110.828 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 4.8 t -68.47 -32.1 71.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 75.519999999999996 110.858 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.576 ' HB1' ' CD1' ' A' ' 410' ' ' TRP . . . -113.93 155.43 45.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.606 0.717 . . . . 71.140000000000001 111.061 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 161.79 44.57 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.654 2.236 . . . . 73.219999999999999 112.425 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.8 -11.47 30.86 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.667 2.245 . . . . 73.420000000000002 112.304 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -106.61 67.33 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 73.150000000000006 110.883 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 5.3 p 177.14 134.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 75.230000000000004 111.147 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 19.9 p -141.55 69.99 1.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 74.430000000000007 111.193 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 23.7 m -133.61 121.71 22.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 65.230000000000004 111.2 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -88.33 134.33 33.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 75.200000000000003 111.15 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.605 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -111.2 121.65 45.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.289 -0.414 . . . . 72.310000000000002 110.942 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . . . . . . . . . 2.3 mp -124.31 102.19 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 72.099999999999994 111.14 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -92.28 -173.19 41.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.69 -0.767 . . . . 62.229999999999997 112.519 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.9 t30 58.76 46.66 13.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 74.450000000000003 110.901 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.449 ' CG2' ' HB2' ' A' ' 352' ' ' ALA . 81.6 mt -100.08 131.38 24.37 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.529 0.68 . . . . 72.019999999999996 111.164 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . 0.523 ' CB ' ' CE1' ' A' ' 351' ' ' PHE . 53.9 Cg_endo -69.71 156.22 64.03 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.736 2.29 . . . . 73.530000000000001 112.372 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.7 -20.83 65.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 70.319999999999993 110.827 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.523 ' CE1' ' CB ' ' A' ' 349' ' ' PRO . 4.8 p90 -94.01 29.35 2.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 74.25 110.929 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . 0.565 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -116.0 96.14 5.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 43.240000000000002 111.109 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 15.2 p -98.39 170.69 8.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 72.340000000000003 111.161 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.5 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.6 OUTLIER -67.31 -29.72 69.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 73.510000000000005 110.843 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.67 -26.21 63.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 74.319999999999993 111.084 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.3 -14.1 13.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 71.349999999999994 110.844 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.455 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 2.8 mp -97.78 -52.14 3.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 73.040000000000006 110.901 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.655 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -42.52 -50.32 12.34 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.627 0.727 . . . . 70.439999999999998 111.137 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 52.9 Cg_endo -69.78 -29.09 24.33 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.684 2.256 . . . . 75.439999999999998 112.313 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.58 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.2 OUTLIER -66.97 -21.83 65.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 74.140000000000001 110.924 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.459 ' CD2' HD13 ' A' ' 360' ' ' LEU . 87.8 m-85 -103.32 -36.04 8.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 73.329999999999998 110.891 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -49.14 -40.27 31.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 75.129999999999995 110.853 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -48.86 -27.84 3.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 72.310000000000002 110.928 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . 0.552 ' CE1' ' HA ' ' A' ' 392' ' ' CYS . 39.7 m-85 -64.19 -56.88 11.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 74.549999999999997 110.902 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -158.98 -84.69 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.786 -0.721 . . . . 54.329999999999998 112.537 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -153.24 145.45 23.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.799 0.333 . . . . 74.519999999999996 110.893 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.473 HG22 ' CG2' ' A' ' 381' ' ' ILE . 27.6 mt -121.1 111.31 31.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 75.019999999999996 111.165 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.86 -23.18 25.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 74.239999999999995 110.934 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.16 120.67 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 72.340000000000003 110.944 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.536 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 32.8 t80 -112.34 140.96 46.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 72.409999999999997 110.845 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.11 101.21 6.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 75.450000000000003 110.909 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.3 t-80 -97.43 124.07 41.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 72.340000000000003 110.795 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -118.02 89.01 33.37 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.698 0.761 . . . . 75.439999999999998 110.911 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . 0.438 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.4 Cg_endo -69.78 -26.16 27.76 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.648 2.232 . . . . 61.409999999999997 112.325 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -72.75 -12.7 61.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 72.120000000000005 110.829 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -119.75 -26.43 5.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 74.329999999999998 110.916 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 86.55 41.52 6.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.738 -0.744 . . . . 64.420000000000002 112.491 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.5 t -159.99 147.74 16.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.745 0.307 . . . . 74.420000000000002 110.863 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.536 ' HB2' ' CE1' ' A' ' 370' ' ' PHE . 21.5 p -134.18 155.13 50.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 75.010000000000005 110.824 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -128.95 122.79 30.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 73.430000000000007 110.887 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.481 ' CG1' ' CD1' ' A' ' 370' ' ' PHE . 1.1 mt -114.17 134.05 58.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 73.099999999999994 111.113 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.37 131.76 48.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 75.209999999999994 110.863 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -112.75 -173.83 2.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 73.439999999999998 110.931 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.62 -39.03 16.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 71.209999999999994 110.873 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 54.7 p -120.82 174.35 6.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 74.420000000000002 111.139 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -87.17 -32.13 20.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 71.239999999999995 110.88 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -61.16 -41.92 97.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 72.340000000000003 110.849 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.93 -35.79 67.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 75.420000000000002 110.892 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.39 -26.12 60.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.227 -0.442 . . . . 70.25 111.13 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . 0.531 ' CB ' ' CG1' ' A' ' 329' ' ' VAL . . . -68.56 -40.42 80.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 63.399999999999999 111.072 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.471 ' CG1' HG21 ' A' ' 324' ' ' VAL . 93.8 t -64.73 -55.2 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 71.129999999999995 111.141 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . 0.552 ' HA ' ' CE1' ' A' ' 364' ' ' PHE . 16.7 p -57.15 -29.69 63.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.485 . . . . 73.340000000000003 110.858 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.483 ' CD1' HG23 ' A' ' 332' ' ' ILE . 8.6 mt -60.03 -55.42 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 61.420000000000002 111.134 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.493 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 1.7 t -72.04 -34.43 50.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 60.32 111.132 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -63.77 -47.86 79.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 75.209999999999994 111.08 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . 0.534 ' C ' ' CG2' ' A' ' 408' ' ' THR . 0.3 OUTLIER -82.14 -6.38 59.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 73.5 110.899 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' ALA . . . . . 0.443 ' N ' HG22 ' A' ' 408' ' ' THR . . . -54.89 112.79 1.12 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.204 -0.453 . . . . 74.200000000000003 111.118 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 44.79 46.29 8.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 73.129999999999995 110.946 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.47 ' CD1' HD12 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -99.29 145.55 30.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.634 0.73 . . . . 73.530000000000001 110.85 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 141.91 46.22 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.714 2.276 . . . . 73.329999999999998 112.358 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' PHE . . . . . 0.453 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 48.2 t80 -151.01 112.86 4.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 74.010000000000005 110.871 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 52.97 32.74 13.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 63.520000000000003 110.917 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 96.63 -26.61 21.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.69 -0.767 . . . . 71.310000000000002 112.448 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 401' ' ' PHE . 9.9 ttt85 -108.57 143.61 37.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.827 0.346 . . . . 70.010000000000005 110.917 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -80.81 155.17 26.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 75.230000000000004 110.933 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 10.4 mt -114.77 175.13 5.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 74.519999999999996 110.899 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -109.02 176.21 5.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 74.549999999999997 110.902 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' THR . . . . . 0.534 ' CG2' ' C ' ' A' ' 396' ' ' LEU . 45.0 p -154.06 149.82 27.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 75.450000000000003 111.147 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 164.03 -159.04 31.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.72 . . . . 64.040000000000006 112.506 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.576 ' CD1' ' HB1' ' A' ' 336' ' ' ALA . 96.5 m95 -109.31 129.2 55.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.731 0.301 . . . . 72.239999999999995 110.974 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -93.45 159.82 24.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.791 -0.719 . . . . 72.430000000000007 112.475 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 413' ' ' GLU . 2.4 tttm -163.25 79.04 0.45 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.727 0.299 . . . . 74.239999999999995 110.918 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 414' ' ' ARG . 39.7 mt-10 35.33 45.72 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 72.319999999999993 110.962 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 413' ' ' GLU . 1.1 ptt180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.495 . . . . 71.129999999999995 110.88 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.462 -0.255 . . . . 72.200000000000003 112.462 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.45 174.72 0.35 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 73.230000000000004 110.867 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -144.64 36.65 1.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 60.020000000000003 110.947 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 318' ' ' ILE . 1.9 m -112.1 143.98 42.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 74.329999999999998 111.115 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.413 ' C ' ' O ' ' A' ' 317' ' ' THR . 5.1 tp -36.58 142.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 72.530000000000001 111.153 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -110.36 -44.11 1.02 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 70.230000000000004 112.525 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 47.65 82.71 0.23 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.566 0.698 . . . . 73.409999999999997 110.94 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 323' ' ' GLN . 54.6 Cg_endo -69.7 170.27 16.9 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.727 2.285 . . . . 74.540000000000006 112.336 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 323' ' ' GLN . 53.4 Cg_endo -69.72 6.98 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.709 2.273 . . . . 74.510000000000005 112.317 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.515 ' CB ' ' O ' ' A' ' 322' ' ' PRO . 0.3 OUTLIER 84.61 41.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 75.209999999999994 110.871 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.471 HG21 ' CG1' ' A' ' 391' ' ' VAL . 1.1 t -156.47 164.82 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 74.200000000000003 111.14 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -108.12 116.23 57.19 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.607 0.718 . . . . 75.140000000000001 110.855 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -14.25 35.85 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.725 2.283 . . . . 75.519999999999996 112.311 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -71.65 -72.17 0.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 74.5 110.899 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -58.63 -25.49 62.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 71.129999999999995 111.065 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.474 ' CG2' HG12 ' A' ' 394' ' ' VAL . 24.6 t -78.21 -29.98 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.434 . . . . 72.319999999999993 111.187 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -54.71 -35.64 63.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 73.319999999999993 110.877 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' HIS . . . . . 0.489 ' CD2' HD12 ' A' ' 332' ' ' ILE . 2.2 t60 -61.69 -38.27 87.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 74.329999999999998 110.884 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.489 HD12 ' CD2' ' A' ' 331' ' ' HIS . 1.1 mp -54.21 -51.42 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 75.200000000000003 111.096 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 9.0 mt -53.67 -38.38 34.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 75.430000000000007 111.121 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -2.45 6.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.530000000000001 110.872 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 43.2 t -108.92 21.76 16.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 75.519999999999996 110.829 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.536 ' HB2' ' CD1' ' A' ' 410' ' ' TRP . . . -175.9 150.88 1.14 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.586 0.707 . . . . 71.140000000000001 111.083 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 154.28 67.65 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.629 2.219 . . . . 73.219999999999999 112.323 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -8.05 22.6 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.678 2.252 . . . . 73.420000000000002 112.351 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.08 -49.72 13.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 73.150000000000006 110.876 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.75 133.05 32.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 75.230000000000004 111.146 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' THR . . . . . 0.448 HG22 ' CB ' ' A' ' 386' ' ' HIS . 30.2 p -135.7 68.02 1.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.117 -0.492 . . . . 74.430000000000007 111.184 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 51.2 m -133.72 136.99 45.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 65.230000000000004 111.154 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.446 ' CB ' ' SG ' ' A' ' 392' ' ' CYS . . . -109.18 129.54 55.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 75.200000000000003 111.088 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.486 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -105.95 134.44 49.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 72.310000000000002 110.899 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . . . . . . . . . 1.9 mp -129.61 100.7 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 72.099999999999994 111.171 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -90.07 178.61 43.56 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.713 -0.756 . . . . 62.229999999999997 112.488 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 405' ' ' ASN . 2.3 t30 67.64 49.23 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 74.450000000000003 110.899 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.47 ' CG2' ' HD2' ' A' ' 349' ' ' PRO . 77.4 mt -105.11 138.51 19.54 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.618 0.723 . . . . 72.019999999999996 111.156 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . 0.539 ' HB2' ' CD1' ' A' ' 351' ' ' PHE . 53.7 Cg_endo -69.75 164.04 36.03 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.708 2.272 . . . . 73.530000000000001 112.361 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -75.57 -18.64 59.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 70.319999999999993 110.817 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.539 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 55.4 p90 -92.88 17.65 10.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 74.25 110.9 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . 0.588 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -105.8 116.04 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 43.240000000000002 111.159 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 25.6 p -114.96 170.42 8.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 72.340000000000003 111.192 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.488 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -64.82 -29.77 70.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 73.510000000000005 110.935 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.48 -26.59 63.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 74.319999999999993 111.108 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.27 -13.6 13.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 71.349999999999994 110.954 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.439 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.5 mp -98.47 -52.27 3.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 73.040000000000006 110.899 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.637 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -41.83 -51.07 9.95 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.639 0.733 . . . . 70.439999999999998 111.066 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.1 Cg_endo -69.79 -35.37 12.69 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.699 2.266 . . . . 75.439999999999998 112.388 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.588 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -59.45 -23.47 62.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 74.140000000000001 110.922 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.531 ' CD1' HD12 ' A' ' 381' ' ' ILE . 82.8 m-85 -100.97 -35.6 9.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 73.329999999999998 110.877 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -53.34 -35.41 60.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 75.129999999999995 110.934 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -54.11 -14.88 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 72.310000000000002 110.875 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -78.62 -56.78 4.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 74.549999999999997 110.862 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -157.09 -85.99 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 54.329999999999998 112.453 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.572 ' CD2' HD22 ' A' ' 368' ' ' LEU . 8.4 t80 -153.64 142.82 21.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 74.519999999999996 110.881 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.401 HG23 ' CG2' ' A' ' 381' ' ' ILE . 50.3 mt -120.87 112.3 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 75.019999999999996 111.156 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.572 HD22 ' CD2' ' A' ' 366' ' ' PHE . 0.3 OUTLIER -86.01 -21.82 27.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 74.239999999999995 110.889 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.94 121.2 0.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 72.340000000000003 110.88 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 33.5 t80 -111.11 139.77 46.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 72.409999999999997 110.891 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -126.82 100.93 6.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 75.450000000000003 110.95 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . 0.588 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 11.0 t-80 -96.37 115.71 27.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 72.340000000000003 110.793 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -107.25 84.58 1.77 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.744 . . . . 75.439999999999998 110.874 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . 0.509 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 53.9 Cg_endo -69.73 -17.38 37.72 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.701 2.267 . . . . 61.409999999999997 112.411 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -78.24 -24.67 46.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 72.120000000000005 110.908 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -108.7 -27.41 9.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 110.948 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 93.4 42.29 4.29 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.676 -0.774 . . . . 64.420000000000002 112.452 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 26.3 p -159.92 158.18 30.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.837 0.351 . . . . 74.420000000000002 110.942 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.57 ' HB2' ' CE1' ' A' ' 370' ' ' PHE . 28.1 p -143.35 152.32 41.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 75.010000000000005 110.872 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 414' ' ' ARG . 38.0 m-85 -125.8 125.03 42.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 73.430000000000007 110.827 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.531 HD12 ' CD1' ' A' ' 361' ' ' PHE . 0.7 OUTLIER -115.28 121.25 66.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 73.099999999999994 111.139 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -87.94 131.95 34.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 75.209999999999994 110.919 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -116.43 162.7 17.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 73.439999999999998 110.889 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -60.99 -45.55 94.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 71.209999999999994 110.873 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 30.2 p -112.92 169.02 9.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 74.420000000000002 111.143 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' HIS . . . . . 0.448 ' CB ' HG22 ' A' ' 341' ' ' THR . 18.0 p-80 -82.62 -36.14 26.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 71.239999999999995 110.891 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -62.73 -26.81 68.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.181 -0.463 . . . . 72.340000000000003 110.896 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -34.96 79.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 75.420000000000002 110.868 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.66 -41.26 62.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 70.25 111.05 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -58.87 -26.36 64.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 63.399999999999999 111.121 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.471 ' CG1' HG21 ' A' ' 324' ' ' VAL . 79.7 t -71.36 -55.76 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 71.129999999999995 111.145 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 343' ' ' ALA . 30.3 p -60.64 -32.05 71.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 73.340000000000003 110.913 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.465 ' CG2' HG12 ' A' ' 332' ' ' ILE . 0.2 OUTLIER -53.54 -54.98 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 61.420000000000002 111.092 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.474 HG12 ' CG2' ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.7 -38.91 68.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 60.32 111.139 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . 0.415 ' N ' ' CG1' ' A' ' 394' ' ' VAL . . . -62.03 -33.91 75.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 75.209999999999994 111.116 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . 0.57 HD11 ' CE1' ' A' ' 399' ' ' PHE . 2.6 mm? -93.61 -15.08 25.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 73.5 110.925 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' ALA . . . . . 0.409 ' N ' HG23 ' A' ' 408' ' ' THR . . . -47.39 111.47 0.42 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 74.200000000000003 111.065 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 43.14 47.43 5.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 73.129999999999995 110.944 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.57 ' CE1' HD11 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -100.88 146.28 31.85 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.661 0.744 . . . . 73.530000000000001 110.841 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.441 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 54.2 Cg_endo -69.76 137.05 34.57 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.717 2.278 . . . . 73.329999999999998 112.339 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' PHE . . . . . 0.563 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 29.9 t80 -142.64 111.13 6.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 74.010000000000005 110.967 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 48.98 34.5 5.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 63.520000000000003 110.935 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 99.28 -31.99 7.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.741 -0.743 . . . . 71.310000000000002 112.454 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.8 134.71 47.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 70.010000000000005 110.859 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.474 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 3.1 m120 -78.2 152.25 32.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 75.230000000000004 110.892 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 10.8 mt -111.62 177.5 4.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 74.519999999999996 110.872 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.77 172.26 7.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 74.549999999999997 110.85 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' THR . . . . . 0.488 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 45.8 p -154.77 146.09 22.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 75.450000000000003 111.18 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 344' ' ' TYR . . . 165.34 138.41 2.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 64.040000000000006 112.512 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.536 ' CD1' ' HB2' ' A' ' 336' ' ' ALA . 18.5 m95 -43.68 134.12 4.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.778 0.323 . . . . 72.239999999999995 110.942 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -110.87 163.92 12.23 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.711 -0.756 . . . . 72.430000000000007 112.552 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.484 ' O ' ' C ' ' A' ' 413' ' ' GLU . 0.0 OUTLIER -133.32 78.2 1.77 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.732 0.301 . . . . 74.239999999999995 110.926 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.484 ' C ' ' O ' ' A' ' 412' ' ' LYS . 5.8 pt-20 31.54 51.21 0.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 72.319999999999993 110.846 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.572 ' HB3' ' CZ ' ' A' ' 380' ' ' PHE . 2.3 ttm180 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 71.129999999999995 110.817 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.503 -0.239 . . . . 72.200000000000003 112.503 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.79 -54.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 73.230000000000004 110.854 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.93 75.46 1.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 60.020000000000003 110.896 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 4.3 t -171.89 157.08 4.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.329999999999998 111.129 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 14.1 tt -134.23 148.31 29.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 72.530000000000001 111.077 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -114.95 114.56 3.24 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.77 -0.729 . . . . 70.230000000000004 112.498 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.5 73.26 12.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.655 0.741 . . . . 73.409999999999997 110.901 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 150.9 68.26 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.654 2.236 . . . . 74.540000000000006 112.315 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 3.34 2.81 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.696 2.264 . . . . 74.510000000000005 112.322 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -89.26 -72.22 0.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 75.209999999999994 110.889 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.87 150.24 26.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 74.200000000000003 111.132 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -113.05 118.89 43.66 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.738 0.78 . . . . 75.140000000000001 110.844 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -14.29 36.03 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.742 2.295 . . . . 75.519999999999996 112.358 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -69.81 -72.61 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 74.5 110.913 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.06 -33.78 63.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 71.129999999999995 111.145 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.573 ' CG1' ' CB ' ' A' ' 390' ' ' ALA . 10.7 t -66.78 -29.88 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.178 -0.464 . . . . 72.319999999999993 111.156 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -54.11 -34.74 61.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 73.319999999999993 110.912 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -70.69 -31.99 69.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.446 . . . . 74.329999999999998 110.86 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.454 HG22 ' NE1' ' A' ' 410' ' ' TRP . 29.4 mm -57.98 -44.9 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 75.200000000000003 111.093 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 6.0 mt -53.66 -44.39 57.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 75.430000000000007 111.181 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 -56.08 -13.85 2.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 74.530000000000001 110.93 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 11.7 t -76.32 -30.56 57.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 75.519999999999996 110.9 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -133.78 165.34 37.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.554 0.693 . . . . 71.140000000000001 111.114 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 148.75 65.85 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.675 2.25 . . . . 73.219999999999999 112.342 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -7.64 21.58 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.716 2.278 . . . . 73.420000000000002 112.313 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -43.8 40.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.224 -0.444 . . . . 73.150000000000006 110.806 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.1 p -81.6 139.73 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 75.230000000000004 111.077 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 34.7 p -138.46 69.09 1.38 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 74.430000000000007 111.171 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.466 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 98.6 m -133.59 124.96 27.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 65.230000000000004 111.088 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -85.6 126.47 33.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 75.200000000000003 111.064 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.455 ' HB3' ' C ' ' A' ' 410' ' ' TRP . 0.0 OUTLIER -106.4 134.29 49.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 72.310000000000002 110.907 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.477 HG23 ' CD1' ' A' ' 406' ' ' LEU . 1.8 mp -135.41 110.97 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 72.099999999999994 111.126 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -100.03 161.08 19.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.696 -0.764 . . . . 62.229999999999997 112.419 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 1.0 OUTLIER 81.09 50.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.775 0.321 . . . . 74.450000000000003 110.882 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.474 ' CG2' ' HD2' ' A' ' 349' ' ' PRO . 46.5 mt -104.1 138.2 19.46 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.619 0.723 . . . . 72.019999999999996 111.149 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . 0.474 ' HD2' ' CG2' ' A' ' 348' ' ' ILE . 53.3 Cg_endo -69.78 166.48 27.47 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.732 2.288 . . . . 73.530000000000001 112.308 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -74.24 -29.66 61.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 70.319999999999993 110.884 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -83.5 12.87 5.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 74.25 110.908 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . 0.594 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -99.15 102.59 14.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 43.240000000000002 111.122 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 22.3 p -105.02 172.0 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 72.340000000000003 111.112 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.487 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.3 OUTLIER -65.6 -30.25 70.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 73.510000000000005 110.845 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -57.25 -26.29 60.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 74.319999999999993 111.095 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.89 -18.68 12.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 71.349999999999994 110.868 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.442 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 4.6 mp -92.68 -52.51 4.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 73.040000000000006 110.957 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.641 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -41.76 -51.1 9.74 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.609 0.718 . . . . 70.439999999999998 111.122 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.8 Cg_endo -69.7 -30.15 23.01 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.669 2.246 . . . . 75.439999999999998 112.353 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.583 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -66.46 -23.96 66.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 74.140000000000001 110.912 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.537 ' CD2' HD12 ' A' ' 360' ' ' LEU . 81.3 m-85 -101.45 -27.43 13.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 73.329999999999998 110.919 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' GLN . . . . . 0.481 ' N ' HD13 ' A' ' 367' ' ' ILE . 0.0 OUTLIER -56.57 -22.93 36.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 75.129999999999995 110.852 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -71.29 -10.38 59.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 72.310000000000002 110.89 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . 0.415 ' CE2' ' SG ' ' A' ' 392' ' ' CYS . 23.6 m-85 -93.17 18.59 9.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 74.549999999999997 110.911 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 130.07 -96.02 0.36 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 54.329999999999998 112.506 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -152.55 150.8 29.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.767 0.318 . . . . 74.519999999999996 110.943 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.481 HD13 ' N ' ' A' ' 362' ' ' GLN . 45.8 mt -121.42 109.86 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 75.019999999999996 111.149 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.75 -18.71 28.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 74.239999999999995 110.922 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.27 120.8 0.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 72.340000000000003 110.906 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 29.4 t80 -112.36 145.4 40.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 72.409999999999997 110.902 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.82 101.16 4.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.469 . . . . 75.450000000000003 110.848 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . 0.594 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 12.9 t-80 -94.99 117.35 29.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 72.340000000000003 110.846 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -109.7 83.64 2.84 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.657 0.741 . . . . 75.439999999999998 110.846 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . 0.502 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 52.7 Cg_endo -69.86 -17.97 36.81 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.691 2.261 . . . . 61.409999999999997 112.304 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.28 -27.19 61.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 72.120000000000005 110.862 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -110.52 -27.29 9.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 74.329999999999998 110.856 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 94.25 43.51 3.74 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 64.420000000000002 112.476 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 79.7 m -154.8 152.93 30.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.827 0.346 . . . . 74.420000000000002 110.918 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 16.0 p -136.21 152.49 50.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 75.010000000000005 110.879 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.466 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 48.6 m-85 -129.02 124.79 35.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.430000000000007 110.869 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.446 HD12 ' CD1' ' A' ' 361' ' ' PHE . 0.7 OUTLIER -117.35 123.28 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 73.099999999999994 111.172 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -89.55 136.19 33.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 75.209999999999994 110.886 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -119.63 -178.63 3.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 73.439999999999998 110.925 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.75 -42.57 40.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.496 . . . . 71.209999999999994 110.874 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 55.4 p -127.97 170.3 13.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 74.420000000000002 111.104 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -80.41 -35.31 35.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 71.239999999999995 110.823 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -59.42 -27.18 65.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 72.340000000000003 110.938 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.84 -34.28 62.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 75.420000000000002 110.879 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -69.04 -44.09 73.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 70.25 111.081 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . 0.573 ' CB ' ' CG1' ' A' ' 329' ' ' VAL . . . -50.22 -28.85 8.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 63.399999999999999 111.082 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.57 -40.07 79.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 71.129999999999995 111.156 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . 0.415 ' SG ' ' CE2' ' A' ' 364' ' ' PHE . 45.4 t -69.93 -33.61 72.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 73.340000000000003 110.892 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.447 HG23 ' CG2' ' A' ' 332' ' ' ILE . 0.9 OUTLIER -53.2 -55.61 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 61.420000000000002 111.19 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.492 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.0 t -71.47 -40.82 72.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 60.32 111.141 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.09 -16.75 54.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 75.209999999999994 111.102 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . 0.553 HD12 ' CE1' ' A' ' 399' ' ' PHE . 0.6 OUTLIER -115.91 -8.7 11.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 73.5 110.934 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -59.23 108.43 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 74.200000000000003 111.136 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 11.1 m120 47.98 49.37 17.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 73.129999999999995 110.911 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.553 ' CE1' HD12 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -108.62 142.75 26.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.694 0.759 . . . . 73.530000000000001 110.884 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.499 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 54.1 Cg_endo -69.71 145.52 57.72 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.702 2.268 . . . . 73.329999999999998 112.306 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' PHE . . . . . 0.485 ' N ' ' O ' ' A' ' 404' ' ' ARG . 50.4 t80 -152.77 110.61 3.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 74.010000000000005 110.797 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 49.54 39.9 18.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.508 . . . . 63.520000000000003 110.948 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 81.72 10.48 84.18 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.775 -0.726 . . . . 71.310000000000002 112.478 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -135.02 132.73 38.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.855 0.36 . . . . 70.010000000000005 110.909 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -82.54 146.02 29.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 75.230000000000004 110.88 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.477 ' CD1' HG23 ' A' ' 345' ' ' ILE . 6.3 mt -112.02 172.6 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 74.519999999999996 110.941 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 345' ' ' ILE . 0.0 OUTLIER -123.16 177.2 5.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 74.549999999999997 110.837 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 19.9 p -157.47 163.4 38.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 75.450000000000003 111.146 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 410' ' ' TRP . . . 152.23 44.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.751 . . . . 64.040000000000006 112.512 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.455 ' C ' ' HB3' ' A' ' 344' ' ' TYR . 75.1 m95 56.84 155.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.813 0.34 . . . . 72.239999999999995 110.907 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -44.33 121.58 4.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.778 -0.725 . . . . 72.430000000000007 112.47 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -154.75 122.59 5.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.739 0.304 . . . . 74.239999999999995 110.902 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -42.67 -62.09 1.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 72.319999999999993 110.871 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 71.129999999999995 110.905 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.445 -0.262 . . . . 72.200000000000003 112.445 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 25.2 p -51.08 150.81 2.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.878 0.371 . . . . 73.230000000000004 110.857 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' GLN . . . . . 0.478 ' O ' ' CG2' ' A' ' 317' ' ' THR . 0.5 OUTLIER -106.16 -61.49 1.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 60.020000000000003 110.878 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.478 ' CG2' ' O ' ' A' ' 316' ' ' GLN . 14.4 t 45.83 -163.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 74.329999999999998 111.179 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.451 HG13 ' N ' ' A' ' 319' ' ' GLY . 3.9 tp -95.4 144.04 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 72.530000000000001 111.119 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.451 ' N ' HG13 ' A' ' 318' ' ' ILE . . . -114.37 55.13 0.54 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 70.230000000000004 112.499 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 8.5 mt -132.79 66.7 77.01 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.599 0.714 . . . . 73.409999999999997 110.873 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 164.17 35.64 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.619 2.213 . . . . 74.540000000000006 112.337 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -40.65 5.04 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.652 2.235 . . . . 74.510000000000005 112.292 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -116.01 -63.81 1.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.433 . . . . 75.209999999999994 110.928 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.453 ' CG1' HG13 ' A' ' 391' ' ' VAL . 1.3 p -174.12 152.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 74.200000000000003 111.114 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -50.63 107.39 0.8 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.671 0.748 . . . . 75.140000000000001 110.807 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.83 -13.74 34.91 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.651 2.234 . . . . 75.519999999999996 112.337 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.32 -71.97 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 74.5 110.842 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -47.96 -25.27 1.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 71.129999999999995 111.117 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.509 ' CG2' ' HB ' ' A' ' 394' ' ' VAL . 14.2 t -83.43 -29.72 7.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 72.319999999999993 111.079 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -53.94 -35.26 61.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 73.319999999999993 110.872 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -68.89 -31.78 70.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 74.329999999999998 110.82 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 31.4 mm -58.38 -51.69 68.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 75.200000000000003 111.151 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 4.8 mt -51.67 -42.54 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 75.430000000000007 111.192 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -53.66 -16.39 1.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 74.530000000000001 110.889 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 6.1 t -88.47 -25.67 22.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 75.519999999999996 110.816 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.512 ' HB1' ' CG ' ' A' ' 410' ' ' TRP . . . -116.56 151.22 46.8 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.556 0.694 . . . . 71.140000000000001 111.16 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.74 161.71 44.89 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.753 2.302 . . . . 73.219999999999999 112.374 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -8.43 23.57 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.704 2.269 . . . . 73.420000000000002 112.366 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -109.25 63.47 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 73.150000000000006 110.882 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.401 ' C ' HG22 ' A' ' 341' ' ' THR . 9.2 p -175.15 126.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.451 . . . . 75.230000000000004 111.131 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' THR . . . . . 0.464 HG23 ' N ' ' A' ' 386' ' ' HIS . 21.5 p -137.88 73.46 1.44 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 74.430000000000007 111.146 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 71.1 m -132.86 124.24 27.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 65.230000000000004 111.148 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -93.77 116.33 28.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 75.200000000000003 111.157 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.461 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -101.55 134.29 44.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.424 . . . . 72.310000000000002 110.864 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . . . . . . . . . 1.8 mp -133.43 112.22 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 72.099999999999994 111.155 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -97.31 176.63 31.67 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.75 -0.738 . . . . 62.229999999999997 112.482 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.3 t30 65.68 49.85 1.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.777 0.322 . . . . 74.450000000000003 110.847 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 74.3 mt -104.98 135.4 19.3 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.614 0.721 . . . . 72.019999999999996 111.124 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.74 164.86 32.94 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.692 2.261 . . . . 73.530000000000001 112.42 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -72.5 -23.34 61.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 70.319999999999993 110.893 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -92.9 28.73 2.0 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.47 . . . . 74.25 110.854 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . 0.545 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -113.63 87.6 2.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 43.240000000000002 111.188 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 38.1 p -87.92 171.29 10.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.201 -0.454 . . . . 72.340000000000003 111.144 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.485 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -66.94 -29.81 69.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 73.510000000000005 110.925 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.21 -26.3 50.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 74.319999999999993 111.047 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.15 -13.28 13.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 71.349999999999994 110.903 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.44 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.3 mp -98.52 -53.88 3.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 73.040000000000006 110.967 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.637 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -41.17 -51.37 7.89 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.671 0.748 . . . . 70.439999999999998 111.15 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' PRO . . . . . 0.637 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.9 Cg_endo -69.76 -31.56 20.3 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.704 2.269 . . . . 75.439999999999998 112.348 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.583 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -63.98 -23.52 67.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 74.140000000000001 110.898 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.527 ' CD2' HD11 ' A' ' 360' ' ' LEU . 86.9 m-85 -102.07 -33.64 9.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 73.329999999999998 110.938 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' GLN . . . . . 0.438 ' N ' HD12 ' A' ' 367' ' ' ILE . 1.4 tt0 -54.06 -31.8 52.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 75.129999999999995 110.927 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -57.2 -21.02 30.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 72.310000000000002 110.86 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . 0.538 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 41.6 m-85 -72.02 -57.4 4.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 74.549999999999997 110.883 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -155.87 -86.28 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.721 . . . . 54.329999999999998 112.483 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -152.41 143.55 23.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 74.519999999999996 110.952 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.438 HD12 ' N ' ' A' ' 362' ' ' GLN . 41.4 mt -120.81 109.17 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 75.019999999999996 111.109 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.27 -21.18 27.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 74.239999999999995 110.91 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.56 121.5 0.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 72.340000000000003 110.881 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.519 ' CD2' HG12 ' A' ' 358' ' ' ILE . 39.1 t80 -115.23 138.95 50.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 72.409999999999997 110.836 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -127.68 100.7 6.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 75.450000000000003 110.852 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 10.8 t-80 -94.98 119.46 33.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 72.340000000000003 110.826 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -113.37 85.58 8.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.67 0.747 . . . . 75.439999999999998 110.873 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . 0.512 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 53.7 Cg_endo -69.83 -29.8 22.95 Favored 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.706 2.27 . . . . 61.409999999999997 112.407 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.02 -17.02 64.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 72.120000000000005 110.869 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -116.36 -27.74 6.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.329999999999998 110.901 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.81 39.96 5.71 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.696 -0.764 . . . . 64.420000000000002 112.526 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 99.6 m -156.84 145.94 20.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.787 0.327 . . . . 74.420000000000002 110.877 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 20.7 p -134.76 153.76 51.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 75.010000000000005 110.892 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.454 ' N ' ' CD1' ' A' ' 380' ' ' PHE . 2.5 m-85 -129.28 131.67 47.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 73.430000000000007 110.89 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.488 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -122.8 119.65 58.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 73.099999999999994 111.063 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.98 134.02 33.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 75.209999999999994 110.909 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -115.36 -178.6 3.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 73.439999999999998 110.893 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -86.51 -29.14 22.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 71.209999999999994 110.873 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 66.0 p -129.54 166.25 20.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 74.420000000000002 111.156 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' HIS . . . . . 0.464 ' N ' HG23 ' A' ' 341' ' ' THR . 41.2 p-80 -80.65 -38.41 29.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 71.239999999999995 110.849 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -60.88 -29.88 69.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 72.340000000000003 110.861 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -35.56 80.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 75.420000000000002 110.875 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -75.63 -38.11 59.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 70.25 111.046 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . 0.498 ' CB ' ' CG1' ' A' ' 329' ' ' VAL . . . -60.29 -36.57 78.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 63.399999999999999 111.102 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.453 HG13 ' CG1' ' A' ' 324' ' ' VAL . 20.0 t -66.37 -33.38 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 71.129999999999995 111.129 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . 0.538 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 2.0 t -83.93 -23.85 30.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 73.340000000000003 110.847 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.508 ' O ' ' CG2' ' A' ' 408' ' ' THR . 13.4 mt -59.9 -57.93 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.262 -0.426 . . . . 61.420000000000002 111.107 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.509 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.7 t -72.1 -36.22 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 60.32 111.07 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -61.79 -22.71 65.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 75.209999999999994 111.086 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . 0.53 HD12 ' CD1' ' A' ' 399' ' ' PHE . 2.2 mm? -104.12 -10.6 17.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 73.5 110.873 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -57.5 119.95 7.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 74.200000000000003 111.076 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.8 m120 44.25 36.53 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 73.129999999999995 110.845 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.53 ' CD1' HD12 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -95.53 141.74 23.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.66 0.743 . . . . 73.530000000000001 110.844 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.462 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.5 Cg_endo -69.76 147.41 62.78 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.622 2.215 . . . . 73.329999999999998 112.372 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' PHE . . . . . 0.527 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 61.2 t80 -154.52 110.79 3.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 74.010000000000005 110.836 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 51.42 33.5 10.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 63.520000000000003 110.886 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 87.57 13.25 65.58 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.724 -0.751 . . . . 71.310000000000002 112.465 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 401' ' ' PHE . 19.3 mtt180 -140.57 135.75 32.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 70.010000000000005 110.882 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -78.93 150.78 32.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 75.230000000000004 110.878 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 11.2 mt -120.3 162.8 18.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.246 -0.434 . . . . 74.519999999999996 110.924 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.39 175.24 5.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 74.549999999999997 110.883 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' THR . . . . . 0.508 ' CG2' ' O ' ' A' ' 393' ' ' ILE . 2.1 p -154.38 155.59 35.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 75.450000000000003 111.179 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 410' ' ' TRP . . . 152.07 129.39 1.49 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.776 -0.726 . . . . 64.040000000000006 112.544 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.512 ' CG ' ' HB1' ' A' ' 336' ' ' ALA . 67.3 m95 -33.83 126.07 0.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 72.239999999999995 110.922 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -48.03 171.75 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 72.430000000000007 112.568 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 414' ' ' ARG . 0.0 OUTLIER -170.89 106.39 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 74.239999999999995 110.927 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 414' ' ' ARG . 2.1 mt-10 -60.0 82.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 72.319999999999993 110.883 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 412' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 71.129999999999995 110.896 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.561 -0.216 . . . . 72.200000000000003 112.561 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.48 122.94 49.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 73.230000000000004 110.837 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -47.32 173.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 60.020000000000003 110.905 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.3 m -96.66 -54.02 3.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 74.329999999999998 111.129 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.46 HG21 ' N ' ' A' ' 319' ' ' GLY . 6.3 tt -162.88 -43.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 72.530000000000001 111.141 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.46 ' N ' HG21 ' A' ' 318' ' ' ILE . . . 96.35 -44.73 1.96 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.73 -0.747 . . . . 70.230000000000004 112.493 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.407 HD13 ' C ' ' A' ' 319' ' ' GLY . 2.4 mp 62.93 81.0 0.23 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.594 0.711 . . . . 73.409999999999997 110.825 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 169.12 19.7 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.708 2.272 . . . . 74.540000000000006 112.327 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.402 ' O ' ' NE2' ' A' ' 323' ' ' GLN . 53.9 Cg_endo -69.67 -50.38 0.48 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.732 2.288 . . . . 74.510000000000005 112.345 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.402 ' NE2' ' O ' ' A' ' 322' ' ' PRO . 30.3 mm-40 -127.62 -70.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 75.209999999999994 110.928 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.433 ' CG2' HG11 ' A' ' 391' ' ' VAL . 7.6 m -123.88 -176.15 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 74.200000000000003 111.145 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.36 121.84 66.97 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.624 0.726 . . . . 75.140000000000001 110.878 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -14.13 35.84 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.661 2.241 . . . . 75.519999999999996 112.411 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.58 -72.08 0.22 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 74.5 110.863 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.33 -24.81 30.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 71.129999999999995 111.05 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.473 ' CG2' ' HB ' ' A' ' 394' ' ' VAL . 19.4 t -76.88 -29.97 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 72.319999999999993 111.1 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -54.61 -40.84 69.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 73.319999999999993 110.878 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -62.7 -32.73 73.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 74.329999999999998 110.912 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.478 ' CG2' HG22 ' A' ' 393' ' ' ILE . 30.9 mm -57.57 -43.49 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 75.200000000000003 111.124 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 18.2 mt -58.23 -32.6 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 75.430000000000007 111.112 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -4.32 11.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 74.530000000000001 110.834 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.69 38.91 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 75.519999999999996 110.901 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . 179.56 164.44 0.78 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.525 0.678 . . . . 71.140000000000001 111.18 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.68 159.66 52.62 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.744 2.296 . . . . 73.219999999999999 112.373 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -24.67 29.41 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.723 2.282 . . . . 73.420000000000002 112.339 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -104.24 73.51 1.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 73.150000000000006 110.854 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.5 p -167.91 128.94 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 75.230000000000004 111.09 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' THR . . . . . 0.457 HG23 ' CA ' ' A' ' 386' ' ' HIS . 19.8 p -137.41 68.07 1.42 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 74.430000000000007 111.093 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 66.4 m -133.87 116.36 15.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.204 -0.453 . . . . 65.230000000000004 111.117 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -86.61 127.01 34.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 75.200000000000003 111.107 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -105.75 135.04 47.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 72.310000000000002 110.886 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 407' ' ' ARG . 1.7 mp -132.94 116.96 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 72.099999999999994 111.179 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -107.01 173.87 19.43 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.681 -0.771 . . . . 62.229999999999997 112.464 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.3 t30 65.68 53.09 1.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.752 0.31 . . . . 74.450000000000003 110.826 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.469 ' CG2' ' HD2' ' A' ' 349' ' ' PRO . 80.0 mt -102.86 138.75 19.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.564 0.697 . . . . 72.019999999999996 111.165 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . 0.469 ' HD2' ' CG2' ' A' ' 348' ' ' ILE . 53.2 Cg_endo -69.78 166.24 28.28 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.7 2.266 . . . . 73.530000000000001 112.325 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -74.18 -22.62 59.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 70.319999999999993 110.888 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.437 ' CE1' ' CB ' ' A' ' 349' ' ' PRO . 2.7 p90 -91.27 27.15 1.99 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 74.25 110.857 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . 0.571 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -111.67 111.91 23.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 43.240000000000002 111.105 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 18.3 p -117.64 168.48 10.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 72.340000000000003 111.15 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.502 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.2 OUTLIER -62.82 -30.43 71.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 73.510000000000005 110.909 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.93 67.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 74.319999999999993 111.096 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.14 -12.93 13.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 71.349999999999994 110.909 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.461 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 2.9 mp -100.51 -51.07 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 73.040000000000006 110.886 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.642 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -40.86 -51.03 7.37 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.641 0.734 . . . . 70.439999999999998 111.106 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.8 Cg_endo -69.67 -31.1 21.61 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.69 2.26 . . . . 75.439999999999998 112.385 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.527 HD22 ' CE1' ' A' ' 401' ' ' PHE . 0.1 OUTLIER -64.47 -27.31 68.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 74.140000000000001 110.889 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 381' ' ' ILE . 86.5 m-85 -95.28 -32.01 13.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 73.329999999999998 110.902 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' GLN . . . . . 0.475 ' N ' HD13 ' A' ' 367' ' ' ILE . 3.7 mt-30 -57.78 -35.55 70.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 75.129999999999995 110.95 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -54.71 -24.17 20.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 72.310000000000002 110.866 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -69.26 -57.75 4.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 74.549999999999997 110.876 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -154.66 -83.45 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.711 -0.757 . . . . 54.329999999999998 112.45 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -153.31 143.48 22.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.343 . . . . 74.519999999999996 110.892 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.475 HD13 ' N ' ' A' ' 362' ' ' GLN . 18.9 mt -121.01 109.16 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 75.019999999999996 111.096 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.29 -16.92 25.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 74.239999999999995 110.92 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -170.35 121.22 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 72.340000000000003 110.884 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 29.9 t80 -114.51 145.41 41.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 72.409999999999997 110.897 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.99 100.65 4.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 75.450000000000003 110.875 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . 0.571 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.4 t-80 -96.5 118.34 32.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 72.340000000000003 110.868 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -109.18 85.21 3.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.699 0.761 . . . . 75.439999999999998 110.949 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . 0.528 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 54.4 Cg_endo -69.7 -17.88 37.59 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.244 . . . . 61.409999999999997 112.369 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.16 -18.29 57.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 72.120000000000005 110.934 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.13 -25.56 7.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 74.329999999999998 110.946 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 91.99 31.11 9.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.782 -0.723 . . . . 64.420000000000002 112.509 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 57.8 m -143.23 154.45 43.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.76 0.314 . . . . 74.420000000000002 110.875 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 19.7 p -143.61 143.79 31.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 75.010000000000005 110.975 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -121.99 139.21 53.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.262 -0.426 . . . . 73.430000000000007 110.906 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -128.58 128.71 68.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 73.099999999999994 111.146 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -93.08 129.53 39.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 75.209999999999994 110.843 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -111.52 -178.61 3.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 73.439999999999998 110.96 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -82.54 -43.91 16.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 71.209999999999994 110.823 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 36.2 p -115.84 166.57 11.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 74.420000000000002 111.115 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' HIS . . . . . 0.457 ' CA ' HG23 ' A' ' 341' ' ' THR . 22.9 p-80 -85.28 -39.57 17.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 71.239999999999995 110.937 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.05 -27.11 63.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 72.340000000000003 110.888 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -52.19 36.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.420000000000002 110.912 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -51.77 -41.19 61.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 70.25 111.082 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -52.42 -34.12 46.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 63.399999999999999 111.094 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.433 HG11 ' CG2' ' A' ' 324' ' ' VAL . 15.0 t -67.42 -43.24 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 71.129999999999995 111.119 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 9.9 t -69.35 -33.65 73.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 73.340000000000003 110.85 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.478 HG22 ' CG2' ' A' ' 332' ' ' ILE . 0.7 OUTLIER -54.0 -54.98 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 61.420000000000002 111.133 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.473 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 0.5 OUTLIER -71.5 -37.52 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 60.32 111.117 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.62 -21.13 66.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 75.209999999999994 111.078 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . 0.538 HD11 ' CE1' ' A' ' 399' ' ' PHE . 1.7 mm? -106.53 -10.93 16.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.259 -0.428 . . . . 73.5 110.861 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -58.9 114.71 2.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.200000000000003 111.091 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . 0.453 ' C ' ' OD1' ' A' ' 405' ' ' ASN . 2.9 t-20 42.7 43.06 3.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 73.129999999999995 110.888 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.568 ' CE1' ' HB2' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -101.18 144.38 28.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.598 0.714 . . . . 73.530000000000001 110.902 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.455 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.8 Cg_endo -69.75 142.04 46.89 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.76 2.307 . . . . 73.329999999999998 112.323 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' PHE . . . . . 0.568 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 75.5 t80 -152.81 110.95 3.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 74.010000000000005 110.907 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . 0.464 ' OE1' ' CZ ' ' A' ' 401' ' ' PHE . 0.4 OUTLIER 53.86 32.6 15.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 63.520000000000003 110.917 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 94.86 -19.84 51.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.776 -0.725 . . . . 71.310000000000002 112.473 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 401' ' ' PHE . 8.6 mmt180 -110.99 141.01 45.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.782 0.325 . . . . 70.010000000000005 110.897 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.453 ' OD1' ' C ' ' A' ' 398' ' ' ASN . 0.5 OUTLIER -86.79 149.91 24.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 75.230000000000004 110.918 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.411 HD21 ' C ' ' A' ' 405' ' ' ASN . 10.1 mt -113.78 171.84 7.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 74.519999999999996 110.941 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 345' ' ' ILE . 1.1 tpt85 -123.41 179.19 4.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 74.549999999999997 110.838 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' THR . . . . . . . . . . . . . 33.9 p -155.88 170.07 22.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 75.450000000000003 111.189 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 410' ' ' TRP . . . 151.64 42.77 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.776 -0.726 . . . . 64.040000000000006 112.48 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.438 ' O ' ' O ' ' A' ' 409' ' ' GLY . 58.8 m95 57.34 153.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.771 0.32 . . . . 72.239999999999995 110.96 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -54.02 169.36 1.31 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.721 . . . . 72.430000000000007 112.426 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.65 179.65 7.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.777 0.322 . . . . 74.239999999999995 110.911 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -96.44 -59.62 1.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 72.319999999999993 110.867 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 71.129999999999995 110.913 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.495 -0.242 . . . . 72.200000000000003 112.495 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 34.3 m -81.1 89.11 5.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.752 0.311 . . . . 73.230000000000004 110.842 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -109.3 132.51 54.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 60.020000000000003 110.941 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 48.1 m -57.71 -54.58 45.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 74.329999999999998 111.152 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 3.8 tp -174.36 133.46 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 72.530000000000001 111.096 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -67.77 -71.82 0.89 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.71 -0.757 . . . . 70.230000000000004 112.531 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 5.0 mt 52.76 71.29 1.49 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.652 0.739 . . . . 73.409999999999997 110.934 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 141.25 44.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.648 2.232 . . . . 74.540000000000006 112.325 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -25.24 28.96 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.647 2.232 . . . . 74.510000000000005 112.373 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -142.4 127.88 18.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 75.209999999999994 110.917 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 32.5 m -51.77 -173.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 74.200000000000003 111.107 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -76.37 119.81 78.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.57 0.7 . . . . 75.140000000000001 110.85 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -14.4 36.12 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.596 2.197 . . . . 75.519999999999996 112.363 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.62 -71.44 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 74.5 110.897 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -57.63 -26.28 61.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 71.129999999999995 111.094 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.509 ' CG2' ' HB ' ' A' ' 394' ' ' VAL . 16.1 t -78.74 -29.93 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 72.319999999999993 111.146 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -54.13 -38.85 65.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 73.319999999999993 110.876 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -65.6 -31.82 73.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 74.329999999999998 110.808 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.449 HG22 ' NE1' ' A' ' 410' ' ' TRP . 46.1 mm -55.55 -48.95 76.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 75.200000000000003 111.092 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 8.8 mt -55.06 -32.1 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 75.430000000000007 111.201 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.75 -7.19 7.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 74.530000000000001 110.942 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 23.0 t -102.63 11.62 37.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 75.519999999999996 110.884 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -158.78 150.02 16.51 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.596 0.713 . . . . 71.140000000000001 111.104 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 164.46 34.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.736 2.291 . . . . 73.219999999999999 112.341 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -11.68 31.33 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.625 2.217 . . . . 73.420000000000002 112.398 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -101.21 55.05 0.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 73.150000000000006 110.905 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.8 p -168.79 126.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 75.230000000000004 111.144 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 21.7 p -142.61 70.95 1.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 74.430000000000007 111.188 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 54.5 m -133.72 123.87 25.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 65.230000000000004 111.124 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -89.97 134.4 34.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 75.200000000000003 111.133 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.454 ' CD1' ' C ' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -114.14 134.38 54.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 72.310000000000002 110.932 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.472 HG22 ' CD1' ' A' ' 348' ' ' ILE . 1.7 mp -132.07 113.22 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.504 . . . . 72.099999999999994 111.148 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -103.89 168.73 17.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.761 . . . . 62.229999999999997 112.501 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 405' ' ' ASN . 2.3 t30 72.22 54.19 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 74.450000000000003 110.958 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.493 ' CD1' ' SG ' ' A' ' 379' ' ' CYS . 87.7 mt -108.45 138.87 20.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.564 0.697 . . . . 72.019999999999996 111.178 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . 0.552 ' HB2' ' CD2' ' A' ' 351' ' ' PHE . 53.3 Cg_endo -69.85 164.89 32.96 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.714 2.276 . . . . 73.530000000000001 112.313 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -77.49 -10.96 59.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 70.319999999999993 110.829 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.552 ' CD2' ' HB2' ' A' ' 349' ' ' PRO . 31.8 p90 -97.38 1.21 49.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 74.25 110.927 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . 0.409 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -89.29 111.85 22.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 43.240000000000002 111.049 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 74.2 p -112.06 173.51 6.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.18 -0.464 . . . . 72.340000000000003 111.106 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.482 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -67.01 -29.53 69.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 73.510000000000005 110.866 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -59.02 -26.38 64.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 74.319999999999993 111.159 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.27 -15.62 13.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 71.349999999999994 110.861 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.442 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.8 mp -94.77 -51.03 4.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 73.040000000000006 110.883 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.669 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.2 mm -43.89 -49.87 20.24 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.677 0.751 . . . . 70.439999999999998 111.184 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.7 Cg_endo -69.83 -20.41 34.56 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.672 2.248 . . . . 75.439999999999998 112.352 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.583 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -77.99 -25.39 48.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 74.140000000000001 110.968 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.517 ' CD2' HD13 ' A' ' 360' ' ' LEU . 85.7 m-85 -98.76 -30.08 12.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.329999999999998 110.941 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -57.64 -42.98 84.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 75.129999999999995 110.912 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -47.02 -21.67 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 72.310000000000002 110.901 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -71.98 -54.49 9.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 74.549999999999997 110.922 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -161.39 -85.62 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.74 -0.743 . . . . 54.329999999999998 112.456 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -153.56 142.29 20.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.775 0.321 . . . . 74.519999999999996 110.86 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.405 HD13 ' CG2' ' A' ' 381' ' ' ILE . 40.3 mt -120.78 109.46 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 75.019999999999996 111.208 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.75 -17.52 38.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.466 . . . . 74.239999999999995 110.964 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.72 121.33 0.58 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 72.340000000000003 110.9 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.565 ' CE1' ' HB3' ' A' ' 379' ' ' CYS . 25.2 t80 -114.97 123.54 49.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 72.409999999999997 110.858 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.19 99.2 7.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 75.450000000000003 110.877 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 3.4 t-80 -95.29 120.6 35.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.436 . . . . 72.340000000000003 110.878 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -113.96 92.28 25.29 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.7 0.762 . . . . 75.439999999999998 110.916 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -18.2 37.43 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.692 2.261 . . . . 61.409999999999997 112.375 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -78.18 -37.11 46.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 72.120000000000005 110.841 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -99.79 -18.01 17.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 74.329999999999998 110.897 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 75.07 43.67 25.83 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.764 -0.731 . . . . 64.420000000000002 112.468 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 1.6 p -151.93 143.45 23.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.758 0.313 . . . . 74.420000000000002 110.962 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.565 ' HB3' ' CE1' ' A' ' 370' ' ' PHE . 61.3 m -124.3 153.34 41.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 75.010000000000005 110.947 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -130.47 104.26 7.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 73.430000000000007 110.85 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.487 ' CG1' ' CD1' ' A' ' 370' ' ' PHE . 0.5 OUTLIER -105.0 129.24 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 73.099999999999994 111.155 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -102.01 136.83 41.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 75.209999999999994 110.923 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -118.18 172.34 7.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 73.439999999999998 110.931 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.62 -37.3 59.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 71.209999999999994 110.857 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 59.3 p -115.96 169.83 8.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 74.420000000000002 111.154 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -85.64 -38.93 17.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 71.239999999999995 110.939 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -60.54 -30.18 69.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 110.929 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -62.17 -38.57 89.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 75.420000000000002 110.852 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -75.94 -33.62 59.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 70.25 111.168 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . 0.466 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -55.91 -35.37 66.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 63.399999999999999 111.066 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 25.6 t -69.13 -46.62 77.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 71.129999999999995 111.057 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 48.8 t -56.18 -31.1 63.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 73.340000000000003 110.933 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . . . . . . . . . 1.1 mt -59.8 -56.36 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 61.420000000000002 111.154 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.509 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.1 t -71.68 -38.48 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 60.32 111.154 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -58.56 -48.07 82.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 75.209999999999994 111.099 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . 0.562 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.9 mm? -85.48 -10.35 56.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 73.5 110.865 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' ALA . . . . . 0.461 ' N ' HG21 ' A' ' 408' ' ' THR . . . -50.66 108.44 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 74.200000000000003 111.086 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 42.99 43.45 3.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 73.129999999999995 110.916 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.562 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -96.75 145.5 29.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.696 0.76 . . . . 73.530000000000001 110.884 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 144.13 52.93 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.647 2.231 . . . . 73.329999999999998 112.39 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' PHE . . . . . 0.517 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 41.9 t80 -151.03 113.23 4.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 74.010000000000005 110.887 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 49.47 32.93 5.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 63.520000000000003 110.871 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.6 -28.36 15.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 71.310000000000002 112.51 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.425 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.9 OUTLIER -105.52 141.05 37.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.361 . . . . 70.010000000000005 110.847 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.448 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 14.3 m120 -82.68 154.92 24.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 75.230000000000004 110.923 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.424 ' CD1' HG21 ' A' ' 345' ' ' ILE . 10.9 mt -114.35 173.8 6.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 74.519999999999996 110.892 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 346' ' ' GLY . 0.0 OUTLIER -113.92 171.93 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 74.549999999999997 110.89 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' THR . . . . . 0.521 ' CG2' ' C ' ' A' ' 396' ' ' LEU . 64.3 p -154.18 154.19 33.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 75.450000000000003 111.098 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 410' ' ' TRP . . . 147.3 127.99 1.81 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 64.040000000000006 112.508 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.464 ' C ' ' O ' ' A' ' 409' ' ' GLY . 57.7 m95 -33.0 131.06 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.838 0.351 . . . . 72.239999999999995 110.951 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -145.69 164.24 28.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.807 -0.711 . . . . 72.430000000000007 112.483 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.77 150.93 41.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 74.239999999999995 110.898 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.88 79.54 2.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.416 . . . . 72.319999999999993 110.851 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 71.129999999999995 110.88 -179.958 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.476 -0.249 . . . . 72.200000000000003 112.476 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 38.6 t -127.67 -53.86 1.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.83 0.348 . . . . 73.230000000000004 110.835 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 176.36 109.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 60.020000000000003 110.953 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 10.0 t -150.44 145.99 26.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 111.161 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.1 tp -133.97 125.87 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 72.530000000000001 111.077 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.13 -66.36 1.35 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.788 -0.72 . . . . 70.230000000000004 112.513 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 2.3 mt 66.04 75.67 0.32 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.602 0.715 . . . . 73.409999999999997 110.917 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 160.2 50.58 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.683 2.256 . . . . 74.540000000000006 112.335 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -36.14 11.44 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.746 2.297 . . . . 74.510000000000005 112.345 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.65 -63.49 0.74 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 75.209999999999994 110.908 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.463 ' CG1' HG12 ' A' ' 391' ' ' VAL . 1.4 p -156.37 148.22 11.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 74.200000000000003 111.043 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -50.39 109.14 1.19 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.66 0.743 . . . . 75.140000000000001 110.9 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -14.34 36.11 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.656 2.237 . . . . 75.519999999999996 112.319 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -74.94 -71.62 0.34 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 74.5 110.862 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -49.28 -24.3 1.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 71.129999999999995 111.064 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.49 ' CG2' ' HB ' ' A' ' 394' ' ' VAL . 10.8 t -80.89 -29.18 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 72.319999999999993 111.146 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -53.42 -37.72 62.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.108 -0.496 . . . . 73.319999999999993 110.876 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -66.07 -31.63 72.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 74.329999999999998 110.796 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 27.4 mm -56.36 -47.74 80.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 75.200000000000003 111.098 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 9.5 mt -54.12 -26.16 14.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 75.430000000000007 111.051 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.66 2.11 5.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 74.530000000000001 110.926 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.69 31.79 6.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 75.519999999999996 110.868 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -174.32 151.15 1.6 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.535 0.684 . . . . 71.140000000000001 111.104 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.74 169.93 17.74 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.677 2.251 . . . . 73.219999999999999 112.353 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.84 -9.2 25.5 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.609 2.206 . . . . 73.420000000000002 112.356 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -115.41 64.1 0.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 73.150000000000006 110.899 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 7.9 p -160.38 129.19 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 75.230000000000004 111.073 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.96 69.2 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 111.102 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.473 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 45.0 m -131.42 108.88 9.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 65.230000000000004 111.224 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -80.28 111.3 16.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 75.200000000000003 111.061 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.571 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -93.78 118.8 31.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 72.310000000000002 110.953 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . . . . . . . . . 1.9 mp -119.47 117.52 54.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 72.099999999999994 111.15 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -107.98 -173.3 21.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.706 -0.759 . . . . 62.229999999999997 112.521 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.95 47.52 12.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.807 0.337 . . . . 74.450000000000003 110.895 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 34.2 mt -99.43 132.62 22.93 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.658 0.742 . . . . 72.019999999999996 111.163 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . 0.489 ' CG ' ' CE1' ' A' ' 351' ' ' PHE . 53.6 Cg_endo -69.82 161.89 44.22 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.621 2.214 . . . . 73.530000000000001 112.328 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -69.01 -21.01 64.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 70.319999999999993 110.813 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.489 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 7.1 p90 -90.85 30.74 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 74.25 110.878 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -116.23 124.82 51.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 43.240000000000002 111.098 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 14.3 p -126.54 167.71 15.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 72.340000000000003 111.128 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.49 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -64.99 -34.06 77.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 73.510000000000005 110.876 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.23 -26.35 50.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 111.128 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.27 -13.12 13.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 71.349999999999994 110.865 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.436 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.5 mp -99.52 -54.21 3.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 73.040000000000006 110.895 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.611 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -39.81 -52.07 5.18 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.692 0.758 . . . . 70.439999999999998 111.199 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.2 Cg_endo -69.72 -39.51 6.49 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.612 2.208 . . . . 75.439999999999998 112.353 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.581 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -53.85 -25.36 19.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 74.140000000000001 110.87 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.471 ' HA ' ' CD2' ' A' ' 364' ' ' PHE . 85.5 m-85 -95.78 -37.22 10.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 73.329999999999998 110.894 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' GLN . . . . . 0.474 ' HG2' ' CD1' ' A' ' 367' ' ' ILE . 3.8 mt-30 -50.01 -46.46 52.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 75.129999999999995 110.879 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . 0.423 ' C ' ' OD1' ' A' ' 363' ' ' ASN . 0.6 OUTLIER -44.46 -25.08 0.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 72.310000000000002 110.79 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . 0.539 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 30.5 m-85 -70.1 -60.24 2.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 74.549999999999997 110.841 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -150.42 -86.64 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.79 -0.719 . . . . 54.329999999999998 112.511 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 368' ' ' LEU . 11.8 t80 -153.43 141.61 20.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.786 0.327 . . . . 74.519999999999996 110.898 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.474 ' CD1' ' HG2' ' A' ' 362' ' ' GLN . 23.9 mt -120.36 113.48 40.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 75.019999999999996 111.101 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 369' ' ' ASP . 2.7 pp -100.45 -14.84 18.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 74.239999999999995 110.862 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.49 ' N ' HD12 ' A' ' 368' ' ' LEU . 10.0 t0 -167.67 120.81 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 72.340000000000003 110.836 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 28.4 t80 -117.54 134.85 54.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 72.409999999999997 110.9 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -120.56 101.5 7.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 75.450000000000003 110.891 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -97.49 135.7 38.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 72.340000000000003 110.906 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -130.75 85.69 54.86 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 121.649 0.738 . . . . 75.439999999999998 110.967 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -22.58 31.73 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.638 2.226 . . . . 61.409999999999997 112.349 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -72.93 -19.39 61.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 72.120000000000005 110.911 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.49 -27.57 6.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 74.329999999999998 110.91 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 89.8 43.82 5.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.715 -0.755 . . . . 64.420000000000002 112.492 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 43.6 m -155.93 149.2 24.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.774 0.321 . . . . 74.420000000000002 110.886 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 15.5 p -140.79 144.14 35.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 75.010000000000005 110.909 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.473 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 18.9 m-85 -122.86 128.81 50.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 73.430000000000007 110.877 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.471 HD13 ' CE1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -117.92 119.37 61.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 73.099999999999994 111.124 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -88.39 127.07 35.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 75.209999999999994 110.94 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -106.08 171.59 7.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.428 . . . . 73.439999999999998 110.946 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -65.29 -37.5 87.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.093 -0.503 . . . . 71.209999999999994 110.897 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 58.6 p -130.12 178.02 6.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 74.420000000000002 111.179 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -83.21 -39.42 20.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 71.239999999999995 110.869 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -57.97 -27.1 63.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 72.340000000000003 110.877 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -37.18 77.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 75.420000000000002 110.858 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -75.77 -36.6 59.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 70.25 111.086 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . 0.479 ' CB ' ' CG1' ' A' ' 329' ' ' VAL . . . -55.34 -32.95 62.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 63.399999999999999 111.061 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.463 HG12 ' CG1' ' A' ' 324' ' ' VAL . 40.2 t -68.09 -55.57 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 71.129999999999995 111.105 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . 0.539 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 2.1 t -64.29 -26.1 68.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 73.340000000000003 110.881 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 408' ' ' THR . 5.6 mt -57.06 -57.2 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 61.420000000000002 111.135 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.49 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.5 t -73.06 -40.3 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 60.32 111.16 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -53.6 -51.47 62.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 75.209999999999994 111.102 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . 0.606 ' CB ' ' CG2' ' A' ' 408' ' ' THR . 1.9 mm? -75.46 -12.63 60.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 73.5 110.951 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' ALA . . . . . 0.462 ' N ' HG23 ' A' ' 408' ' ' THR . . . -50.49 112.9 0.76 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 74.200000000000003 111.076 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 54.8 t30 41.97 49.85 4.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.129999999999995 110.855 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.567 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -105.78 146.58 33.12 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.69 0.757 . . . . 73.530000000000001 110.825 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.8 137.47 35.42 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.679 2.253 . . . . 73.329999999999998 112.362 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' PHE . . . . . 0.526 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 33.8 t80 -141.83 110.78 6.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.010000000000005 110.912 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 49.11 32.71 4.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 63.520000000000003 110.886 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.45 -29.18 13.06 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.669 -0.776 . . . . 71.310000000000002 112.477 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.431 ' O ' ' N ' ' A' ' 401' ' ' PHE . 24.7 ttt85 -107.11 139.1 42.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.321 . . . . 70.010000000000005 110.866 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -79.18 155.19 28.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 75.230000000000004 110.829 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 21.9 mt -118.97 170.32 9.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 74.519999999999996 110.884 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.42 175.59 5.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 74.549999999999997 110.824 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' THR . . . . . 0.606 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 75.5 p -154.05 155.51 35.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 75.450000000000003 111.144 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 157.24 174.27 26.72 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.811 -0.709 . . . . 64.040000000000006 112.55 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -81.02 147.19 30.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.899 0.38 . . . . 72.239999999999995 110.881 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -142.98 136.3 6.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 72.430000000000007 112.488 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 414' ' ' ARG . 4.6 mttt -135.15 78.91 1.76 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.752 0.311 . . . . 74.239999999999995 110.899 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 412' ' ' LYS . 0.1 OUTLIER 36.8 31.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 72.319999999999993 110.92 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 412' ' ' LYS . 7.5 mtp180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 71.129999999999995 110.872 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.479 -0.248 . . . . 72.200000000000003 112.479 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 80.9 p -160.08 140.7 11.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 73.230000000000004 110.877 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 74.9 -69.91 0.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 60.020000000000003 110.911 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 81.4 m -59.27 88.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 74.329999999999998 111.132 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.438 HG13 ' N ' ' A' ' 319' ' ' GLY . 0.9 OUTLIER -114.73 141.13 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 72.530000000000001 111.098 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.438 ' N ' HG13 ' A' ' 318' ' ' ILE . . . -92.08 -50.94 2.52 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.724 -0.75 . . . . 70.230000000000004 112.462 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 58.94 84.18 0.2 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.649 0.737 . . . . 73.409999999999997 110.973 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.87 150.04 67.0 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.669 2.246 . . . . 74.540000000000006 112.37 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 3.13 2.97 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.679 2.253 . . . . 74.510000000000005 112.26 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.74 -70.79 0.66 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 75.209999999999994 110.953 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.417 ' CG2' HG12 ' A' ' 394' ' ' VAL . 2.7 p -155.12 176.84 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 74.200000000000003 111.137 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -80.02 111.68 23.91 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.647 0.737 . . . . 75.140000000000001 110.917 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -13.87 35.31 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.68 2.253 . . . . 75.519999999999996 112.388 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -70.12 -72.28 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 74.5 110.89 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -57.19 -24.87 57.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 71.129999999999995 111.074 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.481 ' CG2' ' HB ' ' A' ' 394' ' ' VAL . 23.4 t -76.66 -29.81 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 72.319999999999993 111.068 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -54.49 -37.75 65.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 73.319999999999993 110.84 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -62.82 -31.93 73.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 74.329999999999998 110.846 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.528 ' CG2' ' NE1' ' A' ' 410' ' ' TRP . 15.3 mm -65.25 -41.83 92.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 75.200000000000003 111.114 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 31.8 mt -52.29 -48.91 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 75.430000000000007 111.059 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.34 -7.03 5.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 74.530000000000001 110.879 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 3.1 t -82.43 -31.92 29.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 75.519999999999996 110.854 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -116.87 153.97 49.46 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.636 0.732 . . . . 71.140000000000001 111.066 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 158.88 55.41 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.708 2.272 . . . . 73.219999999999999 112.31 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -7.46 21.1 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.716 2.278 . . . . 73.420000000000002 112.338 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -101.86 51.0 0.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 73.150000000000006 110.848 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.7 p -175.9 128.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 75.230000000000004 111.157 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' THR . . . . . 0.413 HG22 ' C ' ' A' ' 385' ' ' THR . 20.4 p -137.1 67.92 1.43 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 74.430000000000007 111.207 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 23.3 m -133.76 137.0 44.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 65.230000000000004 111.152 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -100.18 129.47 46.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 75.200000000000003 111.101 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.441 ' HB3' ' C ' ' A' ' 410' ' ' TRP . 0.0 OUTLIER -106.28 135.08 48.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 72.310000000000002 110.882 -179.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.439 HG21 ' CD1' ' A' ' 406' ' ' LEU . 1.7 mp -131.87 117.68 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 72.099999999999994 111.12 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -106.59 161.62 13.97 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.748 -0.739 . . . . 62.229999999999997 112.472 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 0.6 OUTLIER 79.24 49.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 74.450000000000003 110.937 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.454 ' CG2' ' HD2' ' A' ' 349' ' ' PRO . 64.8 mt -103.76 137.72 19.32 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.581 0.705 . . . . 72.019999999999996 111.13 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . 0.564 ' HB2' ' CD1' ' A' ' 351' ' ' PHE . 53.6 Cg_endo -69.75 165.09 32.11 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.714 2.276 . . . . 73.530000000000001 112.307 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -75.88 -17.1 59.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 70.319999999999993 110.846 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.564 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 27.1 p90 -99.05 24.11 8.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 74.25 110.886 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -107.87 93.16 4.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 43.240000000000002 111.17 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 46.2 p -90.54 173.51 8.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 72.340000000000003 111.173 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.485 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -66.96 -29.77 69.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 73.510000000000005 110.824 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.01 -26.11 47.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 74.319999999999993 111.111 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.81 -13.74 13.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 71.349999999999994 110.89 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.431 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.4 mp -98.56 -54.38 3.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 73.040000000000006 110.895 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.636 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -40.88 -51.59 7.1 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.684 0.754 . . . . 70.439999999999998 111.134 179.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.1 Cg_endo -69.85 -34.08 15.0 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.656 2.237 . . . . 75.439999999999998 112.305 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.586 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -61.14 -23.49 65.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 74.140000000000001 110.944 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.569 ' CD2' HD13 ' A' ' 360' ' ' LEU . 81.4 m-85 -102.88 -33.67 9.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 73.329999999999998 110.912 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' GLN . . . . . 0.475 ' N ' HD13 ' A' ' 367' ' ' ILE . 0.1 OUTLIER -58.77 -32.72 69.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.5 . . . . 75.129999999999995 110.984 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -59.24 -11.25 3.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 72.310000000000002 110.924 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . 0.57 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 31.3 m-85 -81.01 -60.12 2.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 74.549999999999997 110.87 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -149.01 -84.03 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.782 -0.723 . . . . 54.329999999999998 112.492 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -152.64 143.61 23.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 74.519999999999996 110.852 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.475 HD13 ' N ' ' A' ' 362' ' ' GLN . 55.5 mt -121.0 109.28 24.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 75.019999999999996 111.126 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.02 -17.66 24.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.947 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -171.15 121.15 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 72.340000000000003 110.863 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.552 ' CD2' HG12 ' A' ' 358' ' ' ILE . 34.6 t80 -113.61 143.42 44.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 72.409999999999997 110.946 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.55 101.17 5.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 75.450000000000003 110.946 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . 0.535 ' CE1' ' HB3' ' A' ' 374' ' ' PRO . 11.2 t-80 -94.61 114.48 26.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 72.340000000000003 110.814 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -107.7 84.12 1.86 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.631 0.729 . . . . 75.439999999999998 110.874 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . 0.535 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 53.6 Cg_endo -69.79 -28.6 24.91 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.661 2.24 . . . . 61.409999999999997 112.355 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -63.44 -19.58 64.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 72.120000000000005 110.921 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.8 -21.7 7.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 74.329999999999998 110.945 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 87.33 38.33 7.79 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.776 -0.726 . . . . 64.420000000000002 112.475 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 19.1 p -147.15 153.63 40.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.764 0.316 . . . . 74.420000000000002 110.941 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 7.2 p -139.35 151.12 46.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 75.010000000000005 110.882 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -131.14 122.73 27.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 73.430000000000007 110.888 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.488 ' CD1' ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -114.28 126.3 71.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 73.099999999999994 111.08 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 10.2 mttp -90.6 133.86 34.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 75.209999999999994 110.877 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -116.21 -178.55 3.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 73.439999999999998 110.996 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.45 -46.3 16.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 71.209999999999994 110.857 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' THR . . . . . 0.413 ' C ' HG22 ' A' ' 341' ' ' THR . 68.0 p -114.83 170.66 8.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 74.420000000000002 111.232 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -85.64 -44.43 12.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 71.239999999999995 110.838 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -57.18 -32.9 66.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 72.340000000000003 110.868 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -67.88 -32.56 73.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 75.420000000000002 110.888 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -67.1 -39.32 86.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 70.25 111.114 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . 0.424 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -59.19 -27.88 66.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 63.399999999999999 111.097 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.58 -40.94 88.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 71.129999999999995 111.158 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . 0.57 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 1.5 t -77.78 -27.1 50.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 73.340000000000003 110.935 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.434 ' O ' ' CG2' ' A' ' 408' ' ' THR . 1.2 mp -54.99 -56.67 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 61.420000000000002 111.078 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.481 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 0.9 OUTLIER -73.06 -45.86 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 60.32 111.067 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -52.87 -21.67 4.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 75.209999999999994 111.076 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . 0.557 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.2 mm? -106.5 -19.27 13.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 73.5 110.945 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -48.76 114.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 74.200000000000003 111.142 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 44.26 46.89 7.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 73.129999999999995 110.855 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.557 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -107.03 144.79 29.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.632 0.73 . . . . 73.530000000000001 110.848 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.502 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.5 Cg_endo -69.85 145.23 56.04 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.672 2.248 . . . . 73.329999999999998 112.333 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' PHE . . . . . 0.554 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 64.6 t80 -152.34 111.81 3.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 74.010000000000005 110.908 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.63 33.36 8.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 63.520000000000003 110.932 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.4 -27.78 17.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 71.310000000000002 112.513 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.482 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -104.75 141.9 35.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.318 . . . . 70.010000000000005 110.895 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -86.99 145.15 26.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 75.230000000000004 110.936 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.439 ' CD1' HG21 ' A' ' 345' ' ' ILE . 8.8 mt -107.03 179.88 4.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.239 -0.437 . . . . 74.519999999999996 110.905 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 345' ' ' ILE . 13.5 ttt85 -130.45 177.48 7.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 74.549999999999997 110.88 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' THR . . . . . 0.434 ' CG2' ' O ' ' A' ' 393' ' ' ILE . 17.2 p -156.13 163.48 39.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 75.450000000000003 111.124 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 410' ' ' TRP . . . 157.22 42.46 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 64.040000000000006 112.474 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.528 ' NE1' ' CG2' ' A' ' 332' ' ' ILE . 68.1 m95 58.69 147.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.845 0.355 . . . . 72.239999999999995 110.897 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -41.0 103.76 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.757 -0.735 . . . . 72.430000000000007 112.532 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 413' ' ' GLU . 0.0 OUTLIER -127.64 122.55 33.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.736 0.303 . . . . 74.239999999999995 110.928 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 412' ' ' LYS . 7.9 pt-20 -38.3 -52.35 1.51 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 72.319999999999993 110.904 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 71.129999999999995 110.907 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.504 -0.238 . . . . 72.200000000000003 112.504 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.51 143.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 73.230000000000004 110.823 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -128.66 143.62 50.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 60.020000000000003 110.896 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' THR . . . . . 0.448 ' O ' ' CB ' ' A' ' 318' ' ' ILE . 12.1 p -125.34 44.33 2.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 74.329999999999998 111.165 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.448 ' CB ' ' O ' ' A' ' 317' ' ' THR . 0.0 OUTLIER 82.16 147.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 72.530000000000001 111.081 179.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -134.21 -41.27 0.16 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 70.230000000000004 112.55 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.42 ' N ' ' CD ' ' A' ' 321' ' ' PRO . 8.1 mt 50.6 55.81 16.86 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.6 0.714 . . . . 73.409999999999997 110.947 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 320' ' ' LEU . 54.1 Cg_endo -69.76 167.15 25.26 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.678 2.252 . . . . 74.540000000000006 112.339 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -27.29 26.34 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.627 2.218 . . . . 74.510000000000005 112.337 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -137.95 -92.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 75.209999999999994 110.918 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.478 HG13 ' CB ' ' A' ' 395' ' ' ALA . 30.3 m -121.06 -171.76 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 74.200000000000003 111.15 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -97.64 119.22 63.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.673 0.749 . . . . 75.140000000000001 110.904 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -14.11 35.61 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.728 2.286 . . . . 75.519999999999996 112.349 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -68.41 -71.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 74.5 110.945 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.66 -32.85 59.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 71.129999999999995 111.065 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.485 ' CG2' ' HB ' ' A' ' 394' ' ' VAL . 11.1 t -70.95 -29.53 37.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 72.319999999999993 111.128 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -53.99 -34.85 60.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 73.319999999999993 110.915 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -68.29 -31.95 71.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 74.329999999999998 110.854 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.481 HG22 ' NE1' ' A' ' 410' ' ' TRP . 37.5 mm -57.05 -51.5 68.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 75.200000000000003 111.102 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.511 HG22 ' CD2' ' A' ' 386' ' ' HIS . 4.0 mt -55.19 -27.76 20.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 75.430000000000007 111.11 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.71 -12.7 55.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 74.530000000000001 110.893 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.43 27.1 9.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 75.519999999999996 110.887 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.56 ' HB2' ' CD1' ' A' ' 410' ' ' TRP . . . -169.41 148.93 3.6 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.472 0.653 . . . . 71.140000000000001 111.159 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 165.54 30.69 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.69 2.26 . . . . 73.219999999999999 112.314 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -15.67 37.02 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.645 2.23 . . . . 73.420000000000002 112.363 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -106.01 55.75 0.67 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 73.150000000000006 110.917 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.472 ' CG1' ' O ' ' A' ' 340' ' ' VAL . 14.4 p -156.1 95.24 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 75.230000000000004 111.117 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' THR . . . . . 0.422 HG22 ' C ' ' A' ' 385' ' ' THR . 18.7 p -113.34 67.73 0.67 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.479 . . . . 74.430000000000007 111.133 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.438 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 34.5 m -134.11 128.85 34.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 65.230000000000004 111.159 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -96.82 126.23 41.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 75.200000000000003 111.11 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.3 133.16 48.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 72.310000000000002 110.944 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.506 HD12 ' CE1' ' A' ' 361' ' ' PHE . 2.0 mp -126.72 125.93 67.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 72.099999999999994 111.171 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -111.65 166.69 12.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.684 -0.77 . . . . 62.229999999999997 112.473 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 6.2 t30 65.03 57.88 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.771 0.319 . . . . 74.450000000000003 110.904 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.473 ' CD1' HG21 ' A' ' 345' ' ' ILE . 97.0 mt -106.64 133.9 20.06 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.629 0.728 . . . . 72.019999999999996 111.096 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 166.51 27.29 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.635 2.224 . . . . 73.530000000000001 112.386 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -71.77 -26.52 62.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 70.319999999999993 110.824 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -85.51 18.12 2.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 74.25 110.889 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . 0.537 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -101.14 101.81 12.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 43.240000000000002 111.086 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 21.1 p -109.55 169.57 8.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 72.340000000000003 111.084 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.5 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.7 OUTLIER -63.46 -29.75 70.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.161 -0.472 . . . . 73.510000000000005 110.907 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -61.94 -25.81 67.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 74.319999999999993 111.084 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.98 -16.2 13.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 71.349999999999994 110.84 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.439 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 4.4 mp -96.7 -49.42 5.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 73.040000000000006 110.939 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.658 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.2 mm -42.94 -50.46 13.52 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.619 0.723 . . . . 70.439999999999998 111.204 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.8 Cg_endo -69.75 -37.8 8.7 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.737 2.291 . . . . 75.439999999999998 112.35 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.571 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -58.06 -25.35 61.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.445 . . . . 74.140000000000001 110.919 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.543 ' CD1' ' CD1' ' A' ' 360' ' ' LEU . 74.1 m-85 -101.62 -38.3 7.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 73.329999999999998 110.945 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -51.36 -37.96 50.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 75.129999999999995 110.895 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -19.38 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 72.310000000000002 110.852 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . 0.569 ' CE2' ' SG ' ' A' ' 392' ' ' CYS . 30.3 m-85 -72.3 -54.54 9.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 74.549999999999997 110.89 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -158.5 -84.69 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.795 -0.717 . . . . 54.329999999999998 112.501 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -153.51 143.1 21.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.815 0.34 . . . . 74.519999999999996 110.893 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . . . . . . . . . 54.1 mt -120.93 109.4 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 75.019999999999996 111.122 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.54 -19.13 29.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 74.239999999999995 110.946 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.48 121.31 0.6 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 72.340000000000003 110.891 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 31.7 t80 -112.73 143.02 44.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 72.409999999999997 110.919 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -128.64 101.64 6.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 75.450000000000003 110.858 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . 0.567 ' CE1' ' HD3' ' A' ' 374' ' ' PRO . 7.9 t-80 -99.05 135.42 40.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 72.340000000000003 110.816 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -129.17 89.91 46.73 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.712 0.768 . . . . 75.439999999999998 110.9 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . 0.567 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.6 Cg_endo -69.78 -20.99 34.02 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.706 2.271 . . . . 61.409999999999997 112.315 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -74.9 -25.81 59.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 72.120000000000005 110.844 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -113.55 -12.32 12.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 74.329999999999998 110.857 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 72.28 43.2 47.53 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.722 -0.752 . . . . 64.420000000000002 112.486 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 15.6 p -150.45 152.74 34.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.33 . . . . 74.420000000000002 110.898 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 14.6 p -146.66 152.75 39.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 75.010000000000005 110.851 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.438 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 54.3 m-85 -131.06 122.5 26.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 73.430000000000007 110.816 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.435 HD11 ' CG ' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -109.36 126.32 66.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 73.099999999999994 111.113 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -92.88 131.08 38.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 75.209999999999994 110.853 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -112.34 -174.42 2.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 73.439999999999998 110.849 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.75 -46.62 9.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 71.209999999999994 110.888 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' THR . . . . . 0.422 ' C ' HG22 ' A' ' 341' ' ' THR . 61.1 p -115.23 161.91 17.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 74.420000000000002 111.137 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' HIS . . . . . 0.754 ' CE1' ' CH2' ' A' ' 410' ' ' TRP . 75.0 t60 -79.58 -39.76 30.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 71.239999999999995 110.882 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.32 -32.74 68.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 72.340000000000003 110.798 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -66.37 -36.99 84.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 75.420000000000002 110.928 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -68.05 -45.78 72.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 70.25 111.074 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -50.06 -30.02 10.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 63.399999999999999 111.11 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 70.5 t -68.94 -50.72 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 71.129999999999995 111.125 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . 0.569 ' SG ' ' CE2' ' A' ' 364' ' ' PHE . 1.9 t -58.92 -26.38 64.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 73.340000000000003 110.882 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.64 -56.26 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 61.420000000000002 111.182 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.485 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.1 t -72.03 -46.91 57.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 60.32 111.094 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . 0.478 ' CB ' HG13 ' A' ' 324' ' ' VAL . . . -60.89 -45.17 95.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 75.209999999999994 111.094 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . 0.567 ' HG ' ' CD1' ' A' ' 399' ' ' PHE . 0.3 OUTLIER -85.01 -4.89 59.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 73.5 110.9 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' ALA . . . . . 0.45 ' O ' ' CG ' ' A' ' 398' ' ' ASN . . . -58.4 115.24 2.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 74.200000000000003 111.085 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . 0.45 ' CG ' ' O ' ' A' ' 397' ' ' ALA . 3.3 p-10 48.25 41.09 15.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 73.129999999999995 110.907 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.567 ' CD1' ' HG ' ' A' ' 396' ' ' LEU . 0.2 OUTLIER -88.1 145.92 37.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.646 0.736 . . . . 73.530000000000001 110.913 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.431 ' HA ' ' ND2' ' A' ' 405' ' ' ASN . 53.4 Cg_endo -69.86 130.02 18.49 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 2.243 . . . . 73.329999999999998 112.325 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' PHE . . . . . 0.418 ' CE2' HD12 ' A' ' 357' ' ' LEU . 64.3 t80 -136.21 111.07 8.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 74.010000000000005 110.868 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 52.18 33.18 11.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 63.520000000000003 110.911 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 95.57 -22.86 36.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 71.310000000000002 112.448 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.28 132.41 53.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.846 0.355 . . . . 70.010000000000005 110.888 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 400' ' ' PRO . 0.6 OUTLIER -73.94 148.9 41.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 75.230000000000004 110.832 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.457 ' CD1' HG23 ' A' ' 345' ' ' ILE . 4.2 mt -111.66 178.21 4.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 74.519999999999996 110.99 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -113.46 -179.38 3.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 74.549999999999997 110.935 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' THR . . . . . 0.466 ' CG2' ' HB3' ' A' ' 396' ' ' LEU . 33.8 p -153.72 153.93 33.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 75.450000000000003 111.107 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 163.61 173.64 32.53 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.751 -0.737 . . . . 64.040000000000006 112.501 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.754 ' CH2' ' CE1' ' A' ' 386' ' ' HIS . 40.7 m95 -83.17 120.59 25.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.843 0.354 . . . . 72.239999999999995 110.865 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.26 132.15 51.94 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 72.430000000000007 112.468 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 413' ' ' GLU . 0.3 OUTLIER -151.38 80.8 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.826 0.346 . . . . 74.239999999999995 110.94 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 412' ' ' LYS . 6.1 tp10 -36.08 133.72 0.45 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 72.319999999999993 110.946 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 71.129999999999995 110.871 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.512 -0.235 . . . . 72.200000000000003 112.512 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.13 144.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.799 0.333 . . . . 73.230000000000004 110.847 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -173.38 94.38 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 60.020000000000003 110.905 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 9.5 t -169.37 177.41 4.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 74.329999999999998 111.154 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 319' ' ' GLY . 0.7 OUTLIER -53.82 -28.49 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 72.530000000000001 111.12 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.452 ' N ' HG22 ' A' ' 318' ' ' ILE . . . 95.84 69.72 1.04 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.704 -0.76 . . . . 70.230000000000004 112.493 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 168.03 82.92 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.562 0.696 . . . . 73.409999999999997 110.869 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 134.9 28.98 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.621 2.214 . . . . 74.540000000000006 112.325 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -11.47 30.94 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.705 2.27 . . . . 74.510000000000005 112.334 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -157.04 143.19 17.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.261 -0.427 . . . . 75.209999999999994 110.892 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.07 118.55 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 74.200000000000003 111.094 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -113.47 145.4 33.22 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.636 0.731 . . . . 75.140000000000001 110.852 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 -14.32 36.0 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.599 2.199 . . . . 75.519999999999996 112.42 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.69 -72.36 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 74.5 110.924 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.8 -25.56 28.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 71.129999999999995 111.125 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.463 ' CG2' ' HB ' ' A' ' 394' ' ' VAL . 8.6 t -81.61 -31.26 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 72.319999999999993 111.129 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -55.03 -38.66 68.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 73.319999999999993 110.906 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -59.0 -35.26 72.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 74.329999999999998 110.825 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.472 ' CG2' HG23 ' A' ' 393' ' ' ILE . 32.4 mm -63.45 -45.9 96.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 75.200000000000003 111.166 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 8.6 mt -57.14 -25.34 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 75.430000000000007 111.206 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -76.2 -1.16 25.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 74.530000000000001 110.858 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.94 36.6 4.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 75.519999999999996 110.847 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.492 ' CB ' ' CD1' ' A' ' 410' ' ' TRP . . . -169.55 147.95 3.24 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.574 0.702 . . . . 71.140000000000001 111.091 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 165.5 30.76 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.677 2.251 . . . . 73.219999999999999 112.375 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -31.9 19.49 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.758 2.305 . . . . 73.420000000000002 112.316 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -93.25 72.39 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 73.150000000000006 110.857 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.403 ' O ' ' CG1' ' A' ' 340' ' ' VAL . 3.3 p -178.2 127.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 75.230000000000004 111.175 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' THR . . . . . 0.407 HG23 ' C ' ' A' ' 385' ' ' THR . 39.4 p -145.74 69.87 1.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 74.430000000000007 111.132 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.463 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 99.8 m -133.63 120.73 21.05 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.211 -0.449 . . . . 65.230000000000004 111.174 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -86.47 129.15 34.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 75.200000000000003 111.033 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.404 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -111.48 134.77 52.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 72.310000000000002 110.936 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.45 HG22 ' CD1' ' A' ' 406' ' ' LEU . 1.7 mp -126.28 124.47 65.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.051 -0.522 . . . . 72.099999999999994 111.166 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . 0.5 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -109.0 154.59 16.42 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 62.229999999999997 112.438 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 1.9 t30 82.82 45.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.859 0.362 . . . . 74.450000000000003 110.891 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.473 ' CG2' ' HB2' ' A' ' 352' ' ' ALA . 68.0 mt -99.26 129.85 28.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.642 0.734 . . . . 72.019999999999996 111.104 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . 0.563 ' HB2' ' CD1' ' A' ' 351' ' ' PHE . 54.1 Cg_endo -69.72 157.87 58.98 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.684 2.256 . . . . 73.530000000000001 112.375 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -60.81 -30.9 70.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 70.319999999999993 110.865 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . 0.563 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 28.1 p90 -86.1 33.3 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 74.25 110.876 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . 0.579 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -113.64 82.59 1.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 43.240000000000002 111.136 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 17.9 p -84.98 167.56 15.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.118 -0.492 . . . . 72.340000000000003 111.185 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.507 ' O ' ' CG1' ' A' ' 358' ' ' ILE . 0.3 OUTLIER -67.21 -29.43 69.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 73.510000000000005 110.88 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -59.12 -25.65 64.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 74.319999999999993 111.108 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.0 -17.1 13.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 71.349999999999994 110.837 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.498 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 4.7 mp -95.56 -53.5 3.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.424 . . . . 73.040000000000006 110.896 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.656 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.3 mm -39.51 -50.7 5.03 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.537 0.684 . . . . 70.439999999999998 111.079 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.1 Cg_endo -69.74 -26.62 27.46 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.715 2.277 . . . . 75.439999999999998 112.311 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.538 HD23 ' CE1' ' A' ' 401' ' ' PHE . 0.1 OUTLIER -70.81 -24.25 62.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 74.140000000000001 110.91 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.569 ' CD1' HD13 ' A' ' 381' ' ' ILE . 91.4 m-85 -102.61 -41.05 6.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 73.329999999999998 110.952 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' GLN . . . . . 0.448 ' N ' HD13 ' A' ' 367' ' ' ILE . 8.4 mt-30 -47.73 -44.68 28.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 75.129999999999995 110.883 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . 0.416 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.3 OUTLIER -45.64 -28.47 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 72.310000000000002 110.922 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . 0.445 ' CD2' ' HA ' ' A' ' 361' ' ' PHE . 33.7 m-85 -63.35 -57.32 10.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 74.549999999999997 110.854 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -154.27 -86.59 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.742 . . . . 54.329999999999998 112.528 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -153.58 140.62 19.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.851 0.358 . . . . 74.519999999999996 110.833 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.448 HD13 ' N ' ' A' ' 362' ' ' GLN . 41.2 mt -120.97 109.09 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 75.019999999999996 111.195 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.8 mp -86.76 -18.04 32.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 74.239999999999995 110.948 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -170.76 120.9 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 72.340000000000003 110.88 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.515 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 33.0 t80 -113.48 141.88 46.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 72.409999999999997 110.903 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.64 101.21 6.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 75.450000000000003 110.905 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . 0.579 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.6 t-80 -98.46 130.25 45.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 72.340000000000003 110.901 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -125.89 90.59 50.05 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.718 0.77 . . . . 75.439999999999998 110.906 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . 0.571 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.5 Cg_endo -69.73 -38.25 8.11 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.739 2.293 . . . . 61.409999999999997 112.299 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.53 -21.3 62.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 72.120000000000005 110.861 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -111.55 -25.74 9.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 110.877 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 84.31 42.29 7.53 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.725 -0.75 . . . . 64.420000000000002 112.519 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 31.1 p -154.84 153.98 32.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.775 0.321 . . . . 74.420000000000002 110.866 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 13.7 p -144.89 146.23 31.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 75.010000000000005 110.867 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.463 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 43.1 m-85 -125.16 122.34 36.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 73.430000000000007 110.882 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.569 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -110.84 133.67 55.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 73.099999999999994 111.171 179.968 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 128.58 46.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 75.209999999999994 110.855 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -111.6 178.4 4.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 73.439999999999998 110.877 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -76.73 -45.54 28.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.078 -0.51 . . . . 71.209999999999994 110.894 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' THR . . . . . 0.407 ' C ' HG23 ' A' ' 341' ' ' THR . 40.5 p -117.08 172.47 7.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 74.420000000000002 111.154 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -85.29 -41.0 15.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 71.239999999999995 110.866 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -33.75 69.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 72.340000000000003 110.863 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -65.12 -34.93 79.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 75.420000000000002 110.889 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -67.11 -39.44 86.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 70.25 111.152 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . 0.411 ' HB3' ' CG1' ' A' ' 329' ' ' VAL . . . -56.07 -33.86 65.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 63.399999999999999 111.148 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.24 -40.21 85.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 71.129999999999995 111.166 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 13.3 t -75.04 -31.56 61.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 73.340000000000003 110.9 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.472 HG23 ' CG2' ' A' ' 332' ' ' ILE . 0.2 OUTLIER -59.52 -54.97 27.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 61.420000000000002 111.145 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.463 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.81 -36.09 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 60.32 111.13 179.811 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.32 -48.25 80.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 111.163 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . 0.56 HD13 ' CD1' ' A' ' 399' ' ' PHE . 0.5 OUTLIER -79.3 -13.72 59.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 73.5 110.927 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -50.21 108.38 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 74.200000000000003 111.103 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 10.5 m120 49.62 50.8 17.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 73.129999999999995 110.91 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.56 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -109.2 146.97 35.0 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.629 0.728 . . . . 73.530000000000001 110.916 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . 0.519 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.7 Cg_endo -69.84 145.18 55.92 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.657 2.238 . . . . 73.329999999999998 112.383 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' PHE . . . . . 0.538 ' CE1' HD23 ' A' ' 360' ' ' LEU . 32.9 t80 -151.01 110.67 4.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 74.010000000000005 110.918 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 48.97 33.99 5.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 63.520000000000003 110.906 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.26 -32.7 7.17 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.727 -0.749 . . . . 71.310000000000002 112.549 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.3 OUTLIER -104.89 144.37 31.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 70.010000000000005 110.807 -179.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.03 154.44 24.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 75.230000000000004 110.849 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.45 ' CD1' HG22 ' A' ' 345' ' ' ILE . 16.8 mt -113.7 169.92 8.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 74.519999999999996 110.959 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 346' ' ' GLY . 2.0 ttt180 -111.27 174.4 5.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 74.549999999999997 110.907 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' THR . . . . . 0.553 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 64.3 p -154.25 148.44 25.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.477 . . . . 75.450000000000003 111.118 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 410' ' ' TRP . . . 157.03 129.45 1.14 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 64.040000000000006 112.488 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.492 ' CD1' ' CB ' ' A' ' 336' ' ' ALA . 51.8 m95 -33.8 130.73 0.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.832 0.349 . . . . 72.239999999999995 110.892 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -145.35 149.98 22.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.783 -0.722 . . . . 72.430000000000007 112.502 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.09 147.5 31.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.741 0.305 . . . . 74.239999999999995 110.917 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -55.42 107.34 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 72.319999999999993 110.83 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 71.129999999999995 110.872 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.458 -0.257 . . . . 72.200000000000003 112.458 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.44 -45.7 13.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.832 0.349 . . . . 73.230000000000004 110.864 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -158.14 42.28 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 60.020000000000003 110.93 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 3.5 t -153.12 139.55 18.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 74.329999999999998 111.18 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' ILE . . . . . 0.436 HG13 ' N ' ' A' ' 319' ' ' GLY . 3.7 tp -178.62 143.96 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 72.530000000000001 111.119 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.436 ' N ' HG13 ' A' ' 318' ' ' ILE . . . -77.81 135.04 15.4 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.682 -0.771 . . . . 70.230000000000004 112.498 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 59.0 mt -143.24 83.29 11.12 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.573 0.702 . . . . 73.409999999999997 110.895 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 164.31 35.0 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.603 2.202 . . . . 74.540000000000006 112.372 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -31.43 20.52 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.654 2.236 . . . . 74.510000000000005 112.329 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.44 142.25 29.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 75.209999999999994 110.83 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.469 ' CG1' HG11 ' A' ' 391' ' ' VAL . 2.0 t 69.75 139.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 74.200000000000003 111.093 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -110.56 122.68 37.71 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.529 0.68 . . . . 75.140000000000001 110.981 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 -14.34 35.73 Favored 'Trans proline' 0 N--CA 1.466 -0.128 0 C-N-CA 122.752 2.301 . . . . 75.519999999999996 112.286 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -70.27 -72.16 0.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 74.5 110.95 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.38 -31.46 61.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 71.129999999999995 111.103 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . 0.523 ' CG1' ' CB ' ' A' ' 390' ' ' ALA . 8.0 t -69.08 -29.58 43.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 72.319999999999993 111.118 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -53.94 -35.17 61.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 73.319999999999993 110.875 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -68.41 -31.85 71.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 74.329999999999998 110.879 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 40.8 mm -57.82 -51.29 72.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 75.200000000000003 111.125 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 5.4 mt -53.44 -37.23 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 75.430000000000007 111.16 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.82 -9.42 4.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 74.530000000000001 110.873 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.1 42.02 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 75.519999999999996 110.83 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.573 ' HB1' ' CD1' ' A' ' 410' ' ' TRP . . . 178.35 162.83 0.64 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.566 0.698 . . . . 71.140000000000001 111.093 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 160.55 49.29 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.737 2.291 . . . . 73.219999999999999 112.371 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -16.0 37.71 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.69 2.26 . . . . 73.420000000000002 112.37 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -112.53 73.91 0.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 73.150000000000006 110.899 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 14.7 p -160.4 121.77 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 75.230000000000004 111.147 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' THR . . . . . 0.433 HG23 ' N ' ' A' ' 386' ' ' HIS . 18.8 p -136.02 67.9 1.46 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 74.430000000000007 111.084 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 33.8 m -133.84 108.23 8.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 65.230000000000004 111.165 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -80.27 129.77 34.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 75.200000000000003 111.178 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 0.502 ' CD1' ' C ' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -112.79 134.67 54.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 72.310000000000002 110.92 -179.801 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.464 HG23 ' CD1' ' A' ' 406' ' ' LEU . 1.5 mp -136.28 99.83 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.127 -0.488 . . . . 72.099999999999994 111.145 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -89.31 176.61 43.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 62.229999999999997 112.58 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.3 t30 68.38 47.27 0.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 74.450000000000003 110.892 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 55.0 mt -101.97 131.13 23.09 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.602 0.715 . . . . 72.019999999999996 111.144 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.85 165.98 29.24 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.249 . . . . 73.530000000000001 112.276 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -69.61 -26.33 64.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 70.319999999999993 110.858 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -85.47 32.23 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 74.25 110.877 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . 0.595 ' O ' ' CE1' ' A' ' 372' ' ' HIS . . . -117.62 110.95 18.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 43.240000000000002 111.146 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 13.7 p -114.5 166.39 11.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 72.340000000000003 111.144 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.491 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -63.45 -33.58 75.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 73.510000000000005 110.968 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.91 -26.77 59.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 74.319999999999993 111.092 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.22 -13.21 13.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 71.349999999999994 110.864 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.438 ' C ' ' HD2' ' A' ' 359' ' ' PRO . 3.7 mp -99.37 -53.66 3.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 73.040000000000006 110.91 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.623 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -40.44 -51.73 6.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.628 0.728 . . . . 70.439999999999998 111.192 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.1 Cg_endo -69.73 -38.51 7.76 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.655 2.237 . . . . 75.439999999999998 112.331 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . 0.573 ' C ' ' CD1' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -54.99 -27.7 46.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 74.140000000000001 110.889 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' PHE . . . . . 0.514 ' CD2' HD12 ' A' ' 360' ' ' LEU . 84.0 m-85 -95.16 -38.1 10.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 73.329999999999998 110.958 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' GLN . . . . . 0.447 ' N ' HD13 ' A' ' 367' ' ' ILE . 30.4 mt-30 -48.68 -43.25 36.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 75.129999999999995 110.911 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' ASN . . . . . 0.437 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.5 OUTLIER -42.87 -28.2 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 72.310000000000002 110.955 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' PHE . . . . . 0.551 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 18.7 m-85 -66.14 -58.55 5.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 74.549999999999997 110.92 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . 0.422 ' HA3' ' CD ' ' A' ' 388' ' ' GLN . . . -156.67 -84.34 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.76 -0.733 . . . . 54.329999999999998 112.519 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.412 ' O ' ' CD2' ' A' ' 383' ' ' TYR . 17.6 t80 -153.96 144.68 22.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 74.519999999999996 110.902 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' ILE . . . . . 0.447 HD13 ' N ' ' A' ' 362' ' ' GLN . 47.1 mt -120.86 108.78 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.019999999999996 111.138 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.32 -16.01 36.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.179 -0.464 . . . . 74.239999999999995 110.894 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -170.58 120.81 0.58 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.445 . . . . 72.340000000000003 110.862 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.574 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 34.7 t80 -115.44 136.11 53.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 72.409999999999997 110.894 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.62 100.3 6.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 75.450000000000003 110.866 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' HIS . . . . . 0.595 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 10.3 t-80 -100.2 110.79 23.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 72.340000000000003 110.862 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.577 ' CE2' ' HB2' ' A' ' 378' ' ' CYS . 1.0 OUTLIER -119.53 94.52 48.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.644 0.735 . . . . 75.439999999999998 110.89 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -17.4 37.3 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.724 2.282 . . . . 61.409999999999997 112.308 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.48 -28.62 69.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 72.120000000000005 110.917 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -111.69 -24.23 10.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 74.329999999999998 110.9 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 91.07 37.44 6.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.717 -0.754 . . . . 64.420000000000002 112.477 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' CYS . . . . . 0.577 ' HB2' ' CE2' ' A' ' 373' ' ' TYR . 0.0 OUTLIER -156.23 151.69 26.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 74.420000000000002 110.872 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' CYS . . . . . 0.574 ' HB2' ' CE1' ' A' ' 370' ' ' PHE . 25.6 p -126.05 171.35 10.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 75.010000000000005 110.834 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' PHE . . . . . 0.551 ' CE2' ' OH ' ' A' ' 373' ' ' TYR . 27.6 m-85 -137.63 107.32 6.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 73.430000000000007 110.829 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' ILE . . . . . 0.44 HD13 ' CE1' ' A' ' 361' ' ' PHE . 0.7 OUTLIER -106.21 113.31 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 73.099999999999994 111.119 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -87.33 130.85 34.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 75.209999999999994 110.9 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.583 ' CD2' ' OE1' ' A' ' 388' ' ' GLN . 46.6 m-85 -113.67 153.94 28.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 73.439999999999998 110.917 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -53.76 -47.3 70.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 71.209999999999994 110.885 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' THR . . . . . 0.427 ' C ' HG23 ' A' ' 341' ' ' THR . 1.7 p -108.82 157.73 18.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 74.420000000000002 111.119 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' HIS . . . . . 0.462 ' CG ' ' N ' ' A' ' 387' ' ' GLU . 20.8 p-80 -83.97 -44.49 14.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 71.239999999999995 110.777 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' GLU . . . . . 0.462 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 0.1 OUTLIER -57.24 -26.94 61.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 72.340000000000003 110.851 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' GLN . . . . . 0.583 ' OE1' ' CD2' ' A' ' 383' ' ' TYR . 0.8 OUTLIER -70.3 -32.52 70.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.182 -0.463 . . . . 75.420000000000002 110.965 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -68.4 -33.86 74.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 70.25 111.11 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . 0.523 ' CB ' ' CG1' ' A' ' 329' ' ' VAL . . . -54.55 -28.76 48.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 63.399999999999999 111.093 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' VAL . . . . . 0.469 HG11 ' CG1' ' A' ' 324' ' ' VAL . 77.7 t -71.36 -51.02 36.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 71.129999999999995 111.196 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' CYS . . . . . 0.551 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 3.6 t -61.46 -31.08 71.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 73.340000000000003 110.847 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . . . . . . . . . 1.1 mt -57.15 -56.02 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 61.420000000000002 111.166 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' VAL . . . . . 0.475 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.2 t -72.39 -35.18 51.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 60.32 111.122 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.85 -49.75 76.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 75.209999999999994 111.116 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' LEU . . . . . 0.574 ' CB ' ' CG2' ' A' ' 408' ' ' THR . 2.7 mm? -77.16 -7.84 56.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.423 . . . . 73.5 110.981 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' ALA . . . . . 0.403 ' N ' HG22 ' A' ' 408' ' ' THR . . . -54.78 112.23 0.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.200000000000003 111.096 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 43.98 48.71 7.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.909 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' PHE . . . . . 0.565 ' CD1' HD11 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -102.79 141.58 22.79 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.726 0.774 . . . . 73.530000000000001 110.86 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 136.37 32.99 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.706 2.271 . . . . 73.329999999999998 112.388 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' PHE . . . . . 0.562 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 36.8 t80 -140.67 110.81 6.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 74.010000000000005 110.868 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 50.19 32.72 6.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 63.520000000000003 110.911 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 100.69 -30.09 11.01 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.699 -0.762 . . . . 71.310000000000002 112.451 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.07 138.89 40.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.838 0.351 . . . . 70.010000000000005 110.901 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -80.69 155.13 26.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 75.230000000000004 110.855 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.464 ' CD1' HG23 ' A' ' 345' ' ' ILE . 16.5 mt -114.61 176.82 4.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.519999999999996 110.955 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.09 173.45 6.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 74.549999999999997 110.91 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' THR . . . . . 0.574 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 72.0 p -154.63 151.06 28.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 75.450000000000003 111.115 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . 0.477 ' O ' ' C ' ' A' ' 410' ' ' TRP . . . 154.44 131.79 1.56 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.778 -0.725 . . . . 64.040000000000006 112.534 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.573 ' CD1' ' HB1' ' A' ' 336' ' ' ALA . 10.2 m95 -31.07 121.29 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.333 . . . . 72.239999999999995 110.987 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 410' ' ' TRP . . . -33.73 140.68 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.778 -0.725 . . . . 72.430000000000007 112.519 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 413' ' ' GLU . 4.3 mttt -164.91 127.98 2.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.78 0.324 . . . . 74.239999999999995 110.851 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 412' ' ' LYS . 81.4 mt-10 -34.44 -87.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 72.319999999999993 110.928 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 71.129999999999995 110.808 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.787 0.327 . . . . 74.5 110.918 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.95 -25.09 27.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 71.13 111.125 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' VAL . . . . . 0.828 HG22 ' HB ' ' A' ' 394' ' ' VAL . 7.9 t -79.96 -29.78 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 71.42 111.096 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.412 ' HA ' HD12 ' A' ' 333' ' ' ILE . 6.8 t70 -54.54 -36.88 64.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 73.32 110.865 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -64.2 -32.24 73.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 74.33 110.854 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.737 HG21 HG21 ' A' ' 393' ' ' ILE . 22.6 mm -60.31 -52.81 56.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 75.2 111.151 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 330' ' ' ASP . 4.8 mt -55.48 -41.63 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 75.03 111.137 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.96 -16.69 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 74.23 110.856 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.56 23.49 8.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 75.52 110.878 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.536 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . -174.96 159.09 2.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.574 0.702 . . . . 70.44 111.087 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.536 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 53.5 Cg_endo -69.73 150.2 68.06 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.67 2.247 . . . . 73.22 112.365 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -14.23 35.74 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.701 2.267 . . . . 62.53 112.332 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.521 ' O ' HG23 ' A' ' 341' ' ' THR . 0.5 OUTLIER -72.43 -63.13 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 72.43 110.882 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.64 143.83 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.34 111.091 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' THR . . . . . 0.677 HG22 ' CA ' ' A' ' 386' ' ' HIS . 22.3 p -146.98 68.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 73.22 111.128 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 87.7 m -133.78 139.46 46.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 65.23 111.116 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -105.78 121.78 44.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 75.2 111.083 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.602 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -102.93 122.09 43.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 72.31 110.877 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.561 HG21 HD13 ' A' ' 406' ' ' LEU . 1.9 mp -118.58 112.85 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 72.1 111.149 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -102.23 171.82 21.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.76 -0.734 . . . . 62.23 112.479 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.416 ' O ' ' CD2' ' A' ' 406' ' ' LEU . 1.4 t30 71.45 46.59 0.41 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.337 . . . . 74.34 110.917 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.615 HG23 ' HD2' ' A' ' 349' ' ' PRO . 86.9 mt -102.77 137.17 19.24 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.622 0.725 . . . . 71.22 111.147 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' PRO . . . . . 0.615 ' HD2' HG23 ' A' ' 348' ' ' ILE . 53.6 Cg_endo -69.76 163.53 37.94 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.679 2.253 . . . . 73.53 112.341 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -70.5 -24.05 62.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 70.32 110.884 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.559 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 29.4 p90 -90.74 29.46 1.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 61.03 110.883 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.795 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -112.63 99.11 7.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 41.44 111.13 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 13.3 p -99.2 169.49 9.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 72.34 111.13 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' GLU . . . . . 0.513 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.29 -29.76 69.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 73.51 110.839 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -59.0 -26.04 64.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 74.32 111.13 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.78 -13.09 13.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 71.35 110.841 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.795 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.5 mp -99.93 -53.24 3.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 51.35 110.936 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.647 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -41.49 -51.14 8.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.574 0.702 . . . . 70.44 111.118 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.4 Cg_endo -69.78 -30.47 22.15 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.668 2.246 . . . . 70.32 112.339 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.891 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -64.96 -20.12 66.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 63.2 110.955 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.596 ' HB2' HD11 ' A' ' 367' ' ' ILE . 88.1 m-85 -104.8 -37.01 7.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 73.33 110.89 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -48.56 -45.51 37.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 65.52 110.931 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ASN . . . . . 0.419 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.8 OUTLIER -44.49 -23.77 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 72.31 110.858 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 364' ' ' PHE . . . . . 0.594 ' CE2' ' HB2' ' A' ' 392' ' ' CYS . 32.2 m-85 -69.85 -51.29 34.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 73.33 110.846 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -163.26 -88.0 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 32.11 112.473 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -151.74 144.49 24.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 74.52 110.913 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ILE . . . . . 0.596 HD11 ' HB2' ' A' ' 361' ' ' PHE . 25.9 mt -121.07 109.74 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 75.02 111.147 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.43 -19.42 29.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 74.24 110.889 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -170.96 120.74 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.889 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 33.5 t80 -113.61 131.33 56.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 63.45 110.902 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.31 100.73 7.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 75.45 110.928 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 372' ' ' HIS . . . . . 0.597 ' CD2' ' HD3' ' A' ' 374' ' ' PRO . 43.1 t60 -97.81 127.44 43.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 63.43 110.905 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -122.85 86.58 50.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.712 0.768 . . . . 71.14 110.944 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' PRO . . . . . 0.597 ' HD3' ' CD2' ' A' ' 372' ' ' HIS . 54.0 Cg_endo -69.76 -21.38 33.56 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.732 2.288 . . . . 42.43 112.357 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.47 -23.76 63.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 72.12 110.871 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -115.39 -25.79 7.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 53.33 110.893 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.09 44.83 4.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.718 -0.753 . . . . 64.42 112.458 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 93.9 m -156.93 147.94 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 73.31 110.886 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.472 ' HB2' ' CE1' ' A' ' 370' ' ' PHE . 21.5 p -138.01 153.18 49.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 75.01 110.882 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 380' ' ' PHE . 2.3 m-85 -128.48 118.92 23.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.877 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.458 HG21 ' CD1' ' A' ' 367' ' ' ILE . 0.8 OUTLIER -107.7 128.73 62.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 73.1 111.108 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.94 132.25 43.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 74.34 110.909 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -114.67 -178.9 3.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 70.34 110.96 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -76.78 -40.58 47.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.469 . . . . 71.21 110.898 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 53.5 p -125.17 167.11 15.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 74.42 111.143 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' HIS . . . . . 0.677 ' CA ' HG22 ' A' ' 341' ' ' THR . 9.8 p-80 -72.99 -40.58 65.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 71.24 110.869 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 387' ' ' GLU . . . . . 0.428 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 0.4 OUTLIER -57.87 -26.97 62.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 52.21 110.878 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -65.71 -33.48 75.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 75.42 110.848 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -78.93 -34.65 44.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 65.12 111.057 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.821 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -61.15 -34.46 75.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.239 -0.437 . . . . 63.4 111.097 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.8 -57.24 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 60.24 111.132 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' CYS . . . . . 0.594 ' HB2' ' CE2' ' A' ' 364' ' ' PHE . 30.1 p -66.28 -27.06 67.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 73.34 110.906 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.858 ' O ' HG21 ' A' ' 408' ' ' THR . 1.3 mt -58.21 -54.56 30.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 45.22 111.112 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.828 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.5 OUTLIER -71.5 -34.21 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 53.43 111.105 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.8 -37.05 85.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 72.34 111.143 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.635 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.8 mm? -86.14 -12.91 48.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 63.21 110.916 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -53.45 111.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 74.2 111.089 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.9 m120 47.73 48.91 17.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.927 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.635 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -104.59 144.26 28.35 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.608 0.718 . . . . 73.53 110.874 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 139.09 39.35 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.653 2.236 . . . . 71.55 112.364 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' PHE . . . . . 0.615 ' CZ ' ' NE2' ' A' ' 402' ' ' GLN . 41.0 t80 -145.85 111.8 5.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 74.01 110.9 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.615 ' NE2' ' CZ ' ' A' ' 401' ' ' PHE . 20.9 mt-30 51.07 32.64 7.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 63.25 110.976 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.92 -26.23 25.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.696 -0.764 . . . . 71.31 112.448 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 401' ' ' PHE . 3.3 ttt180 -109.43 141.3 42.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.761 0.315 . . . . 70.01 110.876 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -82.52 155.19 24.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 42.51 110.873 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.561 HD13 HG21 ' A' ' 345' ' ' ILE . 27.3 mt -117.19 178.31 4.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.52 110.91 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.59 176.02 5.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 73.51 110.864 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' THR . . . . . 0.858 HG21 ' O ' ' A' ' 393' ' ' ILE . 1.8 p -146.77 156.67 43.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 54.13 111.142 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.725 -0.75 . . . . 32.33 112.478 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.797 0.332 . . . . 74.5 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -52.58 -24.84 9.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 71.13 111.082 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' VAL . . . . . 0.853 HG22 ' HB ' ' A' ' 394' ' ' VAL . 5.0 t -81.58 -30.06 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 71.42 111.098 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.474 ' HA ' HD12 ' A' ' 333' ' ' ILE . 6.2 t0 -55.06 -38.06 67.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 73.32 110.817 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -59.9 -37.69 80.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 74.33 110.902 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.544 HG21 HD13 ' A' ' 393' ' ' ILE . 16.6 mm -54.96 -54.46 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 75.2 111.138 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 330' ' ' ASP . 7.2 mt -51.61 -41.35 27.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 75.03 111.148 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -16.84 2.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 74.23 110.853 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.38 29.01 5.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.205 -0.452 . . . . 75.52 110.872 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -159.59 154.27 20.9 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.57 0.7 . . . . 70.44 111.13 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 156.52 63.01 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.677 2.251 . . . . 73.22 112.36 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -6.68 19.19 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.661 2.24 . . . . 62.53 112.395 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -119.93 76.45 1.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 72.43 110.944 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 7.5 p -179.62 141.84 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 72.34 111.156 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' THR . . . . . 0.524 HG22 ' HA ' ' A' ' 386' ' ' HIS . 21.0 p -149.46 69.79 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 73.22 111.13 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 96.4 m -133.5 116.08 15.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 65.23 111.109 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -89.14 121.86 31.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 75.2 111.077 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.56 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -102.99 125.56 49.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 72.31 110.907 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.506 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.9 mp -122.52 118.86 56.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 72.1 111.17 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -105.91 -179.01 23.6 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.725 -0.75 . . . . 62.23 112.482 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.501 ' O ' HD23 ' A' ' 406' ' ' LEU . 0.7 OUTLIER 62.82 49.73 3.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.753 0.311 . . . . 74.34 110.811 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.512 ' CG2' ' HB3' ' A' ' 352' ' ' ALA . 86.8 mt -103.25 134.17 19.92 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.57 0.7 . . . . 71.22 111.177 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' PRO . . . . . 0.513 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.7 Cg_endo -69.77 165.38 31.18 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.704 2.27 . . . . 73.53 112.367 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.78 -25.8 63.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 70.32 110.916 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.402 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 2.9 p90 -89.88 31.87 0.94 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 61.03 110.851 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.853 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -120.62 99.18 6.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 41.44 111.107 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 79.5 p -104.79 173.66 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.269 -0.423 . . . . 72.34 111.208 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' GLU . . . . . 0.513 ' O ' ' CG1' ' A' ' 358' ' ' ILE . 0.6 OUTLIER -66.71 -29.85 69.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 73.51 110.915 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.41 -26.28 63.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 74.32 111.038 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.42 -17.51 12.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.258 -0.428 . . . . 71.35 110.804 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.853 HD11 ' HB1' ' A' ' 352' ' ' ALA . 4.0 mp -92.33 -51.1 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 51.35 110.851 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.681 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.3 mm -42.34 -49.98 11.95 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.581 0.705 . . . . 70.44 111.082 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.6 Cg_endo -69.76 -28.0 25.78 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.685 2.257 . . . . 70.32 112.365 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.845 HD13 ' C ' ' A' ' 360' ' ' LEU . 0.2 OUTLIER -68.11 -25.99 65.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 63.2 110.891 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.641 ' CE2' HD12 ' A' ' 360' ' ' LEU . 85.3 m-85 -102.42 -34.69 9.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 73.33 110.886 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' GLN . . . . . 0.559 ' HG3' HD12 ' A' ' 367' ' ' ILE . 2.0 mt-30 -54.63 -32.36 58.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 65.52 110.882 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -60.05 -13.67 12.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 72.31 110.872 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' PHE . . . . . 0.481 ' CD2' ' HB3' ' A' ' 392' ' ' CYS . 39.3 m-85 -78.78 -55.9 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 73.33 110.926 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -155.19 -86.77 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.647 -0.787 . . . . 32.11 112.443 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.443 ' CE2' ' HG ' ' A' ' 368' ' ' LEU . 61.2 t80 -153.62 140.78 19.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.337 . . . . 74.52 110.906 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ILE . . . . . 0.559 HD12 ' HG3' ' A' ' 362' ' ' GLN . 42.0 mt -120.33 109.29 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 75.02 111.161 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.443 ' HG ' ' CE2' ' A' ' 366' ' ' PHE . 0.9 OUTLIER -86.18 -20.24 28.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.93 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.89 121.36 0.67 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 72.34 110.923 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 35.0 t80 -113.61 145.7 40.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 63.45 110.895 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -131.44 101.97 5.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 75.45 110.952 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' HIS . . . . . 0.637 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 21.2 t60 -100.83 127.24 47.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.295 -0.412 . . . . 63.43 110.856 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -118.2 90.55 38.24 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.703 0.763 . . . . 71.14 110.958 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' PRO . . . . . 0.473 ' HD3' ' CD2' ' A' ' 372' ' ' HIS . 53.4 Cg_endo -69.75 -19.69 35.84 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.718 2.278 . . . . 42.43 112.335 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -84.38 -21.96 30.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 72.12 110.823 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -106.53 -26.43 11.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 53.33 110.866 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' GLY . . . . . 0.4 ' C ' ' SG ' ' A' ' 378' ' ' CYS . . . 84.74 35.38 13.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 64.42 112.489 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 378' ' ' CYS . . . . . 0.4 ' SG ' ' C ' ' A' ' 377' ' ' GLY . 1.8 m -153.64 140.98 19.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.774 0.321 . . . . 73.31 110.901 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 17.7 p -133.14 146.08 51.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 75.01 110.889 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 344' ' ' TYR . 7.4 m-85 -124.15 127.69 48.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 73.43 110.911 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.537 HD13 ' CD1' ' A' ' 361' ' ' PHE . 1.0 OUTLIER -113.36 130.74 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 73.1 111.145 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -94.67 131.35 40.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.922 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -114.85 -174.58 2.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 70.34 110.902 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -93.47 -30.49 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 71.21 110.9 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 24.8 p -125.7 165.8 17.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 74.42 111.088 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' HIS . . . . . 0.524 ' HA ' HG22 ' A' ' 341' ' ' THR . 17.9 p-80 -78.42 -41.46 32.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 71.24 110.855 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 387' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 6.6 tm-20 -57.37 -31.27 65.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 52.21 110.861 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -36.29 82.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 75.42 110.933 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.614 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -76.02 -27.14 57.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 65.12 111.063 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.724 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -72.72 -35.51 67.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 63.4 111.063 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 82.7 t -66.02 -53.57 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 60.24 111.124 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' CYS . . . . . 0.481 ' HB3' ' CD2' ' A' ' 364' ' ' PHE . 31.5 p -65.35 -31.76 73.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.484 . . . . 73.34 110.861 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.762 ' O ' HG21 ' A' ' 408' ' ' THR . 0.7 OUTLIER -55.67 -55.65 16.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 45.22 111.133 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.853 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.67 -36.79 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 53.43 111.164 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.2 -30.57 71.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 72.34 111.119 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.68 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.1 mm? -95.93 -16.07 21.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 63.21 110.889 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -48.58 110.39 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.2 111.131 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 42.5 t30 49.45 50.57 17.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 73.13 110.923 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.68 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -107.47 145.62 31.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.655 0.74 . . . . 73.53 110.899 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 143.32 50.81 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.74 2.293 . . . . 71.55 112.333 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' PHE . . . . . 0.526 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 31.6 t80 -150.37 110.97 4.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 74.01 110.892 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 49.82 33.02 5.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 63.25 110.949 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 99.54 -27.76 18.63 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.683 -0.77 . . . . 71.31 112.503 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.3 OUTLIER -107.0 142.03 37.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.903 0.382 . . . . 70.01 110.901 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -83.05 154.79 24.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 42.51 110.834 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 347' ' ' ASN . 19.6 mt -117.78 167.77 11.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 74.52 110.889 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.58 179.12 4.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 73.51 110.92 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 408' ' ' THR . . . . . 0.762 HG21 ' O ' ' A' ' 393' ' ' ILE . 5.9 p -152.86 153.56 33.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 54.13 111.191 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.749 . . . . 32.33 112.454 -179.978 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.779 0.323 . . . . 74.5 110.874 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -58.48 -25.01 61.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 71.13 111.002 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' VAL . . . . . 0.9 HG22 ' HB ' ' A' ' 394' ' ' VAL . 14.6 t -74.82 -30.03 23.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 71.42 111.117 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.466 ' HA ' HD12 ' A' ' 333' ' ' ILE . 23.5 t0 -55.03 -36.92 66.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.32 110.878 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -62.42 -36.34 82.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 74.33 110.909 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.492 HG21 HG21 ' A' ' 393' ' ' ILE . 20.4 mm -55.42 -53.25 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 75.2 111.071 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 330' ' ' ASP . 5.5 mt -53.02 -40.51 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 75.03 111.163 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -16.27 2.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 74.23 110.844 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' A' ' 336' ' ' ALA . 0.2 OUTLIER -105.02 44.75 1.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 75.52 110.823 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 335' ' ' SER . . . 167.32 147.31 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.659 0.742 . . . . 70.44 111.095 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.913 ' O ' HG12 ' A' ' 340' ' ' VAL . 53.4 Cg_endo -69.81 151.27 68.76 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.667 2.245 . . . . 73.22 112.342 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -8.88 24.74 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.766 2.311 . . . . 62.53 112.332 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.42 16.58 3.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 72.43 110.863 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.913 HG12 ' O ' ' A' ' 337' ' ' PRO . 13.9 p -131.29 140.15 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 72.34 111.164 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' THR . . . . . 0.671 HG22 ' CA ' ' A' ' 386' ' ' HIS . 21.0 p -148.78 68.11 1.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 73.22 111.138 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 28.1 m -133.78 127.62 33.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.474 . . . . 65.23 111.098 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.96 120.69 35.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 75.2 111.169 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.794 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -105.86 131.72 52.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 72.31 110.92 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.8 HG21 HD13 ' A' ' 406' ' ' LEU . 1.7 mp -126.22 117.68 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 72.1 111.121 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -105.11 162.59 14.48 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.741 . . . . 62.23 112.524 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.5 t30 76.14 44.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 74.34 110.888 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.541 HG23 ' HD2' ' A' ' 349' ' ' PRO . 67.3 mt -94.59 135.2 24.23 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.613 0.721 . . . . 71.22 111.115 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 349' ' ' PRO . . . . . 0.554 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 52.9 Cg_endo -69.77 159.75 52.25 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.732 2.288 . . . . 73.53 112.337 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -67.86 -21.47 65.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 70.32 110.817 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 349' ' ' PRO . 5.4 p90 -93.86 28.49 2.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 61.03 110.903 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.765 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -110.83 102.07 10.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 41.44 111.117 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 14.3 p -102.8 169.26 8.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 72.34 111.109 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' GLU . . . . . 0.516 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.49 -31.32 71.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 73.51 110.865 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.96 -26.38 59.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 74.32 111.1 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -111.98 -13.11 13.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 71.35 110.902 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.765 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.4 mp -99.47 -54.18 3.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 51.35 110.91 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.632 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -40.29 -51.79 6.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.664 0.745 . . . . 70.44 111.088 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 359' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.3 Cg_endo -69.76 -38.12 8.24 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.72 2.28 . . . . 70.32 112.339 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.929 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -55.32 -26.67 42.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.442 . . . . 63.2 110.925 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.62 ' N ' HD13 ' A' ' 360' ' ' LEU . 85.2 m-85 -97.42 -39.22 9.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 73.33 110.861 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' GLN . . . . . 0.622 ' HG3' HD12 ' A' ' 367' ' ' ILE . 6.8 mt-30 -47.52 -44.26 25.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 65.52 111.006 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 360' ' ' LEU . 0.9 OUTLIER -45.05 -29.01 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 72.31 110.879 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 364' ' ' PHE . . . . . 0.56 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 34.0 m-85 -63.33 -57.39 10.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 73.33 110.913 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -156.8 -83.7 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.729 . . . . 32.11 112.507 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -153.5 144.76 23.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.798 0.332 . . . . 74.52 110.885 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ILE . . . . . 0.622 HD12 ' HG3' ' A' ' 362' ' ' GLN . 69.1 mt -121.13 109.08 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 75.02 111.12 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.3 mt -88.1 -19.8 26.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 74.24 110.877 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.15 120.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 72.34 110.848 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 372' ' ' HIS . 34.9 t80 -113.1 142.2 46.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 63.45 110.899 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.5 100.48 5.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 75.45 110.88 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 372' ' ' HIS . . . . . 0.587 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.0 t-80 -99.59 119.02 37.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 63.43 110.877 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.86 88.21 11.37 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.709 0.766 . . . . 71.14 110.944 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 374' ' ' PRO . . . . . 0.418 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 54.1 Cg_endo -69.78 -26.9 27.01 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.705 2.27 . . . . 42.43 112.355 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.55 -19.75 62.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 72.12 110.871 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -111.14 -27.07 8.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 53.33 110.895 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 89.11 39.83 6.33 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.781 -0.723 . . . . 64.42 112.479 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.8 p -159.58 153.59 23.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.752 0.31 . . . . 73.31 110.87 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.516 ' C ' ' CD1' ' A' ' 380' ' ' PHE . 15.2 p -138.72 166.71 23.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 75.01 110.866 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 379' ' ' CYS . 7.0 m-85 -142.12 125.57 16.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 73.43 110.806 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.48 126.43 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 73.1 111.15 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.71 128.38 42.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 74.34 110.911 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -109.83 179.32 4.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 70.34 110.95 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -81.05 -34.95 32.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.469 . . . . 71.21 110.878 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 82.8 p -125.65 166.75 16.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 74.42 111.174 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' HIS . . . . . 0.671 ' CA ' HG22 ' A' ' 341' ' ' THR . 2.3 p80 -82.58 -38.69 23.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 71.24 110.861 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 387' ' ' GLU . . . . . 0.403 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 4.5 tt0 -57.4 -27.71 62.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 52.21 110.84 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -35.59 66.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 75.42 110.91 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.51 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -68.47 -37.94 80.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 65.12 111.077 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.642 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -58.59 -33.61 70.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 63.4 111.068 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.3 t -63.58 -57.52 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 60.24 111.128 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' CYS . . . . . 0.56 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 10.5 t -59.33 -30.18 68.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.496 . . . . 73.34 110.919 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.537 HG22 ' N ' ' A' ' 394' ' ' VAL . 0.5 OUTLIER -59.09 -55.21 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 45.22 111.102 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.9 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.79 -34.82 52.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 53.43 111.129 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.19 -45.38 88.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 72.34 111.149 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.609 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.7 mm? -81.59 -12.58 58.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 63.21 110.986 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 397' ' ' ALA . . . . . 0.525 ' N ' HG21 ' A' ' 408' ' ' THR . . . -49.37 111.08 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 74.2 111.098 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 6.6 m120 44.26 48.74 7.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 73.13 110.825 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.609 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -103.6 145.77 31.24 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.66 0.743 . . . . 73.53 110.916 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 141.8 46.19 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.692 2.261 . . . . 71.55 112.34 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' PHE . . . . . 0.551 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 30.4 t80 -146.94 110.85 5.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 74.01 110.913 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 47.92 32.96 3.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 63.25 110.936 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.04 -29.85 11.63 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.815 -0.707 . . . . 71.31 112.517 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.76 137.02 43.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 70.01 110.887 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -81.65 150.38 28.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 42.51 110.89 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.8 HD13 HG21 ' A' ' 345' ' ' ILE . 28.4 mt -112.39 171.43 7.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 74.52 110.902 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 407' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 346' ' ' GLY . 13.4 ttt180 -112.73 174.66 5.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 73.51 110.842 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 408' ' ' THR . . . . . 0.562 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 70.7 p -154.28 146.97 24.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 54.13 111.17 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 C-N-CA 120.764 -0.731 . . . . 32.33 112.506 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.825 0.345 . . . . 74.5 110.922 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -53.78 -24.87 16.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 71.13 111.163 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' VAL . . . . . 0.862 HG22 ' HB ' ' A' ' 394' ' ' VAL . 6.9 t -84.36 -30.06 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 71.42 111.165 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.611 ' HA ' HD12 ' A' ' 333' ' ' ILE . 22.7 t70 -54.67 -41.17 69.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 73.32 110.953 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -56.6 -39.23 73.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 74.33 110.887 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.659 HG21 HD13 ' A' ' 393' ' ' ILE . 21.5 mm -54.4 -54.34 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 75.2 111.097 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.922 HG23 ' NE2' ' A' ' 386' ' ' HIS . 4.3 mt -53.69 -36.34 28.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 75.03 111.124 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -7.98 5.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 74.23 110.873 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.8 7.68 37.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 75.52 110.887 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -153.0 147.1 18.6 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.598 0.714 . . . . 70.44 111.062 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.716 ' O ' HG12 ' A' ' 340' ' ' VAL . 53.3 Cg_endo -69.77 153.27 69.07 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.694 2.263 . . . . 73.22 112.356 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -7.75 21.85 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.67 2.246 . . . . 62.53 112.351 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 31.9 mtt180 -92.25 37.11 0.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 72.43 110.844 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 337' ' ' PRO . 7.7 p -157.74 142.59 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 72.34 111.138 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' THR . . . . . 0.489 HG22 ' HB2' ' A' ' 386' ' ' HIS . 18.2 p -144.39 67.93 1.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 73.22 111.18 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 72.7 m -134.06 137.59 44.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 65.23 111.175 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -108.74 122.22 46.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 75.2 111.138 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -102.06 124.87 48.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.267 -0.424 . . . . 72.31 110.937 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.548 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.9 mp -120.73 104.41 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 72.1 111.083 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -93.3 165.62 27.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.825 -0.703 . . . . 62.23 112.536 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.42 ' O ' HD22 ' A' ' 406' ' ' LEU . 1.5 t30 74.99 55.47 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.358 . . . . 74.34 110.89 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.583 HG23 ' HD2' ' A' ' 349' ' ' PRO . 76.7 mt -110.19 136.36 20.5 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.634 0.73 . . . . 71.22 111.153 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 349' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 348' ' ' ILE . 54.5 Cg_endo -69.68 162.93 40.12 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.664 2.243 . . . . 73.53 112.359 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -72.41 -21.27 61.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 70.32 110.862 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.485 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 7.4 p90 -88.02 19.92 3.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 61.03 110.864 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.697 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -104.65 121.34 43.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 41.44 111.08 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 11.5 p -123.08 167.99 12.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 72.34 111.215 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' GLU . . . . . 0.506 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.3 OUTLIER -63.64 -35.12 79.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 73.51 110.839 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -55.03 -26.89 40.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 74.32 111.114 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.99 -13.5 13.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 71.35 110.914 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.697 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.2 mp -99.06 -55.0 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 51.35 110.94 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.623 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -38.82 -52.42 3.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.704 0.764 . . . . 70.44 111.146 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 359' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.3 Cg_endo -69.75 -40.36 5.42 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.703 2.269 . . . . 70.32 112.381 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.915 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -53.89 -25.28 19.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 63.2 110.929 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.58 ' CE2' HD12 ' A' ' 360' ' ' LEU . 83.4 m-85 -100.46 -39.43 7.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.863 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -51.64 -39.22 57.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 65.52 110.878 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -51.42 -16.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 72.31 110.922 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' PHE . . . . . 0.511 ' CE2' ' HB2' ' A' ' 392' ' ' CYS . 31.6 m-85 -75.55 -60.04 2.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 73.33 110.927 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -150.02 -85.36 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.646 -0.788 . . . . 32.11 112.42 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 368' ' ' LEU . 15.0 t80 -153.62 141.73 20.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.819 0.342 . . . . 74.52 110.876 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' A' ' 361' ' ' PHE . 40.8 mt -121.04 109.04 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 75.02 111.1 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.758 HD11 ' HD3' ' A' ' 382' ' ' LYS . 2.8 pp -89.3 -16.2 31.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.938 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.683 ' HB2' HD12 ' A' ' 368' ' ' LEU . 0.2 OUTLIER -171.02 120.83 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.476 . . . . 72.34 110.903 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 372' ' ' HIS . 35.9 t80 -114.4 141.64 47.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 63.45 110.894 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 5.2 mtmm -129.4 101.12 5.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 75.45 110.907 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' HIS . . . . . 0.567 ' CD2' ' HD3' ' A' ' 374' ' ' PRO . 44.4 t60 -95.93 121.66 37.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 63.43 110.829 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -116.83 84.0 15.12 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.657 0.741 . . . . 71.14 110.926 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 374' ' ' PRO . . . . . 0.567 ' HD3' ' CD2' ' A' ' 372' ' ' HIS . 54.4 Cg_endo -69.71 -27.08 27.16 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.67 2.247 . . . . 42.43 112.37 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -65.65 -23.58 66.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 72.12 110.914 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -112.83 -25.59 8.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 53.33 110.889 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.61 46.32 4.04 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.728 -0.749 . . . . 64.42 112.476 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 27.4 p -159.78 151.82 20.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.877 0.37 . . . . 73.31 110.906 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 15.1 p -140.52 137.38 33.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 75.01 110.922 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -115.99 119.94 37.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 73.43 110.921 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.55 HD13 ' CG ' ' A' ' 361' ' ' PHE . 1.2 mt -107.64 142.51 20.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 73.1 111.18 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' LYS . . . . . 0.758 ' HD3' HD11 ' A' ' 368' ' ' LEU . 0.1 OUTLIER -103.27 131.6 50.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.909 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.455 ' CD2' ' HB3' ' A' ' 388' ' ' GLN . 53.1 m-85 -120.33 137.02 54.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 70.34 110.919 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -45.36 -28.77 0.91 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 71.21 110.864 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 69.4 p -130.07 162.69 28.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 74.42 111.139 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' HIS . . . . . 0.922 ' NE2' HG23 ' A' ' 333' ' ' ILE . 10.0 t60 -80.43 -34.42 36.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 71.24 110.863 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -57.31 -32.19 66.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 52.21 110.954 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.455 ' HB3' ' CD2' ' A' ' 383' ' ' TYR . 0.0 OUTLIER -66.8 -34.49 77.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.113 -0.494 . . . . 75.42 110.906 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -71.35 -23.85 61.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 65.12 111.095 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.765 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -78.79 -38.42 38.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 63.4 111.063 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.24 -48.6 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 60.24 111.103 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' CYS . . . . . 0.511 ' HB2' ' CE2' ' A' ' 364' ' ' PHE . 19.1 p -71.36 -32.44 68.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 73.34 110.856 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.681 ' O ' HG21 ' A' ' 408' ' ' THR . 0.9 OUTLIER -53.68 -55.35 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 45.22 111.171 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.862 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -72.08 -34.32 49.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 53.43 111.144 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -67.08 -29.09 68.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 72.34 111.147 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.673 HD13 ' CD1' ' A' ' 399' ' ' PHE . 1.9 mm? -97.97 -2.82 39.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 63.21 110.858 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -63.53 111.73 2.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 74.2 111.012 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 50.67 48.1 23.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 73.13 110.893 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.673 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -106.48 142.97 26.05 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.642 0.734 . . . . 73.53 110.867 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.421 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.8 Cg_endo -69.77 141.61 45.64 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.747 2.298 . . . . 71.55 112.34 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' PHE . . . . . 0.559 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 50.1 t80 -147.94 114.25 5.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 74.01 110.838 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER 48.91 32.74 3.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 63.25 110.937 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.36 -27.58 18.78 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.76 -0.733 . . . . 71.31 112.504 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.4 138.76 41.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 70.01 110.864 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.407 ' C ' HD23 ' A' ' 406' ' ' LEU . 3.0 m120 -80.66 149.75 29.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 42.51 110.827 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 347' ' ' ASN . 9.3 mt -112.24 174.93 5.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 74.52 110.948 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 407' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 346' ' ' GLY . 0.0 OUTLIER -120.78 173.02 7.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 73.51 110.891 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 408' ' ' THR . . . . . 0.681 HG21 ' O ' ' A' ' 393' ' ' ILE . 2.2 p -146.41 153.6 40.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 54.13 111.072 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 32.33 112.443 179.899 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.835 0.35 . . . . 74.5 110.947 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.1 -24.78 18.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.457 . . . . 71.13 111.104 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' VAL . . . . . 0.82 HG22 ' HB ' ' A' ' 394' ' ' VAL . 5.7 t -84.78 -30.04 6.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 71.42 111.176 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.75 ' HA ' HD12 ' A' ' 333' ' ' ILE . 13.7 t70 -54.74 -45.86 74.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 73.32 110.905 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -53.01 -34.81 58.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.808 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.968 HG21 HG21 ' A' ' 393' ' ' ILE . 26.1 mm -61.29 -48.87 86.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 75.2 111.167 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' A' ' 330' ' ' ASP . 8.0 mt -54.39 -33.05 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 75.03 111.093 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.61 -7.96 12.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.951 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 336' ' ' ALA . 0.8 OUTLIER -94.29 17.58 12.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 75.52 110.894 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.705 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . 177.8 164.49 0.57 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.533 0.682 . . . . 70.44 111.154 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.836 ' O ' HG22 ' A' ' 340' ' ' VAL . 54.7 Cg_endo -69.66 156.86 62.47 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.77 2.313 . . . . 73.22 112.37 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -7.32 20.73 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.678 2.252 . . . . 62.53 112.36 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 35.3 mtt85 -97.57 53.68 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 72.43 110.898 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 337' ' ' PRO . 7.0 m -150.53 135.56 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 72.34 111.088 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' THR . . . . . 0.522 HG22 ' HA ' ' A' ' 386' ' ' HIS . 28.0 p -138.08 66.4 1.44 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 73.22 111.117 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 19.4 m -134.3 142.15 47.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 65.23 111.118 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -118.83 98.93 6.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 75.2 111.121 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.53 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -85.77 121.19 28.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.332 -0.394 . . . . 72.31 110.91 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.813 HG21 HD13 ' A' ' 406' ' ' LEU . 2.0 mp -118.29 118.79 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.086 -0.506 . . . . 72.1 111.131 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -104.64 164.88 14.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.76 -0.733 . . . . 62.23 112.504 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 0.2 OUTLIER 76.62 45.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 74.34 110.884 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.457 HG23 ' HD2' ' A' ' 349' ' ' PRO . 59.4 mt -99.58 133.32 21.94 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.653 0.74 . . . . 71.22 111.142 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' PRO . . . . . 0.777 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.7 Cg_endo -69.74 164.87 32.9 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.657 2.238 . . . . 73.53 112.329 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.32 -20.88 59.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 70.32 110.809 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.504 ' O ' ' CD2' ' A' ' 351' ' ' PHE . 25.0 p90 -97.25 29.48 3.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 61.03 110.885 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.777 ' HB2' ' HG2' ' A' ' 349' ' ' PRO . . . -114.36 90.84 3.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 41.44 111.17 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 19.7 p -87.83 170.77 10.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 72.34 111.101 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' GLU . . . . . 0.51 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -65.6 -31.94 73.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 73.51 110.888 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -53.49 -26.13 19.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 74.32 111.128 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.63 -13.18 13.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.273 -0.421 . . . . 71.35 110.866 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.752 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.3 mp -98.85 -55.86 2.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 51.35 110.952 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.633 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -39.74 -52.16 5.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.625 0.726 . . . . 70.44 111.106 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 359' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.5 Cg_endo -69.66 -35.58 12.66 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.711 2.274 . . . . 70.32 112.37 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.898 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -58.61 -23.55 59.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 63.2 110.927 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.692 ' CG ' HD13 ' A' ' 381' ' ' ILE . 84.9 m-85 -103.02 -35.25 8.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 73.33 110.873 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -54.14 -34.76 61.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 65.52 110.852 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -55.48 -13.47 1.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 72.31 110.954 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 392' ' ' CYS . 38.2 m-85 -81.3 -53.99 5.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 73.33 110.901 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -156.24 -95.35 0.11 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.807 -0.711 . . . . 32.11 112.557 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.43 ' CE2' ' HG ' ' A' ' 368' ' ' LEU . 58.8 t80 -143.81 143.97 31.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.818 0.342 . . . . 74.52 110.909 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ILE . . . . . 0.437 HG12 ' CG2' ' A' ' 381' ' ' ILE . 71.6 mt -120.73 109.05 24.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 75.02 111.145 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.43 ' HG ' ' CE2' ' A' ' 366' ' ' PHE . 1.1 mp -87.64 -19.8 27.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 74.24 110.862 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.92 120.62 0.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 72.34 110.872 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 372' ' ' HIS . 35.1 t80 -112.47 143.0 44.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 63.45 110.888 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.27 101.28 5.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 75.45 110.895 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 372' ' ' HIS . . . . . 0.572 ' HB2' ' CE2' ' A' ' 370' ' ' PHE . 29.9 t60 -99.66 136.01 40.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 63.43 110.884 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -128.19 90.03 48.35 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.73 0.776 . . . . 71.14 110.965 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 374' ' ' PRO . . . . . 0.487 ' HD3' ' CD2' ' A' ' 372' ' ' HIS . 53.9 Cg_endo -69.77 -21.85 32.85 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.791 2.327 . . . . 42.43 112.343 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.0 -33.33 65.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 72.12 110.887 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.08 -18.99 14.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 53.33 110.933 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 81.01 40.16 12.03 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.741 -0.742 . . . . 64.42 112.465 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.2 p -148.49 155.62 41.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.716 0.293 . . . . 73.31 110.976 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 18.6 p -149.78 158.08 43.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.429 . . . . 75.01 110.897 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.494 ' CE2' ' HB2' ' A' ' 344' ' ' TYR . 1.8 m-85 -136.24 132.5 35.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.922 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.692 HD13 ' CG ' ' A' ' 361' ' ' PHE . 0.9 OUTLIER -119.67 123.02 70.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 73.1 111.136 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.19 131.84 34.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 74.34 110.943 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.51 -179.63 3.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 70.34 110.93 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -80.65 -43.76 19.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.082 -0.508 . . . . 71.21 110.884 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 82.3 p -115.71 159.86 20.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 74.42 111.122 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' HIS . . . . . 0.522 ' HA ' HG22 ' A' ' 341' ' ' THR . 19.5 p-80 -69.44 -42.09 75.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 71.24 110.842 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 387' ' ' GLU . . . . . 0.435 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 2.2 tt0 -59.04 -29.83 67.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 52.21 110.876 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.53 -35.07 71.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.865 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -75.46 -24.83 57.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 65.12 111.136 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.813 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -72.39 -37.11 68.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 63.4 111.143 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.83 -56.62 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 60.24 111.085 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' CYS . . . . . 0.601 ' HB2' ' CE2' ' A' ' 364' ' ' PHE . 14.5 p -63.99 -32.77 74.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 73.34 110.845 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.968 HG21 HG21 ' A' ' 332' ' ' ILE . 1.7 mt -53.32 -54.12 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 45.22 111.122 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.82 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.5 OUTLIER -71.18 -34.14 53.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 53.43 111.136 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -69.41 -28.49 66.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 72.34 111.109 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.719 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.4 mm? -97.75 -17.86 19.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.276 -0.42 . . . . 63.21 110.945 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -47.97 114.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 74.2 111.073 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 38.0 t30 44.77 44.75 7.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.13 110.831 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.719 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -100.66 143.99 27.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.644 0.735 . . . . 73.53 110.861 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.405 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.4 Cg_endo -69.75 145.11 56.2 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.674 2.249 . . . . 71.55 112.284 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' PHE . . . . . 0.574 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 56.1 t80 -150.12 110.8 4.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 74.01 110.886 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 49.08 33.45 4.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 63.25 110.923 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 99.95 -28.21 16.68 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.726 -0.749 . . . . 71.31 112.458 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -105.01 141.06 37.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 70.01 110.852 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.429 ' O ' HD23 ' A' ' 406' ' ' LEU . 7.4 m120 -83.88 154.13 23.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 42.51 110.888 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.813 HD13 HG21 ' A' ' 345' ' ' ILE . 8.7 mt -116.4 174.08 6.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 74.52 110.973 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.82 176.85 5.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 73.51 110.886 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 408' ' ' THR . . . . . 0.7 HG21 ' O ' ' A' ' 393' ' ' ILE . 23.5 p -151.67 151.28 31.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 54.13 111.109 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.409 0 C-N-CA 120.74 -0.743 . . . . 32.33 112.501 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.756 0.313 . . . . 74.5 110.89 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.24 -28.25 40.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 71.13 111.066 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' VAL . . . . . 0.97 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 16.0 t -71.1 -29.84 38.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 71.42 111.163 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -54.18 -35.44 62.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 73.32 110.892 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -69.34 -31.78 70.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 74.33 110.825 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.766 HG21 HD13 ' A' ' 393' ' ' ILE . 46.9 mm -54.79 -54.21 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 75.2 111.099 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.522 HG23 ' NE2' ' A' ' 386' ' ' HIS . 8.2 mt -52.36 -40.55 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 75.03 111.149 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -15.41 1.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 74.23 110.857 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' SER . . . . . 0.555 ' O ' ' HB2' ' A' ' 336' ' ' ALA . 0.1 OUTLIER -101.45 41.69 1.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 75.52 110.897 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' A' ' 335' ' ' SER . . . 170.59 157.05 0.21 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.626 0.727 . . . . 70.44 111.048 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.626 ' O ' HG12 ' A' ' 340' ' ' VAL . 54.1 Cg_endo -69.79 153.78 68.4 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.649 2.233 . . . . 73.22 112.369 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -11.55 31.04 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.742 2.295 . . . . 62.53 112.304 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -100.82 66.0 1.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 72.43 110.812 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 337' ' ' PRO . 14.4 p -171.39 131.72 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 72.34 111.054 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 386' ' ' HIS . 22.0 p -137.0 68.53 1.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 73.22 111.11 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 87.5 m -133.59 111.7 10.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.445 . . . . 65.23 111.099 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -85.72 137.39 32.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 75.2 111.139 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.805 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -116.99 134.55 54.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.47 . . . . 72.31 110.882 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.805 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.8 mp -131.68 110.99 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 72.1 111.142 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -101.09 161.62 18.36 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.774 -0.727 . . . . 62.23 112.52 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 2.4 t30 78.95 49.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.794 0.33 . . . . 74.34 110.85 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.559 HG23 ' HD2' ' A' ' 349' ' ' PRO . 85.1 mt -103.69 135.83 19.3 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.662 0.744 . . . . 71.22 111.115 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 349' ' ' PRO . . . . . 0.559 ' HD2' HG23 ' A' ' 348' ' ' ILE . 53.8 Cg_endo -69.73 164.4 34.66 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.687 2.258 . . . . 73.53 112.41 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.62 -28.09 63.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 70.32 110.882 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -83.17 20.09 1.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 61.03 110.892 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.774 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -107.64 112.83 25.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 41.44 111.089 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 19.0 p -116.32 170.94 8.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 72.34 111.107 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' GLU . . . . . 0.498 ' O ' ' CG1' ' A' ' 358' ' ' ILE . 0.2 OUTLIER -66.23 -29.89 70.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 73.51 110.886 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.56 -26.64 63.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 74.32 111.168 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.48 -16.01 12.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 71.35 110.88 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.774 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.5 mp -93.5 -50.92 5.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 51.35 110.928 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.688 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.3 mm -44.0 -49.48 21.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.687 0.756 . . . . 70.44 111.171 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.0 Cg_endo -69.75 -27.84 26.02 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.255 . . . . 70.32 112.361 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.95 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -69.96 -26.95 64.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 63.2 110.907 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.789 ' HB2' HD11 ' A' ' 367' ' ' ILE . 85.6 m-85 -94.75 -36.39 11.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 73.33 110.844 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 362' ' ' GLN . . . . . 0.405 ' O ' ' N ' ' A' ' 364' ' ' PHE . 11.4 mm-40 -49.45 -46.81 48.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 65.52 110.886 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -42.5 -24.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 72.31 110.884 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' PHE . . . . . 0.405 ' N ' ' O ' ' A' ' 362' ' ' GLN . 28.6 m-85 -70.52 -59.77 2.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 73.33 110.904 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -155.1 -86.32 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.762 -0.732 . . . . 32.11 112.51 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -153.52 144.48 22.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 74.52 110.933 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ILE . . . . . 0.789 HD11 ' HB2' ' A' ' 361' ' ' PHE . 17.3 mt -120.92 109.32 24.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 75.02 111.139 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.03 -20.02 27.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.476 . . . . 74.24 110.92 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.3 121.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 72.34 110.837 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 28.9 t80 -113.42 143.52 44.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 63.45 110.855 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.07 101.42 5.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.865 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 372' ' ' HIS . . . . . 0.459 ' CD2' ' HD3' ' A' ' 374' ' ' PRO . 29.0 t60 -97.27 115.13 27.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 63.43 110.811 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -108.04 86.09 2.98 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.685 0.755 . . . . 71.14 110.953 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 374' ' ' PRO . . . . . 0.459 ' HD3' ' CD2' ' A' ' 372' ' ' HIS . 53.7 Cg_endo -69.8 -17.27 37.48 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.671 2.247 . . . . 42.43 112.318 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -79.32 -23.76 43.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 72.12 110.903 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -108.41 -26.65 10.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 53.33 110.952 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.91 41.05 5.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.721 -0.752 . . . . 64.42 112.5 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 27.0 p -159.86 153.27 22.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.89 0.376 . . . . 73.31 110.819 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 29.0 p -138.53 145.32 40.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 75.01 110.886 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -119.85 129.42 54.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.895 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.511 ' CG1' ' CD1' ' A' ' 370' ' ' PHE . 1.0 OUTLIER -120.82 132.94 69.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 73.1 111.147 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -98.77 134.79 41.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 74.34 110.822 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -117.45 -179.46 3.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 70.34 110.893 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.23 -39.56 22.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 71.21 110.849 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 67.3 p -120.42 171.39 8.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.42 111.18 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' HIS . . . . . 0.522 ' NE2' HG23 ' A' ' 333' ' ' ILE . 4.4 t60 -83.65 -42.28 16.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 71.24 110.868 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.3 -28.72 63.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 52.21 110.841 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -36.51 82.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 75.42 110.947 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.545 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -73.9 -34.23 64.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 65.12 111.165 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.97 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -56.05 -34.41 65.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 63.4 111.071 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 95.9 t -71.4 -42.99 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 60.24 111.188 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 35.3 t -65.83 -34.17 77.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 73.34 110.905 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.766 HD13 HG21 ' A' ' 332' ' ' ILE . 1.1 mt -55.9 -56.01 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 45.22 111.159 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.491 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 1.8 t -72.04 -36.87 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 53.43 111.132 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.6 94.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 72.34 111.089 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.941 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.9 mm? -89.09 -18.56 27.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 63.21 110.917 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 397' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 398' ' ' ASN . . . -44.7 117.89 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 74.2 111.031 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 398' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 397' ' ' ALA . 4.6 p-10 34.5 42.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 73.13 110.936 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.941 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -97.38 148.0 33.79 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.664 0.745 . . . . 73.53 110.897 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 144.26 53.72 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.635 2.223 . . . . 71.55 112.399 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' PHE . . . . . 0.437 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 58.3 t80 -153.36 112.96 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 74.01 110.892 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 49.64 33.29 5.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 63.25 110.946 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 97.85 -27.66 17.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.735 -0.745 . . . . 71.31 112.453 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -106.06 142.22 36.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.819 0.342 . . . . 70.01 110.864 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -86.42 150.62 24.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 42.51 110.883 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.801 HD13 HG21 ' A' ' 345' ' ' ILE . 17.8 mt -112.06 -177.98 3.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 74.52 110.94 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 407' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 346' ' ' GLY . 8.3 ttt180 -125.87 177.29 6.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 73.51 110.943 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 408' ' ' THR . . . . . 0.708 HG21 ' O ' ' A' ' 393' ' ' ILE . 16.7 p -153.59 157.91 40.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 54.13 111.102 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' GLY . . . . . 0.437 ' O ' ' CD1' ' A' ' 344' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.262 0 C-N-CA 120.674 -0.774 . . . . 32.33 112.448 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.783 0.325 . . . . 74.5 110.891 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.64 -24.6 34.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 71.13 111.058 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' VAL . . . . . 0.777 HG22 ' HB ' ' A' ' 394' ' ' VAL . 25.5 t -83.45 -29.73 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 71.42 111.175 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -54.57 -45.46 73.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.168 -0.469 . . . . 73.32 110.837 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' HIS . . . . . 0.41 ' O ' ' HG2' ' A' ' 334' ' ' ARG . 3.4 t60 -54.2 -31.9 54.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 74.33 110.916 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.431 HG13 HG21 ' A' ' 393' ' ' ILE . 26.6 mm -69.88 -49.52 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 75.2 111.172 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 54.2 mt -54.18 -39.52 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 75.03 111.184 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 331' ' ' HIS . 12.1 ptt180 -75.99 6.7 4.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.856 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 6.5 t -105.82 -13.2 15.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 75.52 110.914 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -150.19 150.51 29.66 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.641 0.734 . . . . 70.44 111.038 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 158.89 55.36 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.652 2.234 . . . . 73.22 112.322 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -28.84 24.78 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.692 2.261 . . . . 62.53 112.339 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.1 mtm105 -50.15 -40.66 47.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 72.43 110.879 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.7 p -95.17 134.32 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 72.34 111.107 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' THR . . . . . 0.591 HG22 ' CA ' ' A' ' 386' ' ' HIS . 25.3 p -140.46 71.15 1.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 73.22 111.099 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 3.4 m -132.54 128.81 38.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 65.23 111.172 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -95.23 119.42 33.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 75.2 111.094 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.639 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -100.28 129.13 46.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 72.31 110.936 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.831 HG22 HD11 ' A' ' 348' ' ' ILE . 1.8 mp -122.59 126.19 73.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.071 -0.513 . . . . 72.1 111.143 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -112.88 168.89 12.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 62.23 112.463 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.475 ' O ' ' CD2' ' A' ' 406' ' ' LEU . 1.9 t30 70.68 53.23 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.706 0.288 . . . . 74.34 110.877 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.831 HD11 HG22 ' A' ' 345' ' ' ILE . 2.0 mp -102.4 132.39 21.46 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.643 0.735 . . . . 71.22 111.116 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' PRO . . . . . 0.711 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.7 Cg_endo -69.72 153.55 68.97 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.683 2.255 . . . . 73.53 112.379 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.03 -18.96 64.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 70.32 110.836 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.409 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 5.2 p90 -94.38 19.78 9.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 61.03 110.862 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.79 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -111.78 104.19 12.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 41.44 111.038 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 27.2 p -107.24 168.33 9.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 72.34 111.131 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' GLU . . . . . 0.514 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -59.59 -37.25 78.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 73.51 110.884 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -52.41 -26.11 11.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.32 111.067 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -112.14 -13.1 13.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 71.35 110.793 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.79 HD11 ' HB1' ' A' ' 352' ' ' ALA . 2.9 mp -99.25 -55.73 2.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 51.35 110.906 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.624 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -37.69 -52.44 2.67 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.619 0.723 . . . . 70.44 111.103 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 359' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.3 Cg_endo -69.76 -26.71 27.28 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.691 2.261 . . . . 70.32 112.352 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.953 ' O ' HD12 ' A' ' 360' ' ' LEU . 0.1 OUTLIER -70.07 -21.94 63.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 63.2 110.965 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.613 ' HB2' HD11 ' A' ' 367' ' ' ILE . 86.8 m-85 -101.11 -30.77 11.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 73.33 110.9 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -32.84 70.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 65.52 110.9 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -57.79 -16.42 11.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 72.31 110.882 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' PHE . . . . . 0.539 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 36.3 m-85 -75.74 -57.79 3.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 73.33 110.917 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -154.87 -82.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.743 . . . . 32.11 112.468 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.877 ' CD2' HD21 ' A' ' 368' ' ' LEU . 7.5 t80 -153.77 139.55 18.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.377 . . . . 74.52 110.904 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' A' ' 361' ' ' PHE . 13.1 mt -114.78 109.37 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.02 111.161 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.877 HD21 ' CD2' ' A' ' 366' ' ' PHE . 0.9 OUTLIER -89.74 -21.36 22.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 74.24 110.944 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -170.94 121.19 0.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 72.34 110.814 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 30.6 t80 -111.13 138.78 47.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 63.45 110.955 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.11 100.47 6.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 75.45 110.935 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 372' ' ' HIS . . . . . 0.461 ' HB2' ' CE2' ' A' ' 370' ' ' PHE . 25.2 t60 -97.82 132.82 43.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 63.43 110.864 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -123.92 88.82 52.12 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.677 0.751 . . . . 71.14 110.881 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 -17.03 37.86 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.622 2.215 . . . . 42.43 112.449 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -83.73 -26.43 29.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 72.12 110.846 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -104.63 -26.65 12.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 53.33 110.881 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 87.22 38.97 7.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.822 -0.704 . . . . 64.42 112.501 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.4 p -153.0 151.41 30.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 73.31 110.9 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 28.8 p -142.19 141.44 32.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 75.01 110.861 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.521 ' CD2' ' HB2' ' A' ' 344' ' ' TYR . 15.4 m-85 -119.69 138.53 53.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 73.43 110.886 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.441 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.6 OUTLIER -127.18 128.06 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 73.1 111.093 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.49 137.18 32.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 74.34 110.886 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -120.24 156.05 31.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 70.34 110.889 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -53.15 -50.33 64.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.102 -0.499 . . . . 71.21 110.863 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 38.7 p -113.41 176.06 5.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.42 111.203 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' HIS . . . . . 0.591 ' CA ' HG22 ' A' ' 341' ' ' THR . 39.9 p-80 -83.88 -39.7 19.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 71.24 110.852 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 387' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 391' ' ' VAL . 0.1 OUTLIER -59.91 -28.82 67.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 52.21 110.836 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -34.98 79.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 75.42 110.924 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -74.94 -37.51 61.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 65.12 111.098 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.634 ' HB1' HG13 ' A' ' 329' ' ' VAL . . . -60.99 -32.07 71.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 63.4 111.052 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 387' ' ' GLU . 81.2 t -66.29 -39.16 83.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 60.24 111.111 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' CYS . . . . . 0.539 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 1.7 t -79.4 -25.42 42.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 73.34 110.851 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.73 ' O ' HG21 ' A' ' 408' ' ' THR . 0.3 OUTLIER -60.79 -55.5 24.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 45.22 111.149 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.777 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -69.74 -42.27 80.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 53.43 111.071 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 395' ' ' ALA . . . . . 0.483 ' N ' ' CG1' ' A' ' 394' ' ' VAL . . . -55.95 -45.75 78.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 72.34 111.14 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.736 HD13 ' CE1' ' A' ' 399' ' ' PHE . 0.5 OUTLIER -79.76 -19.27 49.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 63.21 110.939 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 397' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 394' ' ' VAL . . . -48.38 113.96 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 74.2 111.1 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 45.52 50.26 10.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 73.13 110.877 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.736 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -110.17 143.7 28.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.712 0.768 . . . . 73.53 110.935 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 133.76 26.39 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.683 2.255 . . . . 71.55 112.382 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' PHE . . . . . 0.611 ' CE1' HD22 ' A' ' 360' ' ' LEU . 36.0 t80 -137.34 111.3 8.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 74.01 110.864 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 48.7 32.81 3.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 63.25 110.873 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.34 -30.72 9.78 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 71.31 112.488 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 134.81 48.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.912 0.387 . . . . 70.01 110.875 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -74.83 154.39 38.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 42.51 110.799 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 345' ' ' ILE . 15.9 mt -117.66 171.05 8.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 74.52 110.898 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.02 177.0 4.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 73.51 110.843 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 408' ' ' THR . . . . . 0.73 HG21 ' O ' ' A' ' 393' ' ' ILE . 6.9 p -152.7 152.17 31.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 54.13 111.181 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.695 -0.764 . . . . 32.33 112.427 179.954 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.79 0.329 . . . . 74.5 110.926 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -52.65 -28.75 22.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 71.13 111.141 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' VAL . . . . . 0.736 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 8.0 t -70.55 -29.87 40.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 71.42 111.087 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -54.21 -36.04 63.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.32 110.82 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -65.42 -31.87 73.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 74.33 110.884 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.475 HG21 HG21 ' A' ' 393' ' ' ILE . 38.7 mm -60.56 -49.01 86.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 75.2 111.185 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.469 ' CG1' ' HB2' ' A' ' 390' ' ' ALA . 19.6 mt -57.44 -32.63 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 75.03 111.055 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -5.74 13.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 74.23 110.814 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.95 7.91 44.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 75.52 110.882 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . -161.33 159.56 23.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 70.44 111.059 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.554 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 54.7 Cg_endo -69.71 154.07 68.38 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.672 2.248 . . . . 73.22 112.369 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -8.98 24.97 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.62 2.213 . . . . 62.53 112.388 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -47.07 15.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 72.43 110.882 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 8.3 p -73.18 132.86 32.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 72.34 111.134 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' THR . . . . . 0.594 HG22 ' CB ' ' A' ' 386' ' ' HIS . 40.6 p -144.43 68.92 1.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 73.22 111.14 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 53.2 m -133.16 117.73 17.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 65.23 111.162 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -81.72 126.89 32.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 75.2 111.078 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.754 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -106.02 134.72 48.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 72.31 110.971 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.754 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.8 mp -130.4 121.2 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 72.1 111.12 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -108.53 167.45 13.17 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.796 -0.716 . . . . 62.23 112.49 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.488 ' O ' ' CD2' ' A' ' 406' ' ' LEU . 1.4 t30 69.55 57.34 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.776 0.322 . . . . 74.34 110.876 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.489 ' CG2' ' HB3' ' A' ' 352' ' ' ALA . 47.7 mt -107.94 131.16 21.93 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.631 0.729 . . . . 71.22 111.091 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' PRO . . . . . 0.432 ' CG ' ' CE1' ' A' ' 351' ' ' PHE . 53.9 Cg_endo -69.68 161.46 45.82 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.687 2.258 . . . . 73.53 112.384 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -64.2 -29.08 70.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 70.32 110.867 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.432 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 6.4 p90 -85.14 33.16 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 61.03 110.887 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.665 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -117.36 100.74 7.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 41.44 111.109 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 17.1 p -105.69 170.0 8.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 72.34 111.083 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' GLU . . . . . 0.512 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.28 -29.88 69.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 73.51 110.92 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.36 -26.31 63.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 74.32 111.102 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.15 -14.95 13.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 71.35 110.837 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.665 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.5 mp -97.24 -52.87 3.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.193 -0.458 . . . . 51.35 110.895 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.652 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -41.87 -50.89 10.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.622 0.725 . . . . 70.44 111.115 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 359' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.5 Cg_endo -69.83 -35.13 13.0 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.671 2.247 . . . . 70.32 112.339 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.929 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -59.73 -26.26 65.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 63.2 110.919 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.696 ' HB2' HD11 ' A' ' 367' ' ' ILE . 85.8 m-85 -96.73 -25.24 15.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.223 -0.444 . . . . 73.33 110.882 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 364' ' ' PHE . 5.4 mt-30 -60.45 -47.76 84.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 65.52 110.903 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -42.44 -23.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 72.31 110.918 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 362' ' ' GLN . 23.3 m-85 -71.46 -60.07 2.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 73.33 110.913 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLY . . . . . 0.415 ' HA3' ' CD ' ' A' ' 388' ' ' GLN . . . -150.7 -88.51 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.735 -0.745 . . . . 32.11 112.543 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.661 ' CE2' HD12 ' A' ' 368' ' ' LEU . 28.8 t80 -153.92 138.77 17.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.852 0.358 . . . . 74.52 110.893 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ILE . . . . . 0.696 HD11 ' HB2' ' A' ' 361' ' ' PHE . 32.5 mt -120.43 116.87 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.477 . . . . 75.02 111.124 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.73 ' N ' HD13 ' A' ' 368' ' ' LEU . 0.0 OUTLIER -104.42 -16.2 15.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 74.24 110.877 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.569 ' N ' HD22 ' A' ' 368' ' ' LEU . 3.7 m-20 -159.86 121.05 3.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 72.34 110.9 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 31.0 t80 -123.21 142.66 50.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 63.45 110.895 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -129.56 101.1 5.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 75.45 110.907 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' HIS . . . . . 0.604 ' CD2' ' HD3' ' A' ' 374' ' ' PRO . 35.1 t60 -97.43 136.61 37.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 63.43 110.879 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -130.76 89.32 43.61 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.695 0.759 . . . . 71.14 110.893 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 374' ' ' PRO . . . . . 0.604 ' HD3' ' CD2' ' A' ' 372' ' ' HIS . 54.0 Cg_endo -69.77 -29.78 23.3 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.627 2.218 . . . . 42.43 112.364 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.1 -14.04 62.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 72.12 110.873 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -119.81 -24.38 6.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 53.33 110.869 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 80.34 44.35 8.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 64.42 112.434 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.2 p -156.83 137.81 13.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.825 0.345 . . . . 73.31 110.887 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 14.6 p -129.79 156.97 43.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 75.01 110.909 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -136.98 128.49 28.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.26 -0.427 . . . . 73.43 110.921 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.494 ' CG2' HG23 ' A' ' 367' ' ' ILE . 0.7 OUTLIER -117.83 131.34 70.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 73.1 111.155 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 382' ' ' LYS . . . . . 0.59 ' HB3' HD21 ' A' ' 368' ' ' LEU . 0.0 OUTLIER -98.72 137.23 37.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 74.34 110.907 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -120.88 173.52 7.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 70.34 110.913 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.56 -26.02 35.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 71.21 110.894 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 41.7 p -129.31 162.48 27.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 74.42 111.083 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' HIS . . . . . 0.594 ' CB ' HG22 ' A' ' 341' ' ' THR . 13.5 p80 -86.78 -33.7 19.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 71.24 110.865 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -60.8 -44.57 96.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 52.21 110.912 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.415 ' CD ' ' HA3' ' A' ' 365' ' ' GLY . 2.2 tt0 -60.36 -35.29 75.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 75.42 110.964 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -68.57 -44.06 75.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 65.12 111.067 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.736 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -50.1 -25.59 3.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 63.4 111.14 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 65.0 t -69.54 -49.76 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 60.24 111.164 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 30.7 t -57.51 -31.57 66.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 73.34 110.893 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.633 HD13 ' HA ' ' A' ' 390' ' ' ALA . 1.0 OUTLIER -56.65 -56.33 14.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.447 . . . . 45.22 111.097 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.507 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.2 t -72.07 -35.21 52.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 53.43 111.056 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.71 95.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 72.34 111.061 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.703 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.5 mm? -93.63 -10.6 34.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.306 -0.407 . . . . 63.21 110.976 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 397' ' ' ALA . . . . . 0.668 ' N ' HG21 ' A' ' 408' ' ' THR . . . -51.8 110.12 0.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 74.2 111.102 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 57.6 t30 43.02 48.07 5.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 73.13 110.874 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.703 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -104.53 147.32 34.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.721 0.772 . . . . 73.53 110.848 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.429 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 54.6 Cg_endo -69.68 141.55 45.84 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.669 2.246 . . . . 71.55 112.339 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 401' ' ' PHE . . . . . 0.504 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 36.4 t80 -147.58 111.22 4.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 74.01 110.815 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 49.01 38.65 13.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 63.25 110.913 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 93.96 -29.07 9.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 71.31 112.409 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.4 OUTLIER -105.93 140.07 39.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.783 0.325 . . . . 70.01 110.97 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.438 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 9.0 m120 -81.62 154.63 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 42.51 110.875 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.646 HD13 HG21 ' A' ' 345' ' ' ILE . 13.3 mt -115.86 172.95 6.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 74.52 110.974 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -113.5 173.24 6.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 73.51 110.897 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 408' ' ' THR . . . . . 0.668 HG21 ' N ' ' A' ' 397' ' ' ALA . 71.0 p -154.18 151.55 29.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 54.13 111.118 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.236 0 C-N-CA 120.748 -0.739 . . . . 32.33 112.489 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.719 0.295 . . . . 74.5 110.905 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -57.14 -24.64 55.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 71.13 111.112 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' VAL . . . . . 0.891 HG22 ' HB ' ' A' ' 394' ' ' VAL . 11.4 t -77.16 -30.1 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 71.42 111.154 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.649 ' HA ' HD12 ' A' ' 333' ' ' ILE . 21.7 t0 -55.0 -41.67 71.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 73.32 110.842 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -55.86 -35.48 66.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.857 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.765 HG21 HG21 ' A' ' 393' ' ' ILE . 39.1 mm -63.67 -49.67 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 75.2 111.108 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.649 HD12 ' HA ' ' A' ' 330' ' ' ASP . 13.3 mt -51.49 -50.06 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 75.03 111.126 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.28 -8.75 6.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 74.23 110.92 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 2.2 t -96.98 25.57 5.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 75.52 110.839 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -173.95 154.75 2.29 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.725 . . . . 70.44 111.082 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.409 ' HG2' HG12 ' A' ' 340' ' ' VAL . 53.6 Cg_endo -69.82 150.76 68.31 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 73.22 112.369 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' PRO . . . . . 0.412 ' HA ' ' ND1' ' A' ' 386' ' ' HIS . 54.4 Cg_endo -69.67 -12.11 32.37 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.669 2.246 . . . . 62.53 112.42 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -78.4 -53.39 7.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.832 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.409 HG12 ' HG2' ' A' ' 337' ' ' PRO . 4.1 p -69.34 135.19 28.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 72.34 111.13 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' THR . . . . . 0.438 HG22 ' CA ' ' A' ' 386' ' ' HIS . 44.6 p -142.69 68.19 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 73.22 111.113 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 3.4 m -133.75 128.93 35.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 65.23 111.183 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -92.91 134.31 35.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 75.2 111.133 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.518 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -112.69 128.57 56.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 72.31 110.918 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.623 HG22 HD11 ' A' ' 348' ' ' ILE . 1.6 mp -124.94 110.05 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 72.1 111.139 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -101.86 161.4 17.63 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 62.23 112.535 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 405' ' ' ASN . 0.7 OUTLIER 81.14 50.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 74.34 110.864 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.68 HG23 ' HD2' ' A' ' 349' ' ' PRO . 74.2 mt -107.06 138.68 19.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.607 0.718 . . . . 71.22 111.118 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 349' ' ' PRO . . . . . 0.68 ' HD2' HG23 ' A' ' 348' ' ' ILE . 54.2 Cg_endo -69.72 166.23 28.24 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.695 2.263 . . . . 73.53 112.364 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -76.34 -15.67 59.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 70.32 110.839 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.558 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 47.8 p90 -100.44 29.31 4.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 61.03 110.85 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.776 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -114.54 99.86 7.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 41.44 111.081 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 10.1 p -96.54 171.08 8.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 72.34 111.056 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' GLU . . . . . 0.516 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.32 -30.4 70.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 73.51 110.843 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -55.1 -26.41 37.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 74.32 111.12 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.3 -12.96 13.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 71.35 110.822 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.776 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.4 mp -98.58 -54.46 3.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 51.35 110.953 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.639 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 0.9 OUTLIER -40.71 -51.5 6.87 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.631 0.729 . . . . 70.44 111.139 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 359' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.5 Cg_endo -69.8 -34.36 14.6 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.7 2.267 . . . . 70.32 112.308 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.912 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -59.65 -25.07 64.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 63.2 110.904 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.679 ' CG ' HD13 ' A' ' 381' ' ' ILE . 87.6 m-85 -98.01 -37.33 9.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.885 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' GLN . . . . . 0.654 ' HG2' HD12 ' A' ' 367' ' ' ILE . 6.3 mm-40 -50.66 -45.02 57.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 65.52 110.863 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -44.95 -21.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 72.31 110.879 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' PHE . . . . . 0.459 ' CE2' ' HA ' ' A' ' 361' ' ' PHE . 30.9 m-85 -75.3 -56.86 4.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 73.33 110.925 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -152.89 -90.26 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 32.11 112.477 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -153.8 142.87 21.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.757 0.313 . . . . 74.52 110.84 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ILE . . . . . 0.667 HD11 ' HB2' ' A' ' 361' ' ' PHE . 59.1 mt -120.95 109.13 24.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.168 -0.469 . . . . 75.02 111.129 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.64 -16.81 35.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 74.24 110.876 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.93 120.74 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 72.34 110.881 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.583 ' CD1' HG12 ' A' ' 381' ' ' ILE . 35.9 t80 -114.13 144.81 42.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 63.45 110.898 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.52 100.09 5.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 75.45 110.875 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 372' ' ' HIS . . . . . 0.591 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 4.0 t-80 -103.13 131.91 49.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 63.43 110.835 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.456 ' CB ' ' HB2' ' A' ' 376' ' ' LYS . 96.6 m-85 -128.73 102.19 20.01 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.639 0.733 . . . . 71.14 110.904 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 374' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 373' ' ' TYR . 53.5 Cg_endo -69.76 -25.13 28.93 Favored 'Trans proline' 0 N--CA 1.466 -0.114 0 C-N-CA 122.711 2.274 . . . . 42.43 112.344 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' GLU . . . . . 0.415 ' C ' ' HD2' ' A' ' 376' ' ' LYS . 8.7 pt-20 -87.57 -8.77 55.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 72.12 110.897 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' LYS . . . . . 0.456 ' HB2' ' CB ' ' A' ' 373' ' ' TYR . 0.0 OUTLIER -106.5 -28.13 10.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 53.33 110.862 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 80.61 24.32 58.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 64.42 112.461 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 92.1 m -155.22 149.8 26.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.776 0.322 . . . . 73.31 110.867 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 14.9 p -133.8 151.27 51.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 75.01 110.874 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 380' ' ' PHE . 3.5 m-85 -124.35 127.72 48.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.864 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.679 HD13 ' CG ' ' A' ' 361' ' ' PHE . 1.3 mt -119.24 121.35 66.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.516 . . . . 73.1 111.041 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.37 130.01 34.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 74.34 110.891 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -115.11 -174.89 2.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 70.34 110.906 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -73.61 -54.93 7.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.061 -0.518 . . . . 71.21 110.943 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 71.1 p -120.2 178.78 4.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 74.42 111.181 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' HIS . . . . . 0.438 ' CA ' HG22 ' A' ' 341' ' ' THR . 21.2 p-80 -83.65 -39.43 20.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 71.24 110.857 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -57.35 -28.82 63.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.425 . . . . 52.21 110.877 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -46.09 78.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 75.42 110.943 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.658 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -62.79 -25.71 68.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.235 -0.439 . . . . 65.12 111.121 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.811 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -58.27 -40.12 81.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 63.4 111.134 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 14.1 t -61.92 -57.9 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 60.24 111.081 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 18.4 p -58.91 -31.34 68.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 73.34 110.895 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.765 HG21 HG21 ' A' ' 332' ' ' ILE . 0.4 OUTLIER -58.97 -55.38 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 45.22 111.087 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.891 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -72.25 -35.74 53.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 53.43 111.187 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.57 -47.81 82.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 72.34 111.095 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.635 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.2 mm? -79.83 -13.42 59.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.258 -0.428 . . . . 63.21 110.913 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -50.33 112.91 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 74.2 111.096 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.2 m120 44.13 51.49 7.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 73.13 110.835 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.635 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -108.0 147.94 36.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.689 0.757 . . . . 73.53 110.865 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.424 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.3 Cg_endo -69.71 145.16 56.58 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.706 2.271 . . . . 71.55 112.324 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 401' ' ' PHE . . . . . 0.571 ' CZ ' ' NE2' ' A' ' 402' ' ' GLN . 40.0 t80 -151.85 111.49 3.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 74.01 110.856 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.571 ' NE2' ' CZ ' ' A' ' 401' ' ' PHE . 4.9 mt-30 46.7 38.63 6.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 63.25 110.893 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 94.57 -29.99 8.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.735 . . . . 71.31 112.539 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -104.91 137.62 42.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 70.01 110.83 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.477 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 4.6 m120 -80.04 152.75 29.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 42.51 110.895 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.405 ' CD2' ' O ' ' A' ' 347' ' ' ASN . 13.9 mt -114.58 173.57 6.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 74.52 110.944 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 407' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 346' ' ' GLY . 5.5 ttm-85 -117.63 175.36 5.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 73.51 110.88 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 408' ' ' THR . . . . . 0.593 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 43.0 p -151.63 153.45 34.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 54.13 111.122 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.665 -0.779 . . . . 32.33 112.412 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.734 0.302 . . . . 74.5 110.898 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -51.05 -33.73 26.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.424 . . . . 71.13 111.11 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' VAL . . . . . 0.937 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 7.9 t -70.27 -28.66 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 71.42 111.113 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -53.11 -37.45 61.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 73.32 110.867 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -71.65 -31.81 67.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 74.33 110.805 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.918 HG21 HG21 ' A' ' 393' ' ' ILE . 33.5 mm -54.59 -56.07 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 75.2 111.141 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 4.3 mt -49.72 -39.24 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 75.03 111.163 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -27.35 31.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 74.23 110.828 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 4.8 t -68.47 -32.1 71.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 75.52 110.858 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.419 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . -113.93 155.43 45.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.606 0.717 . . . . 70.44 111.061 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 54.5 Cg_endo -69.73 161.79 44.57 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.654 2.236 . . . . 73.22 112.425 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.8 -11.47 30.86 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.667 2.245 . . . . 62.53 112.304 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -106.61 67.33 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 72.43 110.883 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 5.3 p 177.14 134.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 72.34 111.147 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 19.9 p -141.55 69.99 1.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.193 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 23.7 m -133.61 121.71 22.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 65.23 111.2 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -88.33 134.33 33.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 75.2 111.15 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.605 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -111.2 121.65 45.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.289 -0.414 . . . . 72.31 110.942 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.539 HG23 ' HB3' ' A' ' 406' ' ' LEU . 2.3 mp -124.31 102.19 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 72.1 111.14 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.443 ' H ' ' CB ' ' A' ' 407' ' ' ARG . . . -92.28 -173.19 41.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.69 -0.767 . . . . 62.23 112.519 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.9 t30 58.76 46.66 13.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 74.34 110.901 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.568 ' CG2' ' HB3' ' A' ' 352' ' ' ALA . 81.6 mt -100.08 131.38 24.37 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.529 0.68 . . . . 71.22 111.164 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' PRO . . . . . 0.523 ' CB ' ' CE1' ' A' ' 351' ' ' PHE . 53.9 Cg_endo -69.71 156.22 64.03 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.736 2.29 . . . . 73.53 112.372 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.7 -20.83 65.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 70.32 110.827 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.523 ' CE1' ' CB ' ' A' ' 349' ' ' PRO . 4.8 p90 -94.01 29.35 2.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 61.03 110.929 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.847 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -116.0 96.14 5.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 41.44 111.109 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 15.2 p -98.39 170.69 8.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 72.34 111.161 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' GLU . . . . . 0.521 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.6 OUTLIER -67.31 -29.72 69.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 73.51 110.843 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.67 -26.21 63.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 74.32 111.084 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.3 -14.1 13.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 71.35 110.844 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.847 HD11 ' HB1' ' A' ' 352' ' ' ALA . 2.8 mp -97.78 -52.14 3.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 51.35 110.901 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.668 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -42.52 -50.32 12.34 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.627 0.727 . . . . 70.44 111.137 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 359' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 52.9 Cg_endo -69.78 -29.09 24.33 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.684 2.256 . . . . 70.32 112.313 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.849 HD13 ' C ' ' A' ' 360' ' ' LEU . 0.2 OUTLIER -66.97 -21.83 65.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 63.2 110.924 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.599 ' HB2' HD11 ' A' ' 367' ' ' ILE . 87.8 m-85 -103.32 -36.04 8.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 73.33 110.891 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -49.14 -40.27 31.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 65.52 110.853 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -48.86 -27.84 3.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 72.31 110.928 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' PHE . . . . . 0.557 ' CE1' ' HA ' ' A' ' 392' ' ' CYS . 39.7 m-85 -64.19 -56.88 11.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 73.33 110.902 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -158.98 -84.69 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.786 -0.721 . . . . 32.11 112.537 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -153.24 145.45 23.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.799 0.333 . . . . 74.52 110.893 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ILE . . . . . 0.599 HD11 ' HB2' ' A' ' 361' ' ' PHE . 27.6 mt -121.1 111.31 31.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 75.02 111.165 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.86 -23.18 25.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 74.24 110.934 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.16 120.67 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 72.34 110.944 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.525 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 32.8 t80 -112.34 140.96 46.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 63.45 110.845 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.11 101.21 6.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 75.45 110.909 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 372' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.3 t-80 -97.43 124.07 41.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 63.43 110.795 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -118.02 89.01 33.37 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.698 0.761 . . . . 71.14 110.911 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 374' ' ' PRO . . . . . 0.417 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.4 Cg_endo -69.78 -26.16 27.76 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.648 2.232 . . . . 42.43 112.325 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -72.75 -12.7 61.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 72.12 110.829 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -119.75 -26.43 5.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 53.33 110.916 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 86.55 41.52 6.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.738 -0.744 . . . . 64.42 112.491 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.5 t -159.99 147.74 16.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.745 0.307 . . . . 73.31 110.863 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.525 ' HB2' ' CE1' ' A' ' 370' ' ' PHE . 21.5 p -134.18 155.13 50.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 75.01 110.824 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -128.95 122.79 30.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 73.43 110.887 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.521 HD13 ' CG ' ' A' ' 361' ' ' PHE . 1.1 mt -114.17 134.05 58.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 73.1 111.113 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.37 131.76 48.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 74.34 110.863 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -112.75 -173.83 2.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 70.34 110.931 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.62 -39.03 16.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 71.21 110.873 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 54.7 p -120.82 174.35 6.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 74.42 111.139 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -87.17 -32.13 20.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 71.24 110.88 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -61.16 -41.92 97.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 52.21 110.849 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.93 -35.79 67.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 75.42 110.892 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.39 -26.12 60.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.227 -0.442 . . . . 65.12 111.13 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.937 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -68.56 -40.42 80.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 63.4 111.072 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.73 -55.2 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 60.24 111.141 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' CYS . . . . . 0.557 ' HA ' ' CE1' ' A' ' 364' ' ' PHE . 16.7 p -57.15 -29.69 63.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.485 . . . . 73.34 110.858 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.918 HG21 HG21 ' A' ' 332' ' ' ILE . 8.6 mt -60.03 -55.42 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 45.22 111.134 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.5 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 1.7 t -72.04 -34.43 50.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 53.43 111.132 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -63.77 -47.86 79.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 72.34 111.08 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.711 HD13 ' CE1' ' A' ' 399' ' ' PHE . 0.3 OUTLIER -82.14 -6.38 59.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 63.21 110.899 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 397' ' ' ALA . . . . . 0.701 ' N ' HG21 ' A' ' 408' ' ' THR . . . -54.89 112.79 1.12 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.204 -0.453 . . . . 74.2 111.118 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 44.79 46.29 8.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 73.13 110.946 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.711 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -99.29 145.55 30.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.634 0.73 . . . . 73.53 110.85 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 141.91 46.22 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.714 2.276 . . . . 71.55 112.358 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' PHE . . . . . 0.461 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 48.2 t80 -151.01 112.86 4.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 74.01 110.871 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 52.97 32.74 13.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 63.25 110.917 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 96.63 -26.61 21.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.69 -0.767 . . . . 71.31 112.448 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 401' ' ' PHE . 9.9 ttt85 -108.57 143.61 37.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.827 0.346 . . . . 70.01 110.917 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -80.81 155.17 26.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 42.51 110.933 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.539 ' HB3' HG23 ' A' ' 345' ' ' ILE . 10.4 mt -114.77 175.13 5.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 74.52 110.899 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 407' ' ' ARG . . . . . 0.443 ' CB ' ' H ' ' A' ' 346' ' ' GLY . 1.0 OUTLIER -109.02 176.21 5.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 73.51 110.902 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 408' ' ' THR . . . . . 0.701 HG21 ' N ' ' A' ' 397' ' ' ALA . 45.0 p -154.06 149.82 27.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 54.13 111.147 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.72 . . . . 32.33 112.506 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.732 0.301 . . . . 74.5 110.899 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -58.63 -25.49 62.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 71.13 111.065 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 329' ' ' VAL . . . . . 0.925 HG22 ' HB ' ' A' ' 394' ' ' VAL . 24.6 t -78.21 -29.98 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.434 . . . . 71.42 111.187 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.445 ' HA ' HD12 ' A' ' 333' ' ' ILE . 21.3 t70 -54.71 -35.64 63.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.877 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.69 -38.27 87.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 74.33 110.884 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.611 ' CG1' HG21 ' A' ' 393' ' ' ILE . 1.1 mp -54.21 -51.42 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 75.2 111.096 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 330' ' ' ASP . 9.0 mt -53.67 -38.38 34.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 75.03 111.121 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -2.45 6.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.23 110.872 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 43.2 t -108.92 21.76 16.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 75.52 110.829 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -175.9 150.88 1.14 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.586 0.707 . . . . 70.44 111.083 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 154.28 67.65 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.629 2.219 . . . . 73.22 112.323 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -8.05 22.6 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.678 2.252 . . . . 62.53 112.351 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.08 -49.72 13.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 72.43 110.876 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.75 133.05 32.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 72.34 111.146 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 341' ' ' THR . . . . . 0.632 HG22 ' CA ' ' A' ' 386' ' ' HIS . 30.2 p -135.7 68.02 1.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.117 -0.492 . . . . 73.22 111.184 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 51.2 m -133.72 136.99 45.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 65.23 111.154 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 343' ' ' ALA . . . . . 0.446 ' CB ' ' SG ' ' A' ' 392' ' ' CYS . . . -109.18 129.54 55.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 75.2 111.088 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.711 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -105.95 134.44 49.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 72.31 110.899 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.711 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.9 mp -129.61 100.7 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 72.1 111.171 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -90.07 178.61 43.56 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.713 -0.756 . . . . 62.23 112.488 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 405' ' ' ASN . 2.3 t30 67.64 49.23 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 74.34 110.899 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.675 HG23 ' HD2' ' A' ' 349' ' ' PRO . 77.4 mt -105.11 138.51 19.54 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.618 0.723 . . . . 71.22 111.156 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 349' ' ' PRO . . . . . 0.675 ' HD2' HG23 ' A' ' 348' ' ' ILE . 53.7 Cg_endo -69.75 164.04 36.03 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.708 2.272 . . . . 73.53 112.361 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -75.57 -18.64 59.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 70.32 110.817 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.563 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 55.4 p90 -92.88 17.65 10.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 61.03 110.9 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.808 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -105.8 116.04 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 41.44 111.159 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 25.6 p -114.96 170.42 8.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 72.34 111.192 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 354' ' ' GLU . . . . . 0.507 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -64.82 -29.77 70.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 73.51 110.935 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.48 -26.59 63.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 74.32 111.108 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.27 -13.6 13.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 71.35 110.954 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.808 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.5 mp -98.47 -52.27 3.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 51.35 110.899 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.649 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -41.83 -51.07 9.95 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.639 0.733 . . . . 70.44 111.066 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 359' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.1 Cg_endo -69.79 -35.37 12.69 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.699 2.266 . . . . 70.32 112.388 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.921 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -59.45 -23.47 62.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 63.2 110.922 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.543 ' N ' HD13 ' A' ' 360' ' ' LEU . 82.8 m-85 -100.97 -35.6 9.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 73.33 110.877 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 362' ' ' GLN . . . . . 0.478 ' HG3' HD12 ' A' ' 367' ' ' ILE . 2.3 mt-30 -53.34 -35.41 60.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 65.52 110.934 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -54.11 -14.88 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 72.31 110.875 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -78.62 -56.78 4.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 73.33 110.862 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -157.09 -85.99 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 32.11 112.453 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.693 ' CD2' HD21 ' A' ' 368' ' ' LEU . 8.4 t80 -153.64 142.82 21.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 74.52 110.881 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 367' ' ' ILE . . . . . 0.478 HD12 ' HG3' ' A' ' 362' ' ' GLN . 50.3 mt -120.87 112.3 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 75.02 111.156 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.693 HD21 ' CD2' ' A' ' 366' ' ' PHE . 0.3 OUTLIER -86.01 -21.82 27.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 74.24 110.889 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.94 121.2 0.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 72.34 110.88 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 33.5 t80 -111.11 139.77 46.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 63.45 110.891 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -126.82 100.93 6.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 75.45 110.95 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' HIS . . . . . 0.482 ' HB2' ' CE2' ' A' ' 370' ' ' PHE . 33.8 t60 -96.37 115.71 27.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 63.43 110.793 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -107.25 84.58 1.77 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.744 . . . . 71.14 110.874 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -17.38 37.72 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.701 2.267 . . . . 42.43 112.411 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -78.24 -24.67 46.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 72.12 110.908 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -108.7 -27.41 9.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 53.33 110.948 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 93.4 42.29 4.29 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.676 -0.774 . . . . 64.42 112.452 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 26.3 p -159.92 158.18 30.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.837 0.351 . . . . 73.31 110.942 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.564 ' HB2' ' CE1' ' A' ' 370' ' ' PHE . 28.1 p -143.35 152.32 41.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 75.01 110.872 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.428 ' CE2' ' HB2' ' A' ' 344' ' ' TYR . 38.0 m-85 -125.8 125.03 42.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 73.43 110.827 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.443 HG22 HG23 ' A' ' 367' ' ' ILE . 0.7 OUTLIER -115.28 121.25 66.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 73.1 111.139 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -87.94 131.95 34.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 74.34 110.919 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -116.43 162.7 17.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 70.34 110.889 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -60.99 -45.55 94.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 71.21 110.873 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 30.2 p -112.92 169.02 9.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 74.42 111.143 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' HIS . . . . . 0.632 ' CA ' HG22 ' A' ' 341' ' ' THR . 18.0 p-80 -82.62 -36.14 26.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 71.24 110.891 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 387' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 391' ' ' VAL . 5.0 tm-20 -62.73 -26.81 68.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.181 -0.463 . . . . 52.21 110.896 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -34.96 79.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 75.42 110.868 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.66 -41.26 62.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 65.12 111.05 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -58.87 -26.36 64.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 63.4 111.121 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 387' ' ' GLU . 79.7 t -71.36 -55.76 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 60.24 111.145 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 343' ' ' ALA . 30.3 p -60.64 -32.05 71.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.913 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.611 HG21 ' CG1' ' A' ' 332' ' ' ILE . 0.2 OUTLIER -53.54 -54.98 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 45.22 111.092 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.925 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.7 -38.91 68.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 53.43 111.139 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 395' ' ' ALA . . . . . 0.415 ' N ' ' CG1' ' A' ' 394' ' ' VAL . . . -62.03 -33.91 75.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 72.34 111.116 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.7 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.6 mm? -93.61 -15.08 25.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 63.21 110.925 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 397' ' ' ALA . . . . . 0.609 ' N ' HG21 ' A' ' 408' ' ' THR . . . -47.39 111.47 0.42 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 74.2 111.065 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 43.14 47.43 5.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 73.13 110.944 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.7 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -100.88 146.28 31.85 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.661 0.744 . . . . 73.53 110.841 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.441 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 54.2 Cg_endo -69.76 137.05 34.57 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.717 2.278 . . . . 71.55 112.339 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 401' ' ' PHE . . . . . 0.571 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 29.9 t80 -142.64 111.13 6.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 74.01 110.967 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 48.98 34.5 5.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 63.25 110.935 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 99.28 -31.99 7.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.741 -0.743 . . . . 71.31 112.454 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.8 134.71 47.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 70.01 110.859 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.474 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 3.1 m120 -78.2 152.25 32.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 42.51 110.892 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.453 ' HB3' HG23 ' A' ' 345' ' ' ILE . 10.8 mt -111.62 177.5 4.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 74.52 110.872 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.77 172.26 7.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 73.51 110.85 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 408' ' ' THR . . . . . 0.609 HG21 ' N ' ' A' ' 397' ' ' ALA . 45.8 p -154.77 146.09 22.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 54.13 111.18 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 32.33 112.512 179.894 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.839 0.352 . . . . 74.5 110.913 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.06 -33.78 63.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 71.13 111.145 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 329' ' ' VAL . . . . . 0.889 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 10.7 t -66.78 -29.88 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.178 -0.464 . . . . 71.42 111.156 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.505 ' HA ' HD12 ' A' ' 333' ' ' ILE . 7.1 t70 -54.11 -34.74 61.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 73.32 110.912 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -70.69 -31.99 69.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.446 . . . . 74.33 110.86 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.907 HG21 HG21 ' A' ' 393' ' ' ILE . 29.4 mm -57.98 -44.9 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 75.2 111.093 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 330' ' ' ASP . 6.0 mt -53.66 -44.39 57.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 75.03 111.181 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 -56.08 -13.85 2.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 74.23 110.93 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 11.7 t -76.32 -30.56 57.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 75.52 110.9 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.752 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . -133.78 165.34 37.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.554 0.693 . . . . 70.44 111.114 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.752 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 53.8 Cg_endo -69.75 148.75 65.85 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.675 2.25 . . . . 73.22 112.342 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -7.64 21.58 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.716 2.278 . . . . 62.53 112.313 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -43.8 40.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.224 -0.444 . . . . 72.43 110.806 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.1 p -81.6 139.73 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 72.34 111.077 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 341' ' ' THR . . . . . 0.488 HG22 ' CA ' ' A' ' 386' ' ' HIS . 34.7 p -138.46 69.09 1.38 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 73.22 111.171 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.476 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 98.6 m -133.59 124.96 27.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 65.23 111.088 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -85.6 126.47 33.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 75.2 111.064 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.818 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -106.4 134.29 49.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 72.31 110.907 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.818 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.8 mp -135.41 110.97 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 72.1 111.126 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -100.03 161.08 19.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.696 -0.764 . . . . 62.23 112.419 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 1.0 OUTLIER 81.09 50.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.775 0.321 . . . . 74.34 110.882 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.647 HG23 ' HD2' ' A' ' 349' ' ' PRO . 46.5 mt -104.1 138.2 19.46 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.619 0.723 . . . . 71.22 111.149 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 349' ' ' PRO . . . . . 0.843 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.3 Cg_endo -69.78 166.48 27.47 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.732 2.288 . . . . 73.53 112.308 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -74.24 -29.66 61.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 70.32 110.884 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -83.5 12.87 5.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 61.03 110.908 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.843 ' HB2' ' HG2' ' A' ' 349' ' ' PRO . . . -99.15 102.59 14.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 41.44 111.122 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 22.3 p -105.02 172.0 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 72.34 111.112 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 354' ' ' GLU . . . . . 0.505 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.3 OUTLIER -65.6 -30.25 70.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 73.51 110.845 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -57.25 -26.29 60.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 74.32 111.095 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.89 -18.68 12.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 71.35 110.868 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.839 HD11 ' HB1' ' A' ' 352' ' ' ALA . 4.6 mp -92.68 -52.51 4.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 51.35 110.957 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.656 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -41.76 -51.1 9.74 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.609 0.718 . . . . 70.44 111.122 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 359' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.8 Cg_endo -69.7 -30.15 23.01 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.669 2.246 . . . . 70.32 112.353 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.925 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -66.46 -23.96 66.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 63.2 110.912 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.564 ' CE2' HD12 ' A' ' 360' ' ' LEU . 81.3 m-85 -101.45 -27.43 13.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 73.33 110.919 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 362' ' ' GLN . . . . . 0.539 ' N ' HD11 ' A' ' 367' ' ' ILE . 0.0 OUTLIER -56.57 -22.93 36.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 65.52 110.852 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -71.29 -10.38 59.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 72.31 110.89 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' PHE . . . . . 0.435 ' HE2' ' HG ' ' A' ' 392' ' ' CYS . 23.6 m-85 -93.17 18.59 9.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.911 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 130.07 -96.02 0.36 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 32.11 112.506 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -152.55 150.8 29.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.767 0.318 . . . . 74.52 110.943 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' ILE . . . . . 0.539 HD11 ' N ' ' A' ' 362' ' ' GLN . 45.8 mt -121.42 109.86 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 75.02 111.149 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.75 -18.71 28.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 74.24 110.922 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.27 120.8 0.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 72.34 110.906 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 29.4 t80 -112.36 145.4 40.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 63.45 110.902 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.82 101.16 4.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.469 . . . . 75.45 110.848 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 372' ' ' HIS . . . . . 0.413 ' HB2' ' CE2' ' A' ' 370' ' ' PHE . 40.2 t60 -94.99 117.35 29.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 63.43 110.846 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -109.7 83.64 2.84 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.657 0.741 . . . . 71.14 110.846 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 374' ' ' PRO . . . . . 0.404 ' HD3' ' CD2' ' A' ' 372' ' ' HIS . 52.7 Cg_endo -69.86 -17.97 36.81 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.691 2.261 . . . . 42.43 112.304 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.28 -27.19 61.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 72.12 110.862 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -110.52 -27.29 9.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 53.33 110.856 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 94.25 43.51 3.74 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 64.42 112.476 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 79.7 m -154.8 152.93 30.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.827 0.346 . . . . 73.31 110.918 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 16.0 p -136.21 152.49 50.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 75.01 110.879 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.476 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 48.6 m-85 -129.02 124.79 35.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.43 110.869 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.508 ' CG2' HG23 ' A' ' 367' ' ' ILE . 0.7 OUTLIER -117.35 123.28 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 73.1 111.172 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -89.55 136.19 33.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 74.34 110.886 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -119.63 -178.63 3.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 70.34 110.925 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.75 -42.57 40.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.496 . . . . 71.21 110.874 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 55.4 p -127.97 170.3 13.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 74.42 111.104 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' HIS . . . . . 0.488 ' CA ' HG22 ' A' ' 341' ' ' THR . 29.3 p-80 -80.41 -35.31 35.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 71.24 110.823 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -59.42 -27.18 65.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 52.21 110.938 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.84 -34.28 62.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 75.42 110.879 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.404 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -69.04 -44.09 73.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 65.12 111.081 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.889 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -50.22 -28.85 8.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 63.4 111.082 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.57 -40.07 79.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 60.24 111.156 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' CYS . . . . . 0.435 ' HG ' ' HE2' ' A' ' 364' ' ' PHE . 45.4 t -69.93 -33.61 72.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 73.34 110.892 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.907 HG21 HG21 ' A' ' 332' ' ' ILE . 0.9 OUTLIER -53.2 -55.61 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 45.22 111.19 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.5 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.0 t -71.47 -40.82 72.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 53.43 111.141 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.09 -16.75 54.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 72.34 111.102 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.581 HD12 HG12 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -115.91 -8.7 11.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 63.21 110.934 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -59.23 108.43 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 74.2 111.136 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 11.1 m120 47.98 49.37 17.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 73.13 110.911 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.5 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -108.62 142.75 26.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.694 0.759 . . . . 73.53 110.884 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.499 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 54.1 Cg_endo -69.71 145.52 57.72 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.702 2.268 . . . . 71.55 112.306 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 401' ' ' PHE . . . . . 0.485 ' N ' ' O ' ' A' ' 404' ' ' ARG . 50.4 t80 -152.77 110.61 3.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 74.01 110.797 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 49.54 39.9 18.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.508 . . . . 63.25 110.948 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 81.72 10.48 84.18 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.775 -0.726 . . . . 71.31 112.478 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -135.02 132.73 38.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.855 0.36 . . . . 70.01 110.909 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.531 ' C ' HD23 ' A' ' 406' ' ' LEU . 34.5 m120 -82.54 146.02 29.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 42.51 110.88 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.707 ' HB3' HG23 ' A' ' 345' ' ' ILE . 6.3 mt -112.02 172.6 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 74.52 110.941 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 407' ' ' ARG . . . . . 0.478 ' O ' HG23 ' A' ' 408' ' ' THR . 0.0 OUTLIER -123.16 177.2 5.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 73.51 110.837 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 408' ' ' THR . . . . . 0.642 HG21 ' O ' ' A' ' 393' ' ' ILE . 19.9 p -157.47 163.4 38.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 54.13 111.146 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.751 . . . . 32.33 112.512 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.836 0.35 . . . . 74.5 110.842 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -47.96 -25.27 1.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 71.13 111.117 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 329' ' ' VAL . . . . . 0.878 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 14.2 t -83.43 -29.72 7.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 71.42 111.079 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.432 ' HA ' HD12 ' A' ' 333' ' ' ILE . 5.2 t0 -53.94 -35.26 61.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 73.32 110.872 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -68.89 -31.78 70.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 74.33 110.82 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.693 HG21 HG21 ' A' ' 393' ' ' ILE . 31.4 mm -58.38 -51.69 68.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 75.2 111.151 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 330' ' ' ASP . 4.8 mt -51.67 -42.54 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 75.03 111.192 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -53.66 -16.39 1.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 74.23 110.889 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 6.1 t -88.47 -25.67 22.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 75.52 110.816 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -116.56 151.22 46.8 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.556 0.694 . . . . 70.44 111.16 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.526 ' O ' HG12 ' A' ' 340' ' ' VAL . 54.9 Cg_endo -69.74 161.71 44.89 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.753 2.302 . . . . 73.22 112.374 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -8.43 23.57 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.704 2.269 . . . . 62.53 112.366 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -109.25 63.47 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 72.43 110.882 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 337' ' ' PRO . 9.2 p -175.15 126.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.451 . . . . 72.34 111.131 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 21.5 p -137.88 73.46 1.44 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 73.22 111.146 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 71.1 m -132.86 124.24 27.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 65.23 111.148 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -93.77 116.33 28.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 75.2 111.157 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.84 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -101.55 134.29 44.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.424 . . . . 72.31 110.864 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.84 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.8 mp -133.43 112.22 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 72.1 111.155 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -97.31 176.63 31.67 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.75 -0.738 . . . . 62.23 112.482 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.3 t30 65.68 49.85 1.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.777 0.322 . . . . 74.34 110.847 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.552 HG23 ' HD2' ' A' ' 349' ' ' PRO . 74.3 mt -104.98 135.4 19.3 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.614 0.721 . . . . 71.22 111.124 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 349' ' ' PRO . . . . . 0.673 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 55.2 Cg_endo -69.74 164.86 32.94 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.692 2.261 . . . . 73.53 112.42 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -72.5 -23.34 61.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 70.32 110.893 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -92.9 28.73 2.0 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.47 . . . . 61.03 110.854 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.828 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -113.63 87.6 2.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 41.44 111.188 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 38.1 p -87.92 171.29 10.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.201 -0.454 . . . . 72.34 111.144 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 354' ' ' GLU . . . . . 0.506 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -66.94 -29.81 69.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 73.51 110.925 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.21 -26.3 50.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.047 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.15 -13.28 13.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 71.35 110.903 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.828 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.3 mp -98.52 -53.88 3.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 51.35 110.967 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.649 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -41.17 -51.37 7.89 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.671 0.748 . . . . 70.44 111.15 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 359' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.9 Cg_endo -69.76 -31.56 20.3 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.704 2.269 . . . . 70.32 112.348 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.911 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -63.98 -23.52 67.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 63.2 110.898 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.611 ' CE2' HD12 ' A' ' 360' ' ' LEU . 86.9 m-85 -102.07 -33.64 9.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.938 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -54.06 -31.8 52.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 65.52 110.927 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -57.2 -21.02 30.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 72.31 110.86 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 41.6 m-85 -72.02 -57.4 4.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.883 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -155.87 -86.28 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.721 . . . . 32.11 112.483 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -152.41 143.55 23.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 74.52 110.952 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' ILE . . . . . 0.457 HG23 ' CG2' ' A' ' 381' ' ' ILE . 41.4 mt -120.81 109.17 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 75.02 111.109 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.27 -21.18 27.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 74.24 110.91 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.56 121.5 0.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 72.34 110.881 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.513 ' CD2' HG12 ' A' ' 358' ' ' ILE . 39.1 t80 -115.23 138.95 50.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 63.45 110.836 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -127.68 100.7 6.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 75.45 110.852 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 372' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 10.8 t-80 -94.98 119.46 33.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 63.43 110.826 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -113.37 85.58 8.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.67 0.747 . . . . 71.14 110.873 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 374' ' ' PRO . . . . . 0.509 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 53.7 Cg_endo -69.83 -29.8 22.95 Favored 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.706 2.27 . . . . 42.43 112.407 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.02 -17.02 64.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 72.12 110.869 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -116.36 -27.74 6.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 53.33 110.901 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.81 39.96 5.71 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.696 -0.764 . . . . 64.42 112.526 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 99.6 m -156.84 145.94 20.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.787 0.327 . . . . 73.31 110.877 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 20.7 p -134.76 153.76 51.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 75.01 110.892 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 380' ' ' PHE . 2.5 m-85 -129.28 131.67 47.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 73.43 110.89 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.543 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -122.8 119.65 58.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 73.1 111.063 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.98 134.02 33.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 74.34 110.909 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -115.36 -178.6 3.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 70.34 110.893 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -86.51 -29.14 22.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 71.21 110.873 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 66.0 p -129.54 166.25 20.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 74.42 111.156 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -80.65 -38.41 29.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 71.24 110.849 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -60.88 -29.88 69.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 52.21 110.861 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -35.56 80.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 75.42 110.875 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -75.63 -38.11 59.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 65.12 111.046 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.878 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -60.29 -36.57 78.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 63.4 111.102 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 20.0 t -66.37 -33.38 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 60.24 111.129 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' CYS . . . . . 0.535 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 2.0 t -83.93 -23.85 30.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 73.34 110.847 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.797 ' O ' HG21 ' A' ' 408' ' ' THR . 13.4 mt -59.9 -57.93 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.262 -0.426 . . . . 45.22 111.107 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.517 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.7 t -72.1 -36.22 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 53.43 111.07 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -61.79 -22.71 65.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 72.34 111.086 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.715 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.2 mm? -104.12 -10.6 17.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 63.21 110.873 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -57.5 119.95 7.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 74.2 111.076 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.8 m120 44.25 36.53 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 73.13 110.845 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.715 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -95.53 141.74 23.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.66 0.743 . . . . 73.53 110.844 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.462 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.5 Cg_endo -69.76 147.41 62.78 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.622 2.215 . . . . 71.55 112.372 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 401' ' ' PHE . . . . . 0.534 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 61.2 t80 -154.52 110.79 3.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 74.01 110.836 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 51.42 33.5 10.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 63.25 110.886 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 87.57 13.25 65.58 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.724 -0.751 . . . . 71.31 112.465 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 401' ' ' PHE . 19.3 mtt180 -140.57 135.75 32.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 70.01 110.882 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.549 ' O ' HD23 ' A' ' 406' ' ' LEU . 15.8 m-80 -78.93 150.78 32.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 42.51 110.878 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.647 ' HB3' HG23 ' A' ' 345' ' ' ILE . 11.2 mt -120.3 162.8 18.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.246 -0.434 . . . . 74.52 110.924 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.39 175.24 5.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 73.51 110.883 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 408' ' ' THR . . . . . 0.797 HG21 ' O ' ' A' ' 393' ' ' ILE . 2.1 p -154.38 155.59 35.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 54.13 111.179 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 C-N-CA 120.776 -0.726 . . . . 32.33 112.544 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.778 0.323 . . . . 74.5 110.863 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.33 -24.81 30.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 71.13 111.05 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 329' ' ' VAL . . . . . 0.829 HG22 ' HB ' ' A' ' 394' ' ' VAL . 19.4 t -76.88 -29.97 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 71.42 111.1 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -54.61 -40.84 69.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 73.32 110.878 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -62.7 -32.73 73.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 74.33 110.912 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.845 HG21 HG21 ' A' ' 393' ' ' ILE . 30.9 mm -57.57 -43.49 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 75.2 111.124 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 18.2 mt -58.23 -32.6 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 75.03 111.112 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -4.32 11.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 74.23 110.834 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.69 38.91 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 75.52 110.901 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.704 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . 179.56 164.44 0.78 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.525 0.678 . . . . 70.44 111.18 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.704 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 53.6 Cg_endo -69.68 159.66 52.62 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.744 2.296 . . . . 73.22 112.373 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -24.67 29.41 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.723 2.282 . . . . 62.53 112.339 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -104.24 73.51 1.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 72.43 110.854 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 337' ' ' PRO . 9.5 p -167.91 128.94 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 72.34 111.09 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 341' ' ' THR . . . . . 0.415 HG22 ' CA ' ' A' ' 386' ' ' HIS . 19.8 p -137.41 68.07 1.42 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 73.22 111.093 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 66.4 m -133.87 116.36 15.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.204 -0.453 . . . . 65.23 111.117 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -86.61 127.01 34.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 75.2 111.107 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.823 ' O ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -105.75 135.04 47.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 72.31 110.886 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.823 HD12 ' O ' ' A' ' 344' ' ' TYR . 1.7 mp -132.94 116.96 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 72.1 111.179 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -107.01 173.87 19.43 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.681 -0.771 . . . . 62.23 112.464 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.3 t30 65.68 53.09 1.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.752 0.31 . . . . 74.34 110.826 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.667 HG23 ' HD2' ' A' ' 349' ' ' PRO . 80.0 mt -102.86 138.75 19.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.564 0.697 . . . . 71.22 111.165 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 349' ' ' PRO . . . . . 0.667 ' HD2' HG23 ' A' ' 348' ' ' ILE . 53.2 Cg_endo -69.78 166.24 28.28 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.7 2.266 . . . . 73.53 112.325 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -74.18 -22.62 59.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 70.32 110.888 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.437 ' CE1' ' CB ' ' A' ' 349' ' ' PRO . 2.7 p90 -91.27 27.15 1.99 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 61.03 110.857 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.764 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -111.67 111.91 23.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 41.44 111.105 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 18.3 p -117.64 168.48 10.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 72.34 111.15 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 354' ' ' GLU . . . . . 0.52 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.2 OUTLIER -62.82 -30.43 71.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 73.51 110.909 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.93 67.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.096 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.14 -12.93 13.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 71.35 110.909 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.764 HD11 ' HB1' ' A' ' 352' ' ' ALA . 2.9 mp -100.51 -51.07 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 51.35 110.886 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.657 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -40.86 -51.03 7.37 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.641 0.734 . . . . 70.44 111.106 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 359' ' ' PRO . . . . . 0.657 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.8 Cg_endo -69.67 -31.1 21.61 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.69 2.26 . . . . 70.32 112.385 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.994 ' O ' HD12 ' A' ' 360' ' ' LEU . 0.1 OUTLIER -64.47 -27.31 68.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 63.2 110.889 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.766 ' HB2' HD11 ' A' ' 367' ' ' ILE . 86.5 m-85 -95.28 -32.01 13.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 73.33 110.902 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -57.78 -35.55 70.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 65.52 110.95 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -54.71 -24.17 20.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 72.31 110.866 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -69.26 -57.75 4.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 73.33 110.876 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -154.66 -83.45 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.711 -0.757 . . . . 32.11 112.45 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -153.31 143.48 22.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.343 . . . . 74.52 110.892 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' ILE . . . . . 0.766 HD11 ' HB2' ' A' ' 361' ' ' PHE . 18.9 mt -121.01 109.16 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 75.02 111.096 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.29 -16.92 25.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 74.24 110.92 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -170.35 121.22 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 72.34 110.884 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 29.9 t80 -114.51 145.41 41.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 63.45 110.897 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.99 100.65 4.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 75.45 110.875 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 372' ' ' HIS . . . . . 0.414 ' HB2' ' CE2' ' A' ' 370' ' ' PHE . 23.3 t60 -96.5 118.34 32.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 63.43 110.868 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -109.18 85.21 3.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.699 0.761 . . . . 71.14 110.949 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -17.88 37.59 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.244 . . . . 42.43 112.369 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.16 -18.29 57.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 72.12 110.934 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.13 -25.56 7.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 53.33 110.946 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 91.99 31.11 9.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.782 -0.723 . . . . 64.42 112.509 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 57.8 m -143.23 154.45 43.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.76 0.314 . . . . 73.31 110.875 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 19.7 p -143.61 143.79 31.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 75.01 110.975 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -121.99 139.21 53.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.262 -0.426 . . . . 73.43 110.906 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.635 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -128.58 128.71 68.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 73.1 111.146 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -93.08 129.53 39.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 74.34 110.843 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -111.52 -178.61 3.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 70.34 110.96 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -82.54 -43.91 16.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 71.21 110.823 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 36.2 p -115.84 166.57 11.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 74.42 111.115 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' HIS . . . . . 0.415 ' CA ' HG22 ' A' ' 341' ' ' THR . 22.9 p-80 -85.28 -39.57 17.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 71.24 110.937 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.05 -27.11 63.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 52.21 110.888 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.27 -52.19 36.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.42 110.912 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.439 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -51.77 -41.19 61.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 65.12 111.082 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.684 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -52.42 -34.12 46.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 63.4 111.094 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 15.0 t -67.42 -43.24 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 60.24 111.119 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 9.9 t -69.35 -33.65 73.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 73.34 110.85 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.845 HG21 HG21 ' A' ' 332' ' ' ILE . 0.7 OUTLIER -54.0 -54.98 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 45.22 111.133 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.829 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.5 OUTLIER -71.5 -37.52 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 53.43 111.117 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.62 -21.13 66.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 72.34 111.078 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.612 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.7 mm? -106.53 -10.93 16.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.259 -0.428 . . . . 63.21 110.861 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -58.9 114.71 2.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.2 111.091 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' ASN . . . . . 0.453 ' C ' ' OD1' ' A' ' 405' ' ' ASN . 2.9 t-20 42.7 43.06 3.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 73.13 110.888 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.612 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -101.18 144.38 28.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.598 0.714 . . . . 73.53 110.902 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.455 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.8 Cg_endo -69.75 142.04 46.89 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.76 2.307 . . . . 71.55 112.323 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 401' ' ' PHE . . . . . 0.611 ' CZ ' ' NE2' ' A' ' 402' ' ' GLN . 75.5 t80 -152.81 110.95 3.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 74.01 110.907 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 402' ' ' GLN . . . . . 0.611 ' NE2' ' CZ ' ' A' ' 401' ' ' PHE . 0.9 OUTLIER 53.86 32.6 15.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 63.25 110.917 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 94.86 -19.84 51.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.776 -0.725 . . . . 71.31 112.473 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 401' ' ' PHE . 8.6 mmt180 -110.99 141.01 45.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.782 0.325 . . . . 70.01 110.897 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.474 ' C ' HD23 ' A' ' 406' ' ' LEU . 0.5 OUTLIER -86.79 149.91 24.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 42.51 110.918 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.589 HD13 HG21 ' A' ' 345' ' ' ILE . 10.1 mt -113.78 171.84 7.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 74.52 110.941 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 407' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 345' ' ' ILE . 1.1 tpt85 -123.41 179.19 4.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 73.51 110.838 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 408' ' ' THR . . . . . 0.592 HG21 ' O ' ' A' ' 393' ' ' ILE . 33.9 p -155.88 170.07 22.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 54.13 111.189 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.776 -0.726 . . . . 32.33 112.48 179.925 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 327' ' ' GLN . . . . . 0.404 ' O ' ' HB3' ' A' ' 330' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.762 0.315 . . . . 74.5 110.897 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -57.63 -26.28 61.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 71.13 111.094 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 329' ' ' VAL . . . . . 0.788 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 16.1 t -78.74 -29.93 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 71.42 111.146 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 327' ' ' GLN . 3.8 t0 -54.13 -38.85 65.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.876 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -65.6 -31.82 73.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 74.33 110.808 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.876 HG21 HD13 ' A' ' 393' ' ' ILE . 46.1 mm -55.55 -48.95 76.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 75.2 111.092 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 8.8 mt -55.06 -32.1 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 75.03 111.201 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.75 -7.19 7.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 74.23 110.942 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 23.0 t -102.63 11.62 37.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 75.52 110.884 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.427 ' HB1' HG11 ' A' ' 340' ' ' VAL . . . -158.78 150.02 16.51 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.596 0.713 . . . . 70.44 111.104 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.642 ' O ' HG12 ' A' ' 340' ' ' VAL . 54.7 Cg_endo -69.73 164.46 34.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.736 2.291 . . . . 73.22 112.341 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -11.68 31.33 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.625 2.217 . . . . 62.53 112.398 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -101.21 55.05 0.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 72.43 110.905 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 337' ' ' PRO . 9.8 p -168.79 126.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 72.34 111.144 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 341' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 386' ' ' HIS . 21.7 p -142.61 70.95 1.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 73.22 111.188 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 54.5 m -133.72 123.87 25.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 65.23 111.124 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -89.97 134.4 34.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 75.2 111.133 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.656 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -114.14 134.38 54.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 72.31 110.932 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.714 HG21 HD13 ' A' ' 406' ' ' LEU . 1.7 mp -132.07 113.22 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.504 . . . . 72.1 111.148 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -103.89 168.73 17.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.761 . . . . 62.23 112.501 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 405' ' ' ASN . 2.3 t30 72.22 54.19 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 74.34 110.958 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.692 HG23 ' HD2' ' A' ' 349' ' ' PRO . 87.7 mt -108.45 138.87 20.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.564 0.697 . . . . 71.22 111.178 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 349' ' ' PRO . . . . . 0.692 ' HD2' HG23 ' A' ' 348' ' ' ILE . 53.3 Cg_endo -69.85 164.89 32.96 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.714 2.276 . . . . 73.53 112.313 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -77.49 -10.96 59.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 70.32 110.829 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.58 ' CD2' ' HB2' ' A' ' 349' ' ' PRO . 31.8 p90 -97.38 1.21 49.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 61.03 110.927 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.871 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -89.29 111.85 22.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 41.44 111.049 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 74.2 p -112.06 173.51 6.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.18 -0.464 . . . . 72.34 111.106 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 354' ' ' GLU . . . . . 0.498 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -67.01 -29.53 69.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 73.51 110.866 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -59.02 -26.38 64.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 74.32 111.159 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.27 -15.62 13.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 71.35 110.861 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.871 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.8 mp -94.77 -51.03 4.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 51.35 110.883 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.683 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.2 mm -43.89 -49.87 20.24 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.677 0.751 . . . . 70.44 111.184 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 359' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.7 Cg_endo -69.83 -20.41 34.56 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.672 2.248 . . . . 70.32 112.352 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.925 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -77.99 -25.39 48.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 63.2 110.968 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.698 ' HB2' HD11 ' A' ' 367' ' ' ILE . 85.7 m-85 -98.76 -30.08 12.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.33 110.941 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 362' ' ' GLN . . . . . 0.459 ' HG2' HD12 ' A' ' 367' ' ' ILE . 2.0 mm-40 -57.64 -42.98 84.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 65.52 110.912 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -47.02 -21.67 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 72.31 110.901 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 364' ' ' PHE . . . . . 0.484 ' HE2' ' HG ' ' A' ' 392' ' ' CYS . 21.5 m-85 -71.98 -54.49 9.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 73.33 110.922 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -161.39 -85.62 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.74 -0.743 . . . . 32.11 112.456 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -153.56 142.29 20.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.775 0.321 . . . . 74.52 110.86 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' ILE . . . . . 0.698 HD11 ' HB2' ' A' ' 361' ' ' PHE . 40.3 mt -120.78 109.46 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 75.02 111.208 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.75 -17.52 38.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.466 . . . . 74.24 110.964 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.72 121.33 0.58 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 72.34 110.9 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.578 ' CE1' ' HB3' ' A' ' 379' ' ' CYS . 25.2 t80 -114.97 123.54 49.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 63.45 110.858 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.19 99.2 7.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 75.45 110.877 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -95.29 120.6 35.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.436 . . . . 63.43 110.878 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 374' ' ' PRO . 25.6 m-85 -113.96 92.28 25.29 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.7 0.762 . . . . 71.14 110.916 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 374' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 373' ' ' TYR . 54.0 Cg_endo -69.7 -18.2 37.43 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.692 2.261 . . . . 42.43 112.375 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -78.18 -37.11 46.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 72.12 110.841 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -99.79 -18.01 17.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 53.33 110.897 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 75.07 43.67 25.83 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.764 -0.731 . . . . 64.42 112.468 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 1.6 p -151.93 143.45 23.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.758 0.313 . . . . 73.31 110.962 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.578 ' HB3' ' CE1' ' A' ' 370' ' ' PHE . 61.3 m -124.3 153.34 41.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 75.01 110.947 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -130.47 104.26 7.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 73.43 110.85 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.493 HG12 ' CD1' ' A' ' 370' ' ' PHE . 0.5 OUTLIER -105.0 129.24 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 73.1 111.155 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -102.01 136.83 41.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 74.34 110.923 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -118.18 172.34 7.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 70.34 110.931 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.62 -37.3 59.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 71.21 110.857 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 59.3 p -115.96 169.83 8.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 74.42 111.154 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' HIS . . . . . 0.539 ' HA ' HG22 ' A' ' 341' ' ' THR . 51.5 p-80 -85.64 -38.93 17.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 71.24 110.939 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -60.54 -30.18 69.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.182 -0.463 . . . . 52.21 110.929 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -62.17 -38.57 89.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 75.42 110.852 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.456 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -75.94 -33.62 59.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 65.12 111.168 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.788 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -55.91 -35.37 66.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 63.4 111.066 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 25.6 t -69.13 -46.62 77.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 60.24 111.057 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' CYS . . . . . 0.484 ' HG ' ' HE2' ' A' ' 364' ' ' PHE . 48.8 t -56.18 -31.1 63.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 73.34 110.933 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.876 HD13 HG21 ' A' ' 332' ' ' ILE . 1.1 mt -59.8 -56.36 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 45.22 111.154 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.516 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.1 t -71.68 -38.48 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 53.43 111.154 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -58.56 -48.07 82.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 72.34 111.099 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.631 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.9 mm? -85.48 -10.35 56.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 63.21 110.865 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 397' ' ' ALA . . . . . 0.66 ' N ' HG21 ' A' ' 408' ' ' THR . . . -50.66 108.44 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 74.2 111.086 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 42.99 43.45 3.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 73.13 110.916 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.631 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -96.75 145.5 29.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.696 0.76 . . . . 73.53 110.884 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 144.13 52.93 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.647 2.231 . . . . 71.55 112.39 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' PHE . . . . . 0.525 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 41.9 t80 -151.03 113.23 4.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 74.01 110.887 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 49.47 32.93 5.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 63.25 110.871 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.6 -28.36 15.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 71.31 112.51 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.9 OUTLIER -105.52 141.05 37.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.361 . . . . 70.01 110.847 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.448 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 14.3 m120 -82.68 154.92 24.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 42.51 110.923 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.714 HD13 HG21 ' A' ' 345' ' ' ILE . 10.9 mt -114.35 173.8 6.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 74.52 110.892 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 407' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 346' ' ' GLY . 0.0 OUTLIER -113.92 171.93 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 73.51 110.89 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 408' ' ' THR . . . . . 0.66 HG21 ' N ' ' A' ' 397' ' ' ALA . 64.3 p -154.18 154.19 33.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 54.13 111.098 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 32.33 112.508 179.956 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.879 0.371 . . . . 74.5 110.862 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -49.28 -24.3 1.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 71.13 111.064 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 329' ' ' VAL . . . . . 0.872 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 10.8 t -80.89 -29.18 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 71.42 111.146 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -53.42 -37.72 62.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.108 -0.496 . . . . 73.32 110.876 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 331' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 334' ' ' ARG . 3.3 t60 -66.07 -31.63 72.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 74.33 110.796 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.69 HG21 HD13 ' A' ' 393' ' ' ILE . 27.4 mm -56.36 -47.74 80.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 75.2 111.098 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 9.5 mt -54.12 -26.16 14.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 75.03 111.051 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 334' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 331' ' ' HIS . 0.0 OUTLIER -71.66 2.11 5.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 74.23 110.926 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.69 31.79 6.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 75.52 110.868 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.945 ' HB1' HG11 ' A' ' 340' ' ' VAL . . . -174.32 151.15 1.6 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.535 0.684 . . . . 70.44 111.104 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.73 ' O ' HG12 ' A' ' 340' ' ' VAL . 54.8 Cg_endo -69.74 169.93 17.74 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.677 2.251 . . . . 73.22 112.353 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.84 -9.2 25.5 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.609 2.206 . . . . 62.53 112.356 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -115.41 64.1 0.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 72.43 110.899 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.945 HG11 ' HB1' ' A' ' 336' ' ' ALA . 7.9 p -160.38 129.19 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 72.34 111.073 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.96 69.2 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 73.22 111.102 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.485 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 45.0 m -131.42 108.88 9.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 65.23 111.224 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -80.28 111.3 16.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 75.2 111.061 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.571 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -93.78 118.8 31.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 72.31 110.953 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.55 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.9 mp -119.47 117.52 54.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 72.1 111.15 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -107.98 -173.3 21.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.706 -0.759 . . . . 62.23 112.521 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.95 47.52 12.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.807 0.337 . . . . 74.34 110.895 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 34.2 mt -99.43 132.62 22.93 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.658 0.742 . . . . 71.22 111.163 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 349' ' ' PRO . . . . . 0.489 ' CG ' ' CE1' ' A' ' 351' ' ' PHE . 53.6 Cg_endo -69.82 161.89 44.22 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.621 2.214 . . . . 73.53 112.328 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -69.01 -21.01 64.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 70.32 110.813 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.489 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 7.1 p90 -90.85 30.74 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 61.03 110.878 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.625 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -116.23 124.82 51.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 41.44 111.098 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 14.3 p -126.54 167.71 15.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 72.34 111.128 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 354' ' ' GLU . . . . . 0.507 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -64.99 -34.06 77.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 73.51 110.876 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.23 -26.35 50.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.32 111.128 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.27 -13.12 13.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 71.35 110.865 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.625 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.5 mp -99.52 -54.21 3.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 51.35 110.895 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.622 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -39.81 -52.07 5.18 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.692 0.758 . . . . 70.44 111.199 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 359' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.2 Cg_endo -69.72 -39.51 6.49 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.612 2.208 . . . . 70.32 112.353 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.922 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -53.85 -25.36 19.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 63.2 110.87 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.864 ' HB2' HD11 ' A' ' 367' ' ' ILE . 85.5 m-85 -95.78 -37.22 10.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 73.33 110.894 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 362' ' ' GLN . . . . . 0.6 ' HG2' HD12 ' A' ' 367' ' ' ILE . 3.8 mt-30 -50.01 -46.46 52.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 65.52 110.879 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 363' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.6 OUTLIER -44.46 -25.08 0.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 72.31 110.79 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 364' ' ' PHE . . . . . 0.536 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 30.5 m-85 -70.1 -60.24 2.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 73.33 110.841 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -150.42 -86.64 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.79 -0.719 . . . . 32.11 112.511 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 368' ' ' LEU . 11.8 t80 -153.43 141.61 20.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.786 0.327 . . . . 74.52 110.898 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 367' ' ' ILE . . . . . 0.864 HD11 ' HB2' ' A' ' 361' ' ' PHE . 23.9 mt -120.36 113.48 40.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 75.02 111.101 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 369' ' ' ASP . 2.7 pp -100.45 -14.84 18.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 74.24 110.862 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.53 ' N ' HD12 ' A' ' 368' ' ' LEU . 10.0 t0 -167.67 120.81 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 72.34 110.836 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 28.4 t80 -117.54 134.85 54.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 63.45 110.9 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -120.56 101.5 7.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 75.45 110.891 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 372' ' ' HIS . . . . . 0.4 ' HB2' ' CE2' ' A' ' 370' ' ' PHE . 12.6 t-80 -97.49 135.7 38.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 63.43 110.906 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -130.75 85.69 54.86 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 121.649 0.738 . . . . 71.14 110.967 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -22.58 31.73 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.638 2.226 . . . . 42.43 112.349 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -72.93 -19.39 61.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 72.12 110.911 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.49 -27.57 6.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 53.33 110.91 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 89.8 43.82 5.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.715 -0.755 . . . . 64.42 112.492 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 43.6 m -155.93 149.2 24.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.774 0.321 . . . . 73.31 110.886 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 15.5 p -140.79 144.14 35.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 75.01 110.909 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.485 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 18.9 m-85 -122.86 128.81 50.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 73.43 110.877 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.577 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -117.92 119.37 61.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 73.1 111.124 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -88.39 127.07 35.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 74.34 110.94 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -106.08 171.59 7.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.428 . . . . 70.34 110.946 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -65.29 -37.5 87.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.093 -0.503 . . . . 71.21 110.897 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 58.6 p -130.12 178.02 6.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 74.42 111.179 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -83.21 -39.42 20.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 71.24 110.869 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -57.97 -27.1 63.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 52.21 110.877 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -37.18 77.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 75.42 110.858 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -75.77 -36.6 59.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 65.12 111.086 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.872 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -55.34 -32.95 62.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 63.4 111.061 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 40.2 t -68.09 -55.57 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 60.24 111.105 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 392' ' ' CYS . . . . . 0.536 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 2.1 t -64.29 -26.1 68.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 73.34 110.881 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.784 HD12 ' HA ' ' A' ' 390' ' ' ALA . 5.6 mt -57.06 -57.2 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 45.22 111.135 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.559 ' O ' ' HB3' ' A' ' 397' ' ' ALA . 2.5 t -73.06 -40.3 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 53.43 111.16 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -53.6 -51.47 62.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 72.34 111.102 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.723 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.9 mm? -75.46 -12.63 60.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 63.21 110.951 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 397' ' ' ALA . . . . . 0.577 ' N ' HG21 ' A' ' 408' ' ' THR . . . -50.49 112.9 0.76 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 74.2 111.076 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 54.8 t30 41.97 49.85 4.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.13 110.855 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.723 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -105.78 146.58 33.12 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.69 0.757 . . . . 73.53 110.825 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.8 137.47 35.42 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.679 2.253 . . . . 71.55 112.362 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' PHE . . . . . 0.537 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 33.8 t80 -141.83 110.78 6.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.01 110.912 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 49.11 32.71 4.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 63.25 110.886 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.45 -29.18 13.06 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.669 -0.776 . . . . 71.31 112.477 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -107.11 139.1 42.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.321 . . . . 70.01 110.866 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -79.18 155.19 28.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 42.51 110.829 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.436 HD11 ' CD2' ' A' ' 401' ' ' PHE . 21.9 mt -118.97 170.32 9.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 74.52 110.884 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.42 175.59 5.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 73.51 110.824 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 408' ' ' THR . . . . . 0.606 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 75.5 p -154.05 155.51 35.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 54.13 111.144 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 C-N-CA 120.811 -0.709 . . . . 32.33 112.55 179.922 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.835 0.35 . . . . 74.5 110.89 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -57.19 -24.87 57.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 71.13 111.074 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 329' ' ' VAL . . . . . 0.782 HG22 ' HB ' ' A' ' 394' ' ' VAL . 23.4 t -76.66 -29.81 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 71.42 111.068 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.419 ' HA ' HD12 ' A' ' 333' ' ' ILE . 17.6 t0 -54.49 -37.75 65.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 73.32 110.84 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -62.82 -31.93 73.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.846 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.458 HG21 HG21 ' A' ' 393' ' ' ILE . 15.3 mm -65.25 -41.83 92.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 75.2 111.114 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 330' ' ' ASP . 31.8 mt -52.29 -48.91 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 75.03 111.059 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.34 -7.03 5.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 74.23 110.879 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 3.1 t -82.43 -31.92 29.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 75.52 110.854 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -116.87 153.97 49.46 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.636 0.732 . . . . 70.44 111.066 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.491 ' O ' HG12 ' A' ' 340' ' ' VAL . 53.4 Cg_endo -69.78 158.88 55.41 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.708 2.272 . . . . 73.22 112.31 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -7.46 21.1 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.716 2.278 . . . . 62.53 112.338 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -101.86 51.0 0.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 72.43 110.848 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 337' ' ' PRO . 9.7 p -175.9 128.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 72.34 111.157 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 341' ' ' THR . . . . . 0.535 HG22 ' HB3' ' A' ' 386' ' ' HIS . 20.4 p -137.1 67.92 1.43 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 73.22 111.207 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 23.3 m -133.76 137.0 44.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 65.23 111.152 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -100.18 129.47 46.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 75.2 111.101 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.745 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -106.28 135.08 48.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 72.31 110.882 -179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.745 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.7 mp -131.87 117.68 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 72.1 111.12 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -106.59 161.62 13.97 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.748 -0.739 . . . . 62.23 112.472 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 0.6 OUTLIER 79.24 49.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 74.34 110.937 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.615 HG23 ' HD2' ' A' ' 349' ' ' PRO . 64.8 mt -103.76 137.72 19.32 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.581 0.705 . . . . 71.22 111.13 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 349' ' ' PRO . . . . . 0.769 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.6 Cg_endo -69.75 165.09 32.11 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.714 2.276 . . . . 73.53 112.307 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -75.88 -17.1 59.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 70.32 110.846 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.588 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 27.1 p90 -99.05 24.11 8.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 61.03 110.886 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.794 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -107.87 93.16 4.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 41.44 111.17 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 46.2 p -90.54 173.51 8.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 72.34 111.173 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 354' ' ' GLU . . . . . 0.506 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -66.96 -29.77 69.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 73.51 110.824 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.01 -26.11 47.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 74.32 111.111 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.81 -13.74 13.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 71.35 110.89 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.794 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.4 mp -98.56 -54.38 3.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 51.35 110.895 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.649 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -40.88 -51.59 7.1 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.684 0.754 . . . . 70.44 111.134 179.846 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 359' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.1 Cg_endo -69.85 -34.08 15.0 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.656 2.237 . . . . 70.32 112.305 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.904 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -61.14 -23.49 65.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 63.2 110.944 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.609 ' CE2' HD12 ' A' ' 360' ' ' LEU . 81.4 m-85 -102.88 -33.67 9.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 73.33 110.912 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 362' ' ' GLN . . . . . 0.601 ' HG3' HD12 ' A' ' 367' ' ' ILE . 0.1 OUTLIER -58.77 -32.72 69.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.5 . . . . 65.52 110.984 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -59.24 -11.25 3.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 72.31 110.924 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' PHE . . . . . 0.566 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 31.3 m-85 -81.01 -60.12 2.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 73.33 110.87 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -149.01 -84.03 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.782 -0.723 . . . . 32.11 112.492 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -152.64 143.61 23.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 74.52 110.852 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' ILE . . . . . 0.601 HD12 ' HG3' ' A' ' 362' ' ' GLN . 55.5 mt -121.0 109.28 24.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 75.02 111.126 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.02 -17.66 24.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.947 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -171.15 121.15 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 72.34 110.863 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.545 ' CD2' HG12 ' A' ' 358' ' ' ILE . 34.6 t80 -113.61 143.42 44.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 63.45 110.946 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.55 101.17 5.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 75.45 110.946 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 372' ' ' HIS . . . . . 0.533 ' CE1' ' HB3' ' A' ' 374' ' ' PRO . 11.2 t-80 -94.61 114.48 26.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 63.43 110.814 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -107.7 84.12 1.86 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.631 0.729 . . . . 71.14 110.874 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 374' ' ' PRO . . . . . 0.533 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 53.6 Cg_endo -69.79 -28.6 24.91 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.661 2.24 . . . . 42.43 112.355 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -63.44 -19.58 64.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 72.12 110.921 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.8 -21.7 7.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 53.33 110.945 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 87.33 38.33 7.79 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.776 -0.726 . . . . 64.42 112.475 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 19.1 p -147.15 153.63 40.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.764 0.316 . . . . 73.31 110.941 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 7.2 p -139.35 151.12 46.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 75.01 110.882 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -131.14 122.73 27.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 73.43 110.888 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.584 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -114.28 126.3 71.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 73.1 111.08 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 10.2 mttp -90.6 133.86 34.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 74.34 110.877 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -116.21 -178.55 3.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 70.34 110.996 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.45 -46.3 16.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 71.21 110.857 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 68.0 p -114.83 170.66 8.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 74.42 111.232 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' HIS . . . . . 0.535 ' HB3' HG22 ' A' ' 341' ' ' THR . 27.1 p-80 -85.64 -44.43 12.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 71.24 110.838 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -57.18 -32.9 66.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 52.21 110.868 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -67.88 -32.56 73.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 75.42 110.888 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -67.1 -39.32 86.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 65.12 111.114 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.597 ' HB1' HG13 ' A' ' 329' ' ' VAL . . . -59.19 -27.88 66.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 63.4 111.097 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.58 -40.94 88.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 60.24 111.158 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' CYS . . . . . 0.566 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 1.5 t -77.78 -27.1 50.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 73.34 110.935 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.722 ' O ' HG21 ' A' ' 408' ' ' THR . 1.2 mp -54.99 -56.67 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 45.22 111.078 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.782 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.9 OUTLIER -73.06 -45.86 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 53.43 111.067 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 395' ' ' ALA . . . . . 0.425 ' N ' HG12 ' A' ' 394' ' ' VAL . . . -52.87 -21.67 4.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 72.34 111.076 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.62 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.2 mm? -106.5 -19.27 13.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 63.21 110.945 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -48.76 114.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 74.2 111.142 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 44.26 46.89 7.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 73.13 110.855 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.62 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -107.03 144.79 29.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.632 0.73 . . . . 73.53 110.848 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.502 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.5 Cg_endo -69.85 145.23 56.04 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.672 2.248 . . . . 71.55 112.333 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 401' ' ' PHE . . . . . 0.565 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 64.6 t80 -152.34 111.81 3.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 74.01 110.908 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.63 33.36 8.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 63.25 110.932 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.4 -27.78 17.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 71.31 112.513 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.482 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -104.75 141.9 35.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.318 . . . . 70.01 110.895 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -86.99 145.15 26.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 42.51 110.936 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.663 HD13 HG21 ' A' ' 345' ' ' ILE . 8.8 mt -107.03 179.88 4.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.239 -0.437 . . . . 74.52 110.905 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 407' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 345' ' ' ILE . 13.5 ttt85 -130.45 177.48 7.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 73.51 110.88 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 408' ' ' THR . . . . . 0.722 HG21 ' O ' ' A' ' 393' ' ' ILE . 17.2 p -156.13 163.48 39.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 54.13 111.124 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 32.33 112.474 179.985 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.757 0.313 . . . . 74.5 110.945 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.66 -32.85 59.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 71.13 111.065 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 329' ' ' VAL . . . . . 0.613 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 11.1 t -70.95 -29.53 37.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 71.42 111.128 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.429 ' HA ' HD12 ' A' ' 333' ' ' ILE . 24.4 t70 -53.99 -34.85 60.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 73.32 110.915 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -68.29 -31.95 71.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 74.33 110.854 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.581 HG21 HD13 ' A' ' 393' ' ' ILE . 37.5 mm -57.05 -51.5 68.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 75.2 111.102 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.95 HG23 ' NE2' ' A' ' 386' ' ' HIS . 4.0 mt -55.19 -27.76 20.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 75.03 111.11 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.71 -12.7 55.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 74.23 110.893 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.43 27.1 9.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 75.52 110.887 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.669 ' HB1' HG11 ' A' ' 340' ' ' VAL . . . -169.41 148.93 3.6 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.472 0.653 . . . . 70.44 111.159 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.843 ' O ' HG12 ' A' ' 340' ' ' VAL . 53.1 Cg_endo -69.81 165.54 30.69 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.69 2.26 . . . . 73.22 112.314 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -15.67 37.02 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.645 2.23 . . . . 62.53 112.363 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -106.01 55.75 0.67 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 72.43 110.917 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.843 HG12 ' O ' ' A' ' 337' ' ' PRO . 14.4 p -156.1 95.24 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 72.34 111.117 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 341' ' ' THR . . . . . 0.624 HG22 ' HA ' ' A' ' 386' ' ' HIS . 18.7 p -113.34 67.73 0.67 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.479 . . . . 73.22 111.133 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.448 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 34.5 m -134.11 128.85 34.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 65.23 111.159 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -96.82 126.23 41.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 75.2 111.11 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.56 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -103.3 133.16 48.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 72.31 110.944 -179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.753 HG21 HD13 ' A' ' 406' ' ' LEU . 2.0 mp -126.72 125.93 67.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 72.1 111.171 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.478 ' H ' ' CB ' ' A' ' 407' ' ' ARG . . . -111.65 166.69 12.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.684 -0.77 . . . . 62.23 112.473 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 6.2 t30 65.03 57.88 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.771 0.319 . . . . 74.34 110.904 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.522 HD11 HG22 ' A' ' 345' ' ' ILE . 97.0 mt -106.64 133.9 20.06 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.629 0.728 . . . . 71.22 111.096 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 349' ' ' PRO . . . . . 0.531 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.7 Cg_endo -69.72 166.51 27.29 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.635 2.224 . . . . 73.53 112.386 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -71.77 -26.52 62.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 70.32 110.824 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -85.51 18.12 2.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 61.03 110.889 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.885 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -101.14 101.81 12.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 41.44 111.086 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 21.1 p -109.55 169.57 8.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 72.34 111.084 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 354' ' ' GLU . . . . . 0.521 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.7 OUTLIER -63.46 -29.75 70.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.161 -0.472 . . . . 73.51 110.907 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -61.94 -25.81 67.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 74.32 111.084 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.98 -16.2 13.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 71.35 110.84 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.885 HD11 ' HB1' ' A' ' 352' ' ' ALA . 4.4 mp -96.7 -49.42 5.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 51.35 110.939 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.671 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.2 mm -42.94 -50.46 13.52 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.619 0.723 . . . . 70.44 111.204 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 359' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.8 Cg_endo -69.75 -37.8 8.7 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.737 2.291 . . . . 70.32 112.35 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.922 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -58.06 -25.35 61.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.445 . . . . 63.2 110.919 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.564 ' N ' HD13 ' A' ' 360' ' ' LEU . 74.1 m-85 -101.62 -38.3 7.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 73.33 110.945 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 362' ' ' GLN . . . . . 0.466 ' N ' HD11 ' A' ' 367' ' ' ILE . 2.6 tt0 -51.36 -37.96 50.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 65.52 110.895 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -49.96 -19.38 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 72.31 110.852 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 364' ' ' PHE . . . . . 0.569 ' CE2' ' SG ' ' A' ' 392' ' ' CYS . 30.3 m-85 -72.3 -54.54 9.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 73.33 110.89 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -158.5 -84.69 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.795 -0.717 . . . . 32.11 112.501 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -153.51 143.1 21.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.815 0.34 . . . . 74.52 110.893 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' ILE . . . . . 0.466 HD11 ' N ' ' A' ' 362' ' ' GLN . 54.1 mt -120.93 109.4 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 75.02 111.122 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.424 HD21 ' OD1' ' A' ' 384' ' ' ASP . 0.4 OUTLIER -86.54 -19.13 29.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 74.24 110.946 179.878 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.48 121.31 0.6 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 72.34 110.891 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 31.7 t80 -112.73 143.02 44.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 63.45 110.919 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 379' ' ' CYS . 1.2 mmtm -128.64 101.64 6.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 75.45 110.858 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 372' ' ' HIS . . . . . 0.549 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 23.9 t60 -99.05 135.42 40.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 63.43 110.816 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -129.17 89.91 46.73 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.712 0.768 . . . . 71.14 110.9 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' PRO . . . . . 0.544 ' HD3' ' CD2' ' A' ' 372' ' ' HIS . 53.6 Cg_endo -69.78 -20.99 34.02 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.706 2.271 . . . . 42.43 112.315 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -74.9 -25.81 59.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 72.12 110.844 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -113.55 -12.32 12.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 53.33 110.857 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 72.28 43.2 47.53 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.722 -0.752 . . . . 64.42 112.486 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 15.6 p -150.45 152.74 34.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.33 . . . . 73.31 110.898 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 14.6 p -146.66 152.75 39.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 75.01 110.851 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.448 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 54.3 m-85 -131.06 122.5 26.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 73.43 110.816 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.425 ' CG2' HG23 ' A' ' 367' ' ' ILE . 0.8 OUTLIER -109.36 126.32 66.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 73.1 111.113 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -92.88 131.08 38.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 74.34 110.853 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -112.34 -174.42 2.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 70.34 110.849 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 384' ' ' ASP . . . . . 0.424 ' OD1' HD21 ' A' ' 368' ' ' LEU . 0.2 OUTLIER -86.75 -46.62 9.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 71.21 110.888 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 61.1 p -115.23 161.91 17.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 74.42 111.137 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' HIS . . . . . 0.95 ' NE2' HG23 ' A' ' 333' ' ' ILE . 75.0 t60 -79.58 -39.76 30.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 71.24 110.882 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.32 -32.74 68.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 52.21 110.798 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -66.37 -36.99 84.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 75.42 110.928 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -68.05 -45.78 72.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 65.12 111.074 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.613 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -50.06 -30.02 10.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 63.4 111.11 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 70.5 t -68.94 -50.72 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 60.24 111.125 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' CYS . . . . . 0.569 ' SG ' ' CE2' ' A' ' 364' ' ' PHE . 1.9 t -58.92 -26.38 64.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.882 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.581 HD13 HG21 ' A' ' 332' ' ' ILE . 0.9 OUTLIER -61.64 -56.26 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 45.22 111.182 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.493 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.1 t -72.03 -46.91 57.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 53.43 111.094 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -60.89 -45.17 95.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 72.34 111.094 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.71 HD11 HD11 ' A' ' 360' ' ' LEU . 0.3 OUTLIER -85.01 -4.89 59.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 63.21 110.9 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 397' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 393' ' ' ILE . . . -58.4 115.24 2.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 74.2 111.085 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 398' ' ' ASN . . . . . 0.45 ' CG ' ' O ' ' A' ' 397' ' ' ALA . 3.3 p-10 48.25 41.09 15.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 73.13 110.907 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.575 ' CD1' ' HG ' ' A' ' 396' ' ' LEU . 0.2 OUTLIER -88.1 145.92 37.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.646 0.736 . . . . 73.53 110.913 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 130.02 18.49 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 2.243 . . . . 71.55 112.325 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' PHE . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 399' ' ' PHE . 64.3 t80 -136.21 111.07 8.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 74.01 110.868 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 52.18 33.18 11.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 63.25 110.911 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 95.57 -22.86 36.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 71.31 112.448 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.28 132.41 53.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.846 0.355 . . . . 70.01 110.888 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.443 ' C ' HD23 ' A' ' 406' ' ' LEU . 0.6 OUTLIER -73.94 148.9 41.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 42.51 110.832 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.753 HD13 HG21 ' A' ' 345' ' ' ILE . 4.2 mt -111.66 178.21 4.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 74.52 110.99 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 407' ' ' ARG . . . . . 0.478 ' CB ' ' H ' ' A' ' 346' ' ' GLY . 3.7 ttt180 -113.46 -179.38 3.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 73.51 110.935 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 408' ' ' THR . . . . . 0.511 HG21 ' N ' ' A' ' 397' ' ' ALA . 33.8 p -153.72 153.93 33.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 54.13 111.107 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 C-N-CA 120.751 -0.737 . . . . 32.33 112.501 179.958 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.804 0.335 . . . . 74.5 110.924 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.8 -25.56 28.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 71.13 111.125 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 329' ' ' VAL . . . . . 0.873 HG22 ' HB ' ' A' ' 394' ' ' VAL . 8.6 t -81.61 -31.26 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 71.42 111.129 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.731 ' HA ' HD12 ' A' ' 333' ' ' ILE . 6.0 t70 -55.03 -38.66 68.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 73.32 110.906 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -59.0 -35.26 72.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 74.33 110.825 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 393' ' ' ILE . 32.4 mm -63.45 -45.9 96.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 75.2 111.166 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 330' ' ' ASP . 8.6 mt -57.14 -25.34 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 75.03 111.206 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -76.2 -1.16 25.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 74.23 110.858 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.94 36.6 4.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 75.52 110.847 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -169.55 147.95 3.24 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.574 0.702 . . . . 70.44 111.091 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.433 ' O ' HG12 ' A' ' 340' ' ' VAL . 53.9 Cg_endo -69.75 165.5 30.76 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.677 2.251 . . . . 73.22 112.375 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -31.9 19.49 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.758 2.305 . . . . 62.53 112.316 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -93.25 72.39 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 72.43 110.857 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 340' ' ' VAL . 3.3 p -178.2 127.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 72.34 111.175 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 341' ' ' THR . . . . . 0.661 HG22 ' HA ' ' A' ' 386' ' ' HIS . 39.4 p -145.74 69.87 1.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 73.22 111.132 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 342' ' ' THR . . . . . 0.463 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 99.8 m -133.63 120.73 21.05 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.211 -0.449 . . . . 65.23 111.174 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -86.47 129.15 34.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 75.2 111.033 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.815 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -111.48 134.77 52.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 72.31 110.936 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.91 HG21 HD13 ' A' ' 406' ' ' LEU . 1.7 mp -126.28 124.47 65.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.051 -0.522 . . . . 72.1 111.166 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.5 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -109.0 154.59 16.42 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 62.23 112.438 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 347' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 1.9 t30 82.82 45.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.859 0.362 . . . . 74.34 110.891 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.513 ' CG2' ' HB3' ' A' ' 352' ' ' ALA . 68.0 mt -99.26 129.85 28.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.642 0.734 . . . . 71.22 111.104 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 349' ' ' PRO . . . . . 0.585 ' HB2' ' CD1' ' A' ' 351' ' ' PHE . 54.1 Cg_endo -69.72 157.87 58.98 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.684 2.256 . . . . 73.53 112.375 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -60.81 -30.9 70.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 70.32 110.865 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 351' ' ' PHE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 28.1 p90 -86.1 33.3 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 61.03 110.876 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.665 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -113.64 82.59 1.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 41.44 111.136 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 17.9 p -84.98 167.56 15.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.118 -0.492 . . . . 72.34 111.185 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' GLU . . . . . 0.507 ' O ' ' CG1' ' A' ' 358' ' ' ILE . 0.3 OUTLIER -67.21 -29.43 69.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 73.51 110.88 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -59.12 -25.65 64.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 74.32 111.108 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.0 -17.1 13.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 71.35 110.837 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.665 HD11 ' HB1' ' A' ' 352' ' ' ALA . 4.7 mp -95.56 -53.5 3.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.424 . . . . 51.35 110.896 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.668 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.3 mm -39.51 -50.7 5.03 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.537 0.684 . . . . 70.44 111.079 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 359' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.1 Cg_endo -69.74 -26.62 27.46 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.715 2.277 . . . . 70.32 112.311 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.997 ' O ' HD12 ' A' ' 360' ' ' LEU . 0.1 OUTLIER -70.81 -24.25 62.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 63.2 110.91 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' A' ' 367' ' ' ILE . 91.4 m-85 -102.61 -41.05 6.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 73.33 110.952 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 362' ' ' GLN . . . . . 0.553 ' HG3' HD12 ' A' ' 367' ' ' ILE . 8.4 mt-30 -47.73 -44.68 28.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 65.52 110.883 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 363' ' ' ASN . . . . . 0.416 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.3 OUTLIER -45.64 -28.47 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 72.31 110.922 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 364' ' ' PHE . . . . . 0.457 ' CD2' ' HA ' ' A' ' 361' ' ' PHE . 33.7 m-85 -63.35 -57.32 10.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.854 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -154.27 -86.59 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.742 . . . . 32.11 112.528 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -153.58 140.62 19.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.851 0.358 . . . . 74.52 110.833 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' ILE . . . . . 0.553 HD12 ' HG3' ' A' ' 362' ' ' GLN . 41.2 mt -120.97 109.09 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 75.02 111.195 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.8 mp -86.76 -18.04 32.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 74.24 110.948 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -170.76 120.9 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 72.34 110.88 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.516 ' CE2' ' HB2' ' A' ' 372' ' ' HIS . 33.0 t80 -113.48 141.88 46.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 63.45 110.903 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.64 101.21 6.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 75.45 110.905 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 372' ' ' HIS . . . . . 0.579 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.6 t-80 -98.46 130.25 45.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 63.43 110.901 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -125.89 90.59 50.05 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.718 0.77 . . . . 71.14 110.906 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 374' ' ' PRO . . . . . 0.552 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.5 Cg_endo -69.73 -38.25 8.11 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.739 2.293 . . . . 42.43 112.299 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.53 -21.3 62.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 72.12 110.861 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -111.55 -25.74 9.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 53.33 110.877 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 84.31 42.29 7.53 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.725 -0.75 . . . . 64.42 112.519 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 31.1 p -154.84 153.98 32.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.775 0.321 . . . . 73.31 110.866 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 13.7 p -144.89 146.23 31.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 75.01 110.867 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.463 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 43.1 m-85 -125.16 122.34 36.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 73.43 110.882 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -110.84 133.67 55.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 73.1 111.171 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 128.58 46.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 74.34 110.855 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -111.6 178.4 4.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 70.34 110.877 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -76.73 -45.54 28.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.078 -0.51 . . . . 71.21 110.894 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 40.5 p -117.08 172.47 7.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 74.42 111.154 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' HIS . . . . . 0.661 ' HA ' HG22 ' A' ' 341' ' ' THR . 47.6 p-80 -85.29 -41.0 15.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 71.24 110.866 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -33.75 69.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 52.21 110.863 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -65.12 -34.93 79.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 75.42 110.889 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -67.11 -39.44 86.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 65.12 111.152 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.794 ' HB1' HG13 ' A' ' 329' ' ' VAL . . . -56.07 -33.86 65.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 63.4 111.148 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.24 -40.21 85.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 60.24 111.166 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 13.3 t -75.04 -31.56 61.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 73.34 110.9 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 332' ' ' ILE . 0.2 OUTLIER -59.52 -54.97 27.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 45.22 111.145 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.873 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.81 -36.09 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 53.43 111.13 179.811 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.32 -48.25 80.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 72.34 111.163 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.678 HD13 ' CD1' ' A' ' 399' ' ' PHE . 0.5 OUTLIER -79.3 -13.72 59.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 63.21 110.927 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -50.21 108.38 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 74.2 111.103 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 10.5 m120 49.62 50.8 17.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 73.13 110.91 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.678 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -109.2 146.97 35.0 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.629 0.728 . . . . 73.53 110.916 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 400' ' ' PRO . . . . . 0.519 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.7 Cg_endo -69.84 145.18 55.92 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.657 2.238 . . . . 71.55 112.383 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 401' ' ' PHE . . . . . 0.574 ' CE1' HD22 ' A' ' 360' ' ' LEU . 32.9 t80 -151.01 110.67 4.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 74.01 110.918 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 48.97 33.99 5.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 63.25 110.906 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.26 -32.7 7.17 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.727 -0.749 . . . . 71.31 112.549 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.3 OUTLIER -104.89 144.37 31.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 70.01 110.807 -179.795 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.03 154.44 24.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 42.51 110.849 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.91 HD13 HG21 ' A' ' 345' ' ' ILE . 16.8 mt -113.7 169.92 8.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 74.52 110.959 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 407' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 346' ' ' GLY . 2.0 ttt180 -111.27 174.4 5.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 73.51 110.907 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 408' ' ' THR . . . . . 0.553 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 64.3 p -154.25 148.44 25.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.477 . . . . 54.13 111.118 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 32.33 112.488 179.964 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.842 0.353 . . . . 74.5 110.95 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.38 -31.46 61.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 71.13 111.103 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 329' ' ' VAL . . . . . 0.889 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 8.0 t -69.08 -29.58 43.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 71.42 111.118 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 330' ' ' ASP . . . . . 0.406 ' HA ' HD12 ' A' ' 333' ' ' ILE . 29.8 t0 -53.94 -35.17 61.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 73.32 110.875 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -68.41 -31.85 71.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 74.33 110.879 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.784 HG21 HG21 ' A' ' 393' ' ' ILE . 40.8 mm -57.82 -51.29 72.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 75.2 111.125 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 330' ' ' ASP . 5.4 mt -53.44 -37.23 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 75.03 111.16 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.82 -9.42 4.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 74.23 110.873 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 335' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 336' ' ' ALA . 0.5 OUTLIER -107.1 42.02 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 75.52 110.83 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . 178.35 162.83 0.64 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.566 0.698 . . . . 70.44 111.093 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 54.2 Cg_endo -69.75 160.55 49.29 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.737 2.291 . . . . 73.22 112.371 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -16.0 37.71 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.69 2.26 . . . . 62.53 112.37 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -112.53 73.91 0.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 72.43 110.899 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 337' ' ' PRO . 14.7 p -160.4 121.77 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 72.34 111.147 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 341' ' ' THR . . . . . 0.788 HG22 ' CA ' ' A' ' 386' ' ' HIS . 18.8 p -136.02 67.9 1.46 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 73.22 111.084 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 33.8 m -133.84 108.23 8.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 65.23 111.165 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -80.27 129.77 34.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 75.2 111.178 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.655 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -112.79 134.67 54.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 72.31 110.92 -179.801 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.717 HG21 HD13 ' A' ' 406' ' ' LEU . 1.5 mp -136.28 99.83 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.127 -0.488 . . . . 72.1 111.145 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 346' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -89.31 176.61 43.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 62.23 112.58 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.3 t30 68.38 47.27 0.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 74.34 110.892 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.461 HD11 HG22 ' A' ' 345' ' ' ILE . 55.0 mt -101.97 131.13 23.09 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.602 0.715 . . . . 71.22 111.144 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.85 165.98 29.24 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.249 . . . . 73.53 112.276 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -69.61 -26.33 64.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 70.32 110.858 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -85.47 32.23 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 61.03 110.877 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 352' ' ' ALA . . . . . 0.788 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -117.62 110.95 18.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 41.44 111.146 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 13.7 p -114.5 166.39 11.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 72.34 111.144 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 354' ' ' GLU . . . . . 0.511 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -63.45 -33.58 75.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 73.51 110.968 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.91 -26.77 59.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 74.32 111.092 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.22 -13.21 13.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 71.35 110.864 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.788 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.7 mp -99.37 -53.66 3.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 51.35 110.91 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.636 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -40.44 -51.73 6.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.628 0.728 . . . . 70.44 111.192 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 359' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.1 Cg_endo -69.73 -38.51 7.76 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.655 2.237 . . . . 70.32 112.331 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 360' ' ' LEU . . . . . 0.941 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -54.99 -27.7 46.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 63.2 110.889 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 361' ' ' PHE . . . . . 0.64 ' N ' HD13 ' A' ' 360' ' ' LEU . 84.0 m-85 -95.16 -38.1 10.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 73.33 110.958 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 362' ' ' GLN . . . . . 0.643 ' HG3' HD12 ' A' ' 367' ' ' ILE . 30.4 mt-30 -48.68 -43.25 36.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 65.52 110.911 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 363' ' ' ASN . . . . . 0.437 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.5 OUTLIER -42.87 -28.2 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.955 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 364' ' ' PHE . . . . . 0.542 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 18.7 m-85 -66.14 -58.55 5.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 73.33 110.92 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 365' ' ' GLY . . . . . 0.425 ' HA3' ' CD ' ' A' ' 388' ' ' GLN . . . -156.67 -84.34 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.76 -0.733 . . . . 32.11 112.519 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.412 ' O ' ' CD2' ' A' ' 383' ' ' TYR . 17.6 t80 -153.96 144.68 22.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 74.52 110.902 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 367' ' ' ILE . . . . . 0.643 HD12 ' HG3' ' A' ' 362' ' ' GLN . 47.1 mt -120.86 108.78 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.02 111.138 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.32 -16.01 36.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.179 -0.464 . . . . 74.24 110.894 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -170.58 120.81 0.58 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.445 . . . . 72.34 110.862 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 34.7 t80 -115.44 136.11 53.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 63.45 110.894 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 371' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 379' ' ' CYS . 0.0 OUTLIER -122.62 100.3 6.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.866 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 372' ' ' HIS . . . . . 0.524 ' HB2' ' CE2' ' A' ' 370' ' ' PHE . 31.7 t60 -100.2 110.79 23.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 63.43 110.862 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.571 ' CE1' ' HA ' ' A' ' 379' ' ' CYS . 1.0 OUTLIER -119.53 94.52 48.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.644 0.735 . . . . 71.14 110.89 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 374' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 373' ' ' TYR . 53.6 Cg_endo -69.82 -17.4 37.3 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.724 2.282 . . . . 42.43 112.308 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.48 -28.62 69.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 72.12 110.917 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -111.69 -24.23 10.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 53.33 110.9 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 91.07 37.44 6.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.717 -0.754 . . . . 64.42 112.477 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' CYS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 373' ' ' TYR . 0.0 OUTLIER -156.23 151.69 26.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 73.31 110.872 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 379' ' ' CYS . . . . . 0.571 ' HA ' ' CE1' ' A' ' 373' ' ' TYR . 25.6 p -126.05 171.35 10.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 75.01 110.834 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 380' ' ' PHE . . . . . 0.551 ' CE2' ' OH ' ' A' ' 373' ' ' TYR . 27.6 m-85 -137.63 107.32 6.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 73.43 110.829 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 381' ' ' ILE . . . . . 0.558 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.7 OUTLIER -106.21 113.31 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 73.1 111.119 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -87.33 130.85 34.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.9 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.583 ' CD2' ' OE1' ' A' ' 388' ' ' GLN . 46.6 m-85 -113.67 153.94 28.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 70.34 110.917 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -53.76 -47.3 70.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 71.21 110.885 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.7 p -108.82 157.73 18.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 74.42 111.119 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' HIS . . . . . 0.788 ' CA ' HG22 ' A' ' 341' ' ' THR . 20.8 p-80 -83.97 -44.49 14.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 71.24 110.777 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 387' ' ' GLU . . . . . 0.462 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 0.1 OUTLIER -57.24 -26.94 61.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 52.21 110.851 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 388' ' ' GLN . . . . . 0.583 ' OE1' ' CD2' ' A' ' 383' ' ' TYR . 0.8 OUTLIER -70.3 -32.52 70.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.182 -0.463 . . . . 75.42 110.965 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.469 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -68.4 -33.86 74.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 65.12 111.11 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' ALA . . . . . 0.889 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -54.55 -28.76 48.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 63.4 111.093 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 77.7 t -71.36 -51.02 36.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 60.24 111.196 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' CYS . . . . . 0.542 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 3.6 t -61.46 -31.08 71.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 73.34 110.847 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 393' ' ' ILE . . . . . 0.784 HG21 HG21 ' A' ' 332' ' ' ILE . 1.1 mt -57.15 -56.02 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 45.22 111.166 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 394' ' ' VAL . . . . . 0.483 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.2 t -72.39 -35.18 51.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 53.43 111.122 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.85 -49.75 76.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 72.34 111.116 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' LEU . . . . . 0.612 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.7 mm? -77.16 -7.84 56.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.423 . . . . 63.21 110.981 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 397' ' ' ALA . . . . . 0.626 ' N ' HG21 ' A' ' 408' ' ' THR . . . -54.78 112.23 0.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.2 111.096 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 43.98 48.71 7.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 73.13 110.909 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' PHE . . . . . 0.612 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -102.79 141.58 22.79 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.726 0.774 . . . . 73.53 110.86 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 136.37 32.99 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.706 2.271 . . . . 71.55 112.388 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' PHE . . . . . 0.571 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 36.8 t80 -140.67 110.81 6.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 74.01 110.868 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 50.19 32.72 6.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 63.25 110.911 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 100.69 -30.09 11.01 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.699 -0.762 . . . . 71.31 112.451 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.07 138.89 40.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.838 0.351 . . . . 70.01 110.901 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -80.69 155.13 26.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 42.51 110.855 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.717 HD13 HG21 ' A' ' 345' ' ' ILE . 16.5 mt -114.61 176.82 4.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.52 110.955 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 407' ' ' ARG . . . . . 0.401 ' N ' ' O ' ' A' ' 346' ' ' GLY . 0.2 OUTLIER -114.09 173.45 6.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 73.51 110.91 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 408' ' ' THR . . . . . 0.626 HG21 ' N ' ' A' ' 397' ' ' ALA . 72.0 p -154.63 151.06 28.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 54.13 111.115 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 120.778 -0.725 . . . . 32.33 112.534 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.45 -0.26 . . . . 64.33 112.45 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 26.9 m -67.82 147.85 52.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 45.32 110.857 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -73.46 95.13 2.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 60.02 110.922 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.7 p -138.54 91.58 2.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 74.33 111.159 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.48 133.6 42.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 65.44 111.125 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -112.49 108.8 2.27 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 65.31 112.485 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.51 77.5 7.94 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.609 0.718 . . . . 73.31 110.934 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 157.39 60.5 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.675 2.25 . . . . 71.31 112.297 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -28.3 25.49 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.697 2.265 . . . . 74.51 112.341 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.56 140.66 49.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 74.24 110.88 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.479 HG13 ' CG1' ' A' ' 394' ' ' VAL . 10.7 t 67.56 142.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 64.22 111.132 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.29 130.5 23.58 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.634 0.73 . . . . 75.14 110.889 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -14.08 35.51 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.644 2.229 . . . . 63.34 112.342 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -71.99 -71.93 0.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 74.5 110.918 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.95 -25.09 27.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 71.13 111.125 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.828 HG22 ' HB ' ' A' ' 394' ' ' VAL . 7.9 t -79.96 -29.78 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 71.42 111.096 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.412 ' HA ' HD12 ' A' ' 333' ' ' ILE . 6.8 t70 -54.54 -36.88 64.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 73.32 110.865 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -64.2 -32.24 73.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 74.33 110.854 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.737 HG21 HG21 ' A' ' 393' ' ' ILE . 22.6 mm -60.31 -52.81 56.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 75.2 111.151 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 330' ' ' ASP . 4.8 mt -55.48 -41.63 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 75.03 111.137 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.96 -16.69 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 74.23 110.856 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.56 23.49 8.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 75.52 110.878 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.536 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . -174.96 159.09 2.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.574 0.702 . . . . 70.44 111.087 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.536 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 53.5 Cg_endo -69.73 150.2 68.06 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.67 2.247 . . . . 73.22 112.365 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -14.23 35.74 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.701 2.267 . . . . 62.53 112.332 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.521 ' O ' HG23 ' A' ' 341' ' ' THR . 0.5 OUTLIER -72.43 -63.13 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 72.43 110.882 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.64 143.83 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.34 111.091 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' THR . . . . . 0.677 HG22 ' CA ' ' A' ' 386' ' ' HIS . 22.3 p -146.98 68.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 73.22 111.128 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 87.7 m -133.78 139.46 46.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 65.23 111.116 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -105.78 121.78 44.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 75.2 111.083 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.602 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -102.93 122.09 43.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 72.31 110.877 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.561 HG21 HD13 ' A' ' 406' ' ' LEU . 1.9 mp -118.58 112.85 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 72.1 111.149 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -102.23 171.82 21.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.76 -0.734 . . . . 62.23 112.479 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.416 ' O ' ' CD2' ' A' ' 406' ' ' LEU . 1.4 t30 71.45 46.59 0.41 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.337 . . . . 74.34 110.917 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.615 HG23 ' HD2' ' A' ' 349' ' ' PRO . 86.9 mt -102.77 137.17 19.24 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.622 0.725 . . . . 71.22 111.147 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' PRO . . . . . 0.615 ' HD2' HG23 ' A' ' 348' ' ' ILE . 53.6 Cg_endo -69.76 163.53 37.94 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.679 2.253 . . . . 73.53 112.341 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -70.5 -24.05 62.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 70.32 110.884 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.559 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 29.4 p90 -90.74 29.46 1.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 61.03 110.883 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.795 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -112.63 99.11 7.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 41.44 111.13 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 13.3 p -99.2 169.49 9.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 72.34 111.13 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.513 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.29 -29.76 69.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 73.51 110.839 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -59.0 -26.04 64.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 74.32 111.13 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.78 -13.09 13.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 71.35 110.841 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.795 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.5 mp -99.93 -53.24 3.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 51.35 110.936 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.647 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -41.49 -51.14 8.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.574 0.702 . . . . 70.44 111.118 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.4 Cg_endo -69.78 -30.47 22.15 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.668 2.246 . . . . 70.32 112.339 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.891 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -64.96 -20.12 66.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 63.2 110.955 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.596 ' HB2' HD11 ' A' ' 367' ' ' ILE . 88.1 m-85 -104.8 -37.01 7.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 73.33 110.89 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -48.56 -45.51 37.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 65.52 110.931 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ASN . . . . . 0.419 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.8 OUTLIER -44.49 -23.77 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 72.31 110.858 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 364' ' ' PHE . . . . . 0.594 ' CE2' ' HB2' ' A' ' 392' ' ' CYS . 32.2 m-85 -69.85 -51.29 34.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 73.33 110.846 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -163.26 -88.0 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 32.11 112.473 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -151.74 144.49 24.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 74.52 110.913 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.596 HD11 ' HB2' ' A' ' 361' ' ' PHE . 25.9 mt -121.07 109.74 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 75.02 111.147 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.43 -19.42 29.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 74.24 110.889 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -170.96 120.74 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.889 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 33.5 t80 -113.61 131.33 56.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 63.45 110.902 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.31 100.73 7.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 75.45 110.928 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' HIS . . . . . 0.597 ' CD2' ' HD3' ' A' ' 374' ' ' PRO . 43.1 t60 -97.81 127.44 43.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 63.43 110.905 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -122.85 86.58 50.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.712 0.768 . . . . 71.14 110.944 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' PRO . . . . . 0.597 ' HD3' ' CD2' ' A' ' 372' ' ' HIS . 54.0 Cg_endo -69.76 -21.38 33.56 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.732 2.288 . . . . 42.43 112.357 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.47 -23.76 63.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 72.12 110.871 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -115.39 -25.79 7.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 53.33 110.893 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.09 44.83 4.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.718 -0.753 . . . . 64.42 112.458 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 93.9 m -156.93 147.94 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 73.31 110.886 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.472 ' HB2' ' CE1' ' A' ' 370' ' ' PHE . 21.5 p -138.01 153.18 49.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 75.01 110.882 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 380' ' ' PHE . 2.3 m-85 -128.48 118.92 23.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.877 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.458 HG21 ' CD1' ' A' ' 367' ' ' ILE . 0.8 OUTLIER -107.7 128.73 62.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 73.1 111.108 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.94 132.25 43.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 74.34 110.909 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -114.67 -178.9 3.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 70.34 110.96 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -76.78 -40.58 47.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.469 . . . . 71.21 110.898 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 53.5 p -125.17 167.11 15.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 74.42 111.143 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' HIS . . . . . 0.677 ' CA ' HG22 ' A' ' 341' ' ' THR . 9.8 p-80 -72.99 -40.58 65.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 71.24 110.869 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' GLU . . . . . 0.428 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 0.4 OUTLIER -57.87 -26.97 62.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 52.21 110.878 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -65.71 -33.48 75.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 75.42 110.848 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -78.93 -34.65 44.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 65.12 111.057 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.821 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -61.15 -34.46 75.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.239 -0.437 . . . . 63.4 111.097 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.8 -57.24 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 60.24 111.132 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' CYS . . . . . 0.594 ' HB2' ' CE2' ' A' ' 364' ' ' PHE . 30.1 p -66.28 -27.06 67.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 73.34 110.906 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.858 ' O ' HG21 ' A' ' 408' ' ' THR . 1.3 mt -58.21 -54.56 30.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 45.22 111.112 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.828 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.5 OUTLIER -71.5 -34.21 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 53.43 111.105 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.8 -37.05 85.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 72.34 111.143 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.635 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.8 mm? -86.14 -12.91 48.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 63.21 110.916 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -53.45 111.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 74.2 111.089 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.9 m120 47.73 48.91 17.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.927 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.635 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -104.59 144.26 28.35 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.608 0.718 . . . . 73.53 110.874 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 139.09 39.35 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.653 2.236 . . . . 71.55 112.364 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' PHE . . . . . 0.615 ' CZ ' ' NE2' ' A' ' 402' ' ' GLN . 41.0 t80 -145.85 111.8 5.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 74.01 110.9 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.615 ' NE2' ' CZ ' ' A' ' 401' ' ' PHE . 20.9 mt-30 51.07 32.64 7.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 63.25 110.976 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.92 -26.23 25.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.696 -0.764 . . . . 71.31 112.448 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 401' ' ' PHE . 3.3 ttt180 -109.43 141.3 42.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.761 0.315 . . . . 70.01 110.876 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -82.52 155.19 24.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 42.51 110.873 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.561 HD13 HG21 ' A' ' 345' ' ' ILE . 27.3 mt -117.19 178.31 4.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.52 110.91 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.59 176.02 5.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 73.51 110.864 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' THR . . . . . 0.858 HG21 ' O ' ' A' ' 393' ' ' ILE . 1.8 p -146.77 156.67 43.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 54.13 111.142 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 166.77 -176.14 41.91 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.725 -0.75 . . . . 32.33 112.478 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.443 ' O ' ' C ' ' A' ' 411' ' ' GLY . 73.3 m95 -95.11 119.04 32.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.757 0.313 . . . . 55.52 110.925 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 410' ' ' TRP . . . -34.36 111.04 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.796 -0.716 . . . . 72.43 112.442 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 413' ' ' GLU . 2.5 mtmp? -134.69 145.63 48.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.712 0.291 . . . . 72.54 110.9 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 412' ' ' LYS . 1.5 mt-10 -34.87 -45.32 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 72.32 110.919 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 71.13 110.877 -179.933 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.464 -0.255 . . . . 64.33 112.464 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 1.5 t -122.56 145.2 48.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.846 0.355 . . . . 45.32 110.875 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.93 -54.15 1.63 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 60.02 110.957 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 31.6 m 64.99 116.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 74.33 111.114 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 10.4 tp -95.98 148.65 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 65.44 111.11 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -98.0 -37.08 4.51 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.782 -0.723 . . . . 65.31 112.493 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 4.9 mt 65.28 67.54 0.78 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.589 0.709 . . . . 73.31 110.923 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 149.51 66.95 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.639 2.226 . . . . 71.31 112.399 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -7.09 20.16 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.738 2.292 . . . . 74.51 112.313 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.21 -168.83 2.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 74.24 110.921 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.596 HG11 ' HB2' ' A' ' 395' ' ' ALA . 21.6 m -38.22 158.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 64.22 111.167 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -113.08 143.77 29.82 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.619 0.723 . . . . 75.14 110.891 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.86 -14.17 35.41 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.664 2.243 . . . . 63.34 112.297 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -72.86 -72.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 74.5 110.869 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -52.58 -24.84 9.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 71.13 111.082 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.853 HG22 ' HB ' ' A' ' 394' ' ' VAL . 5.0 t -81.58 -30.06 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 71.42 111.098 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.474 ' HA ' HD12 ' A' ' 333' ' ' ILE . 6.2 t0 -55.06 -38.06 67.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 73.32 110.817 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -59.9 -37.69 80.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 74.33 110.902 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.544 HG21 HD13 ' A' ' 393' ' ' ILE . 16.6 mm -54.96 -54.46 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 75.2 111.138 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 330' ' ' ASP . 7.2 mt -51.61 -41.35 27.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 75.03 111.148 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -16.84 2.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 74.23 110.853 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.38 29.01 5.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.205 -0.452 . . . . 75.52 110.872 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.58 ' HB2' ' CD1' ' A' ' 410' ' ' TRP . . . -159.59 154.27 20.9 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.57 0.7 . . . . 70.44 111.13 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 156.52 63.01 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.677 2.251 . . . . 73.22 112.36 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -6.68 19.19 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.661 2.24 . . . . 62.53 112.395 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -119.93 76.45 1.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 72.43 110.944 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 7.5 p -179.62 141.84 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 72.34 111.156 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' THR . . . . . 0.524 HG22 ' HA ' ' A' ' 386' ' ' HIS . 21.0 p -149.46 69.79 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 73.22 111.13 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 96.4 m -133.5 116.08 15.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 65.23 111.109 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -89.14 121.86 31.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 75.2 111.077 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.56 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -102.99 125.56 49.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 72.31 110.907 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.506 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.9 mp -122.52 118.86 56.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 72.1 111.17 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -105.91 -179.01 23.6 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.725 -0.75 . . . . 62.23 112.482 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.501 ' O ' HD23 ' A' ' 406' ' ' LEU . 0.7 OUTLIER 62.82 49.73 3.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.753 0.311 . . . . 74.34 110.811 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.512 ' CG2' ' HB3' ' A' ' 352' ' ' ALA . 86.8 mt -103.25 134.17 19.92 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.57 0.7 . . . . 71.22 111.177 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' PRO . . . . . 0.513 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.7 Cg_endo -69.77 165.38 31.18 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.704 2.27 . . . . 73.53 112.367 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.78 -25.8 63.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 70.32 110.916 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.402 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 2.9 p90 -89.88 31.87 0.94 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 61.03 110.851 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.853 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -120.62 99.18 6.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 41.44 111.107 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 79.5 p -104.79 173.66 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.269 -0.423 . . . . 72.34 111.208 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.513 ' O ' ' CG1' ' A' ' 358' ' ' ILE . 0.6 OUTLIER -66.71 -29.85 69.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 73.51 110.915 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.41 -26.28 63.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 74.32 111.038 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.42 -17.51 12.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.258 -0.428 . . . . 71.35 110.804 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.853 HD11 ' HB1' ' A' ' 352' ' ' ALA . 4.0 mp -92.33 -51.1 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 51.35 110.851 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.681 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.3 mm -42.34 -49.98 11.95 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.581 0.705 . . . . 70.44 111.082 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.6 Cg_endo -69.76 -28.0 25.78 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.685 2.257 . . . . 70.32 112.365 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.845 HD13 ' C ' ' A' ' 360' ' ' LEU . 0.2 OUTLIER -68.11 -25.99 65.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 63.2 110.891 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.641 ' CE2' HD12 ' A' ' 360' ' ' LEU . 85.3 m-85 -102.42 -34.69 9.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 73.33 110.886 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' GLN . . . . . 0.559 ' HG3' HD12 ' A' ' 367' ' ' ILE . 2.0 mt-30 -54.63 -32.36 58.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 65.52 110.882 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -60.05 -13.67 12.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 72.31 110.872 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' PHE . . . . . 0.481 ' CD2' ' HB3' ' A' ' 392' ' ' CYS . 39.3 m-85 -78.78 -55.9 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 73.33 110.926 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -155.19 -86.77 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.647 -0.787 . . . . 32.11 112.443 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.443 ' CE2' ' HG ' ' A' ' 368' ' ' LEU . 61.2 t80 -153.62 140.78 19.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.337 . . . . 74.52 110.906 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.559 HD12 ' HG3' ' A' ' 362' ' ' GLN . 42.0 mt -120.33 109.29 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 75.02 111.161 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.443 ' HG ' ' CE2' ' A' ' 366' ' ' PHE . 0.9 OUTLIER -86.18 -20.24 28.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.93 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.89 121.36 0.67 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 72.34 110.923 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 35.0 t80 -113.61 145.7 40.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 63.45 110.895 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -131.44 101.97 5.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 75.45 110.952 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' HIS . . . . . 0.637 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 21.2 t60 -100.83 127.24 47.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.295 -0.412 . . . . 63.43 110.856 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -118.2 90.55 38.24 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.703 0.763 . . . . 71.14 110.958 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' PRO . . . . . 0.473 ' HD3' ' CD2' ' A' ' 372' ' ' HIS . 53.4 Cg_endo -69.75 -19.69 35.84 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.718 2.278 . . . . 42.43 112.335 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -84.38 -21.96 30.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 72.12 110.823 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -106.53 -26.43 11.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 53.33 110.866 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' GLY . . . . . 0.4 ' C ' ' SG ' ' A' ' 378' ' ' CYS . . . 84.74 35.38 13.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 64.42 112.489 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 378' ' ' CYS . . . . . 0.4 ' SG ' ' C ' ' A' ' 377' ' ' GLY . 1.8 m -153.64 140.98 19.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.774 0.321 . . . . 73.31 110.901 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 17.7 p -133.14 146.08 51.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 75.01 110.889 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 344' ' ' TYR . 7.4 m-85 -124.15 127.69 48.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 73.43 110.911 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.537 HD13 ' CD1' ' A' ' 361' ' ' PHE . 1.0 OUTLIER -113.36 130.74 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 73.1 111.145 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -94.67 131.35 40.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.922 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -114.85 -174.58 2.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 70.34 110.902 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -93.47 -30.49 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 71.21 110.9 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 24.8 p -125.7 165.8 17.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 74.42 111.088 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' HIS . . . . . 0.524 ' HA ' HG22 ' A' ' 341' ' ' THR . 17.9 p-80 -78.42 -41.46 32.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 71.24 110.855 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 387' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 6.6 tm-20 -57.37 -31.27 65.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 52.21 110.861 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -36.29 82.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 75.42 110.933 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.614 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -76.02 -27.14 57.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 65.12 111.063 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.724 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -72.72 -35.51 67.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 63.4 111.063 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.479 HG13 HG21 ' A' ' 324' ' ' VAL . 82.7 t -66.02 -53.57 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 60.24 111.124 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' CYS . . . . . 0.481 ' HB3' ' CD2' ' A' ' 364' ' ' PHE . 31.5 p -65.35 -31.76 73.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.484 . . . . 73.34 110.861 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.762 ' O ' HG21 ' A' ' 408' ' ' THR . 0.7 OUTLIER -55.67 -55.65 16.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 45.22 111.133 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.853 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.67 -36.79 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 53.43 111.164 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.596 ' HB2' HG11 ' A' ' 324' ' ' VAL . . . -62.2 -30.57 71.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 72.34 111.119 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.68 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.1 mm? -95.93 -16.07 21.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 63.21 110.889 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -48.58 110.39 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.2 111.131 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 42.5 t30 49.45 50.57 17.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 73.13 110.923 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.68 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -107.47 145.62 31.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.655 0.74 . . . . 73.53 110.899 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 143.32 50.81 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.74 2.293 . . . . 71.55 112.333 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' PHE . . . . . 0.526 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 31.6 t80 -150.37 110.97 4.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 74.01 110.892 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 49.82 33.02 5.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 63.25 110.949 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 99.54 -27.76 18.63 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.683 -0.77 . . . . 71.31 112.503 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.3 OUTLIER -107.0 142.03 37.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.903 0.382 . . . . 70.01 110.901 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -83.05 154.79 24.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 42.51 110.834 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 347' ' ' ASN . 19.6 mt -117.78 167.77 11.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 74.52 110.889 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.58 179.12 4.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 73.51 110.92 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 408' ' ' THR . . . . . 0.762 HG21 ' O ' ' A' ' 393' ' ' ILE . 5.9 p -152.86 153.56 33.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 54.13 111.191 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 169.72 -176.12 43.67 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.749 . . . . 32.33 112.454 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.58 ' CD1' ' HB2' ' A' ' 336' ' ' ALA . 65.7 m95 -97.09 124.26 41.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.885 0.374 . . . . 55.52 110.898 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -47.04 124.21 8.43 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.7 -0.762 . . . . 72.43 112.507 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 413' ' ' GLU . 0.0 OUTLIER -136.4 88.78 2.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.697 0.284 . . . . 72.54 110.938 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 412' ' ' LYS . 0.9 OUTLIER -36.53 113.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 72.32 110.926 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 71.13 110.879 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.494 -0.242 . . . . 64.33 112.494 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 21.0 m -124.63 -68.16 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 45.32 110.896 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -179.94 -42.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 60.02 110.872 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 47.4 p -105.9 167.2 9.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 74.33 111.163 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 319' ' ' GLY . 5.5 tt -168.16 -45.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 65.44 111.121 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.541 ' N ' HG23 ' A' ' 318' ' ' ILE . . . 83.09 -36.49 2.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.761 -0.733 . . . . 65.31 112.472 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 3.5 mt 61.68 59.38 3.0 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.61 0.719 . . . . 73.31 110.933 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.71 164.91 32.71 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.642 2.228 . . . . 71.31 112.375 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -36.95 9.89 Favored 'Trans proline' 0 C--O 1.23 0.109 0 C-N-CA 122.688 2.259 . . . . 74.51 112.355 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.408 ' C ' ' CG2' ' A' ' 324' ' ' VAL . 0.1 OUTLIER 169.83 94.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.907 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.801 HG11 HG13 ' A' ' 391' ' ' VAL . 5.8 t -157.16 148.52 10.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 64.22 111.195 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -112.95 118.27 44.83 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.629 0.728 . . . . 75.14 110.824 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -14.09 35.44 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.737 2.291 . . . . 63.34 112.29 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -70.99 -71.63 0.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 74.5 110.874 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -58.48 -25.01 61.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 71.13 111.002 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.9 HG22 ' HB ' ' A' ' 394' ' ' VAL . 14.6 t -74.82 -30.03 23.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 71.42 111.117 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.466 ' HA ' HD12 ' A' ' 333' ' ' ILE . 23.5 t0 -55.03 -36.92 66.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.32 110.878 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -62.42 -36.34 82.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 74.33 110.909 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.492 HG21 HG21 ' A' ' 393' ' ' ILE . 20.4 mm -55.42 -53.25 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 75.2 111.071 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 330' ' ' ASP . 5.5 mt -53.02 -40.51 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 75.03 111.163 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -16.27 2.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 74.23 110.844 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' A' ' 336' ' ' ALA . 0.2 OUTLIER -105.02 44.75 1.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 75.52 110.823 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 335' ' ' SER . . . 167.32 147.31 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.659 0.742 . . . . 70.44 111.095 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.913 ' O ' HG12 ' A' ' 340' ' ' VAL . 53.4 Cg_endo -69.81 151.27 68.76 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.667 2.245 . . . . 73.22 112.342 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -8.88 24.74 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.766 2.311 . . . . 62.53 112.332 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.42 16.58 3.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 72.43 110.863 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.913 HG12 ' O ' ' A' ' 337' ' ' PRO . 13.9 p -131.29 140.15 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 72.34 111.164 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' THR . . . . . 0.671 HG22 ' CA ' ' A' ' 386' ' ' HIS . 21.0 p -148.78 68.11 1.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 73.22 111.138 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 28.1 m -133.78 127.62 33.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.474 . . . . 65.23 111.098 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.96 120.69 35.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 75.2 111.169 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.794 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -105.86 131.72 52.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 72.31 110.92 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.8 HG21 HD13 ' A' ' 406' ' ' LEU . 1.7 mp -126.22 117.68 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 72.1 111.121 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -105.11 162.59 14.48 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.741 . . . . 62.23 112.524 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.5 t30 76.14 44.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 74.34 110.888 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.541 HG23 ' HD2' ' A' ' 349' ' ' PRO . 67.3 mt -94.59 135.2 24.23 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.613 0.721 . . . . 71.22 111.115 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' PRO . . . . . 0.554 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 52.9 Cg_endo -69.77 159.75 52.25 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.732 2.288 . . . . 73.53 112.337 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -67.86 -21.47 65.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 70.32 110.817 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 349' ' ' PRO . 5.4 p90 -93.86 28.49 2.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 61.03 110.903 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.765 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -110.83 102.07 10.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 41.44 111.117 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 14.3 p -102.8 169.26 8.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 72.34 111.109 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.516 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.49 -31.32 71.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 73.51 110.865 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.96 -26.38 59.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 74.32 111.1 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -111.98 -13.11 13.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 71.35 110.902 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.765 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.4 mp -99.47 -54.18 3.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 51.35 110.91 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.632 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -40.29 -51.79 6.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.664 0.745 . . . . 70.44 111.088 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 359' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.3 Cg_endo -69.76 -38.12 8.24 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.72 2.28 . . . . 70.32 112.339 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.929 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -55.32 -26.67 42.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.442 . . . . 63.2 110.925 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.62 ' N ' HD13 ' A' ' 360' ' ' LEU . 85.2 m-85 -97.42 -39.22 9.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 73.33 110.861 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' GLN . . . . . 0.622 ' HG3' HD12 ' A' ' 367' ' ' ILE . 6.8 mt-30 -47.52 -44.26 25.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 65.52 111.006 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 360' ' ' LEU . 0.9 OUTLIER -45.05 -29.01 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 72.31 110.879 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 364' ' ' PHE . . . . . 0.56 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 34.0 m-85 -63.33 -57.39 10.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 73.33 110.913 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -156.8 -83.7 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.729 . . . . 32.11 112.507 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -153.5 144.76 23.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.798 0.332 . . . . 74.52 110.885 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.622 HD12 ' HG3' ' A' ' 362' ' ' GLN . 69.1 mt -121.13 109.08 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 75.02 111.12 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.3 mt -88.1 -19.8 26.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 74.24 110.877 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.15 120.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 72.34 110.848 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 372' ' ' HIS . 34.9 t80 -113.1 142.2 46.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 63.45 110.899 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.5 100.48 5.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 75.45 110.88 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 372' ' ' HIS . . . . . 0.587 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.0 t-80 -99.59 119.02 37.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 63.43 110.877 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.86 88.21 11.37 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.709 0.766 . . . . 71.14 110.944 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' PRO . . . . . 0.418 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 54.1 Cg_endo -69.78 -26.9 27.01 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.705 2.27 . . . . 42.43 112.355 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.55 -19.75 62.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 72.12 110.871 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -111.14 -27.07 8.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 53.33 110.895 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 89.11 39.83 6.33 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.781 -0.723 . . . . 64.42 112.479 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.8 p -159.58 153.59 23.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.752 0.31 . . . . 73.31 110.87 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.516 ' C ' ' CD1' ' A' ' 380' ' ' PHE . 15.2 p -138.72 166.71 23.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 75.01 110.866 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 379' ' ' CYS . 7.0 m-85 -142.12 125.57 16.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 73.43 110.806 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.48 126.43 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 73.1 111.15 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.71 128.38 42.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 74.34 110.911 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -109.83 179.32 4.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 70.34 110.95 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -81.05 -34.95 32.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.469 . . . . 71.21 110.878 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 82.8 p -125.65 166.75 16.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 74.42 111.174 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' HIS . . . . . 0.671 ' CA ' HG22 ' A' ' 341' ' ' THR . 2.3 p80 -82.58 -38.69 23.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 71.24 110.861 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 387' ' ' GLU . . . . . 0.403 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 4.5 tt0 -57.4 -27.71 62.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 52.21 110.84 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -35.59 66.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 75.42 110.91 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.51 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -68.47 -37.94 80.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 65.12 111.077 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.642 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -58.59 -33.61 70.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 63.4 111.068 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.801 HG13 HG11 ' A' ' 324' ' ' VAL . 58.3 t -63.58 -57.52 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 60.24 111.128 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' CYS . . . . . 0.56 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 10.5 t -59.33 -30.18 68.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.496 . . . . 73.34 110.919 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.537 HG22 ' N ' ' A' ' 394' ' ' VAL . 0.5 OUTLIER -59.09 -55.21 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 45.22 111.102 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.9 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.79 -34.82 52.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 53.43 111.129 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.19 -45.38 88.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 72.34 111.149 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.609 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.7 mm? -81.59 -12.58 58.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 63.21 110.986 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' ALA . . . . . 0.525 ' N ' HG21 ' A' ' 408' ' ' THR . . . -49.37 111.08 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 74.2 111.098 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 6.6 m120 44.26 48.74 7.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 73.13 110.825 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.609 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -103.6 145.77 31.24 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.66 0.743 . . . . 73.53 110.916 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 141.8 46.19 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.692 2.261 . . . . 71.55 112.34 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' PHE . . . . . 0.551 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 30.4 t80 -146.94 110.85 5.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 74.01 110.913 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 47.92 32.96 3.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 63.25 110.936 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.04 -29.85 11.63 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.815 -0.707 . . . . 71.31 112.517 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.76 137.02 43.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 70.01 110.887 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -81.65 150.38 28.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 42.51 110.89 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.8 HD13 HG21 ' A' ' 345' ' ' ILE . 28.4 mt -112.39 171.43 7.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 74.52 110.902 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 407' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 346' ' ' GLY . 13.4 ttt180 -112.73 174.66 5.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 73.51 110.842 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' THR . . . . . 0.562 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 70.7 p -154.28 146.97 24.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 54.13 111.17 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' GLY . . . . . 0.456 ' O ' ' C ' ' A' ' 410' ' ' TRP . . . 159.78 131.91 1.3 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.764 -0.731 . . . . 32.33 112.506 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.48 ' NE1' HG22 ' A' ' 332' ' ' ILE . 66.1 m95 -33.59 144.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.853 0.359 . . . . 55.52 110.907 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -140.59 -172.2 12.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.709 -0.757 . . . . 72.43 112.504 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -144.55 121.26 11.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.748 0.309 . . . . 72.54 110.952 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -47.46 111.39 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 72.32 110.925 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 2.3 ttt-85 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 71.13 110.849 -179.87 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.518 -0.233 . . . . 64.33 112.518 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.21 158.42 24.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.744 0.307 . . . . 45.32 110.898 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -136.27 35.36 2.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 60.02 110.919 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 77.3 p -109.4 150.38 28.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 74.33 111.131 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.4 tt -108.65 -7.42 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.473 . . . . 65.44 111.114 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 70.66 -100.42 0.82 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.753 -0.737 . . . . 65.31 112.521 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 320' ' ' LEU . 7.2 mt 51.67 73.02 1.04 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.531 0.682 . . . . 73.31 110.924 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.433 ' HB3' ' CG ' ' A' ' 325' ' ' ASN . 53.9 Cg_endo -69.74 150.9 68.92 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.643 2.229 . . . . 71.31 112.336 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 -21.83 32.94 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.725 2.283 . . . . 74.51 112.31 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -155.27 -66.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 74.24 110.869 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.5 HG13 ' CG1' ' A' ' 394' ' ' VAL . 1.7 t -147.45 134.84 14.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 64.22 111.1 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.433 ' CG ' ' HB3' ' A' ' 321' ' ' PRO . 2.6 m-20 -113.07 139.12 22.63 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.626 0.727 . . . . 75.14 110.875 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -14.66 36.44 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.723 2.282 . . . . 63.34 112.34 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -73.12 -72.39 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 74.5 110.922 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -53.78 -24.87 16.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 71.13 111.163 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.862 HG22 ' HB ' ' A' ' 394' ' ' VAL . 6.9 t -84.36 -30.06 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 71.42 111.165 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.611 ' HA ' HD12 ' A' ' 333' ' ' ILE . 22.7 t70 -54.67 -41.17 69.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 73.32 110.953 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -56.6 -39.23 73.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 74.33 110.887 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.659 HG21 HD13 ' A' ' 393' ' ' ILE . 21.5 mm -54.4 -54.34 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 75.2 111.097 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.922 HG23 ' NE2' ' A' ' 386' ' ' HIS . 4.3 mt -53.69 -36.34 28.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 75.03 111.124 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -7.98 5.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 74.23 110.873 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.8 7.68 37.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 75.52 110.887 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.434 ' HB2' ' CD1' ' A' ' 410' ' ' TRP . . . -153.0 147.1 18.6 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.598 0.714 . . . . 70.44 111.062 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.716 ' O ' HG12 ' A' ' 340' ' ' VAL . 53.3 Cg_endo -69.77 153.27 69.07 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.694 2.263 . . . . 73.22 112.356 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -7.75 21.85 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.67 2.246 . . . . 62.53 112.351 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 31.9 mtt180 -92.25 37.11 0.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 72.43 110.844 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 337' ' ' PRO . 7.7 p -157.74 142.59 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 72.34 111.138 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' THR . . . . . 0.489 HG22 ' HB2' ' A' ' 386' ' ' HIS . 18.2 p -144.39 67.93 1.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 73.22 111.18 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 72.7 m -134.06 137.59 44.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 65.23 111.175 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -108.74 122.22 46.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 75.2 111.138 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -102.06 124.87 48.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.267 -0.424 . . . . 72.31 110.937 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.548 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.9 mp -120.73 104.41 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 72.1 111.083 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -93.3 165.62 27.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.825 -0.703 . . . . 62.23 112.536 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.42 ' O ' HD22 ' A' ' 406' ' ' LEU . 1.5 t30 74.99 55.47 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.358 . . . . 74.34 110.89 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.583 HG23 ' HD2' ' A' ' 349' ' ' PRO . 76.7 mt -110.19 136.36 20.5 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.634 0.73 . . . . 71.22 111.153 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 348' ' ' ILE . 54.5 Cg_endo -69.68 162.93 40.12 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.664 2.243 . . . . 73.53 112.359 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -72.41 -21.27 61.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 70.32 110.862 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.485 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 7.4 p90 -88.02 19.92 3.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 61.03 110.864 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.697 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -104.65 121.34 43.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 41.44 111.08 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 11.5 p -123.08 167.99 12.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 72.34 111.215 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.506 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.3 OUTLIER -63.64 -35.12 79.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 73.51 110.839 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -55.03 -26.89 40.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 74.32 111.114 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.99 -13.5 13.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 71.35 110.914 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.697 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.2 mp -99.06 -55.0 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 51.35 110.94 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.623 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -38.82 -52.42 3.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.704 0.764 . . . . 70.44 111.146 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.3 Cg_endo -69.75 -40.36 5.42 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.703 2.269 . . . . 70.32 112.381 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.915 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -53.89 -25.28 19.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 63.2 110.929 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.58 ' CE2' HD12 ' A' ' 360' ' ' LEU . 83.4 m-85 -100.46 -39.43 7.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.863 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -51.64 -39.22 57.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 65.52 110.878 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -51.42 -16.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 72.31 110.922 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' PHE . . . . . 0.511 ' CE2' ' HB2' ' A' ' 392' ' ' CYS . 31.6 m-85 -75.55 -60.04 2.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 73.33 110.927 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -150.02 -85.36 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.646 -0.788 . . . . 32.11 112.42 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 368' ' ' LEU . 15.0 t80 -153.62 141.73 20.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.819 0.342 . . . . 74.52 110.876 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' A' ' 361' ' ' PHE . 40.8 mt -121.04 109.04 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 75.02 111.1 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.758 HD11 ' HD3' ' A' ' 382' ' ' LYS . 2.8 pp -89.3 -16.2 31.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.938 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.683 ' HB2' HD12 ' A' ' 368' ' ' LEU . 0.2 OUTLIER -171.02 120.83 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.476 . . . . 72.34 110.903 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 372' ' ' HIS . 35.9 t80 -114.4 141.64 47.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 63.45 110.894 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 5.2 mtmm -129.4 101.12 5.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 75.45 110.907 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' HIS . . . . . 0.567 ' CD2' ' HD3' ' A' ' 374' ' ' PRO . 44.4 t60 -95.93 121.66 37.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 63.43 110.829 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -116.83 84.0 15.12 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.657 0.741 . . . . 71.14 110.926 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' PRO . . . . . 0.567 ' HD3' ' CD2' ' A' ' 372' ' ' HIS . 54.4 Cg_endo -69.71 -27.08 27.16 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.67 2.247 . . . . 42.43 112.37 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -65.65 -23.58 66.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 72.12 110.914 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -112.83 -25.59 8.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 53.33 110.889 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.61 46.32 4.04 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.728 -0.749 . . . . 64.42 112.476 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 27.4 p -159.78 151.82 20.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.877 0.37 . . . . 73.31 110.906 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 15.1 p -140.52 137.38 33.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 75.01 110.922 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -115.99 119.94 37.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 73.43 110.921 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.55 HD13 ' CG ' ' A' ' 361' ' ' PHE . 1.2 mt -107.64 142.51 20.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 73.1 111.18 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' LYS . . . . . 0.758 ' HD3' HD11 ' A' ' 368' ' ' LEU . 0.1 OUTLIER -103.27 131.6 50.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.909 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.455 ' CD2' ' HB3' ' A' ' 388' ' ' GLN . 53.1 m-85 -120.33 137.02 54.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 70.34 110.919 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -45.36 -28.77 0.91 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 71.21 110.864 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 69.4 p -130.07 162.69 28.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 74.42 111.139 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' HIS . . . . . 0.922 ' NE2' HG23 ' A' ' 333' ' ' ILE . 10.0 t60 -80.43 -34.42 36.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 71.24 110.863 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -57.31 -32.19 66.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 52.21 110.954 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.455 ' HB3' ' CD2' ' A' ' 383' ' ' TYR . 0.0 OUTLIER -66.8 -34.49 77.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.113 -0.494 . . . . 75.42 110.906 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -71.35 -23.85 61.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 65.12 111.095 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.765 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -78.79 -38.42 38.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 63.4 111.063 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.24 -48.6 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 60.24 111.103 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' CYS . . . . . 0.511 ' HB2' ' CE2' ' A' ' 364' ' ' PHE . 19.1 p -71.36 -32.44 68.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 73.34 110.856 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.681 ' O ' HG21 ' A' ' 408' ' ' THR . 0.9 OUTLIER -53.68 -55.35 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 45.22 111.171 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.862 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -72.08 -34.32 49.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 53.43 111.144 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -67.08 -29.09 68.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 72.34 111.147 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.673 HD13 ' CD1' ' A' ' 399' ' ' PHE . 1.9 mm? -97.97 -2.82 39.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 63.21 110.858 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -63.53 111.73 2.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 74.2 111.012 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 50.67 48.1 23.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 73.13 110.893 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.673 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -106.48 142.97 26.05 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.642 0.734 . . . . 73.53 110.867 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.421 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.8 Cg_endo -69.77 141.61 45.64 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.747 2.298 . . . . 71.55 112.34 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' PHE . . . . . 0.559 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 50.1 t80 -147.94 114.25 5.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 74.01 110.838 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER 48.91 32.74 3.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 63.25 110.937 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.36 -27.58 18.78 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.76 -0.733 . . . . 71.31 112.504 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.4 138.76 41.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 70.01 110.864 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.407 ' C ' HD23 ' A' ' 406' ' ' LEU . 3.0 m120 -80.66 149.75 29.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 42.51 110.827 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 347' ' ' ASN . 9.3 mt -112.24 174.93 5.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 74.52 110.948 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 346' ' ' GLY . 0.0 OUTLIER -120.78 173.02 7.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 73.51 110.891 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 408' ' ' THR . . . . . 0.681 HG21 ' O ' ' A' ' 393' ' ' ILE . 2.2 p -146.41 153.6 40.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 54.13 111.072 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 163.01 178.05 36.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 32.33 112.443 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 336' ' ' ALA . 77.4 m95 -91.58 132.18 36.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.717 0.294 . . . . 55.52 110.962 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -158.42 -177.98 32.02 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.671 -0.776 . . . . 72.43 112.382 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 414' ' ' ARG . 0.0 OUTLIER -166.73 151.84 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.729 0.3 . . . . 72.54 110.91 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.453 ' O ' ' C ' ' A' ' 414' ' ' ARG . 1.9 tt0 -55.47 82.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 72.32 110.816 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 412' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 71.13 110.898 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.525 -0.23 . . . . 64.33 112.525 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 56.6 m 51.67 19.52 0.91 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.833 0.349 . . . . 45.32 110.844 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 47.39 92.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 60.02 110.909 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 1.7 t -125.11 111.17 15.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 74.33 111.068 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 319' ' ' GLY . 1.4 tt -172.8 -44.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 65.44 111.068 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.436 ' N ' HG23 ' A' ' 318' ' ' ILE . . . 87.99 45.73 5.01 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.724 -0.75 . . . . 65.31 112.464 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.518 ' CB ' ' CD ' ' A' ' 321' ' ' PRO . 4.5 mt -43.92 -63.99 0.92 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.641 0.734 . . . . 73.31 110.897 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.518 ' CD ' ' CB ' ' A' ' 320' ' ' LEU . 53.2 Cg_endo -69.79 127.23 14.28 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.673 2.248 . . . . 71.31 112.334 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 -13.47 34.72 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.671 2.247 . . . . 74.51 112.331 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.411 ' C ' ' CG2' ' A' ' 324' ' ' VAL . 0.6 OUTLIER -166.22 -40.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 74.24 110.891 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.491 ' CG1' ' CG1' ' A' ' 394' ' ' VAL . 1.8 t -154.77 141.51 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 64.22 111.159 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -109.27 139.82 21.41 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.617 0.722 . . . . 75.14 110.912 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -14.44 36.32 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.68 2.254 . . . . 63.34 112.39 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -72.34 -71.61 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 74.5 110.947 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.1 -24.78 18.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.457 . . . . 71.13 111.104 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.82 HG22 ' HB ' ' A' ' 394' ' ' VAL . 5.7 t -84.78 -30.04 6.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 71.42 111.176 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.75 ' HA ' HD12 ' A' ' 333' ' ' ILE . 13.7 t70 -54.74 -45.86 74.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 73.32 110.905 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -53.01 -34.81 58.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.808 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.968 HG21 HG21 ' A' ' 393' ' ' ILE . 26.1 mm -61.29 -48.87 86.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 75.2 111.167 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' A' ' 330' ' ' ASP . 8.0 mt -54.39 -33.05 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 75.03 111.093 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.61 -7.96 12.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.951 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 336' ' ' ALA . 0.8 OUTLIER -94.29 17.58 12.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 75.52 110.894 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.705 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . 177.8 164.49 0.57 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.533 0.682 . . . . 70.44 111.154 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.836 ' O ' HG22 ' A' ' 340' ' ' VAL . 54.7 Cg_endo -69.66 156.86 62.47 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.77 2.313 . . . . 73.22 112.37 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -7.32 20.73 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.678 2.252 . . . . 62.53 112.36 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 35.3 mtt85 -97.57 53.68 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 72.43 110.898 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 337' ' ' PRO . 7.0 m -150.53 135.56 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 72.34 111.088 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' THR . . . . . 0.522 HG22 ' HA ' ' A' ' 386' ' ' HIS . 28.0 p -138.08 66.4 1.44 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 73.22 111.117 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 19.4 m -134.3 142.15 47.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 65.23 111.118 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -118.83 98.93 6.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 75.2 111.121 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.53 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -85.77 121.19 28.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.332 -0.394 . . . . 72.31 110.91 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.813 HG21 HD13 ' A' ' 406' ' ' LEU . 2.0 mp -118.29 118.79 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.086 -0.506 . . . . 72.1 111.131 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -104.64 164.88 14.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.76 -0.733 . . . . 62.23 112.504 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 0.2 OUTLIER 76.62 45.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 74.34 110.884 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.457 HG23 ' HD2' ' A' ' 349' ' ' PRO . 59.4 mt -99.58 133.32 21.94 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.653 0.74 . . . . 71.22 111.142 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' PRO . . . . . 0.777 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.7 Cg_endo -69.74 164.87 32.9 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.657 2.238 . . . . 73.53 112.329 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.32 -20.88 59.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 70.32 110.809 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.504 ' O ' ' CD2' ' A' ' 351' ' ' PHE . 25.0 p90 -97.25 29.48 3.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 61.03 110.885 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.777 ' HB2' ' HG2' ' A' ' 349' ' ' PRO . . . -114.36 90.84 3.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 41.44 111.17 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 19.7 p -87.83 170.77 10.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 72.34 111.101 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.51 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -65.6 -31.94 73.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 73.51 110.888 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -53.49 -26.13 19.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 74.32 111.128 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.63 -13.18 13.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.273 -0.421 . . . . 71.35 110.866 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.752 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.3 mp -98.85 -55.86 2.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 51.35 110.952 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.633 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -39.74 -52.16 5.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.625 0.726 . . . . 70.44 111.106 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 359' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.5 Cg_endo -69.66 -35.58 12.66 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.711 2.274 . . . . 70.32 112.37 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.898 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -58.61 -23.55 59.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 63.2 110.927 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.692 ' CG ' HD13 ' A' ' 381' ' ' ILE . 84.9 m-85 -103.02 -35.25 8.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 73.33 110.873 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -54.14 -34.76 61.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 65.52 110.852 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -55.48 -13.47 1.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 72.31 110.954 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 392' ' ' CYS . 38.2 m-85 -81.3 -53.99 5.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 73.33 110.901 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -156.24 -95.35 0.11 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.807 -0.711 . . . . 32.11 112.557 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.43 ' CE2' ' HG ' ' A' ' 368' ' ' LEU . 58.8 t80 -143.81 143.97 31.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.818 0.342 . . . . 74.52 110.909 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.437 HG12 ' CG2' ' A' ' 381' ' ' ILE . 71.6 mt -120.73 109.05 24.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 75.02 111.145 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.43 ' HG ' ' CE2' ' A' ' 366' ' ' PHE . 1.1 mp -87.64 -19.8 27.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 74.24 110.862 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.92 120.62 0.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 72.34 110.872 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 372' ' ' HIS . 35.1 t80 -112.47 143.0 44.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 63.45 110.888 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.27 101.28 5.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 75.45 110.895 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 372' ' ' HIS . . . . . 0.572 ' HB2' ' CE2' ' A' ' 370' ' ' PHE . 29.9 t60 -99.66 136.01 40.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 63.43 110.884 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -128.19 90.03 48.35 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.73 0.776 . . . . 71.14 110.965 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' PRO . . . . . 0.487 ' HD3' ' CD2' ' A' ' 372' ' ' HIS . 53.9 Cg_endo -69.77 -21.85 32.85 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.791 2.327 . . . . 42.43 112.343 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.0 -33.33 65.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 72.12 110.887 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.08 -18.99 14.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 53.33 110.933 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 81.01 40.16 12.03 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.741 -0.742 . . . . 64.42 112.465 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.2 p -148.49 155.62 41.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.716 0.293 . . . . 73.31 110.976 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 18.6 p -149.78 158.08 43.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.429 . . . . 75.01 110.897 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.494 ' CE2' ' HB2' ' A' ' 344' ' ' TYR . 1.8 m-85 -136.24 132.5 35.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.922 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.692 HD13 ' CG ' ' A' ' 361' ' ' PHE . 0.9 OUTLIER -119.67 123.02 70.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 73.1 111.136 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.19 131.84 34.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 74.34 110.943 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.51 -179.63 3.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 70.34 110.93 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -80.65 -43.76 19.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.082 -0.508 . . . . 71.21 110.884 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 82.3 p -115.71 159.86 20.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 74.42 111.122 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' HIS . . . . . 0.522 ' HA ' HG22 ' A' ' 341' ' ' THR . 19.5 p-80 -69.44 -42.09 75.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 71.24 110.842 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 387' ' ' GLU . . . . . 0.435 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 2.2 tt0 -59.04 -29.83 67.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 52.21 110.876 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.53 -35.07 71.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.865 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -75.46 -24.83 57.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 65.12 111.136 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.813 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -72.39 -37.11 68.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 63.4 111.143 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.83 -56.62 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 60.24 111.085 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' CYS . . . . . 0.601 ' HB2' ' CE2' ' A' ' 364' ' ' PHE . 14.5 p -63.99 -32.77 74.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 73.34 110.845 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.968 HG21 HG21 ' A' ' 332' ' ' ILE . 1.7 mt -53.32 -54.12 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 45.22 111.122 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.82 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.5 OUTLIER -71.18 -34.14 53.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 53.43 111.136 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -69.41 -28.49 66.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 72.34 111.109 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.719 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.4 mm? -97.75 -17.86 19.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.276 -0.42 . . . . 63.21 110.945 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -47.97 114.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 74.2 111.073 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 38.0 t30 44.77 44.75 7.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.13 110.831 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.719 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -100.66 143.99 27.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.644 0.735 . . . . 73.53 110.861 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.405 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.4 Cg_endo -69.75 145.11 56.2 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.674 2.249 . . . . 71.55 112.284 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' PHE . . . . . 0.574 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 56.1 t80 -150.12 110.8 4.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 74.01 110.886 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 49.08 33.45 4.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 63.25 110.923 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 99.95 -28.21 16.68 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.726 -0.749 . . . . 71.31 112.458 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -105.01 141.06 37.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 70.01 110.852 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.429 ' O ' HD23 ' A' ' 406' ' ' LEU . 7.4 m120 -83.88 154.13 23.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 42.51 110.888 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.813 HD13 HG21 ' A' ' 345' ' ' ILE . 8.7 mt -116.4 174.08 6.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 74.52 110.973 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.82 176.85 5.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 73.51 110.886 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 408' ' ' THR . . . . . 0.7 HG21 ' O ' ' A' ' 393' ' ' ILE . 23.5 p -151.67 151.28 31.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 54.13 111.109 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 164.83 173.13 33.13 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.74 -0.743 . . . . 32.33 112.501 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.454 ' CZ3' HG23 ' A' ' 340' ' ' VAL . 99.5 m95 -85.29 150.89 24.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 55.52 110.902 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -136.45 160.22 24.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.798 -0.715 . . . . 72.43 112.518 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -163.01 81.6 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.752 0.31 . . . . 72.54 110.944 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 414' ' ' ARG . 0.7 OUTLIER 43.2 44.72 4.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 72.32 110.953 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 413' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 71.13 110.905 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.465 -0.254 . . . . 64.33 112.465 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 84.9 p -125.38 102.93 7.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.848 0.356 . . . . 45.32 110.822 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' GLN . . . . . 0.509 ' NE2' ' O ' ' A' ' 316' ' ' GLN . 0.5 OUTLIER -149.01 85.72 1.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 60.02 110.936 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.901 HG22 HG22 ' A' ' 318' ' ' ILE . 85.5 m -90.7 -75.71 0.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 74.33 111.154 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.901 HG22 HG22 ' A' ' 317' ' ' THR . 4.1 tp -168.37 -50.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 65.44 111.117 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.5 ' N ' HG23 ' A' ' 318' ' ' ILE . . . 90.57 -55.57 3.46 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.77 -0.729 . . . . 65.31 112.501 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.469 ' N ' ' CD ' ' A' ' 321' ' ' PRO . 0.5 OUTLIER 79.36 52.42 0.12 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.606 0.717 . . . . 73.31 110.893 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' A' ' 320' ' ' LEU . 54.0 Cg_endo -69.76 169.62 18.49 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.718 2.278 . . . . 71.31 112.399 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -50.24 0.48 Allowed 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.698 2.265 . . . . 74.51 112.33 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.433 ' C ' ' CD ' ' A' ' 323' ' ' GLN . 0.0 OUTLIER -175.98 86.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 74.24 110.886 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 1.015 HG11 HG13 ' A' ' 391' ' ' VAL . 58.9 t -140.35 145.82 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 64.22 111.067 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.409 ' HA ' ' HD2' ' A' ' 326' ' ' PRO . 1.7 m120 -106.84 105.84 56.34 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.554 0.692 . . . . 75.14 110.947 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 325' ' ' ASN . 54.4 Cg_endo -69.74 -14.22 35.83 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.698 2.265 . . . . 63.34 112.367 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.95 -72.0 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 74.5 110.89 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.24 -28.25 40.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 71.13 111.066 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.97 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 16.0 t -71.1 -29.84 38.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 71.42 111.163 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -54.18 -35.44 62.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 73.32 110.892 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -69.34 -31.78 70.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 74.33 110.825 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.766 HG21 HD13 ' A' ' 393' ' ' ILE . 46.9 mm -54.79 -54.21 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 75.2 111.099 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.522 HG23 ' NE2' ' A' ' 386' ' ' HIS . 8.2 mt -52.36 -40.55 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 75.03 111.149 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -15.41 1.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 74.23 110.857 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' SER . . . . . 0.555 ' O ' ' HB2' ' A' ' 336' ' ' ALA . 0.1 OUTLIER -101.45 41.69 1.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 75.52 110.897 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' A' ' 335' ' ' SER . . . 170.59 157.05 0.21 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.626 0.727 . . . . 70.44 111.048 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.626 ' O ' HG12 ' A' ' 340' ' ' VAL . 54.1 Cg_endo -69.79 153.78 68.4 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.649 2.233 . . . . 73.22 112.369 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -11.55 31.04 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.742 2.295 . . . . 62.53 112.304 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -100.82 66.0 1.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 72.43 110.812 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 337' ' ' PRO . 14.4 p -171.39 131.72 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 72.34 111.054 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 386' ' ' HIS . 22.0 p -137.0 68.53 1.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 73.22 111.11 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 87.5 m -133.59 111.7 10.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.445 . . . . 65.23 111.099 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -85.72 137.39 32.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 75.2 111.139 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.805 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -116.99 134.55 54.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.47 . . . . 72.31 110.882 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.805 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.8 mp -131.68 110.99 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 72.1 111.142 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -101.09 161.62 18.36 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.774 -0.727 . . . . 62.23 112.52 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 2.4 t30 78.95 49.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.794 0.33 . . . . 74.34 110.85 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.559 HG23 ' HD2' ' A' ' 349' ' ' PRO . 85.1 mt -103.69 135.83 19.3 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.662 0.744 . . . . 71.22 111.115 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 349' ' ' PRO . . . . . 0.559 ' HD2' HG23 ' A' ' 348' ' ' ILE . 53.8 Cg_endo -69.73 164.4 34.66 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.687 2.258 . . . . 73.53 112.41 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.62 -28.09 63.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 70.32 110.882 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -83.17 20.09 1.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 61.03 110.892 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.774 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -107.64 112.83 25.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 41.44 111.089 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 19.0 p -116.32 170.94 8.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 72.34 111.107 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.498 ' O ' ' CG1' ' A' ' 358' ' ' ILE . 0.2 OUTLIER -66.23 -29.89 70.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 73.51 110.886 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.56 -26.64 63.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 74.32 111.168 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.48 -16.01 12.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 71.35 110.88 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.774 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.5 mp -93.5 -50.92 5.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 51.35 110.928 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.688 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.3 mm -44.0 -49.48 21.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.687 0.756 . . . . 70.44 111.171 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.0 Cg_endo -69.75 -27.84 26.02 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.255 . . . . 70.32 112.361 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.95 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -69.96 -26.95 64.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 63.2 110.907 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.789 ' HB2' HD11 ' A' ' 367' ' ' ILE . 85.6 m-85 -94.75 -36.39 11.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 73.33 110.844 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' GLN . . . . . 0.405 ' O ' ' N ' ' A' ' 364' ' ' PHE . 11.4 mm-40 -49.45 -46.81 48.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 65.52 110.886 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -42.5 -24.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 72.31 110.884 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' PHE . . . . . 0.405 ' N ' ' O ' ' A' ' 362' ' ' GLN . 28.6 m-85 -70.52 -59.77 2.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 73.33 110.904 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -155.1 -86.32 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.762 -0.732 . . . . 32.11 112.51 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -153.52 144.48 22.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 74.52 110.933 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.789 HD11 ' HB2' ' A' ' 361' ' ' PHE . 17.3 mt -120.92 109.32 24.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 75.02 111.139 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.03 -20.02 27.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.476 . . . . 74.24 110.92 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.3 121.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 72.34 110.837 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 28.9 t80 -113.42 143.52 44.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 63.45 110.855 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.07 101.42 5.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.865 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 372' ' ' HIS . . . . . 0.459 ' CD2' ' HD3' ' A' ' 374' ' ' PRO . 29.0 t60 -97.27 115.13 27.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 63.43 110.811 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -108.04 86.09 2.98 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.685 0.755 . . . . 71.14 110.953 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' PRO . . . . . 0.459 ' HD3' ' CD2' ' A' ' 372' ' ' HIS . 53.7 Cg_endo -69.8 -17.27 37.48 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.671 2.247 . . . . 42.43 112.318 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -79.32 -23.76 43.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 72.12 110.903 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -108.41 -26.65 10.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 53.33 110.952 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.91 41.05 5.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.721 -0.752 . . . . 64.42 112.5 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 27.0 p -159.86 153.27 22.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.89 0.376 . . . . 73.31 110.819 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 29.0 p -138.53 145.32 40.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 75.01 110.886 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -119.85 129.42 54.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.895 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.511 ' CG1' ' CD1' ' A' ' 370' ' ' PHE . 1.0 OUTLIER -120.82 132.94 69.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 73.1 111.147 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -98.77 134.79 41.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 74.34 110.822 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -117.45 -179.46 3.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 70.34 110.893 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.23 -39.56 22.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 71.21 110.849 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 67.3 p -120.42 171.39 8.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.42 111.18 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' HIS . . . . . 0.638 ' NE2' ' CZ2' ' A' ' 410' ' ' TRP . 4.4 t60 -83.65 -42.28 16.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 71.24 110.868 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.3 -28.72 63.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 52.21 110.841 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -36.51 82.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 75.42 110.947 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.545 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -73.9 -34.23 64.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 65.12 111.165 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.97 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -56.05 -34.41 65.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 63.4 111.071 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 1.015 HG13 HG11 ' A' ' 324' ' ' VAL . 95.9 t -71.4 -42.99 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 60.24 111.188 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 35.3 t -65.83 -34.17 77.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 73.34 110.905 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.766 HD13 HG21 ' A' ' 332' ' ' ILE . 1.1 mt -55.9 -56.01 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 45.22 111.159 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.491 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 1.8 t -72.04 -36.87 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 53.43 111.132 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.6 94.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 72.34 111.089 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.941 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.9 mm? -89.09 -18.56 27.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 63.21 110.917 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 398' ' ' ASN . . . -44.7 117.89 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 74.2 111.031 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 398' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 397' ' ' ALA . 4.6 p-10 34.5 42.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 73.13 110.936 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.941 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -97.38 148.0 33.79 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.664 0.745 . . . . 73.53 110.897 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 144.26 53.72 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.635 2.223 . . . . 71.55 112.399 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' PHE . . . . . 0.437 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 58.3 t80 -153.36 112.96 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 74.01 110.892 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 49.64 33.29 5.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 63.25 110.946 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 97.85 -27.66 17.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.735 -0.745 . . . . 71.31 112.453 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -106.06 142.22 36.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.819 0.342 . . . . 70.01 110.864 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -86.42 150.62 24.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 42.51 110.883 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.801 HD13 HG21 ' A' ' 345' ' ' ILE . 17.8 mt -112.06 -177.98 3.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 74.52 110.94 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 407' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 346' ' ' GLY . 8.3 ttt180 -125.87 177.29 6.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 73.51 110.943 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 408' ' ' THR . . . . . 0.708 HG21 ' O ' ' A' ' 393' ' ' ILE . 16.7 p -153.59 157.91 40.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 54.13 111.102 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 410' ' ' TRP . . . 148.83 126.61 1.54 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.674 -0.774 . . . . 32.33 112.448 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.638 ' CZ2' ' NE2' ' A' ' 386' ' ' HIS . 76.1 m95 -35.11 137.72 0.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.901 0.381 . . . . 55.52 110.878 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -137.65 -172.61 12.6 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.758 -0.734 . . . . 72.43 112.526 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.41 162.46 19.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.736 0.303 . . . . 72.54 110.942 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 414' ' ' ARG . 22.7 tt0 -42.56 -42.54 3.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 72.32 110.834 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 413' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 71.13 110.858 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.477 -0.249 . . . . 64.33 112.477 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.15 -54.55 6.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.771 0.319 . . . . 45.32 110.834 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -89.15 -54.86 3.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 60.02 110.885 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 17.0 m -129.84 120.58 25.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.465 . . . . 74.33 111.168 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 319' ' ' GLY . 1.1 tt -72.54 -44.2 61.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 65.44 111.171 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.5 ' N ' HG23 ' A' ' 318' ' ' ILE . . . 71.43 116.21 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.784 -0.722 . . . . 65.31 112.498 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.426 HD12 HG23 ' A' ' 318' ' ' ILE . 0.3 OUTLIER -133.83 81.4 52.69 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.577 0.704 . . . . 73.31 110.939 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 147.54 63.38 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.744 2.296 . . . . 71.31 112.356 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -25.47 28.95 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.748 2.298 . . . . 74.51 112.289 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -133.8 130.18 37.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 74.24 110.87 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.912 HG11 HG13 ' A' ' 391' ' ' VAL . 13.2 t 64.87 132.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.263 -0.426 . . . . 64.22 111.167 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -113.53 138.25 22.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.615 0.722 . . . . 75.14 110.859 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -14.14 35.65 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.635 2.223 . . . . 63.34 112.358 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -75.2 -72.67 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 74.5 110.891 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.64 -24.6 34.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 71.13 111.058 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.777 HG22 ' HB ' ' A' ' 394' ' ' VAL . 25.5 t -83.45 -29.73 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 71.42 111.175 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -54.57 -45.46 73.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.168 -0.469 . . . . 73.32 110.837 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' HIS . . . . . 0.41 ' O ' ' HG2' ' A' ' 334' ' ' ARG . 3.4 t60 -54.2 -31.9 54.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 74.33 110.916 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.569 HG22 ' NE1' ' A' ' 410' ' ' TRP . 26.6 mm -69.88 -49.52 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 75.2 111.172 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 54.2 mt -54.18 -39.52 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 75.03 111.184 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 331' ' ' HIS . 12.1 ptt180 -75.99 6.7 4.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.856 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 6.5 t -105.82 -13.2 15.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 75.52 110.914 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -150.19 150.51 29.66 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.641 0.734 . . . . 70.44 111.038 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 158.89 55.36 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.652 2.234 . . . . 73.22 112.322 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -28.84 24.78 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.692 2.261 . . . . 62.53 112.339 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.1 mtm105 -50.15 -40.66 47.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 72.43 110.879 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.7 p -95.17 134.32 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 72.34 111.107 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' THR . . . . . 0.591 HG22 ' CA ' ' A' ' 386' ' ' HIS . 25.3 p -140.46 71.15 1.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 73.22 111.099 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 3.4 m -132.54 128.81 38.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 65.23 111.172 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -95.23 119.42 33.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 75.2 111.094 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.639 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -100.28 129.13 46.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 72.31 110.936 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.831 HG22 HD11 ' A' ' 348' ' ' ILE . 1.8 mp -122.59 126.19 73.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.071 -0.513 . . . . 72.1 111.143 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -112.88 168.89 12.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 62.23 112.463 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.475 ' O ' ' CD2' ' A' ' 406' ' ' LEU . 1.9 t30 70.68 53.23 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.706 0.288 . . . . 74.34 110.877 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.831 HD11 HG22 ' A' ' 345' ' ' ILE . 2.0 mp -102.4 132.39 21.46 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.643 0.735 . . . . 71.22 111.116 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' PRO . . . . . 0.711 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.7 Cg_endo -69.72 153.55 68.97 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.683 2.255 . . . . 73.53 112.379 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.03 -18.96 64.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 70.32 110.836 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.409 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 5.2 p90 -94.38 19.78 9.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 61.03 110.862 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.79 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -111.78 104.19 12.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 41.44 111.038 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 27.2 p -107.24 168.33 9.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 72.34 111.131 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.514 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -59.59 -37.25 78.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 73.51 110.884 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -52.41 -26.11 11.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.32 111.067 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -112.14 -13.1 13.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 71.35 110.793 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.79 HD11 ' HB1' ' A' ' 352' ' ' ALA . 2.9 mp -99.25 -55.73 2.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 51.35 110.906 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.624 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -37.69 -52.44 2.67 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.619 0.723 . . . . 70.44 111.103 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 359' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.3 Cg_endo -69.76 -26.71 27.28 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.691 2.261 . . . . 70.32 112.352 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.953 ' O ' HD12 ' A' ' 360' ' ' LEU . 0.1 OUTLIER -70.07 -21.94 63.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 63.2 110.965 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.613 ' HB2' HD11 ' A' ' 367' ' ' ILE . 86.8 m-85 -101.11 -30.77 11.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 73.33 110.9 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -32.84 70.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 65.52 110.9 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -57.79 -16.42 11.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 72.31 110.882 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' PHE . . . . . 0.539 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 36.3 m-85 -75.74 -57.79 3.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 73.33 110.917 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -154.87 -82.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.743 . . . . 32.11 112.468 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.877 ' CD2' HD21 ' A' ' 368' ' ' LEU . 7.5 t80 -153.77 139.55 18.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.377 . . . . 74.52 110.904 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' A' ' 361' ' ' PHE . 13.1 mt -114.78 109.37 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.02 111.161 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.877 HD21 ' CD2' ' A' ' 366' ' ' PHE . 0.9 OUTLIER -89.74 -21.36 22.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 74.24 110.944 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -170.94 121.19 0.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 72.34 110.814 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 30.6 t80 -111.13 138.78 47.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 63.45 110.955 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.11 100.47 6.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 75.45 110.935 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' HIS . . . . . 0.461 ' HB2' ' CE2' ' A' ' 370' ' ' PHE . 25.2 t60 -97.82 132.82 43.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 63.43 110.864 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -123.92 88.82 52.12 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.677 0.751 . . . . 71.14 110.881 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 -17.03 37.86 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.622 2.215 . . . . 42.43 112.449 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -83.73 -26.43 29.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 72.12 110.846 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -104.63 -26.65 12.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 53.33 110.881 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 87.22 38.97 7.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.822 -0.704 . . . . 64.42 112.501 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.4 p -153.0 151.41 30.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 73.31 110.9 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 28.8 p -142.19 141.44 32.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 75.01 110.861 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.521 ' CD2' ' HB2' ' A' ' 344' ' ' TYR . 15.4 m-85 -119.69 138.53 53.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 73.43 110.886 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.441 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.6 OUTLIER -127.18 128.06 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 73.1 111.093 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.49 137.18 32.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 74.34 110.886 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -120.24 156.05 31.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 70.34 110.889 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -53.15 -50.33 64.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.102 -0.499 . . . . 71.21 110.863 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 38.7 p -113.41 176.06 5.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.42 111.203 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' HIS . . . . . 0.591 ' CA ' HG22 ' A' ' 341' ' ' THR . 39.9 p-80 -83.88 -39.7 19.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 71.24 110.852 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 387' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 391' ' ' VAL . 0.1 OUTLIER -59.91 -28.82 67.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 52.21 110.836 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -34.98 79.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 75.42 110.924 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -74.94 -37.51 61.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 65.12 111.098 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.634 ' HB1' HG13 ' A' ' 329' ' ' VAL . . . -60.99 -32.07 71.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 63.4 111.052 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.912 HG13 HG11 ' A' ' 324' ' ' VAL . 81.2 t -66.29 -39.16 83.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 60.24 111.111 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' CYS . . . . . 0.539 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 1.7 t -79.4 -25.42 42.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 73.34 110.851 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.73 ' O ' HG21 ' A' ' 408' ' ' THR . 0.3 OUTLIER -60.79 -55.5 24.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 45.22 111.149 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.777 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -69.74 -42.27 80.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 53.43 111.071 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.483 ' N ' ' CG1' ' A' ' 394' ' ' VAL . . . -55.95 -45.75 78.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 72.34 111.14 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.736 HD13 ' CE1' ' A' ' 399' ' ' PHE . 0.5 OUTLIER -79.76 -19.27 49.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 63.21 110.939 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 397' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 394' ' ' VAL . . . -48.38 113.96 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 74.2 111.1 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 45.52 50.26 10.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 73.13 110.877 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.736 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -110.17 143.7 28.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.712 0.768 . . . . 73.53 110.935 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 133.76 26.39 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.683 2.255 . . . . 71.55 112.382 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' PHE . . . . . 0.611 ' CE1' HD22 ' A' ' 360' ' ' LEU . 36.0 t80 -137.34 111.3 8.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 74.01 110.864 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 48.7 32.81 3.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 63.25 110.873 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.34 -30.72 9.78 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 71.31 112.488 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 134.81 48.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.912 0.387 . . . . 70.01 110.875 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -74.83 154.39 38.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 42.51 110.799 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 345' ' ' ILE . 15.9 mt -117.66 171.05 8.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 74.52 110.898 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.02 177.0 4.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 73.51 110.843 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 408' ' ' THR . . . . . 0.73 HG21 ' O ' ' A' ' 393' ' ' ILE . 6.9 p -152.7 152.17 31.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 54.13 111.181 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 169.28 157.25 11.56 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.695 -0.764 . . . . 32.33 112.427 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.569 ' NE1' HG22 ' A' ' 332' ' ' ILE . 13.9 m95 -68.94 88.22 0.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.836 0.35 . . . . 55.52 110.941 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 410' ' ' TRP . . . 35.14 82.19 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.757 -0.735 . . . . 72.43 112.53 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -105.27 91.02 3.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.776 0.322 . . . . 72.54 110.906 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 414' ' ' ARG . 0.0 OUTLIER -68.0 116.97 9.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 72.32 110.851 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 413' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 71.13 110.862 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.595 -0.202 . . . . 64.33 112.595 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 1.4 m -126.86 -82.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.348 . . . . 45.32 110.794 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -117.49 87.32 2.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 60.02 110.886 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 47.5 p 48.5 -173.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 74.33 111.099 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.542 HG23 ' N ' ' A' ' 319' ' ' GLY . 0.5 OUTLIER -78.05 -46.97 25.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 65.44 111.074 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.542 ' N ' HG23 ' A' ' 318' ' ' ILE . . . 101.43 -69.26 0.41 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.786 -0.721 . . . . 65.31 112.483 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 56.09 74.27 0.72 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.568 0.699 . . . . 73.31 110.969 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 167.47 24.26 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.696 2.264 . . . . 71.31 112.371 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -49.03 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.695 2.264 . . . . 74.51 112.393 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -154.82 -42.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.92 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.889 HG21 HG13 ' A' ' 391' ' ' VAL . 30.6 m -111.04 168.17 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 64.22 111.176 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.429 ' OD1' ' CB ' ' A' ' 327' ' ' GLN . 18.8 t-20 -112.57 121.95 37.53 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.615 0.721 . . . . 75.14 110.913 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -14.21 35.97 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.675 2.25 . . . . 63.34 112.331 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLN . . . . . 0.429 ' CB ' ' OD1' ' A' ' 325' ' ' ASN . 0.0 OUTLIER -69.89 -71.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 74.5 110.926 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -52.65 -28.75 22.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 71.13 111.141 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.736 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 8.0 t -70.55 -29.87 40.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 71.42 111.087 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -54.21 -36.04 63.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.32 110.82 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -65.42 -31.87 73.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 74.33 110.884 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.475 HG21 HG21 ' A' ' 393' ' ' ILE . 38.7 mm -60.56 -49.01 86.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 75.2 111.185 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.469 ' CG1' ' HB2' ' A' ' 390' ' ' ALA . 19.6 mt -57.44 -32.63 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 75.03 111.055 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -5.74 13.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 74.23 110.814 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.95 7.91 44.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 75.52 110.882 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . -161.33 159.56 23.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 70.44 111.059 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.554 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 54.7 Cg_endo -69.71 154.07 68.38 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.672 2.248 . . . . 73.22 112.369 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -8.98 24.97 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.62 2.213 . . . . 62.53 112.388 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -47.07 15.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 72.43 110.882 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 8.3 p -73.18 132.86 32.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 72.34 111.134 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' THR . . . . . 0.594 HG22 ' CB ' ' A' ' 386' ' ' HIS . 40.6 p -144.43 68.92 1.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 73.22 111.14 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 53.2 m -133.16 117.73 17.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 65.23 111.162 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -81.72 126.89 32.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 75.2 111.078 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.754 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -106.02 134.72 48.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 72.31 110.971 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.754 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.8 mp -130.4 121.2 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 72.1 111.12 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -108.53 167.45 13.17 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.796 -0.716 . . . . 62.23 112.49 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.488 ' O ' ' CD2' ' A' ' 406' ' ' LEU . 1.4 t30 69.55 57.34 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.776 0.322 . . . . 74.34 110.876 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.489 ' CG2' ' HB3' ' A' ' 352' ' ' ALA . 47.7 mt -107.94 131.16 21.93 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.631 0.729 . . . . 71.22 111.091 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' PRO . . . . . 0.432 ' CG ' ' CE1' ' A' ' 351' ' ' PHE . 53.9 Cg_endo -69.68 161.46 45.82 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.687 2.258 . . . . 73.53 112.384 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -64.2 -29.08 70.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 70.32 110.867 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.432 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 6.4 p90 -85.14 33.16 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 61.03 110.887 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.665 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -117.36 100.74 7.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 41.44 111.109 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 17.1 p -105.69 170.0 8.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 72.34 111.083 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.512 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.28 -29.88 69.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 73.51 110.92 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.36 -26.31 63.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 74.32 111.102 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.15 -14.95 13.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 71.35 110.837 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.665 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.5 mp -97.24 -52.87 3.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.193 -0.458 . . . . 51.35 110.895 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.652 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -41.87 -50.89 10.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.622 0.725 . . . . 70.44 111.115 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 359' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.5 Cg_endo -69.83 -35.13 13.0 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.671 2.247 . . . . 70.32 112.339 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.929 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -59.73 -26.26 65.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 63.2 110.919 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.696 ' HB2' HD11 ' A' ' 367' ' ' ILE . 85.8 m-85 -96.73 -25.24 15.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.223 -0.444 . . . . 73.33 110.882 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 364' ' ' PHE . 5.4 mt-30 -60.45 -47.76 84.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 65.52 110.903 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -42.44 -23.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 72.31 110.918 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 362' ' ' GLN . 23.3 m-85 -71.46 -60.07 2.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 73.33 110.913 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLY . . . . . 0.415 ' HA3' ' CD ' ' A' ' 388' ' ' GLN . . . -150.7 -88.51 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.735 -0.745 . . . . 32.11 112.543 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.661 ' CE2' HD12 ' A' ' 368' ' ' LEU . 28.8 t80 -153.92 138.77 17.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.852 0.358 . . . . 74.52 110.893 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.696 HD11 ' HB2' ' A' ' 361' ' ' PHE . 32.5 mt -120.43 116.87 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.477 . . . . 75.02 111.124 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.73 ' N ' HD13 ' A' ' 368' ' ' LEU . 0.0 OUTLIER -104.42 -16.2 15.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 74.24 110.877 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.569 ' N ' HD22 ' A' ' 368' ' ' LEU . 3.7 m-20 -159.86 121.05 3.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 72.34 110.9 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 31.0 t80 -123.21 142.66 50.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 63.45 110.895 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -129.56 101.1 5.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 75.45 110.907 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' HIS . . . . . 0.604 ' CD2' ' HD3' ' A' ' 374' ' ' PRO . 35.1 t60 -97.43 136.61 37.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 63.43 110.879 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -130.76 89.32 43.61 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.695 0.759 . . . . 71.14 110.893 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 374' ' ' PRO . . . . . 0.604 ' HD3' ' CD2' ' A' ' 372' ' ' HIS . 54.0 Cg_endo -69.77 -29.78 23.3 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.627 2.218 . . . . 42.43 112.364 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.1 -14.04 62.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 72.12 110.873 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -119.81 -24.38 6.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 53.33 110.869 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 80.34 44.35 8.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 64.42 112.434 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.2 p -156.83 137.81 13.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.825 0.345 . . . . 73.31 110.887 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 14.6 p -129.79 156.97 43.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 75.01 110.909 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -136.98 128.49 28.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.26 -0.427 . . . . 73.43 110.921 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.494 ' CG2' HG23 ' A' ' 367' ' ' ILE . 0.7 OUTLIER -117.83 131.34 70.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 73.1 111.155 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 382' ' ' LYS . . . . . 0.59 ' HB3' HD21 ' A' ' 368' ' ' LEU . 0.0 OUTLIER -98.72 137.23 37.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 74.34 110.907 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -120.88 173.52 7.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 70.34 110.913 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.56 -26.02 35.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 71.21 110.894 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 41.7 p -129.31 162.48 27.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 74.42 111.083 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' HIS . . . . . 0.594 ' CB ' HG22 ' A' ' 341' ' ' THR . 13.5 p80 -86.78 -33.7 19.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 71.24 110.865 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -60.8 -44.57 96.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 52.21 110.912 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.415 ' CD ' ' HA3' ' A' ' 365' ' ' GLY . 2.2 tt0 -60.36 -35.29 75.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 75.42 110.964 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -68.57 -44.06 75.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 65.12 111.067 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.736 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -50.1 -25.59 3.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 63.4 111.14 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.889 HG13 HG21 ' A' ' 324' ' ' VAL . 65.0 t -69.54 -49.76 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 60.24 111.164 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 30.7 t -57.51 -31.57 66.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 73.34 110.893 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.633 HD13 ' HA ' ' A' ' 390' ' ' ALA . 1.0 OUTLIER -56.65 -56.33 14.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.447 . . . . 45.22 111.097 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.507 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.2 t -72.07 -35.21 52.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 53.43 111.056 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.794 ' HB2' HG11 ' A' ' 324' ' ' VAL . . . -63.61 -39.71 95.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 72.34 111.061 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.703 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.5 mm? -93.63 -10.6 34.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.306 -0.407 . . . . 63.21 110.976 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' ALA . . . . . 0.668 ' N ' HG21 ' A' ' 408' ' ' THR . . . -51.8 110.12 0.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 74.2 111.102 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 57.6 t30 43.02 48.07 5.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 73.13 110.874 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.703 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -104.53 147.32 34.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.721 0.772 . . . . 73.53 110.848 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.429 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 54.6 Cg_endo -69.68 141.55 45.84 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.669 2.246 . . . . 71.55 112.339 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 401' ' ' PHE . . . . . 0.504 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 36.4 t80 -147.58 111.22 4.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 74.01 110.815 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 49.01 38.65 13.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 63.25 110.913 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 93.96 -29.07 9.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 71.31 112.409 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.4 OUTLIER -105.93 140.07 39.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.783 0.325 . . . . 70.01 110.97 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.438 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 9.0 m120 -81.62 154.63 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 42.51 110.875 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.646 HD13 HG21 ' A' ' 345' ' ' ILE . 13.3 mt -115.86 172.95 6.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 74.52 110.974 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -113.5 173.24 6.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 73.51 110.897 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 408' ' ' THR . . . . . 0.668 HG21 ' N ' ' A' ' 397' ' ' ALA . 71.0 p -154.18 151.55 29.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 54.13 111.118 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 410' ' ' TRP . . . 153.14 128.59 1.31 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.748 -0.739 . . . . 32.33 112.489 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.47 ' NE1' HG22 ' A' ' 332' ' ' ILE . 21.0 m95 -31.76 113.93 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.786 0.327 . . . . 55.52 110.893 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 410' ' ' TRP . . . 38.08 -158.1 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.736 -0.745 . . . . 72.43 112.437 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.53 ' HB2' ' CD2' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -167.6 -175.61 2.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.694 0.283 . . . . 72.54 110.933 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -104.61 45.54 0.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 72.32 110.835 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 71.13 110.839 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.484 -0.246 . . . . 64.33 112.484 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.23 97.78 5.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.807 0.337 . . . . 45.32 110.785 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -116.52 -55.83 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.083 -0.508 . . . . 60.02 110.915 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 71.5 p -42.22 162.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.491 . . . . 74.33 111.107 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 10.8 tp -116.51 151.5 18.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 65.44 111.171 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.452 ' C ' HD23 ' A' ' 320' ' ' LEU . . . -81.29 40.19 2.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.743 . . . . 65.31 112.456 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.452 HD23 ' C ' ' A' ' 319' ' ' GLY . 0.3 OUTLIER -176.97 75.22 0.24 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.536 0.684 . . . . 73.31 110.934 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 143.63 51.6 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.721 2.281 . . . . 71.31 112.329 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -21.26 33.4 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.71 2.273 . . . . 74.51 112.315 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.545 ' O ' HG22 ' A' ' 324' ' ' VAL . 6.6 mt-30 -140.61 87.61 2.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 74.24 110.933 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 323' ' ' GLN . 33.2 m 45.05 -171.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 64.22 111.049 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.24 110.99 24.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.621 0.724 . . . . 75.14 110.928 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.68 -14.47 36.39 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.666 2.244 . . . . 63.34 112.351 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -68.86 -71.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 74.5 110.905 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -57.14 -24.64 55.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 71.13 111.112 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.891 HG22 ' HB ' ' A' ' 394' ' ' VAL . 11.4 t -77.16 -30.1 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 71.42 111.154 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.649 ' HA ' HD12 ' A' ' 333' ' ' ILE . 21.7 t0 -55.0 -41.67 71.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 73.32 110.842 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -55.86 -35.48 66.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.857 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.765 HG21 HG21 ' A' ' 393' ' ' ILE . 39.1 mm -63.67 -49.67 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 75.2 111.108 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.649 HD12 ' HA ' ' A' ' 330' ' ' ASP . 13.3 mt -51.49 -50.06 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 75.03 111.126 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.28 -8.75 6.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 74.23 110.92 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 2.2 t -96.98 25.57 5.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 75.52 110.839 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.507 ' HB2' ' CD1' ' A' ' 410' ' ' TRP . . . -173.95 154.75 2.29 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.725 . . . . 70.44 111.082 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.409 ' HG2' HG12 ' A' ' 340' ' ' VAL . 53.6 Cg_endo -69.82 150.76 68.31 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 73.22 112.369 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' PRO . . . . . 0.412 ' HA ' ' ND1' ' A' ' 386' ' ' HIS . 54.4 Cg_endo -69.67 -12.11 32.37 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.669 2.246 . . . . 62.53 112.42 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -78.4 -53.39 7.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.832 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.409 HG12 ' HG2' ' A' ' 337' ' ' PRO . 4.1 p -69.34 135.19 28.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 72.34 111.13 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' THR . . . . . 0.438 HG22 ' CA ' ' A' ' 386' ' ' HIS . 44.6 p -142.69 68.19 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 73.22 111.113 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 3.4 m -133.75 128.93 35.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 65.23 111.183 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -92.91 134.31 35.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 75.2 111.133 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.518 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -112.69 128.57 56.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 72.31 110.918 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.623 HG22 HD11 ' A' ' 348' ' ' ILE . 1.6 mp -124.94 110.05 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 72.1 111.139 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -101.86 161.4 17.63 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 62.23 112.535 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 405' ' ' ASN . 0.7 OUTLIER 81.14 50.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 74.34 110.864 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.68 HG23 ' HD2' ' A' ' 349' ' ' PRO . 74.2 mt -107.06 138.68 19.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.607 0.718 . . . . 71.22 111.118 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' PRO . . . . . 0.68 ' HD2' HG23 ' A' ' 348' ' ' ILE . 54.2 Cg_endo -69.72 166.23 28.24 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.695 2.263 . . . . 73.53 112.364 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -76.34 -15.67 59.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 70.32 110.839 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.558 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 47.8 p90 -100.44 29.31 4.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 61.03 110.85 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.776 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -114.54 99.86 7.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 41.44 111.081 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 10.1 p -96.54 171.08 8.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 72.34 111.056 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.516 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.32 -30.4 70.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 73.51 110.843 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -55.1 -26.41 37.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 74.32 111.12 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.3 -12.96 13.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 71.35 110.822 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.776 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.4 mp -98.58 -54.46 3.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 51.35 110.953 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.639 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 0.9 OUTLIER -40.71 -51.5 6.87 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.631 0.729 . . . . 70.44 111.139 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 359' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.5 Cg_endo -69.8 -34.36 14.6 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.7 2.267 . . . . 70.32 112.308 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.912 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -59.65 -25.07 64.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 63.2 110.904 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.679 ' CG ' HD13 ' A' ' 381' ' ' ILE . 87.6 m-85 -98.01 -37.33 9.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.885 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' GLN . . . . . 0.654 ' HG2' HD12 ' A' ' 367' ' ' ILE . 6.3 mm-40 -50.66 -45.02 57.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 65.52 110.863 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -44.95 -21.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 72.31 110.879 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' PHE . . . . . 0.459 ' CE2' ' HA ' ' A' ' 361' ' ' PHE . 30.9 m-85 -75.3 -56.86 4.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 73.33 110.925 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -152.89 -90.26 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 32.11 112.477 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -153.8 142.87 21.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.757 0.313 . . . . 74.52 110.84 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.667 HD11 ' HB2' ' A' ' 361' ' ' PHE . 59.1 mt -120.95 109.13 24.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.168 -0.469 . . . . 75.02 111.129 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.64 -16.81 35.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 74.24 110.876 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.93 120.74 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 72.34 110.881 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.583 ' CD1' HG12 ' A' ' 381' ' ' ILE . 35.9 t80 -114.13 144.81 42.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 63.45 110.898 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.52 100.09 5.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 75.45 110.875 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 372' ' ' HIS . . . . . 0.591 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 4.0 t-80 -103.13 131.91 49.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 63.43 110.835 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.456 ' CB ' ' HB2' ' A' ' 376' ' ' LYS . 96.6 m-85 -128.73 102.19 20.01 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.639 0.733 . . . . 71.14 110.904 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 373' ' ' TYR . 53.5 Cg_endo -69.76 -25.13 28.93 Favored 'Trans proline' 0 N--CA 1.466 -0.114 0 C-N-CA 122.711 2.274 . . . . 42.43 112.344 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' GLU . . . . . 0.415 ' C ' ' HD2' ' A' ' 376' ' ' LYS . 8.7 pt-20 -87.57 -8.77 55.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 72.12 110.897 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' LYS . . . . . 0.456 ' HB2' ' CB ' ' A' ' 373' ' ' TYR . 0.0 OUTLIER -106.5 -28.13 10.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 53.33 110.862 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 80.61 24.32 58.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 64.42 112.461 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 92.1 m -155.22 149.8 26.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.776 0.322 . . . . 73.31 110.867 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 14.9 p -133.8 151.27 51.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 75.01 110.874 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 380' ' ' PHE . 3.5 m-85 -124.35 127.72 48.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.864 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.679 HD13 ' CG ' ' A' ' 361' ' ' PHE . 1.3 mt -119.24 121.35 66.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.516 . . . . 73.1 111.041 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.37 130.01 34.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 74.34 110.891 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -115.11 -174.89 2.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 70.34 110.906 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -73.61 -54.93 7.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.061 -0.518 . . . . 71.21 110.943 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 71.1 p -120.2 178.78 4.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 74.42 111.181 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' HIS . . . . . 0.438 ' CA ' HG22 ' A' ' 341' ' ' THR . 21.2 p-80 -83.65 -39.43 20.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 71.24 110.857 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -57.35 -28.82 63.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.425 . . . . 52.21 110.877 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -46.09 78.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 75.42 110.943 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.658 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -62.79 -25.71 68.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.235 -0.439 . . . . 65.12 111.121 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.811 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -58.27 -40.12 81.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 63.4 111.134 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.45 HG13 HG22 ' A' ' 324' ' ' VAL . 14.1 t -61.92 -57.9 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 60.24 111.081 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 18.4 p -58.91 -31.34 68.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 73.34 110.895 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.765 HG21 HG21 ' A' ' 332' ' ' ILE . 0.4 OUTLIER -58.97 -55.38 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 45.22 111.087 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.891 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -72.25 -35.74 53.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 53.43 111.187 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.494 ' HB2' HG11 ' A' ' 324' ' ' VAL . . . -62.57 -47.81 82.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 72.34 111.095 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.635 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.2 mm? -79.83 -13.42 59.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.258 -0.428 . . . . 63.21 110.913 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -50.33 112.91 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 74.2 111.096 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.2 m120 44.13 51.49 7.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 73.13 110.835 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.635 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -108.0 147.94 36.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.689 0.757 . . . . 73.53 110.865 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.424 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.3 Cg_endo -69.71 145.16 56.58 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.706 2.271 . . . . 71.55 112.324 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 401' ' ' PHE . . . . . 0.571 ' CZ ' ' NE2' ' A' ' 402' ' ' GLN . 40.0 t80 -151.85 111.49 3.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 74.01 110.856 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.571 ' NE2' ' CZ ' ' A' ' 401' ' ' PHE . 4.9 mt-30 46.7 38.63 6.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 63.25 110.893 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 94.57 -29.99 8.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.735 . . . . 71.31 112.539 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -104.91 137.62 42.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 70.01 110.83 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.477 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 4.6 m120 -80.04 152.75 29.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 42.51 110.895 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.405 ' CD2' ' O ' ' A' ' 347' ' ' ASN . 13.9 mt -114.58 173.57 6.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 74.52 110.944 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 346' ' ' GLY . 5.5 ttm-85 -117.63 175.36 5.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 73.51 110.88 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' THR . . . . . 0.593 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 43.0 p -151.63 153.45 34.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 54.13 111.122 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 165.11 174.54 34.9 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.665 -0.779 . . . . 32.33 112.412 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.507 ' CD1' ' HB2' ' A' ' 336' ' ' ALA . 41.1 m95 -81.45 122.64 27.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.787 0.327 . . . . 55.52 110.881 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -38.59 156.01 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.75 -0.738 . . . . 72.43 112.52 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 413' ' ' GLU . 0.0 OUTLIER -160.38 127.35 4.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.736 0.303 . . . . 72.54 110.906 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 412' ' ' LYS . 0.8 OUTLIER -36.63 126.91 0.85 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 72.32 110.925 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 71.13 110.843 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.483 -0.247 . . . . 64.33 112.483 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 34.5 p -69.83 148.92 48.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 45.32 110.924 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -166.6 -59.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 60.02 110.884 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 41.8 p 51.38 178.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 74.33 111.079 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 4.7 tt -166.42 173.9 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 65.44 111.155 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -112.29 67.11 0.24 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 65.31 112.456 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -177.77 140.47 0.43 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.722 . . . . 73.31 110.94 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 161.44 45.94 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.663 2.242 . . . . 71.31 112.3 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -11.9 31.68 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.646 2.231 . . . . 74.51 112.356 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.515 ' O ' ' C ' ' A' ' 324' ' ' VAL . 2.3 mp0 -104.91 143.43 33.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.24 110.946 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 324' ' ' VAL . 11.7 p 28.27 75.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 64.22 111.15 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.54 143.81 98.35 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.625 0.726 . . . . 75.14 110.887 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 -13.6 35.12 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.659 2.239 . . . . 63.34 112.443 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -73.55 -72.22 0.27 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 74.5 110.898 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -51.05 -33.73 26.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.424 . . . . 71.13 111.11 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.937 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 7.9 t -70.27 -28.66 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 71.42 111.113 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -53.11 -37.45 61.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 73.32 110.867 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -71.65 -31.81 67.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 74.33 110.805 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.918 HG21 HG21 ' A' ' 393' ' ' ILE . 33.5 mm -54.59 -56.07 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 75.2 111.141 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 4.3 mt -49.72 -39.24 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 75.03 111.163 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -27.35 31.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 74.23 110.828 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 4.8 t -68.47 -32.1 71.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 75.52 110.858 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.546 ' HB2' ' CG ' ' A' ' 410' ' ' TRP . . . -113.93 155.43 45.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.606 0.717 . . . . 70.44 111.061 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 54.5 Cg_endo -69.73 161.79 44.57 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.654 2.236 . . . . 73.22 112.425 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.8 -11.47 30.86 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.667 2.245 . . . . 62.53 112.304 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -106.61 67.33 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 72.43 110.883 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 5.3 p 177.14 134.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 72.34 111.147 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 19.9 p -141.55 69.99 1.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.193 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 23.7 m -133.61 121.71 22.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 65.23 111.2 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -88.33 134.33 33.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 75.2 111.15 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.605 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -111.2 121.65 45.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.289 -0.414 . . . . 72.31 110.942 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.539 HG23 ' HB3' ' A' ' 406' ' ' LEU . 2.3 mp -124.31 102.19 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 72.1 111.14 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.443 ' H ' ' CB ' ' A' ' 407' ' ' ARG . . . -92.28 -173.19 41.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.69 -0.767 . . . . 62.23 112.519 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.9 t30 58.76 46.66 13.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 74.34 110.901 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.568 ' CG2' ' HB3' ' A' ' 352' ' ' ALA . 81.6 mt -100.08 131.38 24.37 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.529 0.68 . . . . 71.22 111.164 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' PRO . . . . . 0.523 ' CB ' ' CE1' ' A' ' 351' ' ' PHE . 53.9 Cg_endo -69.71 156.22 64.03 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.736 2.29 . . . . 73.53 112.372 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.7 -20.83 65.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 70.32 110.827 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.523 ' CE1' ' CB ' ' A' ' 349' ' ' PRO . 4.8 p90 -94.01 29.35 2.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 61.03 110.929 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.847 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -116.0 96.14 5.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 41.44 111.109 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 15.2 p -98.39 170.69 8.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 72.34 111.161 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.521 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.6 OUTLIER -67.31 -29.72 69.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 73.51 110.843 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.67 -26.21 63.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 74.32 111.084 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.3 -14.1 13.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 71.35 110.844 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.847 HD11 ' HB1' ' A' ' 352' ' ' ALA . 2.8 mp -97.78 -52.14 3.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 51.35 110.901 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.668 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -42.52 -50.32 12.34 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.627 0.727 . . . . 70.44 111.137 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 52.9 Cg_endo -69.78 -29.09 24.33 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.684 2.256 . . . . 70.32 112.313 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.849 HD13 ' C ' ' A' ' 360' ' ' LEU . 0.2 OUTLIER -66.97 -21.83 65.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 63.2 110.924 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.599 ' HB2' HD11 ' A' ' 367' ' ' ILE . 87.8 m-85 -103.32 -36.04 8.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 73.33 110.891 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -49.14 -40.27 31.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 65.52 110.853 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -48.86 -27.84 3.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 72.31 110.928 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' PHE . . . . . 0.557 ' CE1' ' HA ' ' A' ' 392' ' ' CYS . 39.7 m-85 -64.19 -56.88 11.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 73.33 110.902 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -158.98 -84.69 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.786 -0.721 . . . . 32.11 112.537 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -153.24 145.45 23.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.799 0.333 . . . . 74.52 110.893 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.599 HD11 ' HB2' ' A' ' 361' ' ' PHE . 27.6 mt -121.1 111.31 31.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 75.02 111.165 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.86 -23.18 25.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 74.24 110.934 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.16 120.67 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 72.34 110.944 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.525 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 32.8 t80 -112.34 140.96 46.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 63.45 110.845 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.11 101.21 6.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 75.45 110.909 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 372' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.3 t-80 -97.43 124.07 41.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 63.43 110.795 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -118.02 89.01 33.37 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.698 0.761 . . . . 71.14 110.911 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' PRO . . . . . 0.417 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.4 Cg_endo -69.78 -26.16 27.76 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.648 2.232 . . . . 42.43 112.325 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -72.75 -12.7 61.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 72.12 110.829 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -119.75 -26.43 5.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 53.33 110.916 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 86.55 41.52 6.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.738 -0.744 . . . . 64.42 112.491 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.5 t -159.99 147.74 16.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.745 0.307 . . . . 73.31 110.863 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.525 ' HB2' ' CE1' ' A' ' 370' ' ' PHE . 21.5 p -134.18 155.13 50.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 75.01 110.824 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -128.95 122.79 30.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 73.43 110.887 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.521 HD13 ' CG ' ' A' ' 361' ' ' PHE . 1.1 mt -114.17 134.05 58.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 73.1 111.113 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.37 131.76 48.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 74.34 110.863 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -112.75 -173.83 2.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 70.34 110.931 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.62 -39.03 16.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 71.21 110.873 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 54.7 p -120.82 174.35 6.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 74.42 111.139 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -87.17 -32.13 20.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 71.24 110.88 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -61.16 -41.92 97.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 52.21 110.849 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.93 -35.79 67.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 75.42 110.892 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.39 -26.12 60.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.227 -0.442 . . . . 65.12 111.13 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.937 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -68.56 -40.42 80.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 63.4 111.072 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.632 ' O ' HG21 ' A' ' 324' ' ' VAL . 93.8 t -64.73 -55.2 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 60.24 111.141 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' CYS . . . . . 0.557 ' HA ' ' CE1' ' A' ' 364' ' ' PHE . 16.7 p -57.15 -29.69 63.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.485 . . . . 73.34 110.858 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.918 HG21 HG21 ' A' ' 332' ' ' ILE . 8.6 mt -60.03 -55.42 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 45.22 111.134 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.5 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 1.7 t -72.04 -34.43 50.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 53.43 111.132 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -63.77 -47.86 79.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 72.34 111.08 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.711 HD13 ' CE1' ' A' ' 399' ' ' PHE . 0.3 OUTLIER -82.14 -6.38 59.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 63.21 110.899 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 397' ' ' ALA . . . . . 0.701 ' N ' HG21 ' A' ' 408' ' ' THR . . . -54.89 112.79 1.12 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.204 -0.453 . . . . 74.2 111.118 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 44.79 46.29 8.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 73.13 110.946 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.711 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -99.29 145.55 30.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.634 0.73 . . . . 73.53 110.85 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 141.91 46.22 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.714 2.276 . . . . 71.55 112.358 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' PHE . . . . . 0.461 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 48.2 t80 -151.01 112.86 4.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 74.01 110.871 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 52.97 32.74 13.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 63.25 110.917 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 96.63 -26.61 21.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.69 -0.767 . . . . 71.31 112.448 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 401' ' ' PHE . 9.9 ttt85 -108.57 143.61 37.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.827 0.346 . . . . 70.01 110.917 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -80.81 155.17 26.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 42.51 110.933 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.539 ' HB3' HG23 ' A' ' 345' ' ' ILE . 10.4 mt -114.77 175.13 5.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 74.52 110.899 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' ARG . . . . . 0.443 ' CB ' ' H ' ' A' ' 346' ' ' GLY . 1.0 OUTLIER -109.02 176.21 5.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 73.51 110.902 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 408' ' ' THR . . . . . 0.701 HG21 ' N ' ' A' ' 397' ' ' ALA . 45.0 p -154.06 149.82 27.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 54.13 111.147 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 164.03 -159.04 31.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.72 . . . . 32.33 112.506 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.546 ' CG ' ' HB2' ' A' ' 336' ' ' ALA . 96.5 m95 -109.31 129.2 55.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.731 0.301 . . . . 55.52 110.974 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -93.45 159.82 24.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.791 -0.719 . . . . 72.43 112.475 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 413' ' ' GLU . 2.4 tttm -163.25 79.04 0.45 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.727 0.299 . . . . 72.54 110.918 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 414' ' ' ARG . 39.7 mt-10 35.33 45.72 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 72.32 110.962 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 413' ' ' GLU . 1.1 ptt180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.495 . . . . 71.13 110.88 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.462 -0.255 . . . . 64.33 112.462 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.45 174.72 0.35 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 45.32 110.867 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -144.64 36.65 1.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 60.02 110.947 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 318' ' ' ILE . 1.9 m -112.1 143.98 42.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 74.33 111.115 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.413 ' C ' ' O ' ' A' ' 317' ' ' THR . 5.1 tp -36.58 142.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 65.44 111.153 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -110.36 -44.11 1.02 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 65.31 112.525 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 47.65 82.71 0.23 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.566 0.698 . . . . 73.31 110.94 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 170.27 16.9 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.727 2.285 . . . . 71.31 112.336 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 323' ' ' GLN . 53.4 Cg_endo -69.72 6.98 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.709 2.273 . . . . 74.51 112.317 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.515 ' CB ' ' O ' ' A' ' 322' ' ' PRO . 0.3 OUTLIER 84.61 41.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 74.24 110.871 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.588 HG21 HG13 ' A' ' 391' ' ' VAL . 1.1 t -156.47 164.82 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 64.22 111.14 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -108.12 116.23 57.19 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.607 0.718 . . . . 75.14 110.855 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -14.25 35.85 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.725 2.283 . . . . 63.34 112.311 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -71.65 -72.17 0.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 74.5 110.899 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -58.63 -25.49 62.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 71.13 111.065 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.925 HG22 ' HB ' ' A' ' 394' ' ' VAL . 24.6 t -78.21 -29.98 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.434 . . . . 71.42 111.187 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.445 ' HA ' HD12 ' A' ' 333' ' ' ILE . 21.3 t70 -54.71 -35.64 63.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.877 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.69 -38.27 87.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 74.33 110.884 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.611 ' CG1' HG21 ' A' ' 393' ' ' ILE . 1.1 mp -54.21 -51.42 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 75.2 111.096 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 330' ' ' ASP . 9.0 mt -53.67 -38.38 34.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 75.03 111.121 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -2.45 6.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.23 110.872 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 43.2 t -108.92 21.76 16.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 75.52 110.829 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -175.9 150.88 1.14 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.586 0.707 . . . . 70.44 111.083 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 154.28 67.65 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.629 2.219 . . . . 73.22 112.323 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -8.05 22.6 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.678 2.252 . . . . 62.53 112.351 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.08 -49.72 13.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 72.43 110.876 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.75 133.05 32.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 72.34 111.146 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' THR . . . . . 0.632 HG22 ' CA ' ' A' ' 386' ' ' HIS . 30.2 p -135.7 68.02 1.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.117 -0.492 . . . . 73.22 111.184 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 51.2 m -133.72 136.99 45.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 65.23 111.154 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.446 ' CB ' ' SG ' ' A' ' 392' ' ' CYS . . . -109.18 129.54 55.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 75.2 111.088 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.711 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -105.95 134.44 49.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 72.31 110.899 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.711 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.9 mp -129.61 100.7 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 72.1 111.171 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -90.07 178.61 43.56 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.713 -0.756 . . . . 62.23 112.488 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 405' ' ' ASN . 2.3 t30 67.64 49.23 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 74.34 110.899 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.675 HG23 ' HD2' ' A' ' 349' ' ' PRO . 77.4 mt -105.11 138.51 19.54 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.618 0.723 . . . . 71.22 111.156 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 349' ' ' PRO . . . . . 0.675 ' HD2' HG23 ' A' ' 348' ' ' ILE . 53.7 Cg_endo -69.75 164.04 36.03 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.708 2.272 . . . . 73.53 112.361 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -75.57 -18.64 59.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 70.32 110.817 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.563 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 55.4 p90 -92.88 17.65 10.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 61.03 110.9 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.808 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -105.8 116.04 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 41.44 111.159 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 25.6 p -114.96 170.42 8.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 72.34 111.192 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.507 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -64.82 -29.77 70.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 73.51 110.935 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.48 -26.59 63.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 74.32 111.108 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.27 -13.6 13.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 71.35 110.954 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.808 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.5 mp -98.47 -52.27 3.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 51.35 110.899 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.649 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -41.83 -51.07 9.95 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.639 0.733 . . . . 70.44 111.066 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 359' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.1 Cg_endo -69.79 -35.37 12.69 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.699 2.266 . . . . 70.32 112.388 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.921 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -59.45 -23.47 62.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 63.2 110.922 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.543 ' N ' HD13 ' A' ' 360' ' ' LEU . 82.8 m-85 -100.97 -35.6 9.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 73.33 110.877 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 362' ' ' GLN . . . . . 0.478 ' HG3' HD12 ' A' ' 367' ' ' ILE . 2.3 mt-30 -53.34 -35.41 60.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 65.52 110.934 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -54.11 -14.88 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 72.31 110.875 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -78.62 -56.78 4.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 73.33 110.862 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -157.09 -85.99 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 32.11 112.453 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.693 ' CD2' HD21 ' A' ' 368' ' ' LEU . 8.4 t80 -153.64 142.82 21.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 74.52 110.881 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.478 HD12 ' HG3' ' A' ' 362' ' ' GLN . 50.3 mt -120.87 112.3 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 75.02 111.156 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.693 HD21 ' CD2' ' A' ' 366' ' ' PHE . 0.3 OUTLIER -86.01 -21.82 27.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 74.24 110.889 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.94 121.2 0.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 72.34 110.88 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 33.5 t80 -111.11 139.77 46.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 63.45 110.891 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -126.82 100.93 6.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 75.45 110.95 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' HIS . . . . . 0.482 ' HB2' ' CE2' ' A' ' 370' ' ' PHE . 33.8 t60 -96.37 115.71 27.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 63.43 110.793 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -107.25 84.58 1.77 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.744 . . . . 71.14 110.874 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -17.38 37.72 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.701 2.267 . . . . 42.43 112.411 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -78.24 -24.67 46.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 72.12 110.908 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -108.7 -27.41 9.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 53.33 110.948 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 93.4 42.29 4.29 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.676 -0.774 . . . . 64.42 112.452 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 26.3 p -159.92 158.18 30.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.837 0.351 . . . . 73.31 110.942 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.564 ' HB2' ' CE1' ' A' ' 370' ' ' PHE . 28.1 p -143.35 152.32 41.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 75.01 110.872 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 414' ' ' ARG . 38.0 m-85 -125.8 125.03 42.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 73.43 110.827 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.443 HG22 HG23 ' A' ' 367' ' ' ILE . 0.7 OUTLIER -115.28 121.25 66.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 73.1 111.139 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -87.94 131.95 34.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 74.34 110.919 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -116.43 162.7 17.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 70.34 110.889 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -60.99 -45.55 94.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 71.21 110.873 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 30.2 p -112.92 169.02 9.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 74.42 111.143 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' HIS . . . . . 0.632 ' CA ' HG22 ' A' ' 341' ' ' THR . 18.0 p-80 -82.62 -36.14 26.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 71.24 110.891 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 387' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 391' ' ' VAL . 5.0 tm-20 -62.73 -26.81 68.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.181 -0.463 . . . . 52.21 110.896 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -34.96 79.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 75.42 110.868 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.66 -41.26 62.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 65.12 111.05 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -58.87 -26.36 64.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 63.4 111.121 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.588 HG13 HG21 ' A' ' 324' ' ' VAL . 79.7 t -71.36 -55.76 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 60.24 111.145 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 343' ' ' ALA . 30.3 p -60.64 -32.05 71.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.913 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.611 HG21 ' CG1' ' A' ' 332' ' ' ILE . 0.2 OUTLIER -53.54 -54.98 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 45.22 111.092 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.925 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.7 -38.91 68.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 53.43 111.139 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.415 ' N ' ' CG1' ' A' ' 394' ' ' VAL . . . -62.03 -33.91 75.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 72.34 111.116 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.7 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.6 mm? -93.61 -15.08 25.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 63.21 110.925 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' ALA . . . . . 0.609 ' N ' HG21 ' A' ' 408' ' ' THR . . . -47.39 111.47 0.42 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 74.2 111.065 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 43.14 47.43 5.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 73.13 110.944 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.7 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -100.88 146.28 31.85 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.661 0.744 . . . . 73.53 110.841 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.441 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 54.2 Cg_endo -69.76 137.05 34.57 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.717 2.278 . . . . 71.55 112.339 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 401' ' ' PHE . . . . . 0.571 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 29.9 t80 -142.64 111.13 6.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 74.01 110.967 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 48.98 34.5 5.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 63.25 110.935 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 99.28 -31.99 7.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.741 -0.743 . . . . 71.31 112.454 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.8 134.71 47.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 70.01 110.859 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.474 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 3.1 m120 -78.2 152.25 32.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 42.51 110.892 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.453 ' HB3' HG23 ' A' ' 345' ' ' ILE . 10.8 mt -111.62 177.5 4.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 74.52 110.872 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.77 172.26 7.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 73.51 110.85 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 408' ' ' THR . . . . . 0.609 HG21 ' N ' ' A' ' 397' ' ' ALA . 45.8 p -154.77 146.09 22.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 54.13 111.18 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 165.34 138.41 2.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 32.33 112.512 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -43.68 134.12 4.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.778 0.323 . . . . 55.52 110.942 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -110.87 163.92 12.23 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.711 -0.756 . . . . 72.43 112.552 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.484 ' O ' ' C ' ' A' ' 413' ' ' GLU . 0.0 OUTLIER -133.32 78.2 1.77 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.732 0.301 . . . . 72.54 110.926 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.484 ' C ' ' O ' ' A' ' 412' ' ' LYS . 5.8 pt-20 31.54 51.21 0.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 72.32 110.846 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 380' ' ' PHE . 2.3 ttm180 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 71.13 110.817 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.503 -0.239 . . . . 64.33 112.503 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.79 -54.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 45.32 110.854 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.93 75.46 1.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 60.02 110.896 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 4.3 t -171.89 157.08 4.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.33 111.129 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 14.1 tt -134.23 148.31 29.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 65.44 111.077 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -114.95 114.56 3.24 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.77 -0.729 . . . . 65.31 112.498 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.5 73.26 12.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.655 0.741 . . . . 73.31 110.901 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 150.9 68.26 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.654 2.236 . . . . 71.31 112.315 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 3.34 2.81 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.696 2.264 . . . . 74.51 112.322 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -89.26 -72.22 0.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 74.24 110.889 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.87 150.24 26.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 64.22 111.132 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -113.05 118.89 43.66 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.738 0.78 . . . . 75.14 110.844 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -14.29 36.03 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.742 2.295 . . . . 63.34 112.358 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -69.81 -72.61 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 74.5 110.913 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.06 -33.78 63.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 71.13 111.145 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.889 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 10.7 t -66.78 -29.88 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.178 -0.464 . . . . 71.42 111.156 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.505 ' HA ' HD12 ' A' ' 333' ' ' ILE . 7.1 t70 -54.11 -34.74 61.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 73.32 110.912 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -70.69 -31.99 69.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.446 . . . . 74.33 110.86 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.907 HG21 HG21 ' A' ' 393' ' ' ILE . 29.4 mm -57.98 -44.9 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 75.2 111.093 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 330' ' ' ASP . 6.0 mt -53.66 -44.39 57.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 75.03 111.181 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 -56.08 -13.85 2.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 74.23 110.93 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 11.7 t -76.32 -30.56 57.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 75.52 110.9 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.752 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . -133.78 165.34 37.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.554 0.693 . . . . 70.44 111.114 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.752 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 53.8 Cg_endo -69.75 148.75 65.85 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.675 2.25 . . . . 73.22 112.342 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -7.64 21.58 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.716 2.278 . . . . 62.53 112.313 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -43.8 40.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.224 -0.444 . . . . 72.43 110.806 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.1 p -81.6 139.73 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 72.34 111.077 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' THR . . . . . 0.488 HG22 ' CA ' ' A' ' 386' ' ' HIS . 34.7 p -138.46 69.09 1.38 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 73.22 111.171 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.476 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 98.6 m -133.59 124.96 27.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 65.23 111.088 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -85.6 126.47 33.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 75.2 111.064 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.818 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -106.4 134.29 49.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 72.31 110.907 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.818 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.8 mp -135.41 110.97 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 72.1 111.126 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -100.03 161.08 19.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.696 -0.764 . . . . 62.23 112.419 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 1.0 OUTLIER 81.09 50.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.775 0.321 . . . . 74.34 110.882 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.647 HG23 ' HD2' ' A' ' 349' ' ' PRO . 46.5 mt -104.1 138.2 19.46 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.619 0.723 . . . . 71.22 111.149 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 349' ' ' PRO . . . . . 0.843 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.3 Cg_endo -69.78 166.48 27.47 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.732 2.288 . . . . 73.53 112.308 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -74.24 -29.66 61.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 70.32 110.884 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -83.5 12.87 5.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 61.03 110.908 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.843 ' HB2' ' HG2' ' A' ' 349' ' ' PRO . . . -99.15 102.59 14.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 41.44 111.122 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 22.3 p -105.02 172.0 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 72.34 111.112 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.505 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.3 OUTLIER -65.6 -30.25 70.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 73.51 110.845 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -57.25 -26.29 60.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 74.32 111.095 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.89 -18.68 12.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 71.35 110.868 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.839 HD11 ' HB1' ' A' ' 352' ' ' ALA . 4.6 mp -92.68 -52.51 4.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 51.35 110.957 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.656 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -41.76 -51.1 9.74 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.609 0.718 . . . . 70.44 111.122 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 359' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.8 Cg_endo -69.7 -30.15 23.01 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.669 2.246 . . . . 70.32 112.353 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.925 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -66.46 -23.96 66.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 63.2 110.912 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.564 ' CE2' HD12 ' A' ' 360' ' ' LEU . 81.3 m-85 -101.45 -27.43 13.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 73.33 110.919 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' GLN . . . . . 0.539 ' N ' HD11 ' A' ' 367' ' ' ILE . 0.0 OUTLIER -56.57 -22.93 36.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 65.52 110.852 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -71.29 -10.38 59.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 72.31 110.89 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' PHE . . . . . 0.435 ' HE2' ' HG ' ' A' ' 392' ' ' CYS . 23.6 m-85 -93.17 18.59 9.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.911 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 130.07 -96.02 0.36 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 32.11 112.506 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -152.55 150.8 29.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.767 0.318 . . . . 74.52 110.943 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.539 HD11 ' N ' ' A' ' 362' ' ' GLN . 45.8 mt -121.42 109.86 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 75.02 111.149 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.75 -18.71 28.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 74.24 110.922 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.27 120.8 0.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 72.34 110.906 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 29.4 t80 -112.36 145.4 40.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 63.45 110.902 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.82 101.16 4.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.469 . . . . 75.45 110.848 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 372' ' ' HIS . . . . . 0.413 ' HB2' ' CE2' ' A' ' 370' ' ' PHE . 40.2 t60 -94.99 117.35 29.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 63.43 110.846 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -109.7 83.64 2.84 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.657 0.741 . . . . 71.14 110.846 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' PRO . . . . . 0.404 ' HD3' ' CD2' ' A' ' 372' ' ' HIS . 52.7 Cg_endo -69.86 -17.97 36.81 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.691 2.261 . . . . 42.43 112.304 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.28 -27.19 61.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 72.12 110.862 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -110.52 -27.29 9.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 53.33 110.856 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 94.25 43.51 3.74 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 64.42 112.476 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 79.7 m -154.8 152.93 30.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.827 0.346 . . . . 73.31 110.918 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 16.0 p -136.21 152.49 50.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 75.01 110.879 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.476 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 48.6 m-85 -129.02 124.79 35.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.43 110.869 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.508 ' CG2' HG23 ' A' ' 367' ' ' ILE . 0.7 OUTLIER -117.35 123.28 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 73.1 111.172 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -89.55 136.19 33.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 74.34 110.886 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -119.63 -178.63 3.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 70.34 110.925 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.75 -42.57 40.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.496 . . . . 71.21 110.874 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 55.4 p -127.97 170.3 13.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 74.42 111.104 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' HIS . . . . . 0.488 ' CA ' HG22 ' A' ' 341' ' ' THR . 29.3 p-80 -80.41 -35.31 35.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 71.24 110.823 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -59.42 -27.18 65.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 52.21 110.938 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.84 -34.28 62.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 75.42 110.879 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.404 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -69.04 -44.09 73.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 65.12 111.081 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.889 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -50.22 -28.85 8.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 63.4 111.082 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.57 -40.07 79.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 60.24 111.156 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' CYS . . . . . 0.435 ' HG ' ' HE2' ' A' ' 364' ' ' PHE . 45.4 t -69.93 -33.61 72.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 73.34 110.892 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.907 HG21 HG21 ' A' ' 332' ' ' ILE . 0.9 OUTLIER -53.2 -55.61 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 45.22 111.19 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.5 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.0 t -71.47 -40.82 72.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 53.43 111.141 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.09 -16.75 54.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 72.34 111.102 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.581 HD12 HG12 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -115.91 -8.7 11.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 63.21 110.934 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -59.23 108.43 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 74.2 111.136 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 11.1 m120 47.98 49.37 17.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 73.13 110.911 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.5 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -108.62 142.75 26.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.694 0.759 . . . . 73.53 110.884 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.499 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 54.1 Cg_endo -69.71 145.52 57.72 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.702 2.268 . . . . 71.55 112.306 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 401' ' ' PHE . . . . . 0.485 ' N ' ' O ' ' A' ' 404' ' ' ARG . 50.4 t80 -152.77 110.61 3.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 74.01 110.797 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 49.54 39.9 18.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.508 . . . . 63.25 110.948 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 81.72 10.48 84.18 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.775 -0.726 . . . . 71.31 112.478 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -135.02 132.73 38.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.855 0.36 . . . . 70.01 110.909 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.531 ' C ' HD23 ' A' ' 406' ' ' LEU . 34.5 m120 -82.54 146.02 29.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 42.51 110.88 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.707 ' HB3' HG23 ' A' ' 345' ' ' ILE . 6.3 mt -112.02 172.6 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 74.52 110.941 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 407' ' ' ARG . . . . . 0.478 ' O ' HG23 ' A' ' 408' ' ' THR . 0.0 OUTLIER -123.16 177.2 5.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 73.51 110.837 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 408' ' ' THR . . . . . 0.642 HG21 ' O ' ' A' ' 393' ' ' ILE . 19.9 p -157.47 163.4 38.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 54.13 111.146 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 409' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 410' ' ' TRP . . . 152.23 44.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.751 . . . . 32.33 112.512 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.514 ' NE1' HG22 ' A' ' 332' ' ' ILE . 75.1 m95 56.84 155.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.813 0.34 . . . . 55.52 110.907 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -44.33 121.58 4.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.778 -0.725 . . . . 72.43 112.47 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -154.75 122.59 5.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.739 0.304 . . . . 72.54 110.902 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -42.67 -62.09 1.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 72.32 110.871 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 71.13 110.905 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.445 -0.262 . . . . 64.33 112.445 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 25.2 p -51.08 150.81 2.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.878 0.371 . . . . 45.32 110.857 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' GLN . . . . . 0.612 ' O ' HG22 ' A' ' 317' ' ' THR . 0.5 OUTLIER -106.16 -61.49 1.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 60.02 110.878 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.612 HG22 ' O ' ' A' ' 316' ' ' GLN . 14.4 t 45.83 -163.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 74.33 111.179 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.627 HD11 HD12 ' A' ' 320' ' ' LEU . 3.9 tp -95.4 144.04 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 65.44 111.119 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.447 ' N ' HG13 ' A' ' 318' ' ' ILE . . . -114.37 55.13 0.54 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 65.31 112.499 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.627 HD12 HD11 ' A' ' 318' ' ' ILE . 8.5 mt -132.79 66.7 77.01 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.599 0.714 . . . . 73.31 110.873 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 164.17 35.64 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.619 2.213 . . . . 71.31 112.337 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -40.65 5.04 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.652 2.235 . . . . 74.51 112.292 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -116.01 -63.81 1.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.433 . . . . 74.24 110.928 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.648 HG12 HG13 ' A' ' 391' ' ' VAL . 1.3 p -174.12 152.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 64.22 111.114 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 326' ' ' PRO . 1.4 m120 -50.63 107.39 0.8 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.671 0.748 . . . . 75.14 110.807 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 325' ' ' ASN . 54.1 Cg_endo -69.83 -13.74 34.91 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.651 2.234 . . . . 63.34 112.337 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.32 -71.97 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 74.5 110.842 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -47.96 -25.27 1.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 71.13 111.117 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.878 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 14.2 t -83.43 -29.72 7.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 71.42 111.079 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.432 ' HA ' HD12 ' A' ' 333' ' ' ILE . 5.2 t0 -53.94 -35.26 61.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 73.32 110.872 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -68.89 -31.78 70.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 74.33 110.82 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.693 HG21 HG21 ' A' ' 393' ' ' ILE . 31.4 mm -58.38 -51.69 68.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 75.2 111.151 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 330' ' ' ASP . 4.8 mt -51.67 -42.54 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 75.03 111.192 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -53.66 -16.39 1.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 74.23 110.889 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 6.1 t -88.47 -25.67 22.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 75.52 110.816 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.64 ' HB2' ' CG ' ' A' ' 410' ' ' TRP . . . -116.56 151.22 46.8 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.556 0.694 . . . . 70.44 111.16 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.526 ' O ' HG12 ' A' ' 340' ' ' VAL . 54.9 Cg_endo -69.74 161.71 44.89 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.753 2.302 . . . . 73.22 112.374 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -8.43 23.57 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.704 2.269 . . . . 62.53 112.366 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -109.25 63.47 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 72.43 110.882 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 337' ' ' PRO . 9.2 p -175.15 126.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.451 . . . . 72.34 111.131 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 21.5 p -137.88 73.46 1.44 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 73.22 111.146 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 71.1 m -132.86 124.24 27.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 65.23 111.148 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -93.77 116.33 28.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 75.2 111.157 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.84 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -101.55 134.29 44.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.424 . . . . 72.31 110.864 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.84 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.8 mp -133.43 112.22 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 72.1 111.155 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -97.31 176.63 31.67 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.75 -0.738 . . . . 62.23 112.482 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.3 t30 65.68 49.85 1.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.777 0.322 . . . . 74.34 110.847 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.552 HG23 ' HD2' ' A' ' 349' ' ' PRO . 74.3 mt -104.98 135.4 19.3 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.614 0.721 . . . . 71.22 111.124 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 349' ' ' PRO . . . . . 0.673 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 55.2 Cg_endo -69.74 164.86 32.94 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.692 2.261 . . . . 73.53 112.42 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -72.5 -23.34 61.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 70.32 110.893 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -92.9 28.73 2.0 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.47 . . . . 61.03 110.854 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.828 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -113.63 87.6 2.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 41.44 111.188 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 38.1 p -87.92 171.29 10.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.201 -0.454 . . . . 72.34 111.144 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.506 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -66.94 -29.81 69.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 73.51 110.925 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.21 -26.3 50.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.047 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.15 -13.28 13.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 71.35 110.903 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.828 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.3 mp -98.52 -53.88 3.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 51.35 110.967 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.649 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -41.17 -51.37 7.89 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.671 0.748 . . . . 70.44 111.15 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 359' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.9 Cg_endo -69.76 -31.56 20.3 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.704 2.269 . . . . 70.32 112.348 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.911 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -63.98 -23.52 67.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 63.2 110.898 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.611 ' CE2' HD12 ' A' ' 360' ' ' LEU . 86.9 m-85 -102.07 -33.64 9.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.938 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -54.06 -31.8 52.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 65.52 110.927 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -57.2 -21.02 30.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 72.31 110.86 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 41.6 m-85 -72.02 -57.4 4.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.883 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -155.87 -86.28 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.721 . . . . 32.11 112.483 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -152.41 143.55 23.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 74.52 110.952 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.457 HG23 ' CG2' ' A' ' 381' ' ' ILE . 41.4 mt -120.81 109.17 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 75.02 111.109 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.27 -21.18 27.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 74.24 110.91 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.56 121.5 0.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 72.34 110.881 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.513 ' CD2' HG12 ' A' ' 358' ' ' ILE . 39.1 t80 -115.23 138.95 50.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 63.45 110.836 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -127.68 100.7 6.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 75.45 110.852 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 10.8 t-80 -94.98 119.46 33.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 63.43 110.826 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -113.37 85.58 8.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.67 0.747 . . . . 71.14 110.873 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' PRO . . . . . 0.509 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 53.7 Cg_endo -69.83 -29.8 22.95 Favored 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.706 2.27 . . . . 42.43 112.407 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.02 -17.02 64.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 72.12 110.869 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -116.36 -27.74 6.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 53.33 110.901 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.81 39.96 5.71 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.696 -0.764 . . . . 64.42 112.526 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 99.6 m -156.84 145.94 20.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.787 0.327 . . . . 73.31 110.877 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 20.7 p -134.76 153.76 51.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 75.01 110.892 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 380' ' ' PHE . 2.5 m-85 -129.28 131.67 47.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 73.43 110.89 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.543 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -122.8 119.65 58.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 73.1 111.063 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.98 134.02 33.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 74.34 110.909 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -115.36 -178.6 3.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 70.34 110.893 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -86.51 -29.14 22.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 71.21 110.873 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 66.0 p -129.54 166.25 20.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 74.42 111.156 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -80.65 -38.41 29.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 71.24 110.849 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -60.88 -29.88 69.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 52.21 110.861 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -35.56 80.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 75.42 110.875 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -75.63 -38.11 59.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 65.12 111.046 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.878 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -60.29 -36.57 78.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 63.4 111.102 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.648 HG13 HG12 ' A' ' 324' ' ' VAL . 20.0 t -66.37 -33.38 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 60.24 111.129 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' CYS . . . . . 0.535 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 2.0 t -83.93 -23.85 30.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 73.34 110.847 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.797 ' O ' HG21 ' A' ' 408' ' ' THR . 13.4 mt -59.9 -57.93 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.262 -0.426 . . . . 45.22 111.107 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.517 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.7 t -72.1 -36.22 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 53.43 111.07 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -61.79 -22.71 65.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 72.34 111.086 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.715 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.2 mm? -104.12 -10.6 17.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 63.21 110.873 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -57.5 119.95 7.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 74.2 111.076 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.8 m120 44.25 36.53 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 73.13 110.845 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.715 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -95.53 141.74 23.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.66 0.743 . . . . 73.53 110.844 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.462 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.5 Cg_endo -69.76 147.41 62.78 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.622 2.215 . . . . 71.55 112.372 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 401' ' ' PHE . . . . . 0.534 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 61.2 t80 -154.52 110.79 3.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 74.01 110.836 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 51.42 33.5 10.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 63.25 110.886 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 87.57 13.25 65.58 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.724 -0.751 . . . . 71.31 112.465 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 401' ' ' PHE . 19.3 mtt180 -140.57 135.75 32.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 70.01 110.882 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.549 ' O ' HD23 ' A' ' 406' ' ' LEU . 15.8 m-80 -78.93 150.78 32.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 42.51 110.878 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.647 ' HB3' HG23 ' A' ' 345' ' ' ILE . 11.2 mt -120.3 162.8 18.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.246 -0.434 . . . . 74.52 110.924 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.39 175.24 5.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 73.51 110.883 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 408' ' ' THR . . . . . 0.797 HG21 ' O ' ' A' ' 393' ' ' ILE . 2.1 p -154.38 155.59 35.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 54.13 111.179 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 409' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 410' ' ' TRP . . . 152.07 129.39 1.49 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.776 -0.726 . . . . 32.33 112.544 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.64 ' CG ' ' HB2' ' A' ' 336' ' ' ALA . 67.3 m95 -33.83 126.07 0.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 55.52 110.922 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -48.03 171.75 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 72.43 112.568 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 414' ' ' ARG . 0.0 OUTLIER -170.89 106.39 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 72.54 110.927 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 414' ' ' ARG . 2.1 mt-10 -60.0 82.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 72.32 110.883 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 412' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 71.13 110.896 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.561 -0.216 . . . . 64.33 112.561 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.48 122.94 49.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 45.32 110.837 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -47.32 173.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 60.02 110.905 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.3 m -96.66 -54.02 3.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 74.33 111.129 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.471 HG23 ' N ' ' A' ' 319' ' ' GLY . 6.3 tt -162.88 -43.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 65.44 111.141 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.471 ' N ' HG23 ' A' ' 318' ' ' ILE . . . 96.35 -44.73 1.96 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.73 -0.747 . . . . 65.31 112.493 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.465 HD12 ' C ' ' A' ' 319' ' ' GLY . 2.4 mp 62.93 81.0 0.23 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.594 0.711 . . . . 73.31 110.825 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 169.12 19.7 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.708 2.272 . . . . 71.31 112.327 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.402 ' O ' ' NE2' ' A' ' 323' ' ' GLN . 53.9 Cg_endo -69.67 -50.38 0.48 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.732 2.288 . . . . 74.51 112.345 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.402 ' NE2' ' O ' ' A' ' 322' ' ' PRO . 30.3 mm-40 -127.62 -70.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 74.24 110.928 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.591 HG22 HG13 ' A' ' 391' ' ' VAL . 7.6 m -123.88 -176.15 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 64.22 111.145 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.36 121.84 66.97 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.624 0.726 . . . . 75.14 110.878 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -14.13 35.84 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.661 2.241 . . . . 63.34 112.411 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.58 -72.08 0.22 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 74.5 110.863 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.33 -24.81 30.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 71.13 111.05 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.829 HG22 ' HB ' ' A' ' 394' ' ' VAL . 19.4 t -76.88 -29.97 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 71.42 111.1 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -54.61 -40.84 69.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 73.32 110.878 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -62.7 -32.73 73.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 74.33 110.912 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.845 HG21 HG21 ' A' ' 393' ' ' ILE . 30.9 mm -57.57 -43.49 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 75.2 111.124 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 18.2 mt -58.23 -32.6 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 75.03 111.112 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -4.32 11.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 74.23 110.834 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.69 38.91 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 75.52 110.901 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.704 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . 179.56 164.44 0.78 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.525 0.678 . . . . 70.44 111.18 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.704 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 53.6 Cg_endo -69.68 159.66 52.62 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.744 2.296 . . . . 73.22 112.373 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -24.67 29.41 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.723 2.282 . . . . 62.53 112.339 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -104.24 73.51 1.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 72.43 110.854 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 337' ' ' PRO . 9.5 p -167.91 128.94 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 72.34 111.09 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 341' ' ' THR . . . . . 0.415 HG22 ' CA ' ' A' ' 386' ' ' HIS . 19.8 p -137.41 68.07 1.42 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 73.22 111.093 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 66.4 m -133.87 116.36 15.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.204 -0.453 . . . . 65.23 111.117 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -86.61 127.01 34.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 75.2 111.107 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.823 ' O ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -105.75 135.04 47.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 72.31 110.886 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.823 HD12 ' O ' ' A' ' 344' ' ' TYR . 1.7 mp -132.94 116.96 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 72.1 111.179 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -107.01 173.87 19.43 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.681 -0.771 . . . . 62.23 112.464 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.3 t30 65.68 53.09 1.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.752 0.31 . . . . 74.34 110.826 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.667 HG23 ' HD2' ' A' ' 349' ' ' PRO . 80.0 mt -102.86 138.75 19.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.564 0.697 . . . . 71.22 111.165 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 349' ' ' PRO . . . . . 0.667 ' HD2' HG23 ' A' ' 348' ' ' ILE . 53.2 Cg_endo -69.78 166.24 28.28 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.7 2.266 . . . . 73.53 112.325 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -74.18 -22.62 59.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 70.32 110.888 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.437 ' CE1' ' CB ' ' A' ' 349' ' ' PRO . 2.7 p90 -91.27 27.15 1.99 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 61.03 110.857 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.764 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -111.67 111.91 23.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 41.44 111.105 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 18.3 p -117.64 168.48 10.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 72.34 111.15 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.52 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.2 OUTLIER -62.82 -30.43 71.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 73.51 110.909 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.93 67.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.096 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.14 -12.93 13.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 71.35 110.909 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.764 HD11 ' HB1' ' A' ' 352' ' ' ALA . 2.9 mp -100.51 -51.07 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 51.35 110.886 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.657 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -40.86 -51.03 7.37 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.641 0.734 . . . . 70.44 111.106 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 359' ' ' PRO . . . . . 0.657 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.8 Cg_endo -69.67 -31.1 21.61 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.69 2.26 . . . . 70.32 112.385 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.994 ' O ' HD12 ' A' ' 360' ' ' LEU . 0.1 OUTLIER -64.47 -27.31 68.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 63.2 110.889 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.766 ' HB2' HD11 ' A' ' 367' ' ' ILE . 86.5 m-85 -95.28 -32.01 13.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 73.33 110.902 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -57.78 -35.55 70.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 65.52 110.95 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -54.71 -24.17 20.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 72.31 110.866 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -69.26 -57.75 4.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 73.33 110.876 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -154.66 -83.45 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.711 -0.757 . . . . 32.11 112.45 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -153.31 143.48 22.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.343 . . . . 74.52 110.892 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.766 HD11 ' HB2' ' A' ' 361' ' ' PHE . 18.9 mt -121.01 109.16 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 75.02 111.096 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.29 -16.92 25.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 74.24 110.92 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -170.35 121.22 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 72.34 110.884 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 29.9 t80 -114.51 145.41 41.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 63.45 110.897 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.99 100.65 4.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 75.45 110.875 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 372' ' ' HIS . . . . . 0.414 ' HB2' ' CE2' ' A' ' 370' ' ' PHE . 23.3 t60 -96.5 118.34 32.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 63.43 110.868 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -109.18 85.21 3.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.699 0.761 . . . . 71.14 110.949 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -17.88 37.59 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.244 . . . . 42.43 112.369 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.16 -18.29 57.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 72.12 110.934 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.13 -25.56 7.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 53.33 110.946 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 91.99 31.11 9.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.782 -0.723 . . . . 64.42 112.509 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 57.8 m -143.23 154.45 43.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.76 0.314 . . . . 73.31 110.875 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 19.7 p -143.61 143.79 31.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 75.01 110.975 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -121.99 139.21 53.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.262 -0.426 . . . . 73.43 110.906 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.635 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -128.58 128.71 68.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 73.1 111.146 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -93.08 129.53 39.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 74.34 110.843 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -111.52 -178.61 3.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 70.34 110.96 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -82.54 -43.91 16.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 71.21 110.823 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 36.2 p -115.84 166.57 11.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 74.42 111.115 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' HIS . . . . . 0.415 ' CA ' HG22 ' A' ' 341' ' ' THR . 22.9 p-80 -85.28 -39.57 17.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 71.24 110.937 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.05 -27.11 63.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 52.21 110.888 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.27 -52.19 36.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.42 110.912 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.446 ' HB3' ' CH2' ' A' ' 410' ' ' TRP . . . -51.77 -41.19 61.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 65.12 111.082 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.684 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -52.42 -34.12 46.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 63.4 111.094 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.591 HG13 HG22 ' A' ' 324' ' ' VAL . 15.0 t -67.42 -43.24 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 60.24 111.119 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 9.9 t -69.35 -33.65 73.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 73.34 110.85 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.845 HG21 HG21 ' A' ' 332' ' ' ILE . 0.7 OUTLIER -54.0 -54.98 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 45.22 111.133 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.829 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.5 OUTLIER -71.5 -37.52 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 53.43 111.117 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.62 -21.13 66.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 72.34 111.078 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.612 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.7 mm? -106.53 -10.93 16.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.259 -0.428 . . . . 63.21 110.861 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -58.9 114.71 2.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.2 111.091 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' ASN . . . . . 0.453 ' C ' ' OD1' ' A' ' 405' ' ' ASN . 2.9 t-20 42.7 43.06 3.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 73.13 110.888 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.612 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -101.18 144.38 28.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.598 0.714 . . . . 73.53 110.902 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.455 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.8 Cg_endo -69.75 142.04 46.89 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.76 2.307 . . . . 71.55 112.323 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 401' ' ' PHE . . . . . 0.611 ' CZ ' ' NE2' ' A' ' 402' ' ' GLN . 75.5 t80 -152.81 110.95 3.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 74.01 110.907 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 402' ' ' GLN . . . . . 0.611 ' NE2' ' CZ ' ' A' ' 401' ' ' PHE . 0.9 OUTLIER 53.86 32.6 15.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 63.25 110.917 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 94.86 -19.84 51.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.776 -0.725 . . . . 71.31 112.473 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 401' ' ' PHE . 8.6 mmt180 -110.99 141.01 45.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.782 0.325 . . . . 70.01 110.897 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.474 ' C ' HD23 ' A' ' 406' ' ' LEU . 0.5 OUTLIER -86.79 149.91 24.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 42.51 110.918 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.589 HD13 HG21 ' A' ' 345' ' ' ILE . 10.1 mt -113.78 171.84 7.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 74.52 110.941 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 407' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 345' ' ' ILE . 1.1 tpt85 -123.41 179.19 4.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 73.51 110.838 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 408' ' ' THR . . . . . 0.592 HG21 ' O ' ' A' ' 393' ' ' ILE . 33.9 p -155.88 170.07 22.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 54.13 111.189 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 409' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 410' ' ' TRP . . . 151.64 42.77 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.776 -0.726 . . . . 32.33 112.48 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.447 ' C ' ' HB3' ' A' ' 344' ' ' TYR . 58.8 m95 57.34 153.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.771 0.32 . . . . 55.52 110.96 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -54.02 169.36 1.31 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.721 . . . . 72.43 112.426 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.65 179.65 7.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.777 0.322 . . . . 72.54 110.911 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -96.44 -59.62 1.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 72.32 110.867 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 71.13 110.913 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.495 -0.242 . . . . 64.33 112.495 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 34.3 m -81.1 89.11 5.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.752 0.311 . . . . 45.32 110.842 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -109.3 132.51 54.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 60.02 110.941 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.42 HG22 HG22 ' A' ' 318' ' ' ILE . 48.1 m -57.71 -54.58 45.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 74.33 111.152 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.42 HG22 HG22 ' A' ' 317' ' ' THR . 3.8 tp -174.36 133.46 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 65.44 111.096 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -67.77 -71.82 0.89 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.71 -0.757 . . . . 65.31 112.531 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 320' ' ' LEU . 5.0 mt 52.76 71.29 1.49 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.652 0.739 . . . . 73.31 110.934 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 141.25 44.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.648 2.232 . . . . 71.31 112.325 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -25.24 28.96 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.647 2.232 . . . . 74.51 112.373 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -142.4 127.88 18.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 74.24 110.917 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 1.115 HG22 HG13 ' A' ' 391' ' ' VAL . 32.5 m -51.77 -173.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 64.22 111.107 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -76.37 119.81 78.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.57 0.7 . . . . 75.14 110.85 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -14.4 36.12 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.596 2.197 . . . . 63.34 112.363 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' GLN . . . . . 0.404 ' O ' ' HB3' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -68.62 -71.44 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 74.5 110.897 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -57.63 -26.28 61.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 71.13 111.094 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.788 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 16.1 t -78.74 -29.93 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 71.42 111.146 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 327' ' ' GLN . 3.8 t0 -54.13 -38.85 65.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.876 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -65.6 -31.82 73.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 74.33 110.808 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.876 HG21 HD13 ' A' ' 393' ' ' ILE . 46.1 mm -55.55 -48.95 76.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 75.2 111.092 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 8.8 mt -55.06 -32.1 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 75.03 111.201 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.75 -7.19 7.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 74.23 110.942 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 23.0 t -102.63 11.62 37.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 75.52 110.884 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.427 ' HB1' HG11 ' A' ' 340' ' ' VAL . . . -158.78 150.02 16.51 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.596 0.713 . . . . 70.44 111.104 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.642 ' O ' HG12 ' A' ' 340' ' ' VAL . 54.7 Cg_endo -69.73 164.46 34.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.736 2.291 . . . . 73.22 112.341 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -11.68 31.33 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.625 2.217 . . . . 62.53 112.398 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -101.21 55.05 0.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 72.43 110.905 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 337' ' ' PRO . 9.8 p -168.79 126.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 72.34 111.144 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 386' ' ' HIS . 21.7 p -142.61 70.95 1.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 73.22 111.188 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 54.5 m -133.72 123.87 25.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 65.23 111.124 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -89.97 134.4 34.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 75.2 111.133 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.656 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -114.14 134.38 54.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 72.31 110.932 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.714 HG21 HD13 ' A' ' 406' ' ' LEU . 1.7 mp -132.07 113.22 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.504 . . . . 72.1 111.148 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -103.89 168.73 17.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.761 . . . . 62.23 112.501 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 405' ' ' ASN . 2.3 t30 72.22 54.19 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 74.34 110.958 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.692 HG23 ' HD2' ' A' ' 349' ' ' PRO . 87.7 mt -108.45 138.87 20.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.564 0.697 . . . . 71.22 111.178 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 349' ' ' PRO . . . . . 0.692 ' HD2' HG23 ' A' ' 348' ' ' ILE . 53.3 Cg_endo -69.85 164.89 32.96 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.714 2.276 . . . . 73.53 112.313 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -77.49 -10.96 59.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 70.32 110.829 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.58 ' CD2' ' HB2' ' A' ' 349' ' ' PRO . 31.8 p90 -97.38 1.21 49.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 61.03 110.927 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.871 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -89.29 111.85 22.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 41.44 111.049 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 74.2 p -112.06 173.51 6.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.18 -0.464 . . . . 72.34 111.106 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.498 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -67.01 -29.53 69.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 73.51 110.866 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -59.02 -26.38 64.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 74.32 111.159 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.27 -15.62 13.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 71.35 110.861 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.871 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.8 mp -94.77 -51.03 4.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 51.35 110.883 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.683 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.2 mm -43.89 -49.87 20.24 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.677 0.751 . . . . 70.44 111.184 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 359' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.7 Cg_endo -69.83 -20.41 34.56 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.672 2.248 . . . . 70.32 112.352 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.925 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -77.99 -25.39 48.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 63.2 110.968 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.698 ' HB2' HD11 ' A' ' 367' ' ' ILE . 85.7 m-85 -98.76 -30.08 12.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.33 110.941 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 362' ' ' GLN . . . . . 0.459 ' HG2' HD12 ' A' ' 367' ' ' ILE . 2.0 mm-40 -57.64 -42.98 84.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 65.52 110.912 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -47.02 -21.67 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 72.31 110.901 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' PHE . . . . . 0.484 ' HE2' ' HG ' ' A' ' 392' ' ' CYS . 21.5 m-85 -71.98 -54.49 9.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 73.33 110.922 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -161.39 -85.62 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.74 -0.743 . . . . 32.11 112.456 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -153.56 142.29 20.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.775 0.321 . . . . 74.52 110.86 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.698 HD11 ' HB2' ' A' ' 361' ' ' PHE . 40.3 mt -120.78 109.46 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 75.02 111.208 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.75 -17.52 38.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.466 . . . . 74.24 110.964 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.72 121.33 0.58 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 72.34 110.9 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.578 ' CE1' ' HB3' ' A' ' 379' ' ' CYS . 25.2 t80 -114.97 123.54 49.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 63.45 110.858 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.19 99.2 7.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 75.45 110.877 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 372' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -95.29 120.6 35.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.436 . . . . 63.43 110.878 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 374' ' ' PRO . 25.6 m-85 -113.96 92.28 25.29 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.7 0.762 . . . . 71.14 110.916 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 373' ' ' TYR . 54.0 Cg_endo -69.7 -18.2 37.43 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.692 2.261 . . . . 42.43 112.375 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -78.18 -37.11 46.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 72.12 110.841 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -99.79 -18.01 17.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 53.33 110.897 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 75.07 43.67 25.83 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.764 -0.731 . . . . 64.42 112.468 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 1.6 p -151.93 143.45 23.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.758 0.313 . . . . 73.31 110.962 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.578 ' HB3' ' CE1' ' A' ' 370' ' ' PHE . 61.3 m -124.3 153.34 41.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 75.01 110.947 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -130.47 104.26 7.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 73.43 110.85 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.493 HG12 ' CD1' ' A' ' 370' ' ' PHE . 0.5 OUTLIER -105.0 129.24 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 73.1 111.155 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -102.01 136.83 41.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 74.34 110.923 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -118.18 172.34 7.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 70.34 110.931 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.62 -37.3 59.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 71.21 110.857 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 59.3 p -115.96 169.83 8.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 74.42 111.154 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' HIS . . . . . 0.539 ' HA ' HG22 ' A' ' 341' ' ' THR . 51.5 p-80 -85.64 -38.93 17.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 71.24 110.939 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -60.54 -30.18 69.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.182 -0.463 . . . . 52.21 110.929 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -62.17 -38.57 89.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 75.42 110.852 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.456 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -75.94 -33.62 59.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 65.12 111.168 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.788 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -55.91 -35.37 66.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 63.4 111.066 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 1.115 HG13 HG22 ' A' ' 324' ' ' VAL . 25.6 t -69.13 -46.62 77.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 60.24 111.057 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 392' ' ' CYS . . . . . 0.484 ' HG ' ' HE2' ' A' ' 364' ' ' PHE . 48.8 t -56.18 -31.1 63.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 73.34 110.933 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.876 HD13 HG21 ' A' ' 332' ' ' ILE . 1.1 mt -59.8 -56.36 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 45.22 111.154 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.516 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.1 t -71.68 -38.48 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 53.43 111.154 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.435 ' CA ' HG11 ' A' ' 324' ' ' VAL . . . -58.56 -48.07 82.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 72.34 111.099 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.631 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.9 mm? -85.48 -10.35 56.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 63.21 110.865 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' ALA . . . . . 0.66 ' N ' HG21 ' A' ' 408' ' ' THR . . . -50.66 108.44 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 74.2 111.086 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 42.99 43.45 3.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 73.13 110.916 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.631 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -96.75 145.5 29.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.696 0.76 . . . . 73.53 110.884 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 144.13 52.93 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.647 2.231 . . . . 71.55 112.39 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' PHE . . . . . 0.525 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 41.9 t80 -151.03 113.23 4.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 74.01 110.887 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 49.47 32.93 5.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 63.25 110.871 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.6 -28.36 15.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 71.31 112.51 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.9 OUTLIER -105.52 141.05 37.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.361 . . . . 70.01 110.847 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.448 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 14.3 m120 -82.68 154.92 24.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 42.51 110.923 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.714 HD13 HG21 ' A' ' 345' ' ' ILE . 10.9 mt -114.35 173.8 6.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 74.52 110.892 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 407' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 346' ' ' GLY . 0.0 OUTLIER -113.92 171.93 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 73.51 110.89 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 408' ' ' THR . . . . . 0.66 HG21 ' N ' ' A' ' 397' ' ' ALA . 64.3 p -154.18 154.19 33.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 54.13 111.098 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 409' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 410' ' ' TRP . . . 147.3 127.99 1.81 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 32.33 112.508 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.703 ' NE1' HG22 ' A' ' 332' ' ' ILE . 57.7 m95 -33.0 131.06 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.838 0.351 . . . . 55.52 110.951 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -145.69 164.24 28.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.807 -0.711 . . . . 72.43 112.483 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.77 150.93 41.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 72.54 110.898 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.88 79.54 2.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.416 . . . . 72.32 110.851 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 71.13 110.88 -179.958 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.476 -0.249 . . . . 64.33 112.476 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 38.6 t -127.67 -53.86 1.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.83 0.348 . . . . 45.32 110.835 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 176.36 109.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 60.02 110.953 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 10.0 t -150.44 145.99 26.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 74.33 111.161 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.1 tp -133.97 125.87 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 65.44 111.077 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.13 -66.36 1.35 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.788 -0.72 . . . . 65.31 112.513 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 2.3 mt 66.04 75.67 0.32 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.602 0.715 . . . . 73.31 110.917 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 160.2 50.58 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.683 2.256 . . . . 71.31 112.335 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -36.14 11.44 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.746 2.297 . . . . 74.51 112.345 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.65 -63.49 0.74 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 74.24 110.908 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.756 HG12 HG13 ' A' ' 391' ' ' VAL . 1.4 p -156.37 148.22 11.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 64.22 111.043 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 326' ' ' PRO . 3.5 t30 -50.39 109.14 1.19 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.66 0.743 . . . . 75.14 110.9 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 325' ' ' ASN . 53.6 Cg_endo -69.71 -14.34 36.11 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.656 2.237 . . . . 63.34 112.319 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -74.94 -71.62 0.34 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 74.5 110.862 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -49.28 -24.3 1.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 71.13 111.064 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.872 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 10.8 t -80.89 -29.18 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 71.42 111.146 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -53.42 -37.72 62.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.108 -0.496 . . . . 73.32 110.876 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 334' ' ' ARG . 3.3 t60 -66.07 -31.63 72.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 74.33 110.796 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.69 HG21 HD13 ' A' ' 393' ' ' ILE . 27.4 mm -56.36 -47.74 80.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 75.2 111.098 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 9.5 mt -54.12 -26.16 14.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 75.03 111.051 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 331' ' ' HIS . 0.0 OUTLIER -71.66 2.11 5.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 74.23 110.926 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.69 31.79 6.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 75.52 110.868 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.945 ' HB1' HG11 ' A' ' 340' ' ' VAL . . . -174.32 151.15 1.6 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.535 0.684 . . . . 70.44 111.104 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.73 ' O ' HG12 ' A' ' 340' ' ' VAL . 54.8 Cg_endo -69.74 169.93 17.74 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.677 2.251 . . . . 73.22 112.353 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.84 -9.2 25.5 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.609 2.206 . . . . 62.53 112.356 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -115.41 64.1 0.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 72.43 110.899 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.945 HG11 ' HB1' ' A' ' 336' ' ' ALA . 7.9 p -160.38 129.19 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 72.34 111.073 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.96 69.2 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 73.22 111.102 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.485 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 45.0 m -131.42 108.88 9.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 65.23 111.224 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -80.28 111.3 16.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 75.2 111.061 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.571 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -93.78 118.8 31.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 72.31 110.953 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.55 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.9 mp -119.47 117.52 54.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 72.1 111.15 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -107.98 -173.3 21.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.706 -0.759 . . . . 62.23 112.521 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.95 47.52 12.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.807 0.337 . . . . 74.34 110.895 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 34.2 mt -99.43 132.62 22.93 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.658 0.742 . . . . 71.22 111.163 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' PRO . . . . . 0.489 ' CG ' ' CE1' ' A' ' 351' ' ' PHE . 53.6 Cg_endo -69.82 161.89 44.22 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.621 2.214 . . . . 73.53 112.328 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -69.01 -21.01 64.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 70.32 110.813 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.489 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 7.1 p90 -90.85 30.74 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 61.03 110.878 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.625 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -116.23 124.82 51.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 41.44 111.098 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 14.3 p -126.54 167.71 15.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 72.34 111.128 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.507 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -64.99 -34.06 77.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 73.51 110.876 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.23 -26.35 50.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.32 111.128 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.27 -13.12 13.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 71.35 110.865 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.625 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.5 mp -99.52 -54.21 3.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 51.35 110.895 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.622 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -39.81 -52.07 5.18 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.692 0.758 . . . . 70.44 111.199 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 359' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.2 Cg_endo -69.72 -39.51 6.49 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.612 2.208 . . . . 70.32 112.353 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.922 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -53.85 -25.36 19.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 63.2 110.87 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.864 ' HB2' HD11 ' A' ' 367' ' ' ILE . 85.5 m-85 -95.78 -37.22 10.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 73.33 110.894 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' GLN . . . . . 0.6 ' HG2' HD12 ' A' ' 367' ' ' ILE . 3.8 mt-30 -50.01 -46.46 52.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 65.52 110.879 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 363' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.6 OUTLIER -44.46 -25.08 0.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 72.31 110.79 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 364' ' ' PHE . . . . . 0.536 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 30.5 m-85 -70.1 -60.24 2.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 73.33 110.841 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -150.42 -86.64 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.79 -0.719 . . . . 32.11 112.511 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 368' ' ' LEU . 11.8 t80 -153.43 141.61 20.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.786 0.327 . . . . 74.52 110.898 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.864 HD11 ' HB2' ' A' ' 361' ' ' PHE . 23.9 mt -120.36 113.48 40.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 75.02 111.101 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 369' ' ' ASP . 2.7 pp -100.45 -14.84 18.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 74.24 110.862 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.53 ' N ' HD12 ' A' ' 368' ' ' LEU . 10.0 t0 -167.67 120.81 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 72.34 110.836 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 28.4 t80 -117.54 134.85 54.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 63.45 110.9 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -120.56 101.5 7.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 75.45 110.891 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' HIS . . . . . 0.4 ' HB2' ' CE2' ' A' ' 370' ' ' PHE . 12.6 t-80 -97.49 135.7 38.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 63.43 110.906 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -130.75 85.69 54.86 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 121.649 0.738 . . . . 71.14 110.967 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -22.58 31.73 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.638 2.226 . . . . 42.43 112.349 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -72.93 -19.39 61.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 72.12 110.911 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.49 -27.57 6.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 53.33 110.91 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 89.8 43.82 5.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.715 -0.755 . . . . 64.42 112.492 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 43.6 m -155.93 149.2 24.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.774 0.321 . . . . 73.31 110.886 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 15.5 p -140.79 144.14 35.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 75.01 110.909 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.485 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 18.9 m-85 -122.86 128.81 50.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 73.43 110.877 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.577 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -117.92 119.37 61.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 73.1 111.124 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -88.39 127.07 35.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 74.34 110.94 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -106.08 171.59 7.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.428 . . . . 70.34 110.946 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -65.29 -37.5 87.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.093 -0.503 . . . . 71.21 110.897 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 58.6 p -130.12 178.02 6.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 74.42 111.179 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -83.21 -39.42 20.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 71.24 110.869 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -57.97 -27.1 63.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 52.21 110.877 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -37.18 77.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 75.42 110.858 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -75.77 -36.6 59.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 65.12 111.086 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.872 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -55.34 -32.95 62.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 63.4 111.061 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.756 HG13 HG12 ' A' ' 324' ' ' VAL . 40.2 t -68.09 -55.57 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 60.24 111.105 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' CYS . . . . . 0.536 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 2.1 t -64.29 -26.1 68.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 73.34 110.881 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.784 HD12 ' HA ' ' A' ' 390' ' ' ALA . 5.6 mt -57.06 -57.2 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 45.22 111.135 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.559 ' O ' ' HB3' ' A' ' 397' ' ' ALA . 2.5 t -73.06 -40.3 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 53.43 111.16 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -53.6 -51.47 62.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 72.34 111.102 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.723 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.9 mm? -75.46 -12.63 60.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 63.21 110.951 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 397' ' ' ALA . . . . . 0.577 ' N ' HG21 ' A' ' 408' ' ' THR . . . -50.49 112.9 0.76 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 74.2 111.076 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 54.8 t30 41.97 49.85 4.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.13 110.855 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.723 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -105.78 146.58 33.12 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.69 0.757 . . . . 73.53 110.825 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.8 137.47 35.42 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.679 2.253 . . . . 71.55 112.362 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' PHE . . . . . 0.537 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 33.8 t80 -141.83 110.78 6.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.01 110.912 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 49.11 32.71 4.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 63.25 110.886 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.45 -29.18 13.06 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.669 -0.776 . . . . 71.31 112.477 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -107.11 139.1 42.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.321 . . . . 70.01 110.866 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -79.18 155.19 28.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 42.51 110.829 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.436 HD11 ' CD2' ' A' ' 401' ' ' PHE . 21.9 mt -118.97 170.32 9.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 74.52 110.884 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.42 175.59 5.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 73.51 110.824 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 408' ' ' THR . . . . . 0.606 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 75.5 p -154.05 155.51 35.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 54.13 111.144 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 157.24 174.27 26.72 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.811 -0.709 . . . . 32.33 112.55 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.518 ' HE1' HG22 ' A' ' 332' ' ' ILE . 58.9 m95 -81.02 147.19 30.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.899 0.38 . . . . 55.52 110.881 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -142.98 136.3 6.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 72.43 112.488 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 414' ' ' ARG . 4.6 mttt -135.15 78.91 1.76 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.752 0.311 . . . . 72.54 110.899 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 412' ' ' LYS . 0.1 OUTLIER 36.8 31.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 72.32 110.92 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 412' ' ' LYS . 7.5 mtp180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 71.13 110.872 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.479 -0.248 . . . . 64.33 112.479 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 80.9 p -160.08 140.7 11.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 45.32 110.877 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' GLN . . . . . 0.523 ' O ' HG22 ' A' ' 318' ' ' ILE . 1.4 mt-30 74.9 -69.91 0.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 60.02 110.911 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 81.4 m -59.27 88.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 74.33 111.132 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 316' ' ' GLN . 0.9 OUTLIER -114.73 141.13 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 65.44 111.098 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.463 ' N ' HG13 ' A' ' 318' ' ' ILE . . . -92.08 -50.94 2.52 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.724 -0.75 . . . . 65.31 112.462 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 58.94 84.18 0.2 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.649 0.737 . . . . 73.31 110.973 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.87 150.04 67.0 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.669 2.246 . . . . 71.31 112.37 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 3.13 2.97 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.679 2.253 . . . . 74.51 112.26 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.74 -70.79 0.66 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 74.24 110.953 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 1.047 HG12 HG13 ' A' ' 391' ' ' VAL . 2.7 p -155.12 176.84 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 64.22 111.137 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.734 ' H ' HG22 ' A' ' 324' ' ' VAL . 51.1 t30 -80.02 111.68 23.91 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.647 0.737 . . . . 75.14 110.917 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 325' ' ' ASN . 53.8 Cg_endo -69.75 -13.87 35.31 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.68 2.253 . . . . 63.34 112.388 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -70.12 -72.28 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 74.5 110.89 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -57.19 -24.87 57.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 71.13 111.074 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.782 HG22 ' HB ' ' A' ' 394' ' ' VAL . 23.4 t -76.66 -29.81 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 71.42 111.068 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.419 ' HA ' HD12 ' A' ' 333' ' ' ILE . 17.6 t0 -54.49 -37.75 65.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 73.32 110.84 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -62.82 -31.93 73.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.846 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.528 ' CG2' ' NE1' ' A' ' 410' ' ' TRP . 15.3 mm -65.25 -41.83 92.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 75.2 111.114 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 330' ' ' ASP . 31.8 mt -52.29 -48.91 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 75.03 111.059 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.34 -7.03 5.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 74.23 110.879 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 3.1 t -82.43 -31.92 29.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 75.52 110.854 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -116.87 153.97 49.46 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.636 0.732 . . . . 70.44 111.066 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.491 ' O ' HG12 ' A' ' 340' ' ' VAL . 53.4 Cg_endo -69.78 158.88 55.41 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.708 2.272 . . . . 73.22 112.31 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -7.46 21.1 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.716 2.278 . . . . 62.53 112.338 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -101.86 51.0 0.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 72.43 110.848 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 337' ' ' PRO . 9.7 p -175.9 128.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 72.34 111.157 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' THR . . . . . 0.535 HG22 ' HB3' ' A' ' 386' ' ' HIS . 20.4 p -137.1 67.92 1.43 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 73.22 111.207 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 23.3 m -133.76 137.0 44.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 65.23 111.152 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -100.18 129.47 46.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 75.2 111.101 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.745 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -106.28 135.08 48.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 72.31 110.882 -179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.745 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.7 mp -131.87 117.68 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 72.1 111.12 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -106.59 161.62 13.97 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.748 -0.739 . . . . 62.23 112.472 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 0.6 OUTLIER 79.24 49.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 74.34 110.937 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.615 HG23 ' HD2' ' A' ' 349' ' ' PRO . 64.8 mt -103.76 137.72 19.32 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.581 0.705 . . . . 71.22 111.13 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 349' ' ' PRO . . . . . 0.769 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.6 Cg_endo -69.75 165.09 32.11 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.714 2.276 . . . . 73.53 112.307 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -75.88 -17.1 59.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 70.32 110.846 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.588 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 27.1 p90 -99.05 24.11 8.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 61.03 110.886 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.794 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -107.87 93.16 4.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 41.44 111.17 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 46.2 p -90.54 173.51 8.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 72.34 111.173 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.506 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -66.96 -29.77 69.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 73.51 110.824 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.01 -26.11 47.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 74.32 111.111 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.81 -13.74 13.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 71.35 110.89 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.794 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.4 mp -98.56 -54.38 3.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 51.35 110.895 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.649 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -40.88 -51.59 7.1 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.684 0.754 . . . . 70.44 111.134 179.846 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 359' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.1 Cg_endo -69.85 -34.08 15.0 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.656 2.237 . . . . 70.32 112.305 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.904 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -61.14 -23.49 65.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 63.2 110.944 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.609 ' CE2' HD12 ' A' ' 360' ' ' LEU . 81.4 m-85 -102.88 -33.67 9.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 73.33 110.912 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 362' ' ' GLN . . . . . 0.601 ' HG3' HD12 ' A' ' 367' ' ' ILE . 0.1 OUTLIER -58.77 -32.72 69.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.5 . . . . 65.52 110.984 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -59.24 -11.25 3.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 72.31 110.924 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' PHE . . . . . 0.566 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 31.3 m-85 -81.01 -60.12 2.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 73.33 110.87 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -149.01 -84.03 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.782 -0.723 . . . . 32.11 112.492 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -152.64 143.61 23.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 74.52 110.852 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.601 HD12 ' HG3' ' A' ' 362' ' ' GLN . 55.5 mt -121.0 109.28 24.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 75.02 111.126 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.02 -17.66 24.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.947 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -171.15 121.15 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 72.34 110.863 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.545 ' CD2' HG12 ' A' ' 358' ' ' ILE . 34.6 t80 -113.61 143.42 44.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 63.45 110.946 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.55 101.17 5.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 75.45 110.946 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' HIS . . . . . 0.533 ' CE1' ' HB3' ' A' ' 374' ' ' PRO . 11.2 t-80 -94.61 114.48 26.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 63.43 110.814 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -107.7 84.12 1.86 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.631 0.729 . . . . 71.14 110.874 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' PRO . . . . . 0.533 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 53.6 Cg_endo -69.79 -28.6 24.91 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.661 2.24 . . . . 42.43 112.355 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -63.44 -19.58 64.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 72.12 110.921 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.8 -21.7 7.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 53.33 110.945 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 87.33 38.33 7.79 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.776 -0.726 . . . . 64.42 112.475 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 19.1 p -147.15 153.63 40.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.764 0.316 . . . . 73.31 110.941 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 7.2 p -139.35 151.12 46.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 75.01 110.882 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -131.14 122.73 27.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 73.43 110.888 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.584 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -114.28 126.3 71.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 73.1 111.08 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 10.2 mttp -90.6 133.86 34.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 74.34 110.877 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -116.21 -178.55 3.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 70.34 110.996 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.45 -46.3 16.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 71.21 110.857 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 68.0 p -114.83 170.66 8.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 74.42 111.232 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' HIS . . . . . 0.535 ' HB3' HG22 ' A' ' 341' ' ' THR . 27.1 p-80 -85.64 -44.43 12.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 71.24 110.838 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -57.18 -32.9 66.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 52.21 110.868 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -67.88 -32.56 73.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 75.42 110.888 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -67.1 -39.32 86.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 65.12 111.114 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.597 ' HB1' HG13 ' A' ' 329' ' ' VAL . . . -59.19 -27.88 66.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 63.4 111.097 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 1.047 HG13 HG12 ' A' ' 324' ' ' VAL . 70.7 t -61.58 -40.94 88.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 60.24 111.158 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' CYS . . . . . 0.566 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 1.5 t -77.78 -27.1 50.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 73.34 110.935 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.722 ' O ' HG21 ' A' ' 408' ' ' THR . 1.2 mp -54.99 -56.67 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 45.22 111.078 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.782 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.9 OUTLIER -73.06 -45.86 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 53.43 111.067 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.425 ' N ' HG12 ' A' ' 394' ' ' VAL . . . -52.87 -21.67 4.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 72.34 111.076 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.62 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.2 mm? -106.5 -19.27 13.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 63.21 110.945 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -48.76 114.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 74.2 111.142 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 44.26 46.89 7.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 73.13 110.855 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.62 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -107.03 144.79 29.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.632 0.73 . . . . 73.53 110.848 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.502 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.5 Cg_endo -69.85 145.23 56.04 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.672 2.248 . . . . 71.55 112.333 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 401' ' ' PHE . . . . . 0.565 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 64.6 t80 -152.34 111.81 3.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 74.01 110.908 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.63 33.36 8.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 63.25 110.932 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.4 -27.78 17.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 71.31 112.513 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.482 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -104.75 141.9 35.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.318 . . . . 70.01 110.895 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -86.99 145.15 26.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 42.51 110.936 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.663 HD13 HG21 ' A' ' 345' ' ' ILE . 8.8 mt -107.03 179.88 4.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.239 -0.437 . . . . 74.52 110.905 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 407' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 345' ' ' ILE . 13.5 ttt85 -130.45 177.48 7.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 73.51 110.88 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 408' ' ' THR . . . . . 0.722 HG21 ' O ' ' A' ' 393' ' ' ILE . 17.2 p -156.13 163.48 39.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 54.13 111.124 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 409' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 410' ' ' TRP . . . 157.22 42.46 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 32.33 112.474 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.528 ' NE1' ' CG2' ' A' ' 332' ' ' ILE . 68.1 m95 58.69 147.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.845 0.355 . . . . 55.52 110.897 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -41.0 103.76 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.757 -0.735 . . . . 72.43 112.532 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 413' ' ' GLU . 0.0 OUTLIER -127.64 122.55 33.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.736 0.303 . . . . 72.54 110.928 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 412' ' ' LYS . 7.9 pt-20 -38.3 -52.35 1.51 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 72.32 110.904 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 71.13 110.907 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.504 -0.238 . . . . 64.33 112.504 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.51 143.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 45.32 110.823 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -128.66 143.62 50.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 60.02 110.896 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 318' ' ' ILE . 12.1 p -125.34 44.33 2.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 74.33 111.165 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 317' ' ' THR . 0.0 OUTLIER 82.16 147.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 65.44 111.081 179.851 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -134.21 -41.27 0.16 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 65.31 112.55 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.42 ' N ' ' CD ' ' A' ' 321' ' ' PRO . 8.1 mt 50.6 55.81 16.86 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.6 0.714 . . . . 73.31 110.947 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 320' ' ' LEU . 54.1 Cg_endo -69.76 167.15 25.26 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.678 2.252 . . . . 71.31 112.339 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -27.29 26.34 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.627 2.218 . . . . 74.51 112.337 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -137.95 -92.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 74.24 110.918 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.952 HG11 ' HB2' ' A' ' 395' ' ' ALA . 30.3 m -121.06 -171.76 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 64.22 111.15 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -97.64 119.22 63.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.673 0.749 . . . . 75.14 110.904 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -14.11 35.61 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.728 2.286 . . . . 63.34 112.349 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -68.41 -71.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 74.5 110.945 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.66 -32.85 59.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 71.13 111.065 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.613 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 11.1 t -70.95 -29.53 37.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 71.42 111.128 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.429 ' HA ' HD12 ' A' ' 333' ' ' ILE . 24.4 t70 -53.99 -34.85 60.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 73.32 110.915 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -68.29 -31.95 71.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 74.33 110.854 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.654 HG22 ' NE1' ' A' ' 410' ' ' TRP . 37.5 mm -57.05 -51.5 68.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 75.2 111.102 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.95 HG23 ' NE2' ' A' ' 386' ' ' HIS . 4.0 mt -55.19 -27.76 20.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 75.03 111.11 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.71 -12.7 55.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 74.23 110.893 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.43 27.1 9.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 75.52 110.887 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.669 ' HB1' HG11 ' A' ' 340' ' ' VAL . . . -169.41 148.93 3.6 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.472 0.653 . . . . 70.44 111.159 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.843 ' O ' HG12 ' A' ' 340' ' ' VAL . 53.1 Cg_endo -69.81 165.54 30.69 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.69 2.26 . . . . 73.22 112.314 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -15.67 37.02 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.645 2.23 . . . . 62.53 112.363 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -106.01 55.75 0.67 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 72.43 110.917 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.843 HG12 ' O ' ' A' ' 337' ' ' PRO . 14.4 p -156.1 95.24 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 72.34 111.117 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 341' ' ' THR . . . . . 0.624 HG22 ' HA ' ' A' ' 386' ' ' HIS . 18.7 p -113.34 67.73 0.67 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.479 . . . . 73.22 111.133 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.448 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 34.5 m -134.11 128.85 34.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 65.23 111.159 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -96.82 126.23 41.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 75.2 111.11 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.56 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -103.3 133.16 48.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 72.31 110.944 -179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.753 HG21 HD13 ' A' ' 406' ' ' LEU . 2.0 mp -126.72 125.93 67.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 72.1 111.171 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.478 ' H ' ' CB ' ' A' ' 407' ' ' ARG . . . -111.65 166.69 12.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.684 -0.77 . . . . 62.23 112.473 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 6.2 t30 65.03 57.88 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.771 0.319 . . . . 74.34 110.904 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.522 HD11 HG22 ' A' ' 345' ' ' ILE . 97.0 mt -106.64 133.9 20.06 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.629 0.728 . . . . 71.22 111.096 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 349' ' ' PRO . . . . . 0.531 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.7 Cg_endo -69.72 166.51 27.29 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.635 2.224 . . . . 73.53 112.386 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -71.77 -26.52 62.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 70.32 110.824 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -85.51 18.12 2.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 61.03 110.889 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.885 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -101.14 101.81 12.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 41.44 111.086 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 21.1 p -109.55 169.57 8.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 72.34 111.084 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.521 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.7 OUTLIER -63.46 -29.75 70.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.161 -0.472 . . . . 73.51 110.907 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -61.94 -25.81 67.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 74.32 111.084 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.98 -16.2 13.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 71.35 110.84 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.885 HD11 ' HB1' ' A' ' 352' ' ' ALA . 4.4 mp -96.7 -49.42 5.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 51.35 110.939 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.671 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.2 mm -42.94 -50.46 13.52 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.619 0.723 . . . . 70.44 111.204 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.8 Cg_endo -69.75 -37.8 8.7 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.737 2.291 . . . . 70.32 112.35 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.922 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -58.06 -25.35 61.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.445 . . . . 63.2 110.919 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.564 ' N ' HD13 ' A' ' 360' ' ' LEU . 74.1 m-85 -101.62 -38.3 7.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 73.33 110.945 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 362' ' ' GLN . . . . . 0.466 ' N ' HD11 ' A' ' 367' ' ' ILE . 2.6 tt0 -51.36 -37.96 50.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 65.52 110.895 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -49.96 -19.38 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 72.31 110.852 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' PHE . . . . . 0.569 ' CE2' ' SG ' ' A' ' 392' ' ' CYS . 30.3 m-85 -72.3 -54.54 9.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 73.33 110.89 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -158.5 -84.69 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.795 -0.717 . . . . 32.11 112.501 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -153.51 143.1 21.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.815 0.34 . . . . 74.52 110.893 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.466 HD11 ' N ' ' A' ' 362' ' ' GLN . 54.1 mt -120.93 109.4 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 75.02 111.122 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.424 HD21 ' OD1' ' A' ' 384' ' ' ASP . 0.4 OUTLIER -86.54 -19.13 29.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 74.24 110.946 179.878 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.48 121.31 0.6 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 72.34 110.891 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 31.7 t80 -112.73 143.02 44.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 63.45 110.919 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 379' ' ' CYS . 1.2 mmtm -128.64 101.64 6.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 75.45 110.858 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 372' ' ' HIS . . . . . 0.549 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 23.9 t60 -99.05 135.42 40.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 63.43 110.816 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -129.17 89.91 46.73 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.712 0.768 . . . . 71.14 110.9 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' PRO . . . . . 0.544 ' HD3' ' CD2' ' A' ' 372' ' ' HIS . 53.6 Cg_endo -69.78 -20.99 34.02 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.706 2.271 . . . . 42.43 112.315 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -74.9 -25.81 59.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 72.12 110.844 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -113.55 -12.32 12.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 53.33 110.857 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 72.28 43.2 47.53 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.722 -0.752 . . . . 64.42 112.486 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 15.6 p -150.45 152.74 34.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.33 . . . . 73.31 110.898 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 14.6 p -146.66 152.75 39.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 75.01 110.851 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.448 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 54.3 m-85 -131.06 122.5 26.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 73.43 110.816 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.425 ' CG2' HG23 ' A' ' 367' ' ' ILE . 0.8 OUTLIER -109.36 126.32 66.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 73.1 111.113 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -92.88 131.08 38.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 74.34 110.853 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -112.34 -174.42 2.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 70.34 110.849 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' ASP . . . . . 0.424 ' OD1' HD21 ' A' ' 368' ' ' LEU . 0.2 OUTLIER -86.75 -46.62 9.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 71.21 110.888 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 61.1 p -115.23 161.91 17.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 74.42 111.137 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' HIS . . . . . 0.95 ' NE2' HG23 ' A' ' 333' ' ' ILE . 75.0 t60 -79.58 -39.76 30.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 71.24 110.882 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.32 -32.74 68.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 52.21 110.798 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -66.37 -36.99 84.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 75.42 110.928 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -68.05 -45.78 72.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 65.12 111.074 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.613 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -50.06 -30.02 10.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 63.4 111.11 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.67 HG13 HG22 ' A' ' 324' ' ' VAL . 70.5 t -68.94 -50.72 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 60.24 111.125 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' CYS . . . . . 0.569 ' SG ' ' CE2' ' A' ' 364' ' ' PHE . 1.9 t -58.92 -26.38 64.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.882 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.581 HD13 HG21 ' A' ' 332' ' ' ILE . 0.9 OUTLIER -61.64 -56.26 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 45.22 111.182 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.493 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.1 t -72.03 -46.91 57.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 53.43 111.094 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 395' ' ' ALA . . . . . 0.952 ' HB2' HG11 ' A' ' 324' ' ' VAL . . . -60.89 -45.17 95.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 72.34 111.094 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.71 HD11 HD11 ' A' ' 360' ' ' LEU . 0.3 OUTLIER -85.01 -4.89 59.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 63.21 110.9 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 397' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 393' ' ' ILE . . . -58.4 115.24 2.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 74.2 111.085 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 398' ' ' ASN . . . . . 0.45 ' CG ' ' O ' ' A' ' 397' ' ' ALA . 3.3 p-10 48.25 41.09 15.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 73.13 110.907 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.575 ' CD1' ' HG ' ' A' ' 396' ' ' LEU . 0.2 OUTLIER -88.1 145.92 37.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.646 0.736 . . . . 73.53 110.913 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 130.02 18.49 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 2.243 . . . . 71.55 112.325 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' PHE . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 399' ' ' PHE . 64.3 t80 -136.21 111.07 8.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 74.01 110.868 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 52.18 33.18 11.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 63.25 110.911 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 95.57 -22.86 36.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 71.31 112.448 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.28 132.41 53.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.846 0.355 . . . . 70.01 110.888 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.443 ' C ' HD23 ' A' ' 406' ' ' LEU . 0.6 OUTLIER -73.94 148.9 41.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 42.51 110.832 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.753 HD13 HG21 ' A' ' 345' ' ' ILE . 4.2 mt -111.66 178.21 4.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 74.52 110.99 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 407' ' ' ARG . . . . . 0.478 ' CB ' ' H ' ' A' ' 346' ' ' GLY . 3.7 ttt180 -113.46 -179.38 3.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 73.51 110.935 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 408' ' ' THR . . . . . 0.511 HG21 ' N ' ' A' ' 397' ' ' ALA . 33.8 p -153.72 153.93 33.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 54.13 111.107 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 163.61 173.64 32.53 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.751 -0.737 . . . . 32.33 112.501 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.754 ' CH2' ' CE1' ' A' ' 386' ' ' HIS . 40.7 m95 -83.17 120.59 25.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.843 0.354 . . . . 55.52 110.865 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.26 132.15 51.94 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 72.43 112.468 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 413' ' ' GLU . 0.3 OUTLIER -151.38 80.8 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.826 0.346 . . . . 72.54 110.94 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 412' ' ' LYS . 6.1 tp10 -36.08 133.72 0.45 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 72.32 110.946 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 71.13 110.871 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.512 -0.235 . . . . 64.33 112.512 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.13 144.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.799 0.333 . . . . 45.32 110.847 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -173.38 94.38 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 60.02 110.905 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' THR . . . . . 0.5 HG23 ' H ' ' A' ' 319' ' ' GLY . 9.5 t -169.37 177.41 4.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 74.33 111.154 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.768 HG23 ' HG ' ' A' ' 320' ' ' LEU . 0.7 OUTLIER -53.82 -28.49 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 65.44 111.12 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.5 ' H ' HG23 ' A' ' 317' ' ' THR . . . 95.84 69.72 1.04 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.704 -0.76 . . . . 65.31 112.493 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.768 ' HG ' HG23 ' A' ' 318' ' ' ILE . 0.6 OUTLIER 168.03 82.92 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.562 0.696 . . . . 73.31 110.869 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 134.9 28.98 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.621 2.214 . . . . 71.31 112.325 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -11.47 30.94 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.705 2.27 . . . . 74.51 112.334 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -157.04 143.19 17.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.261 -0.427 . . . . 74.24 110.892 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.714 HG11 HG13 ' A' ' 391' ' ' VAL . 42.3 t -62.07 118.55 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 64.22 111.094 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -113.47 145.4 33.22 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.636 0.731 . . . . 75.14 110.852 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 -14.32 36.0 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.599 2.199 . . . . 63.34 112.42 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.69 -72.36 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 74.5 110.924 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.8 -25.56 28.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 71.13 111.125 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.873 HG22 ' HB ' ' A' ' 394' ' ' VAL . 8.6 t -81.61 -31.26 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 71.42 111.129 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.731 ' HA ' HD12 ' A' ' 333' ' ' ILE . 6.0 t70 -55.03 -38.66 68.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 73.32 110.906 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -59.0 -35.26 72.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 74.33 110.825 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 393' ' ' ILE . 32.4 mm -63.45 -45.9 96.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 75.2 111.166 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 330' ' ' ASP . 8.6 mt -57.14 -25.34 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 75.03 111.206 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -76.2 -1.16 25.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 74.23 110.858 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.94 36.6 4.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 75.52 110.847 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.823 ' HB2' ' CD1' ' A' ' 410' ' ' TRP . . . -169.55 147.95 3.24 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.574 0.702 . . . . 70.44 111.091 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.433 ' O ' HG12 ' A' ' 340' ' ' VAL . 53.9 Cg_endo -69.75 165.5 30.76 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.677 2.251 . . . . 73.22 112.375 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -31.9 19.49 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.758 2.305 . . . . 62.53 112.316 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -93.25 72.39 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 72.43 110.857 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 340' ' ' VAL . 3.3 p -178.2 127.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 72.34 111.175 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 341' ' ' THR . . . . . 0.661 HG22 ' HA ' ' A' ' 386' ' ' HIS . 39.4 p -145.74 69.87 1.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 73.22 111.132 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.463 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 99.8 m -133.63 120.73 21.05 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.211 -0.449 . . . . 65.23 111.174 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -86.47 129.15 34.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 75.2 111.033 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.815 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -111.48 134.77 52.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 72.31 110.936 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.91 HG21 HD13 ' A' ' 406' ' ' LEU . 1.7 mp -126.28 124.47 65.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.051 -0.522 . . . . 72.1 111.166 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.5 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -109.0 154.59 16.42 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 62.23 112.438 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 1.9 t30 82.82 45.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.859 0.362 . . . . 74.34 110.891 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.513 ' CG2' ' HB3' ' A' ' 352' ' ' ALA . 68.0 mt -99.26 129.85 28.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.642 0.734 . . . . 71.22 111.104 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 349' ' ' PRO . . . . . 0.585 ' HB2' ' CD1' ' A' ' 351' ' ' PHE . 54.1 Cg_endo -69.72 157.87 58.98 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.684 2.256 . . . . 73.53 112.375 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -60.81 -30.9 70.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 70.32 110.865 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' PHE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 28.1 p90 -86.1 33.3 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 61.03 110.876 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.665 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -113.64 82.59 1.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 41.44 111.136 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 17.9 p -84.98 167.56 15.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.118 -0.492 . . . . 72.34 111.185 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.507 ' O ' ' CG1' ' A' ' 358' ' ' ILE . 0.3 OUTLIER -67.21 -29.43 69.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 73.51 110.88 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -59.12 -25.65 64.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 74.32 111.108 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.0 -17.1 13.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 71.35 110.837 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.665 HD11 ' HB1' ' A' ' 352' ' ' ALA . 4.7 mp -95.56 -53.5 3.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.424 . . . . 51.35 110.896 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.668 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.3 mm -39.51 -50.7 5.03 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.537 0.684 . . . . 70.44 111.079 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 359' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.1 Cg_endo -69.74 -26.62 27.46 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.715 2.277 . . . . 70.32 112.311 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.997 ' O ' HD12 ' A' ' 360' ' ' LEU . 0.1 OUTLIER -70.81 -24.25 62.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 63.2 110.91 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' A' ' 367' ' ' ILE . 91.4 m-85 -102.61 -41.05 6.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 73.33 110.952 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 362' ' ' GLN . . . . . 0.553 ' HG3' HD12 ' A' ' 367' ' ' ILE . 8.4 mt-30 -47.73 -44.68 28.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 65.52 110.883 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 363' ' ' ASN . . . . . 0.416 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.3 OUTLIER -45.64 -28.47 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 72.31 110.922 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 364' ' ' PHE . . . . . 0.457 ' CD2' ' HA ' ' A' ' 361' ' ' PHE . 33.7 m-85 -63.35 -57.32 10.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.854 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -154.27 -86.59 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.742 . . . . 32.11 112.528 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -153.58 140.62 19.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.851 0.358 . . . . 74.52 110.833 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.553 HD12 ' HG3' ' A' ' 362' ' ' GLN . 41.2 mt -120.97 109.09 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 75.02 111.195 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.8 mp -86.76 -18.04 32.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 74.24 110.948 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -170.76 120.9 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 72.34 110.88 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.516 ' CE2' ' HB2' ' A' ' 372' ' ' HIS . 33.0 t80 -113.48 141.88 46.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 63.45 110.903 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.64 101.21 6.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 75.45 110.905 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 372' ' ' HIS . . . . . 0.579 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.6 t-80 -98.46 130.25 45.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 63.43 110.901 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -125.89 90.59 50.05 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.718 0.77 . . . . 71.14 110.906 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' PRO . . . . . 0.552 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.5 Cg_endo -69.73 -38.25 8.11 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.739 2.293 . . . . 42.43 112.299 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.53 -21.3 62.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 72.12 110.861 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -111.55 -25.74 9.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 53.33 110.877 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 84.31 42.29 7.53 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.725 -0.75 . . . . 64.42 112.519 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 31.1 p -154.84 153.98 32.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.775 0.321 . . . . 73.31 110.866 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 13.7 p -144.89 146.23 31.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 75.01 110.867 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.463 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 43.1 m-85 -125.16 122.34 36.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 73.43 110.882 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -110.84 133.67 55.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 73.1 111.171 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 128.58 46.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 74.34 110.855 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -111.6 178.4 4.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 70.34 110.877 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -76.73 -45.54 28.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.078 -0.51 . . . . 71.21 110.894 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 40.5 p -117.08 172.47 7.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 74.42 111.154 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' HIS . . . . . 0.661 ' HA ' HG22 ' A' ' 341' ' ' THR . 47.6 p-80 -85.29 -41.0 15.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 71.24 110.866 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -33.75 69.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 52.21 110.863 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -65.12 -34.93 79.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 75.42 110.889 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -67.11 -39.44 86.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 65.12 111.152 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.794 ' HB1' HG13 ' A' ' 329' ' ' VAL . . . -56.07 -33.86 65.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 63.4 111.148 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.714 HG13 HG11 ' A' ' 324' ' ' VAL . 53.2 t -61.24 -40.21 85.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 60.24 111.166 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 13.3 t -75.04 -31.56 61.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 73.34 110.9 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 332' ' ' ILE . 0.2 OUTLIER -59.52 -54.97 27.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 45.22 111.145 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.873 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.81 -36.09 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 53.43 111.13 179.811 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.32 -48.25 80.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 72.34 111.163 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.678 HD13 ' CD1' ' A' ' 399' ' ' PHE . 0.5 OUTLIER -79.3 -13.72 59.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 63.21 110.927 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -50.21 108.38 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 74.2 111.103 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 10.5 m120 49.62 50.8 17.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 73.13 110.91 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.678 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -109.2 146.97 35.0 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.629 0.728 . . . . 73.53 110.916 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 400' ' ' PRO . . . . . 0.519 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.7 Cg_endo -69.84 145.18 55.92 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.657 2.238 . . . . 71.55 112.383 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' PHE . . . . . 0.574 ' CE1' HD22 ' A' ' 360' ' ' LEU . 32.9 t80 -151.01 110.67 4.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 74.01 110.918 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 48.97 33.99 5.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 63.25 110.906 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.26 -32.7 7.17 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.727 -0.749 . . . . 71.31 112.549 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.3 OUTLIER -104.89 144.37 31.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 70.01 110.807 -179.795 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.03 154.44 24.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 42.51 110.849 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.91 HD13 HG21 ' A' ' 345' ' ' ILE . 16.8 mt -113.7 169.92 8.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 74.52 110.959 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 407' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 346' ' ' GLY . 2.0 ttt180 -111.27 174.4 5.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 73.51 110.907 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 408' ' ' THR . . . . . 0.553 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 64.3 p -154.25 148.44 25.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.477 . . . . 54.13 111.118 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 410' ' ' TRP . . . 157.03 129.45 1.14 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 32.33 112.488 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.823 ' CD1' ' HB2' ' A' ' 336' ' ' ALA . 51.8 m95 -33.8 130.73 0.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.832 0.349 . . . . 55.52 110.892 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -145.35 149.98 22.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.783 -0.722 . . . . 72.43 112.502 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.09 147.5 31.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.741 0.305 . . . . 72.54 110.917 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -55.42 107.34 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 72.32 110.83 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 71.13 110.872 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.458 -0.257 . . . . 64.33 112.458 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.44 -45.7 13.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.832 0.349 . . . . 45.32 110.864 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -158.14 42.28 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 60.02 110.93 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 3.5 t -153.12 139.55 18.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 74.33 111.18 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' ILE . . . . . 0.433 HG13 ' N ' ' A' ' 319' ' ' GLY . 3.7 tp -178.62 143.96 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 65.44 111.119 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.464 ' O ' HD23 ' A' ' 320' ' ' LEU . . . -77.81 135.04 15.4 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.682 -0.771 . . . . 65.31 112.498 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 319' ' ' GLY . 59.0 mt -143.24 83.29 11.12 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.573 0.702 . . . . 73.31 110.895 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 164.31 35.0 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.603 2.202 . . . . 71.31 112.372 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -31.43 20.52 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.654 2.236 . . . . 74.51 112.329 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.543 ' C ' HG23 ' A' ' 324' ' ' VAL . 0.0 OUTLIER -97.44 142.25 29.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 74.24 110.83 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.858 HG11 HG13 ' A' ' 391' ' ' VAL . 2.0 t 69.75 139.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 64.22 111.093 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -110.56 122.68 37.71 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.529 0.68 . . . . 75.14 110.981 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 -14.34 35.73 Favored 'Trans proline' 0 N--CA 1.466 -0.128 0 C-N-CA 122.752 2.301 . . . . 63.34 112.286 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -70.27 -72.16 0.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 74.5 110.95 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.38 -31.46 61.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 71.13 111.103 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.889 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 8.0 t -69.08 -29.58 43.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 71.42 111.118 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 330' ' ' ASP . . . . . 0.406 ' HA ' HD12 ' A' ' 333' ' ' ILE . 29.8 t0 -53.94 -35.17 61.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 73.32 110.875 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -68.41 -31.85 71.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 74.33 110.879 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.784 HG21 HG21 ' A' ' 393' ' ' ILE . 40.8 mm -57.82 -51.29 72.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 75.2 111.125 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 330' ' ' ASP . 5.4 mt -53.44 -37.23 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 75.03 111.16 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.82 -9.42 4.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 74.23 110.873 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 335' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 336' ' ' ALA . 0.5 OUTLIER -107.1 42.02 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 75.52 110.83 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . 178.35 162.83 0.64 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.566 0.698 . . . . 70.44 111.093 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 54.2 Cg_endo -69.75 160.55 49.29 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.737 2.291 . . . . 73.22 112.371 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -16.0 37.71 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.69 2.26 . . . . 62.53 112.37 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -112.53 73.91 0.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 72.43 110.899 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 337' ' ' PRO . 14.7 p -160.4 121.77 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 72.34 111.147 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 341' ' ' THR . . . . . 0.788 HG22 ' CA ' ' A' ' 386' ' ' HIS . 18.8 p -136.02 67.9 1.46 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 73.22 111.084 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 33.8 m -133.84 108.23 8.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 65.23 111.165 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -80.27 129.77 34.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 75.2 111.178 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.655 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -112.79 134.67 54.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 72.31 110.92 -179.801 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.717 HG21 HD13 ' A' ' 406' ' ' LEU . 1.5 mp -136.28 99.83 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.127 -0.488 . . . . 72.1 111.145 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 346' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -89.31 176.61 43.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 62.23 112.58 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.3 t30 68.38 47.27 0.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 74.34 110.892 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.461 HD11 HG22 ' A' ' 345' ' ' ILE . 55.0 mt -101.97 131.13 23.09 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.602 0.715 . . . . 71.22 111.144 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.85 165.98 29.24 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.249 . . . . 73.53 112.276 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -69.61 -26.33 64.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 70.32 110.858 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -85.47 32.23 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 61.03 110.877 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' ALA . . . . . 0.788 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -117.62 110.95 18.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 41.44 111.146 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 13.7 p -114.5 166.39 11.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 72.34 111.144 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.511 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -63.45 -33.58 75.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 73.51 110.968 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.91 -26.77 59.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 74.32 111.092 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.22 -13.21 13.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 71.35 110.864 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.788 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.7 mp -99.37 -53.66 3.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 51.35 110.91 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.636 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -40.44 -51.73 6.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.628 0.728 . . . . 70.44 111.192 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 359' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.1 Cg_endo -69.73 -38.51 7.76 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.655 2.237 . . . . 70.32 112.331 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 360' ' ' LEU . . . . . 0.941 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -54.99 -27.7 46.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 63.2 110.889 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 361' ' ' PHE . . . . . 0.64 ' N ' HD13 ' A' ' 360' ' ' LEU . 84.0 m-85 -95.16 -38.1 10.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 73.33 110.958 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 362' ' ' GLN . . . . . 0.643 ' HG3' HD12 ' A' ' 367' ' ' ILE . 30.4 mt-30 -48.68 -43.25 36.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 65.52 110.911 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 363' ' ' ASN . . . . . 0.437 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.5 OUTLIER -42.87 -28.2 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.955 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 364' ' ' PHE . . . . . 0.542 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 18.7 m-85 -66.14 -58.55 5.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 73.33 110.92 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' GLY . . . . . 0.425 ' HA3' ' CD ' ' A' ' 388' ' ' GLN . . . -156.67 -84.34 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.76 -0.733 . . . . 32.11 112.519 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.412 ' O ' ' CD2' ' A' ' 383' ' ' TYR . 17.6 t80 -153.96 144.68 22.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 74.52 110.902 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 367' ' ' ILE . . . . . 0.643 HD12 ' HG3' ' A' ' 362' ' ' GLN . 47.1 mt -120.86 108.78 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.02 111.138 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.32 -16.01 36.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.179 -0.464 . . . . 74.24 110.894 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -170.58 120.81 0.58 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.445 . . . . 72.34 110.862 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 34.7 t80 -115.44 136.11 53.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 63.45 110.894 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 379' ' ' CYS . 0.0 OUTLIER -122.62 100.3 6.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.866 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 372' ' ' HIS . . . . . 0.524 ' HB2' ' CE2' ' A' ' 370' ' ' PHE . 31.7 t60 -100.2 110.79 23.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 63.43 110.862 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.571 ' CE1' ' HA ' ' A' ' 379' ' ' CYS . 1.0 OUTLIER -119.53 94.52 48.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.644 0.735 . . . . 71.14 110.89 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 374' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 373' ' ' TYR . 53.6 Cg_endo -69.82 -17.4 37.3 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.724 2.282 . . . . 42.43 112.308 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.48 -28.62 69.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 72.12 110.917 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -111.69 -24.23 10.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 53.33 110.9 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 91.07 37.44 6.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.717 -0.754 . . . . 64.42 112.477 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' CYS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 373' ' ' TYR . 0.0 OUTLIER -156.23 151.69 26.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 73.31 110.872 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 379' ' ' CYS . . . . . 0.571 ' HA ' ' CE1' ' A' ' 373' ' ' TYR . 25.6 p -126.05 171.35 10.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 75.01 110.834 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 380' ' ' PHE . . . . . 0.551 ' CE2' ' OH ' ' A' ' 373' ' ' TYR . 27.6 m-85 -137.63 107.32 6.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 73.43 110.829 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 381' ' ' ILE . . . . . 0.558 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.7 OUTLIER -106.21 113.31 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 73.1 111.119 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -87.33 130.85 34.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.9 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.583 ' CD2' ' OE1' ' A' ' 388' ' ' GLN . 46.6 m-85 -113.67 153.94 28.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 70.34 110.917 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -53.76 -47.3 70.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 71.21 110.885 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.7 p -108.82 157.73 18.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 74.42 111.119 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' HIS . . . . . 0.788 ' CA ' HG22 ' A' ' 341' ' ' THR . 20.8 p-80 -83.97 -44.49 14.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 71.24 110.777 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 387' ' ' GLU . . . . . 0.462 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 0.1 OUTLIER -57.24 -26.94 61.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 52.21 110.851 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 388' ' ' GLN . . . . . 0.583 ' OE1' ' CD2' ' A' ' 383' ' ' TYR . 0.8 OUTLIER -70.3 -32.52 70.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.182 -0.463 . . . . 75.42 110.965 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.469 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -68.4 -33.86 74.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 65.12 111.11 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.889 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -54.55 -28.76 48.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 63.4 111.093 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 391' ' ' VAL . . . . . 0.858 HG13 HG11 ' A' ' 324' ' ' VAL . 77.7 t -71.36 -51.02 36.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 60.24 111.196 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 392' ' ' CYS . . . . . 0.542 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 3.6 t -61.46 -31.08 71.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 73.34 110.847 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.784 HG21 HG21 ' A' ' 332' ' ' ILE . 1.1 mt -57.15 -56.02 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 45.22 111.166 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 394' ' ' VAL . . . . . 0.483 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.2 t -72.39 -35.18 51.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 53.43 111.122 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.85 -49.75 76.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 72.34 111.116 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' LEU . . . . . 0.612 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.7 mm? -77.16 -7.84 56.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.423 . . . . 63.21 110.981 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 397' ' ' ALA . . . . . 0.626 ' N ' HG21 ' A' ' 408' ' ' THR . . . -54.78 112.23 0.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.2 111.096 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 43.98 48.71 7.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 73.13 110.909 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' PHE . . . . . 0.612 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -102.79 141.58 22.79 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.726 0.774 . . . . 73.53 110.86 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 136.37 32.99 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.706 2.271 . . . . 71.55 112.388 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' PHE . . . . . 0.571 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 36.8 t80 -140.67 110.81 6.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 74.01 110.868 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 50.19 32.72 6.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 63.25 110.911 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 100.69 -30.09 11.01 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.699 -0.762 . . . . 71.31 112.451 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.07 138.89 40.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.838 0.351 . . . . 70.01 110.901 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -80.69 155.13 26.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 42.51 110.855 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.717 HD13 HG21 ' A' ' 345' ' ' ILE . 16.5 mt -114.61 176.82 4.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.52 110.955 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 407' ' ' ARG . . . . . 0.401 ' N ' ' O ' ' A' ' 346' ' ' GLY . 0.2 OUTLIER -114.09 173.45 6.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 73.51 110.91 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 408' ' ' THR . . . . . 0.626 HG21 ' N ' ' A' ' 397' ' ' ALA . 72.0 p -154.63 151.06 28.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 54.13 111.115 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 409' ' ' GLY . . . . . 0.477 ' O ' ' C ' ' A' ' 410' ' ' TRP . . . 154.44 131.79 1.56 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.778 -0.725 . . . . 32.33 112.534 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.482 ' NE1' HG22 ' A' ' 332' ' ' ILE . 10.2 m95 -31.07 121.29 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.333 . . . . 55.52 110.987 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 411' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 410' ' ' TRP . . . -33.73 140.68 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.778 -0.725 . . . . 72.43 112.519 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 412' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 413' ' ' GLU . 4.3 mttt -164.91 127.98 2.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.78 0.324 . . . . 72.54 110.851 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 413' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 412' ' ' LYS . 81.4 mt-10 -34.44 -87.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 72.32 110.928 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 71.13 110.808 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.787 0.327 . . . . 74.5 110.918 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.95 -25.09 27.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 71.13 111.125 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' VAL . . . . . 0.828 HG22 ' HB ' ' A' ' 394' ' ' VAL . 7.9 t -79.96 -29.78 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 71.42 111.096 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.412 ' HA ' HD12 ' A' ' 333' ' ' ILE . 6.8 t70 -54.54 -36.88 64.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 73.32 110.865 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -64.2 -32.24 73.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 74.33 110.854 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.737 HG21 HG21 ' A' ' 393' ' ' ILE . 22.6 mm -60.31 -52.81 56.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 75.2 111.151 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 330' ' ' ASP . 4.8 mt -55.48 -41.63 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 75.03 111.137 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.96 -16.69 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 74.23 110.856 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.56 23.49 8.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 75.52 110.878 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.536 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . -174.96 159.09 2.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.574 0.702 . . . . 70.44 111.087 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.536 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 53.5 Cg_endo -69.73 150.2 68.06 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.67 2.247 . . . . 73.22 112.365 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -14.23 35.74 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.701 2.267 . . . . 62.53 112.332 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.521 ' O ' HG23 ' A' ' 341' ' ' THR . 0.5 OUTLIER -72.43 -63.13 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 72.43 110.882 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.64 143.83 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.34 111.091 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . 0.677 HG22 ' CA ' ' A' ' 386' ' ' HIS . 22.3 p -146.98 68.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 73.22 111.128 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 87.7 m -133.78 139.46 46.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 65.23 111.116 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -105.78 121.78 44.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 75.2 111.083 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.602 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -102.93 122.09 43.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 72.31 110.877 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.561 HG21 HD13 ' A' ' 406' ' ' LEU . 1.9 mp -118.58 112.85 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 72.1 111.149 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -102.23 171.82 21.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.76 -0.734 . . . . 62.23 112.479 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.416 ' O ' ' CD2' ' A' ' 406' ' ' LEU . 1.4 t30 71.45 46.59 0.41 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.337 . . . . 74.34 110.917 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.615 HG23 ' HD2' ' A' ' 349' ' ' PRO . 86.9 mt -102.77 137.17 19.24 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.622 0.725 . . . . 71.22 111.147 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . 0.615 ' HD2' HG23 ' A' ' 348' ' ' ILE . 53.6 Cg_endo -69.76 163.53 37.94 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.679 2.253 . . . . 73.53 112.341 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -70.5 -24.05 62.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 70.32 110.884 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.559 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 29.4 p90 -90.74 29.46 1.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 61.03 110.883 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.795 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -112.63 99.11 7.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 41.44 111.13 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 13.3 p -99.2 169.49 9.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 72.34 111.13 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . 0.513 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.29 -29.76 69.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 73.51 110.839 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -59.0 -26.04 64.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 74.32 111.13 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.78 -13.09 13.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 71.35 110.841 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.795 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.5 mp -99.93 -53.24 3.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 51.35 110.936 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.647 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -41.49 -51.14 8.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.574 0.702 . . . . 70.44 111.118 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.4 Cg_endo -69.78 -30.47 22.15 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.668 2.246 . . . . 70.32 112.339 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.891 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -64.96 -20.12 66.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 63.2 110.955 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.596 ' HB2' HD11 ' A' ' 367' ' ' ILE . 88.1 m-85 -104.8 -37.01 7.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 73.33 110.89 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -48.56 -45.51 37.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 65.52 110.931 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . 0.419 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.8 OUTLIER -44.49 -23.77 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 72.31 110.858 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . 0.594 ' CE2' ' HB2' ' A' ' 392' ' ' CYS . 32.2 m-85 -69.85 -51.29 34.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 73.33 110.846 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -163.26 -88.0 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 32.11 112.473 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -151.74 144.49 24.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 74.52 110.913 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . 0.596 HD11 ' HB2' ' A' ' 361' ' ' PHE . 25.9 mt -121.07 109.74 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 75.02 111.147 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.43 -19.42 29.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 74.24 110.889 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -170.96 120.74 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.889 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 33.5 t80 -113.61 131.33 56.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 63.45 110.902 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.31 100.73 7.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 75.45 110.928 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . 0.588 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 13.6 t-80 -97.81 127.44 43.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 63.43 110.905 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -122.85 86.58 50.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.712 0.768 . . . . 71.14 110.944 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' PRO . . . . . 0.478 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 54.0 Cg_endo -69.76 -21.38 33.56 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.732 2.288 . . . . 42.43 112.357 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.47 -23.76 63.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 72.12 110.871 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -115.39 -25.79 7.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 53.33 110.893 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.09 44.83 4.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.718 -0.753 . . . . 64.42 112.458 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 93.9 m -156.93 147.94 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 73.31 110.886 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.472 ' HB2' ' CE1' ' A' ' 370' ' ' PHE . 21.5 p -138.01 153.18 49.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 75.01 110.882 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 380' ' ' PHE . 2.3 m-85 -128.48 118.92 23.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.877 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.458 HG21 ' CD1' ' A' ' 367' ' ' ILE . 0.8 OUTLIER -107.7 128.73 62.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 73.1 111.108 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.94 132.25 43.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 74.34 110.909 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -114.67 -178.9 3.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 70.34 110.96 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -76.78 -40.58 47.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.469 . . . . 71.21 110.898 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 53.5 p -125.17 167.11 15.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 74.42 111.143 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' HIS . . . . . 0.677 ' CA ' HG22 ' A' ' 341' ' ' THR . 9.8 p-80 -72.99 -40.58 65.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 71.24 110.869 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . 0.428 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 0.4 OUTLIER -57.87 -26.97 62.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 52.21 110.878 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -65.71 -33.48 75.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 75.42 110.848 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -78.93 -34.65 44.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 65.12 111.057 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.821 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -61.15 -34.46 75.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.239 -0.437 . . . . 63.4 111.097 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.8 -57.24 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 60.24 111.132 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . 0.594 ' HB2' ' CE2' ' A' ' 364' ' ' PHE . 30.1 p -66.28 -27.06 67.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 73.34 110.906 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.858 ' O ' HG21 ' A' ' 408' ' ' THR . 1.3 mt -58.21 -54.56 30.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 45.22 111.112 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.828 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.5 OUTLIER -71.5 -34.21 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 53.43 111.105 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.8 -37.05 85.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 72.34 111.143 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.635 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.8 mm? -86.14 -12.91 48.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 63.21 110.916 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -53.45 111.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 74.2 111.089 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.9 m120 47.73 48.91 17.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.927 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.635 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -104.59 144.26 28.35 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.608 0.718 . . . . 73.53 110.874 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 139.09 39.35 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.653 2.236 . . . . 71.55 112.364 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' PHE . . . . . 0.615 ' CZ ' ' NE2' ' A' ' 402' ' ' GLN . 41.0 t80 -145.85 111.8 5.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 74.01 110.9 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.615 ' NE2' ' CZ ' ' A' ' 401' ' ' PHE . 20.9 mt-30 51.07 32.64 7.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 63.25 110.976 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.92 -26.23 25.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.696 -0.764 . . . . 71.31 112.448 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 401' ' ' PHE . 3.3 ttt180 -109.43 141.3 42.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.761 0.315 . . . . 70.01 110.876 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -82.52 155.19 24.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 42.51 110.873 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.561 HD13 HG21 ' A' ' 345' ' ' ILE . 27.3 mt -117.19 178.31 4.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.52 110.91 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.59 176.02 5.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 73.51 110.864 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . 0.858 HG21 ' O ' ' A' ' 393' ' ' ILE . 1.8 p -146.77 156.67 43.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 54.13 111.142 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.725 -0.75 . . . . 32.33 112.478 179.954 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.797 0.332 . . . . 74.5 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -52.58 -24.84 9.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 71.13 111.082 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' VAL . . . . . 0.853 HG22 ' HB ' ' A' ' 394' ' ' VAL . 5.0 t -81.58 -30.06 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 71.42 111.098 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.474 ' HA ' HD12 ' A' ' 333' ' ' ILE . 6.2 t0 -55.06 -38.06 67.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 73.32 110.817 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -59.9 -37.69 80.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 74.33 110.902 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.544 HG21 HD13 ' A' ' 393' ' ' ILE . 16.6 mm -54.96 -54.46 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 75.2 111.138 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 330' ' ' ASP . 7.2 mt -51.61 -41.35 27.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 75.03 111.148 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -16.84 2.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 74.23 110.853 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.38 29.01 5.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.205 -0.452 . . . . 75.52 110.872 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -159.59 154.27 20.9 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.57 0.7 . . . . 70.44 111.13 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 156.52 63.01 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.677 2.251 . . . . 73.22 112.36 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -6.68 19.19 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.661 2.24 . . . . 62.53 112.395 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -119.93 76.45 1.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 72.43 110.944 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 7.5 p -179.62 141.84 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 72.34 111.156 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . 0.524 HG22 ' HA ' ' A' ' 386' ' ' HIS . 21.0 p -149.46 69.79 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 73.22 111.13 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 96.4 m -133.5 116.08 15.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 65.23 111.109 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -89.14 121.86 31.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 75.2 111.077 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.56 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -102.99 125.56 49.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 72.31 110.907 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.506 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.9 mp -122.52 118.86 56.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 72.1 111.17 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -105.91 -179.01 23.6 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.725 -0.75 . . . . 62.23 112.482 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.501 ' O ' HD23 ' A' ' 406' ' ' LEU . 0.7 OUTLIER 62.82 49.73 3.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.753 0.311 . . . . 74.34 110.811 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.512 ' CG2' ' HB3' ' A' ' 352' ' ' ALA . 86.8 mt -103.25 134.17 19.92 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.57 0.7 . . . . 71.22 111.177 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . 0.513 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.7 Cg_endo -69.77 165.38 31.18 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.704 2.27 . . . . 73.53 112.367 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.78 -25.8 63.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 70.32 110.916 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.402 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 2.9 p90 -89.88 31.87 0.94 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 61.03 110.851 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.853 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -120.62 99.18 6.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 41.44 111.107 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 79.5 p -104.79 173.66 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.269 -0.423 . . . . 72.34 111.208 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . 0.513 ' O ' ' CG1' ' A' ' 358' ' ' ILE . 0.6 OUTLIER -66.71 -29.85 69.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 73.51 110.915 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.41 -26.28 63.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 74.32 111.038 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.42 -17.51 12.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.258 -0.428 . . . . 71.35 110.804 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.853 HD11 ' HB1' ' A' ' 352' ' ' ALA . 4.0 mp -92.33 -51.1 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 51.35 110.851 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.681 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.3 mm -42.34 -49.98 11.95 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.581 0.705 . . . . 70.44 111.082 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.6 Cg_endo -69.76 -28.0 25.78 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.685 2.257 . . . . 70.32 112.365 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.845 HD13 ' C ' ' A' ' 360' ' ' LEU . 0.2 OUTLIER -68.11 -25.99 65.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 63.2 110.891 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.641 ' CE2' HD12 ' A' ' 360' ' ' LEU . 85.3 m-85 -102.42 -34.69 9.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 73.33 110.886 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' GLN . . . . . 0.559 ' HG3' HD12 ' A' ' 367' ' ' ILE . 2.0 mt-30 -54.63 -32.36 58.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 65.52 110.882 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.05 -13.67 12.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 72.31 110.872 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . 0.481 ' CD2' ' HB3' ' A' ' 392' ' ' CYS . 39.3 m-85 -78.78 -55.9 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 73.33 110.926 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -155.19 -86.77 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.647 -0.787 . . . . 32.11 112.443 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.443 ' CE2' ' HG ' ' A' ' 368' ' ' LEU . 61.2 t80 -153.62 140.78 19.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.337 . . . . 74.52 110.906 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . 0.559 HD12 ' HG3' ' A' ' 362' ' ' GLN . 42.0 mt -120.33 109.29 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 75.02 111.161 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.443 ' HG ' ' CE2' ' A' ' 366' ' ' PHE . 0.9 OUTLIER -86.18 -20.24 28.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.93 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.89 121.36 0.67 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 72.34 110.923 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 35.0 t80 -113.61 145.7 40.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 63.45 110.895 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -131.44 101.97 5.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 75.45 110.952 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 6.2 t-80 -100.83 127.24 47.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.295 -0.412 . . . . 63.43 110.856 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -118.2 90.55 38.24 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.703 0.763 . . . . 71.14 110.958 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' PRO . . . . . 0.418 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.4 Cg_endo -69.75 -19.69 35.84 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.718 2.278 . . . . 42.43 112.335 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -84.38 -21.96 30.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 72.12 110.823 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -106.53 -26.43 11.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 53.33 110.866 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . 0.4 ' C ' ' SG ' ' A' ' 378' ' ' CYS . . . 84.74 35.38 13.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 64.42 112.489 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . 0.4 ' SG ' ' C ' ' A' ' 377' ' ' GLY . 1.8 m -153.64 140.98 19.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.774 0.321 . . . . 73.31 110.901 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 17.7 p -133.14 146.08 51.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 75.01 110.889 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 344' ' ' TYR . 7.4 m-85 -124.15 127.69 48.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 73.43 110.911 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.537 HD13 ' CD1' ' A' ' 361' ' ' PHE . 1.0 OUTLIER -113.36 130.74 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 73.1 111.145 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -94.67 131.35 40.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.922 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -114.85 -174.58 2.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 70.34 110.902 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -93.47 -30.49 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 71.21 110.9 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 24.8 p -125.7 165.8 17.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 74.42 111.088 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' HIS . . . . . 0.524 ' HA ' HG22 ' A' ' 341' ' ' THR . 17.9 p-80 -78.42 -41.46 32.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 71.24 110.855 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 6.6 tm-20 -57.37 -31.27 65.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 52.21 110.861 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -36.29 82.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 75.42 110.933 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.614 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -76.02 -27.14 57.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 65.12 111.063 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.724 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -72.72 -35.51 67.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 63.4 111.063 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 82.7 t -66.02 -53.57 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 60.24 111.124 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . 0.481 ' HB3' ' CD2' ' A' ' 364' ' ' PHE . 31.5 p -65.35 -31.76 73.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.484 . . . . 73.34 110.861 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.762 ' O ' HG21 ' A' ' 408' ' ' THR . 0.7 OUTLIER -55.67 -55.65 16.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 45.22 111.133 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.853 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.67 -36.79 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 53.43 111.164 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.2 -30.57 71.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 72.34 111.119 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.68 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.1 mm? -95.93 -16.07 21.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 63.21 110.889 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -48.58 110.39 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.2 111.131 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 42.5 t30 49.45 50.57 17.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 73.13 110.923 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.68 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -107.47 145.62 31.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.655 0.74 . . . . 73.53 110.899 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 143.32 50.81 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.74 2.293 . . . . 71.55 112.333 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' PHE . . . . . 0.526 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 31.6 t80 -150.37 110.97 4.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 74.01 110.892 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 49.82 33.02 5.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 63.25 110.949 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 99.54 -27.76 18.63 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.683 -0.77 . . . . 71.31 112.503 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.3 OUTLIER -107.0 142.03 37.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.903 0.382 . . . . 70.01 110.901 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -83.05 154.79 24.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 42.51 110.834 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 347' ' ' ASN . 19.6 mt -117.78 167.77 11.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 74.52 110.889 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.58 179.12 4.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 73.51 110.92 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . 0.762 HG21 ' O ' ' A' ' 393' ' ' ILE . 5.9 p -152.86 153.56 33.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 54.13 111.191 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.749 . . . . 32.33 112.454 -179.978 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.779 0.323 . . . . 74.5 110.874 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -58.48 -25.01 61.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 71.13 111.002 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' VAL . . . . . 0.9 HG22 ' HB ' ' A' ' 394' ' ' VAL . 14.6 t -74.82 -30.03 23.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 71.42 111.117 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.466 ' HA ' HD12 ' A' ' 333' ' ' ILE . 23.5 t0 -55.03 -36.92 66.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.32 110.878 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -62.42 -36.34 82.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 74.33 110.909 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.492 HG21 HG21 ' A' ' 393' ' ' ILE . 20.4 mm -55.42 -53.25 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 75.2 111.071 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 330' ' ' ASP . 5.5 mt -53.02 -40.51 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 75.03 111.163 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -16.27 2.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 74.23 110.844 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' A' ' 336' ' ' ALA . 0.2 OUTLIER -105.02 44.75 1.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 75.52 110.823 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 335' ' ' SER . . . 167.32 147.31 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.659 0.742 . . . . 70.44 111.095 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.913 ' O ' HG12 ' A' ' 340' ' ' VAL . 53.4 Cg_endo -69.81 151.27 68.76 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.667 2.245 . . . . 73.22 112.342 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -8.88 24.74 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.766 2.311 . . . . 62.53 112.332 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.42 16.58 3.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 72.43 110.863 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.913 HG12 ' O ' ' A' ' 337' ' ' PRO . 13.9 p -131.29 140.15 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 72.34 111.164 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . 0.671 HG22 ' CA ' ' A' ' 386' ' ' HIS . 21.0 p -148.78 68.11 1.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 73.22 111.138 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 28.1 m -133.78 127.62 33.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.474 . . . . 65.23 111.098 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.96 120.69 35.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 75.2 111.169 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.794 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -105.86 131.72 52.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 72.31 110.92 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.8 HG21 HD13 ' A' ' 406' ' ' LEU . 1.7 mp -126.22 117.68 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 72.1 111.121 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -105.11 162.59 14.48 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.741 . . . . 62.23 112.524 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.5 t30 76.14 44.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 74.34 110.888 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.541 HG23 ' HD2' ' A' ' 349' ' ' PRO . 67.3 mt -94.59 135.2 24.23 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.613 0.721 . . . . 71.22 111.115 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . 0.554 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 52.9 Cg_endo -69.77 159.75 52.25 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.732 2.288 . . . . 73.53 112.337 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -67.86 -21.47 65.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 70.32 110.817 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 349' ' ' PRO . 5.4 p90 -93.86 28.49 2.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 61.03 110.903 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.765 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -110.83 102.07 10.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 41.44 111.117 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 14.3 p -102.8 169.26 8.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 72.34 111.109 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . 0.516 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.49 -31.32 71.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 73.51 110.865 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.96 -26.38 59.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 74.32 111.1 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -111.98 -13.11 13.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 71.35 110.902 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.765 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.4 mp -99.47 -54.18 3.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 51.35 110.91 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.632 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -40.29 -51.79 6.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.664 0.745 . . . . 70.44 111.088 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.3 Cg_endo -69.76 -38.12 8.24 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.72 2.28 . . . . 70.32 112.339 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.929 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -55.32 -26.67 42.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.442 . . . . 63.2 110.925 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.62 ' N ' HD13 ' A' ' 360' ' ' LEU . 85.2 m-85 -97.42 -39.22 9.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 73.33 110.861 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' GLN . . . . . 0.622 ' HG3' HD12 ' A' ' 367' ' ' ILE . 6.8 mt-30 -47.52 -44.26 25.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 65.52 111.006 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 360' ' ' LEU . 0.9 OUTLIER -45.05 -29.01 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 72.31 110.879 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . 0.56 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 34.0 m-85 -63.33 -57.39 10.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 73.33 110.913 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -156.8 -83.7 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.729 . . . . 32.11 112.507 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -153.5 144.76 23.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.798 0.332 . . . . 74.52 110.885 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . 0.622 HD12 ' HG3' ' A' ' 362' ' ' GLN . 69.1 mt -121.13 109.08 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 75.02 111.12 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.3 mt -88.1 -19.8 26.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 74.24 110.877 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.15 120.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 72.34 110.848 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 372' ' ' HIS . 34.9 t80 -113.1 142.2 46.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 63.45 110.899 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.5 100.48 5.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 75.45 110.88 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . 0.587 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.0 t-80 -99.59 119.02 37.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 63.43 110.877 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.86 88.21 11.37 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.709 0.766 . . . . 71.14 110.944 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' PRO . . . . . 0.418 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 54.1 Cg_endo -69.78 -26.9 27.01 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.705 2.27 . . . . 42.43 112.355 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.55 -19.75 62.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 72.12 110.871 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -111.14 -27.07 8.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 53.33 110.895 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 89.11 39.83 6.33 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.781 -0.723 . . . . 64.42 112.479 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.8 p -159.58 153.59 23.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.752 0.31 . . . . 73.31 110.87 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.516 ' C ' ' CD1' ' A' ' 380' ' ' PHE . 15.2 p -138.72 166.71 23.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 75.01 110.866 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 379' ' ' CYS . 7.0 m-85 -142.12 125.57 16.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 73.43 110.806 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.48 126.43 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 73.1 111.15 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.71 128.38 42.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 74.34 110.911 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -109.83 179.32 4.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 70.34 110.95 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -81.05 -34.95 32.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.469 . . . . 71.21 110.878 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 82.8 p -125.65 166.75 16.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 74.42 111.174 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' HIS . . . . . 0.671 ' CA ' HG22 ' A' ' 341' ' ' THR . 4.1 p-80 -82.58 -38.69 23.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 71.24 110.861 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . 0.403 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 4.5 tt0 -57.4 -27.71 62.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 52.21 110.84 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -35.59 66.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 75.42 110.91 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.51 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -68.47 -37.94 80.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 65.12 111.077 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.642 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -58.59 -33.61 70.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 63.4 111.068 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 58.3 t -63.58 -57.52 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 60.24 111.128 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . 0.56 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 10.5 t -59.33 -30.18 68.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.496 . . . . 73.34 110.919 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.537 HG22 ' N ' ' A' ' 394' ' ' VAL . 0.5 OUTLIER -59.09 -55.21 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 45.22 111.102 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.9 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.79 -34.82 52.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 53.43 111.129 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.19 -45.38 88.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 72.34 111.149 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.609 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.7 mm? -81.59 -12.58 58.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 63.21 110.986 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' ALA . . . . . 0.525 ' N ' HG21 ' A' ' 408' ' ' THR . . . -49.37 111.08 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 74.2 111.098 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 6.6 m120 44.26 48.74 7.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 73.13 110.825 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.609 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -103.6 145.77 31.24 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.66 0.743 . . . . 73.53 110.916 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 141.8 46.19 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.692 2.261 . . . . 71.55 112.34 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' PHE . . . . . 0.551 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 30.4 t80 -146.94 110.85 5.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 74.01 110.913 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 47.92 32.96 3.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 63.25 110.936 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.04 -29.85 11.63 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.815 -0.707 . . . . 71.31 112.517 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.76 137.02 43.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 70.01 110.887 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -81.65 150.38 28.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 42.51 110.89 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.8 HD13 HG21 ' A' ' 345' ' ' ILE . 28.4 mt -112.39 171.43 7.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 74.52 110.902 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 346' ' ' GLY . 13.4 ttt180 -112.73 174.66 5.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 73.51 110.842 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . 0.562 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 70.7 p -154.28 146.97 24.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 54.13 111.17 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.383 0 C-N-CA 120.764 -0.731 . . . . 32.33 112.506 179.962 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.825 0.345 . . . . 74.5 110.922 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -53.78 -24.87 16.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 71.13 111.163 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' VAL . . . . . 0.862 HG22 ' HB ' ' A' ' 394' ' ' VAL . 6.9 t -84.36 -30.06 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 71.42 111.165 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.611 ' HA ' HD12 ' A' ' 333' ' ' ILE . 22.7 t70 -54.67 -41.17 69.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 73.32 110.953 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -56.6 -39.23 73.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 74.33 110.887 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.659 HG21 HD13 ' A' ' 393' ' ' ILE . 21.5 mm -54.4 -54.34 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 75.2 111.097 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.922 HG23 ' NE2' ' A' ' 386' ' ' HIS . 4.3 mt -53.69 -36.34 28.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 75.03 111.124 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -7.98 5.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 74.23 110.873 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.8 7.68 37.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 75.52 110.887 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -153.0 147.1 18.6 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.598 0.714 . . . . 70.44 111.062 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.716 ' O ' HG12 ' A' ' 340' ' ' VAL . 53.3 Cg_endo -69.77 153.27 69.07 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.694 2.263 . . . . 73.22 112.356 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -7.75 21.85 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.67 2.246 . . . . 62.53 112.351 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 31.9 mtt180 -92.25 37.11 0.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 72.43 110.844 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 337' ' ' PRO . 7.7 p -157.74 142.59 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 72.34 111.138 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . 0.489 HG22 ' HB2' ' A' ' 386' ' ' HIS . 18.2 p -144.39 67.93 1.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 73.22 111.18 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 72.7 m -134.06 137.59 44.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 65.23 111.175 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -108.74 122.22 46.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 75.2 111.138 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -102.06 124.87 48.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.267 -0.424 . . . . 72.31 110.937 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.548 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.9 mp -120.73 104.41 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 72.1 111.083 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -93.3 165.62 27.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.825 -0.703 . . . . 62.23 112.536 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.42 ' O ' HD22 ' A' ' 406' ' ' LEU . 1.5 t30 74.99 55.47 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.358 . . . . 74.34 110.89 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.583 HG23 ' HD2' ' A' ' 349' ' ' PRO . 76.7 mt -110.19 136.36 20.5 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.634 0.73 . . . . 71.22 111.153 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 348' ' ' ILE . 54.5 Cg_endo -69.68 162.93 40.12 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.664 2.243 . . . . 73.53 112.359 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.41 -21.27 61.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 70.32 110.862 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.485 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 7.4 p90 -88.02 19.92 3.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 61.03 110.864 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.697 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -104.65 121.34 43.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 41.44 111.08 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 11.5 p -123.08 167.99 12.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 72.34 111.215 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . 0.506 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.3 OUTLIER -63.64 -35.12 79.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 73.51 110.839 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -55.03 -26.89 40.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 74.32 111.114 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.99 -13.5 13.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 71.35 110.914 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.697 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.2 mp -99.06 -55.0 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 51.35 110.94 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.623 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -38.82 -52.42 3.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.704 0.764 . . . . 70.44 111.146 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.3 Cg_endo -69.75 -40.36 5.42 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.703 2.269 . . . . 70.32 112.381 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.915 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -53.89 -25.28 19.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 63.2 110.929 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.58 ' CE2' HD12 ' A' ' 360' ' ' LEU . 83.4 m-85 -100.46 -39.43 7.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.863 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -51.64 -39.22 57.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 65.52 110.878 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -51.42 -16.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 72.31 110.922 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . 0.511 ' CE2' ' HB2' ' A' ' 392' ' ' CYS . 31.6 m-85 -75.55 -60.04 2.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 73.33 110.927 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -150.02 -85.36 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.646 -0.788 . . . . 32.11 112.42 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 368' ' ' LEU . 15.0 t80 -153.62 141.73 20.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.819 0.342 . . . . 74.52 110.876 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' A' ' 361' ' ' PHE . 40.8 mt -121.04 109.04 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 75.02 111.1 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.758 HD11 ' HD3' ' A' ' 382' ' ' LYS . 2.8 pp -89.3 -16.2 31.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.938 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.683 ' HB2' HD12 ' A' ' 368' ' ' LEU . 0.2 OUTLIER -171.02 120.83 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.476 . . . . 72.34 110.903 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 372' ' ' HIS . 35.9 t80 -114.4 141.64 47.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 63.45 110.894 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 5.2 mtmm -129.4 101.12 5.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 75.45 110.907 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . 0.598 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 14.2 t-80 -95.93 121.66 37.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 63.43 110.829 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -116.83 84.0 15.12 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.657 0.741 . . . . 71.14 110.926 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' PRO . . . . . 0.474 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 54.4 Cg_endo -69.71 -27.08 27.16 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.67 2.247 . . . . 42.43 112.37 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -65.65 -23.58 66.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 72.12 110.914 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -112.83 -25.59 8.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 53.33 110.889 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.61 46.32 4.04 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.728 -0.749 . . . . 64.42 112.476 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 27.4 p -159.78 151.82 20.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.877 0.37 . . . . 73.31 110.906 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 15.1 p -140.52 137.38 33.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 75.01 110.922 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -115.99 119.94 37.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 73.43 110.921 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.55 HD13 ' CG ' ' A' ' 361' ' ' PHE . 1.2 mt -107.64 142.51 20.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 73.1 111.18 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . 0.758 ' HD3' HD11 ' A' ' 368' ' ' LEU . 0.1 OUTLIER -103.27 131.6 50.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.909 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.455 ' CD2' ' HB3' ' A' ' 388' ' ' GLN . 53.1 m-85 -120.33 137.02 54.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 70.34 110.919 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -45.36 -28.77 0.91 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 71.21 110.864 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 69.4 p -130.07 162.69 28.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 74.42 111.139 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' HIS . . . . . 0.922 ' NE2' HG23 ' A' ' 333' ' ' ILE . 10.0 t60 -80.43 -34.42 36.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 71.24 110.863 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -57.31 -32.19 66.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 52.21 110.954 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.455 ' HB3' ' CD2' ' A' ' 383' ' ' TYR . 0.0 OUTLIER -66.8 -34.49 77.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.113 -0.494 . . . . 75.42 110.906 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -71.35 -23.85 61.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 65.12 111.095 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.765 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -78.79 -38.42 38.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 63.4 111.063 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.24 -48.6 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 60.24 111.103 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . 0.511 ' HB2' ' CE2' ' A' ' 364' ' ' PHE . 19.1 p -71.36 -32.44 68.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 73.34 110.856 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.681 ' O ' HG21 ' A' ' 408' ' ' THR . 0.9 OUTLIER -53.68 -55.35 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 45.22 111.171 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.862 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -72.08 -34.32 49.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 53.43 111.144 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -67.08 -29.09 68.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 72.34 111.147 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.673 HD13 ' CD1' ' A' ' 399' ' ' PHE . 1.9 mm? -97.97 -2.82 39.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 63.21 110.858 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -63.53 111.73 2.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 74.2 111.012 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 50.67 48.1 23.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 73.13 110.893 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.673 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -106.48 142.97 26.05 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.642 0.734 . . . . 73.53 110.867 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.421 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.8 Cg_endo -69.77 141.61 45.64 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.747 2.298 . . . . 71.55 112.34 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' PHE . . . . . 0.559 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 50.1 t80 -147.94 114.25 5.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 74.01 110.838 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER 48.91 32.74 3.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 63.25 110.937 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.36 -27.58 18.78 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.76 -0.733 . . . . 71.31 112.504 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.4 138.76 41.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 70.01 110.864 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.407 ' C ' HD23 ' A' ' 406' ' ' LEU . 3.0 m120 -80.66 149.75 29.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 42.51 110.827 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 347' ' ' ASN . 9.3 mt -112.24 174.93 5.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 74.52 110.948 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 346' ' ' GLY . 0.0 OUTLIER -120.78 173.02 7.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 73.51 110.891 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . 0.681 HG21 ' O ' ' A' ' 393' ' ' ILE . 2.2 p -146.41 153.6 40.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 54.13 111.072 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 32.33 112.443 179.899 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.835 0.35 . . . . 74.5 110.947 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.1 -24.78 18.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.457 . . . . 71.13 111.104 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' VAL . . . . . 0.82 HG22 ' HB ' ' A' ' 394' ' ' VAL . 5.7 t -84.78 -30.04 6.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 71.42 111.176 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.75 ' HA ' HD12 ' A' ' 333' ' ' ILE . 13.7 t70 -54.74 -45.86 74.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 73.32 110.905 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -53.01 -34.81 58.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.808 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.968 HG21 HG21 ' A' ' 393' ' ' ILE . 26.1 mm -61.29 -48.87 86.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 75.2 111.167 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' A' ' 330' ' ' ASP . 8.0 mt -54.39 -33.05 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 75.03 111.093 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.61 -7.96 12.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.951 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 336' ' ' ALA . 0.8 OUTLIER -94.29 17.58 12.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 75.52 110.894 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.705 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . 177.8 164.49 0.57 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.533 0.682 . . . . 70.44 111.154 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.836 ' O ' HG22 ' A' ' 340' ' ' VAL . 54.7 Cg_endo -69.66 156.86 62.47 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.77 2.313 . . . . 73.22 112.37 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -7.32 20.73 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.678 2.252 . . . . 62.53 112.36 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 35.3 mtt85 -97.57 53.68 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 72.43 110.898 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 337' ' ' PRO . 7.0 m -150.53 135.56 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 72.34 111.088 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . 0.522 HG22 ' HA ' ' A' ' 386' ' ' HIS . 28.0 p -138.08 66.4 1.44 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 73.22 111.117 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 19.4 m -134.3 142.15 47.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 65.23 111.118 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -118.83 98.93 6.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 75.2 111.121 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.53 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -85.77 121.19 28.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.332 -0.394 . . . . 72.31 110.91 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.813 HG21 HD13 ' A' ' 406' ' ' LEU . 2.0 mp -118.29 118.79 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.086 -0.506 . . . . 72.1 111.131 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -104.64 164.88 14.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.76 -0.733 . . . . 62.23 112.504 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 0.2 OUTLIER 76.62 45.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 74.34 110.884 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.457 HG23 ' HD2' ' A' ' 349' ' ' PRO . 59.4 mt -99.58 133.32 21.94 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.653 0.74 . . . . 71.22 111.142 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . 0.777 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.7 Cg_endo -69.74 164.87 32.9 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.657 2.238 . . . . 73.53 112.329 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.32 -20.88 59.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 70.32 110.809 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.504 ' O ' ' CD2' ' A' ' 351' ' ' PHE . 25.0 p90 -97.25 29.48 3.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 61.03 110.885 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.777 ' HB2' ' HG2' ' A' ' 349' ' ' PRO . . . -114.36 90.84 3.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 41.44 111.17 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 19.7 p -87.83 170.77 10.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 72.34 111.101 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . 0.51 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -65.6 -31.94 73.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 73.51 110.888 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -53.49 -26.13 19.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 74.32 111.128 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.63 -13.18 13.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.273 -0.421 . . . . 71.35 110.866 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.752 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.3 mp -98.85 -55.86 2.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 51.35 110.952 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.633 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -39.74 -52.16 5.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.625 0.726 . . . . 70.44 111.106 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.5 Cg_endo -69.66 -35.58 12.66 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.711 2.274 . . . . 70.32 112.37 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.898 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -58.61 -23.55 59.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 63.2 110.927 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.692 ' CG ' HD13 ' A' ' 381' ' ' ILE . 84.9 m-85 -103.02 -35.25 8.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 73.33 110.873 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -54.14 -34.76 61.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 65.52 110.852 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -55.48 -13.47 1.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 72.31 110.954 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 392' ' ' CYS . 38.2 m-85 -81.3 -53.99 5.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 73.33 110.901 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -156.24 -95.35 0.11 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.807 -0.711 . . . . 32.11 112.557 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.43 ' CE2' ' HG ' ' A' ' 368' ' ' LEU . 58.8 t80 -143.81 143.97 31.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.818 0.342 . . . . 74.52 110.909 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . 0.437 HG12 ' CG2' ' A' ' 381' ' ' ILE . 71.6 mt -120.73 109.05 24.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 75.02 111.145 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.43 ' HG ' ' CE2' ' A' ' 366' ' ' PHE . 1.1 mp -87.64 -19.8 27.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 74.24 110.862 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.92 120.62 0.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 72.34 110.872 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 372' ' ' HIS . 35.1 t80 -112.47 143.0 44.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 63.45 110.888 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.27 101.28 5.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 75.45 110.895 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . 0.602 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 10.0 t-80 -99.66 136.01 40.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 63.43 110.884 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -128.19 90.03 48.35 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.73 0.776 . . . . 71.14 110.965 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' PRO . . . . . 0.402 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.9 Cg_endo -69.77 -21.85 32.85 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.791 2.327 . . . . 42.43 112.343 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.0 -33.33 65.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 72.12 110.887 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.08 -18.99 14.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 53.33 110.933 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 81.01 40.16 12.03 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.741 -0.742 . . . . 64.42 112.465 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.2 p -148.49 155.62 41.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.716 0.293 . . . . 73.31 110.976 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 18.6 p -149.78 158.08 43.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.429 . . . . 75.01 110.897 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.494 ' CE2' ' HB2' ' A' ' 344' ' ' TYR . 1.8 m-85 -136.24 132.5 35.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.922 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.692 HD13 ' CG ' ' A' ' 361' ' ' PHE . 0.9 OUTLIER -119.67 123.02 70.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 73.1 111.136 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.19 131.84 34.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 74.34 110.943 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.51 -179.63 3.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 70.34 110.93 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -80.65 -43.76 19.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.082 -0.508 . . . . 71.21 110.884 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 82.3 p -115.71 159.86 20.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 74.42 111.122 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' HIS . . . . . 0.522 ' HA ' HG22 ' A' ' 341' ' ' THR . 19.5 p-80 -69.44 -42.09 75.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 71.24 110.842 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . 0.435 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 2.2 tt0 -59.04 -29.83 67.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 52.21 110.876 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.53 -35.07 71.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.865 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -75.46 -24.83 57.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 65.12 111.136 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.813 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -72.39 -37.11 68.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 63.4 111.143 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.83 -56.62 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 60.24 111.085 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . 0.601 ' HB2' ' CE2' ' A' ' 364' ' ' PHE . 14.5 p -63.99 -32.77 74.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 73.34 110.845 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.968 HG21 HG21 ' A' ' 332' ' ' ILE . 1.7 mt -53.32 -54.12 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 45.22 111.122 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.82 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.5 OUTLIER -71.18 -34.14 53.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 53.43 111.136 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -69.41 -28.49 66.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 72.34 111.109 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.719 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.4 mm? -97.75 -17.86 19.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.276 -0.42 . . . . 63.21 110.945 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -47.97 114.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 74.2 111.073 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 38.0 t30 44.77 44.75 7.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.13 110.831 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.719 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -100.66 143.99 27.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.644 0.735 . . . . 73.53 110.861 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.405 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.4 Cg_endo -69.75 145.11 56.2 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.674 2.249 . . . . 71.55 112.284 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' PHE . . . . . 0.574 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 56.1 t80 -150.12 110.8 4.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 74.01 110.886 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 49.08 33.45 4.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 63.25 110.923 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 99.95 -28.21 16.68 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.726 -0.749 . . . . 71.31 112.458 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -105.01 141.06 37.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 70.01 110.852 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.429 ' O ' HD23 ' A' ' 406' ' ' LEU . 7.4 m120 -83.88 154.13 23.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 42.51 110.888 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.813 HD13 HG21 ' A' ' 345' ' ' ILE . 8.7 mt -116.4 174.08 6.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 74.52 110.973 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.82 176.85 5.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 73.51 110.886 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . 0.7 HG21 ' O ' ' A' ' 393' ' ' ILE . 23.5 p -151.67 151.28 31.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 54.13 111.109 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.409 0 C-N-CA 120.74 -0.743 . . . . 32.33 112.501 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.756 0.313 . . . . 74.5 110.89 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.24 -28.25 40.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 71.13 111.066 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' VAL . . . . . 0.97 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 16.0 t -71.1 -29.84 38.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 71.42 111.163 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -54.18 -35.44 62.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 73.32 110.892 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -69.34 -31.78 70.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 74.33 110.825 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.766 HG21 HD13 ' A' ' 393' ' ' ILE . 46.9 mm -54.79 -54.21 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 75.2 111.099 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.522 HG23 ' NE2' ' A' ' 386' ' ' HIS . 8.2 mt -52.36 -40.55 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 75.03 111.149 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -15.41 1.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 74.23 110.857 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . 0.555 ' O ' ' HB2' ' A' ' 336' ' ' ALA . 0.1 OUTLIER -101.45 41.69 1.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 75.52 110.897 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' A' ' 335' ' ' SER . . . 170.59 157.05 0.21 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.626 0.727 . . . . 70.44 111.048 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.626 ' O ' HG12 ' A' ' 340' ' ' VAL . 54.1 Cg_endo -69.79 153.78 68.4 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.649 2.233 . . . . 73.22 112.369 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -11.55 31.04 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.742 2.295 . . . . 62.53 112.304 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -100.82 66.0 1.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 72.43 110.812 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 337' ' ' PRO . 14.4 p -171.39 131.72 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 72.34 111.054 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 386' ' ' HIS . 22.0 p -137.0 68.53 1.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 73.22 111.11 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 87.5 m -133.59 111.7 10.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.445 . . . . 65.23 111.099 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -85.72 137.39 32.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 75.2 111.139 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.805 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -116.99 134.55 54.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.47 . . . . 72.31 110.882 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.805 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.8 mp -131.68 110.99 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 72.1 111.142 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -101.09 161.62 18.36 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.774 -0.727 . . . . 62.23 112.52 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 2.4 t30 78.95 49.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.794 0.33 . . . . 74.34 110.85 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.559 HG23 ' HD2' ' A' ' 349' ' ' PRO . 85.1 mt -103.69 135.83 19.3 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.662 0.744 . . . . 71.22 111.115 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . 0.559 ' HD2' HG23 ' A' ' 348' ' ' ILE . 53.8 Cg_endo -69.73 164.4 34.66 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.687 2.258 . . . . 73.53 112.41 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.62 -28.09 63.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 70.32 110.882 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -83.17 20.09 1.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 61.03 110.892 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.774 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -107.64 112.83 25.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 41.44 111.089 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 19.0 p -116.32 170.94 8.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 72.34 111.107 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . 0.498 ' O ' ' CG1' ' A' ' 358' ' ' ILE . 0.2 OUTLIER -66.23 -29.89 70.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 73.51 110.886 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.56 -26.64 63.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 74.32 111.168 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.48 -16.01 12.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 71.35 110.88 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.774 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.5 mp -93.5 -50.92 5.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 51.35 110.928 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.688 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.3 mm -44.0 -49.48 21.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.687 0.756 . . . . 70.44 111.171 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.0 Cg_endo -69.75 -27.84 26.02 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.255 . . . . 70.32 112.361 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.95 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -69.96 -26.95 64.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 63.2 110.907 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.789 ' HB2' HD11 ' A' ' 367' ' ' ILE . 85.6 m-85 -94.75 -36.39 11.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 73.33 110.844 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' GLN . . . . . 0.405 ' O ' ' N ' ' A' ' 364' ' ' PHE . 11.4 mm-40 -49.45 -46.81 48.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 65.52 110.886 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -42.5 -24.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 72.31 110.884 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . 0.405 ' N ' ' O ' ' A' ' 362' ' ' GLN . 28.6 m-85 -70.52 -59.77 2.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 73.33 110.904 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -155.1 -86.32 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.762 -0.732 . . . . 32.11 112.51 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -153.52 144.48 22.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 74.52 110.933 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . 0.789 HD11 ' HB2' ' A' ' 361' ' ' PHE . 17.3 mt -120.92 109.32 24.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 75.02 111.139 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.03 -20.02 27.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.476 . . . . 74.24 110.92 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.3 121.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 72.34 110.837 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 28.9 t80 -113.42 143.52 44.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 63.45 110.855 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.07 101.42 5.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.865 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 9.3 t-80 -97.27 115.13 27.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 63.43 110.811 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -108.04 86.09 2.98 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.685 0.755 . . . . 71.14 110.953 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' PRO . . . . . 0.489 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 53.7 Cg_endo -69.8 -17.27 37.48 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.671 2.247 . . . . 42.43 112.318 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -79.32 -23.76 43.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 72.12 110.903 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -108.41 -26.65 10.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 53.33 110.952 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.91 41.05 5.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.721 -0.752 . . . . 64.42 112.5 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 27.0 p -159.86 153.27 22.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.89 0.376 . . . . 73.31 110.819 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 29.0 p -138.53 145.32 40.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 75.01 110.886 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -119.85 129.42 54.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.895 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.511 ' CG1' ' CD1' ' A' ' 370' ' ' PHE . 1.0 OUTLIER -120.82 132.94 69.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 73.1 111.147 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -98.77 134.79 41.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 74.34 110.822 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -117.45 -179.46 3.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 70.34 110.893 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.23 -39.56 22.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 71.21 110.849 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 67.3 p -120.42 171.39 8.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.42 111.18 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' HIS . . . . . 0.522 ' NE2' HG23 ' A' ' 333' ' ' ILE . 4.4 t60 -83.65 -42.28 16.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 71.24 110.868 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.3 -28.72 63.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 52.21 110.841 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -36.51 82.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 75.42 110.947 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.545 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -73.9 -34.23 64.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 65.12 111.165 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.97 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -56.05 -34.41 65.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 63.4 111.071 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 95.9 t -71.4 -42.99 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 60.24 111.188 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 35.3 t -65.83 -34.17 77.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 73.34 110.905 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.766 HD13 HG21 ' A' ' 332' ' ' ILE . 1.1 mt -55.9 -56.01 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 45.22 111.159 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.491 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 1.8 t -72.04 -36.87 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 53.43 111.132 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.6 94.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 72.34 111.089 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.941 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.9 mm? -89.09 -18.56 27.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 63.21 110.917 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 398' ' ' ASN . . . -44.7 117.89 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 74.2 111.031 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 397' ' ' ALA . 4.6 p-10 34.5 42.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 73.13 110.936 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.941 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -97.38 148.0 33.79 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.664 0.745 . . . . 73.53 110.897 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 144.26 53.72 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.635 2.223 . . . . 71.55 112.399 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' PHE . . . . . 0.437 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 58.3 t80 -153.36 112.96 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 74.01 110.892 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 49.64 33.29 5.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 63.25 110.946 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 97.85 -27.66 17.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.735 -0.745 . . . . 71.31 112.453 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -106.06 142.22 36.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.819 0.342 . . . . 70.01 110.864 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -86.42 150.62 24.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 42.51 110.883 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.801 HD13 HG21 ' A' ' 345' ' ' ILE . 17.8 mt -112.06 -177.98 3.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 74.52 110.94 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 346' ' ' GLY . 8.3 ttt180 -125.87 177.29 6.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 73.51 110.943 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . 0.708 HG21 ' O ' ' A' ' 393' ' ' ILE . 16.7 p -153.59 157.91 40.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 54.13 111.102 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . 0.437 ' O ' ' CD1' ' A' ' 344' ' ' TYR . . . . . . . . 0 N--CA 1.452 -0.262 0 C-N-CA 120.674 -0.774 . . . . 32.33 112.448 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.783 0.325 . . . . 74.5 110.891 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.64 -24.6 34.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 71.13 111.058 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' VAL . . . . . 0.777 HG22 ' HB ' ' A' ' 394' ' ' VAL . 25.5 t -83.45 -29.73 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 71.42 111.175 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -54.57 -45.46 73.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.168 -0.469 . . . . 73.32 110.837 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' HIS . . . . . 0.41 ' O ' ' HG2' ' A' ' 334' ' ' ARG . 3.4 t60 -54.2 -31.9 54.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 74.33 110.916 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.431 HG13 HG21 ' A' ' 393' ' ' ILE . 26.6 mm -69.88 -49.52 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 75.2 111.172 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 54.2 mt -54.18 -39.52 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 75.03 111.184 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 331' ' ' HIS . 12.1 ptt180 -75.99 6.7 4.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.856 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 6.5 t -105.82 -13.2 15.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 75.52 110.914 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -150.19 150.51 29.66 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.641 0.734 . . . . 70.44 111.038 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 158.89 55.36 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.652 2.234 . . . . 73.22 112.322 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -28.84 24.78 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.692 2.261 . . . . 62.53 112.339 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.1 mtm105 -50.15 -40.66 47.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 72.43 110.879 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.7 p -95.17 134.32 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 72.34 111.107 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . 0.591 HG22 ' CA ' ' A' ' 386' ' ' HIS . 25.3 p -140.46 71.15 1.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 73.22 111.099 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 3.4 m -132.54 128.81 38.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 65.23 111.172 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -95.23 119.42 33.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 75.2 111.094 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.639 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -100.28 129.13 46.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 72.31 110.936 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.831 HG22 HD11 ' A' ' 348' ' ' ILE . 1.8 mp -122.59 126.19 73.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.071 -0.513 . . . . 72.1 111.143 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -112.88 168.89 12.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 62.23 112.463 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.475 ' O ' ' CD2' ' A' ' 406' ' ' LEU . 1.9 t30 70.68 53.23 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.706 0.288 . . . . 74.34 110.877 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.831 HD11 HG22 ' A' ' 345' ' ' ILE . 2.0 mp -102.4 132.39 21.46 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.643 0.735 . . . . 71.22 111.116 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . 0.711 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.7 Cg_endo -69.72 153.55 68.97 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.683 2.255 . . . . 73.53 112.379 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.03 -18.96 64.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 70.32 110.836 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.409 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 5.2 p90 -94.38 19.78 9.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 61.03 110.862 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.79 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -111.78 104.19 12.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 41.44 111.038 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 27.2 p -107.24 168.33 9.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 72.34 111.131 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . 0.514 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -59.59 -37.25 78.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 73.51 110.884 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -52.41 -26.11 11.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.32 111.067 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -112.14 -13.1 13.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 71.35 110.793 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.79 HD11 ' HB1' ' A' ' 352' ' ' ALA . 2.9 mp -99.25 -55.73 2.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 51.35 110.906 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.624 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -37.69 -52.44 2.67 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.619 0.723 . . . . 70.44 111.103 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.3 Cg_endo -69.76 -26.71 27.28 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.691 2.261 . . . . 70.32 112.352 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.953 ' O ' HD12 ' A' ' 360' ' ' LEU . 0.1 OUTLIER -70.07 -21.94 63.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 63.2 110.965 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.613 ' HB2' HD11 ' A' ' 367' ' ' ILE . 86.8 m-85 -101.11 -30.77 11.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 73.33 110.9 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -32.84 70.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 65.52 110.9 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -57.79 -16.42 11.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 72.31 110.882 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . 0.539 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 36.3 m-85 -75.74 -57.79 3.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 73.33 110.917 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -154.87 -82.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.743 . . . . 32.11 112.468 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.877 ' CD2' HD21 ' A' ' 368' ' ' LEU . 7.5 t80 -153.77 139.55 18.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.377 . . . . 74.52 110.904 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' A' ' 361' ' ' PHE . 13.1 mt -114.78 109.37 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.02 111.161 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.877 HD21 ' CD2' ' A' ' 366' ' ' PHE . 0.9 OUTLIER -89.74 -21.36 22.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 74.24 110.944 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -170.94 121.19 0.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 72.34 110.814 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 30.6 t80 -111.13 138.78 47.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 63.45 110.955 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.11 100.47 6.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 75.45 110.935 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . 0.478 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 10.4 t-80 -97.82 132.82 43.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 63.43 110.864 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -123.92 88.82 52.12 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.677 0.751 . . . . 71.14 110.881 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 -17.03 37.86 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.622 2.215 . . . . 42.43 112.449 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -83.73 -26.43 29.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 72.12 110.846 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -104.63 -26.65 12.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 53.33 110.881 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 87.22 38.97 7.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.822 -0.704 . . . . 64.42 112.501 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.4 p -153.0 151.41 30.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 73.31 110.9 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 28.8 p -142.19 141.44 32.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 75.01 110.861 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.521 ' CD2' ' HB2' ' A' ' 344' ' ' TYR . 15.4 m-85 -119.69 138.53 53.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 73.43 110.886 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.441 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.6 OUTLIER -127.18 128.06 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 73.1 111.093 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.49 137.18 32.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 74.34 110.886 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -120.24 156.05 31.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 70.34 110.889 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -53.15 -50.33 64.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.102 -0.499 . . . . 71.21 110.863 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 38.7 p -113.41 176.06 5.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.42 111.203 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' HIS . . . . . 0.591 ' CA ' HG22 ' A' ' 341' ' ' THR . 39.9 p-80 -83.88 -39.7 19.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 71.24 110.852 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 391' ' ' VAL . 0.1 OUTLIER -59.91 -28.82 67.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 52.21 110.836 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -34.98 79.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 75.42 110.924 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -74.94 -37.51 61.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 65.12 111.098 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.634 ' HB1' HG13 ' A' ' 329' ' ' VAL . . . -60.99 -32.07 71.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 63.4 111.052 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 387' ' ' GLU . 81.2 t -66.29 -39.16 83.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 60.24 111.111 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . 0.539 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 1.7 t -79.4 -25.42 42.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 73.34 110.851 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.73 ' O ' HG21 ' A' ' 408' ' ' THR . 0.3 OUTLIER -60.79 -55.5 24.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 45.22 111.149 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.777 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -69.74 -42.27 80.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 53.43 111.071 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . 0.483 ' N ' ' CG1' ' A' ' 394' ' ' VAL . . . -55.95 -45.75 78.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 72.34 111.14 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.736 HD13 ' CE1' ' A' ' 399' ' ' PHE . 0.5 OUTLIER -79.76 -19.27 49.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 63.21 110.939 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 394' ' ' VAL . . . -48.38 113.96 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 74.2 111.1 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 45.52 50.26 10.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 73.13 110.877 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.736 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -110.17 143.7 28.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.712 0.768 . . . . 73.53 110.935 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 133.76 26.39 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.683 2.255 . . . . 71.55 112.382 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' PHE . . . . . 0.611 ' CE1' HD22 ' A' ' 360' ' ' LEU . 36.0 t80 -137.34 111.3 8.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 74.01 110.864 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 48.7 32.81 3.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 63.25 110.873 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.34 -30.72 9.78 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 71.31 112.488 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 134.81 48.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.912 0.387 . . . . 70.01 110.875 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -74.83 154.39 38.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 42.51 110.799 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 345' ' ' ILE . 15.9 mt -117.66 171.05 8.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 74.52 110.898 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.02 177.0 4.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 73.51 110.843 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . 0.73 HG21 ' O ' ' A' ' 393' ' ' ILE . 6.9 p -152.7 152.17 31.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 54.13 111.181 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.695 -0.764 . . . . 32.33 112.427 179.954 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 120.79 0.329 . . . . 74.5 110.926 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -52.65 -28.75 22.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 71.13 111.141 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' VAL . . . . . 0.736 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 8.0 t -70.55 -29.87 40.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 71.42 111.087 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -54.21 -36.04 63.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.32 110.82 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -65.42 -31.87 73.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 74.33 110.884 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.475 HG21 HG21 ' A' ' 393' ' ' ILE . 38.7 mm -60.56 -49.01 86.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 75.2 111.185 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.469 ' CG1' ' HB2' ' A' ' 390' ' ' ALA . 19.6 mt -57.44 -32.63 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 75.03 111.055 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -5.74 13.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 74.23 110.814 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.95 7.91 44.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 75.52 110.882 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . -161.33 159.56 23.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 70.44 111.059 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.554 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 54.7 Cg_endo -69.71 154.07 68.38 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.672 2.248 . . . . 73.22 112.369 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -8.98 24.97 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.62 2.213 . . . . 62.53 112.388 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -47.07 15.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 72.43 110.882 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 8.3 p -73.18 132.86 32.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 72.34 111.134 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . 0.594 HG22 ' CB ' ' A' ' 386' ' ' HIS . 40.6 p -144.43 68.92 1.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 73.22 111.14 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 53.2 m -133.16 117.73 17.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 65.23 111.162 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -81.72 126.89 32.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 75.2 111.078 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.754 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -106.02 134.72 48.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 72.31 110.971 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.754 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.8 mp -130.4 121.2 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 72.1 111.12 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -108.53 167.45 13.17 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.796 -0.716 . . . . 62.23 112.49 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.488 ' O ' ' CD2' ' A' ' 406' ' ' LEU . 1.4 t30 69.55 57.34 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.776 0.322 . . . . 74.34 110.876 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.489 ' CG2' ' HB3' ' A' ' 352' ' ' ALA . 47.7 mt -107.94 131.16 21.93 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.631 0.729 . . . . 71.22 111.091 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . 0.432 ' CG ' ' CE1' ' A' ' 351' ' ' PHE . 53.9 Cg_endo -69.68 161.46 45.82 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.687 2.258 . . . . 73.53 112.384 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -64.2 -29.08 70.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 70.32 110.867 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.432 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 6.4 p90 -85.14 33.16 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 61.03 110.887 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.665 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -117.36 100.74 7.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 41.44 111.109 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 17.1 p -105.69 170.0 8.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 72.34 111.083 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . 0.512 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.28 -29.88 69.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 73.51 110.92 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.36 -26.31 63.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 74.32 111.102 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.15 -14.95 13.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 71.35 110.837 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.665 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.5 mp -97.24 -52.87 3.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.193 -0.458 . . . . 51.35 110.895 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.652 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -41.87 -50.89 10.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.622 0.725 . . . . 70.44 111.115 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.5 Cg_endo -69.83 -35.13 13.0 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.671 2.247 . . . . 70.32 112.339 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.929 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -59.73 -26.26 65.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 63.2 110.919 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.696 ' HB2' HD11 ' A' ' 367' ' ' ILE . 85.8 m-85 -96.73 -25.24 15.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.223 -0.444 . . . . 73.33 110.882 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 364' ' ' PHE . 5.4 mt-30 -60.45 -47.76 84.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 65.52 110.903 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -42.44 -23.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 72.31 110.918 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 362' ' ' GLN . 23.3 m-85 -71.46 -60.07 2.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 73.33 110.913 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . 0.415 ' HA3' ' CD ' ' A' ' 388' ' ' GLN . . . -150.7 -88.51 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.735 -0.745 . . . . 32.11 112.543 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.661 ' CE2' HD12 ' A' ' 368' ' ' LEU . 28.8 t80 -153.92 138.77 17.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.852 0.358 . . . . 74.52 110.893 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . 0.696 HD11 ' HB2' ' A' ' 361' ' ' PHE . 32.5 mt -120.43 116.87 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.477 . . . . 75.02 111.124 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.73 ' N ' HD13 ' A' ' 368' ' ' LEU . 0.0 OUTLIER -104.42 -16.2 15.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 74.24 110.877 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.569 ' N ' HD22 ' A' ' 368' ' ' LEU . 3.7 m-20 -159.86 121.05 3.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 72.34 110.9 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 31.0 t80 -123.21 142.66 50.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 63.45 110.895 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -129.56 101.1 5.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 75.45 110.907 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . 0.602 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 11.2 t-80 -97.43 136.61 37.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 63.43 110.879 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -130.76 89.32 43.61 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.695 0.759 . . . . 71.14 110.893 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' PRO . . . . . 0.546 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 54.0 Cg_endo -69.77 -29.78 23.3 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.627 2.218 . . . . 42.43 112.364 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.1 -14.04 62.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 72.12 110.873 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -119.81 -24.38 6.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 53.33 110.869 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 80.34 44.35 8.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 64.42 112.434 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.2 p -156.83 137.81 13.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.825 0.345 . . . . 73.31 110.887 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 14.6 p -129.79 156.97 43.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 75.01 110.909 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -136.98 128.49 28.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.26 -0.427 . . . . 73.43 110.921 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.494 ' CG2' HG23 ' A' ' 367' ' ' ILE . 0.7 OUTLIER -117.83 131.34 70.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 73.1 111.155 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . 0.59 ' HB3' HD21 ' A' ' 368' ' ' LEU . 0.0 OUTLIER -98.72 137.23 37.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 74.34 110.907 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -120.88 173.52 7.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 70.34 110.913 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.56 -26.02 35.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 71.21 110.894 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 41.7 p -129.31 162.48 27.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 74.42 111.083 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' HIS . . . . . 0.594 ' CB ' HG22 ' A' ' 341' ' ' THR . 26.3 p-80 -86.78 -33.7 19.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 71.24 110.865 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -60.8 -44.57 96.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 52.21 110.912 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.415 ' CD ' ' HA3' ' A' ' 365' ' ' GLY . 2.2 tt0 -60.36 -35.29 75.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 75.42 110.964 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -68.57 -44.06 75.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 65.12 111.067 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.736 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -50.1 -25.59 3.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 63.4 111.14 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 65.0 t -69.54 -49.76 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 60.24 111.164 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 30.7 t -57.51 -31.57 66.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 73.34 110.893 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.633 HD13 ' HA ' ' A' ' 390' ' ' ALA . 1.0 OUTLIER -56.65 -56.33 14.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.447 . . . . 45.22 111.097 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.507 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.2 t -72.07 -35.21 52.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 53.43 111.056 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.71 95.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 72.34 111.061 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.703 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.5 mm? -93.63 -10.6 34.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.306 -0.407 . . . . 63.21 110.976 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' ALA . . . . . 0.668 ' N ' HG21 ' A' ' 408' ' ' THR . . . -51.8 110.12 0.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 74.2 111.102 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 57.6 t30 43.02 48.07 5.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 73.13 110.874 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.703 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -104.53 147.32 34.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.721 0.772 . . . . 73.53 110.848 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.429 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 54.6 Cg_endo -69.68 141.55 45.84 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.669 2.246 . . . . 71.55 112.339 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' PHE . . . . . 0.504 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 36.4 t80 -147.58 111.22 4.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 74.01 110.815 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 49.01 38.65 13.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 63.25 110.913 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 93.96 -29.07 9.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 71.31 112.409 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.4 OUTLIER -105.93 140.07 39.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.783 0.325 . . . . 70.01 110.97 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.438 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 9.0 m120 -81.62 154.63 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 42.51 110.875 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.646 HD13 HG21 ' A' ' 345' ' ' ILE . 13.3 mt -115.86 172.95 6.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 74.52 110.974 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -113.5 173.24 6.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 73.51 110.897 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . 0.668 HG21 ' N ' ' A' ' 397' ' ' ALA . 71.0 p -154.18 151.55 29.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 54.13 111.118 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.236 0 C-N-CA 120.748 -0.739 . . . . 32.33 112.489 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.719 0.295 . . . . 74.5 110.905 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -57.14 -24.64 55.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 71.13 111.112 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' VAL . . . . . 0.891 HG22 ' HB ' ' A' ' 394' ' ' VAL . 11.4 t -77.16 -30.1 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 71.42 111.154 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.649 ' HA ' HD12 ' A' ' 333' ' ' ILE . 21.7 t0 -55.0 -41.67 71.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 73.32 110.842 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -55.86 -35.48 66.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.857 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.765 HG21 HG21 ' A' ' 393' ' ' ILE . 39.1 mm -63.67 -49.67 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 75.2 111.108 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.649 HD12 ' HA ' ' A' ' 330' ' ' ASP . 13.3 mt -51.49 -50.06 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 75.03 111.126 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.28 -8.75 6.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 74.23 110.92 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 2.2 t -96.98 25.57 5.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 75.52 110.839 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -173.95 154.75 2.29 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.725 . . . . 70.44 111.082 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.409 ' HG2' HG12 ' A' ' 340' ' ' VAL . 53.6 Cg_endo -69.82 150.76 68.31 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 73.22 112.369 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . 0.412 ' HA ' ' ND1' ' A' ' 386' ' ' HIS . 54.4 Cg_endo -69.67 -12.11 32.37 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.669 2.246 . . . . 62.53 112.42 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -78.4 -53.39 7.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.832 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.409 HG12 ' HG2' ' A' ' 337' ' ' PRO . 4.1 p -69.34 135.19 28.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 72.34 111.13 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . 0.438 HG22 ' CA ' ' A' ' 386' ' ' HIS . 44.6 p -142.69 68.19 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 73.22 111.113 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 3.4 m -133.75 128.93 35.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 65.23 111.183 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -92.91 134.31 35.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 75.2 111.133 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.518 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -112.69 128.57 56.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 72.31 110.918 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.623 HG22 HD11 ' A' ' 348' ' ' ILE . 1.6 mp -124.94 110.05 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 72.1 111.139 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -101.86 161.4 17.63 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 62.23 112.535 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 405' ' ' ASN . 0.7 OUTLIER 81.14 50.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 74.34 110.864 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.68 HG23 ' HD2' ' A' ' 349' ' ' PRO . 74.2 mt -107.06 138.68 19.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.607 0.718 . . . . 71.22 111.118 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . 0.68 ' HD2' HG23 ' A' ' 348' ' ' ILE . 54.2 Cg_endo -69.72 166.23 28.24 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.695 2.263 . . . . 73.53 112.364 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -76.34 -15.67 59.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 70.32 110.839 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.558 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 47.8 p90 -100.44 29.31 4.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 61.03 110.85 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.776 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -114.54 99.86 7.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 41.44 111.081 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 10.1 p -96.54 171.08 8.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 72.34 111.056 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . 0.516 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.32 -30.4 70.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 73.51 110.843 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -55.1 -26.41 37.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 74.32 111.12 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.3 -12.96 13.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 71.35 110.822 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.776 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.4 mp -98.58 -54.46 3.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 51.35 110.953 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.639 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 0.9 OUTLIER -40.71 -51.5 6.87 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.631 0.729 . . . . 70.44 111.139 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.5 Cg_endo -69.8 -34.36 14.6 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.7 2.267 . . . . 70.32 112.308 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.912 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -59.65 -25.07 64.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 63.2 110.904 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.679 ' CG ' HD13 ' A' ' 381' ' ' ILE . 87.6 m-85 -98.01 -37.33 9.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.885 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' GLN . . . . . 0.654 ' HG2' HD12 ' A' ' 367' ' ' ILE . 6.3 mm-40 -50.66 -45.02 57.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 65.52 110.863 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -44.95 -21.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 72.31 110.879 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . 0.459 ' CE2' ' HA ' ' A' ' 361' ' ' PHE . 30.9 m-85 -75.3 -56.86 4.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 73.33 110.925 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -152.89 -90.26 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 32.11 112.477 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -153.8 142.87 21.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.757 0.313 . . . . 74.52 110.84 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . 0.667 HD11 ' HB2' ' A' ' 361' ' ' PHE . 59.1 mt -120.95 109.13 24.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.168 -0.469 . . . . 75.02 111.129 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.64 -16.81 35.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 74.24 110.876 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.93 120.74 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 72.34 110.881 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.583 ' CD1' HG12 ' A' ' 381' ' ' ILE . 35.9 t80 -114.13 144.81 42.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 63.45 110.898 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.52 100.09 5.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 75.45 110.875 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . 0.591 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 4.0 t-80 -103.13 131.91 49.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 63.43 110.835 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.456 ' CB ' ' HB2' ' A' ' 376' ' ' LYS . 96.6 m-85 -128.73 102.19 20.01 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.639 0.733 . . . . 71.14 110.904 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 373' ' ' TYR . 53.5 Cg_endo -69.76 -25.13 28.93 Favored 'Trans proline' 0 N--CA 1.466 -0.114 0 C-N-CA 122.711 2.274 . . . . 42.43 112.344 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' GLU . . . . . 0.415 ' C ' ' HD2' ' A' ' 376' ' ' LYS . 8.7 pt-20 -87.57 -8.77 55.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 72.12 110.897 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' LYS . . . . . 0.456 ' HB2' ' CB ' ' A' ' 373' ' ' TYR . 0.0 OUTLIER -106.5 -28.13 10.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 53.33 110.862 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 80.61 24.32 58.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 64.42 112.461 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 92.1 m -155.22 149.8 26.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.776 0.322 . . . . 73.31 110.867 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 14.9 p -133.8 151.27 51.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 75.01 110.874 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 380' ' ' PHE . 3.5 m-85 -124.35 127.72 48.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.864 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.679 HD13 ' CG ' ' A' ' 361' ' ' PHE . 1.3 mt -119.24 121.35 66.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.516 . . . . 73.1 111.041 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.37 130.01 34.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 74.34 110.891 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -115.11 -174.89 2.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 70.34 110.906 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -73.61 -54.93 7.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.061 -0.518 . . . . 71.21 110.943 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 71.1 p -120.2 178.78 4.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 74.42 111.181 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' HIS . . . . . 0.438 ' CA ' HG22 ' A' ' 341' ' ' THR . 21.2 p-80 -83.65 -39.43 20.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 71.24 110.857 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -57.35 -28.82 63.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.425 . . . . 52.21 110.877 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -46.09 78.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 75.42 110.943 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.658 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -62.79 -25.71 68.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.235 -0.439 . . . . 65.12 111.121 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.811 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -58.27 -40.12 81.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 63.4 111.134 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 14.1 t -61.92 -57.9 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 60.24 111.081 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 18.4 p -58.91 -31.34 68.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 73.34 110.895 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.765 HG21 HG21 ' A' ' 332' ' ' ILE . 0.4 OUTLIER -58.97 -55.38 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 45.22 111.087 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.891 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -72.25 -35.74 53.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 53.43 111.187 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.57 -47.81 82.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 72.34 111.095 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.635 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.2 mm? -79.83 -13.42 59.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.258 -0.428 . . . . 63.21 110.913 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -50.33 112.91 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 74.2 111.096 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.2 m120 44.13 51.49 7.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 73.13 110.835 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.635 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -108.0 147.94 36.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.689 0.757 . . . . 73.53 110.865 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.424 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.3 Cg_endo -69.71 145.16 56.58 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.706 2.271 . . . . 71.55 112.324 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' PHE . . . . . 0.571 ' CZ ' ' NE2' ' A' ' 402' ' ' GLN . 40.0 t80 -151.85 111.49 3.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 74.01 110.856 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.571 ' NE2' ' CZ ' ' A' ' 401' ' ' PHE . 4.9 mt-30 46.7 38.63 6.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 63.25 110.893 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 94.57 -29.99 8.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.735 . . . . 71.31 112.539 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -104.91 137.62 42.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 70.01 110.83 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.477 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 4.6 m120 -80.04 152.75 29.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 42.51 110.895 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.405 ' CD2' ' O ' ' A' ' 347' ' ' ASN . 13.9 mt -114.58 173.57 6.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 74.52 110.944 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 346' ' ' GLY . 5.5 ttm-85 -117.63 175.36 5.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 73.51 110.88 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . 0.593 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 43.0 p -151.63 153.45 34.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 54.13 111.122 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.665 -0.779 . . . . 32.33 112.412 -179.963 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.734 0.302 . . . . 74.5 110.898 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -51.05 -33.73 26.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.424 . . . . 71.13 111.11 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' VAL . . . . . 0.937 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 7.9 t -70.27 -28.66 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 71.42 111.113 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -53.11 -37.45 61.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 73.32 110.867 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -71.65 -31.81 67.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 74.33 110.805 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.918 HG21 HG21 ' A' ' 393' ' ' ILE . 33.5 mm -54.59 -56.07 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 75.2 111.141 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 4.3 mt -49.72 -39.24 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 75.03 111.163 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -27.35 31.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 74.23 110.828 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 4.8 t -68.47 -32.1 71.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 75.52 110.858 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.419 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . -113.93 155.43 45.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.606 0.717 . . . . 70.44 111.061 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 54.5 Cg_endo -69.73 161.79 44.57 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.654 2.236 . . . . 73.22 112.425 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.8 -11.47 30.86 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.667 2.245 . . . . 62.53 112.304 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -106.61 67.33 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 72.43 110.883 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 5.3 p 177.14 134.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 72.34 111.147 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 19.9 p -141.55 69.99 1.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.193 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 23.7 m -133.61 121.71 22.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 65.23 111.2 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -88.33 134.33 33.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 75.2 111.15 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.605 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -111.2 121.65 45.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.289 -0.414 . . . . 72.31 110.942 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.539 HG23 ' HB3' ' A' ' 406' ' ' LEU . 2.3 mp -124.31 102.19 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 72.1 111.14 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.443 ' H ' ' CB ' ' A' ' 407' ' ' ARG . . . -92.28 -173.19 41.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.69 -0.767 . . . . 62.23 112.519 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.9 t30 58.76 46.66 13.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 74.34 110.901 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.568 ' CG2' ' HB3' ' A' ' 352' ' ' ALA . 81.6 mt -100.08 131.38 24.37 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.529 0.68 . . . . 71.22 111.164 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . 0.523 ' CB ' ' CE1' ' A' ' 351' ' ' PHE . 53.9 Cg_endo -69.71 156.22 64.03 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.736 2.29 . . . . 73.53 112.372 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.7 -20.83 65.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 70.32 110.827 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.523 ' CE1' ' CB ' ' A' ' 349' ' ' PRO . 4.8 p90 -94.01 29.35 2.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 61.03 110.929 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.847 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -116.0 96.14 5.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 41.44 111.109 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 15.2 p -98.39 170.69 8.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 72.34 111.161 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . 0.521 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.6 OUTLIER -67.31 -29.72 69.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 73.51 110.843 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.67 -26.21 63.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 74.32 111.084 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.3 -14.1 13.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 71.35 110.844 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.847 HD11 ' HB1' ' A' ' 352' ' ' ALA . 2.8 mp -97.78 -52.14 3.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 51.35 110.901 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.668 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -42.52 -50.32 12.34 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.627 0.727 . . . . 70.44 111.137 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 52.9 Cg_endo -69.78 -29.09 24.33 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.684 2.256 . . . . 70.32 112.313 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.849 HD13 ' C ' ' A' ' 360' ' ' LEU . 0.2 OUTLIER -66.97 -21.83 65.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 63.2 110.924 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.599 ' HB2' HD11 ' A' ' 367' ' ' ILE . 87.8 m-85 -103.32 -36.04 8.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 73.33 110.891 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -49.14 -40.27 31.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 65.52 110.853 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -48.86 -27.84 3.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 72.31 110.928 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . 0.557 ' CE1' ' HA ' ' A' ' 392' ' ' CYS . 39.7 m-85 -64.19 -56.88 11.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 73.33 110.902 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -158.98 -84.69 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.786 -0.721 . . . . 32.11 112.537 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -153.24 145.45 23.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.799 0.333 . . . . 74.52 110.893 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . 0.599 HD11 ' HB2' ' A' ' 361' ' ' PHE . 27.6 mt -121.1 111.31 31.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 75.02 111.165 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.86 -23.18 25.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 74.24 110.934 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.16 120.67 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 72.34 110.944 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.525 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 32.8 t80 -112.34 140.96 46.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 63.45 110.845 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.11 101.21 6.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 75.45 110.909 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.3 t-80 -97.43 124.07 41.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 63.43 110.795 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -118.02 89.01 33.37 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.698 0.761 . . . . 71.14 110.911 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' PRO . . . . . 0.417 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.4 Cg_endo -69.78 -26.16 27.76 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.648 2.232 . . . . 42.43 112.325 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -72.75 -12.7 61.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 72.12 110.829 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -119.75 -26.43 5.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 53.33 110.916 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 86.55 41.52 6.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.738 -0.744 . . . . 64.42 112.491 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.5 t -159.99 147.74 16.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.745 0.307 . . . . 73.31 110.863 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.525 ' HB2' ' CE1' ' A' ' 370' ' ' PHE . 21.5 p -134.18 155.13 50.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 75.01 110.824 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -128.95 122.79 30.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 73.43 110.887 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.521 HD13 ' CG ' ' A' ' 361' ' ' PHE . 1.1 mt -114.17 134.05 58.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 73.1 111.113 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.37 131.76 48.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 74.34 110.863 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -112.75 -173.83 2.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 70.34 110.931 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.62 -39.03 16.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 71.21 110.873 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 54.7 p -120.82 174.35 6.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 74.42 111.139 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -87.17 -32.13 20.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 71.24 110.88 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -61.16 -41.92 97.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 52.21 110.849 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.93 -35.79 67.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 75.42 110.892 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.39 -26.12 60.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.227 -0.442 . . . . 65.12 111.13 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.937 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -68.56 -40.42 80.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 63.4 111.072 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.73 -55.2 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 60.24 111.141 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . 0.557 ' HA ' ' CE1' ' A' ' 364' ' ' PHE . 16.7 p -57.15 -29.69 63.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.485 . . . . 73.34 110.858 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.918 HG21 HG21 ' A' ' 332' ' ' ILE . 8.6 mt -60.03 -55.42 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 45.22 111.134 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.5 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 1.7 t -72.04 -34.43 50.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 53.43 111.132 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -63.77 -47.86 79.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 72.34 111.08 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.711 HD13 ' CE1' ' A' ' 399' ' ' PHE . 0.3 OUTLIER -82.14 -6.38 59.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 63.21 110.899 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' ALA . . . . . 0.701 ' N ' HG21 ' A' ' 408' ' ' THR . . . -54.89 112.79 1.12 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.204 -0.453 . . . . 74.2 111.118 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 44.79 46.29 8.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 73.13 110.946 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.711 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -99.29 145.55 30.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.634 0.73 . . . . 73.53 110.85 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 141.91 46.22 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.714 2.276 . . . . 71.55 112.358 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' PHE . . . . . 0.461 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 48.2 t80 -151.01 112.86 4.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 74.01 110.871 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 52.97 32.74 13.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 63.25 110.917 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 96.63 -26.61 21.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.69 -0.767 . . . . 71.31 112.448 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 401' ' ' PHE . 9.9 ttt85 -108.57 143.61 37.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.827 0.346 . . . . 70.01 110.917 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -80.81 155.17 26.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 42.51 110.933 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.539 ' HB3' HG23 ' A' ' 345' ' ' ILE . 10.4 mt -114.77 175.13 5.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 74.52 110.899 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' ARG . . . . . 0.443 ' CB ' ' H ' ' A' ' 346' ' ' GLY . 1.0 OUTLIER -109.02 176.21 5.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 73.51 110.902 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . 0.701 HG21 ' N ' ' A' ' 397' ' ' ALA . 45.0 p -154.06 149.82 27.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 54.13 111.147 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.72 . . . . 32.33 112.506 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.732 0.301 . . . . 74.5 110.899 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -58.63 -25.49 62.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 71.13 111.065 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' VAL . . . . . 0.925 HG22 ' HB ' ' A' ' 394' ' ' VAL . 24.6 t -78.21 -29.98 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.434 . . . . 71.42 111.187 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.445 ' HA ' HD12 ' A' ' 333' ' ' ILE . 21.3 t70 -54.71 -35.64 63.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.877 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' HIS . . . . . 0.521 ' CD2' HD12 ' A' ' 332' ' ' ILE . 2.2 t60 -61.69 -38.27 87.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 74.33 110.884 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.611 ' CG1' HG21 ' A' ' 393' ' ' ILE . 1.1 mp -54.21 -51.42 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 75.2 111.096 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 330' ' ' ASP . 9.0 mt -53.67 -38.38 34.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 75.03 111.121 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -2.45 6.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.23 110.872 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 43.2 t -108.92 21.76 16.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 75.52 110.829 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -175.9 150.88 1.14 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.586 0.707 . . . . 70.44 111.083 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 154.28 67.65 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.629 2.219 . . . . 73.22 112.323 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -8.05 22.6 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.678 2.252 . . . . 62.53 112.351 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.08 -49.72 13.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 72.43 110.876 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.75 133.05 32.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 72.34 111.146 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . 0.632 HG22 ' CA ' ' A' ' 386' ' ' HIS . 30.2 p -135.7 68.02 1.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.117 -0.492 . . . . 73.22 111.184 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 51.2 m -133.72 136.99 45.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 65.23 111.154 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . 0.446 ' CB ' ' SG ' ' A' ' 392' ' ' CYS . . . -109.18 129.54 55.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 75.2 111.088 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.711 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -105.95 134.44 49.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 72.31 110.899 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.711 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.9 mp -129.61 100.7 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 72.1 111.171 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -90.07 178.61 43.56 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.713 -0.756 . . . . 62.23 112.488 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 405' ' ' ASN . 2.3 t30 67.64 49.23 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 74.34 110.899 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.675 HG23 ' HD2' ' A' ' 349' ' ' PRO . 77.4 mt -105.11 138.51 19.54 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.618 0.723 . . . . 71.22 111.156 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . 0.675 ' HD2' HG23 ' A' ' 348' ' ' ILE . 53.7 Cg_endo -69.75 164.04 36.03 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.708 2.272 . . . . 73.53 112.361 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -75.57 -18.64 59.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 70.32 110.817 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.563 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 55.4 p90 -92.88 17.65 10.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 61.03 110.9 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.808 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -105.8 116.04 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 41.44 111.159 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 25.6 p -114.96 170.42 8.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 72.34 111.192 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . 0.507 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -64.82 -29.77 70.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 73.51 110.935 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.48 -26.59 63.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 74.32 111.108 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.27 -13.6 13.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 71.35 110.954 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.808 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.5 mp -98.47 -52.27 3.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 51.35 110.899 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.649 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -41.83 -51.07 9.95 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.639 0.733 . . . . 70.44 111.066 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.1 Cg_endo -69.79 -35.37 12.69 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.699 2.266 . . . . 70.32 112.388 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.921 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -59.45 -23.47 62.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 63.2 110.922 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.543 ' N ' HD13 ' A' ' 360' ' ' LEU . 82.8 m-85 -100.97 -35.6 9.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 73.33 110.877 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' GLN . . . . . 0.478 ' HG3' HD12 ' A' ' 367' ' ' ILE . 2.3 mt-30 -53.34 -35.41 60.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 65.52 110.934 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -54.11 -14.88 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 72.31 110.875 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -78.62 -56.78 4.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 73.33 110.862 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -157.09 -85.99 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 32.11 112.453 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.693 ' CD2' HD21 ' A' ' 368' ' ' LEU . 8.4 t80 -153.64 142.82 21.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 74.52 110.881 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . 0.478 HD12 ' HG3' ' A' ' 362' ' ' GLN . 50.3 mt -120.87 112.3 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 75.02 111.156 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.693 HD21 ' CD2' ' A' ' 366' ' ' PHE . 0.3 OUTLIER -86.01 -21.82 27.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 74.24 110.889 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.94 121.2 0.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 72.34 110.88 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 33.5 t80 -111.11 139.77 46.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 63.45 110.891 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -126.82 100.93 6.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 75.45 110.95 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . 0.588 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 11.0 t-80 -96.37 115.71 27.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 63.43 110.793 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -107.25 84.58 1.77 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.744 . . . . 71.14 110.874 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' PRO . . . . . 0.503 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 53.9 Cg_endo -69.73 -17.38 37.72 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.701 2.267 . . . . 42.43 112.411 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -78.24 -24.67 46.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 72.12 110.908 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -108.7 -27.41 9.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 53.33 110.948 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 93.4 42.29 4.29 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.676 -0.774 . . . . 64.42 112.452 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 26.3 p -159.92 158.18 30.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.837 0.351 . . . . 73.31 110.942 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.564 ' HB2' ' CE1' ' A' ' 370' ' ' PHE . 28.1 p -143.35 152.32 41.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 75.01 110.872 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.428 ' CE2' ' HB2' ' A' ' 344' ' ' TYR . 38.0 m-85 -125.8 125.03 42.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 73.43 110.827 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.443 HG22 HG23 ' A' ' 367' ' ' ILE . 0.7 OUTLIER -115.28 121.25 66.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 73.1 111.139 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -87.94 131.95 34.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 74.34 110.919 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -116.43 162.7 17.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 70.34 110.889 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -60.99 -45.55 94.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 71.21 110.873 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 30.2 p -112.92 169.02 9.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 74.42 111.143 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' HIS . . . . . 0.632 ' CA ' HG22 ' A' ' 341' ' ' THR . 18.0 p-80 -82.62 -36.14 26.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 71.24 110.891 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 391' ' ' VAL . 5.0 tm-20 -62.73 -26.81 68.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.181 -0.463 . . . . 52.21 110.896 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -34.96 79.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 75.42 110.868 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.66 -41.26 62.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 65.12 111.05 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -58.87 -26.36 64.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 63.4 111.121 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 387' ' ' GLU . 79.7 t -71.36 -55.76 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 60.24 111.145 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 343' ' ' ALA . 30.3 p -60.64 -32.05 71.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.913 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.611 HG21 ' CG1' ' A' ' 332' ' ' ILE . 0.2 OUTLIER -53.54 -54.98 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 45.22 111.092 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.925 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.7 -38.91 68.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 53.43 111.139 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . 0.415 ' N ' ' CG1' ' A' ' 394' ' ' VAL . . . -62.03 -33.91 75.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 72.34 111.116 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.7 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.6 mm? -93.61 -15.08 25.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 63.21 110.925 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' ALA . . . . . 0.609 ' N ' HG21 ' A' ' 408' ' ' THR . . . -47.39 111.47 0.42 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 74.2 111.065 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 43.14 47.43 5.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 73.13 110.944 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.7 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -100.88 146.28 31.85 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.661 0.744 . . . . 73.53 110.841 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.441 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 54.2 Cg_endo -69.76 137.05 34.57 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.717 2.278 . . . . 71.55 112.339 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' PHE . . . . . 0.571 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 29.9 t80 -142.64 111.13 6.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 74.01 110.967 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 48.98 34.5 5.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 63.25 110.935 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 99.28 -31.99 7.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.741 -0.743 . . . . 71.31 112.454 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.8 134.71 47.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 70.01 110.859 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.474 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 3.1 m120 -78.2 152.25 32.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 42.51 110.892 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.453 ' HB3' HG23 ' A' ' 345' ' ' ILE . 10.8 mt -111.62 177.5 4.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 74.52 110.872 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.77 172.26 7.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 73.51 110.85 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . 0.609 HG21 ' N ' ' A' ' 397' ' ' ALA . 45.8 p -154.77 146.09 22.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 54.13 111.18 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 32.33 112.512 179.894 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.839 0.352 . . . . 74.5 110.913 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.06 -33.78 63.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 71.13 111.145 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' VAL . . . . . 0.889 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 10.7 t -66.78 -29.88 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.178 -0.464 . . . . 71.42 111.156 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.505 ' HA ' HD12 ' A' ' 333' ' ' ILE . 7.1 t70 -54.11 -34.74 61.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 73.32 110.912 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -70.69 -31.99 69.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.446 . . . . 74.33 110.86 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.907 HG21 HG21 ' A' ' 393' ' ' ILE . 29.4 mm -57.98 -44.9 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 75.2 111.093 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 330' ' ' ASP . 6.0 mt -53.66 -44.39 57.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 75.03 111.181 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 -56.08 -13.85 2.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 74.23 110.93 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 11.7 t -76.32 -30.56 57.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 75.52 110.9 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.752 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . -133.78 165.34 37.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.554 0.693 . . . . 70.44 111.114 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.752 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 53.8 Cg_endo -69.75 148.75 65.85 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.675 2.25 . . . . 73.22 112.342 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -7.64 21.58 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.716 2.278 . . . . 62.53 112.313 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -43.8 40.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.224 -0.444 . . . . 72.43 110.806 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.1 p -81.6 139.73 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 72.34 111.077 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . 0.488 HG22 ' CA ' ' A' ' 386' ' ' HIS . 34.7 p -138.46 69.09 1.38 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 73.22 111.171 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.476 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 98.6 m -133.59 124.96 27.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 65.23 111.088 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -85.6 126.47 33.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 75.2 111.064 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.818 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -106.4 134.29 49.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 72.31 110.907 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.818 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.8 mp -135.41 110.97 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 72.1 111.126 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -100.03 161.08 19.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.696 -0.764 . . . . 62.23 112.419 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 1.0 OUTLIER 81.09 50.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.775 0.321 . . . . 74.34 110.882 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.647 HG23 ' HD2' ' A' ' 349' ' ' PRO . 46.5 mt -104.1 138.2 19.46 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.619 0.723 . . . . 71.22 111.149 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . 0.843 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.3 Cg_endo -69.78 166.48 27.47 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.732 2.288 . . . . 73.53 112.308 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -74.24 -29.66 61.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 70.32 110.884 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -83.5 12.87 5.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 61.03 110.908 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.843 ' HB2' ' HG2' ' A' ' 349' ' ' PRO . . . -99.15 102.59 14.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 41.44 111.122 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 22.3 p -105.02 172.0 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 72.34 111.112 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . 0.505 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.3 OUTLIER -65.6 -30.25 70.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 73.51 110.845 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -57.25 -26.29 60.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 74.32 111.095 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.89 -18.68 12.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 71.35 110.868 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.839 HD11 ' HB1' ' A' ' 352' ' ' ALA . 4.6 mp -92.68 -52.51 4.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 51.35 110.957 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.656 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -41.76 -51.1 9.74 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.609 0.718 . . . . 70.44 111.122 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.8 Cg_endo -69.7 -30.15 23.01 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.669 2.246 . . . . 70.32 112.353 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.925 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -66.46 -23.96 66.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 63.2 110.912 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.564 ' CE2' HD12 ' A' ' 360' ' ' LEU . 81.3 m-85 -101.45 -27.43 13.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 73.33 110.919 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' GLN . . . . . 0.539 ' N ' HD11 ' A' ' 367' ' ' ILE . 0.0 OUTLIER -56.57 -22.93 36.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 65.52 110.852 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -71.29 -10.38 59.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 72.31 110.89 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . 0.435 ' HE2' ' HG ' ' A' ' 392' ' ' CYS . 23.6 m-85 -93.17 18.59 9.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.911 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 130.07 -96.02 0.36 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 32.11 112.506 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -152.55 150.8 29.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.767 0.318 . . . . 74.52 110.943 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . 0.539 HD11 ' N ' ' A' ' 362' ' ' GLN . 45.8 mt -121.42 109.86 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 75.02 111.149 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.75 -18.71 28.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 74.24 110.922 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.27 120.8 0.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 72.34 110.906 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 29.4 t80 -112.36 145.4 40.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 63.45 110.902 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.82 101.16 4.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.469 . . . . 75.45 110.848 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . 0.594 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 12.9 t-80 -94.99 117.35 29.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 63.43 110.846 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -109.7 83.64 2.84 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.657 0.741 . . . . 71.14 110.846 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' PRO . . . . . 0.496 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 52.7 Cg_endo -69.86 -17.97 36.81 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.691 2.261 . . . . 42.43 112.304 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.28 -27.19 61.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 72.12 110.862 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -110.52 -27.29 9.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 53.33 110.856 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 94.25 43.51 3.74 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 64.42 112.476 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 79.7 m -154.8 152.93 30.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.827 0.346 . . . . 73.31 110.918 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 16.0 p -136.21 152.49 50.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 75.01 110.879 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.476 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 48.6 m-85 -129.02 124.79 35.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.43 110.869 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.508 ' CG2' HG23 ' A' ' 367' ' ' ILE . 0.7 OUTLIER -117.35 123.28 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 73.1 111.172 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -89.55 136.19 33.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 74.34 110.886 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -119.63 -178.63 3.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 70.34 110.925 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.75 -42.57 40.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.496 . . . . 71.21 110.874 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 55.4 p -127.97 170.3 13.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 74.42 111.104 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' HIS . . . . . 0.488 ' CA ' HG22 ' A' ' 341' ' ' THR . 29.3 p-80 -80.41 -35.31 35.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 71.24 110.823 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -59.42 -27.18 65.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 52.21 110.938 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.84 -34.28 62.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 75.42 110.879 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.404 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -69.04 -44.09 73.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 65.12 111.081 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.889 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -50.22 -28.85 8.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 63.4 111.082 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.57 -40.07 79.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 60.24 111.156 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . 0.435 ' HG ' ' HE2' ' A' ' 364' ' ' PHE . 45.4 t -69.93 -33.61 72.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 73.34 110.892 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.907 HG21 HG21 ' A' ' 332' ' ' ILE . 0.9 OUTLIER -53.2 -55.61 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 45.22 111.19 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.5 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.0 t -71.47 -40.82 72.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 53.43 111.141 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.09 -16.75 54.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 72.34 111.102 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.581 HD12 HG12 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -115.91 -8.7 11.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 63.21 110.934 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -59.23 108.43 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 74.2 111.136 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 11.1 m120 47.98 49.37 17.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 73.13 110.911 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.5 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -108.62 142.75 26.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.694 0.759 . . . . 73.53 110.884 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.499 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 54.1 Cg_endo -69.71 145.52 57.72 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.702 2.268 . . . . 71.55 112.306 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' PHE . . . . . 0.485 ' N ' ' O ' ' A' ' 404' ' ' ARG . 50.4 t80 -152.77 110.61 3.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 74.01 110.797 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 49.54 39.9 18.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.508 . . . . 63.25 110.948 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 81.72 10.48 84.18 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.775 -0.726 . . . . 71.31 112.478 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -135.02 132.73 38.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.855 0.36 . . . . 70.01 110.909 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.531 ' C ' HD23 ' A' ' 406' ' ' LEU . 34.5 m120 -82.54 146.02 29.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 42.51 110.88 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.707 ' HB3' HG23 ' A' ' 345' ' ' ILE . 6.3 mt -112.02 172.6 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 74.52 110.941 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' ARG . . . . . 0.478 ' O ' HG23 ' A' ' 408' ' ' THR . 0.0 OUTLIER -123.16 177.2 5.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 73.51 110.837 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . 0.642 HG21 ' O ' ' A' ' 393' ' ' ILE . 19.9 p -157.47 163.4 38.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 54.13 111.146 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.751 . . . . 32.33 112.512 -179.959 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.836 0.35 . . . . 74.5 110.842 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -47.96 -25.27 1.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 71.13 111.117 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' VAL . . . . . 0.878 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 14.2 t -83.43 -29.72 7.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 71.42 111.079 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.432 ' HA ' HD12 ' A' ' 333' ' ' ILE . 5.2 t0 -53.94 -35.26 61.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 73.32 110.872 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -68.89 -31.78 70.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 74.33 110.82 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.693 HG21 HG21 ' A' ' 393' ' ' ILE . 31.4 mm -58.38 -51.69 68.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 75.2 111.151 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 330' ' ' ASP . 4.8 mt -51.67 -42.54 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 75.03 111.192 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -53.66 -16.39 1.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 74.23 110.889 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 6.1 t -88.47 -25.67 22.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 75.52 110.816 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -116.56 151.22 46.8 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.556 0.694 . . . . 70.44 111.16 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.526 ' O ' HG12 ' A' ' 340' ' ' VAL . 54.9 Cg_endo -69.74 161.71 44.89 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.753 2.302 . . . . 73.22 112.374 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -8.43 23.57 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.704 2.269 . . . . 62.53 112.366 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -109.25 63.47 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 72.43 110.882 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 337' ' ' PRO . 9.2 p -175.15 126.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.451 . . . . 72.34 111.131 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 21.5 p -137.88 73.46 1.44 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 73.22 111.146 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 71.1 m -132.86 124.24 27.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 65.23 111.148 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -93.77 116.33 28.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 75.2 111.157 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.84 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -101.55 134.29 44.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.424 . . . . 72.31 110.864 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.84 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.8 mp -133.43 112.22 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 72.1 111.155 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -97.31 176.63 31.67 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.75 -0.738 . . . . 62.23 112.482 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.3 t30 65.68 49.85 1.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.777 0.322 . . . . 74.34 110.847 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.552 HG23 ' HD2' ' A' ' 349' ' ' PRO . 74.3 mt -104.98 135.4 19.3 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.614 0.721 . . . . 71.22 111.124 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . 0.673 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 55.2 Cg_endo -69.74 164.86 32.94 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.692 2.261 . . . . 73.53 112.42 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -72.5 -23.34 61.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 70.32 110.893 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -92.9 28.73 2.0 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.47 . . . . 61.03 110.854 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.828 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -113.63 87.6 2.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 41.44 111.188 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 38.1 p -87.92 171.29 10.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.201 -0.454 . . . . 72.34 111.144 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . 0.506 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -66.94 -29.81 69.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 73.51 110.925 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.21 -26.3 50.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.047 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.15 -13.28 13.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 71.35 110.903 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.828 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.3 mp -98.52 -53.88 3.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 51.35 110.967 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.649 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -41.17 -51.37 7.89 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.671 0.748 . . . . 70.44 111.15 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.9 Cg_endo -69.76 -31.56 20.3 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.704 2.269 . . . . 70.32 112.348 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.911 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -63.98 -23.52 67.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 63.2 110.898 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.611 ' CE2' HD12 ' A' ' 360' ' ' LEU . 86.9 m-85 -102.07 -33.64 9.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.938 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -54.06 -31.8 52.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 65.52 110.927 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -57.2 -21.02 30.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 72.31 110.86 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 41.6 m-85 -72.02 -57.4 4.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.883 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -155.87 -86.28 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.721 . . . . 32.11 112.483 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -152.41 143.55 23.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 74.52 110.952 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . 0.457 HG23 ' CG2' ' A' ' 381' ' ' ILE . 41.4 mt -120.81 109.17 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 75.02 111.109 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.27 -21.18 27.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 74.24 110.91 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.56 121.5 0.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 72.34 110.881 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.513 ' CD2' HG12 ' A' ' 358' ' ' ILE . 39.1 t80 -115.23 138.95 50.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 63.45 110.836 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -127.68 100.7 6.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 75.45 110.852 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 10.8 t-80 -94.98 119.46 33.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 63.43 110.826 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -113.37 85.58 8.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.67 0.747 . . . . 71.14 110.873 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' PRO . . . . . 0.509 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 53.7 Cg_endo -69.83 -29.8 22.95 Favored 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.706 2.27 . . . . 42.43 112.407 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.02 -17.02 64.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 72.12 110.869 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -116.36 -27.74 6.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 53.33 110.901 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.81 39.96 5.71 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.696 -0.764 . . . . 64.42 112.526 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 99.6 m -156.84 145.94 20.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.787 0.327 . . . . 73.31 110.877 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 20.7 p -134.76 153.76 51.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 75.01 110.892 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 380' ' ' PHE . 2.5 m-85 -129.28 131.67 47.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 73.43 110.89 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.543 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -122.8 119.65 58.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 73.1 111.063 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.98 134.02 33.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 74.34 110.909 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -115.36 -178.6 3.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 70.34 110.893 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -86.51 -29.14 22.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 71.21 110.873 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 66.0 p -129.54 166.25 20.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 74.42 111.156 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -80.65 -38.41 29.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 71.24 110.849 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -60.88 -29.88 69.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 52.21 110.861 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -35.56 80.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 75.42 110.875 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -75.63 -38.11 59.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 65.12 111.046 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.878 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -60.29 -36.57 78.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 63.4 111.102 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 20.0 t -66.37 -33.38 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 60.24 111.129 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . 0.535 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 2.0 t -83.93 -23.85 30.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 73.34 110.847 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.797 ' O ' HG21 ' A' ' 408' ' ' THR . 13.4 mt -59.9 -57.93 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.262 -0.426 . . . . 45.22 111.107 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.517 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.7 t -72.1 -36.22 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 53.43 111.07 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -61.79 -22.71 65.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 72.34 111.086 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.715 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.2 mm? -104.12 -10.6 17.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 63.21 110.873 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -57.5 119.95 7.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 74.2 111.076 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.8 m120 44.25 36.53 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 73.13 110.845 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.715 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -95.53 141.74 23.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.66 0.743 . . . . 73.53 110.844 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.462 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.5 Cg_endo -69.76 147.41 62.78 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.622 2.215 . . . . 71.55 112.372 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' PHE . . . . . 0.534 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 61.2 t80 -154.52 110.79 3.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 74.01 110.836 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 51.42 33.5 10.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 63.25 110.886 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 87.57 13.25 65.58 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.724 -0.751 . . . . 71.31 112.465 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 401' ' ' PHE . 19.3 mtt180 -140.57 135.75 32.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 70.01 110.882 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.549 ' O ' HD23 ' A' ' 406' ' ' LEU . 8.5 m120 -78.93 150.78 32.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 42.51 110.878 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.647 ' HB3' HG23 ' A' ' 345' ' ' ILE . 11.2 mt -120.3 162.8 18.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.246 -0.434 . . . . 74.52 110.924 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.39 175.24 5.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 73.51 110.883 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . 0.797 HG21 ' O ' ' A' ' 393' ' ' ILE . 2.1 p -154.38 155.59 35.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 54.13 111.179 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 C-N-CA 120.776 -0.726 . . . . 32.33 112.544 -179.969 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.778 0.323 . . . . 74.5 110.863 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.33 -24.81 30.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 71.13 111.05 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' VAL . . . . . 0.829 HG22 ' HB ' ' A' ' 394' ' ' VAL . 19.4 t -76.88 -29.97 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 71.42 111.1 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -54.61 -40.84 69.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 73.32 110.878 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -62.7 -32.73 73.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 74.33 110.912 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.845 HG21 HG21 ' A' ' 393' ' ' ILE . 30.9 mm -57.57 -43.49 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 75.2 111.124 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 18.2 mt -58.23 -32.6 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 75.03 111.112 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -4.32 11.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 74.23 110.834 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.69 38.91 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 75.52 110.901 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.704 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . 179.56 164.44 0.78 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.525 0.678 . . . . 70.44 111.18 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.704 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 53.6 Cg_endo -69.68 159.66 52.62 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.744 2.296 . . . . 73.22 112.373 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -24.67 29.41 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.723 2.282 . . . . 62.53 112.339 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -104.24 73.51 1.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 72.43 110.854 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 337' ' ' PRO . 9.5 p -167.91 128.94 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 72.34 111.09 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . 0.415 HG22 ' CA ' ' A' ' 386' ' ' HIS . 19.8 p -137.41 68.07 1.42 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 73.22 111.093 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 66.4 m -133.87 116.36 15.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.204 -0.453 . . . . 65.23 111.117 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -86.61 127.01 34.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 75.2 111.107 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.823 ' O ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -105.75 135.04 47.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 72.31 110.886 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.823 HD12 ' O ' ' A' ' 344' ' ' TYR . 1.7 mp -132.94 116.96 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 72.1 111.179 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -107.01 173.87 19.43 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.681 -0.771 . . . . 62.23 112.464 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.3 t30 65.68 53.09 1.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.752 0.31 . . . . 74.34 110.826 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.667 HG23 ' HD2' ' A' ' 349' ' ' PRO . 80.0 mt -102.86 138.75 19.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.564 0.697 . . . . 71.22 111.165 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . 0.667 ' HD2' HG23 ' A' ' 348' ' ' ILE . 53.2 Cg_endo -69.78 166.24 28.28 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.7 2.266 . . . . 73.53 112.325 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -74.18 -22.62 59.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 70.32 110.888 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.437 ' CE1' ' CB ' ' A' ' 349' ' ' PRO . 2.7 p90 -91.27 27.15 1.99 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 61.03 110.857 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.764 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -111.67 111.91 23.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 41.44 111.105 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 18.3 p -117.64 168.48 10.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 72.34 111.15 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . 0.52 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.2 OUTLIER -62.82 -30.43 71.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 73.51 110.909 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.93 67.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.096 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.14 -12.93 13.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 71.35 110.909 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.764 HD11 ' HB1' ' A' ' 352' ' ' ALA . 2.9 mp -100.51 -51.07 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 51.35 110.886 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.657 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -40.86 -51.03 7.37 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.641 0.734 . . . . 70.44 111.106 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' PRO . . . . . 0.657 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.8 Cg_endo -69.67 -31.1 21.61 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.69 2.26 . . . . 70.32 112.385 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.994 ' O ' HD12 ' A' ' 360' ' ' LEU . 0.1 OUTLIER -64.47 -27.31 68.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 63.2 110.889 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.766 ' HB2' HD11 ' A' ' 367' ' ' ILE . 86.5 m-85 -95.28 -32.01 13.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 73.33 110.902 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -57.78 -35.55 70.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 65.52 110.95 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -54.71 -24.17 20.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 72.31 110.866 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -69.26 -57.75 4.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 73.33 110.876 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -154.66 -83.45 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.711 -0.757 . . . . 32.11 112.45 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -153.31 143.48 22.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.343 . . . . 74.52 110.892 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . 0.766 HD11 ' HB2' ' A' ' 361' ' ' PHE . 18.9 mt -121.01 109.16 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 75.02 111.096 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.29 -16.92 25.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 74.24 110.92 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -170.35 121.22 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 72.34 110.884 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 29.9 t80 -114.51 145.41 41.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 63.45 110.897 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.99 100.65 4.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 75.45 110.875 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . 0.571 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.4 t-80 -96.5 118.34 32.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 63.43 110.868 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -109.18 85.21 3.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.699 0.761 . . . . 71.14 110.949 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' PRO . . . . . 0.523 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 54.4 Cg_endo -69.7 -17.88 37.59 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.244 . . . . 42.43 112.369 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.16 -18.29 57.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 72.12 110.934 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.13 -25.56 7.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 53.33 110.946 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 91.99 31.11 9.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.782 -0.723 . . . . 64.42 112.509 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 57.8 m -143.23 154.45 43.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.76 0.314 . . . . 73.31 110.875 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 19.7 p -143.61 143.79 31.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 75.01 110.975 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -121.99 139.21 53.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.262 -0.426 . . . . 73.43 110.906 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.635 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -128.58 128.71 68.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 73.1 111.146 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -93.08 129.53 39.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 74.34 110.843 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -111.52 -178.61 3.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 70.34 110.96 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -82.54 -43.91 16.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 71.21 110.823 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 36.2 p -115.84 166.57 11.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 74.42 111.115 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' HIS . . . . . 0.415 ' CA ' HG22 ' A' ' 341' ' ' THR . 22.9 p-80 -85.28 -39.57 17.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 71.24 110.937 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.05 -27.11 63.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 52.21 110.888 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -52.19 36.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.42 110.912 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.439 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -51.77 -41.19 61.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 65.12 111.082 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.684 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -52.42 -34.12 46.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 63.4 111.094 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 15.0 t -67.42 -43.24 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 60.24 111.119 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 9.9 t -69.35 -33.65 73.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 73.34 110.85 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.845 HG21 HG21 ' A' ' 332' ' ' ILE . 0.7 OUTLIER -54.0 -54.98 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 45.22 111.133 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.829 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.5 OUTLIER -71.5 -37.52 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 53.43 111.117 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.62 -21.13 66.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 72.34 111.078 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.612 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.7 mm? -106.53 -10.93 16.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.259 -0.428 . . . . 63.21 110.861 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -58.9 114.71 2.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.2 111.091 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . 0.453 ' C ' ' OD1' ' A' ' 405' ' ' ASN . 2.9 t-20 42.7 43.06 3.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 73.13 110.888 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.612 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -101.18 144.38 28.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.598 0.714 . . . . 73.53 110.902 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.455 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.8 Cg_endo -69.75 142.04 46.89 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.76 2.307 . . . . 71.55 112.323 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' PHE . . . . . 0.586 ' CE1' HD22 ' A' ' 360' ' ' LEU . 75.5 t80 -152.81 110.95 3.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 74.01 110.907 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . 0.464 ' OE1' ' CZ ' ' A' ' 401' ' ' PHE . 0.4 OUTLIER 53.86 32.6 15.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 63.25 110.917 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 94.86 -19.84 51.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.776 -0.725 . . . . 71.31 112.473 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 401' ' ' PHE . 8.6 mmt180 -110.99 141.01 45.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.782 0.325 . . . . 70.01 110.897 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.474 ' C ' HD23 ' A' ' 406' ' ' LEU . 0.5 OUTLIER -86.79 149.91 24.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 42.51 110.918 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.589 HD13 HG21 ' A' ' 345' ' ' ILE . 10.1 mt -113.78 171.84 7.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 74.52 110.941 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 345' ' ' ILE . 1.1 tpt85 -123.41 179.19 4.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 73.51 110.838 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . 0.592 HG21 ' O ' ' A' ' 393' ' ' ILE . 33.9 p -155.88 170.07 22.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 54.13 111.189 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.776 -0.726 . . . . 32.33 112.48 179.925 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . 0.404 ' O ' ' HB3' ' A' ' 330' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.762 0.315 . . . . 74.5 110.897 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -57.63 -26.28 61.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 71.13 111.094 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' VAL . . . . . 0.788 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 16.1 t -78.74 -29.93 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 71.42 111.146 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 327' ' ' GLN . 3.8 t0 -54.13 -38.85 65.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.876 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -65.6 -31.82 73.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 74.33 110.808 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.876 HG21 HD13 ' A' ' 393' ' ' ILE . 46.1 mm -55.55 -48.95 76.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 75.2 111.092 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 8.8 mt -55.06 -32.1 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 75.03 111.201 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.75 -7.19 7.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 74.23 110.942 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 23.0 t -102.63 11.62 37.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 75.52 110.884 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.427 ' HB1' HG11 ' A' ' 340' ' ' VAL . . . -158.78 150.02 16.51 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.596 0.713 . . . . 70.44 111.104 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.642 ' O ' HG12 ' A' ' 340' ' ' VAL . 54.7 Cg_endo -69.73 164.46 34.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.736 2.291 . . . . 73.22 112.341 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -11.68 31.33 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.625 2.217 . . . . 62.53 112.398 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -101.21 55.05 0.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 72.43 110.905 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 337' ' ' PRO . 9.8 p -168.79 126.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 72.34 111.144 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 386' ' ' HIS . 21.7 p -142.61 70.95 1.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 73.22 111.188 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 54.5 m -133.72 123.87 25.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 65.23 111.124 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -89.97 134.4 34.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 75.2 111.133 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.656 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -114.14 134.38 54.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 72.31 110.932 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.714 HG21 HD13 ' A' ' 406' ' ' LEU . 1.7 mp -132.07 113.22 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.504 . . . . 72.1 111.148 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -103.89 168.73 17.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.761 . . . . 62.23 112.501 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 405' ' ' ASN . 2.3 t30 72.22 54.19 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 74.34 110.958 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.692 HG23 ' HD2' ' A' ' 349' ' ' PRO . 87.7 mt -108.45 138.87 20.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.564 0.697 . . . . 71.22 111.178 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . 0.692 ' HD2' HG23 ' A' ' 348' ' ' ILE . 53.3 Cg_endo -69.85 164.89 32.96 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.714 2.276 . . . . 73.53 112.313 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -77.49 -10.96 59.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 70.32 110.829 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.58 ' CD2' ' HB2' ' A' ' 349' ' ' PRO . 31.8 p90 -97.38 1.21 49.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 61.03 110.927 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.871 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -89.29 111.85 22.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 41.44 111.049 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 74.2 p -112.06 173.51 6.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.18 -0.464 . . . . 72.34 111.106 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . 0.498 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -67.01 -29.53 69.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 73.51 110.866 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -59.02 -26.38 64.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 74.32 111.159 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.27 -15.62 13.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 71.35 110.861 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.871 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.8 mp -94.77 -51.03 4.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 51.35 110.883 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.683 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.2 mm -43.89 -49.87 20.24 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.677 0.751 . . . . 70.44 111.184 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.7 Cg_endo -69.83 -20.41 34.56 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.672 2.248 . . . . 70.32 112.352 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.925 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -77.99 -25.39 48.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 63.2 110.968 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.698 ' HB2' HD11 ' A' ' 367' ' ' ILE . 85.7 m-85 -98.76 -30.08 12.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.33 110.941 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' GLN . . . . . 0.459 ' HG2' HD12 ' A' ' 367' ' ' ILE . 2.0 mm-40 -57.64 -42.98 84.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 65.52 110.912 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -47.02 -21.67 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 72.31 110.901 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . 0.484 ' HE2' ' HG ' ' A' ' 392' ' ' CYS . 21.5 m-85 -71.98 -54.49 9.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 73.33 110.922 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -161.39 -85.62 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.74 -0.743 . . . . 32.11 112.456 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -153.56 142.29 20.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.775 0.321 . . . . 74.52 110.86 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . 0.698 HD11 ' HB2' ' A' ' 361' ' ' PHE . 40.3 mt -120.78 109.46 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 75.02 111.208 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.75 -17.52 38.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.466 . . . . 74.24 110.964 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.72 121.33 0.58 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 72.34 110.9 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.578 ' CE1' ' HB3' ' A' ' 379' ' ' CYS . 25.2 t80 -114.97 123.54 49.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 63.45 110.858 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.19 99.2 7.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 75.45 110.877 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 3.4 t-80 -95.29 120.6 35.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.436 . . . . 63.43 110.878 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 374' ' ' PRO . 25.6 m-85 -113.96 92.28 25.29 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.7 0.762 . . . . 71.14 110.916 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 373' ' ' TYR . 54.0 Cg_endo -69.7 -18.2 37.43 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.692 2.261 . . . . 42.43 112.375 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -78.18 -37.11 46.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 72.12 110.841 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -99.79 -18.01 17.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 53.33 110.897 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 75.07 43.67 25.83 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.764 -0.731 . . . . 64.42 112.468 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 1.6 p -151.93 143.45 23.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.758 0.313 . . . . 73.31 110.962 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.578 ' HB3' ' CE1' ' A' ' 370' ' ' PHE . 61.3 m -124.3 153.34 41.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 75.01 110.947 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -130.47 104.26 7.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 73.43 110.85 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.493 HG12 ' CD1' ' A' ' 370' ' ' PHE . 0.5 OUTLIER -105.0 129.24 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 73.1 111.155 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -102.01 136.83 41.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 74.34 110.923 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -118.18 172.34 7.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 70.34 110.931 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.62 -37.3 59.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 71.21 110.857 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 59.3 p -115.96 169.83 8.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 74.42 111.154 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' HIS . . . . . 0.539 ' HA ' HG22 ' A' ' 341' ' ' THR . 51.5 p-80 -85.64 -38.93 17.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 71.24 110.939 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -60.54 -30.18 69.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.182 -0.463 . . . . 52.21 110.929 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -62.17 -38.57 89.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 75.42 110.852 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.456 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -75.94 -33.62 59.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 65.12 111.168 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.788 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -55.91 -35.37 66.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 63.4 111.066 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 25.6 t -69.13 -46.62 77.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 60.24 111.057 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . 0.484 ' HG ' ' HE2' ' A' ' 364' ' ' PHE . 48.8 t -56.18 -31.1 63.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 73.34 110.933 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.876 HD13 HG21 ' A' ' 332' ' ' ILE . 1.1 mt -59.8 -56.36 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 45.22 111.154 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.516 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.1 t -71.68 -38.48 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 53.43 111.154 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -58.56 -48.07 82.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 72.34 111.099 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.631 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.9 mm? -85.48 -10.35 56.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 63.21 110.865 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' ALA . . . . . 0.66 ' N ' HG21 ' A' ' 408' ' ' THR . . . -50.66 108.44 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 74.2 111.086 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 42.99 43.45 3.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 73.13 110.916 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.631 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -96.75 145.5 29.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.696 0.76 . . . . 73.53 110.884 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 144.13 52.93 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.647 2.231 . . . . 71.55 112.39 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' PHE . . . . . 0.525 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 41.9 t80 -151.03 113.23 4.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 74.01 110.887 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 49.47 32.93 5.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 63.25 110.871 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.6 -28.36 15.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 71.31 112.51 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.9 OUTLIER -105.52 141.05 37.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.361 . . . . 70.01 110.847 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.448 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 14.3 m120 -82.68 154.92 24.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 42.51 110.923 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.714 HD13 HG21 ' A' ' 345' ' ' ILE . 10.9 mt -114.35 173.8 6.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 74.52 110.892 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 346' ' ' GLY . 0.0 OUTLIER -113.92 171.93 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 73.51 110.89 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . 0.66 HG21 ' N ' ' A' ' 397' ' ' ALA . 64.3 p -154.18 154.19 33.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 54.13 111.098 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 32.33 112.508 179.956 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.879 0.371 . . . . 74.5 110.862 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -49.28 -24.3 1.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 71.13 111.064 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' VAL . . . . . 0.872 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 10.8 t -80.89 -29.18 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 71.42 111.146 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -53.42 -37.72 62.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.108 -0.496 . . . . 73.32 110.876 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 334' ' ' ARG . 3.3 t60 -66.07 -31.63 72.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 74.33 110.796 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.69 HG21 HD13 ' A' ' 393' ' ' ILE . 27.4 mm -56.36 -47.74 80.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 75.2 111.098 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 9.5 mt -54.12 -26.16 14.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 75.03 111.051 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 331' ' ' HIS . 0.0 OUTLIER -71.66 2.11 5.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 74.23 110.926 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.69 31.79 6.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 75.52 110.868 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.945 ' HB1' HG11 ' A' ' 340' ' ' VAL . . . -174.32 151.15 1.6 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.535 0.684 . . . . 70.44 111.104 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.73 ' O ' HG12 ' A' ' 340' ' ' VAL . 54.8 Cg_endo -69.74 169.93 17.74 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.677 2.251 . . . . 73.22 112.353 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.84 -9.2 25.5 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.609 2.206 . . . . 62.53 112.356 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -115.41 64.1 0.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 72.43 110.899 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.945 HG11 ' HB1' ' A' ' 336' ' ' ALA . 7.9 p -160.38 129.19 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 72.34 111.073 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.96 69.2 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 73.22 111.102 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.485 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 45.0 m -131.42 108.88 9.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 65.23 111.224 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -80.28 111.3 16.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 75.2 111.061 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.571 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -93.78 118.8 31.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 72.31 110.953 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.55 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.9 mp -119.47 117.52 54.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 72.1 111.15 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -107.98 -173.3 21.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.706 -0.759 . . . . 62.23 112.521 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.95 47.52 12.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.807 0.337 . . . . 74.34 110.895 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 34.2 mt -99.43 132.62 22.93 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.658 0.742 . . . . 71.22 111.163 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . 0.489 ' CG ' ' CE1' ' A' ' 351' ' ' PHE . 53.6 Cg_endo -69.82 161.89 44.22 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.621 2.214 . . . . 73.53 112.328 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -69.01 -21.01 64.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 70.32 110.813 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.489 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 7.1 p90 -90.85 30.74 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 61.03 110.878 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.625 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -116.23 124.82 51.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 41.44 111.098 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 14.3 p -126.54 167.71 15.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 72.34 111.128 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . 0.507 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -64.99 -34.06 77.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 73.51 110.876 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.23 -26.35 50.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.32 111.128 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.27 -13.12 13.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 71.35 110.865 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.625 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.5 mp -99.52 -54.21 3.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 51.35 110.895 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.622 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -39.81 -52.07 5.18 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.692 0.758 . . . . 70.44 111.199 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.2 Cg_endo -69.72 -39.51 6.49 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.612 2.208 . . . . 70.32 112.353 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.922 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -53.85 -25.36 19.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 63.2 110.87 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.864 ' HB2' HD11 ' A' ' 367' ' ' ILE . 85.5 m-85 -95.78 -37.22 10.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 73.33 110.894 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' GLN . . . . . 0.6 ' HG2' HD12 ' A' ' 367' ' ' ILE . 3.8 mt-30 -50.01 -46.46 52.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 65.52 110.879 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.6 OUTLIER -44.46 -25.08 0.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 72.31 110.79 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . 0.536 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 30.5 m-85 -70.1 -60.24 2.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 73.33 110.841 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -150.42 -86.64 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.79 -0.719 . . . . 32.11 112.511 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 368' ' ' LEU . 11.8 t80 -153.43 141.61 20.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.786 0.327 . . . . 74.52 110.898 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . 0.864 HD11 ' HB2' ' A' ' 361' ' ' PHE . 23.9 mt -120.36 113.48 40.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 75.02 111.101 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 369' ' ' ASP . 2.7 pp -100.45 -14.84 18.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 74.24 110.862 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.53 ' N ' HD12 ' A' ' 368' ' ' LEU . 10.0 t0 -167.67 120.81 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 72.34 110.836 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 28.4 t80 -117.54 134.85 54.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 63.45 110.9 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -120.56 101.5 7.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 75.45 110.891 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . 0.4 ' HB2' ' CE2' ' A' ' 370' ' ' PHE . 12.6 t-80 -97.49 135.7 38.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 63.43 110.906 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -130.75 85.69 54.86 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 121.649 0.738 . . . . 71.14 110.967 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -22.58 31.73 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.638 2.226 . . . . 42.43 112.349 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -72.93 -19.39 61.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 72.12 110.911 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.49 -27.57 6.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 53.33 110.91 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 89.8 43.82 5.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.715 -0.755 . . . . 64.42 112.492 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 43.6 m -155.93 149.2 24.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.774 0.321 . . . . 73.31 110.886 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 15.5 p -140.79 144.14 35.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 75.01 110.909 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.485 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 18.9 m-85 -122.86 128.81 50.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 73.43 110.877 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.577 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -117.92 119.37 61.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 73.1 111.124 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -88.39 127.07 35.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 74.34 110.94 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -106.08 171.59 7.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.428 . . . . 70.34 110.946 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -65.29 -37.5 87.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.093 -0.503 . . . . 71.21 110.897 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 58.6 p -130.12 178.02 6.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 74.42 111.179 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -83.21 -39.42 20.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 71.24 110.869 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -57.97 -27.1 63.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 52.21 110.877 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -37.18 77.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 75.42 110.858 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -75.77 -36.6 59.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 65.12 111.086 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.872 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -55.34 -32.95 62.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 63.4 111.061 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 40.2 t -68.09 -55.57 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 60.24 111.105 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . 0.536 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 2.1 t -64.29 -26.1 68.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 73.34 110.881 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.784 HD12 ' HA ' ' A' ' 390' ' ' ALA . 5.6 mt -57.06 -57.2 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 45.22 111.135 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.559 ' O ' ' HB3' ' A' ' 397' ' ' ALA . 2.5 t -73.06 -40.3 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 53.43 111.16 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -53.6 -51.47 62.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 72.34 111.102 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.723 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.9 mm? -75.46 -12.63 60.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 63.21 110.951 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' ALA . . . . . 0.577 ' N ' HG21 ' A' ' 408' ' ' THR . . . -50.49 112.9 0.76 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 74.2 111.076 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 54.8 t30 41.97 49.85 4.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.13 110.855 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.723 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -105.78 146.58 33.12 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.69 0.757 . . . . 73.53 110.825 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.8 137.47 35.42 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.679 2.253 . . . . 71.55 112.362 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' PHE . . . . . 0.537 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 33.8 t80 -141.83 110.78 6.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.01 110.912 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 49.11 32.71 4.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 63.25 110.886 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.45 -29.18 13.06 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.669 -0.776 . . . . 71.31 112.477 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -107.11 139.1 42.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.321 . . . . 70.01 110.866 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -79.18 155.19 28.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 42.51 110.829 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.436 HD11 ' CD2' ' A' ' 401' ' ' PHE . 21.9 mt -118.97 170.32 9.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 74.52 110.884 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.42 175.59 5.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 73.51 110.824 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . 0.606 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 75.5 p -154.05 155.51 35.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 54.13 111.144 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 C-N-CA 120.811 -0.709 . . . . 32.33 112.55 179.922 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.835 0.35 . . . . 74.5 110.89 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -57.19 -24.87 57.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 71.13 111.074 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' VAL . . . . . 0.782 HG22 ' HB ' ' A' ' 394' ' ' VAL . 23.4 t -76.66 -29.81 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 71.42 111.068 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.419 ' HA ' HD12 ' A' ' 333' ' ' ILE . 17.6 t0 -54.49 -37.75 65.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 73.32 110.84 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -62.82 -31.93 73.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.846 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.458 HG21 HG21 ' A' ' 393' ' ' ILE . 15.3 mm -65.25 -41.83 92.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 75.2 111.114 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 330' ' ' ASP . 31.8 mt -52.29 -48.91 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 75.03 111.059 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.34 -7.03 5.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 74.23 110.879 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 3.1 t -82.43 -31.92 29.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 75.52 110.854 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -116.87 153.97 49.46 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.636 0.732 . . . . 70.44 111.066 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.491 ' O ' HG12 ' A' ' 340' ' ' VAL . 53.4 Cg_endo -69.78 158.88 55.41 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.708 2.272 . . . . 73.22 112.31 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -7.46 21.1 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.716 2.278 . . . . 62.53 112.338 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -101.86 51.0 0.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 72.43 110.848 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 337' ' ' PRO . 9.7 p -175.9 128.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 72.34 111.157 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . 0.535 HG22 ' HB3' ' A' ' 386' ' ' HIS . 20.4 p -137.1 67.92 1.43 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 73.22 111.207 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 23.3 m -133.76 137.0 44.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 65.23 111.152 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -100.18 129.47 46.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 75.2 111.101 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.745 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -106.28 135.08 48.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 72.31 110.882 -179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.745 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.7 mp -131.87 117.68 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 72.1 111.12 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -106.59 161.62 13.97 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.748 -0.739 . . . . 62.23 112.472 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 0.6 OUTLIER 79.24 49.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 74.34 110.937 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.615 HG23 ' HD2' ' A' ' 349' ' ' PRO . 64.8 mt -103.76 137.72 19.32 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.581 0.705 . . . . 71.22 111.13 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . 0.769 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.6 Cg_endo -69.75 165.09 32.11 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.714 2.276 . . . . 73.53 112.307 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -75.88 -17.1 59.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 70.32 110.846 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.588 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 27.1 p90 -99.05 24.11 8.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 61.03 110.886 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.794 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -107.87 93.16 4.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 41.44 111.17 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 46.2 p -90.54 173.51 8.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 72.34 111.173 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . 0.506 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -66.96 -29.77 69.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 73.51 110.824 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.01 -26.11 47.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 74.32 111.111 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.81 -13.74 13.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 71.35 110.89 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.794 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.4 mp -98.56 -54.38 3.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 51.35 110.895 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.649 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -40.88 -51.59 7.1 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.684 0.754 . . . . 70.44 111.134 179.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.1 Cg_endo -69.85 -34.08 15.0 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.656 2.237 . . . . 70.32 112.305 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.904 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -61.14 -23.49 65.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 63.2 110.944 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.609 ' CE2' HD12 ' A' ' 360' ' ' LEU . 81.4 m-85 -102.88 -33.67 9.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 73.33 110.912 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' GLN . . . . . 0.601 ' HG3' HD12 ' A' ' 367' ' ' ILE . 0.1 OUTLIER -58.77 -32.72 69.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.5 . . . . 65.52 110.984 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -59.24 -11.25 3.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 72.31 110.924 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . 0.566 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 31.3 m-85 -81.01 -60.12 2.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 73.33 110.87 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -149.01 -84.03 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.782 -0.723 . . . . 32.11 112.492 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -152.64 143.61 23.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 74.52 110.852 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . 0.601 HD12 ' HG3' ' A' ' 362' ' ' GLN . 55.5 mt -121.0 109.28 24.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 75.02 111.126 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.02 -17.66 24.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.947 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -171.15 121.15 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 72.34 110.863 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.545 ' CD2' HG12 ' A' ' 358' ' ' ILE . 34.6 t80 -113.61 143.42 44.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 63.45 110.946 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.55 101.17 5.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 75.45 110.946 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . 0.533 ' CE1' ' HB3' ' A' ' 374' ' ' PRO . 11.2 t-80 -94.61 114.48 26.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 63.43 110.814 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -107.7 84.12 1.86 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.631 0.729 . . . . 71.14 110.874 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' PRO . . . . . 0.533 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 53.6 Cg_endo -69.79 -28.6 24.91 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.661 2.24 . . . . 42.43 112.355 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -63.44 -19.58 64.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 72.12 110.921 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.8 -21.7 7.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 53.33 110.945 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 87.33 38.33 7.79 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.776 -0.726 . . . . 64.42 112.475 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 19.1 p -147.15 153.63 40.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.764 0.316 . . . . 73.31 110.941 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 7.2 p -139.35 151.12 46.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 75.01 110.882 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -131.14 122.73 27.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 73.43 110.888 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.584 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -114.28 126.3 71.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 73.1 111.08 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 10.2 mttp -90.6 133.86 34.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 74.34 110.877 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -116.21 -178.55 3.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 70.34 110.996 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.45 -46.3 16.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 71.21 110.857 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 68.0 p -114.83 170.66 8.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 74.42 111.232 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' HIS . . . . . 0.535 ' HB3' HG22 ' A' ' 341' ' ' THR . 27.1 p-80 -85.64 -44.43 12.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 71.24 110.838 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -57.18 -32.9 66.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 52.21 110.868 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -67.88 -32.56 73.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 75.42 110.888 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -67.1 -39.32 86.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 65.12 111.114 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.597 ' HB1' HG13 ' A' ' 329' ' ' VAL . . . -59.19 -27.88 66.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 63.4 111.097 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.58 -40.94 88.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 60.24 111.158 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . 0.566 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 1.5 t -77.78 -27.1 50.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 73.34 110.935 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.722 ' O ' HG21 ' A' ' 408' ' ' THR . 1.2 mp -54.99 -56.67 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 45.22 111.078 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.782 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.9 OUTLIER -73.06 -45.86 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 53.43 111.067 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . 0.425 ' N ' HG12 ' A' ' 394' ' ' VAL . . . -52.87 -21.67 4.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 72.34 111.076 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.62 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.2 mm? -106.5 -19.27 13.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 63.21 110.945 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -48.76 114.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 74.2 111.142 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 44.26 46.89 7.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 73.13 110.855 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.62 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -107.03 144.79 29.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.632 0.73 . . . . 73.53 110.848 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.502 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.5 Cg_endo -69.85 145.23 56.04 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.672 2.248 . . . . 71.55 112.333 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' PHE . . . . . 0.565 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 64.6 t80 -152.34 111.81 3.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 74.01 110.908 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.63 33.36 8.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 63.25 110.932 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.4 -27.78 17.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 71.31 112.513 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.482 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -104.75 141.9 35.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.318 . . . . 70.01 110.895 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -86.99 145.15 26.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 42.51 110.936 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.663 HD13 HG21 ' A' ' 345' ' ' ILE . 8.8 mt -107.03 179.88 4.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.239 -0.437 . . . . 74.52 110.905 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 345' ' ' ILE . 13.5 ttt85 -130.45 177.48 7.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 73.51 110.88 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . 0.722 HG21 ' O ' ' A' ' 393' ' ' ILE . 17.2 p -156.13 163.48 39.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 54.13 111.124 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 32.33 112.474 179.985 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.757 0.313 . . . . 74.5 110.945 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.66 -32.85 59.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 71.13 111.065 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' VAL . . . . . 0.613 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 11.1 t -70.95 -29.53 37.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 71.42 111.128 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.429 ' HA ' HD12 ' A' ' 333' ' ' ILE . 24.4 t70 -53.99 -34.85 60.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 73.32 110.915 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -68.29 -31.95 71.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 74.33 110.854 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.581 HG21 HD13 ' A' ' 393' ' ' ILE . 37.5 mm -57.05 -51.5 68.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 75.2 111.102 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.95 HG23 ' NE2' ' A' ' 386' ' ' HIS . 4.0 mt -55.19 -27.76 20.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 75.03 111.11 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.71 -12.7 55.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 74.23 110.893 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.43 27.1 9.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 75.52 110.887 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.669 ' HB1' HG11 ' A' ' 340' ' ' VAL . . . -169.41 148.93 3.6 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.472 0.653 . . . . 70.44 111.159 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.843 ' O ' HG12 ' A' ' 340' ' ' VAL . 53.1 Cg_endo -69.81 165.54 30.69 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.69 2.26 . . . . 73.22 112.314 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -15.67 37.02 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.645 2.23 . . . . 62.53 112.363 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -106.01 55.75 0.67 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 72.43 110.917 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.843 HG12 ' O ' ' A' ' 337' ' ' PRO . 14.4 p -156.1 95.24 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 72.34 111.117 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . 0.624 HG22 ' HA ' ' A' ' 386' ' ' HIS . 18.7 p -113.34 67.73 0.67 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.479 . . . . 73.22 111.133 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.448 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 34.5 m -134.11 128.85 34.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 65.23 111.159 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -96.82 126.23 41.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 75.2 111.11 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.56 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -103.3 133.16 48.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 72.31 110.944 -179.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.753 HG21 HD13 ' A' ' 406' ' ' LEU . 2.0 mp -126.72 125.93 67.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 72.1 111.171 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.478 ' H ' ' CB ' ' A' ' 407' ' ' ARG . . . -111.65 166.69 12.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.684 -0.77 . . . . 62.23 112.473 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 6.2 t30 65.03 57.88 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.771 0.319 . . . . 74.34 110.904 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.522 HD11 HG22 ' A' ' 345' ' ' ILE . 97.0 mt -106.64 133.9 20.06 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.629 0.728 . . . . 71.22 111.096 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . 0.531 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.7 Cg_endo -69.72 166.51 27.29 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.635 2.224 . . . . 73.53 112.386 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -71.77 -26.52 62.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 70.32 110.824 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -85.51 18.12 2.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 61.03 110.889 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.885 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -101.14 101.81 12.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 41.44 111.086 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 21.1 p -109.55 169.57 8.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 72.34 111.084 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . 0.521 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.7 OUTLIER -63.46 -29.75 70.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.161 -0.472 . . . . 73.51 110.907 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -61.94 -25.81 67.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 74.32 111.084 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.98 -16.2 13.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 71.35 110.84 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.885 HD11 ' HB1' ' A' ' 352' ' ' ALA . 4.4 mp -96.7 -49.42 5.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 51.35 110.939 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.671 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.2 mm -42.94 -50.46 13.52 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.619 0.723 . . . . 70.44 111.204 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.8 Cg_endo -69.75 -37.8 8.7 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.737 2.291 . . . . 70.32 112.35 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.922 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -58.06 -25.35 61.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.445 . . . . 63.2 110.919 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.564 ' N ' HD13 ' A' ' 360' ' ' LEU . 74.1 m-85 -101.62 -38.3 7.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 73.33 110.945 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' GLN . . . . . 0.466 ' N ' HD11 ' A' ' 367' ' ' ILE . 3.5 tt0 -51.36 -37.96 50.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 65.52 110.895 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -19.38 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 72.31 110.852 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . 0.569 ' CE2' ' SG ' ' A' ' 392' ' ' CYS . 30.3 m-85 -72.3 -54.54 9.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 73.33 110.89 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -158.5 -84.69 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.795 -0.717 . . . . 32.11 112.501 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -153.51 143.1 21.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.815 0.34 . . . . 74.52 110.893 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . 0.466 HD11 ' N ' ' A' ' 362' ' ' GLN . 54.1 mt -120.93 109.4 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 75.02 111.122 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.424 HD21 ' OD1' ' A' ' 384' ' ' ASP . 0.4 OUTLIER -86.54 -19.13 29.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 74.24 110.946 179.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.48 121.31 0.6 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 72.34 110.891 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 31.7 t80 -112.73 143.02 44.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 63.45 110.919 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 379' ' ' CYS . 1.2 mmtm -128.64 101.64 6.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 75.45 110.858 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . 0.547 ' CE1' ' HD3' ' A' ' 374' ' ' PRO . 7.9 t-80 -99.05 135.42 40.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 63.43 110.816 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -129.17 89.91 46.73 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.712 0.768 . . . . 71.14 110.9 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' PRO . . . . . 0.547 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.6 Cg_endo -69.78 -20.99 34.02 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.706 2.271 . . . . 42.43 112.315 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -74.9 -25.81 59.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 72.12 110.844 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -113.55 -12.32 12.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 53.33 110.857 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 72.28 43.2 47.53 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.722 -0.752 . . . . 64.42 112.486 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 15.6 p -150.45 152.74 34.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.33 . . . . 73.31 110.898 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 14.6 p -146.66 152.75 39.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 75.01 110.851 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.448 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 54.3 m-85 -131.06 122.5 26.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 73.43 110.816 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.425 ' CG2' HG23 ' A' ' 367' ' ' ILE . 0.8 OUTLIER -109.36 126.32 66.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 73.1 111.113 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -92.88 131.08 38.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 74.34 110.853 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -112.34 -174.42 2.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 70.34 110.849 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . 0.424 ' OD1' HD21 ' A' ' 368' ' ' LEU . 0.2 OUTLIER -86.75 -46.62 9.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 71.21 110.888 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 61.1 p -115.23 161.91 17.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 74.42 111.137 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' HIS . . . . . 0.95 ' NE2' HG23 ' A' ' 333' ' ' ILE . 75.0 t60 -79.58 -39.76 30.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 71.24 110.882 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.32 -32.74 68.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 52.21 110.798 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -66.37 -36.99 84.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 75.42 110.928 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -68.05 -45.78 72.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 65.12 111.074 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.613 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -50.06 -30.02 10.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 63.4 111.11 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 70.5 t -68.94 -50.72 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 60.24 111.125 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . 0.569 ' SG ' ' CE2' ' A' ' 364' ' ' PHE . 1.9 t -58.92 -26.38 64.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.882 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.581 HD13 HG21 ' A' ' 332' ' ' ILE . 0.9 OUTLIER -61.64 -56.26 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 45.22 111.182 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.493 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.1 t -72.03 -46.91 57.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 53.43 111.094 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -60.89 -45.17 95.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 72.34 111.094 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.71 HD11 HD11 ' A' ' 360' ' ' LEU . 0.3 OUTLIER -85.01 -4.89 59.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 63.21 110.9 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 393' ' ' ILE . . . -58.4 115.24 2.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 74.2 111.085 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . 0.45 ' CG ' ' O ' ' A' ' 397' ' ' ALA . 3.3 p-10 48.25 41.09 15.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 73.13 110.907 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.575 ' CD1' ' HG ' ' A' ' 396' ' ' LEU . 0.2 OUTLIER -88.1 145.92 37.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.646 0.736 . . . . 73.53 110.913 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 130.02 18.49 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 2.243 . . . . 71.55 112.325 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' PHE . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 399' ' ' PHE . 64.3 t80 -136.21 111.07 8.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 74.01 110.868 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 52.18 33.18 11.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 63.25 110.911 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 95.57 -22.86 36.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 71.31 112.448 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.28 132.41 53.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.846 0.355 . . . . 70.01 110.888 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.443 ' C ' HD23 ' A' ' 406' ' ' LEU . 0.6 OUTLIER -73.94 148.9 41.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 42.51 110.832 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.753 HD13 HG21 ' A' ' 345' ' ' ILE . 4.2 mt -111.66 178.21 4.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 74.52 110.99 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' ARG . . . . . 0.478 ' CB ' ' H ' ' A' ' 346' ' ' GLY . 3.7 ttt180 -113.46 -179.38 3.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 73.51 110.935 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . 0.511 HG21 ' N ' ' A' ' 397' ' ' ALA . 33.8 p -153.72 153.93 33.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 54.13 111.107 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 C-N-CA 120.751 -0.737 . . . . 32.33 112.501 179.958 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.804 0.335 . . . . 74.5 110.924 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.8 -25.56 28.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 71.13 111.125 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' VAL . . . . . 0.873 HG22 ' HB ' ' A' ' 394' ' ' VAL . 8.6 t -81.61 -31.26 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 71.42 111.129 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.731 ' HA ' HD12 ' A' ' 333' ' ' ILE . 6.0 t70 -55.03 -38.66 68.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 73.32 110.906 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -59.0 -35.26 72.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 74.33 110.825 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 393' ' ' ILE . 32.4 mm -63.45 -45.9 96.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 75.2 111.166 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 330' ' ' ASP . 8.6 mt -57.14 -25.34 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 75.03 111.206 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -76.2 -1.16 25.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 74.23 110.858 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.94 36.6 4.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 75.52 110.847 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -169.55 147.95 3.24 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.574 0.702 . . . . 70.44 111.091 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.433 ' O ' HG12 ' A' ' 340' ' ' VAL . 53.9 Cg_endo -69.75 165.5 30.76 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.677 2.251 . . . . 73.22 112.375 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -31.9 19.49 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.758 2.305 . . . . 62.53 112.316 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -93.25 72.39 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 72.43 110.857 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 340' ' ' VAL . 3.3 p -178.2 127.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 72.34 111.175 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . 0.661 HG22 ' HA ' ' A' ' 386' ' ' HIS . 39.4 p -145.74 69.87 1.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 73.22 111.132 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . 0.463 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 99.8 m -133.63 120.73 21.05 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.211 -0.449 . . . . 65.23 111.174 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -86.47 129.15 34.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 75.2 111.033 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.815 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -111.48 134.77 52.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 72.31 110.936 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.91 HG21 HD13 ' A' ' 406' ' ' LEU . 1.7 mp -126.28 124.47 65.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.051 -0.522 . . . . 72.1 111.166 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.5 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -109.0 154.59 16.42 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 62.23 112.438 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 1.9 t30 82.82 45.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.859 0.362 . . . . 74.34 110.891 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.513 ' CG2' ' HB3' ' A' ' 352' ' ' ALA . 68.0 mt -99.26 129.85 28.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.642 0.734 . . . . 71.22 111.104 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . 0.585 ' HB2' ' CD1' ' A' ' 351' ' ' PHE . 54.1 Cg_endo -69.72 157.87 58.98 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.684 2.256 . . . . 73.53 112.375 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -60.81 -30.9 70.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 70.32 110.865 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 28.1 p90 -86.1 33.3 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 61.03 110.876 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.665 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -113.64 82.59 1.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 41.44 111.136 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 17.9 p -84.98 167.56 15.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.118 -0.492 . . . . 72.34 111.185 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . 0.507 ' O ' ' CG1' ' A' ' 358' ' ' ILE . 0.3 OUTLIER -67.21 -29.43 69.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 73.51 110.88 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -59.12 -25.65 64.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 74.32 111.108 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.0 -17.1 13.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 71.35 110.837 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.665 HD11 ' HB1' ' A' ' 352' ' ' ALA . 4.7 mp -95.56 -53.5 3.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.424 . . . . 51.35 110.896 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.668 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.3 mm -39.51 -50.7 5.03 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.537 0.684 . . . . 70.44 111.079 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.1 Cg_endo -69.74 -26.62 27.46 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.715 2.277 . . . . 70.32 112.311 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.997 ' O ' HD12 ' A' ' 360' ' ' LEU . 0.1 OUTLIER -70.81 -24.25 62.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 63.2 110.91 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' A' ' 367' ' ' ILE . 91.4 m-85 -102.61 -41.05 6.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 73.33 110.952 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' GLN . . . . . 0.553 ' HG3' HD12 ' A' ' 367' ' ' ILE . 8.4 mt-30 -47.73 -44.68 28.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 65.52 110.883 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . 0.416 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.3 OUTLIER -45.64 -28.47 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 72.31 110.922 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . 0.457 ' CD2' ' HA ' ' A' ' 361' ' ' PHE . 33.7 m-85 -63.35 -57.32 10.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.854 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -154.27 -86.59 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.742 . . . . 32.11 112.528 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -153.58 140.62 19.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.851 0.358 . . . . 74.52 110.833 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . 0.553 HD12 ' HG3' ' A' ' 362' ' ' GLN . 41.2 mt -120.97 109.09 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 75.02 111.195 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.8 mp -86.76 -18.04 32.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 74.24 110.948 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -170.76 120.9 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 72.34 110.88 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.516 ' CE2' ' HB2' ' A' ' 372' ' ' HIS . 33.0 t80 -113.48 141.88 46.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 63.45 110.903 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.64 101.21 6.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 75.45 110.905 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . 0.579 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.6 t-80 -98.46 130.25 45.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 63.43 110.901 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -125.89 90.59 50.05 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.718 0.77 . . . . 71.14 110.906 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' PRO . . . . . 0.552 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.5 Cg_endo -69.73 -38.25 8.11 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.739 2.293 . . . . 42.43 112.299 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.53 -21.3 62.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 72.12 110.861 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -111.55 -25.74 9.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 53.33 110.877 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 84.31 42.29 7.53 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.725 -0.75 . . . . 64.42 112.519 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 31.1 p -154.84 153.98 32.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.775 0.321 . . . . 73.31 110.866 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 13.7 p -144.89 146.23 31.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 75.01 110.867 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.463 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 43.1 m-85 -125.16 122.34 36.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 73.43 110.882 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -110.84 133.67 55.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 73.1 111.171 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 128.58 46.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 74.34 110.855 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -111.6 178.4 4.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 70.34 110.877 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -76.73 -45.54 28.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.078 -0.51 . . . . 71.21 110.894 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 40.5 p -117.08 172.47 7.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 74.42 111.154 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' HIS . . . . . 0.661 ' HA ' HG22 ' A' ' 341' ' ' THR . 47.6 p-80 -85.29 -41.0 15.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 71.24 110.866 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -33.75 69.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 52.21 110.863 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -65.12 -34.93 79.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 75.42 110.889 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -67.11 -39.44 86.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 65.12 111.152 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.794 ' HB1' HG13 ' A' ' 329' ' ' VAL . . . -56.07 -33.86 65.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 63.4 111.148 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.24 -40.21 85.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 60.24 111.166 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 13.3 t -75.04 -31.56 61.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 73.34 110.9 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 332' ' ' ILE . 0.2 OUTLIER -59.52 -54.97 27.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 45.22 111.145 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.873 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.81 -36.09 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 53.43 111.13 179.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.32 -48.25 80.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 72.34 111.163 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.678 HD13 ' CD1' ' A' ' 399' ' ' PHE . 0.5 OUTLIER -79.3 -13.72 59.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 63.21 110.927 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -50.21 108.38 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 74.2 111.103 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 10.5 m120 49.62 50.8 17.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 73.13 110.91 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.678 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -109.2 146.97 35.0 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.629 0.728 . . . . 73.53 110.916 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . 0.519 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.7 Cg_endo -69.84 145.18 55.92 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.657 2.238 . . . . 71.55 112.383 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' PHE . . . . . 0.574 ' CE1' HD22 ' A' ' 360' ' ' LEU . 32.9 t80 -151.01 110.67 4.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 74.01 110.918 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 48.97 33.99 5.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 63.25 110.906 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.26 -32.7 7.17 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.727 -0.749 . . . . 71.31 112.549 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.3 OUTLIER -104.89 144.37 31.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 70.01 110.807 -179.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.03 154.44 24.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 42.51 110.849 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.91 HD13 HG21 ' A' ' 345' ' ' ILE . 16.8 mt -113.7 169.92 8.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 74.52 110.959 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 346' ' ' GLY . 2.0 ttt180 -111.27 174.4 5.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 73.51 110.907 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . 0.553 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 64.3 p -154.25 148.44 25.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.477 . . . . 54.13 111.118 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 32.33 112.488 179.964 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.842 0.353 . . . . 74.5 110.95 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.38 -31.46 61.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 71.13 111.103 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' VAL . . . . . 0.889 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 8.0 t -69.08 -29.58 43.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 71.42 111.118 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' ASP . . . . . 0.406 ' HA ' HD12 ' A' ' 333' ' ' ILE . 29.8 t0 -53.94 -35.17 61.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 73.32 110.875 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -68.41 -31.85 71.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 74.33 110.879 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.784 HG21 HG21 ' A' ' 393' ' ' ILE . 40.8 mm -57.82 -51.29 72.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 75.2 111.125 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 330' ' ' ASP . 5.4 mt -53.44 -37.23 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 75.03 111.16 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.82 -9.42 4.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 74.23 110.873 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 336' ' ' ALA . 0.5 OUTLIER -107.1 42.02 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 75.52 110.83 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . 178.35 162.83 0.64 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.566 0.698 . . . . 70.44 111.093 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 54.2 Cg_endo -69.75 160.55 49.29 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.737 2.291 . . . . 73.22 112.371 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -16.0 37.71 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.69 2.26 . . . . 62.53 112.37 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -112.53 73.91 0.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 72.43 110.899 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 337' ' ' PRO . 14.7 p -160.4 121.77 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 72.34 111.147 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' THR . . . . . 0.788 HG22 ' CA ' ' A' ' 386' ' ' HIS . 18.8 p -136.02 67.9 1.46 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 73.22 111.084 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 33.8 m -133.84 108.23 8.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 65.23 111.165 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -80.27 129.77 34.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 75.2 111.178 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.655 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -112.79 134.67 54.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 72.31 110.92 -179.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.717 HG21 HD13 ' A' ' 406' ' ' LEU . 1.5 mp -136.28 99.83 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.127 -0.488 . . . . 72.1 111.145 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -89.31 176.61 43.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 62.23 112.58 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.3 t30 68.38 47.27 0.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 74.34 110.892 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.461 HD11 HG22 ' A' ' 345' ' ' ILE . 55.0 mt -101.97 131.13 23.09 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.602 0.715 . . . . 71.22 111.144 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.85 165.98 29.24 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.249 . . . . 73.53 112.276 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -69.61 -26.33 64.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 70.32 110.858 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -85.47 32.23 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 61.03 110.877 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' ALA . . . . . 0.788 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -117.62 110.95 18.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 41.44 111.146 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 13.7 p -114.5 166.39 11.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 72.34 111.144 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' GLU . . . . . 0.511 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -63.45 -33.58 75.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 73.51 110.968 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.91 -26.77 59.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 74.32 111.092 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.22 -13.21 13.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 71.35 110.864 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.788 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.7 mp -99.37 -53.66 3.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 51.35 110.91 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.636 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -40.44 -51.73 6.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.628 0.728 . . . . 70.44 111.192 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.1 Cg_endo -69.73 -38.51 7.76 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.655 2.237 . . . . 70.32 112.331 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' LEU . . . . . 0.941 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -54.99 -27.7 46.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 63.2 110.889 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' PHE . . . . . 0.64 ' N ' HD13 ' A' ' 360' ' ' LEU . 84.0 m-85 -95.16 -38.1 10.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 73.33 110.958 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' GLN . . . . . 0.643 ' HG3' HD12 ' A' ' 367' ' ' ILE . 30.4 mt-30 -48.68 -43.25 36.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 65.52 110.911 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' ASN . . . . . 0.437 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.5 OUTLIER -42.87 -28.2 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.955 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' PHE . . . . . 0.542 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 18.7 m-85 -66.14 -58.55 5.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 73.33 110.92 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . 0.425 ' HA3' ' CD ' ' A' ' 388' ' ' GLN . . . -156.67 -84.34 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.76 -0.733 . . . . 32.11 112.519 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.412 ' O ' ' CD2' ' A' ' 383' ' ' TYR . 17.6 t80 -153.96 144.68 22.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 74.52 110.902 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' ILE . . . . . 0.643 HD12 ' HG3' ' A' ' 362' ' ' GLN . 47.1 mt -120.86 108.78 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.02 111.138 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.32 -16.01 36.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.179 -0.464 . . . . 74.24 110.894 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -170.58 120.81 0.58 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.445 . . . . 72.34 110.862 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 34.7 t80 -115.44 136.11 53.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 63.45 110.894 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 379' ' ' CYS . 0.0 OUTLIER -122.62 100.3 6.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.866 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' HIS . . . . . 0.595 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 10.3 t-80 -100.2 110.79 23.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 63.43 110.862 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.571 ' CE1' ' HA ' ' A' ' 379' ' ' CYS . 1.0 OUTLIER -119.53 94.52 48.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.644 0.735 . . . . 71.14 110.89 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 373' ' ' TYR . 53.6 Cg_endo -69.82 -17.4 37.3 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.724 2.282 . . . . 42.43 112.308 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.48 -28.62 69.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 72.12 110.917 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -111.69 -24.23 10.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 53.33 110.9 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 91.07 37.44 6.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.717 -0.754 . . . . 64.42 112.477 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' CYS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 373' ' ' TYR . 0.0 OUTLIER -156.23 151.69 26.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 73.31 110.872 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' CYS . . . . . 0.571 ' HA ' ' CE1' ' A' ' 373' ' ' TYR . 25.6 p -126.05 171.35 10.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 75.01 110.834 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' PHE . . . . . 0.551 ' CE2' ' OH ' ' A' ' 373' ' ' TYR . 27.6 m-85 -137.63 107.32 6.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 73.43 110.829 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' ILE . . . . . 0.558 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.7 OUTLIER -106.21 113.31 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 73.1 111.119 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -87.33 130.85 34.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.9 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.583 ' CD2' ' OE1' ' A' ' 388' ' ' GLN . 46.6 m-85 -113.67 153.94 28.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 70.34 110.917 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -53.76 -47.3 70.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 71.21 110.885 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.7 p -108.82 157.73 18.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 74.42 111.119 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' HIS . . . . . 0.788 ' CA ' HG22 ' A' ' 341' ' ' THR . 20.8 p-80 -83.97 -44.49 14.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 71.24 110.777 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' GLU . . . . . 0.462 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 0.1 OUTLIER -57.24 -26.94 61.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 52.21 110.851 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' GLN . . . . . 0.583 ' OE1' ' CD2' ' A' ' 383' ' ' TYR . 0.8 OUTLIER -70.3 -32.52 70.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.182 -0.463 . . . . 75.42 110.965 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.469 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -68.4 -33.86 74.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 65.12 111.11 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' ALA . . . . . 0.889 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -54.55 -28.76 48.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 63.4 111.093 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 77.7 t -71.36 -51.02 36.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 60.24 111.196 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' CYS . . . . . 0.542 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 3.6 t -61.46 -31.08 71.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 73.34 110.847 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' ILE . . . . . 0.784 HG21 HG21 ' A' ' 332' ' ' ILE . 1.1 mt -57.15 -56.02 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 45.22 111.166 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' VAL . . . . . 0.483 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.2 t -72.39 -35.18 51.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 53.43 111.122 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.85 -49.75 76.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 72.34 111.116 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' LEU . . . . . 0.612 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.7 mm? -77.16 -7.84 56.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.423 . . . . 63.21 110.981 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' ALA . . . . . 0.626 ' N ' HG21 ' A' ' 408' ' ' THR . . . -54.78 112.23 0.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.2 111.096 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 43.98 48.71 7.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 73.13 110.909 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' PHE . . . . . 0.612 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -102.79 141.58 22.79 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.726 0.774 . . . . 73.53 110.86 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 136.37 32.99 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.706 2.271 . . . . 71.55 112.388 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' PHE . . . . . 0.571 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 36.8 t80 -140.67 110.81 6.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 74.01 110.868 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 50.19 32.72 6.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 63.25 110.911 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 100.69 -30.09 11.01 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.699 -0.762 . . . . 71.31 112.451 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.07 138.89 40.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.838 0.351 . . . . 70.01 110.901 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -80.69 155.13 26.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 42.51 110.855 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.717 HD13 HG21 ' A' ' 345' ' ' ILE . 16.5 mt -114.61 176.82 4.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.52 110.955 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' ARG . . . . . 0.401 ' N ' ' O ' ' A' ' 346' ' ' GLY . 0.2 OUTLIER -114.09 173.45 6.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 73.51 110.91 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' THR . . . . . 0.626 HG21 ' N ' ' A' ' 397' ' ' ALA . 72.0 p -154.63 151.06 28.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 54.13 111.115 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 120.778 -0.725 . . . . 32.33 112.534 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.45 -0.26 . . . . 64.33 112.45 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 26.9 m -67.82 147.85 52.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 45.32 110.857 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -73.46 95.13 2.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 60.02 110.922 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.7 p -138.54 91.58 2.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 74.33 111.159 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.48 133.6 42.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 65.44 111.125 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -112.49 108.8 2.27 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 65.31 112.485 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.51 77.5 7.94 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.609 0.718 . . . . 73.31 110.934 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 157.39 60.5 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.675 2.25 . . . . 71.31 112.297 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -28.3 25.49 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.697 2.265 . . . . 74.51 112.341 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.56 140.66 49.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 74.24 110.88 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.479 HG13 ' CG1' ' A' ' 394' ' ' VAL . 10.7 t 67.56 142.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 64.22 111.132 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.29 130.5 23.58 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.634 0.73 . . . . 75.14 110.889 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -14.08 35.51 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.644 2.229 . . . . 63.34 112.342 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -71.99 -71.93 0.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 74.5 110.918 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.95 -25.09 27.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 71.13 111.125 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.828 HG22 ' HB ' ' A' ' 394' ' ' VAL . 7.9 t -79.96 -29.78 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 71.42 111.096 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.412 ' HA ' HD12 ' A' ' 333' ' ' ILE . 6.8 t70 -54.54 -36.88 64.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 73.32 110.865 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -64.2 -32.24 73.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 74.33 110.854 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.737 HG21 HG21 ' A' ' 393' ' ' ILE . 22.6 mm -60.31 -52.81 56.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 75.2 111.151 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 330' ' ' ASP . 4.8 mt -55.48 -41.63 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 75.03 111.137 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.96 -16.69 2.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 74.23 110.856 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.56 23.49 8.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 75.52 110.878 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.536 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . -174.96 159.09 2.27 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.574 0.702 . . . . 70.44 111.087 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.536 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 53.5 Cg_endo -69.73 150.2 68.06 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.67 2.247 . . . . 73.22 112.365 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -14.23 35.74 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.701 2.267 . . . . 62.53 112.332 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.521 ' O ' HG23 ' A' ' 341' ' ' THR . 0.5 OUTLIER -72.43 -63.13 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 72.43 110.882 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.9 p -52.64 143.83 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 72.34 111.091 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . 0.677 HG22 ' CA ' ' A' ' 386' ' ' HIS . 22.3 p -146.98 68.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 73.22 111.128 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 87.7 m -133.78 139.46 46.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 65.23 111.116 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -105.78 121.78 44.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 75.2 111.083 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.602 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -102.93 122.09 43.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 72.31 110.877 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.561 HG21 HD13 ' A' ' 406' ' ' LEU . 1.9 mp -118.58 112.85 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.085 -0.507 . . . . 72.1 111.149 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -102.23 171.82 21.77 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.76 -0.734 . . . . 62.23 112.479 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.416 ' O ' ' CD2' ' A' ' 406' ' ' LEU . 1.4 t30 71.45 46.59 0.41 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.337 . . . . 74.34 110.917 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.615 HG23 ' HD2' ' A' ' 349' ' ' PRO . 86.9 mt -102.77 137.17 19.24 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.622 0.725 . . . . 71.22 111.147 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . 0.615 ' HD2' HG23 ' A' ' 348' ' ' ILE . 53.6 Cg_endo -69.76 163.53 37.94 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.679 2.253 . . . . 73.53 112.341 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -70.5 -24.05 62.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 70.32 110.884 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.559 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 29.4 p90 -90.74 29.46 1.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 61.03 110.883 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.795 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -112.63 99.11 7.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 41.44 111.13 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 13.3 p -99.2 169.49 9.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 72.34 111.13 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.513 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.29 -29.76 69.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 73.51 110.839 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -59.0 -26.04 64.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 74.32 111.13 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.78 -13.09 13.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 71.35 110.841 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.795 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.5 mp -99.93 -53.24 3.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 51.35 110.936 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.647 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -41.49 -51.14 8.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.574 0.702 . . . . 70.44 111.118 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' PRO . . . . . 0.647 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.4 Cg_endo -69.78 -30.47 22.15 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.668 2.246 . . . . 70.32 112.339 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.891 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -64.96 -20.12 66.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 63.2 110.955 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.596 ' HB2' HD11 ' A' ' 367' ' ' ILE . 88.1 m-85 -104.8 -37.01 7.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 73.33 110.89 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -48.56 -45.51 37.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 65.52 110.931 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . 0.419 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.8 OUTLIER -44.49 -23.77 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 72.31 110.858 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . 0.594 ' CE2' ' HB2' ' A' ' 392' ' ' CYS . 32.2 m-85 -69.85 -51.29 34.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 73.33 110.846 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -163.26 -88.0 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 32.11 112.473 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -151.74 144.49 24.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 74.52 110.913 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.596 HD11 ' HB2' ' A' ' 361' ' ' PHE . 25.9 mt -121.07 109.74 26.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 75.02 111.147 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.43 -19.42 29.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 74.24 110.889 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -170.96 120.74 0.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.889 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 33.5 t80 -113.61 131.33 56.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 63.45 110.902 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.31 100.73 7.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 75.45 110.928 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . 0.588 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 13.6 t-80 -97.81 127.44 43.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 63.43 110.905 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -122.85 86.58 50.28 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.712 0.768 . . . . 71.14 110.944 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . 0.478 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 54.0 Cg_endo -69.76 -21.38 33.56 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.732 2.288 . . . . 42.43 112.357 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -69.47 -23.76 63.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 72.12 110.871 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -115.39 -25.79 7.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 53.33 110.893 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.09 44.83 4.63 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.718 -0.753 . . . . 64.42 112.458 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 93.9 m -156.93 147.94 21.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 73.31 110.886 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.472 ' HB2' ' CE1' ' A' ' 370' ' ' PHE . 21.5 p -138.01 153.18 49.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 75.01 110.882 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 380' ' ' PHE . 2.3 m-85 -128.48 118.92 23.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.877 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.458 HG21 ' CD1' ' A' ' 367' ' ' ILE . 0.8 OUTLIER -107.7 128.73 62.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 73.1 111.108 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -97.94 132.25 43.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 74.34 110.909 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -114.67 -178.9 3.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 70.34 110.96 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -76.78 -40.58 47.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.469 . . . . 71.21 110.898 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 53.5 p -125.17 167.11 15.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 74.42 111.143 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' HIS . . . . . 0.677 ' CA ' HG22 ' A' ' 341' ' ' THR . 9.8 p-80 -72.99 -40.58 65.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 71.24 110.869 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . 0.428 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 0.4 OUTLIER -57.87 -26.97 62.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 52.21 110.878 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -65.71 -33.48 75.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 75.42 110.848 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -78.93 -34.65 44.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 65.12 111.057 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.821 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -61.15 -34.46 75.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.239 -0.437 . . . . 63.4 111.097 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 92.2 t -64.8 -57.24 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 60.24 111.132 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . 0.594 ' HB2' ' CE2' ' A' ' 364' ' ' PHE . 30.1 p -66.28 -27.06 67.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 73.34 110.906 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.858 ' O ' HG21 ' A' ' 408' ' ' THR . 1.3 mt -58.21 -54.56 30.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 45.22 111.112 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.828 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.5 OUTLIER -71.5 -34.21 52.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 53.43 111.105 179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.8 -37.05 85.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 72.34 111.143 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.635 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.8 mm? -86.14 -12.91 48.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 63.21 110.916 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -53.45 111.03 0.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 74.2 111.089 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.9 m120 47.73 48.91 17.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 73.13 110.927 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.635 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -104.59 144.26 28.35 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.608 0.718 . . . . 73.53 110.874 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 139.09 39.35 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.653 2.236 . . . . 71.55 112.364 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' PHE . . . . . 0.615 ' CZ ' ' NE2' ' A' ' 402' ' ' GLN . 41.0 t80 -145.85 111.8 5.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 74.01 110.9 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.615 ' NE2' ' CZ ' ' A' ' 401' ' ' PHE . 20.9 mt-30 51.07 32.64 7.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 63.25 110.976 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.92 -26.23 25.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.696 -0.764 . . . . 71.31 112.448 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 401' ' ' PHE . 3.3 ttt180 -109.43 141.3 42.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.761 0.315 . . . . 70.01 110.876 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -82.52 155.19 24.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 42.51 110.873 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.561 HD13 HG21 ' A' ' 345' ' ' ILE . 27.3 mt -117.19 178.31 4.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 74.52 110.91 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.59 176.02 5.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 73.51 110.864 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . 0.858 HG21 ' O ' ' A' ' 393' ' ' ILE . 1.8 p -146.77 156.67 43.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 54.13 111.142 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 166.77 -176.14 41.91 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.725 -0.75 . . . . 32.33 112.478 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.443 ' O ' ' C ' ' A' ' 411' ' ' GLY . 73.3 m95 -95.11 119.04 32.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.757 0.313 . . . . 55.52 110.925 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 410' ' ' TRP . . . -34.36 111.04 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.796 -0.716 . . . . 72.43 112.442 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 413' ' ' GLU . 2.5 mtmp? -134.69 145.63 48.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.712 0.291 . . . . 72.54 110.9 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 412' ' ' LYS . 1.5 mt-10 -34.87 -45.32 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 72.32 110.919 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 71.13 110.877 -179.933 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.464 -0.255 . . . . 64.33 112.464 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 1.5 t -122.56 145.2 48.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.846 0.355 . . . . 45.32 110.875 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.93 -54.15 1.63 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 60.02 110.957 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 31.6 m 64.99 116.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 74.33 111.114 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 10.4 tp -95.98 148.65 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 65.44 111.11 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -98.0 -37.08 4.51 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.782 -0.723 . . . . 65.31 112.493 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 4.9 mt 65.28 67.54 0.78 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.589 0.709 . . . . 73.31 110.923 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 149.51 66.95 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.639 2.226 . . . . 71.31 112.399 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -7.09 20.16 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.738 2.292 . . . . 74.51 112.313 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.21 -168.83 2.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 74.24 110.921 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.596 HG11 ' HB2' ' A' ' 395' ' ' ALA . 21.6 m -38.22 158.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 64.22 111.167 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -113.08 143.77 29.82 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.619 0.723 . . . . 75.14 110.891 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.86 -14.17 35.41 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.664 2.243 . . . . 63.34 112.297 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -72.86 -72.03 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 74.5 110.869 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -52.58 -24.84 9.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 71.13 111.082 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.853 HG22 ' HB ' ' A' ' 394' ' ' VAL . 5.0 t -81.58 -30.06 10.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 71.42 111.098 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.474 ' HA ' HD12 ' A' ' 333' ' ' ILE . 6.2 t0 -55.06 -38.06 67.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 73.32 110.817 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -59.9 -37.69 80.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 74.33 110.902 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.544 HG21 HD13 ' A' ' 393' ' ' ILE . 16.6 mm -54.96 -54.46 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 75.2 111.138 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.474 HD12 ' HA ' ' A' ' 330' ' ' ASP . 7.2 mt -51.61 -41.35 27.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 75.03 111.148 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.18 -16.84 2.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 74.23 110.853 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.38 29.01 5.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.205 -0.452 . . . . 75.52 110.872 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.58 ' HB2' ' CD1' ' A' ' 410' ' ' TRP . . . -159.59 154.27 20.9 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.57 0.7 . . . . 70.44 111.13 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 156.52 63.01 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.677 2.251 . . . . 73.22 112.36 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -6.68 19.19 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.661 2.24 . . . . 62.53 112.395 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -119.93 76.45 1.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 72.43 110.944 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 7.5 p -179.62 141.84 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 72.34 111.156 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . 0.524 HG22 ' HA ' ' A' ' 386' ' ' HIS . 21.0 p -149.46 69.79 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 73.22 111.13 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 96.4 m -133.5 116.08 15.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 65.23 111.109 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -89.14 121.86 31.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 75.2 111.077 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.56 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -102.99 125.56 49.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 72.31 110.907 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.506 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.9 mp -122.52 118.86 56.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 72.1 111.17 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -105.91 -179.01 23.6 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.725 -0.75 . . . . 62.23 112.482 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.501 ' O ' HD23 ' A' ' 406' ' ' LEU . 0.7 OUTLIER 62.82 49.73 3.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.753 0.311 . . . . 74.34 110.811 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.512 ' CG2' ' HB3' ' A' ' 352' ' ' ALA . 86.8 mt -103.25 134.17 19.92 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.57 0.7 . . . . 71.22 111.177 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . 0.513 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.7 Cg_endo -69.77 165.38 31.18 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.704 2.27 . . . . 73.53 112.367 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.78 -25.8 63.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.273 -0.421 . . . . 70.32 110.916 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.402 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 2.9 p90 -89.88 31.87 0.94 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 61.03 110.851 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.853 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -120.62 99.18 6.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 41.44 111.107 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 79.5 p -104.79 173.66 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.269 -0.423 . . . . 72.34 111.208 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.513 ' O ' ' CG1' ' A' ' 358' ' ' ILE . 0.6 OUTLIER -66.71 -29.85 69.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 73.51 110.915 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.41 -26.28 63.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 74.32 111.038 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.42 -17.51 12.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.258 -0.428 . . . . 71.35 110.804 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.853 HD11 ' HB1' ' A' ' 352' ' ' ALA . 4.0 mp -92.33 -51.1 5.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 51.35 110.851 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.681 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.3 mm -42.34 -49.98 11.95 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.581 0.705 . . . . 70.44 111.082 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.6 Cg_endo -69.76 -28.0 25.78 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.685 2.257 . . . . 70.32 112.365 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.845 HD13 ' C ' ' A' ' 360' ' ' LEU . 0.2 OUTLIER -68.11 -25.99 65.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 63.2 110.891 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.641 ' CE2' HD12 ' A' ' 360' ' ' LEU . 85.3 m-85 -102.42 -34.69 9.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 73.33 110.886 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' GLN . . . . . 0.559 ' HG3' HD12 ' A' ' 367' ' ' ILE . 2.0 mt-30 -54.63 -32.36 58.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.491 . . . . 65.52 110.882 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.05 -13.67 12.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 72.31 110.872 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . 0.481 ' CD2' ' HB3' ' A' ' 392' ' ' CYS . 39.3 m-85 -78.78 -55.9 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 73.33 110.926 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -155.19 -86.77 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.647 -0.787 . . . . 32.11 112.443 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.443 ' CE2' ' HG ' ' A' ' 368' ' ' LEU . 61.2 t80 -153.62 140.78 19.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.809 0.337 . . . . 74.52 110.906 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.559 HD12 ' HG3' ' A' ' 362' ' ' GLN . 42.0 mt -120.33 109.29 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 75.02 111.161 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.443 ' HG ' ' CE2' ' A' ' 366' ' ' PHE . 0.9 OUTLIER -86.18 -20.24 28.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.93 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -169.89 121.36 0.67 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.227 -0.442 . . . . 72.34 110.923 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 35.0 t80 -113.61 145.7 40.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 63.45 110.895 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -131.44 101.97 5.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 75.45 110.952 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 6.2 t-80 -100.83 127.24 47.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.295 -0.412 . . . . 63.43 110.856 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -118.2 90.55 38.24 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.703 0.763 . . . . 71.14 110.958 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . 0.418 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.4 Cg_endo -69.75 -19.69 35.84 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.718 2.278 . . . . 42.43 112.335 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -84.38 -21.96 30.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 72.12 110.823 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -106.53 -26.43 11.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 53.33 110.866 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . 0.4 ' C ' ' SG ' ' A' ' 378' ' ' CYS . . . 84.74 35.38 13.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 64.42 112.489 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . 0.4 ' SG ' ' C ' ' A' ' 377' ' ' GLY . 1.8 m -153.64 140.98 19.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.774 0.321 . . . . 73.31 110.901 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 17.7 p -133.14 146.08 51.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 75.01 110.889 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 344' ' ' TYR . 7.4 m-85 -124.15 127.69 48.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 73.43 110.911 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.537 HD13 ' CD1' ' A' ' 361' ' ' PHE . 1.0 OUTLIER -113.36 130.74 66.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 73.1 111.145 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -94.67 131.35 40.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.922 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -114.85 -174.58 2.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 70.34 110.902 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -93.47 -30.49 15.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.096 -0.502 . . . . 71.21 110.9 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 24.8 p -125.7 165.8 17.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 74.42 111.088 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' HIS . . . . . 0.524 ' HA ' HG22 ' A' ' 341' ' ' THR . 17.9 p-80 -78.42 -41.46 32.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 71.24 110.855 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 6.6 tm-20 -57.37 -31.27 65.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 52.21 110.861 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -36.29 82.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 75.42 110.933 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.614 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -76.02 -27.14 57.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 65.12 111.063 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.724 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -72.72 -35.51 67.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 63.4 111.063 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.479 HG13 HG21 ' A' ' 324' ' ' VAL . 82.7 t -66.02 -53.57 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.12 -0.491 . . . . 60.24 111.124 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . 0.481 ' HB3' ' CD2' ' A' ' 364' ' ' PHE . 31.5 p -65.35 -31.76 73.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.134 -0.484 . . . . 73.34 110.861 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.762 ' O ' HG21 ' A' ' 408' ' ' THR . 0.7 OUTLIER -55.67 -55.65 16.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 45.22 111.133 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.853 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.67 -36.79 60.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 53.43 111.164 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.596 ' HB2' HG11 ' A' ' 324' ' ' VAL . . . -62.2 -30.57 71.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 72.34 111.119 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.68 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.1 mm? -95.93 -16.07 21.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 63.21 110.889 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -48.58 110.39 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.2 111.131 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 42.5 t30 49.45 50.57 17.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 73.13 110.923 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.68 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -107.47 145.62 31.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.655 0.74 . . . . 73.53 110.899 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 143.32 50.81 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.74 2.293 . . . . 71.55 112.333 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' PHE . . . . . 0.526 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 31.6 t80 -150.37 110.97 4.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 74.01 110.892 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 49.82 33.02 5.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 63.25 110.949 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 99.54 -27.76 18.63 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.683 -0.77 . . . . 71.31 112.503 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.3 OUTLIER -107.0 142.03 37.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.903 0.382 . . . . 70.01 110.901 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -83.05 154.79 24.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 42.51 110.834 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 347' ' ' ASN . 19.6 mt -117.78 167.77 11.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.451 . . . . 74.52 110.889 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.58 179.12 4.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 73.51 110.92 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . 0.762 HG21 ' O ' ' A' ' 393' ' ' ILE . 5.9 p -152.86 153.56 33.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 54.13 111.191 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 169.72 -176.12 43.67 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.726 -0.749 . . . . 32.33 112.454 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.58 ' CD1' ' HB2' ' A' ' 336' ' ' ALA . 65.7 m95 -97.09 124.26 41.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.885 0.374 . . . . 55.52 110.898 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -47.04 124.21 8.43 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.7 -0.762 . . . . 72.43 112.507 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 413' ' ' GLU . 0.0 OUTLIER -136.4 88.78 2.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.697 0.284 . . . . 72.54 110.938 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 412' ' ' LYS . 0.9 OUTLIER -36.53 113.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 72.32 110.926 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 71.13 110.879 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.494 -0.242 . . . . 64.33 112.494 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 21.0 m -124.63 -68.16 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.879 0.371 . . . . 45.32 110.896 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -179.94 -42.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 60.02 110.872 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 47.4 p -105.9 167.2 9.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 74.33 111.163 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 319' ' ' GLY . 5.5 tt -168.16 -45.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 65.44 111.121 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.541 ' N ' HG23 ' A' ' 318' ' ' ILE . . . 83.09 -36.49 2.72 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.761 -0.733 . . . . 65.31 112.472 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 3.5 mt 61.68 59.38 3.0 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.61 0.719 . . . . 73.31 110.933 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.71 164.91 32.71 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.642 2.228 . . . . 71.31 112.375 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -36.95 9.89 Favored 'Trans proline' 0 C--O 1.23 0.109 0 C-N-CA 122.688 2.259 . . . . 74.51 112.355 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.488 ' HA ' ' NE2' ' A' ' 323' ' ' GLN . 0.0 OUTLIER 169.83 94.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.907 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.801 HG11 HG13 ' A' ' 391' ' ' VAL . 5.8 t -157.16 148.52 10.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 64.22 111.195 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -112.95 118.27 44.83 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.629 0.728 . . . . 75.14 110.824 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 -14.09 35.44 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.737 2.291 . . . . 63.34 112.29 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -70.99 -71.63 0.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 74.5 110.874 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -58.48 -25.01 61.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.213 -0.449 . . . . 71.13 111.002 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.9 HG22 ' HB ' ' A' ' 394' ' ' VAL . 14.6 t -74.82 -30.03 23.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 71.42 111.117 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.466 ' HA ' HD12 ' A' ' 333' ' ' ILE . 23.5 t0 -55.03 -36.92 66.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 73.32 110.878 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -62.42 -36.34 82.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 74.33 110.909 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.492 HG21 HG21 ' A' ' 393' ' ' ILE . 20.4 mm -55.42 -53.25 37.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 75.2 111.071 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.466 HD12 ' HA ' ' A' ' 330' ' ' ASP . 5.5 mt -53.02 -40.51 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 75.03 111.163 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.92 -16.27 2.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 74.23 110.844 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' A' ' 336' ' ' ALA . 0.2 OUTLIER -105.02 44.75 1.0 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 75.52 110.823 -179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 335' ' ' SER . . . 167.32 147.31 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.659 0.742 . . . . 70.44 111.095 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.913 ' O ' HG12 ' A' ' 340' ' ' VAL . 53.4 Cg_endo -69.81 151.27 68.76 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.667 2.245 . . . . 73.22 112.342 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -8.88 24.74 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.766 2.311 . . . . 62.53 112.332 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.42 16.58 3.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 72.43 110.863 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.913 HG12 ' O ' ' A' ' 337' ' ' PRO . 13.9 p -131.29 140.15 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 72.34 111.164 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . 0.671 HG22 ' CA ' ' A' ' 386' ' ' HIS . 21.0 p -148.78 68.11 1.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 73.22 111.138 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 28.1 m -133.78 127.62 33.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.474 . . . . 65.23 111.098 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -94.96 120.69 35.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 75.2 111.169 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.794 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -105.86 131.72 52.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 72.31 110.92 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.8 HG21 HD13 ' A' ' 406' ' ' LEU . 1.7 mp -126.22 117.68 49.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 72.1 111.121 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -105.11 162.59 14.48 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.741 . . . . 62.23 112.524 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.5 t30 76.14 44.71 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.86 0.362 . . . . 74.34 110.888 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.541 HG23 ' HD2' ' A' ' 349' ' ' PRO . 67.3 mt -94.59 135.2 24.23 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.613 0.721 . . . . 71.22 111.115 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . 0.554 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 52.9 Cg_endo -69.77 159.75 52.25 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.732 2.288 . . . . 73.53 112.337 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -67.86 -21.47 65.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 70.32 110.817 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 349' ' ' PRO . 5.4 p90 -93.86 28.49 2.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 61.03 110.903 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.765 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -110.83 102.07 10.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 41.44 111.117 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 14.3 p -102.8 169.26 8.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 72.34 111.109 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.516 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.49 -31.32 71.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.457 . . . . 73.51 110.865 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.96 -26.38 59.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 74.32 111.1 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -111.98 -13.11 13.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 71.35 110.902 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.765 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.4 mp -99.47 -54.18 3.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 51.35 110.91 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.632 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -40.29 -51.79 6.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.664 0.745 . . . . 70.44 111.088 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.3 Cg_endo -69.76 -38.12 8.24 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.72 2.28 . . . . 70.32 112.339 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.929 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -55.32 -26.67 42.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.442 . . . . 63.2 110.925 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.62 ' N ' HD13 ' A' ' 360' ' ' LEU . 85.2 m-85 -97.42 -39.22 9.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 73.33 110.861 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' GLN . . . . . 0.622 ' HG3' HD12 ' A' ' 367' ' ' ILE . 6.8 mt-30 -47.52 -44.26 25.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 65.52 111.006 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 360' ' ' LEU . 0.9 OUTLIER -45.05 -29.01 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 72.31 110.879 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . 0.56 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 34.0 m-85 -63.33 -57.39 10.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 73.33 110.913 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -156.8 -83.7 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.729 . . . . 32.11 112.507 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -153.5 144.76 23.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.798 0.332 . . . . 74.52 110.885 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.622 HD12 ' HG3' ' A' ' 362' ' ' GLN . 69.1 mt -121.13 109.08 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 75.02 111.12 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.3 mt -88.1 -19.8 26.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.456 . . . . 74.24 110.877 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.15 120.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 72.34 110.848 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.508 ' CE2' ' HB2' ' A' ' 372' ' ' HIS . 34.9 t80 -113.1 142.2 46.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 63.45 110.899 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.5 100.48 5.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 75.45 110.88 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . 0.587 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.0 t-80 -99.59 119.02 37.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 63.43 110.877 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -112.86 88.21 11.37 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.709 0.766 . . . . 71.14 110.944 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . 0.418 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 54.1 Cg_endo -69.78 -26.9 27.01 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.705 2.27 . . . . 42.43 112.355 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.55 -19.75 62.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.446 . . . . 72.12 110.871 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -111.14 -27.07 8.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 53.33 110.895 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 89.11 39.83 6.33 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.781 -0.723 . . . . 64.42 112.479 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.8 p -159.58 153.59 23.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.752 0.31 . . . . 73.31 110.87 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.516 ' C ' ' CD1' ' A' ' 380' ' ' PHE . 15.2 p -138.72 166.71 23.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 75.01 110.866 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 379' ' ' CYS . 7.0 m-85 -142.12 125.57 16.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 73.43 110.806 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.48 126.43 73.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 73.1 111.15 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.71 128.38 42.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 74.34 110.911 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -109.83 179.32 4.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 70.34 110.95 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -81.05 -34.95 32.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.169 -0.469 . . . . 71.21 110.878 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 82.8 p -125.65 166.75 16.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 74.42 111.174 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' HIS . . . . . 0.671 ' CA ' HG22 ' A' ' 341' ' ' THR . 4.1 p-80 -82.58 -38.69 23.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 71.24 110.861 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . 0.403 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 4.5 tt0 -57.4 -27.71 62.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 52.21 110.84 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -35.59 66.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 75.42 110.91 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.51 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -68.47 -37.94 80.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 65.12 111.077 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.642 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -58.59 -33.61 70.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 63.4 111.068 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.801 HG13 HG11 ' A' ' 324' ' ' VAL . 58.3 t -63.58 -57.52 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 60.24 111.128 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . 0.56 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 10.5 t -59.33 -30.18 68.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.496 . . . . 73.34 110.919 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.537 HG22 ' N ' ' A' ' 394' ' ' VAL . 0.5 OUTLIER -59.09 -55.21 25.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 45.22 111.102 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.9 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.79 -34.82 52.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 53.43 111.129 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -64.19 -45.38 88.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 72.34 111.149 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.609 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.7 mm? -81.59 -12.58 58.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 63.21 110.986 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' ALA . . . . . 0.525 ' N ' HG21 ' A' ' 408' ' ' THR . . . -49.37 111.08 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 74.2 111.098 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 6.6 m120 44.26 48.74 7.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 73.13 110.825 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.609 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -103.6 145.77 31.24 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.66 0.743 . . . . 73.53 110.916 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 141.8 46.19 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.692 2.261 . . . . 71.55 112.34 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' PHE . . . . . 0.551 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 30.4 t80 -146.94 110.85 5.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 74.01 110.913 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 47.92 32.96 3.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 63.25 110.936 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.04 -29.85 11.63 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.815 -0.707 . . . . 71.31 112.517 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.76 137.02 43.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.831 0.348 . . . . 70.01 110.887 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -81.65 150.38 28.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 42.51 110.89 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.8 HD13 HG21 ' A' ' 345' ' ' ILE . 28.4 mt -112.39 171.43 7.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 74.52 110.902 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 346' ' ' GLY . 13.4 ttt180 -112.73 174.66 5.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 73.51 110.842 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . 0.562 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 70.7 p -154.28 146.97 24.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 54.13 111.17 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . 0.456 ' O ' ' C ' ' A' ' 410' ' ' TRP . . . 159.78 131.91 1.3 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.764 -0.731 . . . . 32.33 112.506 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.48 ' NE1' HG22 ' A' ' 332' ' ' ILE . 66.1 m95 -33.59 144.47 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.853 0.359 . . . . 55.52 110.907 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -140.59 -172.2 12.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.709 -0.757 . . . . 72.43 112.504 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -144.55 121.26 11.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.748 0.309 . . . . 72.54 110.952 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -47.46 111.39 0.41 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 72.32 110.925 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 2.3 ttt-85 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.489 . . . . 71.13 110.849 -179.87 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.518 -0.233 . . . . 64.33 112.518 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.21 158.42 24.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.744 0.307 . . . . 45.32 110.898 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -136.27 35.36 2.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 60.02 110.919 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 77.3 p -109.4 150.38 28.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 74.33 111.131 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.4 tt -108.65 -7.42 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.473 . . . . 65.44 111.114 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 70.66 -100.42 0.82 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.753 -0.737 . . . . 65.31 112.521 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 320' ' ' LEU . 7.2 mt 51.67 73.02 1.04 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.531 0.682 . . . . 73.31 110.924 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.433 ' HB3' ' CG ' ' A' ' 325' ' ' ASN . 53.9 Cg_endo -69.74 150.9 68.92 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.643 2.229 . . . . 71.31 112.336 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 -21.83 32.94 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.725 2.283 . . . . 74.51 112.31 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -155.27 -66.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 74.24 110.869 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.5 HG13 ' CG1' ' A' ' 394' ' ' VAL . 1.7 t -147.45 134.84 14.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 64.22 111.1 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.433 ' CG ' ' HB3' ' A' ' 321' ' ' PRO . 2.6 m-20 -113.07 139.12 22.63 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.626 0.727 . . . . 75.14 110.875 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -14.66 36.44 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.723 2.282 . . . . 63.34 112.34 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -73.12 -72.39 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 74.5 110.922 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -53.78 -24.87 16.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 71.13 111.163 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.862 HG22 ' HB ' ' A' ' 394' ' ' VAL . 6.9 t -84.36 -30.06 7.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 71.42 111.165 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.611 ' HA ' HD12 ' A' ' 333' ' ' ILE . 22.7 t70 -54.67 -41.17 69.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 73.32 110.953 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -56.6 -39.23 73.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 74.33 110.887 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.659 HG21 HD13 ' A' ' 393' ' ' ILE . 21.5 mm -54.4 -54.34 22.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 75.2 111.097 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.922 HG23 ' NE2' ' A' ' 386' ' ' HIS . 4.3 mt -53.69 -36.34 28.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 75.03 111.124 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -7.98 5.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 74.23 110.873 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.8 7.68 37.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.155 -0.475 . . . . 75.52 110.887 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.434 ' HB2' ' CD1' ' A' ' 410' ' ' TRP . . . -153.0 147.1 18.6 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.598 0.714 . . . . 70.44 111.062 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.716 ' O ' HG12 ' A' ' 340' ' ' VAL . 53.3 Cg_endo -69.77 153.27 69.07 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.694 2.263 . . . . 73.22 112.356 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -7.75 21.85 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.67 2.246 . . . . 62.53 112.351 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 31.9 mtt180 -92.25 37.11 0.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 72.43 110.844 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 337' ' ' PRO . 7.7 p -157.74 142.59 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 72.34 111.138 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . 0.489 HG22 ' HB2' ' A' ' 386' ' ' HIS . 18.2 p -144.39 67.93 1.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 73.22 111.18 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 72.7 m -134.06 137.59 44.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 65.23 111.175 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -108.74 122.22 46.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 75.2 111.138 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -102.06 124.87 48.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.267 -0.424 . . . . 72.31 110.937 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.548 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.9 mp -120.73 104.41 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 72.1 111.083 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -93.3 165.62 27.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.825 -0.703 . . . . 62.23 112.536 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.42 ' O ' HD22 ' A' ' 406' ' ' LEU . 1.5 t30 74.99 55.47 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.851 0.358 . . . . 74.34 110.89 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.583 HG23 ' HD2' ' A' ' 349' ' ' PRO . 76.7 mt -110.19 136.36 20.5 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.634 0.73 . . . . 71.22 111.153 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . 0.583 ' HD2' HG23 ' A' ' 348' ' ' ILE . 54.5 Cg_endo -69.68 162.93 40.12 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.664 2.243 . . . . 73.53 112.359 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.41 -21.27 61.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 70.32 110.862 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.485 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 7.4 p90 -88.02 19.92 3.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 61.03 110.864 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.697 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -104.65 121.34 43.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 41.44 111.08 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 11.5 p -123.08 167.99 12.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 72.34 111.215 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.506 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.3 OUTLIER -63.64 -35.12 79.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 73.51 110.839 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -55.03 -26.89 40.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 74.32 111.114 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.99 -13.5 13.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 71.35 110.914 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.697 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.2 mp -99.06 -55.0 2.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 51.35 110.94 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.623 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -38.82 -52.42 3.69 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.704 0.764 . . . . 70.44 111.146 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.3 Cg_endo -69.75 -40.36 5.42 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.703 2.269 . . . . 70.32 112.381 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.915 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -53.89 -25.28 19.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 63.2 110.929 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.58 ' CE2' HD12 ' A' ' 360' ' ' LEU . 83.4 m-85 -100.46 -39.43 7.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.863 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -51.64 -39.22 57.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 65.52 110.878 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -51.42 -16.8 0.63 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 72.31 110.922 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . 0.511 ' CE2' ' HB2' ' A' ' 392' ' ' CYS . 31.6 m-85 -75.55 -60.04 2.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 73.33 110.927 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -150.02 -85.36 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.646 -0.788 . . . . 32.11 112.42 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 368' ' ' LEU . 15.0 t80 -153.62 141.73 20.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.819 0.342 . . . . 74.52 110.876 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' A' ' 361' ' ' PHE . 40.8 mt -121.04 109.04 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 75.02 111.1 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.758 HD11 ' HD3' ' A' ' 382' ' ' LYS . 2.8 pp -89.3 -16.2 31.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.938 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.683 ' HB2' HD12 ' A' ' 368' ' ' LEU . 0.2 OUTLIER -171.02 120.83 0.53 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.476 . . . . 72.34 110.903 179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 372' ' ' HIS . 35.9 t80 -114.4 141.64 47.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 63.45 110.894 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 5.2 mtmm -129.4 101.12 5.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.125 -0.489 . . . . 75.45 110.907 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . 0.598 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 14.2 t-80 -95.93 121.66 37.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 63.43 110.829 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -116.83 84.0 15.12 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.657 0.741 . . . . 71.14 110.926 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . 0.474 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 54.4 Cg_endo -69.71 -27.08 27.16 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.67 2.247 . . . . 42.43 112.37 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -65.65 -23.58 66.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 72.12 110.914 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -112.83 -25.59 8.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 53.33 110.889 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.61 46.32 4.04 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.728 -0.749 . . . . 64.42 112.476 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 27.4 p -159.78 151.82 20.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.877 0.37 . . . . 73.31 110.906 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 15.1 p -140.52 137.38 33.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 75.01 110.922 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -115.99 119.94 37.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 73.43 110.921 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.55 HD13 ' CG ' ' A' ' 361' ' ' PHE . 1.2 mt -107.64 142.51 20.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 73.1 111.18 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . 0.758 ' HD3' HD11 ' A' ' 368' ' ' LEU . 0.1 OUTLIER -103.27 131.6 50.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.909 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.455 ' CD2' ' HB3' ' A' ' 388' ' ' GLN . 53.1 m-85 -120.33 137.02 54.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 70.34 110.919 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -45.36 -28.77 0.91 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.071 -0.513 . . . . 71.21 110.864 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 69.4 p -130.07 162.69 28.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 74.42 111.139 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' HIS . . . . . 0.922 ' NE2' HG23 ' A' ' 333' ' ' ILE . 10.0 t60 -80.43 -34.42 36.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 71.24 110.863 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -57.31 -32.19 66.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 52.21 110.954 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.455 ' HB3' ' CD2' ' A' ' 383' ' ' TYR . 0.0 OUTLIER -66.8 -34.49 77.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.113 -0.494 . . . . 75.42 110.906 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -71.35 -23.85 61.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 65.12 111.095 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.765 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -78.79 -38.42 38.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 63.4 111.063 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 74.6 t -61.24 -48.6 88.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 60.24 111.103 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . 0.511 ' HB2' ' CE2' ' A' ' 364' ' ' PHE . 19.1 p -71.36 -32.44 68.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 73.34 110.856 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.681 ' O ' HG21 ' A' ' 408' ' ' THR . 0.9 OUTLIER -53.68 -55.35 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 45.22 111.171 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.862 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -72.08 -34.32 49.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.063 -0.517 . . . . 53.43 111.144 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -67.08 -29.09 68.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 72.34 111.147 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.673 HD13 ' CD1' ' A' ' 399' ' ' PHE . 1.9 mm? -97.97 -2.82 39.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 63.21 110.858 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -63.53 111.73 2.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 74.2 111.012 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 50.67 48.1 23.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 73.13 110.893 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.673 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -106.48 142.97 26.05 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.642 0.734 . . . . 73.53 110.867 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.421 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.8 Cg_endo -69.77 141.61 45.64 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.747 2.298 . . . . 71.55 112.34 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' PHE . . . . . 0.559 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 50.1 t80 -147.94 114.25 5.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 74.01 110.838 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER 48.91 32.74 3.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.06 -0.518 . . . . 63.25 110.937 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.36 -27.58 18.78 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.76 -0.733 . . . . 71.31 112.504 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.4 138.76 41.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 70.01 110.864 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.407 ' C ' HD23 ' A' ' 406' ' ' LEU . 3.0 m120 -80.66 149.75 29.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 42.51 110.827 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.42 HD22 ' O ' ' A' ' 347' ' ' ASN . 9.3 mt -112.24 174.93 5.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 74.52 110.948 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 346' ' ' GLY . 0.0 OUTLIER -120.78 173.02 7.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 73.51 110.891 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . 0.681 HG21 ' O ' ' A' ' 393' ' ' ILE . 2.2 p -146.41 153.6 40.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 54.13 111.072 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 163.01 178.05 36.5 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 32.33 112.443 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 336' ' ' ALA . 77.4 m95 -91.58 132.18 36.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.717 0.294 . . . . 55.52 110.962 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -158.42 -177.98 32.02 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.671 -0.776 . . . . 72.43 112.382 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 414' ' ' ARG . 0.0 OUTLIER -166.73 151.84 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.729 0.3 . . . . 72.54 110.91 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.453 ' O ' ' C ' ' A' ' 414' ' ' ARG . 1.9 tt0 -55.47 82.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 72.32 110.816 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 412' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 71.13 110.898 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.525 -0.23 . . . . 64.33 112.525 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 56.6 m 51.67 19.52 0.91 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.833 0.349 . . . . 45.32 110.844 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 10.8 mp0 47.39 92.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 60.02 110.909 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 1.7 t -125.11 111.17 15.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 74.33 111.068 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 319' ' ' GLY . 1.4 tt -172.8 -44.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 65.44 111.068 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.436 ' N ' HG23 ' A' ' 318' ' ' ILE . . . 87.99 45.73 5.01 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.724 -0.75 . . . . 65.31 112.464 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.518 ' CB ' ' CD ' ' A' ' 321' ' ' PRO . 4.5 mt -43.92 -63.99 0.92 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.641 0.734 . . . . 73.31 110.897 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.518 ' CD ' ' CB ' ' A' ' 320' ' ' LEU . 53.2 Cg_endo -69.79 127.23 14.28 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.673 2.248 . . . . 71.31 112.334 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 -13.47 34.72 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.671 2.247 . . . . 74.51 112.331 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.411 ' C ' ' CG2' ' A' ' 324' ' ' VAL . 0.7 OUTLIER -166.22 -40.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 74.24 110.891 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.491 ' CG1' ' CG1' ' A' ' 394' ' ' VAL . 1.8 t -154.77 141.51 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 64.22 111.159 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -109.27 139.82 21.41 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.617 0.722 . . . . 75.14 110.912 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -14.44 36.32 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.68 2.254 . . . . 63.34 112.39 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -72.34 -71.61 0.28 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 74.5 110.947 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.1 -24.78 18.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.196 -0.457 . . . . 71.13 111.104 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.82 HG22 ' HB ' ' A' ' 394' ' ' VAL . 5.7 t -84.78 -30.04 6.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 71.42 111.176 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.75 ' HA ' HD12 ' A' ' 333' ' ' ILE . 13.7 t70 -54.74 -45.86 74.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 73.32 110.905 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -53.01 -34.81 58.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.808 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.968 HG21 HG21 ' A' ' 393' ' ' ILE . 26.1 mm -61.29 -48.87 86.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 75.2 111.167 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' A' ' 330' ' ' ASP . 8.0 mt -54.39 -33.05 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 75.03 111.093 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.61 -7.96 12.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.951 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 336' ' ' ALA . 0.8 OUTLIER -94.29 17.58 12.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 75.52 110.894 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.705 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . 177.8 164.49 0.57 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.533 0.682 . . . . 70.44 111.154 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.836 ' O ' HG22 ' A' ' 340' ' ' VAL . 54.7 Cg_endo -69.66 156.86 62.47 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.77 2.313 . . . . 73.22 112.37 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -7.32 20.73 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.678 2.252 . . . . 62.53 112.36 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 35.3 mtt85 -97.57 53.68 1.15 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 72.43 110.898 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 337' ' ' PRO . 7.0 m -150.53 135.56 10.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.179 -0.464 . . . . 72.34 111.088 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . 0.522 HG22 ' HA ' ' A' ' 386' ' ' HIS . 28.0 p -138.08 66.4 1.44 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 73.22 111.117 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 19.4 m -134.3 142.15 47.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 65.23 111.118 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -118.83 98.93 6.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 75.2 111.121 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.53 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -85.77 121.19 28.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.332 -0.394 . . . . 72.31 110.91 -179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.813 HG21 HD13 ' A' ' 406' ' ' LEU . 2.0 mp -118.29 118.79 59.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.086 -0.506 . . . . 72.1 111.131 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -104.64 164.88 14.59 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.76 -0.733 . . . . 62.23 112.504 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 0.2 OUTLIER 76.62 45.89 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.337 . . . . 74.34 110.884 -179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.457 HG23 ' HD2' ' A' ' 349' ' ' PRO . 59.4 mt -99.58 133.32 21.94 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.653 0.74 . . . . 71.22 111.142 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . 0.777 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.7 Cg_endo -69.74 164.87 32.9 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.657 2.238 . . . . 73.53 112.329 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.32 -20.88 59.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 70.32 110.809 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.504 ' O ' ' CD2' ' A' ' 351' ' ' PHE . 25.0 p90 -97.25 29.48 3.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 61.03 110.885 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.777 ' HB2' ' HG2' ' A' ' 349' ' ' PRO . . . -114.36 90.84 3.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 41.44 111.17 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 19.7 p -87.83 170.77 10.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 72.34 111.101 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.51 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -65.6 -31.94 73.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 73.51 110.888 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -53.49 -26.13 19.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 74.32 111.128 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.63 -13.18 13.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.273 -0.421 . . . . 71.35 110.866 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.752 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.3 mp -98.85 -55.86 2.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 51.35 110.952 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.633 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -39.74 -52.16 5.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.625 0.726 . . . . 70.44 111.106 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.5 Cg_endo -69.66 -35.58 12.66 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.711 2.274 . . . . 70.32 112.37 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.898 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -58.61 -23.55 59.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 63.2 110.927 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.692 ' CG ' HD13 ' A' ' 381' ' ' ILE . 84.9 m-85 -103.02 -35.25 8.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 73.33 110.873 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -54.14 -34.76 61.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 65.52 110.852 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -55.48 -13.47 1.52 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 72.31 110.954 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . 0.601 ' CE2' ' HB2' ' A' ' 392' ' ' CYS . 38.2 m-85 -81.3 -53.99 5.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 73.33 110.901 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -156.24 -95.35 0.11 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.807 -0.711 . . . . 32.11 112.557 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.43 ' CE2' ' HG ' ' A' ' 368' ' ' LEU . 58.8 t80 -143.81 143.97 31.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.818 0.342 . . . . 74.52 110.909 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.437 HG12 ' CG2' ' A' ' 381' ' ' ILE . 71.6 mt -120.73 109.05 24.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 75.02 111.145 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.43 ' HG ' ' CE2' ' A' ' 366' ' ' PHE . 1.1 mp -87.64 -19.8 27.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 74.24 110.862 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.92 120.62 0.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 72.34 110.872 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 372' ' ' HIS . 35.1 t80 -112.47 143.0 44.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 63.45 110.888 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.27 101.28 5.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 75.45 110.895 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . 0.602 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 10.0 t-80 -99.66 136.01 40.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 63.43 110.884 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -128.19 90.03 48.35 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.73 0.776 . . . . 71.14 110.965 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . 0.402 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.9 Cg_endo -69.77 -21.85 32.85 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.791 2.327 . . . . 42.43 112.343 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.0 -33.33 65.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 72.12 110.887 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.08 -18.99 14.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 53.33 110.933 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 81.01 40.16 12.03 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.741 -0.742 . . . . 64.42 112.465 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.2 p -148.49 155.62 41.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.716 0.293 . . . . 73.31 110.976 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 18.6 p -149.78 158.08 43.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.429 . . . . 75.01 110.897 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.494 ' CE2' ' HB2' ' A' ' 344' ' ' TYR . 1.8 m-85 -136.24 132.5 35.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.922 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.692 HD13 ' CG ' ' A' ' 361' ' ' PHE . 0.9 OUTLIER -119.67 123.02 70.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 73.1 111.136 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.19 131.84 34.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 74.34 110.943 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.51 -179.63 3.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 70.34 110.93 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -80.65 -43.76 19.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.082 -0.508 . . . . 71.21 110.884 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 82.3 p -115.71 159.86 20.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 74.42 111.122 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' HIS . . . . . 0.522 ' HA ' HG22 ' A' ' 341' ' ' THR . 19.5 p-80 -69.44 -42.09 75.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 71.24 110.842 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . 0.435 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 2.2 tt0 -59.04 -29.83 67.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 52.21 110.876 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.53 -35.07 71.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.865 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -75.46 -24.83 57.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 65.12 111.136 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.813 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -72.39 -37.11 68.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 63.4 111.143 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 62.1 t -61.83 -56.62 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 60.24 111.085 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . 0.601 ' HB2' ' CE2' ' A' ' 364' ' ' PHE . 14.5 p -63.99 -32.77 74.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 73.34 110.845 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.968 HG21 HG21 ' A' ' 332' ' ' ILE . 1.7 mt -53.32 -54.12 19.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 45.22 111.122 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.82 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.5 OUTLIER -71.18 -34.14 53.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 53.43 111.136 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -69.41 -28.49 66.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 72.34 111.109 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.719 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.4 mm? -97.75 -17.86 19.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.276 -0.42 . . . . 63.21 110.945 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -47.97 114.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 74.2 111.073 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 38.0 t30 44.77 44.75 7.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.13 110.831 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.719 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -100.66 143.99 27.63 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.644 0.735 . . . . 73.53 110.861 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.405 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.4 Cg_endo -69.75 145.11 56.2 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.674 2.249 . . . . 71.55 112.284 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' PHE . . . . . 0.574 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 56.1 t80 -150.12 110.8 4.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 74.01 110.886 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 49.08 33.45 4.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 63.25 110.923 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 99.95 -28.21 16.68 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.726 -0.749 . . . . 71.31 112.458 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -105.01 141.06 37.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 70.01 110.852 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.429 ' O ' HD23 ' A' ' 406' ' ' LEU . 7.4 m120 -83.88 154.13 23.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 42.51 110.888 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.813 HD13 HG21 ' A' ' 345' ' ' ILE . 8.7 mt -116.4 174.08 6.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 74.52 110.973 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.82 176.85 5.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 73.51 110.886 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . 0.7 HG21 ' O ' ' A' ' 393' ' ' ILE . 23.5 p -151.67 151.28 31.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 54.13 111.109 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 164.83 173.13 33.13 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.74 -0.743 . . . . 32.33 112.501 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.454 ' CZ3' HG23 ' A' ' 340' ' ' VAL . 99.5 m95 -85.29 150.89 24.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.328 . . . . 55.52 110.902 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -136.45 160.22 24.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.798 -0.715 . . . . 72.43 112.518 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -163.01 81.6 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.752 0.31 . . . . 72.54 110.944 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 414' ' ' ARG . 0.7 OUTLIER 43.2 44.72 4.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 72.32 110.953 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 413' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 71.13 110.905 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.277 0 N-CA-C 112.465 -0.254 . . . . 64.33 112.465 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 84.9 p -125.38 102.93 7.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.848 0.356 . . . . 45.32 110.822 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -149.01 85.72 1.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 60.02 110.936 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.901 HG22 HG22 ' A' ' 318' ' ' ILE . 85.5 m -90.7 -75.71 0.46 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 74.33 111.154 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.901 HG22 HG22 ' A' ' 317' ' ' THR . 4.1 tp -168.37 -50.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 65.44 111.117 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.5 ' N ' HG23 ' A' ' 318' ' ' ILE . . . 90.57 -55.57 3.46 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.77 -0.729 . . . . 65.31 112.501 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.469 ' N ' ' CD ' ' A' ' 321' ' ' PRO . 0.5 OUTLIER 79.36 52.42 0.12 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.606 0.717 . . . . 73.31 110.893 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' A' ' 320' ' ' LEU . 54.0 Cg_endo -69.76 169.62 18.49 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.718 2.278 . . . . 71.31 112.399 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -50.24 0.48 Allowed 'Trans proline' 0 N--CA 1.466 -0.141 0 C-N-CA 122.698 2.265 . . . . 74.51 112.33 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.433 ' C ' ' CD ' ' A' ' 323' ' ' GLN . 0.0 OUTLIER -175.98 86.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 74.24 110.886 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 1.015 HG11 HG13 ' A' ' 391' ' ' VAL . 58.9 t -140.35 145.82 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.431 . . . . 64.22 111.067 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.409 ' HA ' ' HD2' ' A' ' 326' ' ' PRO . 1.7 m120 -106.84 105.84 56.34 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.554 0.692 . . . . 75.14 110.947 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 325' ' ' ASN . 54.4 Cg_endo -69.74 -14.22 35.83 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.698 2.265 . . . . 63.34 112.367 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.95 -72.0 0.25 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 74.5 110.89 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.24 -28.25 40.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 71.13 111.066 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.97 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 16.0 t -71.1 -29.84 38.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 71.42 111.163 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -54.18 -35.44 62.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 73.32 110.892 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -69.34 -31.78 70.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 74.33 110.825 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.766 HG21 HD13 ' A' ' 393' ' ' ILE . 46.9 mm -54.79 -54.21 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 75.2 111.099 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.522 HG23 ' NE2' ' A' ' 386' ' ' HIS . 8.2 mt -52.36 -40.55 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 75.03 111.149 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.79 -15.41 1.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 74.23 110.857 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . 0.555 ' O ' ' HB2' ' A' ' 336' ' ' ALA . 0.1 OUTLIER -101.45 41.69 1.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 75.52 110.897 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' A' ' 335' ' ' SER . . . 170.59 157.05 0.21 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.626 0.727 . . . . 70.44 111.048 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.626 ' O ' HG12 ' A' ' 340' ' ' VAL . 54.1 Cg_endo -69.79 153.78 68.4 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.649 2.233 . . . . 73.22 112.369 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -11.55 31.04 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.742 2.295 . . . . 62.53 112.304 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -100.82 66.0 1.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 72.43 110.812 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 337' ' ' PRO . 14.4 p -171.39 131.72 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.266 -0.424 . . . . 72.34 111.054 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 386' ' ' HIS . 22.0 p -137.0 68.53 1.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 73.22 111.11 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 87.5 m -133.59 111.7 10.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.445 . . . . 65.23 111.099 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -85.72 137.39 32.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 75.2 111.139 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.805 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -116.99 134.55 54.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.47 . . . . 72.31 110.882 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.805 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.8 mp -131.68 110.99 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.133 -0.485 . . . . 72.1 111.142 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.439 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -101.09 161.62 18.36 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.774 -0.727 . . . . 62.23 112.52 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 2.4 t30 78.95 49.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.794 0.33 . . . . 74.34 110.85 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.559 HG23 ' HD2' ' A' ' 349' ' ' PRO . 85.1 mt -103.69 135.83 19.3 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.662 0.744 . . . . 71.22 111.115 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . 0.559 ' HD2' HG23 ' A' ' 348' ' ' ILE . 53.8 Cg_endo -69.73 164.4 34.66 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.687 2.258 . . . . 73.53 112.41 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.62 -28.09 63.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 70.32 110.882 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -83.17 20.09 1.33 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 61.03 110.892 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.774 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -107.64 112.83 25.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 41.44 111.089 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 19.0 p -116.32 170.94 8.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 72.34 111.107 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.498 ' O ' ' CG1' ' A' ' 358' ' ' ILE . 0.2 OUTLIER -66.23 -29.89 70.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 73.51 110.886 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.56 -26.64 63.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 74.32 111.168 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.48 -16.01 12.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 71.35 110.88 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.774 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.5 mp -93.5 -50.92 5.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 51.35 110.928 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.688 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.3 mm -44.0 -49.48 21.65 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.687 0.756 . . . . 70.44 111.171 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.0 Cg_endo -69.75 -27.84 26.02 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.255 . . . . 70.32 112.361 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.95 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -69.96 -26.95 64.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 63.2 110.907 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.789 ' HB2' HD11 ' A' ' 367' ' ' ILE . 85.6 m-85 -94.75 -36.39 11.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 73.33 110.844 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' GLN . . . . . 0.405 ' O ' ' N ' ' A' ' 364' ' ' PHE . 11.4 mm-40 -49.45 -46.81 48.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 65.52 110.886 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -42.5 -24.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 72.31 110.884 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . 0.405 ' N ' ' O ' ' A' ' 362' ' ' GLN . 28.6 m-85 -70.52 -59.77 2.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 73.33 110.904 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -155.1 -86.32 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.762 -0.732 . . . . 32.11 112.51 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -153.52 144.48 22.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 74.52 110.933 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.789 HD11 ' HB2' ' A' ' 361' ' ' PHE . 17.3 mt -120.92 109.32 24.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 75.02 111.139 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.03 -20.02 27.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.476 . . . . 74.24 110.92 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.3 121.08 0.62 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 72.34 110.837 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 28.9 t80 -113.42 143.52 44.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 63.45 110.855 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.07 101.42 5.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.865 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 9.3 t-80 -97.27 115.13 27.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 63.43 110.811 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -108.04 86.09 2.98 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.685 0.755 . . . . 71.14 110.953 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . 0.489 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 53.7 Cg_endo -69.8 -17.27 37.48 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.671 2.247 . . . . 42.43 112.318 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -79.32 -23.76 43.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 72.12 110.903 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -108.41 -26.65 10.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 53.33 110.952 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.91 41.05 5.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.721 -0.752 . . . . 64.42 112.5 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 27.0 p -159.86 153.27 22.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.89 0.376 . . . . 73.31 110.819 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.561 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 29.0 p -138.53 145.32 40.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 75.01 110.886 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -119.85 129.42 54.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.895 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.511 ' CG1' ' CD1' ' A' ' 370' ' ' PHE . 1.0 OUTLIER -120.82 132.94 69.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 73.1 111.147 179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -98.77 134.79 41.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 74.34 110.822 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -117.45 -179.46 3.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 70.34 110.893 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.23 -39.56 22.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 71.21 110.849 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 67.3 p -120.42 171.39 8.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.42 111.18 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' HIS . . . . . 0.638 ' NE2' ' CZ2' ' A' ' 410' ' ' TRP . 4.4 t60 -83.65 -42.28 16.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 71.24 110.868 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.3 -28.72 63.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 52.21 110.841 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -36.51 82.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 75.42 110.947 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.545 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -73.9 -34.23 64.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 65.12 111.165 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.97 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -56.05 -34.41 65.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 63.4 111.071 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 1.015 HG13 HG11 ' A' ' 324' ' ' VAL . 95.9 t -71.4 -42.99 73.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.241 -0.436 . . . . 60.24 111.188 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 35.3 t -65.83 -34.17 77.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 73.34 110.905 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.766 HD13 HG21 ' A' ' 332' ' ' ILE . 1.1 mt -55.9 -56.01 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 45.22 111.159 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.491 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 1.8 t -72.04 -36.87 58.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 53.43 111.132 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.6 94.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 72.34 111.089 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.941 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.9 mm? -89.09 -18.56 27.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 63.21 110.917 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 398' ' ' ASN . . . -44.7 117.89 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 74.2 111.031 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 397' ' ' ALA . 4.6 p-10 34.5 42.67 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 73.13 110.936 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.941 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -97.38 148.0 33.79 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.664 0.745 . . . . 73.53 110.897 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 144.26 53.72 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.635 2.223 . . . . 71.55 112.399 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' PHE . . . . . 0.437 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 58.3 t80 -153.36 112.96 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 74.01 110.892 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 49.64 33.29 5.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 63.25 110.946 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 97.85 -27.66 17.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.735 -0.745 . . . . 71.31 112.453 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.437 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -106.06 142.22 36.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.819 0.342 . . . . 70.01 110.864 -179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -86.42 150.62 24.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 42.51 110.883 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.801 HD13 HG21 ' A' ' 345' ' ' ILE . 17.8 mt -112.06 -177.98 3.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 74.52 110.94 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 346' ' ' GLY . 8.3 ttt180 -125.87 177.29 6.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 73.51 110.943 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . 0.708 HG21 ' O ' ' A' ' 393' ' ' ILE . 16.7 p -153.59 157.91 40.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 54.13 111.102 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 410' ' ' TRP . . . 148.83 126.61 1.54 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.674 -0.774 . . . . 32.33 112.448 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.638 ' CZ2' ' NE2' ' A' ' 386' ' ' HIS . 76.1 m95 -35.11 137.72 0.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.901 0.381 . . . . 55.52 110.878 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -137.65 -172.61 12.6 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.758 -0.734 . . . . 72.43 112.526 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.41 162.46 19.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.736 0.303 . . . . 72.54 110.942 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 414' ' ' ARG . 22.7 tt0 -42.56 -42.54 3.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 72.32 110.834 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 413' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 71.13 110.858 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 N-CA-C 112.477 -0.249 . . . . 64.33 112.477 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.15 -54.55 6.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.771 0.319 . . . . 45.32 110.834 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -89.15 -54.86 3.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 60.02 110.885 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 17.0 m -129.84 120.58 25.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.465 . . . . 74.33 111.168 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 319' ' ' GLY . 1.1 tt -72.54 -44.2 61.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 65.44 111.171 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.5 ' N ' HG23 ' A' ' 318' ' ' ILE . . . 71.43 116.21 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.784 -0.722 . . . . 65.31 112.498 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.426 HD12 HG23 ' A' ' 318' ' ' ILE . 0.3 OUTLIER -133.83 81.4 52.69 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.577 0.704 . . . . 73.31 110.939 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 147.54 63.38 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.744 2.296 . . . . 71.31 112.356 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -25.47 28.95 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.748 2.298 . . . . 74.51 112.289 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -133.8 130.18 37.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.291 -0.413 . . . . 74.24 110.87 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.912 HG11 HG13 ' A' ' 391' ' ' VAL . 13.2 t 64.87 132.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.263 -0.426 . . . . 64.22 111.167 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -113.53 138.25 22.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.615 0.722 . . . . 75.14 110.859 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -14.14 35.65 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.635 2.223 . . . . 63.34 112.358 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -75.2 -72.67 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 74.5 110.891 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.64 -24.6 34.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 71.13 111.058 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.777 HG22 ' HB ' ' A' ' 394' ' ' VAL . 25.5 t -83.45 -29.73 7.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 71.42 111.175 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -54.57 -45.46 73.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.168 -0.469 . . . . 73.32 110.837 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' HIS . . . . . 0.41 ' O ' ' HG2' ' A' ' 334' ' ' ARG . 3.4 t60 -54.2 -31.9 54.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 74.33 110.916 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.569 HG22 ' NE1' ' A' ' 410' ' ' TRP . 26.6 mm -69.88 -49.52 56.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.126 -0.488 . . . . 75.2 111.172 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 54.2 mt -54.18 -39.52 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 75.03 111.184 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 331' ' ' HIS . 12.1 ptt180 -75.99 6.7 4.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.856 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 6.5 t -105.82 -13.2 15.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 75.52 110.914 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -150.19 150.51 29.66 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.641 0.734 . . . . 70.44 111.038 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 158.89 55.36 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.652 2.234 . . . . 73.22 112.322 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -28.84 24.78 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.692 2.261 . . . . 62.53 112.339 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.1 mtm105 -50.15 -40.66 47.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 72.43 110.879 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.7 p -95.17 134.32 32.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.475 . . . . 72.34 111.107 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . 0.591 HG22 ' CA ' ' A' ' 386' ' ' HIS . 25.3 p -140.46 71.15 1.36 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 73.22 111.099 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 3.4 m -132.54 128.81 38.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 65.23 111.172 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -95.23 119.42 33.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 75.2 111.094 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.639 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -100.28 129.13 46.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 72.31 110.936 -179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.831 HG22 HD11 ' A' ' 348' ' ' ILE . 1.8 mp -122.59 126.19 73.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.071 -0.513 . . . . 72.1 111.143 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -112.88 168.89 12.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 62.23 112.463 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.475 ' O ' ' CD2' ' A' ' 406' ' ' LEU . 1.9 t30 70.68 53.23 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.706 0.288 . . . . 74.34 110.877 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.831 HD11 HG22 ' A' ' 345' ' ' ILE . 2.0 mp -102.4 132.39 21.46 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.643 0.735 . . . . 71.22 111.116 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . 0.711 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.7 Cg_endo -69.72 153.55 68.97 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.683 2.255 . . . . 73.53 112.379 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.03 -18.96 64.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 70.32 110.836 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.409 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 5.2 p90 -94.38 19.78 9.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 61.03 110.862 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.79 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -111.78 104.19 12.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 41.44 111.038 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 27.2 p -107.24 168.33 9.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 72.34 111.131 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.514 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -59.59 -37.25 78.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 73.51 110.884 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -52.41 -26.11 11.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.32 111.067 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -112.14 -13.1 13.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 71.35 110.793 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.79 HD11 ' HB1' ' A' ' 352' ' ' ALA . 2.9 mp -99.25 -55.73 2.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.257 -0.429 . . . . 51.35 110.906 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.624 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -37.69 -52.44 2.67 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.619 0.723 . . . . 70.44 111.103 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.3 Cg_endo -69.76 -26.71 27.28 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.691 2.261 . . . . 70.32 112.352 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.953 ' O ' HD12 ' A' ' 360' ' ' LEU . 0.1 OUTLIER -70.07 -21.94 63.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 63.2 110.965 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.613 ' HB2' HD11 ' A' ' 367' ' ' ILE . 86.8 m-85 -101.11 -30.77 11.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 73.33 110.9 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.24 -32.84 70.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 65.52 110.9 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -57.79 -16.42 11.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 72.31 110.882 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . 0.539 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 36.3 m-85 -75.74 -57.79 3.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 73.33 110.917 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -154.87 -82.53 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.741 -0.743 . . . . 32.11 112.468 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.877 ' CD2' HD21 ' A' ' 368' ' ' LEU . 7.5 t80 -153.77 139.55 18.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.891 0.377 . . . . 74.52 110.904 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' A' ' 361' ' ' PHE . 13.1 mt -114.78 109.37 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 75.02 111.161 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.877 HD21 ' CD2' ' A' ' 366' ' ' PHE . 0.9 OUTLIER -89.74 -21.36 22.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 74.24 110.944 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -170.94 121.19 0.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 72.34 110.814 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 30.6 t80 -111.13 138.78 47.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 63.45 110.955 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.11 100.47 6.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 75.45 110.935 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . 0.478 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 10.4 t-80 -97.82 132.82 43.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 63.43 110.864 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -123.92 88.82 52.12 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.677 0.751 . . . . 71.14 110.881 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.75 -17.03 37.86 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.622 2.215 . . . . 42.43 112.449 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -83.73 -26.43 29.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 72.12 110.846 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -104.63 -26.65 12.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 53.33 110.881 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 87.22 38.97 7.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.822 -0.704 . . . . 64.42 112.501 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.4 p -153.0 151.41 30.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 73.31 110.9 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 28.8 p -142.19 141.44 32.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 75.01 110.861 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.521 ' CD2' ' HB2' ' A' ' 344' ' ' TYR . 15.4 m-85 -119.69 138.53 53.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 73.43 110.886 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.441 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.6 OUTLIER -127.18 128.06 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 73.1 111.093 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.49 137.18 32.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 74.34 110.886 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -120.24 156.05 31.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 70.34 110.889 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -53.15 -50.33 64.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.102 -0.499 . . . . 71.21 110.863 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 38.7 p -113.41 176.06 5.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 74.42 111.203 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' HIS . . . . . 0.591 ' CA ' HG22 ' A' ' 341' ' ' THR . 39.9 p-80 -83.88 -39.7 19.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 71.24 110.852 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . 0.437 ' O ' HG23 ' A' ' 391' ' ' VAL . 0.1 OUTLIER -59.91 -28.82 67.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 52.21 110.836 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -34.98 79.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 75.42 110.924 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -74.94 -37.51 61.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 65.12 111.098 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.634 ' HB1' HG13 ' A' ' 329' ' ' VAL . . . -60.99 -32.07 71.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 63.4 111.052 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.912 HG13 HG11 ' A' ' 324' ' ' VAL . 81.2 t -66.29 -39.16 83.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 60.24 111.111 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . 0.539 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 1.7 t -79.4 -25.42 42.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 73.34 110.851 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.73 ' O ' HG21 ' A' ' 408' ' ' THR . 0.3 OUTLIER -60.79 -55.5 24.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 45.22 111.149 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.777 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -69.74 -42.27 80.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 53.43 111.071 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.483 ' N ' ' CG1' ' A' ' 394' ' ' VAL . . . -55.95 -45.75 78.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 72.34 111.14 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.736 HD13 ' CE1' ' A' ' 399' ' ' PHE . 0.5 OUTLIER -79.76 -19.27 49.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 63.21 110.939 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 394' ' ' VAL . . . -48.38 113.96 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 74.2 111.1 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 45.52 50.26 10.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 73.13 110.877 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.736 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -110.17 143.7 28.57 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.712 0.768 . . . . 73.53 110.935 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 133.76 26.39 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.683 2.255 . . . . 71.55 112.382 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' PHE . . . . . 0.611 ' CE1' HD22 ' A' ' 360' ' ' LEU . 36.0 t80 -137.34 111.3 8.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 74.01 110.864 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 48.7 32.81 3.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 63.25 110.873 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.34 -30.72 9.78 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.738 -0.744 . . . . 71.31 112.488 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 134.81 48.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.912 0.387 . . . . 70.01 110.875 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -74.83 154.39 38.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 42.51 110.799 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 345' ' ' ILE . 15.9 mt -117.66 171.05 8.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 74.52 110.898 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.02 177.0 4.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 73.51 110.843 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . 0.73 HG21 ' O ' ' A' ' 393' ' ' ILE . 6.9 p -152.7 152.17 31.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 54.13 111.181 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 169.28 157.25 11.56 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.695 -0.764 . . . . 32.33 112.427 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.569 ' NE1' HG22 ' A' ' 332' ' ' ILE . 13.9 m95 -68.94 88.22 0.38 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.836 0.35 . . . . 55.52 110.941 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 410' ' ' TRP . . . 35.14 82.19 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.757 -0.735 . . . . 72.43 112.53 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -105.27 91.02 3.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.776 0.322 . . . . 72.54 110.906 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 414' ' ' ARG . 0.0 OUTLIER -68.0 116.97 9.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 72.32 110.851 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 413' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 71.13 110.862 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.595 -0.202 . . . . 64.33 112.595 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 1.4 m -126.86 -82.9 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.348 . . . . 45.32 110.794 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -117.49 87.32 2.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 60.02 110.886 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 47.5 p 48.5 -173.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 74.33 111.099 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.542 HG23 ' N ' ' A' ' 319' ' ' GLY . 0.5 OUTLIER -78.05 -46.97 25.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 65.44 111.074 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.542 ' N ' HG23 ' A' ' 318' ' ' ILE . . . 101.43 -69.26 0.41 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.786 -0.721 . . . . 65.31 112.483 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 56.09 74.27 0.72 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.568 0.699 . . . . 73.31 110.969 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 167.47 24.26 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.696 2.264 . . . . 71.31 112.371 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -49.03 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.695 2.264 . . . . 74.51 112.393 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -154.82 -42.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.92 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.889 HG21 HG13 ' A' ' 391' ' ' VAL . 30.6 m -111.04 168.17 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 64.22 111.176 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.429 ' OD1' ' CB ' ' A' ' 327' ' ' GLN . 18.8 t-20 -112.57 121.95 37.53 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.615 0.721 . . . . 75.14 110.913 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 -14.21 35.97 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.675 2.25 . . . . 63.34 112.331 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . 0.429 ' CB ' ' OD1' ' A' ' 325' ' ' ASN . 0.0 OUTLIER -69.89 -71.93 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 74.5 110.926 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -52.65 -28.75 22.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 71.13 111.141 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.736 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 8.0 t -70.55 -29.87 40.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 71.42 111.087 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -54.21 -36.04 63.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.32 110.82 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -65.42 -31.87 73.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 74.33 110.884 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.475 HG21 HG21 ' A' ' 393' ' ' ILE . 38.7 mm -60.56 -49.01 86.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 75.2 111.185 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.469 ' CG1' ' HB2' ' A' ' 390' ' ' ALA . 19.6 mt -57.44 -32.63 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 75.03 111.055 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -5.74 13.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 74.23 110.814 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.95 7.91 44.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 75.52 110.882 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . -161.33 159.56 23.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 70.44 111.059 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.554 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 54.7 Cg_endo -69.71 154.07 68.38 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.672 2.248 . . . . 73.22 112.369 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -8.98 24.97 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.62 2.213 . . . . 62.53 112.388 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -47.07 15.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 72.43 110.882 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 8.3 p -73.18 132.86 32.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 72.34 111.134 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . 0.594 HG22 ' CB ' ' A' ' 386' ' ' HIS . 40.6 p -144.43 68.92 1.26 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 73.22 111.14 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 53.2 m -133.16 117.73 17.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 65.23 111.162 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -81.72 126.89 32.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.212 -0.449 . . . . 75.2 111.078 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.754 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -106.02 134.72 48.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 72.31 110.971 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.754 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.8 mp -130.4 121.2 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.1 -0.5 . . . . 72.1 111.12 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -108.53 167.45 13.17 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.796 -0.716 . . . . 62.23 112.49 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.488 ' O ' ' CD2' ' A' ' 406' ' ' LEU . 1.4 t30 69.55 57.34 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.776 0.322 . . . . 74.34 110.876 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.489 ' CG2' ' HB3' ' A' ' 352' ' ' ALA . 47.7 mt -107.94 131.16 21.93 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.631 0.729 . . . . 71.22 111.091 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . 0.432 ' CG ' ' CE1' ' A' ' 351' ' ' PHE . 53.9 Cg_endo -69.68 161.46 45.82 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 122.687 2.258 . . . . 73.53 112.384 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -64.2 -29.08 70.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 70.32 110.867 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.432 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 6.4 p90 -85.14 33.16 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 61.03 110.887 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.665 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -117.36 100.74 7.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 41.44 111.109 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 17.1 p -105.69 170.0 8.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 72.34 111.083 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.512 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.28 -29.88 69.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 73.51 110.92 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.36 -26.31 63.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 74.32 111.102 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.15 -14.95 13.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 71.35 110.837 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.665 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.5 mp -97.24 -52.87 3.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.193 -0.458 . . . . 51.35 110.895 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.652 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -41.87 -50.89 10.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.622 0.725 . . . . 70.44 111.115 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' PRO . . . . . 0.652 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.5 Cg_endo -69.83 -35.13 13.0 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.671 2.247 . . . . 70.32 112.339 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.929 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -59.73 -26.26 65.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 63.2 110.919 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.696 ' HB2' HD11 ' A' ' 367' ' ' ILE . 85.8 m-85 -96.73 -25.24 15.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.223 -0.444 . . . . 73.33 110.882 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 364' ' ' PHE . 5.4 mt-30 -60.45 -47.76 84.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 65.52 110.903 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -42.44 -23.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 72.31 110.918 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 362' ' ' GLN . 23.3 m-85 -71.46 -60.07 2.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 73.33 110.913 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . 0.415 ' HA3' ' CD ' ' A' ' 388' ' ' GLN . . . -150.7 -88.51 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.735 -0.745 . . . . 32.11 112.543 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.661 ' CE2' HD12 ' A' ' 368' ' ' LEU . 28.8 t80 -153.92 138.77 17.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.852 0.358 . . . . 74.52 110.893 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.696 HD11 ' HB2' ' A' ' 361' ' ' PHE . 32.5 mt -120.43 116.87 51.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.477 . . . . 75.02 111.124 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.73 ' N ' HD13 ' A' ' 368' ' ' LEU . 0.0 OUTLIER -104.42 -16.2 15.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.12 -0.491 . . . . 74.24 110.877 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.569 ' N ' HD22 ' A' ' 368' ' ' LEU . 3.7 m-20 -159.86 121.05 3.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 72.34 110.9 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.556 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 31.0 t80 -123.21 142.66 50.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 63.45 110.895 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -129.56 101.1 5.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 75.45 110.907 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . 0.602 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 11.2 t-80 -97.43 136.61 37.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.134 -0.485 . . . . 63.43 110.879 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -130.76 89.32 43.61 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.695 0.759 . . . . 71.14 110.893 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . 0.546 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 54.0 Cg_endo -69.77 -29.78 23.3 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.627 2.218 . . . . 42.43 112.364 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.1 -14.04 62.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 72.12 110.873 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -119.81 -24.38 6.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 53.33 110.869 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 80.34 44.35 8.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 64.42 112.434 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 29.2 p -156.83 137.81 13.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.825 0.345 . . . . 73.31 110.887 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.556 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 14.6 p -129.79 156.97 43.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.164 -0.471 . . . . 75.01 110.909 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -136.98 128.49 28.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.26 -0.427 . . . . 73.43 110.921 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.494 ' CG2' HG23 ' A' ' 367' ' ' ILE . 0.7 OUTLIER -117.83 131.34 70.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 73.1 111.155 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . 0.59 ' HB3' HD21 ' A' ' 368' ' ' LEU . 0.0 OUTLIER -98.72 137.23 37.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 74.34 110.907 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -120.88 173.52 7.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 70.34 110.913 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.56 -26.02 35.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 71.21 110.894 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 41.7 p -129.31 162.48 27.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 74.42 111.083 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' HIS . . . . . 0.594 ' CB ' HG22 ' A' ' 341' ' ' THR . 26.3 p-80 -86.78 -33.7 19.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 71.24 110.865 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -60.8 -44.57 96.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.193 -0.458 . . . . 52.21 110.912 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.415 ' CD ' ' HA3' ' A' ' 365' ' ' GLY . 2.2 tt0 -60.36 -35.29 75.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 75.42 110.964 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -68.57 -44.06 75.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 65.12 111.067 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.736 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -50.1 -25.59 3.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 63.4 111.14 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.889 HG13 HG21 ' A' ' 324' ' ' VAL . 65.0 t -69.54 -49.76 56.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 60.24 111.164 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 30.7 t -57.51 -31.57 66.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 73.34 110.893 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.633 HD13 ' HA ' ' A' ' 390' ' ' ALA . 1.0 OUTLIER -56.65 -56.33 14.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.218 -0.447 . . . . 45.22 111.097 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.507 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.2 t -72.07 -35.21 52.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 53.43 111.056 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.794 ' HB2' HG11 ' A' ' 324' ' ' VAL . . . -63.61 -39.71 95.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 72.34 111.061 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.703 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.5 mm? -93.63 -10.6 34.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.306 -0.407 . . . . 63.21 110.976 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' ALA . . . . . 0.668 ' N ' HG21 ' A' ' 408' ' ' THR . . . -51.8 110.12 0.43 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 74.2 111.102 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 57.6 t30 43.02 48.07 5.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 73.13 110.874 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.703 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -104.53 147.32 34.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.721 0.772 . . . . 73.53 110.848 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.429 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 54.6 Cg_endo -69.68 141.55 45.84 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.669 2.246 . . . . 71.55 112.339 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' PHE . . . . . 0.504 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 36.4 t80 -147.58 111.22 4.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 74.01 110.815 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 49.01 38.65 13.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 63.25 110.913 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 93.96 -29.07 9.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 71.31 112.409 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.4 OUTLIER -105.93 140.07 39.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.783 0.325 . . . . 70.01 110.97 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.438 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 9.0 m120 -81.62 154.63 26.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 42.51 110.875 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.646 HD13 HG21 ' A' ' 345' ' ' ILE . 13.3 mt -115.86 172.95 6.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 74.52 110.974 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -113.5 173.24 6.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 73.51 110.897 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . 0.668 HG21 ' N ' ' A' ' 397' ' ' ALA . 71.0 p -154.18 151.55 29.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 54.13 111.118 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . 0.467 ' O ' ' C ' ' A' ' 410' ' ' TRP . . . 153.14 128.59 1.31 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.748 -0.739 . . . . 32.33 112.489 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.47 ' NE1' HG22 ' A' ' 332' ' ' ILE . 21.0 m95 -31.76 113.93 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.786 0.327 . . . . 55.52 110.893 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 410' ' ' TRP . . . 38.08 -158.1 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.736 -0.745 . . . . 72.43 112.437 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.53 ' HB2' ' CD2' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -167.6 -175.61 2.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.694 0.283 . . . . 72.54 110.933 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -104.61 45.54 0.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 72.32 110.835 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 71.13 110.839 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.484 -0.246 . . . . 64.33 112.484 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.23 97.78 5.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.807 0.337 . . . . 45.32 110.785 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -116.52 -55.83 2.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.083 -0.508 . . . . 60.02 110.915 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 71.5 p -42.22 162.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.491 . . . . 74.33 111.107 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 10.8 tp -116.51 151.5 18.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 65.44 111.171 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.452 ' C ' HD23 ' A' ' 320' ' ' LEU . . . -81.29 40.19 2.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.743 . . . . 65.31 112.456 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.452 HD23 ' C ' ' A' ' 319' ' ' GLY . 0.3 OUTLIER -176.97 75.22 0.24 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.536 0.684 . . . . 73.31 110.934 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 143.63 51.6 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.721 2.281 . . . . 71.31 112.329 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -21.26 33.4 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.71 2.273 . . . . 74.51 112.315 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.545 ' O ' HG22 ' A' ' 324' ' ' VAL . 6.6 mt-30 -140.61 87.61 2.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 74.24 110.933 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 323' ' ' GLN . 33.2 m 45.05 -171.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 64.22 111.049 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.24 110.99 24.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.621 0.724 . . . . 75.14 110.928 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.68 -14.47 36.39 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.666 2.244 . . . . 63.34 112.351 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -68.86 -71.64 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 74.5 110.905 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -57.14 -24.64 55.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 71.13 111.112 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.891 HG22 ' HB ' ' A' ' 394' ' ' VAL . 11.4 t -77.16 -30.1 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 71.42 111.154 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.649 ' HA ' HD12 ' A' ' 333' ' ' ILE . 21.7 t0 -55.0 -41.67 71.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 73.32 110.842 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -55.86 -35.48 66.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.857 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.765 HG21 HG21 ' A' ' 393' ' ' ILE . 39.1 mm -63.67 -49.67 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 75.2 111.108 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.649 HD12 ' HA ' ' A' ' 330' ' ' ASP . 13.3 mt -51.49 -50.06 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 75.03 111.126 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.28 -8.75 6.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 74.23 110.92 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 2.2 t -96.98 25.57 5.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 75.52 110.839 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.507 ' HB2' ' CD1' ' A' ' 410' ' ' TRP . . . -173.95 154.75 2.29 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.621 0.725 . . . . 70.44 111.082 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.409 ' HG2' HG12 ' A' ' 340' ' ' VAL . 53.6 Cg_endo -69.82 150.76 68.31 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 73.22 112.369 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . 0.412 ' HA ' ' ND1' ' A' ' 386' ' ' HIS . 54.4 Cg_endo -69.67 -12.11 32.37 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.669 2.246 . . . . 62.53 112.42 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -78.4 -53.39 7.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.832 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.409 HG12 ' HG2' ' A' ' 337' ' ' PRO . 4.1 p -69.34 135.19 28.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 72.34 111.13 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . 0.438 HG22 ' CA ' ' A' ' 386' ' ' HIS . 44.6 p -142.69 68.19 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 73.22 111.113 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 3.4 m -133.75 128.93 35.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.451 . . . . 65.23 111.183 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -92.91 134.31 35.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 75.2 111.133 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.518 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -112.69 128.57 56.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 72.31 110.918 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.623 HG22 HD11 ' A' ' 348' ' ' ILE . 1.6 mp -124.94 110.05 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.483 . . . . 72.1 111.139 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -101.86 161.4 17.63 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 62.23 112.535 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 405' ' ' ASN . 0.7 OUTLIER 81.14 50.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 74.34 110.864 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.68 HG23 ' HD2' ' A' ' 349' ' ' PRO . 74.2 mt -107.06 138.68 19.9 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.607 0.718 . . . . 71.22 111.118 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . 0.68 ' HD2' HG23 ' A' ' 348' ' ' ILE . 54.2 Cg_endo -69.72 166.23 28.24 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.695 2.263 . . . . 73.53 112.364 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -76.34 -15.67 59.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.247 -0.433 . . . . 70.32 110.839 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.558 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 47.8 p90 -100.44 29.31 4.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 61.03 110.85 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.776 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -114.54 99.86 7.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 41.44 111.081 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 10.1 p -96.54 171.08 8.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 72.34 111.056 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.516 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -67.32 -30.4 70.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 73.51 110.843 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -55.1 -26.41 37.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 74.32 111.12 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.3 -12.96 13.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 71.35 110.822 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.776 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.4 mp -98.58 -54.46 3.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 51.35 110.953 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.639 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 0.9 OUTLIER -40.71 -51.5 6.87 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.631 0.729 . . . . 70.44 111.139 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.5 Cg_endo -69.8 -34.36 14.6 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.7 2.267 . . . . 70.32 112.308 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.912 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -59.65 -25.07 64.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 63.2 110.904 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.679 ' CG ' HD13 ' A' ' 381' ' ' ILE . 87.6 m-85 -98.01 -37.33 9.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.885 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' GLN . . . . . 0.654 ' HG2' HD12 ' A' ' 367' ' ' ILE . 6.3 mm-40 -50.66 -45.02 57.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 65.52 110.863 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -44.95 -21.61 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 72.31 110.879 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . 0.459 ' CE2' ' HA ' ' A' ' 361' ' ' PHE . 30.9 m-85 -75.3 -56.86 4.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 73.33 110.925 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -152.89 -90.26 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 32.11 112.477 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -153.8 142.87 21.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.757 0.313 . . . . 74.52 110.84 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.667 HD11 ' HB2' ' A' ' 361' ' ' PHE . 59.1 mt -120.95 109.13 24.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.168 -0.469 . . . . 75.02 111.129 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.64 -16.81 35.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 74.24 110.876 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.93 120.74 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 72.34 110.881 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.583 ' CD1' HG12 ' A' ' 381' ' ' ILE . 35.9 t80 -114.13 144.81 42.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 63.45 110.898 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.52 100.09 5.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 75.45 110.875 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . 0.591 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 4.0 t-80 -103.13 131.91 49.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.311 -0.404 . . . . 63.43 110.835 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.456 ' CB ' ' HB2' ' A' ' 376' ' ' LYS . 96.6 m-85 -128.73 102.19 20.01 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.639 0.733 . . . . 71.14 110.904 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 373' ' ' TYR . 53.5 Cg_endo -69.76 -25.13 28.93 Favored 'Trans proline' 0 N--CA 1.466 -0.114 0 C-N-CA 122.711 2.274 . . . . 42.43 112.344 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' GLU . . . . . 0.415 ' C ' ' HD2' ' A' ' 376' ' ' LYS . 8.7 pt-20 -87.57 -8.77 55.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 72.12 110.897 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . 0.456 ' HB2' ' CB ' ' A' ' 373' ' ' TYR . 0.0 OUTLIER -106.5 -28.13 10.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 53.33 110.862 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 80.61 24.32 58.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 64.42 112.461 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 92.1 m -155.22 149.8 26.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.776 0.322 . . . . 73.31 110.867 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 14.9 p -133.8 151.27 51.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 75.01 110.874 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 380' ' ' PHE . 3.5 m-85 -124.35 127.72 48.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 73.43 110.864 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.679 HD13 ' CG ' ' A' ' 361' ' ' PHE . 1.3 mt -119.24 121.35 66.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.066 -0.516 . . . . 73.1 111.041 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.37 130.01 34.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 74.34 110.891 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -115.11 -174.89 2.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 70.34 110.906 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -73.61 -54.93 7.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.061 -0.518 . . . . 71.21 110.943 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 71.1 p -120.2 178.78 4.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 74.42 111.181 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' HIS . . . . . 0.438 ' CA ' HG22 ' A' ' 341' ' ' THR . 21.2 p-80 -83.65 -39.43 20.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 71.24 110.857 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -57.35 -28.82 63.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.425 . . . . 52.21 110.877 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -46.09 78.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 75.42 110.943 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.658 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -62.79 -25.71 68.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.235 -0.439 . . . . 65.12 111.121 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.811 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -58.27 -40.12 81.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 63.4 111.134 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.45 HG13 HG22 ' A' ' 324' ' ' VAL . 14.1 t -61.92 -57.9 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 60.24 111.081 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 18.4 p -58.91 -31.34 68.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 73.34 110.895 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.765 HG21 HG21 ' A' ' 332' ' ' ILE . 0.4 OUTLIER -58.97 -55.38 23.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 45.22 111.087 -179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.891 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -72.25 -35.74 53.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 53.43 111.187 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.494 ' HB2' HG11 ' A' ' 324' ' ' VAL . . . -62.57 -47.81 82.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.126 -0.488 . . . . 72.34 111.095 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.635 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.2 mm? -79.83 -13.42 59.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.258 -0.428 . . . . 63.21 110.913 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -50.33 112.91 0.76 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 74.2 111.096 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.2 m120 44.13 51.49 7.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 73.13 110.835 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.635 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -108.0 147.94 36.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.689 0.757 . . . . 73.53 110.865 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.424 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.3 Cg_endo -69.71 145.16 56.58 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.706 2.271 . . . . 71.55 112.324 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' PHE . . . . . 0.571 ' CZ ' ' NE2' ' A' ' 402' ' ' GLN . 40.0 t80 -151.85 111.49 3.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 74.01 110.856 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.571 ' NE2' ' CZ ' ' A' ' 401' ' ' PHE . 4.9 mt-30 46.7 38.63 6.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 63.25 110.893 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 94.57 -29.99 8.38 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.735 . . . . 71.31 112.539 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -104.91 137.62 42.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 70.01 110.83 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.477 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 4.6 m120 -80.04 152.75 29.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 42.51 110.895 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.405 ' CD2' ' O ' ' A' ' 347' ' ' ASN . 13.9 mt -114.58 173.57 6.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 74.52 110.944 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' ARG . . . . . 0.479 ' N ' ' O ' ' A' ' 346' ' ' GLY . 5.5 ttm-85 -117.63 175.36 5.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 73.51 110.88 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . 0.593 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 43.0 p -151.63 153.45 34.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 54.13 111.122 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 165.11 174.54 34.9 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.665 -0.779 . . . . 32.33 112.412 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.507 ' CD1' ' HB2' ' A' ' 336' ' ' ALA . 41.1 m95 -81.45 122.64 27.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.787 0.327 . . . . 55.52 110.881 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -38.59 156.01 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.75 -0.738 . . . . 72.43 112.52 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 413' ' ' GLU . 0.0 OUTLIER -160.38 127.35 4.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.736 0.303 . . . . 72.54 110.906 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 412' ' ' LYS . 0.8 OUTLIER -36.63 126.91 0.85 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 72.32 110.925 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.48 . . . . 71.13 110.843 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.483 -0.247 . . . . 64.33 112.483 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 34.5 p -69.83 148.92 48.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 45.32 110.924 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -166.6 -59.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 60.02 110.884 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 41.8 p 51.38 178.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 74.33 111.079 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 4.7 tt -166.42 173.9 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 65.44 111.155 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -112.29 67.11 0.24 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.754 -0.736 . . . . 65.31 112.456 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -177.77 140.47 0.43 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.722 . . . . 73.31 110.94 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 161.44 45.94 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.663 2.242 . . . . 71.31 112.3 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -11.9 31.68 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.646 2.231 . . . . 74.51 112.356 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.515 ' O ' ' C ' ' A' ' 324' ' ' VAL . 2.3 mp0 -104.91 143.43 33.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.24 110.946 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 324' ' ' VAL . 11.7 p 28.27 75.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 64.22 111.15 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.54 143.81 98.35 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.625 0.726 . . . . 75.14 110.887 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 -13.6 35.12 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.659 2.239 . . . . 63.34 112.443 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -73.55 -72.22 0.27 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 74.5 110.898 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -51.05 -33.73 26.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.424 . . . . 71.13 111.11 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.937 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 7.9 t -70.27 -28.66 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 71.42 111.113 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -53.11 -37.45 61.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.148 -0.478 . . . . 73.32 110.867 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -71.65 -31.81 67.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 74.33 110.805 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.918 HG21 HG21 ' A' ' 393' ' ' ILE . 33.5 mm -54.59 -56.07 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 75.2 111.141 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 4.3 mt -49.72 -39.24 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 75.03 111.163 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -27.35 31.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 74.23 110.828 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 4.8 t -68.47 -32.1 71.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 75.52 110.858 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.546 ' HB2' ' CG ' ' A' ' 410' ' ' TRP . . . -113.93 155.43 45.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.606 0.717 . . . . 70.44 111.061 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 54.5 Cg_endo -69.73 161.79 44.57 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.654 2.236 . . . . 73.22 112.425 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.8 -11.47 30.86 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.667 2.245 . . . . 62.53 112.304 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -106.61 67.33 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 72.43 110.883 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 5.3 p 177.14 134.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 72.34 111.147 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 19.9 p -141.55 69.99 1.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.193 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 23.7 m -133.61 121.71 22.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 65.23 111.2 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -88.33 134.33 33.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 75.2 111.15 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.605 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -111.2 121.65 45.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.289 -0.414 . . . . 72.31 110.942 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.539 HG23 ' HB3' ' A' ' 406' ' ' LEU . 2.3 mp -124.31 102.19 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 72.1 111.14 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.443 ' H ' ' CB ' ' A' ' 407' ' ' ARG . . . -92.28 -173.19 41.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.69 -0.767 . . . . 62.23 112.519 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.9 t30 58.76 46.66 13.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 74.34 110.901 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.568 ' CG2' ' HB3' ' A' ' 352' ' ' ALA . 81.6 mt -100.08 131.38 24.37 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.529 0.68 . . . . 71.22 111.164 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . 0.523 ' CB ' ' CE1' ' A' ' 351' ' ' PHE . 53.9 Cg_endo -69.71 156.22 64.03 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.736 2.29 . . . . 73.53 112.372 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.7 -20.83 65.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 70.32 110.827 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.523 ' CE1' ' CB ' ' A' ' 349' ' ' PRO . 4.8 p90 -94.01 29.35 2.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 61.03 110.929 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.847 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -116.0 96.14 5.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 41.44 111.109 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 15.2 p -98.39 170.69 8.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 72.34 111.161 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.521 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.6 OUTLIER -67.31 -29.72 69.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 73.51 110.843 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.67 -26.21 63.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.226 -0.443 . . . . 74.32 111.084 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.3 -14.1 13.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 71.35 110.844 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.847 HD11 ' HB1' ' A' ' 352' ' ' ALA . 2.8 mp -97.78 -52.14 3.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 51.35 110.901 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.668 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -42.52 -50.32 12.34 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.627 0.727 . . . . 70.44 111.137 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 52.9 Cg_endo -69.78 -29.09 24.33 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.684 2.256 . . . . 70.32 112.313 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.849 HD13 ' C ' ' A' ' 360' ' ' LEU . 0.2 OUTLIER -66.97 -21.83 65.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 63.2 110.924 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.599 ' HB2' HD11 ' A' ' 367' ' ' ILE . 87.8 m-85 -103.32 -36.04 8.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 73.33 110.891 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -49.14 -40.27 31.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 65.52 110.853 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -48.86 -27.84 3.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 72.31 110.928 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . 0.557 ' CE1' ' HA ' ' A' ' 392' ' ' CYS . 39.7 m-85 -64.19 -56.88 11.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 73.33 110.902 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -158.98 -84.69 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.786 -0.721 . . . . 32.11 112.537 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -153.24 145.45 23.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.799 0.333 . . . . 74.52 110.893 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.599 HD11 ' HB2' ' A' ' 361' ' ' PHE . 27.6 mt -121.1 111.31 31.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 75.02 111.165 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.86 -23.18 25.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 74.24 110.934 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.16 120.67 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 72.34 110.944 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.525 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 32.8 t80 -112.34 140.96 46.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 63.45 110.845 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.11 101.21 6.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.5 . . . . 75.45 110.909 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.3 t-80 -97.43 124.07 41.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 63.43 110.795 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -118.02 89.01 33.37 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.698 0.761 . . . . 71.14 110.911 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . 0.417 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.4 Cg_endo -69.78 -26.16 27.76 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.648 2.232 . . . . 42.43 112.325 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -72.75 -12.7 61.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 72.12 110.829 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -119.75 -26.43 5.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 53.33 110.916 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 86.55 41.52 6.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.738 -0.744 . . . . 64.42 112.491 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 8.5 t -159.99 147.74 16.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.745 0.307 . . . . 73.31 110.863 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.525 ' HB2' ' CE1' ' A' ' 370' ' ' PHE . 21.5 p -134.18 155.13 50.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.221 -0.445 . . . . 75.01 110.824 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -128.95 122.79 30.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 73.43 110.887 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.521 HD13 ' CG ' ' A' ' 361' ' ' PHE . 1.1 mt -114.17 134.05 58.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 73.1 111.113 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.37 131.76 48.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 74.34 110.863 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -112.75 -173.83 2.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 70.34 110.931 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.62 -39.03 16.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 71.21 110.873 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 54.7 p -120.82 174.35 6.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 74.42 111.139 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -87.17 -32.13 20.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 71.24 110.88 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -61.16 -41.92 97.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 52.21 110.849 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -55.93 -35.79 67.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 75.42 110.892 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.39 -26.12 60.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.227 -0.442 . . . . 65.12 111.13 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.937 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -68.56 -40.42 80.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 63.4 111.072 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.632 ' O ' HG21 ' A' ' 324' ' ' VAL . 93.8 t -64.73 -55.2 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 60.24 111.141 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . 0.557 ' HA ' ' CE1' ' A' ' 364' ' ' PHE . 16.7 p -57.15 -29.69 63.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.485 . . . . 73.34 110.858 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.918 HG21 HG21 ' A' ' 332' ' ' ILE . 8.6 mt -60.03 -55.42 24.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 45.22 111.134 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.5 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 1.7 t -72.04 -34.43 50.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 53.43 111.132 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -63.77 -47.86 79.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 72.34 111.08 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.711 HD13 ' CE1' ' A' ' 399' ' ' PHE . 0.3 OUTLIER -82.14 -6.38 59.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.296 -0.411 . . . . 63.21 110.899 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' ALA . . . . . 0.701 ' N ' HG21 ' A' ' 408' ' ' THR . . . -54.89 112.79 1.12 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.204 -0.453 . . . . 74.2 111.118 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 44.79 46.29 8.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 73.13 110.946 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.711 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -99.29 145.55 30.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.634 0.73 . . . . 73.53 110.85 -179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 141.91 46.22 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.714 2.276 . . . . 71.55 112.358 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' PHE . . . . . 0.461 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 48.2 t80 -151.01 112.86 4.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 74.01 110.871 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 52.97 32.74 13.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 63.25 110.917 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 96.63 -26.61 21.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.69 -0.767 . . . . 71.31 112.448 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 401' ' ' PHE . 9.9 ttt85 -108.57 143.61 37.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.827 0.346 . . . . 70.01 110.917 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -80.81 155.17 26.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 42.51 110.933 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.539 ' HB3' HG23 ' A' ' 345' ' ' ILE . 10.4 mt -114.77 175.13 5.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.476 . . . . 74.52 110.899 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' ARG . . . . . 0.443 ' CB ' ' H ' ' A' ' 346' ' ' GLY . 1.0 OUTLIER -109.02 176.21 5.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 73.51 110.902 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . 0.701 HG21 ' N ' ' A' ' 397' ' ' ALA . 45.0 p -154.06 149.82 27.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 54.13 111.147 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 164.03 -159.04 31.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.787 -0.72 . . . . 32.33 112.506 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.546 ' CG ' ' HB2' ' A' ' 336' ' ' ALA . 96.5 m95 -109.31 129.2 55.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.731 0.301 . . . . 55.52 110.974 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -93.45 159.82 24.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.791 -0.719 . . . . 72.43 112.475 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 413' ' ' GLU . 2.4 tttm -163.25 79.04 0.45 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.727 0.299 . . . . 72.54 110.918 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 414' ' ' ARG . 39.7 mt-10 35.33 45.72 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 72.32 110.962 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 413' ' ' GLU . 1.1 ptt180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.495 . . . . 71.13 110.88 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.462 -0.255 . . . . 64.33 112.462 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.45 174.72 0.35 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 45.32 110.867 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -144.64 36.65 1.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 60.02 110.947 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 318' ' ' ILE . 1.9 m -112.1 143.98 42.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.141 -0.481 . . . . 74.33 111.115 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.413 ' C ' ' O ' ' A' ' 317' ' ' THR . 5.1 tp -36.58 142.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 65.44 111.153 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -110.36 -44.11 1.02 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 65.31 112.525 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 47.65 82.71 0.23 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.566 0.698 . . . . 73.31 110.94 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.7 170.27 16.9 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.727 2.285 . . . . 71.31 112.336 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 323' ' ' GLN . 53.4 Cg_endo -69.72 6.98 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.709 2.273 . . . . 74.51 112.317 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.515 ' CB ' ' O ' ' A' ' 322' ' ' PRO . 0.3 OUTLIER 84.61 41.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 74.24 110.871 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.588 HG21 HG13 ' A' ' 391' ' ' VAL . 1.1 t -156.47 164.82 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 64.22 111.14 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -108.12 116.23 57.19 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.607 0.718 . . . . 75.14 110.855 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -14.25 35.85 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.725 2.283 . . . . 63.34 112.311 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -71.65 -72.17 0.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 74.5 110.899 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -58.63 -25.49 62.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 71.13 111.065 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.925 HG22 ' HB ' ' A' ' 394' ' ' VAL . 24.6 t -78.21 -29.98 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.434 . . . . 71.42 111.187 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.445 ' HA ' HD12 ' A' ' 333' ' ' ILE . 21.3 t70 -54.71 -35.64 63.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.877 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' HIS . . . . . 0.521 ' CD2' HD12 ' A' ' 332' ' ' ILE . 2.2 t60 -61.69 -38.27 87.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 74.33 110.884 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.611 ' CG1' HG21 ' A' ' 393' ' ' ILE . 1.1 mp -54.21 -51.42 47.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 75.2 111.096 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 330' ' ' ASP . 9.0 mt -53.67 -38.38 34.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 75.03 111.121 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.6 -2.45 6.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.23 110.872 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 43.2 t -108.92 21.76 16.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 75.52 110.829 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -175.9 150.88 1.14 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.586 0.707 . . . . 70.44 111.083 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 154.28 67.65 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.629 2.219 . . . . 73.22 112.323 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -8.05 22.6 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.678 2.252 . . . . 62.53 112.351 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.08 -49.72 13.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.207 -0.451 . . . . 72.43 110.876 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.75 133.05 32.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 72.34 111.146 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . 0.632 HG22 ' CA ' ' A' ' 386' ' ' HIS . 30.2 p -135.7 68.02 1.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.117 -0.492 . . . . 73.22 111.184 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 51.2 m -133.72 136.99 45.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 65.23 111.154 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.446 ' CB ' ' SG ' ' A' ' 392' ' ' CYS . . . -109.18 129.54 55.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 75.2 111.088 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.711 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -105.95 134.44 49.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 72.31 110.899 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.711 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.9 mp -129.61 100.7 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 72.1 111.171 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -90.07 178.61 43.56 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.713 -0.756 . . . . 62.23 112.488 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 405' ' ' ASN . 2.3 t30 67.64 49.23 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 74.34 110.899 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.675 HG23 ' HD2' ' A' ' 349' ' ' PRO . 77.4 mt -105.11 138.51 19.54 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.618 0.723 . . . . 71.22 111.156 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . 0.675 ' HD2' HG23 ' A' ' 348' ' ' ILE . 53.7 Cg_endo -69.75 164.04 36.03 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.708 2.272 . . . . 73.53 112.361 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -75.57 -18.64 59.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 70.32 110.817 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.563 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 55.4 p90 -92.88 17.65 10.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 61.03 110.9 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.808 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -105.8 116.04 31.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 41.44 111.159 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 25.6 p -114.96 170.42 8.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 72.34 111.192 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.507 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.1 OUTLIER -64.82 -29.77 70.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 73.51 110.935 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -58.48 -26.59 63.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 74.32 111.108 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.27 -13.6 13.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 71.35 110.954 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.808 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.5 mp -98.47 -52.27 3.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.488 . . . . 51.35 110.899 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.649 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -41.83 -51.07 9.95 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.639 0.733 . . . . 70.44 111.066 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.1 Cg_endo -69.79 -35.37 12.69 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.699 2.266 . . . . 70.32 112.388 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.921 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -59.45 -23.47 62.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 63.2 110.922 179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.543 ' N ' HD13 ' A' ' 360' ' ' LEU . 82.8 m-85 -100.97 -35.6 9.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 73.33 110.877 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' GLN . . . . . 0.478 ' HG3' HD12 ' A' ' 367' ' ' ILE . 2.3 mt-30 -53.34 -35.41 60.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 65.52 110.934 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -54.11 -14.88 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 72.31 110.875 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -78.62 -56.78 4.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 73.33 110.862 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -157.09 -85.99 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.756 -0.735 . . . . 32.11 112.453 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.693 ' CD2' HD21 ' A' ' 368' ' ' LEU . 8.4 t80 -153.64 142.82 21.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.819 0.342 . . . . 74.52 110.881 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.478 HD12 ' HG3' ' A' ' 362' ' ' GLN . 50.3 mt -120.87 112.3 35.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 75.02 111.156 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.693 HD21 ' CD2' ' A' ' 366' ' ' PHE . 0.3 OUTLIER -86.01 -21.82 27.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 74.24 110.889 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -168.94 121.2 0.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.186 -0.461 . . . . 72.34 110.88 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 33.5 t80 -111.11 139.77 46.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.258 -0.428 . . . . 63.45 110.891 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -126.82 100.93 6.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 75.45 110.95 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . 0.588 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 11.0 t-80 -96.37 115.71 27.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 63.43 110.793 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -107.25 84.58 1.77 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.744 . . . . 71.14 110.874 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . 0.503 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 53.9 Cg_endo -69.73 -17.38 37.72 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.701 2.267 . . . . 42.43 112.411 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -78.24 -24.67 46.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 72.12 110.908 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -108.7 -27.41 9.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 53.33 110.948 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 93.4 42.29 4.29 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.676 -0.774 . . . . 64.42 112.452 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 26.3 p -159.92 158.18 30.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.837 0.351 . . . . 73.31 110.942 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.564 ' HB2' ' CE1' ' A' ' 370' ' ' PHE . 28.1 p -143.35 152.32 41.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 75.01 110.872 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 414' ' ' ARG . 38.0 m-85 -125.8 125.03 42.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 73.43 110.827 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.443 HG22 HG23 ' A' ' 367' ' ' ILE . 0.7 OUTLIER -115.28 121.25 66.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 73.1 111.139 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 13.8 tttt -87.94 131.95 34.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 74.34 110.919 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -116.43 162.7 17.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 70.34 110.889 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -60.99 -45.55 94.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 71.21 110.873 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 30.2 p -112.92 169.02 9.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 74.42 111.143 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' HIS . . . . . 0.632 ' CA ' HG22 ' A' ' 341' ' ' THR . 18.0 p-80 -82.62 -36.14 26.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 71.24 110.891 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 391' ' ' VAL . 5.0 tm-20 -62.73 -26.81 68.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.181 -0.463 . . . . 52.21 110.896 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -34.96 79.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 75.42 110.868 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -73.66 -41.26 62.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 65.12 111.05 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -58.87 -26.36 64.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 63.4 111.121 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.588 HG13 HG21 ' A' ' 324' ' ' VAL . 79.7 t -71.36 -55.76 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 60.24 111.145 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 343' ' ' ALA . 30.3 p -60.64 -32.05 71.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.913 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.611 HG21 ' CG1' ' A' ' 332' ' ' ILE . 0.2 OUTLIER -53.54 -54.98 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 45.22 111.092 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.925 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.7 -38.91 68.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 53.43 111.139 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.415 ' N ' ' CG1' ' A' ' 394' ' ' VAL . . . -62.03 -33.91 75.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 72.34 111.116 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.7 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.6 mm? -93.61 -15.08 25.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 63.21 110.925 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' ALA . . . . . 0.609 ' N ' HG21 ' A' ' 408' ' ' THR . . . -47.39 111.47 0.42 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 74.2 111.065 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 43.14 47.43 5.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.469 . . . . 73.13 110.944 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.7 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -100.88 146.28 31.85 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.661 0.744 . . . . 73.53 110.841 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.441 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 54.2 Cg_endo -69.76 137.05 34.57 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.717 2.278 . . . . 71.55 112.339 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' PHE . . . . . 0.571 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 29.9 t80 -142.64 111.13 6.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 74.01 110.967 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 48.98 34.5 5.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.278 -0.419 . . . . 63.25 110.935 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 99.28 -31.99 7.65 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.741 -0.743 . . . . 71.31 112.454 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.8 134.71 47.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 70.01 110.859 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.474 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 3.1 m120 -78.2 152.25 32.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 42.51 110.892 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.453 ' HB3' HG23 ' A' ' 345' ' ' ILE . 10.8 mt -111.62 177.5 4.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 74.52 110.872 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.77 172.26 7.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 73.51 110.85 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . 0.609 HG21 ' N ' ' A' ' 397' ' ' ALA . 45.8 p -154.77 146.09 22.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 54.13 111.18 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 165.34 138.41 2.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.739 -0.743 . . . . 32.33 112.512 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -43.68 134.12 4.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.778 0.323 . . . . 55.52 110.942 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -110.87 163.92 12.23 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.711 -0.756 . . . . 72.43 112.552 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.484 ' O ' ' C ' ' A' ' 413' ' ' GLU . 0.0 OUTLIER -133.32 78.2 1.77 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.732 0.301 . . . . 72.54 110.926 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.484 ' C ' ' O ' ' A' ' 412' ' ' LYS . 5.8 pt-20 31.54 51.21 0.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 72.32 110.846 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 380' ' ' PHE . 2.3 ttm180 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 71.13 110.817 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 N-CA-C 112.503 -0.239 . . . . 64.33 112.503 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.79 -54.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 45.32 110.854 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.93 75.46 1.29 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 60.02 110.896 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 4.3 t -171.89 157.08 4.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 74.33 111.129 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 14.1 tt -134.23 148.31 29.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 65.44 111.077 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -114.95 114.56 3.24 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.77 -0.729 . . . . 65.31 112.498 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.5 73.26 12.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.655 0.741 . . . . 73.31 110.901 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 150.9 68.26 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.654 2.236 . . . . 71.31 112.315 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 3.34 2.81 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.696 2.264 . . . . 74.51 112.322 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -89.26 -72.22 0.56 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 74.24 110.889 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.87 150.24 26.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 64.22 111.132 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -113.05 118.89 43.66 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.738 0.78 . . . . 75.14 110.844 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -14.29 36.03 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.742 2.295 . . . . 63.34 112.358 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -69.81 -72.61 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 74.5 110.913 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.06 -33.78 63.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 71.13 111.145 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.889 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 10.7 t -66.78 -29.88 47.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.178 -0.464 . . . . 71.42 111.156 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.505 ' HA ' HD12 ' A' ' 333' ' ' ILE . 7.1 t70 -54.11 -34.74 61.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 73.32 110.912 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -70.69 -31.99 69.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.446 . . . . 74.33 110.86 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.907 HG21 HG21 ' A' ' 393' ' ' ILE . 29.4 mm -57.98 -44.9 87.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 75.2 111.093 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 330' ' ' ASP . 6.0 mt -53.66 -44.39 57.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 75.03 111.181 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 1.6 ttm-85 -56.08 -13.85 2.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.475 . . . . 74.23 110.93 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 11.7 t -76.32 -30.56 57.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 75.52 110.9 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.752 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . -133.78 165.34 37.44 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.554 0.693 . . . . 70.44 111.114 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.752 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 53.8 Cg_endo -69.75 148.75 65.85 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.675 2.25 . . . . 73.22 112.342 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -7.64 21.58 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.716 2.278 . . . . 62.53 112.313 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -43.8 40.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.224 -0.444 . . . . 72.43 110.806 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . . . . . . . . . 9.1 p -81.6 139.73 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 72.34 111.077 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . 0.488 HG22 ' CA ' ' A' ' 386' ' ' HIS . 34.7 p -138.46 69.09 1.38 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.12 -0.491 . . . . 73.22 111.171 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.476 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 98.6 m -133.59 124.96 27.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 65.23 111.088 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -85.6 126.47 33.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 75.2 111.064 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.818 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -106.4 134.29 49.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 72.31 110.907 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.818 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.8 mp -135.41 110.97 12.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 72.1 111.126 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -100.03 161.08 19.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.696 -0.764 . . . . 62.23 112.419 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 1.0 OUTLIER 81.09 50.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.775 0.321 . . . . 74.34 110.882 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.647 HG23 ' HD2' ' A' ' 349' ' ' PRO . 46.5 mt -104.1 138.2 19.46 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.619 0.723 . . . . 71.22 111.149 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . 0.843 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.3 Cg_endo -69.78 166.48 27.47 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.732 2.288 . . . . 73.53 112.308 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -74.24 -29.66 61.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 70.32 110.884 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -83.5 12.87 5.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 61.03 110.908 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.843 ' HB2' ' HG2' ' A' ' 349' ' ' PRO . . . -99.15 102.59 14.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 41.44 111.122 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 22.3 p -105.02 172.0 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 72.34 111.112 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.505 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.3 OUTLIER -65.6 -30.25 70.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.437 . . . . 73.51 110.845 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -57.25 -26.29 60.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.177 -0.465 . . . . 74.32 111.095 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.89 -18.68 12.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 71.35 110.868 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.839 HD11 ' HB1' ' A' ' 352' ' ' ALA . 4.6 mp -92.68 -52.51 4.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 51.35 110.957 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.656 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -41.76 -51.1 9.74 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.609 0.718 . . . . 70.44 111.122 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' PRO . . . . . 0.656 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.8 Cg_endo -69.7 -30.15 23.01 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.669 2.246 . . . . 70.32 112.353 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.925 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -66.46 -23.96 66.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 63.2 110.912 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.564 ' CE2' HD12 ' A' ' 360' ' ' LEU . 81.3 m-85 -101.45 -27.43 13.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 73.33 110.919 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' GLN . . . . . 0.539 ' N ' HD11 ' A' ' 367' ' ' ILE . 0.0 OUTLIER -56.57 -22.93 36.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 65.52 110.852 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -71.29 -10.38 59.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.252 -0.431 . . . . 72.31 110.89 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . 0.435 ' HE2' ' HG ' ' A' ' 392' ' ' CYS . 23.6 m-85 -93.17 18.59 9.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.911 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 130.07 -96.02 0.36 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.731 -0.747 . . . . 32.11 112.506 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -152.55 150.8 29.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.767 0.318 . . . . 74.52 110.943 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.539 HD11 ' N ' ' A' ' 362' ' ' GLN . 45.8 mt -121.42 109.86 26.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 75.02 111.149 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.75 -18.71 28.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 74.24 110.922 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.27 120.8 0.51 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 72.34 110.906 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 29.4 t80 -112.36 145.4 40.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 63.45 110.902 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.82 101.16 4.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.167 -0.469 . . . . 75.45 110.848 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . 0.594 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 12.9 t-80 -94.99 117.35 29.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.266 -0.425 . . . . 63.43 110.846 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -109.7 83.64 2.84 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.657 0.741 . . . . 71.14 110.846 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . 0.496 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 52.7 Cg_endo -69.86 -17.97 36.81 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.691 2.261 . . . . 42.43 112.304 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -73.28 -27.19 61.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 72.12 110.862 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -110.52 -27.29 9.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 53.33 110.856 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 94.25 43.51 3.74 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 64.42 112.476 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 79.7 m -154.8 152.93 30.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.827 0.346 . . . . 73.31 110.918 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 16.0 p -136.21 152.49 50.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 75.01 110.879 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.476 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 48.6 m-85 -129.02 124.79 35.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 73.43 110.869 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.508 ' CG2' HG23 ' A' ' 367' ' ' ILE . 0.7 OUTLIER -117.35 123.28 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 73.1 111.172 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 29.8 mtpt -89.55 136.19 33.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 74.34 110.886 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -119.63 -178.63 3.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 70.34 110.925 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -76.75 -42.57 40.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.496 . . . . 71.21 110.874 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 55.4 p -127.97 170.3 13.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 74.42 111.104 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' HIS . . . . . 0.488 ' CA ' HG22 ' A' ' 341' ' ' THR . 29.3 p-80 -80.41 -35.31 35.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 71.24 110.823 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -59.42 -27.18 65.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 52.21 110.938 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.84 -34.28 62.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 75.42 110.879 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.404 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -69.04 -44.09 73.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 65.12 111.081 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.889 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -50.22 -28.85 8.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 63.4 111.082 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.57 -40.07 79.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 60.24 111.156 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . 0.435 ' HG ' ' HE2' ' A' ' 364' ' ' PHE . 45.4 t -69.93 -33.61 72.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 73.34 110.892 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.907 HG21 HG21 ' A' ' 332' ' ' ILE . 0.9 OUTLIER -53.2 -55.61 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 45.22 111.19 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.5 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.0 t -71.47 -40.82 72.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 53.43 111.141 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.09 -16.75 54.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 72.34 111.102 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.581 HD12 HG12 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -115.91 -8.7 11.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 63.21 110.934 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -59.23 108.43 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 74.2 111.136 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 11.1 m120 47.98 49.37 17.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 73.13 110.911 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.5 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -108.62 142.75 26.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.694 0.759 . . . . 73.53 110.884 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.499 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 54.1 Cg_endo -69.71 145.52 57.72 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.702 2.268 . . . . 71.55 112.306 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' PHE . . . . . 0.485 ' N ' ' O ' ' A' ' 404' ' ' ARG . 50.4 t80 -152.77 110.61 3.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 74.01 110.797 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 49.54 39.9 18.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.508 . . . . 63.25 110.948 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 81.72 10.48 84.18 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.775 -0.726 . . . . 71.31 112.478 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -135.02 132.73 38.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.855 0.36 . . . . 70.01 110.909 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.531 ' C ' HD23 ' A' ' 406' ' ' LEU . 34.5 m120 -82.54 146.02 29.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 42.51 110.88 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.707 ' HB3' HG23 ' A' ' 345' ' ' ILE . 6.3 mt -112.02 172.6 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 74.52 110.941 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' ARG . . . . . 0.478 ' O ' HG23 ' A' ' 408' ' ' THR . 0.0 OUTLIER -123.16 177.2 5.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 73.51 110.837 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . 0.642 HG21 ' O ' ' A' ' 393' ' ' ILE . 19.9 p -157.47 163.4 38.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 54.13 111.146 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 410' ' ' TRP . . . 152.23 44.75 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.722 -0.751 . . . . 32.33 112.512 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.514 ' NE1' HG22 ' A' ' 332' ' ' ILE . 75.1 m95 56.84 155.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.813 0.34 . . . . 55.52 110.907 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -44.33 121.58 4.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.778 -0.725 . . . . 72.43 112.47 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -154.75 122.59 5.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.739 0.304 . . . . 72.54 110.902 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -42.67 -62.09 1.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 72.32 110.871 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 71.13 110.905 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.445 -0.262 . . . . 64.33 112.445 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 25.2 p -51.08 150.81 2.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.878 0.371 . . . . 45.32 110.857 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' GLN . . . . . 0.612 ' O ' HG22 ' A' ' 317' ' ' THR . 0.5 OUTLIER -106.16 -61.49 1.51 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 60.02 110.878 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.612 HG22 ' O ' ' A' ' 316' ' ' GLN . 14.4 t 45.83 -163.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 74.33 111.179 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.627 HD11 HD12 ' A' ' 320' ' ' LEU . 3.9 tp -95.4 144.04 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 65.44 111.119 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.447 ' N ' HG13 ' A' ' 318' ' ' ILE . . . -114.37 55.13 0.54 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 65.31 112.499 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.627 HD12 HD11 ' A' ' 318' ' ' ILE . 8.5 mt -132.79 66.7 77.01 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.599 0.714 . . . . 73.31 110.873 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 164.17 35.64 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.619 2.213 . . . . 71.31 112.337 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -40.65 5.04 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.652 2.235 . . . . 74.51 112.292 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -116.01 -63.81 1.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.433 . . . . 74.24 110.928 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.648 HG12 HG13 ' A' ' 391' ' ' VAL . 1.3 p -174.12 152.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 64.22 111.114 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.429 ' HA ' ' HD2' ' A' ' 326' ' ' PRO . 1.4 m120 -50.63 107.39 0.8 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.671 0.748 . . . . 75.14 110.807 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 325' ' ' ASN . 54.1 Cg_endo -69.83 -13.74 34.91 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.651 2.234 . . . . 63.34 112.337 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.32 -71.97 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 74.5 110.842 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -47.96 -25.27 1.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 71.13 111.117 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.878 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 14.2 t -83.43 -29.72 7.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 71.42 111.079 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.432 ' HA ' HD12 ' A' ' 333' ' ' ILE . 5.2 t0 -53.94 -35.26 61.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 73.32 110.872 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -68.89 -31.78 70.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 74.33 110.82 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.693 HG21 HG21 ' A' ' 393' ' ' ILE . 31.4 mm -58.38 -51.69 68.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 75.2 111.151 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 330' ' ' ASP . 4.8 mt -51.67 -42.54 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 75.03 111.192 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -53.66 -16.39 1.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 74.23 110.889 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 6.1 t -88.47 -25.67 22.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 75.52 110.816 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.64 ' HB2' ' CG ' ' A' ' 410' ' ' TRP . . . -116.56 151.22 46.8 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.556 0.694 . . . . 70.44 111.16 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.526 ' O ' HG12 ' A' ' 340' ' ' VAL . 54.9 Cg_endo -69.74 161.71 44.89 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.753 2.302 . . . . 73.22 112.374 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -8.43 23.57 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.704 2.269 . . . . 62.53 112.366 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -109.25 63.47 0.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 72.43 110.882 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 337' ' ' PRO . 9.2 p -175.15 126.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.451 . . . . 72.34 111.131 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 21.5 p -137.88 73.46 1.44 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 73.22 111.146 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 71.1 m -132.86 124.24 27.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 65.23 111.148 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -93.77 116.33 28.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 75.2 111.157 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.84 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -101.55 134.29 44.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.424 . . . . 72.31 110.864 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.84 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.8 mp -133.43 112.22 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 72.1 111.155 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -97.31 176.63 31.67 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.75 -0.738 . . . . 62.23 112.482 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.3 t30 65.68 49.85 1.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.777 0.322 . . . . 74.34 110.847 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.552 HG23 ' HD2' ' A' ' 349' ' ' PRO . 74.3 mt -104.98 135.4 19.3 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.614 0.721 . . . . 71.22 111.124 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . 0.673 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 55.2 Cg_endo -69.74 164.86 32.94 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.692 2.261 . . . . 73.53 112.42 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -72.5 -23.34 61.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 70.32 110.893 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -92.9 28.73 2.0 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.167 -0.47 . . . . 61.03 110.854 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.828 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -113.63 87.6 2.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 41.44 111.188 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 38.1 p -87.92 171.29 10.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.201 -0.454 . . . . 72.34 111.144 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.506 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -66.94 -29.81 69.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 73.51 110.925 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.21 -26.3 50.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.047 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.15 -13.28 13.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 71.35 110.903 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.828 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.3 mp -98.52 -53.88 3.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 51.35 110.967 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.649 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -41.17 -51.37 7.89 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.671 0.748 . . . . 70.44 111.15 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.9 Cg_endo -69.76 -31.56 20.3 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.704 2.269 . . . . 70.32 112.348 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.911 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -63.98 -23.52 67.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 63.2 110.898 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.611 ' CE2' HD12 ' A' ' 360' ' ' LEU . 86.9 m-85 -102.07 -33.64 9.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.938 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -54.06 -31.8 52.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 65.52 110.927 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -57.2 -21.02 30.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 72.31 110.86 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 41.6 m-85 -72.02 -57.4 4.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.883 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -155.87 -86.28 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.721 . . . . 32.11 112.483 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -152.41 143.55 23.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.827 0.346 . . . . 74.52 110.952 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.457 HG23 ' CG2' ' A' ' 381' ' ' ILE . 41.4 mt -120.81 109.17 24.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 75.02 111.109 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.27 -21.18 27.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 74.24 110.91 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.56 121.5 0.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.46 . . . . 72.34 110.881 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.513 ' CD2' HG12 ' A' ' 358' ' ' ILE . 39.1 t80 -115.23 138.95 50.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 63.45 110.836 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -127.68 100.7 6.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.14 -0.482 . . . . 75.45 110.852 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . 0.545 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 10.8 t-80 -94.98 119.46 33.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 63.43 110.826 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -113.37 85.58 8.86 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.67 0.747 . . . . 71.14 110.873 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . 0.509 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 53.7 Cg_endo -69.83 -29.8 22.95 Favored 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.706 2.27 . . . . 42.43 112.407 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.02 -17.02 64.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 72.12 110.869 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -116.36 -27.74 6.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 53.33 110.901 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 90.81 39.96 5.71 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.696 -0.764 . . . . 64.42 112.526 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 99.6 m -156.84 145.94 20.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.787 0.327 . . . . 73.31 110.877 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 20.7 p -134.76 153.76 51.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 75.01 110.892 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 380' ' ' PHE . 2.5 m-85 -129.28 131.67 47.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 73.43 110.89 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.543 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -122.8 119.65 58.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 73.1 111.063 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.98 134.02 33.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 74.34 110.909 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -115.36 -178.6 3.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 70.34 110.893 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -86.51 -29.14 22.94 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.077 -0.51 . . . . 71.21 110.873 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 66.0 p -129.54 166.25 20.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 74.42 111.156 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -80.65 -38.41 29.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 71.24 110.849 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -60.88 -29.88 69.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 52.21 110.861 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -35.56 80.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 75.42 110.875 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -75.63 -38.11 59.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 65.12 111.046 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.878 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -60.29 -36.57 78.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.238 -0.437 . . . . 63.4 111.102 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.648 HG13 HG12 ' A' ' 324' ' ' VAL . 20.0 t -66.37 -33.38 63.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 60.24 111.129 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . 0.535 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 2.0 t -83.93 -23.85 30.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 73.34 110.847 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.797 ' O ' HG21 ' A' ' 408' ' ' THR . 13.4 mt -59.9 -57.93 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.262 -0.426 . . . . 45.22 111.107 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.517 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.7 t -72.1 -36.22 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 53.43 111.07 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -61.79 -22.71 65.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 72.34 111.086 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.715 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.2 mm? -104.12 -10.6 17.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 63.21 110.873 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -57.5 119.95 7.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 74.2 111.076 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.8 m120 44.25 36.53 1.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 73.13 110.845 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.715 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -95.53 141.74 23.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.66 0.743 . . . . 73.53 110.844 -179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.462 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.5 Cg_endo -69.76 147.41 62.78 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.622 2.215 . . . . 71.55 112.372 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' PHE . . . . . 0.534 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 61.2 t80 -154.52 110.79 3.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 74.01 110.836 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 51.42 33.5 10.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 63.25 110.886 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 87.57 13.25 65.58 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.724 -0.751 . . . . 71.31 112.465 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 401' ' ' PHE . 19.3 mtt180 -140.57 135.75 32.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 70.01 110.882 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.549 ' O ' HD23 ' A' ' 406' ' ' LEU . 8.5 m120 -78.93 150.78 32.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 42.51 110.878 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.647 ' HB3' HG23 ' A' ' 345' ' ' ILE . 11.2 mt -120.3 162.8 18.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.246 -0.434 . . . . 74.52 110.924 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.39 175.24 5.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 73.51 110.883 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . 0.797 HG21 ' O ' ' A' ' 393' ' ' ILE . 2.1 p -154.38 155.59 35.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 54.13 111.179 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . 0.447 ' O ' ' C ' ' A' ' 410' ' ' TRP . . . 152.07 129.39 1.49 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.776 -0.726 . . . . 32.33 112.544 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.64 ' CG ' ' HB2' ' A' ' 336' ' ' ALA . 67.3 m95 -33.83 126.07 0.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 55.52 110.922 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -48.03 171.75 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.72 -0.752 . . . . 72.43 112.568 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 414' ' ' ARG . 0.0 OUTLIER -170.89 106.39 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 72.54 110.927 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 414' ' ' ARG . 2.1 mt-10 -60.0 82.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 72.32 110.883 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 412' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 71.13 110.896 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.561 -0.216 . . . . 64.33 112.561 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -112.48 122.94 49.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 45.32 110.837 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -47.32 173.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 60.02 110.905 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 26.3 m -96.66 -54.02 3.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 74.33 111.129 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.471 HG23 ' N ' ' A' ' 319' ' ' GLY . 6.3 tt -162.88 -43.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 65.44 111.141 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.471 ' N ' HG23 ' A' ' 318' ' ' ILE . . . 96.35 -44.73 1.96 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.73 -0.747 . . . . 65.31 112.493 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.465 HD12 ' C ' ' A' ' 319' ' ' GLY . 2.4 mp 62.93 81.0 0.23 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.594 0.711 . . . . 73.31 110.825 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 169.12 19.7 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.708 2.272 . . . . 71.31 112.327 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.402 ' O ' ' NE2' ' A' ' 323' ' ' GLN . 53.9 Cg_endo -69.67 -50.38 0.48 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.732 2.288 . . . . 74.51 112.345 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.402 ' NE2' ' O ' ' A' ' 322' ' ' PRO . 30.3 mm-40 -127.62 -70.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 74.24 110.928 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.591 HG22 HG13 ' A' ' 391' ' ' VAL . 7.6 m -123.88 -176.15 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 64.22 111.145 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.36 121.84 66.97 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.624 0.726 . . . . 75.14 110.878 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -14.13 35.84 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.661 2.241 . . . . 63.34 112.411 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.58 -72.08 0.22 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 74.5 110.863 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.33 -24.81 30.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 71.13 111.05 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.829 HG22 ' HB ' ' A' ' 394' ' ' VAL . 19.4 t -76.88 -29.97 17.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 71.42 111.1 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -54.61 -40.84 69.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 73.32 110.878 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -62.7 -32.73 73.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 74.33 110.912 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.845 HG21 HG21 ' A' ' 393' ' ' ILE . 30.9 mm -57.57 -43.49 83.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 75.2 111.124 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 18.2 mt -58.23 -32.6 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 75.03 111.112 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -4.32 11.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 74.23 110.834 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.69 38.91 1.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 75.52 110.901 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.704 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . 179.56 164.44 0.78 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.525 0.678 . . . . 70.44 111.18 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.704 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 53.6 Cg_endo -69.68 159.66 52.62 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.744 2.296 . . . . 73.22 112.373 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -24.67 29.41 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.723 2.282 . . . . 62.53 112.339 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 40.6 mtt-85 -104.24 73.51 1.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 72.43 110.854 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 337' ' ' PRO . 9.5 p -167.91 128.94 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 72.34 111.09 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . 0.415 HG22 ' CA ' ' A' ' 386' ' ' HIS . 19.8 p -137.41 68.07 1.42 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 73.22 111.093 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 66.4 m -133.87 116.36 15.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.204 -0.453 . . . . 65.23 111.117 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -86.61 127.01 34.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 75.2 111.107 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.823 ' O ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -105.75 135.04 47.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 72.31 110.886 -179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.823 HD12 ' O ' ' A' ' 344' ' ' TYR . 1.7 mp -132.94 116.96 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 72.1 111.179 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -107.01 173.87 19.43 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.681 -0.771 . . . . 62.23 112.464 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 1.3 t30 65.68 53.09 1.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.752 0.31 . . . . 74.34 110.826 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.667 HG23 ' HD2' ' A' ' 349' ' ' PRO . 80.0 mt -102.86 138.75 19.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.564 0.697 . . . . 71.22 111.165 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . 0.667 ' HD2' HG23 ' A' ' 348' ' ' ILE . 53.2 Cg_endo -69.78 166.24 28.28 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.7 2.266 . . . . 73.53 112.325 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -74.18 -22.62 59.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 70.32 110.888 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.437 ' CE1' ' CB ' ' A' ' 349' ' ' PRO . 2.7 p90 -91.27 27.15 1.99 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 61.03 110.857 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.764 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -111.67 111.91 23.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.489 . . . . 41.44 111.105 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 18.3 p -117.64 168.48 10.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 72.34 111.15 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.52 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.2 OUTLIER -62.82 -30.43 71.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 73.51 110.909 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -61.44 -25.93 67.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 74.32 111.096 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.14 -12.93 13.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 71.35 110.909 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.764 HD11 ' HB1' ' A' ' 352' ' ' ALA . 2.9 mp -100.51 -51.07 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.463 . . . . 51.35 110.886 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.657 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -40.86 -51.03 7.37 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.641 0.734 . . . . 70.44 111.106 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' PRO . . . . . 0.657 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.8 Cg_endo -69.67 -31.1 21.61 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.69 2.26 . . . . 70.32 112.385 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.994 ' O ' HD12 ' A' ' 360' ' ' LEU . 0.1 OUTLIER -64.47 -27.31 68.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 63.2 110.889 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.766 ' HB2' HD11 ' A' ' 367' ' ' ILE . 86.5 m-85 -95.28 -32.01 13.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 73.33 110.902 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -57.78 -35.55 70.94 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 65.52 110.95 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -54.71 -24.17 20.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 72.31 110.866 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -69.26 -57.75 4.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 73.33 110.876 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -154.66 -83.45 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.711 -0.757 . . . . 32.11 112.45 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -153.31 143.48 22.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.343 . . . . 74.52 110.892 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.766 HD11 ' HB2' ' A' ' 361' ' ' PHE . 18.9 mt -121.01 109.16 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 75.02 111.096 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.29 -16.92 25.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.146 -0.479 . . . . 74.24 110.92 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -170.35 121.22 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 72.34 110.884 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 29.9 t80 -114.51 145.41 41.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 63.45 110.897 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.99 100.65 4.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 75.45 110.875 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . 0.571 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.4 t-80 -96.5 118.34 32.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 63.43 110.868 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -109.18 85.21 3.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.699 0.761 . . . . 71.14 110.949 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . 0.523 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 54.4 Cg_endo -69.7 -17.88 37.59 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.244 . . . . 42.43 112.369 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.16 -18.29 57.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 72.12 110.934 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.13 -25.56 7.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 53.33 110.946 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 91.99 31.11 9.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.782 -0.723 . . . . 64.42 112.509 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 57.8 m -143.23 154.45 43.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.76 0.314 . . . . 73.31 110.875 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 19.7 p -143.61 143.79 31.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 75.01 110.975 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -121.99 139.21 53.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.262 -0.426 . . . . 73.43 110.906 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.635 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -128.58 128.71 68.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 73.1 111.146 179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -93.08 129.53 39.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 74.34 110.843 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -111.52 -178.61 3.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 70.34 110.96 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -82.54 -43.91 16.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 71.21 110.823 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 36.2 p -115.84 166.57 11.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 74.42 111.115 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' HIS . . . . . 0.415 ' CA ' HG22 ' A' ' 341' ' ' THR . 22.9 p-80 -85.28 -39.57 17.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 71.24 110.937 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.05 -27.11 63.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 52.21 110.888 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -52.19 36.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 75.42 110.912 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.446 ' HB3' ' CH2' ' A' ' 410' ' ' TRP . . . -51.77 -41.19 61.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 65.12 111.082 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.684 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -52.42 -34.12 46.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 63.4 111.094 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.591 HG13 HG22 ' A' ' 324' ' ' VAL . 15.0 t -67.42 -43.24 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 60.24 111.119 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 9.9 t -69.35 -33.65 73.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 73.34 110.85 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.845 HG21 HG21 ' A' ' 332' ' ' ILE . 0.7 OUTLIER -54.0 -54.98 16.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 45.22 111.133 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.829 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.5 OUTLIER -71.5 -37.52 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 53.43 111.117 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -65.62 -21.13 66.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 72.34 111.078 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.612 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.7 mm? -106.53 -10.93 16.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.259 -0.428 . . . . 63.21 110.861 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -58.9 114.71 2.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.2 111.091 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . 0.453 ' C ' ' OD1' ' A' ' 405' ' ' ASN . 2.9 t-20 42.7 43.06 3.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 73.13 110.888 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.612 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -101.18 144.38 28.44 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.598 0.714 . . . . 73.53 110.902 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.455 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.8 Cg_endo -69.75 142.04 46.89 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.76 2.307 . . . . 71.55 112.323 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' PHE . . . . . 0.586 ' CE1' HD22 ' A' ' 360' ' ' LEU . 75.5 t80 -152.81 110.95 3.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 74.01 110.907 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . 0.464 ' OE1' ' CZ ' ' A' ' 401' ' ' PHE . 0.4 OUTLIER 53.86 32.6 15.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 63.25 110.917 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 94.86 -19.84 51.91 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.776 -0.725 . . . . 71.31 112.473 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 401' ' ' PHE . 8.6 mmt180 -110.99 141.01 45.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.782 0.325 . . . . 70.01 110.897 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.474 ' C ' HD23 ' A' ' 406' ' ' LEU . 0.5 OUTLIER -86.79 149.91 24.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 42.51 110.918 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.589 HD13 HG21 ' A' ' 345' ' ' ILE . 10.1 mt -113.78 171.84 7.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 74.52 110.941 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 345' ' ' ILE . 1.1 tpt85 -123.41 179.19 4.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 73.51 110.838 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . 0.592 HG21 ' O ' ' A' ' 393' ' ' ILE . 33.9 p -155.88 170.07 22.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 54.13 111.189 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 410' ' ' TRP . . . 151.64 42.77 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.776 -0.726 . . . . 32.33 112.48 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.447 ' C ' ' HB3' ' A' ' 344' ' ' TYR . 58.8 m95 57.34 153.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.771 0.32 . . . . 55.52 110.96 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -54.02 169.36 1.31 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.721 . . . . 72.43 112.426 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.65 179.65 7.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.777 0.322 . . . . 72.54 110.911 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -96.44 -59.62 1.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 72.32 110.867 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 71.13 110.913 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.495 -0.242 . . . . 64.33 112.495 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 34.3 m -81.1 89.11 5.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.752 0.311 . . . . 45.32 110.842 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -109.3 132.51 54.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 60.02 110.941 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.42 HG22 HG22 ' A' ' 318' ' ' ILE . 48.1 m -57.71 -54.58 45.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 74.33 111.152 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.42 HG22 HG22 ' A' ' 317' ' ' THR . 3.8 tp -174.36 133.46 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 65.44 111.096 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -67.77 -71.82 0.89 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.71 -0.757 . . . . 65.31 112.531 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 320' ' ' LEU . 5.0 mt 52.76 71.29 1.49 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.652 0.739 . . . . 73.31 110.934 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 141.25 44.43 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.648 2.232 . . . . 71.31 112.325 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -25.24 28.96 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.647 2.232 . . . . 74.51 112.373 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 6.5 mp0 -142.4 127.88 18.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 74.24 110.917 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 1.115 HG22 HG13 ' A' ' 391' ' ' VAL . 32.5 m -51.77 -173.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 64.22 111.107 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -76.37 119.81 78.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.57 0.7 . . . . 75.14 110.85 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -14.4 36.12 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.596 2.197 . . . . 63.34 112.363 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . 0.404 ' O ' ' HB3' ' A' ' 330' ' ' ASP . 0.0 OUTLIER -68.62 -71.44 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 74.5 110.897 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -57.63 -26.28 61.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 71.13 111.094 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.788 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 16.1 t -78.74 -29.93 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 71.42 111.146 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 327' ' ' GLN . 3.8 t0 -54.13 -38.85 65.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.876 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -65.6 -31.82 73.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 74.33 110.808 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.876 HG21 HD13 ' A' ' 393' ' ' ILE . 46.1 mm -55.55 -48.95 76.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 75.2 111.092 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 8.8 mt -55.06 -32.1 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 75.03 111.201 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.75 -7.19 7.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 74.23 110.942 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 23.0 t -102.63 11.62 37.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 75.52 110.884 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.427 ' HB1' HG11 ' A' ' 340' ' ' VAL . . . -158.78 150.02 16.51 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.596 0.713 . . . . 70.44 111.104 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.642 ' O ' HG12 ' A' ' 340' ' ' VAL . 54.7 Cg_endo -69.73 164.46 34.41 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.736 2.291 . . . . 73.22 112.341 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -11.68 31.33 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.625 2.217 . . . . 62.53 112.398 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -101.21 55.05 0.83 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 72.43 110.905 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 337' ' ' PRO . 9.8 p -168.79 126.45 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 72.34 111.144 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 386' ' ' HIS . 21.7 p -142.61 70.95 1.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 73.22 111.188 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 54.5 m -133.72 123.87 25.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 65.23 111.124 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -89.97 134.4 34.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 75.2 111.133 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.656 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -114.14 134.38 54.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 72.31 110.932 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.714 HG21 HD13 ' A' ' 406' ' ' LEU . 1.7 mp -132.07 113.22 21.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.092 -0.504 . . . . 72.1 111.148 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.409 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -103.89 168.73 17.26 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.703 -0.761 . . . . 62.23 112.501 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 405' ' ' ASN . 2.3 t30 72.22 54.19 0.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 74.34 110.958 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.692 HG23 ' HD2' ' A' ' 349' ' ' PRO . 87.7 mt -108.45 138.87 20.33 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.564 0.697 . . . . 71.22 111.178 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . 0.692 ' HD2' HG23 ' A' ' 348' ' ' ILE . 53.3 Cg_endo -69.85 164.89 32.96 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.714 2.276 . . . . 73.53 112.313 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -77.49 -10.96 59.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 70.32 110.829 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.58 ' CD2' ' HB2' ' A' ' 349' ' ' PRO . 31.8 p90 -97.38 1.21 49.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 61.03 110.927 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.871 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -89.29 111.85 22.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 41.44 111.049 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 74.2 p -112.06 173.51 6.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.18 -0.464 . . . . 72.34 111.106 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.498 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -67.01 -29.53 69.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 73.51 110.866 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -59.02 -26.38 64.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 74.32 111.159 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.27 -15.62 13.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 71.35 110.861 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.871 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.8 mp -94.77 -51.03 4.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 51.35 110.883 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.683 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.2 mm -43.89 -49.87 20.24 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.677 0.751 . . . . 70.44 111.184 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.7 Cg_endo -69.83 -20.41 34.56 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.672 2.248 . . . . 70.32 112.352 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.925 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -77.99 -25.39 48.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 63.2 110.968 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.698 ' HB2' HD11 ' A' ' 367' ' ' ILE . 85.7 m-85 -98.76 -30.08 12.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.33 110.941 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' GLN . . . . . 0.459 ' HG2' HD12 ' A' ' 367' ' ' ILE . 2.0 mm-40 -57.64 -42.98 84.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 65.52 110.912 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -47.02 -21.67 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 72.31 110.901 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . 0.484 ' HE2' ' HG ' ' A' ' 392' ' ' CYS . 21.5 m-85 -71.98 -54.49 9.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 73.33 110.922 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -161.39 -85.62 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.74 -0.743 . . . . 32.11 112.456 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -153.56 142.29 20.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.775 0.321 . . . . 74.52 110.86 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.698 HD11 ' HB2' ' A' ' 361' ' ' PHE . 40.3 mt -120.78 109.46 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 75.02 111.208 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.75 -17.52 38.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.466 . . . . 74.24 110.964 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -170.72 121.33 0.58 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 72.34 110.9 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.578 ' CE1' ' HB3' ' A' ' 379' ' ' CYS . 25.2 t80 -114.97 123.54 49.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 63.45 110.858 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.19 99.2 7.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.151 -0.477 . . . . 75.45 110.877 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 3.4 t-80 -95.29 120.6 35.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.436 . . . . 63.43 110.878 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 374' ' ' PRO . 25.6 m-85 -113.96 92.28 25.29 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.7 0.762 . . . . 71.14 110.916 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 373' ' ' TYR . 54.0 Cg_endo -69.7 -18.2 37.43 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.692 2.261 . . . . 42.43 112.375 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -78.18 -37.11 46.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 72.12 110.841 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -99.79 -18.01 17.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.474 . . . . 53.33 110.897 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 75.07 43.67 25.83 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.764 -0.731 . . . . 64.42 112.468 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 1.6 p -151.93 143.45 23.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.758 0.313 . . . . 73.31 110.962 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.578 ' HB3' ' CE1' ' A' ' 370' ' ' PHE . 61.3 m -124.3 153.34 41.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 75.01 110.947 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -130.47 104.26 7.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 73.43 110.85 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.493 HG12 ' CD1' ' A' ' 370' ' ' PHE . 0.5 OUTLIER -105.0 129.24 57.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 73.1 111.155 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -102.01 136.83 41.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 74.34 110.923 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -118.18 172.34 7.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 70.34 110.931 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.62 -37.3 59.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.094 -0.503 . . . . 71.21 110.857 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 59.3 p -115.96 169.83 8.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 74.42 111.154 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' HIS . . . . . 0.539 ' HA ' HG22 ' A' ' 341' ' ' THR . 51.5 p-80 -85.64 -38.93 17.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 71.24 110.939 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -60.54 -30.18 69.6 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.182 -0.463 . . . . 52.21 110.929 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -62.17 -38.57 89.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 75.42 110.852 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.456 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -75.94 -33.62 59.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 65.12 111.168 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.788 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -55.91 -35.37 66.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 63.4 111.066 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 1.115 HG13 HG22 ' A' ' 324' ' ' VAL . 25.6 t -69.13 -46.62 77.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.267 -0.424 . . . . 60.24 111.057 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . 0.484 ' HG ' ' HE2' ' A' ' 364' ' ' PHE . 48.8 t -56.18 -31.1 63.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 73.34 110.933 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.876 HD13 HG21 ' A' ' 332' ' ' ILE . 1.1 mt -59.8 -56.36 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 45.22 111.154 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.516 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.1 t -71.68 -38.48 66.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.166 -0.47 . . . . 53.43 111.154 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.435 ' CA ' HG11 ' A' ' 324' ' ' VAL . . . -58.56 -48.07 82.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 72.34 111.099 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.631 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.9 mm? -85.48 -10.35 56.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 63.21 110.865 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' ALA . . . . . 0.66 ' N ' HG21 ' A' ' 408' ' ' THR . . . -50.66 108.44 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 74.2 111.086 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 42.99 43.45 3.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 73.13 110.916 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.631 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -96.75 145.5 29.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.696 0.76 . . . . 73.53 110.884 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 144.13 52.93 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.647 2.231 . . . . 71.55 112.39 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' PHE . . . . . 0.525 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 41.9 t80 -151.03 113.23 4.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 74.01 110.887 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 49.47 32.93 5.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 63.25 110.871 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.6 -28.36 15.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.715 -0.755 . . . . 71.31 112.51 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.9 OUTLIER -105.52 141.05 37.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.361 . . . . 70.01 110.847 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.448 ' O ' ' ND2' ' A' ' 347' ' ' ASN . 14.3 m120 -82.68 154.92 24.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 42.51 110.923 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.714 HD13 HG21 ' A' ' 345' ' ' ILE . 10.9 mt -114.35 173.8 6.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 74.52 110.892 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 346' ' ' GLY . 0.0 OUTLIER -113.92 171.93 7.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 73.51 110.89 179.924 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . 0.66 HG21 ' N ' ' A' ' 397' ' ' ALA . 64.3 p -154.18 154.19 33.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 54.13 111.098 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 410' ' ' TRP . . . 147.3 127.99 1.81 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 32.33 112.508 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.703 ' NE1' HG22 ' A' ' 332' ' ' ILE . 57.7 m95 -33.0 131.06 0.18 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.838 0.351 . . . . 55.52 110.951 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -145.69 164.24 28.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.807 -0.711 . . . . 72.43 112.483 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.77 150.93 41.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 72.54 110.898 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.88 79.54 2.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.416 . . . . 72.32 110.851 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 71.13 110.88 -179.958 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.476 -0.249 . . . . 64.33 112.476 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 38.6 t -127.67 -53.86 1.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.83 0.348 . . . . 45.32 110.835 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 176.36 109.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 60.02 110.953 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 10.0 t -150.44 145.99 26.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 74.33 111.161 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . . . . . . . . . 2.1 tp -133.97 125.87 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 65.44 111.077 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -87.13 -66.36 1.35 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.788 -0.72 . . . . 65.31 112.513 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 2.3 mt 66.04 75.67 0.32 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.602 0.715 . . . . 73.31 110.917 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 160.2 50.58 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.683 2.256 . . . . 71.31 112.335 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -36.14 11.44 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.746 2.297 . . . . 74.51 112.345 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.65 -63.49 0.74 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.216 -0.447 . . . . 74.24 110.908 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.756 HG12 HG13 ' A' ' 391' ' ' VAL . 1.4 p -156.37 148.22 11.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 64.22 111.043 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 326' ' ' PRO . 3.5 t30 -50.39 109.14 1.19 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.66 0.743 . . . . 75.14 110.9 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 325' ' ' ASN . 53.6 Cg_endo -69.71 -14.34 36.11 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.656 2.237 . . . . 63.34 112.319 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -74.94 -71.62 0.34 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 74.5 110.862 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -49.28 -24.3 1.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 71.13 111.064 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.872 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 10.8 t -80.89 -29.18 11.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 71.42 111.146 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -53.42 -37.72 62.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.108 -0.496 . . . . 73.32 110.876 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 334' ' ' ARG . 3.3 t60 -66.07 -31.63 72.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 74.33 110.796 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.69 HG21 HD13 ' A' ' 393' ' ' ILE . 27.4 mm -56.36 -47.74 80.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 75.2 111.098 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 9.5 mt -54.12 -26.16 14.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 75.03 111.051 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 331' ' ' HIS . 0.0 OUTLIER -71.66 2.11 5.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 74.23 110.926 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.69 31.79 6.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 75.52 110.868 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.945 ' HB1' HG11 ' A' ' 340' ' ' VAL . . . -174.32 151.15 1.6 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.535 0.684 . . . . 70.44 111.104 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.73 ' O ' HG12 ' A' ' 340' ' ' VAL . 54.8 Cg_endo -69.74 169.93 17.74 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.677 2.251 . . . . 73.22 112.353 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.84 -9.2 25.5 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.609 2.206 . . . . 62.53 112.356 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -115.41 64.1 0.69 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 72.43 110.899 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.945 HG11 ' HB1' ' A' ' 336' ' ' ALA . 7.9 p -160.38 129.19 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 72.34 111.073 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -150.96 69.2 0.96 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 73.22 111.102 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.485 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 45.0 m -131.42 108.88 9.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 65.23 111.224 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -80.28 111.3 16.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 75.2 111.061 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.571 ' O ' ' CD1' ' A' ' 344' ' ' TYR . 0.0 OUTLIER -93.78 118.8 31.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 72.31 110.953 -179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.55 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.9 mp -119.47 117.52 54.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 72.1 111.15 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . . . . . . . . . . . -107.98 -173.3 21.93 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.706 -0.759 . . . . 62.23 112.521 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 58.95 47.52 12.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.807 0.337 . . . . 74.34 110.895 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 34.2 mt -99.43 132.62 22.93 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.658 0.742 . . . . 71.22 111.163 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . 0.489 ' CG ' ' CE1' ' A' ' 351' ' ' PHE . 53.6 Cg_endo -69.82 161.89 44.22 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.621 2.214 . . . . 73.53 112.328 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -69.01 -21.01 64.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.44 . . . . 70.32 110.813 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.489 ' CE1' ' CG ' ' A' ' 349' ' ' PRO . 7.1 p90 -90.85 30.74 1.14 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 61.03 110.878 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.625 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -116.23 124.82 51.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 41.44 111.098 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 14.3 p -126.54 167.71 15.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 72.34 111.128 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.507 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -64.99 -34.06 77.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 73.51 110.876 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.23 -26.35 50.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.32 111.128 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.27 -13.12 13.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 71.35 110.865 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.625 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.5 mp -99.52 -54.21 3.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 51.35 110.895 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.622 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -39.81 -52.07 5.18 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.692 0.758 . . . . 70.44 111.199 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.2 Cg_endo -69.72 -39.51 6.49 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.612 2.208 . . . . 70.32 112.353 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.922 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -53.85 -25.36 19.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 63.2 110.87 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.864 ' HB2' HD11 ' A' ' 367' ' ' ILE . 85.5 m-85 -95.78 -37.22 10.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 73.33 110.894 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' GLN . . . . . 0.6 ' HG2' HD12 ' A' ' 367' ' ' ILE . 3.8 mt-30 -50.01 -46.46 52.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 65.52 110.879 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.6 OUTLIER -44.46 -25.08 0.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 72.31 110.79 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . 0.536 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 30.5 m-85 -70.1 -60.24 2.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 73.33 110.841 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -150.42 -86.64 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.79 -0.719 . . . . 32.11 112.511 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 368' ' ' LEU . 11.8 t80 -153.43 141.61 20.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.786 0.327 . . . . 74.52 110.898 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.864 HD11 ' HB2' ' A' ' 361' ' ' PHE . 23.9 mt -120.36 113.48 40.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 75.02 111.101 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 369' ' ' ASP . 2.7 pp -100.45 -14.84 18.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 74.24 110.862 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.53 ' N ' HD12 ' A' ' 368' ' ' LEU . 10.0 t0 -167.67 120.81 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 72.34 110.836 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 28.4 t80 -117.54 134.85 54.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 63.45 110.9 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -120.56 101.5 7.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 75.45 110.891 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . 0.4 ' HB2' ' CE2' ' A' ' 370' ' ' PHE . 12.6 t-80 -97.49 135.7 38.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 63.43 110.906 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -130.75 85.69 54.86 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 121.649 0.738 . . . . 71.14 110.967 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 -22.58 31.73 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.638 2.226 . . . . 42.43 112.349 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -72.93 -19.39 61.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.278 -0.419 . . . . 72.12 110.911 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.49 -27.57 6.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.102 -0.499 . . . . 53.33 110.91 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 89.8 43.82 5.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.715 -0.755 . . . . 64.42 112.492 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 43.6 m -155.93 149.2 24.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.774 0.321 . . . . 73.31 110.886 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 15.5 p -140.79 144.14 35.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.207 -0.451 . . . . 75.01 110.909 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.485 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 18.9 m-85 -122.86 128.81 50.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 73.43 110.877 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.577 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -117.92 119.37 61.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 73.1 111.124 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -88.39 127.07 35.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 74.34 110.94 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -106.08 171.59 7.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.428 . . . . 70.34 110.946 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -65.29 -37.5 87.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.093 -0.503 . . . . 71.21 110.897 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 58.6 p -130.12 178.02 6.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 74.42 111.179 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -83.21 -39.42 20.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 71.24 110.869 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -57.97 -27.1 63.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 52.21 110.877 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -37.18 77.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 75.42 110.858 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -75.77 -36.6 59.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 65.12 111.086 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.872 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -55.34 -32.95 62.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 63.4 111.061 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.756 HG13 HG12 ' A' ' 324' ' ' VAL . 40.2 t -68.09 -55.57 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 60.24 111.105 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . 0.536 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 2.1 t -64.29 -26.1 68.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 73.34 110.881 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.784 HD12 ' HA ' ' A' ' 390' ' ' ALA . 5.6 mt -57.06 -57.2 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 45.22 111.135 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.559 ' O ' ' HB3' ' A' ' 397' ' ' ALA . 2.5 t -73.06 -40.3 58.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 53.43 111.16 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -53.6 -51.47 62.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 72.34 111.102 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.723 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.9 mm? -75.46 -12.63 60.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.213 -0.449 . . . . 63.21 110.951 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' ALA . . . . . 0.577 ' N ' HG21 ' A' ' 408' ' ' THR . . . -50.49 112.9 0.76 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 74.2 111.076 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 54.8 t30 41.97 49.85 4.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 73.13 110.855 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.723 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -105.78 146.58 33.12 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.69 0.757 . . . . 73.53 110.825 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.8 137.47 35.42 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.679 2.253 . . . . 71.55 112.362 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' PHE . . . . . 0.537 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 33.8 t80 -141.83 110.78 6.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.01 110.912 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 49.11 32.71 4.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 63.25 110.886 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.45 -29.18 13.06 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.669 -0.776 . . . . 71.31 112.477 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 -107.11 139.1 42.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.321 . . . . 70.01 110.866 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -79.18 155.19 28.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 42.51 110.829 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.436 HD11 ' CD2' ' A' ' 401' ' ' PHE . 21.9 mt -118.97 170.32 9.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 74.52 110.884 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.42 175.59 5.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 73.51 110.824 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . 0.606 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 75.5 p -154.05 155.51 35.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 54.13 111.144 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 157.24 174.27 26.72 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.811 -0.709 . . . . 32.33 112.55 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.518 ' HE1' HG22 ' A' ' 332' ' ' ILE . 58.9 m95 -81.02 147.19 30.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.899 0.38 . . . . 55.52 110.881 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -142.98 136.3 6.99 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.744 -0.741 . . . . 72.43 112.488 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 414' ' ' ARG . 4.6 mttt -135.15 78.91 1.76 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.752 0.311 . . . . 72.54 110.899 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 412' ' ' LYS . 0.1 OUTLIER 36.8 31.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 72.32 110.92 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 412' ' ' LYS . 7.5 mtp180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.484 . . . . 71.13 110.872 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.479 -0.248 . . . . 64.33 112.479 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 80.9 p -160.08 140.7 11.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.782 0.325 . . . . 45.32 110.877 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' GLN . . . . . 0.523 ' O ' HG22 ' A' ' 318' ' ' ILE . 1.4 mt-30 74.9 -69.91 0.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 60.02 110.911 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 81.4 m -59.27 88.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.176 -0.465 . . . . 74.33 111.132 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 316' ' ' GLN . 0.9 OUTLIER -114.73 141.13 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 65.44 111.098 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.463 ' N ' HG13 ' A' ' 318' ' ' ILE . . . -92.08 -50.94 2.52 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.724 -0.75 . . . . 65.31 112.462 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 58.94 84.18 0.2 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.649 0.737 . . . . 73.31 110.973 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.87 150.04 67.0 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.669 2.246 . . . . 71.31 112.37 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 3.13 2.97 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.679 2.253 . . . . 74.51 112.26 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.74 -70.79 0.66 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 74.24 110.953 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 1.047 HG12 HG13 ' A' ' 391' ' ' VAL . 2.7 p -155.12 176.84 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 64.22 111.137 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.734 ' H ' HG22 ' A' ' 324' ' ' VAL . 51.1 t30 -80.02 111.68 23.91 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.647 0.737 . . . . 75.14 110.917 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 325' ' ' ASN . 53.8 Cg_endo -69.75 -13.87 35.31 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.68 2.253 . . . . 63.34 112.388 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -70.12 -72.28 0.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 74.5 110.89 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -57.19 -24.87 57.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 71.13 111.074 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.782 HG22 ' HB ' ' A' ' 394' ' ' VAL . 23.4 t -76.66 -29.81 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 71.42 111.068 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.419 ' HA ' HD12 ' A' ' 333' ' ' ILE . 17.6 t0 -54.49 -37.75 65.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 73.32 110.84 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -62.82 -31.93 73.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.846 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.528 ' CG2' ' NE1' ' A' ' 410' ' ' TRP . 15.3 mm -65.25 -41.83 92.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 75.2 111.114 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 330' ' ' ASP . 31.8 mt -52.29 -48.91 43.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 75.03 111.059 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.34 -7.03 5.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 74.23 110.879 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 3.1 t -82.43 -31.92 29.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 75.52 110.854 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -116.87 153.97 49.46 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.636 0.732 . . . . 70.44 111.066 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.491 ' O ' HG12 ' A' ' 340' ' ' VAL . 53.4 Cg_endo -69.78 158.88 55.41 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.708 2.272 . . . . 73.22 112.31 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 -7.46 21.1 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.716 2.278 . . . . 62.53 112.338 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -101.86 51.0 0.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 72.43 110.848 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 337' ' ' PRO . 9.7 p -175.9 128.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 72.34 111.157 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . 0.535 HG22 ' HB3' ' A' ' 386' ' ' HIS . 20.4 p -137.1 67.92 1.43 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 73.22 111.207 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 23.3 m -133.76 137.0 44.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 65.23 111.152 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -100.18 129.47 46.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 75.2 111.101 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.745 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -106.28 135.08 48.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 72.31 110.882 -179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.745 HD12 ' C ' ' A' ' 344' ' ' TYR . 1.7 mp -131.87 117.68 34.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 72.1 111.12 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -106.59 161.62 13.97 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.748 -0.739 . . . . 62.23 112.472 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.447 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 0.6 OUTLIER 79.24 49.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 74.34 110.937 -179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.615 HG23 ' HD2' ' A' ' 349' ' ' PRO . 64.8 mt -103.76 137.72 19.32 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.581 0.705 . . . . 71.22 111.13 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . 0.769 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.6 Cg_endo -69.75 165.09 32.11 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.714 2.276 . . . . 73.53 112.307 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -75.88 -17.1 59.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.472 . . . . 70.32 110.846 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.588 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 27.1 p90 -99.05 24.11 8.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 61.03 110.886 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.794 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -107.87 93.16 4.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 41.44 111.17 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 46.2 p -90.54 173.51 8.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 72.34 111.173 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.506 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -66.96 -29.77 69.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 73.51 110.824 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.01 -26.11 47.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 74.32 111.111 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.81 -13.74 13.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 71.35 110.89 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.794 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.4 mp -98.56 -54.38 3.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 51.35 110.895 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.649 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.0 OUTLIER -40.88 -51.59 7.1 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.684 0.754 . . . . 70.44 111.134 179.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.1 Cg_endo -69.85 -34.08 15.0 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.656 2.237 . . . . 70.32 112.305 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.904 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -61.14 -23.49 65.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 63.2 110.944 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.609 ' CE2' HD12 ' A' ' 360' ' ' LEU . 81.4 m-85 -102.88 -33.67 9.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 73.33 110.912 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' GLN . . . . . 0.601 ' HG3' HD12 ' A' ' 367' ' ' ILE . 0.1 OUTLIER -58.77 -32.72 69.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.099 -0.5 . . . . 65.52 110.984 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -59.24 -11.25 3.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 72.31 110.924 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . 0.566 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 31.3 m-85 -81.01 -60.12 2.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.118 -0.492 . . . . 73.33 110.87 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -149.01 -84.03 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.782 -0.723 . . . . 32.11 112.492 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -152.64 143.61 23.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 74.52 110.852 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.601 HD12 ' HG3' ' A' ' 362' ' ' GLN . 55.5 mt -121.0 109.28 24.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 75.02 111.126 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.02 -17.66 24.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.947 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -171.15 121.15 0.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.481 . . . . 72.34 110.863 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.545 ' CD2' HG12 ' A' ' 358' ' ' ILE . 34.6 t80 -113.61 143.42 44.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 63.45 110.946 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.55 101.17 5.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 75.45 110.946 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . 0.533 ' CE1' ' HB3' ' A' ' 374' ' ' PRO . 11.2 t-80 -94.61 114.48 26.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 63.43 110.814 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -107.7 84.12 1.86 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.631 0.729 . . . . 71.14 110.874 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . 0.533 ' HB3' ' CE1' ' A' ' 372' ' ' HIS . 53.6 Cg_endo -69.79 -28.6 24.91 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.661 2.24 . . . . 42.43 112.355 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -63.44 -19.58 64.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 72.12 110.921 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.8 -21.7 7.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 53.33 110.945 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 87.33 38.33 7.79 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.776 -0.726 . . . . 64.42 112.475 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 19.1 p -147.15 153.63 40.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.764 0.316 . . . . 73.31 110.941 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 7.2 p -139.35 151.12 46.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 75.01 110.882 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -131.14 122.73 27.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 73.43 110.888 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.584 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.8 OUTLIER -114.28 126.3 71.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 73.1 111.08 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 10.2 mttp -90.6 133.86 34.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 74.34 110.877 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -116.21 -178.55 3.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 70.34 110.996 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.45 -46.3 16.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 71.21 110.857 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 68.0 p -114.83 170.66 8.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 74.42 111.232 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' HIS . . . . . 0.535 ' HB3' HG22 ' A' ' 341' ' ' THR . 27.1 p-80 -85.64 -44.43 12.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 71.24 110.838 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -57.18 -32.9 66.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 52.21 110.868 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -67.88 -32.56 73.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 75.42 110.888 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -67.1 -39.32 86.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 65.12 111.114 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.597 ' HB1' HG13 ' A' ' 329' ' ' VAL . . . -59.19 -27.88 66.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 63.4 111.097 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 1.047 HG13 HG12 ' A' ' 324' ' ' VAL . 70.7 t -61.58 -40.94 88.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 60.24 111.158 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . 0.566 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 1.5 t -77.78 -27.1 50.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 73.34 110.935 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.722 ' O ' HG21 ' A' ' 408' ' ' THR . 1.2 mp -54.99 -56.67 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 45.22 111.078 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.782 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.9 OUTLIER -73.06 -45.86 53.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 53.43 111.067 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.425 ' N ' HG12 ' A' ' 394' ' ' VAL . . . -52.87 -21.67 4.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 72.34 111.076 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.62 HD13 ' CE1' ' A' ' 399' ' ' PHE . 1.2 mm? -106.5 -19.27 13.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 63.21 110.945 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -48.76 114.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 74.2 111.142 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 44.26 46.89 7.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 73.13 110.855 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.62 ' CE1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -107.03 144.79 29.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.632 0.73 . . . . 73.53 110.848 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.502 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.5 Cg_endo -69.85 145.23 56.04 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.672 2.248 . . . . 71.55 112.333 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' PHE . . . . . 0.565 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 64.6 t80 -152.34 111.81 3.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 74.01 110.908 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.63 33.36 8.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 63.25 110.932 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 98.4 -27.78 17.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 71.31 112.513 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.482 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.0 OUTLIER -104.75 141.9 35.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.767 0.318 . . . . 70.01 110.895 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -86.99 145.15 26.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 42.51 110.936 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.663 HD13 HG21 ' A' ' 345' ' ' ILE . 8.8 mt -107.03 179.88 4.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.239 -0.437 . . . . 74.52 110.905 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 345' ' ' ILE . 13.5 ttt85 -130.45 177.48 7.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 73.51 110.88 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . 0.722 HG21 ' O ' ' A' ' 393' ' ' ILE . 17.2 p -156.13 163.48 39.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 54.13 111.124 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 410' ' ' TRP . . . 157.22 42.46 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 32.33 112.474 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.528 ' NE1' ' CG2' ' A' ' 332' ' ' ILE . 68.1 m95 58.69 147.75 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.845 0.355 . . . . 55.52 110.897 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -41.0 103.76 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.757 -0.735 . . . . 72.43 112.532 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 413' ' ' GLU . 0.0 OUTLIER -127.64 122.55 33.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.736 0.303 . . . . 72.54 110.928 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 412' ' ' LYS . 7.9 pt-20 -38.3 -52.35 1.51 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 72.32 110.904 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 71.13 110.907 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.504 -0.238 . . . . 64.33 112.504 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.51 143.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.862 0.363 . . . . 45.32 110.823 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -128.66 143.62 50.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 60.02 110.896 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 318' ' ' ILE . 12.1 p -125.34 44.33 2.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 74.33 111.165 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 317' ' ' THR . 0.0 OUTLIER 82.16 147.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 65.44 111.081 179.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -134.21 -41.27 0.16 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.739 . . . . 65.31 112.55 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.42 ' N ' ' CD ' ' A' ' 321' ' ' PRO . 8.1 mt 50.6 55.81 16.86 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.6 0.714 . . . . 73.31 110.947 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 320' ' ' LEU . 54.1 Cg_endo -69.76 167.15 25.26 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.678 2.252 . . . . 71.31 112.339 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -27.29 26.34 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.627 2.218 . . . . 74.51 112.337 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -137.95 -92.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 74.24 110.918 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.952 HG11 ' HB2' ' A' ' 395' ' ' ALA . 30.3 m -121.06 -171.76 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 64.22 111.15 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -97.64 119.22 63.07 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.673 0.749 . . . . 75.14 110.904 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -14.11 35.61 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.728 2.286 . . . . 63.34 112.349 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -68.41 -71.84 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 74.5 110.945 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.66 -32.85 59.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 71.13 111.065 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.613 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 11.1 t -70.95 -29.53 37.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 71.42 111.128 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.429 ' HA ' HD12 ' A' ' 333' ' ' ILE . 24.4 t70 -53.99 -34.85 60.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 73.32 110.915 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -68.29 -31.95 71.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 74.33 110.854 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.654 HG22 ' NE1' ' A' ' 410' ' ' TRP . 37.5 mm -57.05 -51.5 68.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 75.2 111.102 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.95 HG23 ' NE2' ' A' ' 386' ' ' HIS . 4.0 mt -55.19 -27.76 20.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 75.03 111.11 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.71 -12.7 55.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.169 -0.469 . . . . 74.23 110.893 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.43 27.1 9.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 75.52 110.887 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.669 ' HB1' HG11 ' A' ' 340' ' ' VAL . . . -169.41 148.93 3.6 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.472 0.653 . . . . 70.44 111.159 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.843 ' O ' HG12 ' A' ' 340' ' ' VAL . 53.1 Cg_endo -69.81 165.54 30.69 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.69 2.26 . . . . 73.22 112.314 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -15.67 37.02 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.645 2.23 . . . . 62.53 112.363 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -106.01 55.75 0.67 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 72.43 110.917 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.843 HG12 ' O ' ' A' ' 337' ' ' PRO . 14.4 p -156.1 95.24 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 72.34 111.117 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . 0.624 HG22 ' HA ' ' A' ' 386' ' ' HIS . 18.7 p -113.34 67.73 0.67 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.479 . . . . 73.22 111.133 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.448 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 34.5 m -134.11 128.85 34.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 65.23 111.159 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -96.82 126.23 41.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 75.2 111.11 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.56 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -103.3 133.16 48.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.227 -0.442 . . . . 72.31 110.944 -179.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.753 HG21 HD13 ' A' ' 406' ' ' LEU . 2.0 mp -126.72 125.93 67.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 72.1 111.171 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.478 ' H ' ' CB ' ' A' ' 407' ' ' ARG . . . -111.65 166.69 12.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.684 -0.77 . . . . 62.23 112.473 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 6.2 t30 65.03 57.88 0.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.771 0.319 . . . . 74.34 110.904 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.522 HD11 HG22 ' A' ' 345' ' ' ILE . 97.0 mt -106.64 133.9 20.06 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.629 0.728 . . . . 71.22 111.096 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . 0.531 ' HG2' ' HB2' ' A' ' 352' ' ' ALA . 53.7 Cg_endo -69.72 166.51 27.29 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.635 2.224 . . . . 73.53 112.386 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -71.77 -26.52 62.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 70.32 110.824 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -85.51 18.12 2.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 61.03 110.889 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.885 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -101.14 101.81 12.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 41.44 111.086 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 21.1 p -109.55 169.57 8.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 72.34 111.084 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.521 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.7 OUTLIER -63.46 -29.75 70.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.161 -0.472 . . . . 73.51 110.907 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -61.94 -25.81 67.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 74.32 111.084 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.98 -16.2 13.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 71.35 110.84 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.885 HD11 ' HB1' ' A' ' 352' ' ' ALA . 4.4 mp -96.7 -49.42 5.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 51.35 110.939 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.671 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.2 mm -42.94 -50.46 13.52 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.619 0.723 . . . . 70.44 111.204 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.8 Cg_endo -69.75 -37.8 8.7 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.737 2.291 . . . . 70.32 112.35 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.922 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.1 OUTLIER -58.06 -25.35 61.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.445 . . . . 63.2 110.919 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.564 ' N ' HD13 ' A' ' 360' ' ' LEU . 74.1 m-85 -101.62 -38.3 7.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 73.33 110.945 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' GLN . . . . . 0.466 ' N ' HD11 ' A' ' 367' ' ' ILE . 3.5 tt0 -51.36 -37.96 50.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 65.52 110.895 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -49.96 -19.38 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 72.31 110.852 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . 0.569 ' CE2' ' SG ' ' A' ' 392' ' ' CYS . 30.3 m-85 -72.3 -54.54 9.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 73.33 110.89 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -158.5 -84.69 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.795 -0.717 . . . . 32.11 112.501 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -153.51 143.1 21.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.815 0.34 . . . . 74.52 110.893 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.466 HD11 ' N ' ' A' ' 362' ' ' GLN . 54.1 mt -120.93 109.4 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 75.02 111.122 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.424 HD21 ' OD1' ' A' ' 384' ' ' ASP . 0.4 OUTLIER -86.54 -19.13 29.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 74.24 110.946 179.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.48 121.31 0.6 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.481 . . . . 72.34 110.891 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 379' ' ' CYS . 31.7 t80 -112.73 143.02 44.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 63.45 110.919 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 379' ' ' CYS . 1.2 mmtm -128.64 101.64 6.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 75.45 110.858 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . 0.547 ' CE1' ' HD3' ' A' ' 374' ' ' PRO . 7.9 t-80 -99.05 135.42 40.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 63.43 110.816 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -129.17 89.91 46.73 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.712 0.768 . . . . 71.14 110.9 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . 0.547 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.6 Cg_endo -69.78 -20.99 34.02 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.706 2.271 . . . . 42.43 112.315 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -74.9 -25.81 59.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 72.12 110.844 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -113.55 -12.32 12.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 53.33 110.857 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 72.28 43.2 47.53 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.722 -0.752 . . . . 64.42 112.486 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 15.6 p -150.45 152.74 34.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.33 . . . . 73.31 110.898 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 14.6 p -146.66 152.75 39.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 75.01 110.851 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.448 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 54.3 m-85 -131.06 122.5 26.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 73.43 110.816 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.425 ' CG2' HG23 ' A' ' 367' ' ' ILE . 0.8 OUTLIER -109.36 126.32 66.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 73.1 111.113 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -92.88 131.08 38.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 74.34 110.853 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -112.34 -174.42 2.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 70.34 110.849 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . 0.424 ' OD1' HD21 ' A' ' 368' ' ' LEU . 0.2 OUTLIER -86.75 -46.62 9.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 71.21 110.888 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 61.1 p -115.23 161.91 17.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 74.42 111.137 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' HIS . . . . . 0.95 ' NE2' HG23 ' A' ' 333' ' ' ILE . 75.0 t60 -79.58 -39.76 30.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.24 -0.436 . . . . 71.24 110.882 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.32 -32.74 68.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 52.21 110.798 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -66.37 -36.99 84.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 75.42 110.928 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -68.05 -45.78 72.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 65.12 111.074 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.613 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -50.06 -30.02 10.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 63.4 111.11 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.67 HG13 HG22 ' A' ' 324' ' ' VAL . 70.5 t -68.94 -50.72 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 60.24 111.125 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . 0.569 ' SG ' ' CE2' ' A' ' 364' ' ' PHE . 1.9 t -58.92 -26.38 64.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.882 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.581 HD13 HG21 ' A' ' 332' ' ' ILE . 0.9 OUTLIER -61.64 -56.26 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 45.22 111.182 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.493 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.1 t -72.03 -46.91 57.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 53.43 111.094 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . 0.952 ' HB2' HG11 ' A' ' 324' ' ' VAL . . . -60.89 -45.17 95.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.24 -0.436 . . . . 72.34 111.094 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.71 HD11 HD11 ' A' ' 360' ' ' LEU . 0.3 OUTLIER -85.01 -4.89 59.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 63.21 110.9 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 393' ' ' ILE . . . -58.4 115.24 2.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 74.2 111.085 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . 0.45 ' CG ' ' O ' ' A' ' 397' ' ' ALA . 3.3 p-10 48.25 41.09 15.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 73.13 110.907 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.575 ' CD1' ' HG ' ' A' ' 396' ' ' LEU . 0.2 OUTLIER -88.1 145.92 37.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.646 0.736 . . . . 73.53 110.913 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 130.02 18.49 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.664 2.243 . . . . 71.55 112.325 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' PHE . . . . . 0.409 ' HB2' ' CZ ' ' A' ' 399' ' ' PHE . 64.3 t80 -136.21 111.07 8.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 74.01 110.868 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 52.18 33.18 11.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 63.25 110.911 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 95.57 -22.86 36.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 71.31 112.448 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.28 132.41 53.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.846 0.355 . . . . 70.01 110.888 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.443 ' C ' HD23 ' A' ' 406' ' ' LEU . 0.6 OUTLIER -73.94 148.9 41.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 42.51 110.832 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.753 HD13 HG21 ' A' ' 345' ' ' ILE . 4.2 mt -111.66 178.21 4.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.087 -0.506 . . . . 74.52 110.99 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' ARG . . . . . 0.478 ' CB ' ' H ' ' A' ' 346' ' ' GLY . 3.7 ttt180 -113.46 -179.38 3.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 73.51 110.935 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . 0.511 HG21 ' N ' ' A' ' 397' ' ' ALA . 33.8 p -153.72 153.93 33.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 54.13 111.107 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 163.61 173.64 32.53 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.751 -0.737 . . . . 32.33 112.501 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.754 ' CH2' ' CE1' ' A' ' 386' ' ' HIS . 40.7 m95 -83.17 120.59 25.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.843 0.354 . . . . 55.52 110.865 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -59.26 132.15 51.94 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 72.43 112.468 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 413' ' ' GLU . 0.3 OUTLIER -151.38 80.8 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.826 0.346 . . . . 72.54 110.94 179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 412' ' ' LYS . 6.1 tp10 -36.08 133.72 0.45 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 72.32 110.946 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 71.13 110.871 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.512 -0.235 . . . . 64.33 112.512 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 63.13 144.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.799 0.333 . . . . 45.32 110.847 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -173.38 94.38 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 60.02 110.905 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . 0.5 HG23 ' H ' ' A' ' 319' ' ' GLY . 9.5 t -169.37 177.41 4.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 74.33 111.154 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.768 HG23 ' HG ' ' A' ' 320' ' ' LEU . 0.7 OUTLIER -53.82 -28.49 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 65.44 111.12 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.5 ' H ' HG23 ' A' ' 317' ' ' THR . . . 95.84 69.72 1.04 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.704 -0.76 . . . . 65.31 112.493 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.768 ' HG ' HG23 ' A' ' 318' ' ' ILE . 0.6 OUTLIER 168.03 82.92 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.562 0.696 . . . . 73.31 110.869 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 134.9 28.98 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.621 2.214 . . . . 71.31 112.325 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -11.47 30.94 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.705 2.27 . . . . 74.51 112.334 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -157.04 143.19 17.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.261 -0.427 . . . . 74.24 110.892 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.714 HG11 HG13 ' A' ' 391' ' ' VAL . 42.3 t -62.07 118.55 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 64.22 111.094 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -113.47 145.4 33.22 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.636 0.731 . . . . 75.14 110.852 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 -14.32 36.0 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.599 2.199 . . . . 63.34 112.42 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.69 -72.36 0.29 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 74.5 110.924 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -54.8 -25.56 28.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 71.13 111.125 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.873 HG22 ' HB ' ' A' ' 394' ' ' VAL . 8.6 t -81.61 -31.26 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 71.42 111.129 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.731 ' HA ' HD12 ' A' ' 333' ' ' ILE . 6.0 t70 -55.03 -38.66 68.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 73.32 110.906 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -59.0 -35.26 72.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 74.33 110.825 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 393' ' ' ILE . 32.4 mm -63.45 -45.9 96.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.247 -0.433 . . . . 75.2 111.166 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.731 HD12 ' HA ' ' A' ' 330' ' ' ASP . 8.6 mt -57.14 -25.34 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 75.03 111.206 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 9.1 ttt85 -76.2 -1.16 25.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 74.23 110.858 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.94 36.6 4.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 75.52 110.847 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.823 ' HB2' ' CD1' ' A' ' 410' ' ' TRP . . . -169.55 147.95 3.24 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.574 0.702 . . . . 70.44 111.091 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.433 ' O ' HG12 ' A' ' 340' ' ' VAL . 53.9 Cg_endo -69.75 165.5 30.76 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.677 2.251 . . . . 73.22 112.375 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -31.9 19.49 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.758 2.305 . . . . 62.53 112.316 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -93.25 72.39 4.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 72.43 110.857 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 340' ' ' VAL . 3.3 p -178.2 127.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 72.34 111.175 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . 0.661 HG22 ' HA ' ' A' ' 386' ' ' HIS . 39.4 p -145.74 69.87 1.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 73.22 111.132 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.463 ' CG2' ' HB3' ' A' ' 380' ' ' PHE . 99.8 m -133.63 120.73 21.05 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.211 -0.449 . . . . 65.23 111.174 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -86.47 129.15 34.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 75.2 111.033 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.815 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -111.48 134.77 52.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 72.31 110.936 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.91 HG21 HD13 ' A' ' 406' ' ' LEU . 1.7 mp -126.28 124.47 65.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.051 -0.522 . . . . 72.1 111.166 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.5 ' O ' ' CB ' ' A' ' 347' ' ' ASN . . . -109.0 154.59 16.42 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 62.23 112.438 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 346' ' ' GLY . 1.9 t30 82.82 45.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.859 0.362 . . . . 74.34 110.891 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.513 ' CG2' ' HB3' ' A' ' 352' ' ' ALA . 68.0 mt -99.26 129.85 28.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.642 0.734 . . . . 71.22 111.104 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . 0.585 ' HB2' ' CD1' ' A' ' 351' ' ' PHE . 54.1 Cg_endo -69.72 157.87 58.98 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.684 2.256 . . . . 73.53 112.375 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -60.81 -30.9 70.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 70.32 110.865 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 349' ' ' PRO . 28.1 p90 -86.1 33.3 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 61.03 110.876 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.665 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -113.64 82.59 1.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 41.44 111.136 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 17.9 p -84.98 167.56 15.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.118 -0.492 . . . . 72.34 111.185 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.507 ' O ' ' CG1' ' A' ' 358' ' ' ILE . 0.3 OUTLIER -67.21 -29.43 69.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 73.51 110.88 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -59.12 -25.65 64.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 74.32 111.108 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.0 -17.1 13.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 71.35 110.837 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.665 HD11 ' HB1' ' A' ' 352' ' ' ALA . 4.7 mp -95.56 -53.5 3.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.266 -0.424 . . . . 51.35 110.896 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.668 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.3 mm -39.51 -50.7 5.03 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.537 0.684 . . . . 70.44 111.079 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 53.1 Cg_endo -69.74 -26.62 27.46 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.715 2.277 . . . . 70.32 112.311 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.997 ' O ' HD12 ' A' ' 360' ' ' LEU . 0.1 OUTLIER -70.81 -24.25 62.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 63.2 110.91 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.536 ' HB2' HD11 ' A' ' 367' ' ' ILE . 91.4 m-85 -102.61 -41.05 6.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 73.33 110.952 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' GLN . . . . . 0.553 ' HG3' HD12 ' A' ' 367' ' ' ILE . 8.4 mt-30 -47.73 -44.68 28.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 65.52 110.883 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . 0.416 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.3 OUTLIER -45.64 -28.47 0.99 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 72.31 110.922 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . 0.457 ' CD2' ' HA ' ' A' ' 361' ' ' PHE . 33.7 m-85 -63.35 -57.32 10.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.854 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . -154.27 -86.59 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.742 . . . . 32.11 112.528 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -153.58 140.62 19.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.851 0.358 . . . . 74.52 110.833 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.553 HD12 ' HG3' ' A' ' 362' ' ' GLN . 41.2 mt -120.97 109.09 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 75.02 111.195 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.8 mp -86.76 -18.04 32.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 74.24 110.948 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -170.76 120.9 0.56 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 72.34 110.88 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.516 ' CE2' ' HB2' ' A' ' 372' ' ' HIS . 33.0 t80 -113.48 141.88 46.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 63.45 110.903 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.64 101.21 6.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 75.45 110.905 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . 0.579 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 8.6 t-80 -98.46 130.25 45.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 63.43 110.901 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -125.89 90.59 50.05 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.718 0.77 . . . . 71.14 110.906 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . 0.552 ' HD3' ' CE1' ' A' ' 372' ' ' HIS . 53.5 Cg_endo -69.73 -38.25 8.11 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.739 2.293 . . . . 42.43 112.299 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.53 -21.3 62.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 72.12 110.861 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 7.1 mttm -111.55 -25.74 9.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 53.33 110.877 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 84.31 42.29 7.53 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.725 -0.75 . . . . 64.42 112.519 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . . . . . . . . . 31.1 p -154.84 153.98 32.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.775 0.321 . . . . 73.31 110.866 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.514 ' HB2' ' CZ ' ' A' ' 370' ' ' PHE . 13.7 p -144.89 146.23 31.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 75.01 110.867 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.463 ' HB3' ' CG2' ' A' ' 342' ' ' THR . 43.1 m-85 -125.16 122.34 36.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 73.43 110.882 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -110.84 133.67 55.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 73.1 111.171 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 128.58 46.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 74.34 110.855 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -111.6 178.4 4.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 70.34 110.877 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -76.73 -45.54 28.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.078 -0.51 . . . . 71.21 110.894 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 40.5 p -117.08 172.47 7.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 74.42 111.154 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' HIS . . . . . 0.661 ' HA ' HG22 ' A' ' 341' ' ' THR . 47.6 p-80 -85.29 -41.0 15.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 71.24 110.866 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -33.75 69.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 52.21 110.863 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -65.12 -34.93 79.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 75.42 110.889 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -67.11 -39.44 86.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 65.12 111.152 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.794 ' HB1' HG13 ' A' ' 329' ' ' VAL . . . -56.07 -33.86 65.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 63.4 111.148 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.714 HG13 HG11 ' A' ' 324' ' ' VAL . 53.2 t -61.24 -40.21 85.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 60.24 111.166 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . . . . . . . . . 13.3 t -75.04 -31.56 61.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 73.34 110.9 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 332' ' ' ILE . 0.2 OUTLIER -59.52 -54.97 27.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 45.22 111.145 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.873 ' HB ' HG22 ' A' ' 329' ' ' VAL . 0.3 OUTLIER -71.81 -36.09 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 53.43 111.13 179.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -62.32 -48.25 80.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 72.34 111.163 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.678 HD13 ' CD1' ' A' ' 399' ' ' PHE . 0.5 OUTLIER -79.3 -13.72 59.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 63.21 110.927 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' ALA . . . . . . . . . . . . . . . -50.21 108.38 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 74.2 111.103 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 10.5 m120 49.62 50.8 17.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 73.13 110.91 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.678 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -109.2 146.97 35.0 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.629 0.728 . . . . 73.53 110.916 -179.968 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . 0.519 ' O ' ' CE2' ' A' ' 399' ' ' PHE . 53.7 Cg_endo -69.84 145.18 55.92 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.657 2.238 . . . . 71.55 112.383 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' PHE . . . . . 0.574 ' CE1' HD22 ' A' ' 360' ' ' LEU . 32.9 t80 -151.01 110.67 4.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 74.01 110.918 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 48.97 33.99 5.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 63.25 110.906 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 101.26 -32.7 7.17 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.727 -0.749 . . . . 71.31 112.549 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 401' ' ' PHE . 0.3 OUTLIER -104.89 144.37 31.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 70.01 110.807 -179.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.03 154.44 24.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 42.51 110.849 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.91 HD13 HG21 ' A' ' 345' ' ' ILE . 16.8 mt -113.7 169.92 8.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.173 -0.467 . . . . 74.52 110.959 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 346' ' ' GLY . 2.0 ttt180 -111.27 174.4 5.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 73.51 110.907 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . 0.553 ' CG2' ' CB ' ' A' ' 396' ' ' LEU . 64.3 p -154.25 148.44 25.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.477 . . . . 54.13 111.118 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 410' ' ' TRP . . . 157.03 129.45 1.14 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 32.33 112.488 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.823 ' CD1' ' HB2' ' A' ' 336' ' ' ALA . 51.8 m95 -33.8 130.73 0.28 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.832 0.349 . . . . 55.52 110.892 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . -145.35 149.98 22.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.783 -0.722 . . . . 72.43 112.502 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.09 147.5 31.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.741 0.305 . . . . 72.54 110.917 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -55.42 107.34 0.31 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 72.32 110.83 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 71.13 110.872 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.458 -0.257 . . . . 64.33 112.458 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.44 -45.7 13.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.832 0.349 . . . . 45.32 110.864 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -158.14 42.28 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 60.02 110.93 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' THR . . . . . . . . . . . . . 3.5 t -153.12 139.55 18.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 74.33 111.18 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' ILE . . . . . 0.433 HG13 ' N ' ' A' ' 319' ' ' GLY . 3.7 tp -178.62 143.96 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 65.44 111.119 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.464 ' O ' HD23 ' A' ' 320' ' ' LEU . . . -77.81 135.04 15.4 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.682 -0.771 . . . . 65.31 112.498 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 319' ' ' GLY . 59.0 mt -143.24 83.29 11.12 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 121.573 0.702 . . . . 73.31 110.895 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 164.31 35.0 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.603 2.202 . . . . 71.31 112.372 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -31.43 20.52 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.654 2.236 . . . . 74.51 112.329 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.543 ' C ' HG23 ' A' ' 324' ' ' VAL . 0.0 OUTLIER -97.44 142.25 29.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 74.24 110.83 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.858 HG11 HG13 ' A' ' 391' ' ' VAL . 2.0 t 69.75 139.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 64.22 111.093 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -110.56 122.68 37.71 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.529 0.68 . . . . 75.14 110.981 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 -14.34 35.73 Favored 'Trans proline' 0 N--CA 1.466 -0.128 0 C-N-CA 122.752 2.301 . . . . 63.34 112.286 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -70.27 -72.16 0.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 74.5 110.95 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . . . . . . . . . . . -55.38 -31.46 61.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 71.13 111.103 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.889 ' CG1' ' HB1' ' A' ' 390' ' ' ALA . 8.0 t -69.08 -29.58 43.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 71.42 111.118 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . 0.406 ' HA ' HD12 ' A' ' 333' ' ' ILE . 29.8 t0 -53.94 -35.17 61.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 73.32 110.875 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -68.41 -31.85 71.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 74.33 110.879 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.784 HG21 HG21 ' A' ' 393' ' ' ILE . 40.8 mm -57.82 -51.29 72.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 75.2 111.125 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 330' ' ' ASP . 5.4 mt -53.44 -37.23 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 75.03 111.16 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.82 -9.42 4.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 74.23 110.873 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 336' ' ' ALA . 0.5 OUTLIER -107.1 42.02 1.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 75.52 110.83 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 337' ' ' PRO . . . 178.35 162.83 0.64 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.566 0.698 . . . . 70.44 111.093 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 336' ' ' ALA . 54.2 Cg_endo -69.75 160.55 49.29 Favored 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.737 2.291 . . . . 73.22 112.371 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -16.0 37.71 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.69 2.26 . . . . 62.53 112.37 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -112.53 73.91 0.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 72.43 110.899 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 337' ' ' PRO . 14.7 p -160.4 121.77 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 72.34 111.147 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' THR . . . . . 0.788 HG22 ' CA ' ' A' ' 386' ' ' HIS . 18.8 p -136.02 67.9 1.46 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 73.22 111.084 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . . . . . . . . . 33.8 m -133.84 108.23 8.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 65.23 111.165 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . . . . . . . . . . . -80.27 129.77 34.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 75.2 111.178 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.655 ' C ' HD12 ' A' ' 345' ' ' ILE . 0.0 OUTLIER -112.79 134.67 54.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 72.31 110.92 -179.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.717 HG21 HD13 ' A' ' 406' ' ' LEU . 1.5 mp -136.28 99.83 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.127 -0.488 . . . . 72.1 111.145 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 407' ' ' ARG . . . -89.31 176.61 43.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.686 -0.769 . . . . 62.23 112.58 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 2.3 t30 68.38 47.27 0.97 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 74.34 110.892 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.461 HD11 HG22 ' A' ' 345' ' ' ILE . 55.0 mt -101.97 131.13 23.09 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.602 0.715 . . . . 71.22 111.144 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.85 165.98 29.24 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.674 2.249 . . . . 73.53 112.276 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -69.61 -26.33 64.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.455 . . . . 70.32 110.858 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -85.47 32.23 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 61.03 110.877 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . 0.788 ' HB1' HD11 ' A' ' 357' ' ' LEU . . . -117.62 110.95 18.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 41.44 111.146 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 13.7 p -114.5 166.39 11.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 72.34 111.144 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.511 ' HB3' ' CG1' ' A' ' 358' ' ' ILE . 0.5 OUTLIER -63.45 -33.58 75.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 73.51 110.968 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -56.91 -26.77 59.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 74.32 111.092 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.22 -13.21 13.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 71.35 110.864 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.788 HD11 ' HB1' ' A' ' 352' ' ' ALA . 3.7 mp -99.37 -53.66 3.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 51.35 110.91 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.636 ' N ' ' HD2' ' A' ' 359' ' ' PRO . 1.1 mm -40.44 -51.73 6.32 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.628 0.728 . . . . 70.44 111.192 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 358' ' ' ILE . 54.1 Cg_endo -69.73 -38.51 7.76 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.655 2.237 . . . . 70.32 112.331 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . 0.941 HD22 ' O ' ' A' ' 360' ' ' LEU . 0.0 OUTLIER -54.99 -27.7 46.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.231 -0.44 . . . . 63.2 110.889 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' PHE . . . . . 0.64 ' N ' HD13 ' A' ' 360' ' ' LEU . 84.0 m-85 -95.16 -38.1 10.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 73.33 110.958 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' GLN . . . . . 0.643 ' HG3' HD12 ' A' ' 367' ' ' ILE . 30.4 mt-30 -48.68 -43.25 36.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 65.52 110.911 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' ASN . . . . . 0.437 ' OD1' ' C ' ' A' ' 363' ' ' ASN . 0.5 OUTLIER -42.87 -28.2 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.955 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' PHE . . . . . 0.542 ' CD2' ' HB2' ' A' ' 392' ' ' CYS . 18.7 m-85 -66.14 -58.55 5.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 73.33 110.92 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . 0.425 ' HA3' ' CD ' ' A' ' 388' ' ' GLN . . . -156.67 -84.34 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.76 -0.733 . . . . 32.11 112.519 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.412 ' O ' ' CD2' ' A' ' 383' ' ' TYR . 17.6 t80 -153.96 144.68 22.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 74.52 110.902 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' ILE . . . . . 0.643 HD12 ' HG3' ' A' ' 362' ' ' GLN . 47.1 mt -120.86 108.78 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 75.02 111.138 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.32 -16.01 36.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.179 -0.464 . . . . 74.24 110.894 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -170.58 120.81 0.58 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.445 . . . . 72.34 110.862 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 379' ' ' CYS . 34.7 t80 -115.44 136.11 53.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 63.45 110.894 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 379' ' ' CYS . 0.0 OUTLIER -122.62 100.3 6.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 75.45 110.866 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' HIS . . . . . 0.595 ' CE1' ' O ' ' A' ' 352' ' ' ALA . 10.3 t-80 -100.2 110.79 23.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 63.43 110.862 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.571 ' CE1' ' HA ' ' A' ' 379' ' ' CYS . 1.0 OUTLIER -119.53 94.52 48.51 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.644 0.735 . . . . 71.14 110.89 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 373' ' ' TYR . 53.6 Cg_endo -69.82 -17.4 37.3 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.724 2.282 . . . . 42.43 112.308 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.48 -28.62 69.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 72.12 110.917 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -111.69 -24.23 10.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 53.33 110.9 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 91.07 37.44 6.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.717 -0.754 . . . . 64.42 112.477 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' CYS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 373' ' ' TYR . 0.0 OUTLIER -156.23 151.69 26.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.839 0.352 . . . . 73.31 110.872 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' CYS . . . . . 0.571 ' HA ' ' CE1' ' A' ' 373' ' ' TYR . 25.6 p -126.05 171.35 10.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 75.01 110.834 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' PHE . . . . . 0.551 ' CE2' ' OH ' ' A' ' 373' ' ' TYR . 27.6 m-85 -137.63 107.32 6.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 73.43 110.829 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' ILE . . . . . 0.558 HD13 ' CD1' ' A' ' 361' ' ' PHE . 0.7 OUTLIER -106.21 113.31 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.135 -0.484 . . . . 73.1 111.119 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -87.33 130.85 34.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.9 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.583 ' CD2' ' OE1' ' A' ' 388' ' ' GLN . 46.6 m-85 -113.67 153.94 28.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 70.34 110.917 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -53.76 -47.3 70.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 71.21 110.885 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' THR . . . . . . . . . . . . . 1.7 p -108.82 157.73 18.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 74.42 111.119 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' HIS . . . . . 0.788 ' CA ' HG22 ' A' ' 341' ' ' THR . 20.8 p-80 -83.97 -44.49 14.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 71.24 110.777 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' GLU . . . . . 0.462 ' N ' ' CG ' ' A' ' 386' ' ' HIS . 0.1 OUTLIER -57.24 -26.94 61.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 52.21 110.851 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' GLN . . . . . 0.583 ' OE1' ' CD2' ' A' ' 383' ' ' TYR . 0.8 OUTLIER -70.3 -32.52 70.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.182 -0.463 . . . . 75.42 110.965 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.469 ' O ' HD12 ' A' ' 393' ' ' ILE . . . -68.4 -33.86 74.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 65.12 111.11 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.889 ' HB1' ' CG1' ' A' ' 329' ' ' VAL . . . -54.55 -28.76 48.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 63.4 111.093 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' VAL . . . . . 0.858 HG13 HG11 ' A' ' 324' ' ' VAL . 77.7 t -71.36 -51.02 36.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 60.24 111.196 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' CYS . . . . . 0.542 ' HB2' ' CD2' ' A' ' 364' ' ' PHE . 3.6 t -61.46 -31.08 71.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 73.34 110.847 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.784 HG21 HG21 ' A' ' 332' ' ' ILE . 1.1 mt -57.15 -56.02 17.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 45.22 111.166 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' VAL . . . . . 0.483 ' HB ' ' CG2' ' A' ' 329' ' ' VAL . 2.2 t -72.39 -35.18 51.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 53.43 111.122 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' ALA . . . . . . . . . . . . . . . -59.85 -49.75 76.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 72.34 111.116 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' LEU . . . . . 0.612 HD13 ' CD1' ' A' ' 399' ' ' PHE . 2.7 mm? -77.16 -7.84 56.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.423 . . . . 63.21 110.981 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' ALA . . . . . 0.626 ' N ' HG21 ' A' ' 408' ' ' THR . . . -54.78 112.23 0.99 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.2 111.096 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 43.98 48.71 7.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 73.13 110.909 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' PHE . . . . . 0.612 ' CD1' HD13 ' A' ' 396' ' ' LEU . 0.0 OUTLIER -102.79 141.58 22.79 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.726 0.774 . . . . 73.53 110.86 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 136.37 32.99 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.706 2.271 . . . . 71.55 112.388 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' PHE . . . . . 0.571 ' HB2' ' CE1' ' A' ' 399' ' ' PHE . 36.8 t80 -140.67 110.81 6.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 74.01 110.868 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 50.19 32.72 6.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 63.25 110.911 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' GLY . . . . . . . . . . . . . . . 100.69 -30.09 11.01 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.699 -0.762 . . . . 71.31 112.451 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.07 138.89 40.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.838 0.351 . . . . 70.01 110.901 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -80.69 155.13 26.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 42.51 110.855 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.717 HD13 HG21 ' A' ' 345' ' ' ILE . 16.5 mt -114.61 176.82 4.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.52 110.955 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' ARG . . . . . 0.401 ' N ' ' O ' ' A' ' 346' ' ' GLY . 0.2 OUTLIER -114.09 173.45 6.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 73.51 110.91 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' THR . . . . . 0.626 HG21 ' N ' ' A' ' 397' ' ' ALA . 72.0 p -154.63 151.06 28.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.272 -0.422 . . . . 54.13 111.115 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . 0.477 ' O ' ' C ' ' A' ' 410' ' ' TRP . . . 154.44 131.79 1.56 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.778 -0.725 . . . . 32.33 112.534 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.482 ' NE1' HG22 ' A' ' 332' ' ' ILE . 10.2 m95 -31.07 121.29 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.8 0.333 . . . . 55.52 110.987 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 410' ' ' TRP . . . -33.73 140.68 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.778 -0.725 . . . . 72.43 112.519 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 413' ' ' GLU . 4.3 mttt -164.91 127.98 2.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.78 0.324 . . . . 72.54 110.851 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 412' ' ' LYS . 81.4 mt-10 -34.44 -87.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 72.32 110.928 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 71.13 110.808 -179.92 . . . . . . . . 1 1 . 1 stop_ save_